data_1dxw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dxw _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.297 0.57 . . . . 0.0 110.166 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.52 129.98 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -116.63 127.78 54.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.688 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.33 136.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.91 174.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.534 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.1 t -138.24 136.19 36.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.093 0.949 . . . . 0.0 109.129 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.4 p -113.64 179.9 3.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.912 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.64 32.92 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.5 p -104.78 -36.73 7.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.302 -0.873 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.6 -169.14 0.48 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.853 -1.154 . . . . 0.0 111.957 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 68.1 m -123.71 143.76 50.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.862 -0.524 . . . . 0.0 109.601 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.2 p90 -160.26 -138.12 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.549 -0.719 . . . . 0.0 109.911 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.0 mt -135.4 166.64 22.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.421 -1.425 . . . . 0.0 113.653 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.05 122.81 8.66 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.243 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 32.7 m -101.14 127.21 47.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.44 -0.787 . . . . 0.0 111.729 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.3 m -74.11 123.11 23.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.825 -0.547 . . . . 0.0 109.827 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.95 130.04 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.455 -0.778 . . . . 0.0 110.096 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.67 40.01 29.45 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.476 -0.765 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.19 28.04 73.49 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.439 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 63.5 t -140.04 117.0 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.963 . . . . 0.0 109.29 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.4 t -76.28 122.99 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.294 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 95.5 m95 -113.48 130.02 56.42 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.427 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 11.8 t -133.08 -179.75 5.68 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 7.0 m -90.72 131.0 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.076 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.92 -40.04 87.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 49.8 p-80 -74.82 68.74 1.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.29 1.043 . . . . 0.0 108.829 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.0 -38.43 0.16 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.792 -0.828 . . . . 0.0 109.182 178.706 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.547 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 39.8 mt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -96.24 144.83 26.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.731 -0.606 . . . . 0.0 110.626 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 14.8 pt20 -75.94 151.4 37.3 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.574 -0.704 . . . . 0.0 110.784 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.6 ttt -98.78 -39.84 8.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.547 -0.721 . . . . 0.0 110.398 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -139.97 166.75 23.82 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.417 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 24.0 m -154.68 111.06 3.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.628 -0.67 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.86 78.61 5.38 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -40.0 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.428 -0.795 . . . . 0.0 109.767 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -55.74 -26.22 44.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 0.0 109.003 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -111.66 -0.71 15.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.736 -0.602 . . . . 0.0 110.762 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.7 t70 59.95 57.75 2.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.105 -0.997 . . . . 0.0 109.553 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -146.23 152.37 39.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.92 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.421 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -143.11 127.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.25 123.96 5.76 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.262 -1.446 . . . . 0.0 111.753 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.444 ' CD1' ' HA ' ' A' ' 73' ' ' GLN . 3.2 m-90 -84.72 -174.94 5.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.144 -0.621 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -110.07 73.71 0.85 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.175 0 O-C-N 121.791 -0.568 . . . . 0.0 111.436 -179.543 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 121.39 0.614 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.65 167.09 15.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.661 -0.649 . . . . 0.0 110.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.432 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 3.8 m -89.49 135.23 31.21 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.318 -1.054 0 O-C-N 123.894 1.471 . . . . 0.0 110.067 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -117.46 14.62 14.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 111.375 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.18 75.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 108.786 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.28 176.19 8.9 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.479 0.657 . . . . 0.0 111.125 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.9 m-85 -140.96 131.89 26.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.96 148.13 35.68 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.946 0.879 . . . . 0.0 111.529 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.9 t -119.97 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 26.7 p -81.08 179.9 7.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.287 -0.883 . . . . 0.0 109.525 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -41.87 -29.9 0.23 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -116.66 -50.01 2.63 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.12 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.86 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.934 -1.104 . . . . 0.0 111.597 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 16.9 t70 47.08 73.67 0.18 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.088 -1.008 . . . . 0.0 111.203 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -82.56 99.99 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.189 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.8 mm -120.95 150.01 52.21 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.753 -0.592 . . . . 0.0 109.542 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 48.3 Cg_endo -90.44 133.03 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 124.015 1.534 . . . . 0.0 110.559 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.57 130.03 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -90.34 118.23 29.68 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.42 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.6 ttp180 -62.07 125.8 25.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.805 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -98.43 4.36 48.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.787 -0.571 . . . . 0.0 109.569 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.99 170.67 32.17 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 107.436 -2.266 . . . . 0.0 107.436 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 78.2 m-20 -60.83 -19.69 60.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -1.022 . . . . 0.0 110.122 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -121.56 15.98 11.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 0.0 111.822 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -146.08 143.27 29.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.987 -1.07 . . . . 0.0 111.431 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.51 141.85 11.81 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.4 m -90.3 111.6 22.85 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.951 -0.735 . . . . 0.0 110.326 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -73.56 109.93 7.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.347 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.8 mm? -60.03 -30.0 68.89 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.4 m -114.25 97.75 46.6 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.516 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.91 142.18 74.34 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.909 1.478 . . . . 0.0 109.965 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -149.99 161.06 32.3 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.81 122.84 12.42 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.832 1.438 . . . . 0.0 110.92 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.98 -28.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 t -59.01 -34.9 72.4 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.66 0.743 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.04 -27.32 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.47 5.6 30.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.484 -0.76 . . . . 0.0 110.858 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -68.11 110.16 3.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.04 55.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.6 p -74.9 -17.93 60.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -1.04 . . . . 0.0 109.056 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.09 149.51 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 108.885 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.51 77.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.15 -151.52 4.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 51.7 Cg_endo -147.5 148.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 116.307 -1.996 . . . . 0.0 112.921 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.89 98.43 9.21 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 135.61 34.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.425 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 84.4 m -58.82 175.6 0.32 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 40.5 Cg_endo -72.11 -5.04 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 117.215 -1.39 . . . . 0.0 110.977 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.8 t -106.14 -0.22 24.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.905 -1.122 . . . . 0.0 112.27 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.84 6.55 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.432 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 34.7 m170 -114.04 118.53 34.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.34 121.86 24.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.394 -0.816 . . . . 0.0 110.685 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.03 -4.12 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.799 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.472 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -152.79 131.08 3.22 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.279 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.411 ' CD1' ' CE ' ' A' ' 175' ' ' MET . 74.5 mt -109.91 119.14 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.098 -1.236 . . . . 0.0 108.163 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 16.9 t80 -49.99 129.29 20.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.393 -0.817 . . . . 0.0 112.362 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -117.22 -30.08 5.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.938 -0.476 . . . . 0.0 111.569 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.08 146.56 12.51 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.585 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.97 138.29 37.24 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 42.9 t -95.72 90.97 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.1 p -94.03 122.24 36.33 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.115 0.96 . . . . 0.0 112.111 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 80.4 m -87.1 -102.07 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.116 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -59.98 -50.0 75.47 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.601 -1.312 . . . . 0.0 109.464 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.18 30.53 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.84 145.89 17.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -75.92 125.34 28.91 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 0.0 111.24 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -103.88 7.14 36.84 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.298 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -175.26 137.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' GLY . 16.0 m -105.82 134.68 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.428 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -100.41 146.59 26.82 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 40.3 p90 -152.55 162.96 40.5 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.314 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.82 143.76 58.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.499 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.75 141.54 9.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.747 1.393 . . . . 0.0 111.717 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.05 -27.67 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.08 -28.69 66.72 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.3 t -70.65 -26.28 63.38 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.411 ' CE ' ' CD1' ' A' ' 153' ' ' ILE . 66.3 mtt -69.32 -36.62 77.14 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.778 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.011 -1.056 . . . . 0.0 109.525 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.483 0.659 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.89 123.45 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -94.68 122.84 37.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.719 . . . . 0.0 111.314 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.1 t -82.78 132.83 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.79 175.13 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.756 0.788 . . . . 0.0 110.427 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -140.04 149.82 43.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 43' ' ' PHE . 3.4 t -116.8 79.03 1.27 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.376 1.084 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.45 -52.51 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.449 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -120.7 9.28 10.73 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.585 -1.322 . . . . 0.0 113.966 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -161.73 178.07 9.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.628 -1.295 . . . . 0.0 112.236 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.7 m -129.92 150.2 51.31 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.218 0.532 . . . . 0.0 109.942 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 9.9 p90 -160.32 -148.14 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 0.0 109.414 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 54' ' ' THR . 93.5 mt -136.42 165.34 26.05 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.608 -1.308 . . . . 0.0 113.772 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.4 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -152.42 130.71 12.03 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.41 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 99.7 m -99.9 120.46 39.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.402 -0.811 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -72.15 124.58 25.31 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.14 127.66 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 50.1 39.97 20.54 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.552 -0.718 . . . . 0.0 111.432 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.35 73.6 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 53' ' ' TRP . 58.9 t -137.7 115.04 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -1.111 . . . . 0.0 109.348 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 29.1 t -75.4 119.68 19.83 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.25 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.46 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 84.9 m95 -108.53 127.42 53.92 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.869 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.464 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 6.9 t -133.99 -178.6 5.1 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 21.2 m -93.24 131.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.238 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.0 -41.89 93.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.506 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 45.9 p-80 -70.0 -14.5 62.73 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.699 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.1 -47.94 2.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.8 -0.823 . . . . 0.0 109.066 178.399 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.423 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.748 0 O-C-N 120.739 -1.225 . . . . 0.0 109.424 179.127 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.371 0.605 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.83 153.1 17.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.681 -0.637 . . . . 0.0 110.381 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 5.4 pt20 -80.09 159.97 25.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.658 -0.652 . . . . 0.0 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.2 ttp -101.91 -32.19 10.34 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.632 -0.667 . . . . 0.0 109.592 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -149.99 168.98 22.29 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.483 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 91.0 m -153.84 118.55 4.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.382 -0.824 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -101.05 74.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.96 -38.65 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.52 -0.738 . . . . 0.0 109.725 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -54.34 -26.79 31.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.512 -0.743 . . . . 0.0 109.03 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.61 0.71 14.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.733 -0.605 . . . . 0.0 111.05 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 60.07 56.84 3.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -145.96 146.57 31.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.457 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -146.06 136.62 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -122.05 123.78 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.531 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.464 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.4 m-90 -88.47 -173.72 4.29 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.16 109.97 21.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 108.628 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.566 -0.709 . . . . 0.0 110.753 -179.016 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.1 p . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.452 0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.91 161.73 13.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.828 -0.545 . . . . 0.0 110.475 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 94.4 m -103.7 150.01 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.664 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 O-C-N 123.97 1.51 . . . . 0.0 109.957 179.534 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.221 0.534 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.9 m -98.55 19.78 13.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -69.95 75.56 0.47 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.93 175.34 7.24 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.067 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 47.9 p90 -151.76 139.01 19.31 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 41.6 tp -109.82 162.92 14.01 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.774 0.797 . . . . 0.0 111.633 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.442 ' N ' ' HG ' ' A' ' 106' ' ' LEU . 75.1 t -110.01 123.99 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.803 -0.561 . . . . 0.0 110.197 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.443 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -82.9 -179.65 7.5 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -49.18 -24.21 1.62 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.844 -0.535 . . . . 0.0 110.279 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -94.06 -71.33 0.66 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.611 -0.68 . . . . 0.0 110.383 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.91 -50.88 0.09 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.91 151.84 51.65 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.988 -1.07 . . . . 0.0 112.827 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 108' ' ' THR . 15.9 t -118.91 43.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 59.97 178.65 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.29 138.99 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.757 1.399 . . . . 0.0 110.871 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.3 132.94 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.094 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -90.28 120.04 31.09 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.15 123.37 18.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 110.16 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -100.05 4.55 44.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.621 -0.674 . . . . 0.0 109.778 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.98 172.74 38.86 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.0 m-20 -61.97 -22.5 65.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.488 -1.007 . . . . 0.0 110.218 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.2 p -123.21 17.2 9.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -144.13 139.43 28.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.887 -1.133 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.16 142.9 14.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 t -92.16 110.01 21.39 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.727 -0.866 . . . . 0.0 110.566 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -71.59 105.79 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.06 -31.49 70.04 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.365 0.602 . . . . 0.0 110.089 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.5 m -115.07 94.59 39.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.637 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.61 148.06 86.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.885 1.466 . . . . 0.0 109.697 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.01 168.76 11.63 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -59.32 125.75 18.88 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.887 1.467 . . . . 0.0 110.334 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.96 -24.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.762 -0.587 . . . . 0.0 111.387 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -52.91 -32.84 47.53 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.405 -0.809 . . . . 0.0 109.677 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -71.94 -28.87 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.49 0.09 54.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.736 . . . . 0.0 111.587 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -70.78 108.35 4.41 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.28 -0.888 . . . . 0.0 108.647 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.16 -9.42 56.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.3 t -76.16 -14.99 60.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.427 -1.043 . . . . 0.0 109.246 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.95 147.34 53.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.839 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.405 ' CA ' HG12 ' A' ' 55' ' ' VAL . . . 94.06 -10.84 71.53 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.23 -158.28 4.7 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 49.1 Cg_endo -144.54 144.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 116.818 -1.655 . . . . 0.0 112.467 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.0 mt -98.32 97.57 8.93 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 6.0 mp -89.47 144.71 25.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 54.6 m -63.95 -174.03 0.11 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 41.3 Cg_endo -86.01 9.9 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.573 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -107.91 -23.52 12.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.998 . . . . 0.0 110.767 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.8 36.1 1.19 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 73.0 m80 -120.09 127.73 52.81 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -1.061 . . . . 0.0 110.82 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.24 120.82 23.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.506 -0.746 . . . . 0.0 109.434 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.43 -4.54 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.896 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -160.06 128.58 2.0 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.281 -1.438 . . . . 0.0 111.33 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.5 mt -107.82 117.93 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.211 -1.17 . . . . 0.0 108.286 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.427 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 16.4 t80 -51.96 128.72 25.09 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.539 0.685 . . . . 0.0 112.402 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -117.75 -29.22 5.77 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.833 -0.542 . . . . 0.0 111.498 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.27 145.63 13.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.207 -0.933 . . . . 0.0 111.412 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.59 139.39 35.31 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -88.24 93.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.55 122.26 33.97 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.273 1.035 . . . . 0.0 112.81 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -120.06 130.06 54.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.771 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 56.16 23.46 7.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.477 -0.764 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.19 20.02 43.89 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.38 -0.825 . . . . 0.0 111.787 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.98 142.85 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.06 -1.259 . . . . 0.0 109.352 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.35 129.06 34.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 111.129 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -119.77 11.3 11.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.0 110.302 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -174.33 141.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 19.0 m -113.65 135.17 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.711 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -101.6 145.14 29.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 39.3 p90 -154.4 163.81 39.59 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.033 -1.467 . . . . 0.0 112.892 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.48 130.0 51.0 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.99 147.48 21.17 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 O-C-N 123.688 1.362 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.1 p -70.0 -30.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.733 -0.604 . . . . 0.0 109.528 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.88 -32.91 71.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -75.01 -32.67 61.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.559 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.401 ' HE1' ' CD1' ' A' ' 53' ' ' TRP . 1.0 OUTLIER -65.03 -35.61 81.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.895 -0.503 . . . . 0.0 109.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -45.73 91.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.742 -0.599 . . . . 0.0 109.389 177.721 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 121.316 0.579 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.95 130.05 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.644 -0.66 . . . . 0.0 109.329 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -98.99 122.83 42.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.86 128.48 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.02 176.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.176 -0.953 . . . . 0.0 110.593 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 32.1 t -149.24 144.25 26.41 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.788 0.804 . . . . 0.0 108.895 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -118.83 -178.38 3.54 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.54 -17.52 1.29 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.807 -0.558 . . . . 0.0 112.227 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.8 p -96.57 -40.76 8.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.058 . . . . 0.0 112.287 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 -170.56 0.64 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.885 -1.134 . . . . 0.0 112.641 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 67.8 m -109.99 143.26 40.22 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.9 p90 -161.79 -146.38 0.12 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.152 -0.967 . . . . 0.0 110.749 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -134.26 166.59 22.45 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.707 1.241 . . . . 0.0 113.925 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.423 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -151.94 118.56 5.71 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.712 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 53.9 m -91.59 123.11 34.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 0.0 111.219 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 47.3 t -74.87 110.0 8.81 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.99 130.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.538 -0.726 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.29 40.03 25.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.561 -0.712 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.33 27.39 71.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 60.6 t -139.99 117.64 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -77.23 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.54 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.501 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.4 m95 -107.14 124.39 49.62 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.139 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.479 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 9.8 t -128.61 -175.33 3.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 27.7 m -93.15 130.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.504 -1.278 . . . . 0.0 112.703 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.94 -44.17 94.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.462 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -66.81 -18.13 65.22 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.774 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.54 -36.12 5.98 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.663 -0.904 . . . . 0.0 110.503 179.787 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.458 ' CD2' ' CZ2' ' A' ' 85' ' ' TRP . 4.5 mm? . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.489 179.394 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.7 m -111.94 139.1 47.72 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.466 -0.771 . . . . 0.0 112.391 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.473 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 6.9 pt20 -83.99 165.06 18.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.654 . . . . 0.0 111.837 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.8 mtp -100.03 -45.45 5.67 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.564 -0.71 . . . . 0.0 109.969 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -158.84 -177.96 6.9 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.407 ' HB ' HG13 ' A' ' 83' ' ' VAL . 5.1 t -159.98 142.69 13.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.719 0.771 . . . . 0.0 110.27 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -104.96 83.09 1.94 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.96 -40.05 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -55.15 -26.16 36.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -111.74 0.35 16.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.82 -0.55 . . . . 0.0 110.836 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.0 59.55 2.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 44.5 tp -145.72 152.1 39.05 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.454 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.477 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 1.5 m -140.0 132.07 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -121.63 126.9 6.67 Favored Glycine 0 N--CA 1.508 3.459 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.852 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.479 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.1 m-90 -90.52 -169.59 2.45 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.046 -0.679 . . . . 0.0 111.243 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -113.04 95.46 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.683 -0.636 . . . . 0.0 110.42 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.419 -0.801 . . . . 0.0 109.878 179.209 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.591 0.71 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 150' ' ' ALA . 83.2 mt -109.78 148.63 31.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -105.53 -173.91 0.3 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.189 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.485 0.992 0 O-C-N 123.847 1.446 . . . . 0.0 110.276 179.572 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 m -96.49 17.12 16.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 111.217 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.56 69.22 1.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.07 174.6 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.755 -0.591 . . . . 0.0 110.903 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.1 m-85 -140.52 130.01 24.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.676 -0.64 . . . . 0.0 109.519 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.2 tp -110.56 152.03 26.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.727 0.775 . . . . 0.0 111.286 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 81.1 t -108.97 132.26 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' HIS . 75.8 p -80.83 169.36 17.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -34.39 -32.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 108' ' ' THR . 81.7 m-70 -97.73 -85.34 0.36 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.79 16.01 0.1 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.177 -0.952 . . . . 0.0 112.327 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -68.43 130.03 41.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.835 -1.166 . . . . 0.0 110.036 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.37 117.43 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.698 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tt -116.29 119.82 35.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.572 -0.705 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.0 Cg_endo -70.2 131.32 20.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.616 1.324 . . . . 0.0 111.701 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -130.0 132.29 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.771 -0.581 . . . . 0.0 109.456 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -88.19 112.06 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.44 122.56 10.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 111.13 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -98.51 0.45 45.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.636 -0.665 . . . . 0.0 110.047 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.79 -174.4 46.85 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 91.0 m-20 -70.07 -22.7 63.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -1.043 . . . . 0.0 110.053 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.3 p -124.9 17.38 8.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.569 -0.707 . . . . 0.0 111.465 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.99 145.2 37.52 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.281 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.29 142.14 11.81 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.0 t -88.82 111.56 22.19 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.873 -0.781 . . . . 0.0 109.785 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.38 112.37 6.63 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.08 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.95 -19.98 63.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.825 -0.547 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.7 m -120.0 79.96 25.93 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.672 -0.643 . . . . 0.0 109.945 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -57.78 142.47 96.12 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.849 1.447 . . . . 0.0 110.641 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -155.33 167.15 14.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -58.9 128.02 26.46 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.746 1.393 . . . . 0.0 109.76 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.25 -25.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.683 -0.635 . . . . 0.0 111.085 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 91.0 p -58.44 -30.37 66.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.598 -0.689 . . . . 0.0 109.564 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -70.04 -29.31 66.31 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.42 3.98 25.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -66.89 111.63 3.88 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.5 55.84 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -77.81 -13.64 59.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.529 -0.983 . . . . 0.0 109.924 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -67.59 147.35 52.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.078 -1.014 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.96 -9.99 75.44 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.87 -163.64 1.72 Allowed Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.43 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 50.0 Cg_endo -143.26 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 117.033 -1.512 . . . . 0.0 111.852 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.77 96.96 10.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 mp -83.6 143.83 29.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.201 1.0 . . . . 0.0 113.132 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 12.8 m -69.4 163.75 55.62 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.39 -11.2 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.577 1.304 . . . . 0.0 111.504 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.7 m -95.71 -0.06 51.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.925 -1.11 . . . . 0.0 111.808 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.93 33.5 6.62 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -118.73 128.49 54.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -1.147 . . . . 0.0 109.968 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -91.71 116.66 29.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.78 1.28 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.648 . . . . 0.0 111.904 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.465 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -147.96 128.3 2.84 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.856 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 68.8 mt -109.97 120.83 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.018 -1.284 . . . . 0.0 108.181 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 12.7 t80 -50.02 129.36 20.54 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.866 0.841 . . . . 0.0 112.711 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -117.31 -28.51 6.12 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 149.2 8.34 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.707 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.69 135.86 43.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.838 -0.538 . . . . 0.0 111.209 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.0 t -85.12 86.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 27.5 p -88.09 104.05 16.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.743 1.258 . . . . 0.0 112.191 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -99.72 133.91 43.37 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.162 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 54.8 22.88 4.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.21 17.74 49.23 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.356 -0.84 . . . . 0.0 111.836 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.02 140.74 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.255 . . . . 0.0 109.687 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 118.85 19.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.587 -0.696 . . . . 0.0 111.763 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -111.01 10.55 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.825 -0.547 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -175.04 140.01 0.51 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.82 135.88 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -103.94 147.36 27.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.465 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.1 p90 -154.32 164.25 38.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.263 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.25 138.46 45.36 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -77.65 149.3 26.67 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.741 1.39 . . . . 0.0 110.786 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.4 -29.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.316 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -29.29 68.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.242 -0.911 . . . . 0.0 108.846 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.5 t -70.21 -32.65 70.64 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.653 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -66.52 -39.92 88.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.596 -0.69 . . . . 0.0 109.643 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.18 -43.27 96.0 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.631 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 47.7 p . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.672 -0.642 . . . . 0.0 110.57 179.583 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 . . . . . 0 N--CA 1.5 2.043 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.96 119.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.547 -0.721 . . . . 0.0 109.343 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -102.26 125.3 48.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.639 -0.663 . . . . 0.0 110.79 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.68 128.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.73 174.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.631 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.3 p -146.92 133.63 19.98 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.703 0.763 . . . . 0.0 109.217 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -107.48 -179.93 4.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.2 5.89 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.591 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 p -99.34 -37.23 9.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 112.607 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.47 -170.0 0.77 Allowed 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.62 -1.3 . . . . 0.0 113.13 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 28.6 p -116.25 141.14 48.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 14.9 p90 -163.67 -146.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.236 -0.915 . . . . 0.0 110.638 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 79.4 mt -131.92 160.43 35.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.777 -1.202 . . . . 0.0 113.121 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.28 128.44 9.74 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.817 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.409 HG23 ' CD1' ' A' ' 153' ' ' ILE . 7.6 t -80.01 -151.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -160.12 106.35 1.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.425 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.2 40.01 30.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.797 -0.564 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.45 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 45.5 t -133.93 113.06 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.973 . . . . 0.0 109.745 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 t -76.07 121.87 23.43 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 96.4 m95 -108.47 127.56 54.02 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.474 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.468 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 5.4 t -135.58 -179.14 5.46 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' A' ' 139' ' ' SER . 14.5 m -89.69 126.81 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 C-N-CA 118.18 -1.408 . . . . 0.0 112.213 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -59.95 -42.49 94.17 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.61 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -71.31 73.74 0.7 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.589 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.83 -32.72 0.56 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.575 -0.956 . . . . 0.0 110.927 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 120.874 -1.141 . . . . 0.0 109.013 179.464 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 34.9 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.6 m -91.23 140.97 29.3 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.421 0.629 . . . . 0.0 110.826 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.25 147.02 49.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.783 -0.573 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.84 -29.87 12.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.434 ' CG ' ' N ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -149.96 169.97 19.93 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.434 ' N ' ' CG ' ' A' ' 75' ' ' TYR . 27.3 m -154.28 112.41 3.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 110.69 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ASP . 20.4 t-20 -91.12 77.85 5.95 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.02 -40.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -56.07 -25.6 45.91 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.94 -1.41 15.47 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.734 -0.604 . . . . 0.0 110.833 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.8 t0 60.78 57.36 2.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.965 -1.085 . . . . 0.0 109.152 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.0 tp -145.36 154.52 42.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.657 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.458 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -145.67 128.22 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.9 119.76 4.76 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.037 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.468 ' CZ3' HG23 ' A' ' 54' ' ' THR . 5.4 m-90 -86.45 174.61 8.86 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -95.93 91.75 6.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.009 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.587 -0.696 . . . . 0.0 111.153 -179.071 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.366 0.603 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 159.96 20.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.6 163.34 18.09 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.379 -0.826 . . . . 0.0 111.024 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.491 1.33 0 O-C-N 124.071 1.564 . . . . 0.0 109.848 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.757 0.789 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.17 15.48 6.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.778 -0.576 . . . . 0.0 111.399 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -84.56 79.6 9.53 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.2 mt -88.04 174.6 8.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.037 0.923 . . . . 0.0 112.368 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 97.4 m-85 -145.32 129.97 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.7 144.43 34.81 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.629 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 76.0 t -90.57 120.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.7 p -91.54 178.05 6.05 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.798 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -47.13 -25.98 1.0 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.896 -0.502 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -97.28 -70.13 0.73 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.638 -0.664 . . . . 0.0 109.311 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.06 -164.99 1.99 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.95 0.881 . . . . 0.0 110.06 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 8.9 t0 -52.92 -93.96 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.598 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.9 t 57.02 156.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.139 -0.976 . . . . 0.0 110.977 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.3 mt 53.7 105.33 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.274 -0.892 . . . . 0.0 111.849 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 50.2 Cg_endo -90.42 150.1 4.4 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.803 1.422 . . . . 0.0 109.319 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.26 139.87 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.322 -0.862 . . . . 0.0 110.832 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -98.49 117.06 32.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.444 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 22.5 ttp85 -62.82 129.16 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.328 -0.857 . . . . 0.0 110.996 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -102.92 4.81 37.96 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.445 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.33 178.76 40.82 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.56 -26.57 68.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.451 -1.029 . . . . 0.0 109.87 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.6 p -120.07 16.86 12.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.662 -0.649 . . . . 0.0 111.868 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -140.04 139.05 35.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.011 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.59 138.7 9.15 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -89.28 110.72 21.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.909 -0.759 . . . . 0.0 110.181 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -70.86 110.67 5.75 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.819 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.97 -21.72 63.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.831 -0.543 . . . . 0.0 110.515 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.7 m -120.43 82.95 32.87 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.617 . . . . 0.0 110.197 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -59.42 139.81 91.31 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 O-C-N 123.803 1.423 . . . . 0.0 110.152 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -152.27 164.26 20.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -54.06 125.97 20.51 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 O-C-N 123.786 1.414 . . . . 0.0 110.93 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 p -50.08 -25.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.86 -0.525 . . . . 0.0 110.91 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.0 m -58.81 -35.36 72.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.605 -0.684 . . . . 0.0 109.496 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -68.4 -28.13 66.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.2 0.95 38.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.351 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -70.63 119.49 14.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.256 -0.903 . . . . 0.0 108.597 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.53 -10.09 66.83 Favored Glycine 0 C--N 1.286 -2.207 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.4 t -78.65 -13.5 59.79 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.56 -0.965 . . . . 0.0 109.815 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 55' ' ' VAL . 14.5 m -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.007 -1.058 . . . . 0.0 110.695 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.94 -9.71 76.35 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.66 -179.23 3.25 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -128.04 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 117.206 -1.396 . . . . 0.0 111.761 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mt -94.52 97.19 9.97 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -89.62 141.31 28.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -167.33 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.97 16.46 1.45 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.749 1.394 . . . . 0.0 110.905 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -122.03 -51.08 2.02 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -0.95 . . . . 0.0 110.916 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.62 42.42 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -127.13 126.62 43.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -1.068 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.0 103.0 15.29 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.92 8.18 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.386 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -159.19 134.08 3.62 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.873 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.415 ' CD1' ' CB ' ' A' ' 53' ' ' TRP . 1.6 mt -118.27 120.81 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.288 -1.124 . . . . 0.0 108.309 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 19.3 t80 -54.33 128.03 29.74 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.398 0.618 . . . . 0.0 112.5 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -119.28 -24.17 6.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 111.311 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.52 148.39 12.67 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.59 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -104.88 143.81 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.291 0.567 . . . . 0.0 111.38 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 47.2 t -94.74 88.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.0 p -89.88 111.08 22.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.505 1.145 . . . . 0.0 112.454 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 162' ' ' GLY . 93.6 m -92.59 125.95 37.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 160' ' ' THR . 73.9 ttt180 62.14 -70.6 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 122.014 -0.429 . . . . 0.0 110.056 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.05 24.98 0.25 Allowed Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.178 -1.011 . . . . 0.0 110.588 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -149.65 144.85 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.086 -1.244 . . . . 0.0 109.472 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.07 123.55 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.434 0.635 . . . . 0.0 111.123 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -112.47 11.41 19.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.784 -0.573 . . . . 0.0 110.581 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.77 144.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.87 137.3 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.889 0.852 . . . . 0.0 112.674 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -104.02 146.01 29.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 33.9 p90 -154.61 160.62 41.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.17 -1.412 . . . . 0.0 112.205 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.2 129.98 64.63 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.6 155.87 49.65 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.749 1.394 . . . . 0.0 110.784 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.41 -24.39 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.616 -0.677 . . . . 0.0 109.49 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.87 -30.23 67.58 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -71.9 -39.97 69.19 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.496 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.408 ' HG2' ' CG ' ' A' ' 53' ' ' TRP . 1.9 mpp? -64.72 -39.69 94.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -32.21 70.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.812 -0.555 . . . . 0.0 110.334 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 121.442 -0.787 . . . . 0.0 109.94 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -110.06 120.44 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -93.02 130.16 38.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.77 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.961 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.4 p -157.89 143.93 17.38 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 58' ' ' GLY . 4.5 t -109.37 -177.7 3.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.71 -14.44 0.91 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.577 -0.702 . . . . 0.0 112.869 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.5 t -112.0 -21.27 11.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -169.65 -171.88 1.31 Allowed 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.368 -1.457 . . . . 0.0 113.174 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -125.59 146.65 49.6 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 6.7 p90 -162.79 -142.58 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.414 ' O ' ' OG1' ' A' ' 54' ' ' THR . 91.3 mt -135.63 162.03 33.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.525 -1.359 . . . . 0.0 113.229 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -151.46 130.0 12.22 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.286 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -99.92 125.35 45.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.702 . . . . 0.0 111.218 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.4 t -73.0 119.46 17.28 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.18 135.44 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.469 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 52.69 39.7 28.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.69 -0.632 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.67 23.37 73.89 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 60.5 t -140.62 120.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -1.078 . . . . 0.0 110.335 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.9 m -73.99 120.61 19.81 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.433 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 96.7 m95 -107.17 125.97 51.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.481 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -132.93 -176.41 4.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 32.3 m -87.03 127.17 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 C-N-CA 118.346 -1.342 . . . . 0.0 112.83 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.61 -40.03 93.38 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.6 p-80 -72.54 68.85 0.83 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.286 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' CG2' ' A' ' 38' ' ' THR . . . 163.14 -59.45 0.28 Allowed Glycine 0 N--CA 1.484 1.856 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 43' ' ' PHE . . . . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.694 -0.886 . . . . 0.0 111.2 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 85' ' ' TRP 0.266 2.0 tm? . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.326 0.584 . . . . 0.0 110.462 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.156 0 O-C-N 121.344 -0.847 . . . . 0.0 109.987 -179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 85' ' ' TRP . 63.4 mt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.527 0.679 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.9 m -96.24 140.01 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.417 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 4.1 pt20 -66.01 149.84 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.708 . . . . 0.0 110.627 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.3 mmm -103.55 -27.27 12.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.731 -0.606 . . . . 0.0 109.889 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -154.95 171.15 20.17 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.516 -0.74 . . . . 0.0 109.314 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.437 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 39.9 m -154.12 115.86 4.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.632 -0.667 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.76 76.36 3.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.99 -33.06 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.686 -0.634 . . . . 0.0 109.298 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.6 -26.6 13.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.07 8.36 6.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.13 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 62.42 61.77 1.22 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.765 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.5 tp -144.19 152.56 41.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -146.32 133.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.65 121.67 5.17 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.232 -1.461 . . . . 0.0 111.767 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.481 ' CZ3' HG23 ' A' ' 54' ' ' THR . 6.2 m-90 -89.19 -169.68 2.6 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.795 -0.826 . . . . 0.0 109.359 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -94.05 107.68 19.58 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.026 0 O-C-N 121.563 -0.711 . . . . 0.0 112.522 -177.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 4.5 mm? -85.26 173.46 10.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.844 -0.535 . . . . 0.0 110.349 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -95.19 -168.4 0.17 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.596 -0.69 . . . . 0.0 110.915 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 95' ' ' THR . 49.6 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 O-C-N 123.986 1.519 . . . . 0.0 109.318 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.313 0.578 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 58.08 21.44 7.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.778 -0.576 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.0 71.07 10.12 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 73.0 mt -79.75 174.38 11.64 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 111.779 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 94.0 m-85 -140.47 126.44 19.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.3 128.59 55.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.342 -0.849 . . . . 0.0 111.427 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -75.59 134.74 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' HIS . 45.6 p -84.42 175.94 9.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.536 -0.728 . . . . 0.0 110.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -32.92 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' THR . 4.1 p80 -112.88 -65.24 1.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.31 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.6 -33.99 0.07 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.956 -1.09 . . . . 0.0 113.198 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -44.01 116.54 1.01 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.331 -0.856 . . . . 0.0 112.038 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.29 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.264 0.554 . . . . 0.0 110.665 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.3 mm -113.9 110.85 48.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.668 . . . . 0.0 109.454 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 46.0 Cg_endo -64.28 120.01 7.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 O-C-N 123.875 1.46 . . . . 0.0 110.688 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.51 133.93 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 109.219 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -87.44 118.84 27.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.216 -0.928 . . . . 0.0 108.763 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -62.31 122.17 15.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -97.46 0.16 47.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.0 176.62 44.36 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 77.7 m-20 -62.3 -24.06 67.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -1.028 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 p -123.65 17.34 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 111.962 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -141.67 141.8 33.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 111.136 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.78 142.66 13.23 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.0 t -88.64 110.69 21.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.803 -0.822 . . . . 0.0 109.563 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.46 109.99 4.51 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.569 -0.853 . . . . 0.0 108.804 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.51 -25.88 64.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.854 -0.528 . . . . 0.0 110.282 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.1 t -107.04 102.42 42.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.19 130.69 11.29 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 124.077 1.567 . . . . 0.0 109.573 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -152.46 163.13 24.55 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -55.39 128.39 30.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.744 1.391 . . . . 0.0 110.508 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -51.25 -24.91 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.854 -0.529 . . . . 0.0 111.135 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.9 p -57.51 -31.33 65.92 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -70.02 -28.81 65.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.48 2.4 37.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.482 -0.761 . . . . 0.0 111.024 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -66.86 107.81 2.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.37 -8.79 58.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -72.97 -16.61 61.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -1.069 . . . . 0.0 108.427 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.46 151.29 45.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.412 ' N ' ' CG1' ' A' ' 55' ' ' VAL . . . 89.45 -10.05 74.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.53 -159.68 4.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -138.73 138.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 O-C-N 123.821 1.432 . . . . 0.0 111.977 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 3.0 mt -95.43 95.38 8.4 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.21 133.6 33.64 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.411 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 32.1 p -82.51 -172.46 0.36 Allowed Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.411 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 47.9 Cg_endo -84.24 20.53 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.106 1.056 . . . . 0.0 112.453 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.1 m -100.88 -18.03 16.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.015 -1.053 . . . . 0.0 111.102 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.98 39.94 3.21 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.412 ' CE1' HG21 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -149.93 165.57 32.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 110.871 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.51 120.2 32.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.669 -0.645 . . . . 0.0 109.425 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.6 t -99.97 -20.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.662 -0.649 . . . . 0.0 110.888 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . -159.4 140.94 7.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mt -107.17 118.93 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.146 -1.208 . . . . 0.0 107.792 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 20.8 t80 -52.69 127.34 22.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.579 0.704 . . . . 0.0 111.957 -178.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -116.02 -28.69 6.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.849 -0.532 . . . . 0.0 111.962 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.37 140.9 11.73 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.201 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -98.64 134.37 41.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.726 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.9 t -89.96 92.44 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.1 p -89.99 109.91 20.92 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.52 1.152 . . . . 0.0 112.364 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 m -97.14 121.76 39.4 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.779 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 59.97 19.93 8.99 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.381 -0.824 . . . . 0.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.02 13.61 31.06 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.395 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.91 140.03 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 118.684 1.242 . . . . 0.0 109.445 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 129.94 37.48 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.833 0.825 . . . . 0.0 111.603 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.63 14.43 7.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.731 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.21 150.84 2.49 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 9.6 m -133.64 135.84 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 119.376 -0.929 . . . . 0.0 112.695 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -102.14 149.08 24.64 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 36.1 p90 -154.74 164.68 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.076 -1.45 . . . . 0.0 112.583 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.61 137.25 38.82 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.59 145.64 14.74 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.582 1.306 . . . . 0.0 111.99 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.405 ' HA ' ' HE2' ' A' ' 175' ' ' MET . 10.7 p -69.97 -27.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 109.607 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.84 -29.97 65.38 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 m -73.1 -22.9 60.47 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.151 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 172' ' ' VAL . 66.3 mtt -68.72 -40.11 80.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.206 -0.934 . . . . 0.0 108.931 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.07 -39.21 85.25 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.89 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 0.0 110.688 -178.829 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.129 0.49 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -111.03 119.96 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.54 132.67 40.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.71 -0.619 . . . . 0.0 110.444 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -80.8 138.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 16.5 m -139.99 171.72 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.621 0.724 . . . . 0.0 110.138 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -153.29 153.42 32.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.403 HG21 ' HG2' ' A' ' 41' ' ' GLN . 2.9 t -117.82 75.86 1.03 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.546 1.165 . . . . 0.0 109.358 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.13 -48.69 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -120.7 11.08 11.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.446 -1.408 . . . . 0.0 114.007 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HG2' HG21 ' A' ' 38' ' ' THR . 14.7 pt20 -160.01 169.96 22.33 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.593 -1.317 . . . . 0.0 111.746 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.5 m -128.8 152.25 48.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.49 0.662 . . . . 0.0 110.131 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 p90 -160.5 -145.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 78.2 mt -135.27 165.54 25.21 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.36 -1.462 . . . . 0.0 113.843 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -151.99 126.84 9.63 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.25 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.408 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 53.4 m -104.94 127.46 52.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.352 -0.843 . . . . 0.0 111.44 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 44.7 t -74.55 121.36 21.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.792 -0.567 . . . . 0.0 109.517 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.47 130.18 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.912 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.77 39.98 30.95 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.479 -0.763 . . . . 0.0 110.728 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 25.5 75.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.14 122.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -1.011 . . . . 0.0 109.271 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 6.4 t -74.17 139.22 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.409 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.431 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 78.2 m95 -136.1 130.02 32.73 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.924 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.482 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 8.8 t -139.13 -174.74 3.94 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 13.4 m -87.99 131.83 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.31 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.03 -41.97 93.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.467 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.4 p-80 -69.96 -13.96 62.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.735 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.04 -41.32 3.54 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.606 -0.938 . . . . 0.0 110.358 179.212 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.489 ' CD2' ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.791 -1.193 . . . . 0.0 109.8 179.909 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 122.175 0.988 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 m -130.76 123.59 29.53 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.97 -60.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.433 ' C ' ' CG ' ' A' ' 75' ' ' TYR . 10.8 mmt -92.91 -65.84 0.97 Allowed 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.538 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CG ' ' C ' ' A' ' 74' ' ' MET . 0.1 OUTLIER 174.88 -171.82 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.941 -1.099 . . . . 0.0 112.012 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.421 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 99.8 m -138.43 117.3 12.38 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -94.37 81.96 4.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.06 -40.07 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 109.425 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.02 -26.75 27.99 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 109.075 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -111.82 -2.2 15.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.734 -0.604 . . . . 0.0 110.706 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.94 55.09 3.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' CD2' ' CZ3' ' A' ' 53' ' ' TRP . 42.5 tp -146.95 156.43 43.05 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.903 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -144.33 138.71 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' C ' ' CE3' ' A' ' 85' ' ' TRP . . . -136.66 162.28 25.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 118.632 -1.746 . . . . 0.0 113.079 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.489 ' CE2' ' CD2' ' A' ' 64' ' ' LEU . 2.6 m-90 -148.25 170.12 18.59 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 114.297 -0.951 . . . . 0.0 108.927 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.48 115.38 23.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.984 0 O-C-N 121.612 -0.68 . . . . 0.0 110.746 -179.2 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 p . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.187 0.518 . . . . 0.0 110.385 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 3.2 mm? -120.86 163.83 17.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.57 -0.706 . . . . 0.0 109.673 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.447 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 26.3 m -102.01 145.1 29.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.079 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 O-C-N 123.751 1.395 . . . . 0.0 110.694 -179.81 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.045 0.45 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -103.61 19.02 20.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.713 . . . . 0.0 110.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -72.97 67.57 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -0.788 . . . . 0.0 108.943 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.71 174.73 11.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.873 -0.517 . . . . 0.0 109.914 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 43.5 p90 -154.06 138.84 17.07 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.9 tp -113.29 153.85 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.98 0.895 . . . . 0.0 111.603 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.29 136.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.412 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 31.6 p -81.76 -178.94 7.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -36.33 -32.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.78 -51.14 2.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.339 -0.85 . . . . 0.0 111.291 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.28 -95.4 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.967 -1.083 . . . . 0.0 111.719 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 17.2 t0 44.07 70.23 0.34 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.095 -1.003 . . . . 0.0 111.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 105' ' ' TYR . 13.7 p -71.78 64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.435 -0.791 . . . . 0.0 109.926 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 12.3 pt -70.04 150.03 96.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.522 -0.736 . . . . 0.0 110.073 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -102.05 130.16 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.715 1.376 . . . . 0.0 110.032 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.45 131.94 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -88.11 117.32 26.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -61.8 123.87 19.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.552 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -97.29 1.07 49.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.781 -0.574 . . . . 0.0 109.81 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.86 179.72 43.01 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.6 m-20 -64.84 -23.42 67.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.326 -1.102 . . . . 0.0 110.362 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.0 p -123.2 16.83 9.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.513 -0.742 . . . . 0.0 111.752 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -140.0 142.8 36.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.06 140.7 10.25 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 m -89.94 110.02 21.01 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.8 -0.824 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 114' ' ' ILE . 31.9 tp -72.98 108.55 5.95 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.18 -28.03 68.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.322 0.582 . . . . 0.0 109.801 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -109.99 103.75 54.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.85 -0.531 . . . . 0.0 110.171 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.37 140.54 36.99 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.877 1.461 . . . . 0.0 109.955 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -147.09 159.26 43.18 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.18 124.41 14.77 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.898 1.473 . . . . 0.0 110.361 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.13 -26.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.328 0.585 . . . . 0.0 110.685 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -38.3 82.28 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -69.32 -27.53 65.45 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.69 2.76 36.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.783 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -68.65 109.6 3.87 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.77 -8.87 58.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.8 t -76.1 -15.69 60.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -1.005 . . . . 0.0 109.079 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.22 154.64 41.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.235 -0.916 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.99 -8.48 79.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.92 -159.04 6.89 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.96 148.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 116.588 -1.808 . . . . 0.0 112.582 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.49 98.27 9.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 4.6 mm? -82.14 137.07 35.06 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.133 0.968 . . . . 0.0 113.182 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -66.62 -161.48 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.017 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -92.16 17.27 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.714 1.376 . . . . 0.0 110.978 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -138.74 25.82 2.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.122 -0.986 . . . . 0.0 111.962 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.11 37.96 59.66 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 41.6 m170 -118.91 118.91 32.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.559 -0.965 . . . . 0.0 110.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.49 125.12 29.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 0.0 109.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.03 -6.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.92 130.31 2.8 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.263 -1.446 . . . . 0.0 111.509 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.25 116.06 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.401 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 18.7 t80 -51.87 128.66 24.65 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.6 -0.688 . . . . 0.0 112.272 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -119.44 -24.48 6.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.702 -0.624 . . . . 0.0 112.308 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.2 139.12 11.86 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.269 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -100.36 136.72 39.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 158' ' ' VAL . 7.3 p -102.99 98.88 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.0 p -93.47 123.53 36.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.209 1.004 . . . . 0.0 111.278 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.9 m -86.38 -70.02 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -104.19 26.18 9.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.475 -0.765 . . . . 0.0 110.206 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 107.69 10.27 27.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.26 138.93 33.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -80.1 114.11 18.77 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.667 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -96.95 11.54 35.62 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.606 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.405 ' CB ' ' CG1' ' A' ' 158' ' ' VAL . . . -167.77 154.49 8.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.401 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 17.4 m -128.58 140.02 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.947 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -107.46 146.45 31.74 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 38.7 p90 -152.98 165.09 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.999 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.37 137.64 42.15 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.831 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.94 146.22 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.78 1.411 . . . . 0.0 110.747 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.03 -29.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.67 . . . . 0.0 109.61 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.32 -29.54 65.99 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.7 m -73.42 -24.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.8 -0.562 . . . . 0.0 110.234 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.67 -46.2 80.01 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.06 -41.07 91.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.301 0.572 . . . . 0.0 109.959 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.624 -0.673 . . . . 0.0 110.965 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.03 120.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.01 124.36 45.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.805 -0.559 . . . . 0.0 110.623 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.29 133.84 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.42 174.53 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.891 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.3 m -147.99 126.48 12.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -106.34 -179.14 3.85 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.49 -16.89 4.28 Favored 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.823 -0.548 . . . . 0.0 112.377 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.4 p -102.49 -34.85 8.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.036 -1.04 . . . . 0.0 113.245 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -172.83 -169.17 0.55 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.776 -1.203 . . . . 0.0 112.756 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.2 p -116.71 145.3 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.1 p90 -162.02 -143.86 0.09 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.21 -0.931 . . . . 0.0 110.802 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.1 mt -129.06 161.77 29.23 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.618 -1.301 . . . . 0.0 114.0 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.464 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.3 123.61 7.08 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.759 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 53' ' ' TRP . 9.7 t -80.47 -156.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.4 m -153.16 112.42 3.81 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.0 137.03 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.104 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 m120 50.58 39.45 21.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.577 -0.702 . . . . 0.0 111.163 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 26.59 74.41 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.44 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 55.6 t -137.6 118.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -1.009 . . . . 0.0 110.218 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.7 t -75.53 120.08 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 75' ' ' TYR . 89.1 m95 -106.74 128.74 54.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.03 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 45' ' ' ALA . 15.0 t -134.5 -177.76 4.75 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 6.4 m -89.52 125.47 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.792 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.0 -41.88 93.07 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.584 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.463 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 26.1 p-80 -66.04 -34.42 78.04 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.437 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.23 -34.23 64.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.681 -0.894 . . . . 0.0 110.14 179.688 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' ' CE2' ' A' ' 85' ' ' TRP 0.254 11.8 tp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.415 ' H ' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.077 -1.015 . . . . 0.0 109.607 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.6 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.9 m -93.62 127.8 39.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.644 -0.66 . . . . 0.0 110.102 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -64.88 163.9 13.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.619 -0.676 . . . . 0.0 110.146 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -93.51 -40.08 10.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -155.72 -176.65 6.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.414 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 57.6 m -152.01 123.5 7.82 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.787 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -93.77 77.84 4.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.0 -40.1 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.681 -0.637 . . . . 0.0 109.686 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -55.25 -25.8 35.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -112.41 -0.61 15.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.74 -0.6 . . . . 0.0 110.906 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 60.04 56.77 3.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.046 -1.034 . . . . 0.0 109.321 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -144.37 154.53 43.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -142.05 133.26 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.93 123.21 5.54 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.319 -1.419 . . . . 0.0 112.058 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.466 ' CZ3' ' HB ' ' A' ' 83' ' ' VAL . 3.6 m-90 -88.25 -171.7 3.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.063 -0.669 . . . . 0.0 109.395 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -100.01 111.94 24.24 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.948 0 O-C-N 121.446 -0.784 . . . . 0.0 111.85 -178.052 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.575 0.702 . . . . 0.0 110.036 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 4.4 mm? -115.95 170.93 8.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 164.05 37.12 Favored Pre-proline 0 N--CA 1.495 1.822 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.19 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.316 -1.176 0 O-C-N 123.923 1.486 . . . . 0.0 109.436 179.416 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -102.67 9.86 38.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.554 -0.716 . . . . 0.0 111.438 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -71.97 75.73 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 108.584 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.96 174.67 11.3 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.389 0.614 . . . . 0.0 111.138 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 77.5 m-85 -144.37 127.3 16.41 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.1 tp -115.07 153.56 30.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.923 0.868 . . . . 0.0 111.841 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.7 t -119.17 135.17 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 68.8 p -85.22 175.28 9.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.132 -0.98 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -37.16 -34.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 121.172 0.51 . . . . 0.0 112.056 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -100.15 -70.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.41 -80.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.864 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 11.4 t70 46.6 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.593 -0.692 . . . . 0.0 111.595 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.69 107.67 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.249 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.95 159.99 68.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.7 -0.625 . . . . 0.0 109.731 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.9 Cg_endo -106.88 134.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.966 1.508 . . . . 0.0 111.224 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.6 t -124.23 130.07 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -89.13 115.34 26.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.421 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 28.4 ttp85 -59.91 126.18 26.57 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.237 -0.915 . . . . 0.0 110.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -103.3 8.09 38.29 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.676 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.65 43.84 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 12.0 p-10 -59.96 -36.39 77.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -1.067 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -121.09 19.18 11.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.882 -0.511 . . . . 0.0 112.091 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -131.24 141.05 49.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.974 -1.079 . . . . 0.0 110.558 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.76 143.54 13.54 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -92.06 110.12 21.48 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 122.097 -0.649 . . . . 0.0 110.02 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.3 tp -72.67 109.89 6.63 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.993 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.7 -31.03 69.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.457 0.646 . . . . 0.0 109.596 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -105.88 107.92 60.54 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.88 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.56 143.28 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.84 1.442 . . . . 0.0 110.357 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -148.36 160.01 37.77 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -60.36 126.24 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.842 1.443 . . . . 0.0 110.4 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.08 -26.12 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.75 -0.594 . . . . 0.0 110.675 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 68.6 m -59.31 -34.66 72.59 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.881 0.848 . . . . 0.0 109.212 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -73.82 -26.78 60.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.514 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.27 -4.82 58.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 112.939 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.88 66.59 1.55 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.647 1.213 . . . . 0.0 109.025 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.51 -26.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 t -72.57 -9.1 58.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.395 -1.062 . . . . 0.0 111.841 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.458 ' HB3' HG12 ' A' ' 55' ' ' VAL . 7.1 m -58.6 142.31 49.72 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.869 -1.145 . . . . 0.0 109.559 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.47 -9.86 76.26 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.02 157.06 53.56 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -103.01 138.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.92 1.484 . . . . 0.0 112.799 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.9 mp -100.16 98.81 9.47 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.6 mp -87.64 147.81 25.1 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.028 0.918 . . . . 0.0 113.064 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -158.86 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -99.69 16.61 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.69 1.363 . . . . 0.0 110.732 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.4 p -127.42 0.14 6.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.156 -0.965 . . . . 0.0 112.271 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.94 39.97 3.21 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -125.75 121.84 34.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -1.122 . . . . 0.0 110.791 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.94 101.51 12.41 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.07 7.13 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 0.0 112.237 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -156.58 134.74 4.17 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.406 ' CD1' ' CB ' ' A' ' 53' ' ' TRP . 1.1 mt -118.66 122.63 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.385 -1.068 . . . . 0.0 108.398 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.421 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 10.3 t80 -50.86 128.56 21.35 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.894 0.854 . . . . 0.0 112.326 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -116.78 -29.77 5.95 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.872 -0.518 . . . . 0.0 110.751 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.421 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.93 153.21 10.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.15 141.49 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.812 -0.555 . . . . 0.0 111.024 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 30.5 t -94.5 93.42 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.6 p -91.8 115.78 28.34 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.383 1.087 . . . . 0.0 112.704 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 162' ' ' GLY . 22.1 m -92.02 120.28 32.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 160' ' ' THR . 14.8 ttm180 65.3 -67.67 0.12 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.986 -0.446 . . . . 0.0 109.892 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.7 24.49 0.23 Allowed Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.686 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 34.6 m -150.01 143.18 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -1.205 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -79.0 130.0 35.06 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.663 0.744 . . . . 0.0 111.547 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -125.58 16.42 8.18 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.39 150.02 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.421 HG13 ' CE1' ' A' ' 154' ' ' PHE . 13.3 m -130.29 137.67 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.27 -0.972 . . . . 0.0 113.013 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -104.32 145.51 30.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 29.5 p90 -152.98 161.9 41.98 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.243 -1.383 . . . . 0.0 112.541 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.41 139.87 55.8 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.979 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.37 156.74 12.62 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.683 1.36 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.03 -25.71 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.64 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -26.74 66.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 108.964 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.8 p -75.47 -33.07 60.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 110.348 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.418 ' HG2' ' CG ' ' A' ' 53' ' ' TRP . 1.1 mpp? -66.92 -48.46 68.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.724 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 177' ' ' THR . 12.5 pt-20 -62.4 -40.4 96.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.555 -0.715 . . . . 0.0 110.441 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 33.8 p . . . . . 0 N--CA 1.498 1.937 0 O-C-N 121.602 -0.686 . . . . 0.0 109.962 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 120.718 0.294 . . . . 0.0 111.381 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.5 t -114.56 119.99 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 0.0 109.454 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -102.94 121.98 43.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 0.0 111.353 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.96 130.82 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.31 175.1 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.879 0.847 . . . . 0.0 110.818 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -138.41 129.43 26.95 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.724 0.773 . . . . 0.0 109.309 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 62.1 p -110.9 -179.08 3.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -17.22 9.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.61 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.5 p -101.33 -41.12 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 112.278 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -175.61 -162.51 0.1 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 121.033 -1.042 . . . . 0.0 111.457 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.8 m -121.76 146.93 46.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.707 -0.621 . . . . 0.0 109.371 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.42 ' CZ ' HG22 ' A' ' 38' ' ' THR . 7.4 p90 -160.71 -141.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.624 -0.673 . . . . 0.0 109.764 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt -130.79 161.0 32.72 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.489 -1.382 . . . . 0.0 114.271 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.58 120.2 4.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.693 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 HG22 ' CB ' ' A' ' 142' ' ' PRO . 0.3 OUTLIER -85.75 -159.99 0.5 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.146 -0.971 . . . . 0.0 110.162 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 39.1 t -149.98 113.14 4.89 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.04 129.95 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.058 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 51.78 40.0 26.76 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.653 -0.654 . . . . 0.0 110.715 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 26.53 74.23 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.432 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 41.5 t -133.86 111.9 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -1.077 . . . . 0.0 109.616 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 29.3 t -75.47 129.53 37.42 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.485 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 84.7 m95 -118.58 129.27 55.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.55 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 45' ' ' ALA . 12.5 t -135.72 179.7 6.18 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.3 m -88.66 133.33 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.696 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.819 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -59.97 -42.5 94.29 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.453 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 46.9 p-80 -74.0 69.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.22 -35.85 0.08 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.496 -1.003 . . . . 0.0 108.79 178.873 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.844 -1.16 . . . . 0.0 110.239 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 40.3 mt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 6.2 m -94.83 144.79 25.36 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.71 0.766 . . . . 0.0 111.596 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 85' ' ' TRP . 14.3 pt20 -78.45 160.34 27.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.872 -0.518 . . . . 0.0 111.2 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.9 mmm -93.34 -39.61 10.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.662 -0.649 . . . . 0.0 109.609 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 -176.37 5.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.73 . . . . 0.0 109.516 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.4 m -149.94 118.71 6.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.726 -0.609 . . . . 0.0 109.384 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.1 t30 -91.67 77.26 5.64 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.02 -38.14 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.734 -0.604 . . . . 0.0 109.42 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -54.73 -25.98 31.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -115.91 1.28 13.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.696 -0.627 . . . . 0.0 111.139 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t70 60.03 59.99 2.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.969 -1.082 . . . . 0.0 108.971 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.436 HD22 ' CE3' ' A' ' 53' ' ' TRP . 27.4 tp -147.04 152.5 38.66 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.597 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.42 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -140.18 130.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.35 127.07 5.94 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.12 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 73' ' ' GLN . 3.9 m-90 -90.4 178.47 6.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.19 84.05 2.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.299 -0.875 . . . . 0.0 108.709 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.581 -178.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.375 0.607 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.74 164.07 20.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.44 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 95.2 m -115.98 153.73 48.31 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 O-C-N 123.404 1.213 . . . . 0.0 111.023 -179.653 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -97.01 17.04 17.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.602 -0.686 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -71.49 73.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.72 175.12 10.23 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.33 0.586 . . . . 0.0 110.342 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -141.7 120.61 12.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -100.09 140.2 34.66 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.503 0.668 . . . . 0.0 110.233 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.8 t -91.75 120.05 40.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.344 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -84.63 173.31 10.86 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -38.84 -31.73 0.07 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.983 -0.448 . . . . 0.0 112.195 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -100.26 -69.25 0.78 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.828 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 -162.35 1.53 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.34 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.181 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t 50.87 22.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.312 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -171.27 117.05 0.44 Allowed Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.011 -1.056 . . . . 0.0 110.299 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -98.91 145.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.748 1.393 . . . . 0.0 109.357 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.97 139.55 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 111.073 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -97.06 120.26 37.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -60.02 125.2 22.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 111.063 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -101.68 5.37 41.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.707 -0.621 . . . . 0.0 109.419 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.07 34.77 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 26.9 t0 -58.48 -22.93 56.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.473 -1.016 . . . . 0.0 110.634 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -124.61 17.15 8.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.529 -0.732 . . . . 0.0 111.361 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -139.99 144.55 37.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.045 -1.034 . . . . 0.0 110.953 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.79 141.07 10.64 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.0 t -88.67 112.03 22.63 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.926 -0.75 . . . . 0.0 109.954 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.89 107.36 5.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.18 -19.92 65.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.809 -0.557 . . . . 0.0 110.535 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.0 m -122.45 79.99 46.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.672 -0.643 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -58.51 150.4 68.95 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 O-C-N 123.771 1.406 . . . . 0.0 110.374 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -151.14 163.07 24.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.55 122.56 11.97 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 O-C-N 123.774 1.407 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.72 -25.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.808 -0.558 . . . . 0.0 111.524 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.3 m -59.58 -39.97 85.86 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.608 0.718 . . . . 0.0 109.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.94 -27.08 64.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.3 1.65 47.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.0 111.644 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.23 66.01 1.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.989 -1.07 . . . . 0.0 109.029 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.1 -24.4 0.08 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.1 p -70.59 -13.77 62.22 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.53 -0.982 . . . . 0.0 111.65 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.429 ' HB3' HG12 ' A' ' 55' ' ' VAL . 6.9 m -60.97 141.93 56.91 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.973 -1.079 . . . . 0.0 109.833 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.02 -9.98 75.51 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.35 -161.44 0.49 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.429 ' CB ' HG22 ' A' ' 46' ' ' THR . 56.1 Cg_endo -146.36 137.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 116.282 -2.012 . . . . 0.0 112.277 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.09 96.52 9.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.7 mp -87.68 145.14 26.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.0 m -67.92 174.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.69 -2.03 11.91 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.655 1.345 . . . . 0.0 111.695 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.1 m -103.3 0.07 30.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.974 -1.079 . . . . 0.0 112.085 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.26 36.24 5.24 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.44 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 77.3 m80 -121.16 124.04 43.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -1.121 . . . . 0.0 110.902 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.41 22.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.765 -0.584 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.8 1.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 111.839 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.458 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.0 136.65 5.25 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.83 120.05 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 12.0 t80 -50.14 127.6 17.24 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.903 0.859 . . . . 0.0 113.28 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -116.67 -28.64 6.32 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.741 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.89 151.21 10.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.112 -0.993 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.59 146.73 29.27 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 58.6 t -90.06 94.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 83.5 m -91.57 119.2 31.28 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.258 1.028 . . . . 0.0 112.711 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.3 m -120.04 132.59 55.52 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.989 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 56.78 23.79 8.38 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.31 51.35 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.818 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.15 143.85 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.015 -1.285 . . . . 0.0 109.564 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.93 126.03 30.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 111.26 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -118.82 15.74 13.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.295 0.569 . . . . 0.0 110.051 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.19 149.05 1.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 15.6 m -124.01 135.42 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.03 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -106.08 149.32 26.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -154.53 163.96 39.41 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.267 -1.373 . . . . 0.0 112.791 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.27 141.56 53.71 Favored Pre-proline 0 N--CA 1.498 1.945 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.314 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.79 151.21 14.55 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.702 1.369 . . . . 0.0 110.754 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -73.16 -30.04 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.654 -0.654 . . . . 0.0 110.136 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.93 -32.95 70.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.43 -0.794 . . . . 0.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.9 m -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.884 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.485 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 4.8 mtp -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.692 -0.63 . . . . 0.0 109.911 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -61.41 -40.01 92.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.436 -0.79 . . . . 0.0 111.592 -179.091 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.435 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.218 0.532 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.136 0.493 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.455 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.438 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CZ3' HG23 ' A' ' 54' ' ' THR . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.093 0.473 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' CA ' ' CD1' ' A' ' 169' ' ' PHE . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.41 ' CD1' ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.471 ' CD1' ' CA ' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.41 ' CE ' ' CD1' ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.153 0.502 . . . . 0.0 110.655 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -109.89 140.01 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -0.762 . . . . 0.0 109.653 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -138.83 147.76 42.88 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.574 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -86.0 130.52 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.337 0.589 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.464 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -132.67 159.99 42.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.7 -0.625 . . . . 0.0 109.603 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 m -141.56 149.93 41.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 t -115.42 76.77 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.498 1.142 . . . . 0.0 109.755 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.3 -48.9 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -120.06 9.72 11.26 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.405 -1.434 . . . . 0.0 113.851 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.36 170.52 19.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.646 -1.284 . . . . 0.0 111.703 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -127.75 154.36 45.46 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.496 0.665 . . . . 0.0 109.825 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 36' ' ' VAL . 10.0 p90 -162.95 -145.8 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.427 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 79.4 mt -135.69 161.71 34.77 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.488 -1.383 . . . . 0.0 112.852 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.98 130.4 13.83 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 21.8 m -112.42 125.29 54.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.364 -0.835 . . . . 0.0 111.453 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 27.5 p -74.16 130.14 39.19 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.493 0.663 . . . . 0.0 110.784 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.8 t -140.34 137.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.25 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 52.09 37.88 22.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.387 -0.821 . . . . 0.0 110.785 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.74 28.06 72.52 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.94 120.02 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.487 -1.008 . . . . 0.0 109.812 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 33.9 m -72.43 129.31 38.05 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -122.9 133.28 54.41 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.8 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.486 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 3.7 t -140.57 -179.21 5.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 4.8 m -88.81 128.29 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 C-N-CA 118.146 -1.422 . . . . 0.0 111.895 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE1' HG21 ' A' ' 78' ' ' VAL . 88.3 t80 -59.98 -40.08 87.91 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.496 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 43.1 p-80 -67.8 -20.06 65.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.487 -1.285 . . . . 0.0 108.518 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -85.51 -35.25 12.13 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.196 -2.362 . . . . 0.0 107.196 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.742 -0.858 . . . . 0.0 109.08 178.671 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 108.285 179.528 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 72.1 mt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 122.265 1.031 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -137.1 126.67 25.22 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -138.3 -71.67 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.6 mtt -87.67 -64.68 1.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -171.56 -168.15 0.58 Allowed 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.182 -176.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.443 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 99.5 m -149.75 115.3 5.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.618 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 3.0 t-20 -99.04 83.58 2.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.182 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 56' ' ' TYR . 61.0 t -63.96 -37.4 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.427 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.77 -27.13 27.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.593 -0.692 . . . . 0.0 109.254 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.18 -1.78 14.27 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.675 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.6 t70 61.23 54.97 3.09 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 108.672 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.6 tp -147.12 148.83 31.98 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.503 ' HB ' ' CH2' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -142.87 139.93 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 108.87 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.29 133.24 7.14 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 118.931 -1.604 . . . . 0.0 110.882 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.503 ' CH2' ' HB ' ' A' ' 83' ' ' VAL . 21.0 m-90 -106.96 -160.83 0.75 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -116.18 113.39 23.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.038 0 O-C-N 121.543 -0.723 . . . . 0.0 110.961 -178.691 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.386 0.612 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.6 165.34 12.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.7 168.05 8.46 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.615 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.486 1.039 0 O-C-N 124.003 1.528 . . . . 0.0 109.869 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.7 m -105.02 -2.52 24.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.75 76.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.017 -1.052 . . . . 0.0 109.17 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.1 mt -84.37 174.69 9.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.744 0.783 . . . . 0.0 111.845 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 93.7 m-85 -146.39 130.96 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -112.73 152.69 28.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.012 0.91 . . . . 0.0 111.759 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.6 t -109.95 131.09 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 80.0 p -81.94 169.06 17.23 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.455 -0.778 . . . . 0.0 110.283 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -34.0 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -98.76 -85.29 0.38 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.34 5.34 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 113.06 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.07 137.91 57.99 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.561 -1.337 . . . . 0.0 109.956 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.27 120.05 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 0.0 110.319 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.01 112.43 34.89 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 109.577 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 45.5 Cg_endo -62.55 132.07 36.44 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.596 1.314 . . . . 0.0 111.487 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.93 134.18 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -91.07 119.99 31.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 108.769 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 ttm180 -58.71 124.28 19.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.922 . . . . 0.0 110.958 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -99.58 3.44 45.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 109.634 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.31 45.96 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.5 m-20 -63.41 -27.09 69.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -1.084 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.2 p -123.49 18.67 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.6 -0.688 . . . . 0.0 111.808 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -138.52 145.83 41.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.089 -1.007 . . . . 0.0 111.378 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.53 142.17 12.11 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 t -90.4 110.01 21.12 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.872 -0.781 . . . . 0.0 110.227 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.36 108.42 4.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.51 -35.41 75.89 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.585 0.707 . . . . 0.0 109.732 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -110.87 107.82 57.82 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.254 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.45 148.17 37.59 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 O-C-N 123.873 1.46 . . . . 0.0 109.899 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -150.02 160.96 32.54 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.91 124.3 15.67 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.858 1.451 . . . . 0.0 110.441 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.01 -27.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.268 0.556 . . . . 0.0 110.806 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.4 m -57.47 -30.88 65.42 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.823 0.82 . . . . 0.0 109.23 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -74.09 -29.05 61.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.383 -0.823 . . . . 0.0 109.125 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.05 -1.42 57.95 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 65.85 1.35 Allowed 'General case' 0 N--CA 1.513 2.68 0 O-C-N 120.8 -1.188 . . . . 0.0 109.369 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 173.6 -25.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.2 t -70.32 -12.58 61.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -1.056 . . . . 0.0 111.316 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.401 ' HB3' HG12 ' A' ' 55' ' ' VAL . 11.1 m -59.92 140.4 56.72 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 88.93 -7.98 80.83 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.06 -158.21 0.74 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.41 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 58.6 Cg_endo -143.32 140.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 116.356 -1.963 . . . . 0.0 112.077 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.93 96.25 7.43 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 142' ' ' PRO . 7.3 mp -86.93 132.58 33.77 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.816 0.817 . . . . 0.0 112.737 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -61.25 -161.44 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -98.85 15.78 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.666 1.351 . . . . 0.0 110.15 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -120.33 12.4 11.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.209 -0.932 . . . . 0.0 112.047 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.38 20.64 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.94 -1.1 . . . . 0.0 110.488 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -127.15 128.75 46.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 0.0 110.639 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.61 100.13 12.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.99 6.79 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.177 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -149.95 124.43 1.76 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.278 -1.439 . . . . 0.0 111.462 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.98 120.07 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.24 . . . . 0.0 107.984 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 13.5 t80 -52.56 128.83 27.29 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.673 0.749 . . . . 0.0 112.495 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -116.27 -28.19 6.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.851 -0.53 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.3 151.0 9.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.2 -0.938 . . . . 0.0 111.836 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.73 145.31 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.824 -0.547 . . . . 0.0 111.331 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 49.0 t -93.43 91.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.3 p -94.59 113.84 25.72 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.667 1.222 . . . . 0.0 112.625 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 162' ' ' GLY . 62.8 m -98.57 133.31 43.1 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 63.45 -72.43 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -164.39 25.83 0.19 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -149.95 144.02 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.056 -1.261 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -79.18 127.59 32.23 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.592 0.71 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -118.35 14.89 13.88 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.176 0.512 . . . . 0.0 110.04 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.72 146.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.422 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 14.7 m -121.12 135.39 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.729 0.776 . . . . 0.0 112.464 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -103.39 147.14 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 36.2 p90 -156.14 161.26 40.37 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.306 -1.358 . . . . 0.0 112.757 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.55 130.34 47.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.863 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -79.23 156.69 26.01 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.06 -29.94 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -59.47 -27.63 66.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -75.04 -25.99 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.706 -0.621 . . . . 0.0 110.236 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.4 mtt -64.65 -50.07 68.52 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.306 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.91 -45.11 94.05 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.495 1.814 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.756 -179.495 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.156 0.503 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.58 121.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.673 -0.642 . . . . 0.0 109.755 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -91.61 127.96 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.71 127.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.49 173.99 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.36 -0.838 . . . . 0.0 110.38 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 8.2 t -150.1 141.99 23.81 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.822 0.82 . . . . 0.0 109.081 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.2 t -117.48 179.34 4.08 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -18.48 1.51 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.5 p -104.55 -31.09 9.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.995 -1.066 . . . . 0.0 113.595 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -171.88 -169.14 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.588 -1.32 . . . . 0.0 113.183 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 53.6 m -118.4 145.71 44.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 10.2 p90 -161.12 -145.2 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.384 -0.822 . . . . 0.0 110.71 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.434 ' O ' ' OG1' ' A' ' 54' ' ' THR . 88.9 mt -134.08 160.66 37.11 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.629 -1.294 . . . . 0.0 113.287 -176.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.18 126.72 10.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.068 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.3 m -96.74 127.28 42.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.115 -0.99 . . . . 0.0 111.743 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 22.3 m -76.32 123.82 26.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.854 -0.529 . . . . 0.0 110.434 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.52 130.01 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.54 -0.725 . . . . 0.0 110.19 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 50.37 39.92 21.55 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.355 -0.84 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.34 26.16 74.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 53' ' ' TRP . 53.2 t -136.19 113.86 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -1.029 . . . . 0.0 109.556 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 47.5 t -75.65 119.97 20.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.73 -0.606 . . . . 0.0 109.399 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.449 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 86.7 m95 -107.68 123.45 48.53 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.471 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -127.62 -179.87 5.15 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 139' ' ' SER . 10.5 m -90.22 124.99 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 C-N-CA 118.194 -1.403 . . . . 0.0 111.999 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.412 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.444 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.4 p-80 -73.02 68.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.119 0.962 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 168.57 -49.31 0.22 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.71 -0.876 . . . . 0.0 109.753 178.88 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.43 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.762 0 O-C-N 120.743 -1.223 . . . . 0.0 110.712 179.776 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.42 HG23 ' CD1' ' A' ' 85' ' ' TRP . 27.0 mt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.666 0.746 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -99.94 140.34 34.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.922 -0.486 . . . . 0.0 110.534 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -72.19 156.05 39.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.524 -0.735 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -95.35 -35.51 11.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.499 0.666 . . . . 0.0 109.27 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -159.26 -177.02 6.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -150.48 122.49 8.22 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.653 -0.654 . . . . 0.0 109.565 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.79 76.41 2.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.04 -39.91 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.651 -0.655 . . . . 0.0 109.71 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -54.95 -26.09 33.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -110.48 -2.58 16.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.703 -0.623 . . . . 0.0 110.794 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 60.01 54.97 3.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.907 -1.121 . . . . 0.0 108.372 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 8.1 tp -147.33 153.57 39.86 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.839 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.442 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.18 141.2 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -124.14 122.01 4.65 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.094 -1.527 . . . . 0.0 111.877 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.471 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 6.9 m-90 -90.99 -170.24 2.61 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -101.83 112.72 25.43 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.421 -0.799 . . . . 0.0 110.48 -179.336 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.46 0.648 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.4 mt -109.37 158.61 17.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.919 -0.488 . . . . 0.0 109.927 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.2 p -101.1 149.98 36.71 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.475 -0.766 . . . . 0.0 110.662 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.49 1.283 0 O-C-N 123.834 1.439 . . . . 0.0 110.637 -179.393 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.114 0.483 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.0 m -98.42 4.88 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.586 -0.696 . . . . 0.0 111.439 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -70.56 73.8 0.54 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.53 175.56 9.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.584 0.707 . . . . 0.0 111.085 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 89.6 m-85 -143.54 123.96 13.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -100.6 141.07 33.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 110.925 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -89.89 120.27 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.919 -0.488 . . . . 0.0 109.693 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 p -85.27 176.74 8.14 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.622 -0.674 . . . . 0.0 109.221 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -42.73 -29.19 0.29 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.052 0.453 . . . . 0.0 111.654 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.52 -67.92 0.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.552 -0.717 . . . . 0.0 110.091 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.31 -163.09 1.7 Allowed 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.474 -0.766 . . . . 0.0 109.546 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -55.55 -71.95 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.668 -0.645 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 t 65.41 -52.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.7 pt -118.9 149.96 47.66 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.72 -1.237 . . . . 0.0 112.087 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 53.8 Cg_endo -111.07 156.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.721 1.379 . . . . 0.0 109.736 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.05 139.97 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -95.68 116.02 28.27 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -58.06 125.51 23.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.946 . . . . 0.0 111.379 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -96.89 -2.67 43.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.42 -176.28 44.71 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 94.1 m-20 -70.01 -18.5 63.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.293 -1.122 . . . . 0.0 110.243 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.6 p -120.17 14.23 12.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.493 -0.754 . . . . 0.0 111.916 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -148.98 147.57 28.74 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.059 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.37 138.57 9.12 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.4 t -88.89 109.98 20.69 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.833 -0.804 . . . . 0.0 110.265 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.8 tp -73.67 109.01 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.64 -19.75 65.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.693 -0.63 . . . . 0.0 110.392 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -119.96 79.97 25.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.669 -0.644 . . . . 0.0 110.212 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.68 146.99 82.51 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.681 1.359 . . . . 0.0 110.087 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -154.13 168.5 11.69 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.696 -0.627 . . . . 0.0 109.659 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.39 124.93 15.68 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.943 1.496 . . . . 0.0 110.077 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.75 -24.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.813 -0.555 . . . . 0.0 111.923 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.3 p -57.5 -34.25 68.88 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.398 -0.814 . . . . 0.0 109.514 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -69.92 -29.59 66.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.85 4.14 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.857 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.41 114.13 7.37 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.146 0.974 . . . . 0.0 109.039 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.66 -7.91 61.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.6 t -73.81 -17.14 61.12 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.504 -0.998 . . . . 0.0 109.569 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.459 ' HB3' HG12 ' A' ' 55' ' ' VAL . 2.9 m -65.3 148.7 51.24 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.052 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.92 -10.0 75.35 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.36 -167.22 5.31 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -139.58 147.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 117.087 -1.476 . . . . 0.0 111.734 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mt -97.55 102.29 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -81.32 130.04 34.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -176.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -160.18 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -95.21 16.24 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.635 1.334 . . . . 0.0 110.712 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.0 p -130.77 19.93 5.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.245 -0.909 . . . . 0.0 111.691 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.41 30.47 64.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 50.8 m170 -115.92 118.64 33.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.486 -1.008 . . . . 0.0 109.907 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.66 124.69 27.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.906 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.58 -2.54 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 111.559 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.474 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.18 128.63 2.42 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.487 -1.34 . . . . 0.0 111.317 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.3 mt -110.07 119.98 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.06 -1.259 . . . . 0.0 107.866 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 14.0 t80 -52.0 127.31 20.99 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.808 0.813 . . . . 0.0 112.909 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -115.68 -28.13 6.85 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.947 -0.471 . . . . 0.0 110.82 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.53 148.92 9.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.918 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -101.91 141.98 33.92 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.4 t -89.65 92.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 77.2 m -88.49 117.89 27.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.33 1.062 . . . . 0.0 112.218 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.6 m -120.04 131.96 55.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.725 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 58.3 21.25 8.03 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.401 -0.812 . . . . 0.0 110.224 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.83 18.86 49.9 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.532 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.98 143.91 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.235 -1.156 . . . . 0.0 109.4 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.56 121.29 23.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.476 -0.765 . . . . 0.0 110.854 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -111.11 11.14 21.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.714 -0.617 . . . . 0.0 110.51 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -175.25 139.46 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 17.1 m -110.09 137.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.155 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -106.55 148.09 28.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -155.21 164.57 38.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.616 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.23 135.68 41.45 Favored Pre-proline 0 N--CA 1.497 1.902 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 148.83 46.36 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.843 1.444 . . . . 0.0 110.099 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 173' ' ' GLU . 7.3 p -71.68 -28.53 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 0.0 109.922 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.414 ' N ' HG11 ' A' ' 172' ' ' VAL . 98.9 mt-10 -59.95 -30.62 69.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.465 -0.772 . . . . 0.0 109.128 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.4 t -72.12 -33.68 68.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.786 -0.571 . . . . 0.0 110.159 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.449 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 3.4 mtp -68.26 -40.08 82.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.5 -40.05 95.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 109.843 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 111.78 -179.235 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.287 0.565 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -125.55 130.04 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -94.85 120.44 35.07 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.01 130.26 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.32 171.26 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.641 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.0 p -142.21 127.91 19.21 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.699 0.762 . . . . 0.0 109.183 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.2 p -107.76 179.94 4.09 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -17.11 7.56 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.51 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -96.55 -41.41 8.56 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.273 -0.892 . . . . 0.0 112.019 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -173.47 -170.27 0.59 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.869 -1.144 . . . . 0.0 112.511 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 55.4 m -112.58 141.32 46.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 17.0 p90 -163.64 -145.72 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 0.0 110.628 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 54' ' ' THR . 92.0 mt -137.75 169.04 18.47 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.714 -1.241 . . . . 0.0 112.54 -177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.25 127.35 11.23 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 62.6 m -99.13 127.81 45.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 111.526 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -74.6 124.29 26.39 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.8 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.56 126.79 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.482 -0.761 . . . . 0.0 109.992 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.8 40.05 26.89 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.621 -0.675 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.71 26.78 72.17 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG13 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -139.81 115.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.396 -1.061 . . . . 0.0 109.409 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.2 t -76.63 121.83 23.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.287 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.513 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 94.2 m95 -109.75 126.87 54.19 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.671 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.459 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 1.4 t -132.21 176.83 8.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 15.6 m -87.31 126.01 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 118.307 -1.357 . . . . 0.0 111.649 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.619 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.479 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 31.9 p-80 -66.85 -19.99 65.84 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.144 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -81.75 -39.27 12.2 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.681 -0.894 . . . . 0.0 109.166 178.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 120.901 -1.124 . . . . 0.0 110.518 -179.696 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 42.9 mt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -98.14 145.33 26.69 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.492 0.663 . . . . 0.0 111.553 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 2.4 pp0? -77.27 155.24 32.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.774 -0.579 . . . . 0.0 109.933 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.2 ttm -102.58 -29.14 11.74 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.536 -0.727 . . . . 0.0 110.501 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -147.72 164.73 32.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.235 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -150.86 116.95 5.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.608 -0.683 . . . . 0.0 110.137 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 78.05 4.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.97 -33.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 0.0 109.929 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -53.1 -26.59 16.99 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.55 3.97 8.98 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.867 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.22 61.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.94 -1.1 . . . . 0.0 109.883 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.6 tp -142.41 151.74 42.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.423 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.86 129.15 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.401 -0.812 . . . . 0.0 109.58 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.07 122.49 5.48 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.192 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.459 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.1 m-90 -85.9 -171.74 3.74 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.988 -0.713 . . . . 0.0 110.12 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -102.57 95.26 6.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.44 -0.787 . . . . 0.0 110.853 -178.745 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.737 0.779 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.0 mt -71.15 163.96 26.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.24 155.48 37.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.836 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.49 1.288 0 O-C-N 123.969 1.51 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.272 0.558 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m 54.26 20.38 2.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.531 -0.731 . . . . 0.0 111.254 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -86.45 79.59 8.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 96.5 mt -89.53 170.61 10.35 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.381 0.61 . . . . 0.0 110.678 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 45.1 p90 -155.86 140.75 17.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.13 153.17 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.07 0.938 . . . . 0.0 111.748 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.99 130.01 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' HIS . 60.1 p -81.35 171.6 14.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.412 -0.805 . . . . 0.0 110.284 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -32.26 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 108' ' ' THR . 83.3 m-70 -98.87 -87.19 0.35 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.108 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.2 26.37 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.124 -0.985 . . . . 0.0 111.226 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.2 158.28 14.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.066 -1.021 . . . . 0.0 110.694 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.11 120.03 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 126' ' ' LEU . 85.9 mt -130.01 83.86 62.29 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 110.259 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.68 120.61 7.83 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.982 1.517 . . . . 0.0 110.744 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.48 132.95 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.684 . . . . 0.0 109.422 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -84.86 120.09 26.07 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -60.82 123.51 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 110.569 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.743 -0.598 . . . . 0.0 109.491 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.72 -179.94 43.89 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.422 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 30.1 p-10 -62.04 -29.32 70.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.98 . . . . 0.0 110.564 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 m -121.52 18.55 11.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.831 -0.543 . . . . 0.0 112.056 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -139.31 144.33 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 111.04 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.41 140.4 10.24 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.3 t -87.59 109.97 20.04 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.782 -0.834 . . . . 0.0 109.821 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.421 ' CD1' ' CG2' ' A' ' 114' ' ' ILE . 22.8 tp -69.33 105.78 2.68 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.51 -25.34 66.64 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.202 0.525 . . . . 0.0 110.055 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 p -106.41 100.71 31.37 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.764 -0.585 . . . . 0.0 110.158 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.88 134.25 16.19 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 124.024 1.539 . . . . 0.0 109.55 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.67 167.22 14.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -57.98 128.71 29.93 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.824 1.434 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.69 -26.43 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.628 -0.67 . . . . 0.0 110.616 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 75.3 m -57.86 -31.36 66.61 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.719 0.771 . . . . 0.0 109.274 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -70.86 -30.89 67.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.3 mt -89.98 -0.02 57.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.539 -0.725 . . . . 0.0 112.557 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -75.7 124.81 27.88 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 120.837 -1.164 . . . . 0.0 109.001 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.66 -11.4 61.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 p -78.55 -10.24 59.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.34 -1.094 . . . . 0.0 109.669 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' ' 55' ' ' VAL . 1.5 m -60.45 143.86 52.43 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.81 -9.94 75.47 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.11 -163.53 0.89 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.424 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.19 135.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 116.624 -1.784 . . . . 0.0 112.145 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 3.9 mp -94.82 97.11 9.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 7.2 mp -88.76 141.48 28.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.953 0.882 . . . . 0.0 113.33 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 1.3 m -74.01 -172.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.0 Cg_endo -82.02 5.28 6.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.739 1.389 . . . . 0.0 111.446 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 14.1 m -110.2 17.8 20.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.996 -1.065 . . . . 0.0 111.883 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.72 38.31 61.09 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 147' ' ' SER . 46.4 m170 -122.97 123.64 41.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.465 -1.021 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.16 102.76 14.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.04 7.4 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.912 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.61 133.94 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.575 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.1 mt -116.52 120.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.276 -1.132 . . . . 0.0 108.072 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.411 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 13.0 t80 -49.96 127.71 17.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.857 0.837 . . . . 0.0 112.978 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.28 -30.33 6.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.942 -0.474 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.411 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.16 150.42 9.38 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.684 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -101.62 140.77 35.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 57.3 t -93.12 88.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.509 -0.744 . . . . 0.0 109.006 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.2 p -92.84 115.72 28.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.273 1.035 . . . . 0.0 111.103 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.5 m -90.01 -80.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.502 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -97.71 61.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.172 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 19.13 75.21 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.3 m -147.74 140.18 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 121.282 -1.128 . . . . 0.0 108.956 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.24 128.27 33.33 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.546 0.688 . . . . 0.0 111.325 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -122.22 16.14 10.65 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -171.55 154.13 3.68 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.27 138.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.885 0.85 . . . . 0.0 112.237 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -107.23 148.34 29.06 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 35.7 p90 -153.45 163.95 39.05 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.713 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.02 141.63 54.83 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.994 -0.442 . . . . 0.0 110.714 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.42 150.87 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.523 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.69 -28.13 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.689 . . . . 0.0 110.355 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -59.95 -32.49 70.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.1 t -75.52 -29.71 59.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.987 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.513 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 7.3 mtp -69.92 -37.93 76.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.96 -36.4 77.03 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.265 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.399 -0.813 . . . . 0.0 110.624 -179.268 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 120.829 0.347 . . . . 0.0 111.48 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.08 129.96 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.858 . . . . 0.0 110.658 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -99.24 123.77 43.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.622 -0.674 . . . . 0.0 110.623 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.7 t -81.69 131.22 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.91 174.03 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.094 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 88.0 p -145.49 125.78 13.89 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.718 0.77 . . . . 0.0 108.98 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.6 p -103.52 -179.54 3.98 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.34 -15.03 8.83 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.528 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -100.42 -39.21 8.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 112.572 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -172.02 -170.0 0.71 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.798 -1.189 . . . . 0.0 112.694 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 73.6 m -115.21 141.54 47.88 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.6 p90 -162.61 -147.33 0.12 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 110.499 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.07 166.01 22.72 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.602 -1.311 . . . . 0.0 113.342 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -152.86 131.86 12.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.837 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -96.75 123.65 40.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 84.2 m -73.78 127.22 32.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.68 -0.637 . . . . 0.0 109.805 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 38.7 t -140.42 127.24 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.796 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 49.98 40.7 21.76 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.585 -0.697 . . . . 0.0 111.619 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.93 68.59 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.439 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 59.9 t -139.94 117.37 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -1.04 . . . . 0.0 109.572 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 13.6 t -75.68 119.62 19.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 96.2 m95 -106.86 125.74 51.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.902 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.474 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.2 t -132.52 -179.26 5.34 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 139' ' ' SER . 24.0 m -90.22 125.57 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 118.193 -1.403 . . . . 0.0 112.242 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.03 -39.99 87.81 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.443 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.5 p-80 -73.42 68.64 1.12 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.139 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.09 -38.13 0.31 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.597 -0.943 . . . . 0.0 110.224 179.307 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.425 HD23 ' CZ2' ' A' ' 85' ' ' TRP . 4.3 mm? . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.163 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 137.61 32.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 0.0 111.742 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -70.03 141.54 52.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.734 -0.604 . . . . 0.0 109.899 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.8 ttp -105.33 -34.36 7.89 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.427 -0.796 . . . . 0.0 110.693 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -153.33 170.47 20.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.467 -0.771 . . . . 0.0 109.755 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.437 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 71.5 m -153.4 115.94 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.69 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 76.6 3.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.06 -39.99 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.451 -0.781 . . . . 0.0 109.553 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -55.65 -26.64 45.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -110.86 -0.4 16.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.751 -0.593 . . . . 0.0 110.751 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 60.17 56.31 3.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.947 -1.096 . . . . 0.0 109.393 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 49.1 tp -145.57 153.19 40.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -146.03 130.68 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 109.415 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.78 121.01 5.11 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.625 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.474 ' CZ3' HG23 ' A' ' 54' ' ' THR . 5.3 m-90 -87.07 -170.28 2.99 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.88 -0.777 . . . . 0.0 109.314 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -100.01 112.22 24.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.973 -178.434 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.342 0.592 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 3.7 mm? -114.32 150.62 34.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.532 -0.73 . . . . 0.0 109.846 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.406 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 2.9 p -98.46 151.06 37.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.434 -0.791 . . . . 0.0 110.93 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 O-C-N 123.865 1.455 . . . . 0.0 110.037 179.72 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -106.65 15.87 25.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.704 . . . . 0.0 110.971 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -73.1 78.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -99.12 175.09 6.02 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.395 0.616 . . . . 0.0 110.32 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.3 p90 -150.27 131.75 14.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.99 147.25 22.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.846 0.831 . . . . 0.0 110.897 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.9 t -90.07 110.0 21.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.4 p -81.38 177.58 8.89 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.216 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -43.74 -25.51 0.18 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.817 -0.552 . . . . 0.0 111.744 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -90.16 -79.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.573 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.38 -44.07 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.291 -0.881 . . . . 0.0 111.183 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -163.84 -65.33 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.746 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t 64.42 -58.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -125.41 150.96 69.26 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.951 -1.093 . . . . 0.0 111.737 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -106.65 163.87 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.804 1.423 . . . . 0.0 109.788 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.1 140.08 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.834 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -95.0 115.81 27.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.99 124.8 21.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -99.26 -0.05 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 0.0 109.766 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.83 44.35 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 34.4 m-20 -65.12 -22.89 67.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.931 . . . . 0.0 110.251 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.2 p -124.96 17.41 8.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 111.46 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -140.66 140.83 35.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.068 -1.02 . . . . 0.0 111.088 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.73 141.25 11.47 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.3 t -89.9 112.19 23.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.834 -0.803 . . . . 0.0 110.161 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.9 tp -71.2 104.47 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.04 -32.67 71.13 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 110.079 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -112.89 99.92 49.62 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.28 145.97 74.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.908 1.478 . . . . 0.0 109.018 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -154.29 163.17 25.01 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.599 -0.688 . . . . 0.0 109.685 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -60.52 122.8 11.85 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.064 1.56 . . . . 0.0 109.88 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -46.5 -25.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.928 -0.482 . . . . 0.0 111.724 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.4 p -58.23 -34.32 70.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.0 108.992 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -69.99 -30.03 67.26 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.25 2.02 33.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.763 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -72.21 112.44 8.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.234 -0.916 . . . . 0.0 108.603 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 -10.1 58.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.5 t -76.69 -12.86 60.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 110.111 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB3' HG12 ' A' ' 55' ' ' VAL . 2.7 m -66.53 150.99 48.16 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.001 -1.062 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.9 -9.91 75.66 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.93 -167.7 4.03 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -141.48 140.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 116.956 -1.563 . . . . 0.0 112.143 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.2 94.02 8.11 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 6.0 mp -85.65 150.24 24.76 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -162.89 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 16.57 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.645 1.339 . . . . 0.0 110.504 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.1 m -124.78 -51.98 1.69 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.06 40.64 0.02 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.406 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.4 m80 -119.99 129.42 54.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.26 121.16 17.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.563 -0.711 . . . . 0.0 110.001 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.24 -29.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.803 -0.561 . . . . 0.0 110.112 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -155.12 150.38 21.86 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.985 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.37 120.86 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.341 -1.093 . . . . 0.0 108.073 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 12.9 t80 -50.01 128.94 19.86 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.948 0.88 . . . . 0.0 113.044 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -117.06 -27.88 6.4 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.404 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 147.59 7.7 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.08 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -98.42 140.43 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.7 t -91.19 92.66 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 86.1 m -94.49 123.32 37.84 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.77 0.795 . . . . 0.0 111.479 -177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.9 m -85.37 -97.51 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.773 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -69.77 -55.5 9.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.782 -1.199 . . . . 0.0 109.119 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -163.96 28.32 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -148.83 146.01 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -81.34 129.25 34.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.568 -0.708 . . . . 0.0 111.168 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.82 15.22 13.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.266 0.555 . . . . 0.0 109.999 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.39 153.02 2.29 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 m -130.1 138.22 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.513 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -105.3 147.63 27.91 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 36.6 p90 -153.2 165.61 35.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.169 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.15 130.07 51.39 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.86 157.52 51.49 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.759 1.4 . . . . 0.0 110.487 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.466 ' HA ' ' CE ' ' A' ' 175' ' ' MET . 7.2 p -76.03 -23.28 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.644 . . . . 0.0 109.653 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.52 -30.83 67.37 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.6 m -73.31 -36.8 66.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.36 0.6 . . . . 0.0 109.631 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.466 ' CE ' ' HA ' ' A' ' 172' ' ' VAL . 0.4 OUTLIER -67.96 -36.6 80.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.522 -0.737 . . . . 0.0 109.019 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -33.1 71.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.885 -0.509 . . . . 0.0 110.33 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.173 -0.954 . . . . 0.0 110.453 -179.313 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -140.01 140.69 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.945 -1.097 . . . . 0.0 111.268 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.01 121.39 32.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.309 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.44 138.89 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.75 169.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.088 0.946 . . . . 0.0 111.544 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -142.76 120.0 11.52 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.428 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 62.6 p -107.15 -179.07 3.82 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.66 -16.48 16.39 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.659 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.3 p -102.69 -39.68 6.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.268 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -174.64 -168.91 0.39 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.064 -1.023 . . . . 0.0 111.855 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 m -116.57 147.43 41.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 38' ' ' THR . 11.7 p90 -161.76 -142.97 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.443 ' O ' ' OG1' ' A' ' 54' ' ' THR . 85.5 mt -134.33 161.48 34.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.675 -1.265 . . . . 0.0 113.352 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -147.84 123.43 10.45 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.143 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.443 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 25.1 m -97.9 120.04 37.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.486 -0.759 . . . . 0.0 110.674 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 21.5 m -76.79 125.99 30.21 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.123 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -123.16 124.61 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 52.67 45.3 28.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.307 -0.87 . . . . 0.0 110.625 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.64 77.28 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.168 -1.015 . . . . 0.0 110.74 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' NE1' ' A' ' 53' ' ' TRP . 61.9 t -130.01 111.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.261 -1.141 . . . . 0.0 109.24 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 15.6 t -74.61 121.85 22.25 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 87.0 m95 -112.84 126.21 55.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.475 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 2.1 t -131.51 178.96 6.33 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 16.6 m -89.57 123.84 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.705 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.02 -39.97 87.66 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 34.6 p-80 -71.31 74.42 0.72 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.872 0.844 . . . . 0.0 109.069 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.07 -25.51 0.71 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HA ' ' CG2' ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.407 -1.055 . . . . 0.0 110.859 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.514 2.77 0 CA-C-O 120.59 0.234 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.433 ' N ' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 109.947 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 72' ' ' THR . 8.6 mt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.928 0.394 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 10.1 m 60.52 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.488 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 3.8 pt20 -80.06 159.29 26.21 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.335 -0.853 . . . . 0.0 112.167 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.77 -30.01 8.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.058 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 1.3 t80 -140.37 164.22 30.69 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.525 -0.734 . . . . 0.0 109.248 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.44 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 39.8 m -154.35 115.33 4.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 0.0 110.304 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -99.15 74.03 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.431 -0.793 . . . . 0.0 109.168 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.05 -39.97 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.272 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -55.19 -26.08 36.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -111.99 -2.59 15.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.682 -0.636 . . . . 0.0 110.589 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t0 62.56 55.18 2.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 109.249 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.6 tp -147.14 151.75 37.31 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.449 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -147.1 139.34 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.068 -1.02 . . . . 0.0 109.296 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.45 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -124.69 122.14 4.62 Favored Glycine 0 N--CA 1.5 2.933 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.656 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.475 ' CD1' ' HA ' ' A' ' 73' ' ' GLN . 9.4 m-90 -90.36 -166.72 1.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.076 -0.661 . . . . 0.0 109.387 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -112.55 96.96 6.28 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.075 0 O-C-N 121.498 -0.751 . . . . 0.0 111.127 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.01 160.59 16.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.34 -0.85 . . . . 0.0 111.133 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.417 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.1 p -112.12 157.12 40.71 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.611 -0.68 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.315 -1.192 0 O-C-N 123.874 1.46 . . . . 0.0 109.592 179.118 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.363 0.602 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.8 m -105.09 18.85 21.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.725 -0.609 . . . . 0.0 109.989 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -70.47 76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.0 mt -94.11 174.32 7.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.283 0.563 . . . . 0.0 109.664 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.6 p90 -152.4 136.1 16.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -103.83 141.25 36.44 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.724 0.774 . . . . 0.0 111.146 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -86.31 119.92 35.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.4 p -80.44 179.98 7.44 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.097 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -43.02 -27.92 0.23 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.756 -0.59 . . . . 0.0 112.24 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -115.27 -50.92 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.865 . . . . 0.0 111.571 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.62 -179.0 7.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.89 -1.131 . . . . 0.0 110.338 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 57.7 t0 -60.09 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.163 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.4 t 51.67 25.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.392 -0.817 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.402 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 6.5 tp -164.83 100.07 0.83 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.874 . . . . 0.0 111.024 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.82 136.41 2.11 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.571 1.301 . . . . 0.0 109.761 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.4 140.32 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.324 -0.86 . . . . 0.0 111.027 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -93.77 119.47 32.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.421 ' NH2' ' CZ ' ' A' ' 169' ' ' PHE . 10.9 ttm-85 -60.59 127.38 31.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.802 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -99.77 -0.01 40.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.666 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.75 -177.37 43.86 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 82.8 m-20 -69.23 -20.02 63.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -1.03 . . . . 0.0 110.171 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 p -123.47 15.15 9.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.409 -0.807 . . . . 0.0 111.642 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -143.25 144.59 32.2 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.14 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.14 140.99 10.79 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.6 t -88.69 111.37 21.87 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.759 -0.848 . . . . 0.0 109.67 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.402 ' CD1' ' CD1' ' A' ' 114' ' ' ILE . 23.6 tp -70.31 110.23 5.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.01 -18.88 65.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.852 -0.53 . . . . 0.0 110.655 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -129.95 82.25 66.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 110.399 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -61.19 143.84 98.71 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.856 1.45 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -154.99 168.36 12.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.643 -0.661 . . . . 0.0 109.345 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.86 125.37 18.43 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.842 1.443 . . . . 0.0 110.354 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.05 -27.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 121.516 0.674 . . . . 0.0 110.534 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 39.7 t -61.42 -15.08 33.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.785 -0.572 . . . . 0.0 110.135 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -86.75 -31.79 20.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 136' ' ' LYS . 84.4 mt -76.7 -55.85 5.13 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.79 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 133' ' ' SER . 4.5 pttt 7.12 104.74 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.22 -4.2 55.14 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.3 p -76.07 -14.78 60.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.534 -0.98 . . . . 0.0 109.261 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.425 ' HB3' HG12 ' A' ' 55' ' ' VAL . 4.0 m -61.97 142.23 57.58 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.161 -0.962 . . . . 0.0 110.143 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.06 -10.11 75.13 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.05 -162.02 0.68 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.443 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 55.5 Cg_endo -146.69 138.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 116.605 -1.796 . . . . 0.0 112.469 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mp -96.0 97.84 9.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 7.3 mp -87.29 151.68 22.93 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.414 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -64.42 -159.62 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.215 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 51.2 Cg_endo -96.8 17.34 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.503 1.265 . . . . 0.0 110.098 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.5 p -130.54 11.06 5.27 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.273 -0.892 . . . . 0.0 112.066 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.52 32.0 10.84 Favored Glycine 0 N--CA 1.502 3.039 0 O-C-N 120.917 -1.114 . . . . 0.0 110.558 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.7 m80 -113.91 118.45 34.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -1.19 . . . . 0.0 110.536 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.22 123.41 24.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.505 -0.747 . . . . 0.0 110.222 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.35 -5.56 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.551 -0.718 . . . . 0.0 111.572 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.479 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -160.04 127.67 1.84 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.791 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.58 120.71 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -1.082 . . . . 0.0 108.555 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 15.8 t80 -50.75 128.61 21.2 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.621 0.724 . . . . 0.0 112.601 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -116.78 -26.45 6.95 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.867 -0.521 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.96 149.18 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.957 . . . . 0.0 111.751 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.98 141.59 32.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.718 -0.614 . . . . 0.0 110.889 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 49.1 t -95.15 93.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -89.43 117.78 28.6 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.13 0.967 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.8 m -83.92 -69.96 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.16 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -117.36 57.57 0.8 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.057 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.35 76.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.4 m -146.84 139.9 19.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 121.374 -1.074 . . . . 0.0 108.27 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.98 129.92 35.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.732 0.777 . . . . 0.0 111.338 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -123.86 17.28 9.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.272 0.558 . . . . 0.0 110.077 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -174.33 139.93 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.31 138.67 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.148 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -108.5 143.33 37.63 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.479 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 39.2 p90 -150.96 166.02 31.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.12 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.3 130.53 47.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.996 -0.44 . . . . 0.0 110.326 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.7 135.82 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 O-C-N 123.722 1.38 . . . . 0.0 110.195 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.21 -29.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.588 -0.695 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.08 -31.09 69.69 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.8 m -72.6 -35.28 67.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.423 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 1.4 mtp -64.68 -47.16 79.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.75 -44.46 96.15 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.937 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 110.683 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.868 0.366 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.08 129.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.391 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.59 117.65 30.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -84.81 131.66 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 43' ' ' PHE . 33.9 m -140.43 178.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.493 -0.754 . . . . 0.0 109.268 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 m -140.91 126.94 19.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.718 0.771 . . . . 0.0 109.209 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 43' ' ' PHE . 14.7 t -113.0 -168.57 1.34 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.36 5.04 0.82 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -120.89 -39.35 2.73 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.701 -1.25 . . . . 0.0 111.941 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -173.08 -155.38 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.098 -1.001 . . . . 0.0 112.348 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 m -102.71 119.01 38.09 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 38' ' ' THR 0.27 3.3 m-85 -90.25 -174.67 4.26 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 117.398 2.369 . . . . 0.0 117.398 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' O ' ' OG1' ' A' ' 54' ' ' THR . 26.5 mt -142.55 136.07 28.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.378 -2.192 . . . . 0.0 106.842 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -145.78 136.66 24.48 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 m -101.69 125.77 48.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.583 -0.698 . . . . 0.0 111.586 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -72.45 119.98 17.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.72 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.83 129.97 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.456 -0.777 . . . . 0.0 109.994 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 50.12 40.14 21.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.472 -0.768 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.96 26.57 74.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 58.5 t -138.75 115.97 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.267 -1.137 . . . . 0.0 109.658 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.2 t -76.72 118.61 19.52 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.433 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 91.8 m95 -106.27 124.24 49.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.0 111.189 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -130.65 179.98 5.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 140' ' ' GLY . 2.8 m -84.32 123.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 C-N-CA 117.195 -1.802 . . . . 0.0 113.373 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.98 -40.31 88.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.802 . . . . 0.0 109.9 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.479 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.6 p-80 -69.2 101.9 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.701 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.16 -41.72 1.42 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.947 . . . . 0.0 109.997 -179.722 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 109.505 179.322 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.5 mt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.086 0.47 . . . . 0.0 111.441 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.6 m 58.7 136.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.955 0.883 . . . . 0.0 112.175 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.482 ' HG2' ' CE2' ' A' ' 85' ' ' TRP . 16.1 mt-30 -80.28 157.19 26.5 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.531 -0.731 . . . . 0.0 112.564 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 88.8 mtp -100.56 -38.23 8.45 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.21 -176.46 4.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.7 m -153.49 127.42 8.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.559 -0.713 . . . . 0.0 109.59 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.16 76.96 2.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.95 -40.06 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.643 -0.66 . . . . 0.0 110.009 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.41 -26.17 40.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.476 -0.765 . . . . 0.0 108.972 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -112.59 0.02 15.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.643 . . . . 0.0 110.735 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.03 59.71 2.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.045 -1.034 . . . . 0.0 109.189 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.454 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 24.3 tp -145.99 154.01 41.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.171 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.41 135.83 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.76 121.99 4.7 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.949 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.482 ' CE2' ' HG2' ' A' ' 73' ' ' GLN . 11.1 m-90 -89.92 -173.11 3.77 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -104.05 91.66 4.05 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.805 -0.56 . . . . 0.0 110.28 -179.43 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.4 mt -106.61 159.68 16.01 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.086 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.64 166.1 11.42 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.97 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 124.054 1.555 . . . . 0.0 110.905 -179.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -103.72 18.33 22.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 111.19 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.51 78.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 174.19 7.85 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.477 0.656 . . . . 0.0 110.546 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.9 113.49 9.02 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.52 146.64 24.47 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.127 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -92.97 119.42 40.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.159 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.0 p -85.94 175.24 8.73 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -42.86 -28.61 0.26 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.796 -0.565 . . . . 0.0 111.954 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -100.07 -69.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.12 -163.27 1.74 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.438 -0.789 . . . . 0.0 109.506 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 73.9 m-20 -57.29 -66.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.741 -0.599 . . . . 0.0 110.585 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.7 t 56.58 -85.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.99 -0.444 . . . . 0.0 111.298 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.0 pt -76.51 145.28 75.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.078 -1.013 . . . . 0.0 112.006 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -112.63 153.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 O-C-N 123.756 1.398 . . . . 0.0 108.657 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.2 t -136.42 139.64 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.074 -1.016 . . . . 0.0 111.66 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.32 118.49 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -63.37 122.2 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.0 110.219 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -101.05 7.43 43.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.688 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.32 173.59 42.09 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.446 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 75.5 m-20 -60.3 -25.83 66.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.379 -1.071 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.7 18.58 7.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.548 -0.72 . . . . 0.0 111.85 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.41 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 92.7 mtt180 -138.12 143.41 40.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.833 -1.167 . . . . 0.0 111.012 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.11 142.17 12.26 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.1 t -89.64 110.99 21.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.971 -0.723 . . . . 0.0 109.814 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -69.96 113.74 7.47 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.99 -20.96 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.874 -0.516 . . . . 0.0 110.756 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 m -126.77 80.86 70.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.43 139.79 91.21 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 O-C-N 123.754 1.397 . . . . 0.0 110.346 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -146.96 163.15 30.14 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -55.47 124.49 16.42 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.808 1.425 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.8 p -51.61 -23.46 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.888 -0.507 . . . . 0.0 111.639 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -57.19 -34.34 68.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.312 -0.868 . . . . 0.0 109.28 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -74.22 -21.87 59.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.02 -0.49 54.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 0.0 111.194 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.77 109.89 2.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.108 -0.995 . . . . 0.0 108.81 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.94 -6.73 64.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.41 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 12.7 t -74.27 -13.32 60.75 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.562 -0.963 . . . . 0.0 108.686 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.3 147.68 39.98 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.372 -0.83 . . . . 0.0 109.384 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 95.25 -12.16 68.37 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.3 -157.6 0.22 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -144.12 132.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 116.514 -1.857 . . . . 0.0 113.426 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.24 85.79 6.7 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 149' ' ' HIS . 0.7 OUTLIER -92.57 138.32 31.61 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 0.0 112.524 -175.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.48 -177.17 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -91.18 3.6 4.36 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.553 1.291 . . . . 0.0 110.536 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.4 m -103.63 -15.97 15.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.82 28.64 3.11 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 74.2 m80 -116.65 109.98 17.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.103 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.74 121.97 22.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.65 -1.35 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 112.077 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.46 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -158.68 138.01 5.5 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.334 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.418 ' CG2' ' HA2' ' A' ' 140' ' ' GLY . 25.7 mt -120.09 118.42 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 13.7 t80 -49.92 127.31 16.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.873 0.844 . . . . 0.0 112.9 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -121.58 -21.53 6.18 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.619 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -162.82 138.96 7.25 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.917 -1.114 . . . . 0.0 112.148 -178.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -100.01 138.97 36.35 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 39.9 t -89.91 94.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 77.2 m -89.99 110.02 21.02 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.104 0.954 . . . . 0.0 112.793 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.3 m -100.48 125.18 46.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.3 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 56.3 22.81 6.59 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -0.827 . . . . 0.0 111.31 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.23 17.71 36.13 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.019 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.3 139.99 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.117 -1.225 . . . . 0.0 109.0 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -78.12 122.09 25.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.274 -0.891 . . . . 0.0 111.552 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -116.24 15.95 15.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.794 -0.566 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.33 150.89 2.42 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 17.3 m -128.6 136.77 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.633 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -105.43 150.45 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.46 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -154.51 161.09 41.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.914 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.3 t -80.34 139.93 52.27 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.1 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -82.17 148.24 14.91 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.779 1.41 . . . . 0.0 110.525 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.22 -30.06 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.644 -0.66 . . . . 0.0 110.007 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.85 -31.48 69.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 109.014 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.0 t -73.06 -31.04 64.14 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.438 0.637 . . . . 0.0 109.559 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.454 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 2.7 mtp -70.03 -39.39 75.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.658 -0.651 . . . . 0.0 109.461 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -59.99 -41.46 92.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.655 -0.653 . . . . 0.0 109.433 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.495 1.783 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.497 178.844 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 121.023 0.44 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.25 124.28 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -94.59 124.2 38.48 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.2 t -80.29 131.17 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.7 175.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.414 -0.803 . . . . 0.0 110.262 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.5 p -146.32 133.24 20.18 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.837 0.827 . . . . 0.0 109.206 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 59' ' ' ALA . 24.3 p -108.25 -179.73 3.97 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.69 -14.92 23.82 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 p -107.92 -32.34 7.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 113.185 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.88 -169.98 0.72 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.705 -1.247 . . . . 0.0 112.769 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 m -121.43 148.79 43.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.7 p90 -164.3 -145.55 0.09 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.525 -0.734 . . . . 0.0 110.299 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' OG1' ' A' ' 54' ' ' THR . 82.9 mt -134.87 159.99 39.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.644 -1.285 . . . . 0.0 112.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 128.79 18.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 98.1 m -96.8 132.84 42.11 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.0 111.799 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.19 117.31 20.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.44 129.93 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.041 -1.037 . . . . 0.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 54.05 40.05 31.22 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.534 -0.729 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 24.95 74.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.424 HG13 ' CZ2' ' A' ' 53' ' ' TRP . 60.0 t -138.58 123.02 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.544 -0.974 . . . . 0.0 109.099 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.0 m -75.3 143.34 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.563 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CG ' ' HG2' ' A' ' 175' ' ' MET . 91.2 m95 -136.0 125.51 25.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.732 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.79 -174.21 3.19 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.466 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 35.1 m -86.41 131.52 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.312 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -60.43 -40.09 89.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.776 -0.577 . . . . 0.0 109.641 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 37.8 p-80 -73.41 72.43 1.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.391 1.091 . . . . 0.0 108.745 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.36 -36.07 0.81 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.808 -0.819 . . . . 0.0 111.143 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.41 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.766 -1.209 . . . . 0.0 110.202 179.86 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.412 HG21 ' CD1' ' A' ' 85' ' ' TRP . 8.3 mt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 50.9 m 60.06 124.64 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.562 0.696 . . . . 0.0 110.913 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 95.3 mt-30 -59.94 137.71 58.01 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.271 -0.893 . . . . 0.0 112.547 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.4 ttm -97.08 -27.63 14.5 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -147.04 167.65 23.52 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.421 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 19.0 m -154.61 116.7 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 110.398 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -95.02 75.2 3.5 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.01 -40.04 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -55.8 -26.27 45.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -111.02 0.09 16.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.706 -0.621 . . . . 0.0 110.832 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 60.17 57.4 2.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.499 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.9 tp -148.06 151.53 35.84 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.652 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.453 ' CG2' HG21 ' A' ' 54' ' ' THR . 14.6 m -139.74 140.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' HA2' ' CE3' ' A' ' 85' ' ' TRP . . . -125.47 171.21 17.38 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.151 -1.499 . . . . 0.0 112.102 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.555 ' CD1' ' HA ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -148.67 -162.08 1.48 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -100.36 111.31 23.57 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 111.542 -178.746 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.468 0.652 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -109.98 149.91 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 7.6 p -105.38 157.56 34.16 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.339 -178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 N--CA 1.493 1.484 0 O-C-N 123.824 1.434 . . . . 0.0 110.604 179.719 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.3 m -98.4 16.38 21.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 111.268 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -67.81 86.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.9 mt -99.02 176.64 5.5 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.616 0.722 . . . . 0.0 111.28 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.45 111.13 5.68 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.36 143.93 27.6 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.465 0.65 . . . . 0.0 110.315 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 80.5 t -88.97 114.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.4 p -84.21 174.87 9.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -41.55 -29.33 0.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.816 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -100.04 -70.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.541 -0.724 . . . . 0.0 109.654 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.92 -162.92 1.66 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.523 -0.736 . . . . 0.0 109.023 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-20 -57.81 -63.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.632 -0.667 . . . . 0.0 110.08 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.8 t 54.02 -86.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.008 -0.433 . . . . 0.0 111.617 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.23 134.63 70.42 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.101 -0.999 . . . . 0.0 111.731 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -104.67 148.1 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.604 1.318 . . . . 0.0 109.13 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.5 t -134.06 138.61 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.275 -0.891 . . . . 0.0 110.803 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.83 124.17 39.73 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -62.62 121.56 13.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.409 -0.807 . . . . 0.0 110.356 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.02 7.4 44.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.631 -0.668 . . . . 0.0 109.574 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.97 173.81 43.73 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 16.8 t0 -61.33 -25.28 67.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -125.71 18.59 7.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.551 -0.718 . . . . 0.0 111.757 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.415 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 95.2 mtt-85 -138.26 145.37 41.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.884 -1.135 . . . . 0.0 111.161 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.29 141.2 10.93 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 55.3 p -89.21 113.1 24.27 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.951 -0.735 . . . . 0.0 109.858 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 tp -71.06 110.06 5.52 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.687 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.95 -18.0 63.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 110.738 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.0 m -119.95 79.96 25.52 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.615 -0.678 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.72 137.75 78.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.807 1.425 . . . . 0.0 109.903 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -154.11 169.8 9.43 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.699 -0.626 . . . . 0.0 109.344 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.56 124.38 15.34 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.963 1.507 . . . . 0.0 110.335 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.36 -23.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.794 -0.566 . . . . 0.0 111.635 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.324 -0.86 . . . . 0.0 109.356 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -70.67 -28.03 64.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.25 -0.32 51.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.557 -0.714 . . . . 0.0 111.271 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -70.31 110.84 5.49 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.76 -10.57 57.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 p -74.65 -15.24 60.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 109.159 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.405 ' HA ' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -71.29 151.33 44.32 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 179.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.92 -10.74 72.86 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.23 -157.92 3.62 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.422 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 49.6 Cg_endo -142.35 137.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 116.982 -1.546 . . . . 0.0 112.212 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 mt -95.06 99.16 11.21 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.2 mp -90.86 146.41 23.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -59.86 -164.8 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 49.0 Cg_endo -90.14 17.98 1.43 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.521 1.274 . . . . 0.0 111.022 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.3 m -126.51 -55.42 1.43 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.096 -1.002 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.0 43.32 0.02 OUTLIER Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.6 m80 -125.19 120.99 32.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -1.037 . . . . 0.0 110.797 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.61 124.3 29.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.266 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.21 -1.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.724 . . . . 0.0 111.901 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.467 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.86 125.46 1.65 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.168 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.0 mt -105.8 117.48 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.297 -1.119 . . . . 0.0 108.156 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 16.2 t80 -50.14 126.8 15.43 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.601 0.715 . . . . 0.0 112.529 -177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -119.85 -22.48 6.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.82 -0.55 . . . . 0.0 112.224 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.96 136.62 6.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.894 -1.129 . . . . 0.0 111.974 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.0 133.25 40.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 122.001 -0.437 . . . . 0.0 111.375 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -84.66 91.08 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 64.2 m -94.23 119.73 33.45 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.824 0.821 . . . . 0.0 111.352 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -89.95 -79.96 0.33 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.075 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -106.41 64.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.404 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.93 18.79 79.23 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.67 137.94 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.29 -1.123 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -83.14 129.98 35.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.549 -0.72 . . . . 0.0 111.072 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -119.94 14.82 12.46 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.215 0.531 . . . . 0.0 110.089 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.06 152.15 2.84 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 m -132.18 137.3 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.461 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -104.71 152.0 23.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.467 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -153.71 166.66 32.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.644 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.7 130.88 62.5 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.094 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.04 148.61 45.18 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.744 1.392 . . . . 0.0 109.863 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.41 ' HA ' ' HE3' ' A' ' 175' ' ' MET . 7.2 p -72.33 -25.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.917 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.98 -29.69 68.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.312 -0.867 . . . . 0.0 108.72 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.9 m -71.08 -32.79 69.52 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.409 0.623 . . . . 0.0 109.395 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.471 ' HG2' ' CG ' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.37 -38.45 78.07 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.8 0.81 . . . . 0.0 108.937 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.01 -39.24 85.13 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.589 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.496 1.864 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.27 -178.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -138.14 129.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -140.08 141.36 36.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.27 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.47 139.02 18.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.54 159.98 42.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.57 0.7 . . . . 0.0 110.215 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.7 m -137.28 121.39 17.88 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.8 0.81 . . . . 0.0 108.897 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -107.48 -179.87 4.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -14.92 18.45 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.213 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.6 p -99.14 -40.95 7.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 112.191 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -173.55 -168.52 0.45 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.926 -1.109 . . . . 0.0 112.098 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 p -118.4 144.66 45.76 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 8.4 p90 -161.4 -143.35 0.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.738 . . . . 0.0 110.132 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.9 mt -134.64 162.96 30.83 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.615 -1.303 . . . . 0.0 112.833 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -151.89 129.84 11.76 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.648 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 m -103.07 127.7 50.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 0.0 111.418 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 86.9 m -74.82 122.56 23.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.746 -0.596 . . . . 0.0 109.568 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.55 129.48 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.4 t30 49.99 39.99 20.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.584 -0.698 . . . . 0.0 111.264 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.42 26.19 73.84 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.414 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 62.9 t -137.82 113.02 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -1.038 . . . . 0.0 109.611 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 7.9 t -74.47 121.28 21.23 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.454 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 87.6 m95 -110.01 129.96 55.6 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.493 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.474 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 4.5 t -136.74 179.99 6.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.442 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 30.3 m -90.2 126.37 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.138 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -60.08 -40.89 91.15 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -74.64 67.06 1.51 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.13 0.967 . . . . 0.0 108.64 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.1 -36.6 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.875 . . . . 0.0 109.366 178.848 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.109 . . . . 0.0 109.034 179.324 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 66.7 mt . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.462 0.648 . . . . 0.0 109.751 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -95.37 145.25 25.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.791 -0.568 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 11.5 pt20 -75.27 157.41 34.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.669 -0.645 . . . . 0.0 111.101 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.3 mmm -96.88 -39.97 9.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.706 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.33 -178.18 7.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.598 -0.689 . . . . 0.0 109.333 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.4 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 88.2 m -150.9 125.55 9.63 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.81 76.69 4.24 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.93 -39.23 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 109.466 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -53.84 -26.2 23.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -115.66 0.64 13.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.656 -0.653 . . . . 0.0 110.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t0 60.37 56.82 3.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.893 -1.129 . . . . 0.0 108.591 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.408 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 22.6 tp -142.77 155.47 44.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.869 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -145.1 137.55 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.435 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.52 125.99 5.19 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.44 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.474 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.5 m-90 -90.04 -170.04 2.64 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -108.44 109.84 21.22 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.965 0 O-C-N 121.508 -0.745 . . . . 0.0 110.556 -179.343 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 121.464 0.65 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.44 153.89 37.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.99 161.49 22.65 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.364 -0.835 . . . . 0.0 110.8 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.492 1.42 0 O-C-N 123.797 1.42 . . . . 0.0 110.083 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.2 m -101.66 7.84 41.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.426 -0.796 . . . . 0.0 111.511 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.88 76.1 1.16 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 108.618 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt -95.26 172.42 8.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.753 -0.592 . . . . 0.0 109.808 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 53.0 p90 -152.06 142.2 22.29 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 38.9 tp -115.03 155.8 26.31 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.98 0.895 . . . . 0.0 111.908 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.402 ' N ' ' HG ' ' A' ' 106' ' ' LEU . 92.4 t -109.97 135.7 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.1 p -83.25 175.79 9.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -41.95 -31.29 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.296 0.57 . . . . 0.0 111.422 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -99.99 -70.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.77 -82.44 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.566 -0.709 . . . . 0.0 110.328 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.2 t0 46.86 90.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.389 -0.82 . . . . 0.0 111.4 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.19 49.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.685 . . . . 0.0 110.439 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 pt -70.06 156.03 92.49 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -103.31 141.11 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.982 1.517 . . . . 0.0 111.523 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.02 130.06 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -90.26 116.59 28.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -60.39 123.48 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.93 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -100.01 4.51 44.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 109.935 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.76 176.99 41.78 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 92.5 m-20 -65.64 -21.54 66.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -1.059 . . . . 0.0 110.119 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -124.49 17.0 8.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -140.3 139.93 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.975 -1.078 . . . . 0.0 110.774 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.19 144.02 14.77 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 t -90.9 111.97 23.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.789 -0.83 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.3 tp -73.49 104.64 4.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -27.43 66.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.225 0.536 . . . . 0.0 110.387 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 t -112.39 105.49 56.12 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.713 -0.617 . . . . 0.0 110.76 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.78 141.74 19.6 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.911 1.479 . . . . 0.0 109.442 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.88 165.23 18.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.573 -0.704 . . . . 0.0 109.258 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.12 125.19 16.93 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.895 1.471 . . . . 0.0 109.935 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -49.64 -25.14 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.799 -0.563 . . . . 0.0 111.254 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -55.5 -38.12 68.76 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.654 0.74 . . . . 0.0 109.434 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -70.02 -29.18 66.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.87 2.0 50.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.583 -0.698 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -70.5 113.01 7.21 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.152 -0.967 . . . . 0.0 108.56 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.7 -9.05 56.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.6 t -75.27 -17.13 60.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.0 109.083 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -65.14 146.21 55.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 179.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 96.85 -14.98 63.39 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.54 -158.08 0.61 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.405 ' HB2' ' CD1' ' A' ' 144' ' ' LEU . 56.8 Cg_endo -142.74 140.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 116.683 -1.745 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.08 97.33 9.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 7.3 mp -90.01 138.13 31.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.03 -154.89 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -104.16 15.04 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.453 1.238 . . . . 0.0 110.365 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 m -117.14 16.9 14.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.44 37.59 46.8 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -125.2 132.08 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.85 119.97 37.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.18 -1.56 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.269 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.89 126.85 2.35 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.506 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.3 mt -109.94 117.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.105 -1.232 . . . . 0.0 108.283 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 15.2 t80 -50.92 128.67 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -119.34 -25.56 6.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.722 -0.612 . . . . 0.0 111.648 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.44 12.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 111.827 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 140.1 31.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.4 t -89.95 92.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 61.8 m -92.59 118.17 30.73 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.696 0.76 . . . . 0.0 111.028 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.7 m -89.94 -78.38 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -105.99 54.58 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.79 16.57 72.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -146.36 141.31 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.353 -1.086 . . . . 0.0 108.335 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -84.52 128.29 34.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.545 -0.722 . . . . 0.0 111.047 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -120.0 15.83 12.48 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.163 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -171.31 145.87 2.23 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 16.0 m -121.65 135.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.698 -177.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -102.57 147.34 26.9 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 41.5 p90 -152.65 165.16 36.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.089 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 67.3 t -81.65 131.81 56.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.09 143.1 31.88 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.887 1.467 . . . . 0.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.77 -29.94 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 109.659 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.98 -33.09 70.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 m -75.54 -29.65 59.48 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.855 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 3.5 mtp -69.95 -39.88 75.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 109.586 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.04 -39.92 87.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.73 -0.606 . . . . 0.0 110.069 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 64.6 p . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.453 -0.78 . . . . 0.0 109.823 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 121.157 0.503 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.3 t -111.26 126.32 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.0 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -96.25 139.85 31.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.417 0.627 . . . . 0.0 110.341 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.33 140.16 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.92 159.97 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 122.346 1.069 . . . . 0.0 112.0 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 78.2 p -148.5 116.93 6.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 p -108.71 179.98 4.03 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.396 0.617 . . . . 0.0 109.651 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.65 -16.27 15.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -111.29 -27.35 8.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 113.166 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -170.93 -170.01 0.83 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.582 -1.324 . . . . 0.0 112.54 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 75.3 m -127.84 140.79 51.82 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.7 p90 -159.69 -141.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 109.996 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt -136.82 171.16 14.92 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.594 -1.316 . . . . 0.0 113.39 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -148.11 122.91 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.389 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 93.5 m -85.89 120.83 27.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.592 -0.693 . . . . 0.0 110.541 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.46 119.7 19.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.362 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -140.89 131.88 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.37 -0.831 . . . . 0.0 110.465 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 52.86 40.03 30.05 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.508 -0.745 . . . . 0.0 111.025 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.59 27.36 73.58 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.401 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 84.0 t -140.0 118.87 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.542 -0.976 . . . . 0.0 109.675 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -74.04 129.01 37.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 175' ' ' MET . 90.2 m95 -117.33 120.06 37.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.813 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' A' ' 45' ' ' ALA . 6.5 t -129.15 -178.16 4.53 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 24.1 m -88.42 134.54 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 C-N-CA 118.942 -1.103 . . . . 0.0 113.359 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -64.37 -40.0 94.98 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.366 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.472 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.8 p-80 -71.65 75.07 0.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.09 0.948 . . . . 0.0 109.326 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.55 -42.61 0.49 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.671 -0.9 . . . . 0.0 110.915 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.522 3.148 0 CA-C-O 121.181 0.515 . . . . 0.0 112.377 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.709 -0.619 . . . . 0.0 109.6 -179.013 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -88.1 136.49 32.95 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 111.436 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 19.4 pt20 -73.3 146.47 45.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.812 -0.555 . . . . 0.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.11 -37.71 8.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.517 -0.739 . . . . 0.0 109.955 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.96 -177.56 1.95 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -159.99 143.6 14.16 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.732 0.777 . . . . 0.0 110.13 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.92 80.67 1.46 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.93 -39.99 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.74 . . . . 0.0 110.056 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -56.58 -26.55 55.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.288 -0.883 . . . . 0.0 108.853 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -110.39 2.44 19.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.717 -0.614 . . . . 0.0 110.706 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 60.56 56.38 3.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 111.336 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -144.54 150.56 37.73 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.527 -0.733 . . . . 0.0 110.261 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -136.95 128.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.27 123.56 5.7 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 118.876 -1.63 . . . . 0.0 113.222 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CZ3' ' HB ' ' A' ' 83' ' ' VAL . 5.8 m-90 -92.69 -170.78 2.55 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 122.025 -0.691 . . . . 0.0 109.676 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.2 100.99 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 111.091 -178.575 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.37 154.38 19.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.834 -0.541 . . . . 0.0 110.088 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.51 164.51 17.03 Favored Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.555 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 123.87 1.458 . . . . 0.0 110.324 179.769 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.2 m -95.4 20.43 9.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.629 -0.669 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -69.97 73.7 0.44 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.611 -0.681 . . . . 0.0 109.188 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.5 mt -90.17 174.48 7.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -153.14 144.53 23.24 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' PRO . 28.1 tp -116.35 142.53 46.73 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.705 0.764 . . . . 0.0 111.297 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -91.66 125.08 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 110' ' ' HIS . 72.0 p -85.82 170.66 12.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.731 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -28.89 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.892 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 108' ' ' THR . 73.6 m-70 -99.99 -86.32 0.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.132 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.64 22.33 0.12 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.191 -0.943 . . . . 0.0 111.358 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -66.43 129.07 38.61 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.052 -1.03 . . . . 0.0 110.466 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -69.97 -53.38 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.686 -0.634 . . . . 0.0 110.514 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 126' ' ' LEU . 83.1 mt 46.46 73.69 0.94 Allowed Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.526 -0.734 . . . . 0.0 111.083 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -59.74 130.52 35.47 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.864 1.455 . . . . 0.0 111.187 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.95 131.98 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 109.532 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -87.64 124.59 33.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 108.708 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -63.93 123.01 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.549 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -97.88 1.45 48.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.4 170.23 38.08 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.1 m-20 -58.7 -23.74 60.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.158 -1.201 . . . . 0.0 110.365 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.0 p -121.67 17.6 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 112.331 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -144.07 142.39 30.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.03 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.71 13.4 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.0 p -88.77 114.84 25.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.839 -0.8 . . . . 0.0 109.477 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.413 ' CD1' ' CG2' ' A' ' 114' ' ' ILE . 20.5 tp -72.26 109.98 6.38 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.92 -20.58 65.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.86 -0.525 . . . . 0.0 110.375 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -117.67 84.23 19.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.744 -0.597 . . . . 0.0 109.962 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -58.34 138.29 85.04 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.761 1.4 . . . . 0.0 110.381 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -152.99 164.69 19.53 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.55 127.43 24.59 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.77 1.405 . . . . 0.0 110.473 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -50.11 -25.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.814 -0.554 . . . . 0.0 110.702 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -59.91 -37.63 79.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.577 -0.702 . . . . 0.0 109.469 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -69.01 -25.86 64.72 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.76 -1.73 44.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.46 -0.775 . . . . 0.0 110.406 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -70.17 122.1 18.82 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.152 -0.968 . . . . 0.0 108.563 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.92 -11.41 64.23 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.1 t -79.03 -16.23 57.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.443 -1.034 . . . . 0.0 109.672 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.436 ' HB3' HG12 ' A' ' 55' ' ' VAL . 14.9 m -62.26 147.42 48.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.451 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.09 -9.91 75.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.9 -169.56 5.97 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . 0.412 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 48.1 Cg_endo -140.34 142.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 116.974 -1.551 . . . . 0.0 112.396 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.59 96.35 8.59 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.39 141.55 28.55 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 85.2 m -63.71 -173.0 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.2 Cg_endo -87.79 17.27 1.74 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 117.249 -1.368 . . . . 0.0 111.6 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -122.03 18.11 10.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.07 -1.018 . . . . 0.0 111.764 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.14 35.74 37.42 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -122.87 123.38 40.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.374 -1.074 . . . . 0.0 110.34 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.95 123.33 34.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.621 -0.674 . . . . 0.0 110.179 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.02 -2.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.638 -0.664 . . . . 0.0 111.694 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -145.45 126.66 2.63 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.419 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.1 mt -110.07 121.76 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.188 -1.184 . . . . 0.0 108.407 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 8.0 t80 -51.76 122.83 8.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.841 0.829 . . . . 0.0 112.442 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.406 ' HD2' ' CG1' ' A' ' 170' ' ' VAL . 39.6 ttt-85 -115.9 -29.41 6.37 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -166.07 169.43 14.56 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.926 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.12 47.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 166' ' ' ALA . 15.5 m -107.6 105.39 18.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.742 0.782 . . . . 0.0 109.501 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.5 p -95.36 121.84 37.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 110.36 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -89.98 -79.89 0.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.567 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.96 52.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.96 15.94 77.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.2 m -144.67 140.01 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.386 -1.067 . . . . 0.0 108.35 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -81.56 116.93 21.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.657 0.741 . . . . 0.0 111.675 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.57 8.12 45.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.722 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 158' ' ' VAL . . . -171.53 141.83 1.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.286 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.62 143.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.713 0.768 . . . . 0.0 112.687 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -111.19 142.07 43.88 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 34.2 p90 -152.83 165.04 36.65 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.276 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.406 ' CG1' ' HD2' ' A' ' 155' ' ' ARG . 26.9 m -90.68 133.03 33.33 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.908 -0.495 . . . . 0.0 110.015 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.63 157.2 56.35 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.719 1.378 . . . . 0.0 109.936 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 175' ' ' MET . 7.1 p -64.36 -27.23 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.49 -0.756 . . . . 0.0 109.594 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.59 -25.39 62.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 108.547 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.3 m -74.15 -40.1 62.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.596 -0.69 . . . . 0.0 111.934 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.493 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 16.7 ptp -69.85 -41.06 75.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.667 -1.271 . . . . 0.0 108.815 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 175' ' ' MET . 98.9 mt-10 -59.98 -39.97 87.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.793 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.4 p . . . . . 0 N--CA 1.498 1.966 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.179 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.435 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.435 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.451 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.408 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.424 HD22 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.218 0.532 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.5 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.136 0.493 . . . . 0.0 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.455 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.438 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CZ3' HG23 ' A' ' 54' ' ' THR . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.093 0.473 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' CA ' ' CD1' ' A' ' 169' ' ' PHE . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.41 ' CD1' ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.471 ' CD1' ' CA ' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.41 ' CE ' ' CD1' ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.411 0.624 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.02 133.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -139.96 151.96 45.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.77 137.82 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -143.95 170.16 9.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -150.63 149.26 29.63 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.928 0.87 . . . . 0.0 109.603 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.7 t -119.69 -180.0 4.06 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.62 -16.25 2.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.612 -0.68 . . . . 0.0 112.274 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.3 p -98.27 -37.21 9.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.902 -1.124 . . . . 0.0 112.887 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -171.48 -174.21 1.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.805 -1.184 . . . . 0.0 112.313 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.3 p -116.76 143.74 45.29 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 6.9 p90 -162.52 -139.09 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.416 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 76.1 mt -134.57 164.61 27.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 113.363 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.45 125.29 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.315 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.421 HG23 ' CD1' ' A' ' 153' ' ' ILE . 5.9 t -83.55 -152.0 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 0.0 110.745 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 46' ' ' THR . 13.6 t -159.35 113.52 2.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.1 t -138.71 135.52 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.299 -0.961 . . . . 0.0 111.371 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 49.99 39.98 20.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.667 -0.645 . . . . 0.0 110.935 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.93 74.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.417 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 61.0 t -133.7 113.66 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.831 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 130.08 38.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.507 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.1 m95 -118.46 133.93 55.48 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.453 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.483 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -139.01 -178.47 5.35 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 21.2 m -82.77 134.26 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.671 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 78' ' ' VAL . 49.7 t80 -64.22 -39.96 95.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.463 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 11.5 p-80 -63.11 -16.27 59.43 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.531 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.7 -82.7 1.4 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' N ' ' CZ ' ' A' ' 43' ' ' PHE . . . . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.397 -1.061 . . . . 0.0 111.19 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.416 HD23 ' CZ2' ' A' ' 85' ' ' TRP . 20.2 tp . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.316 0.103 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.057 0 O-C-N 120.876 -1.14 . . . . 0.0 110.565 -179.289 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 120.869 0.366 . . . . 0.0 110.198 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 70.0 m -139.32 132.86 30.34 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.467 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 8.1 pt20 -76.22 153.22 36.25 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.444 -0.785 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.5 ttp -107.88 -30.05 8.71 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -148.84 167.71 24.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.45 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 29.7 m -154.03 114.15 3.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.636 -0.665 . . . . 0.0 110.428 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 76.98 4.22 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 56' ' ' TYR . 98.3 t -59.95 -40.0 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.405 -0.809 . . . . 0.0 109.724 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.55 -25.85 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.68 -1.23 16.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.792 -0.567 . . . . 0.0 110.703 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.92 57.72 3.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.1 -1.0 . . . . 0.0 109.332 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.9 tp -147.77 153.55 39.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.691 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.469 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -143.09 131.78 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.73 124.79 5.79 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.768 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CD1' ' CG2' ' A' ' 71' ' ' ILE . 3.3 m-90 -84.69 170.01 13.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 122.049 -0.677 . . . . 0.0 109.771 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.28 89.29 4.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 109.352 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.552 -0.717 . . . . 0.0 110.532 -179.756 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.231 0.539 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.14 170.03 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 110.161 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.434 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 92.6 m -111.94 164.18 15.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.639 179.474 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.136 0.493 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -89.95 11.76 19.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.0 111.386 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -70.01 80.08 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 108.694 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.62 176.73 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.66 . . . . 0.0 110.95 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -146.24 100.89 3.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.24 139.95 41.39 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.513 0.673 . . . . 0.0 110.013 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 78.3 t -85.32 111.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' ALA . 55.5 p -81.38 172.39 13.61 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -42.6 -27.95 0.2 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.712 -0.618 . . . . 0.0 112.149 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -100.01 -68.91 0.79 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.407 -0.808 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 108' ' ' THR . . . -146.53 -161.71 1.38 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 26.8 p-10 -60.0 -44.69 94.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.535 -0.728 . . . . 0.0 110.244 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.7 t 46.28 -89.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.1 pt -74.84 142.82 77.2 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 112.712 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -105.81 141.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 O-C-N 123.777 1.409 . . . . 0.0 108.718 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.93 133.13 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.028 -1.045 . . . . 0.0 111.447 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -92.61 119.25 31.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -61.06 126.02 25.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 110.798 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -99.1 1.4 45.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.803 -0.56 . . . . 0.0 109.698 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.13 43.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 86.4 m-20 -67.19 -21.87 65.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.7 p -123.38 16.33 9.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.513 -0.742 . . . . 0.0 111.46 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.39 143.56 35.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.072 -1.018 . . . . 0.0 111.244 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.34 139.21 8.71 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.6 t -88.84 110.51 21.11 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.909 -0.76 . . . . 0.0 110.125 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 59.6 tp -71.03 114.58 9.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.782 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.5 mm? -68.87 -25.0 64.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.234 0.54 . . . . 0.0 110.335 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.8 m -120.82 84.54 38.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.763 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -61.69 143.26 96.31 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.919 1.483 . . . . 0.0 110.039 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -152.96 167.78 12.72 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -57.54 125.29 18.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.773 1.407 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.9 -25.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.749 -0.594 . . . . 0.0 110.931 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.1 t -57.93 -34.95 70.42 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 109.496 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.87 1.52 38.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.549 -0.719 . . . . 0.0 110.913 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -72.33 68.92 0.78 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.129 0.966 . . . . 0.0 109.173 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 157.05 -21.28 0.43 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 t -75.0 -11.45 60.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.506 -0.997 . . . . 0.0 110.367 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . 0.401 ' HA ' ' CD2' ' A' ' 154' ' ' PHE . 0.8 OUTLIER -68.71 150.9 47.37 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.314 -0.866 . . . . 0.0 109.216 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 87.31 -11.49 65.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.54 -167.41 6.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -139.98 140.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 116.866 -1.623 . . . . 0.0 111.622 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.67 99.2 11.94 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.4 mp -86.47 142.39 28.41 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.797 0.808 . . . . 0.0 112.759 -176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.04 -170.15 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.36 12.55 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.62 1.326 . . . . 0.0 111.031 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -119.86 -18.95 8.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 111.36 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 39.12 0.81 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 55.9 m80 -122.96 118.65 28.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -1.043 . . . . 0.0 110.538 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.08 120.29 24.64 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 109.354 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.18 -3.89 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 112.068 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.462 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.6 124.41 1.85 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.362 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 46' ' ' THR . 14.9 mt -106.12 121.75 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.014 -1.286 . . . . 0.0 109.009 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 10.5 t80 -51.36 124.53 12.09 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.76 0.791 . . . . 0.0 111.978 -178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -114.63 -34.13 5.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.843 -0.535 . . . . 0.0 110.818 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.54 164.41 26.89 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.488 -0.757 . . . . 0.0 110.326 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.78 158.06 37.55 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 2.7 t -99.96 98.79 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.9 p -96.23 118.27 32.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.432 1.11 . . . . 0.0 112.32 -177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 162' ' ' GLY . 90.9 m -93.45 119.52 32.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.0 ttm105 65.51 -64.4 0.19 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.958 -0.464 . . . . 0.0 110.135 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -165.1 25.54 0.18 Allowed Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.819 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.2 m -148.9 139.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -1.186 . . . . 0.0 109.494 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -82.26 123.01 28.65 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.596 0.712 . . . . 0.0 111.679 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -113.83 17.65 17.89 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.25 0.548 . . . . 0.0 109.851 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.43 149.34 2.16 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.4 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.64 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -107.39 149.5 27.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.3 p90 -152.13 166.36 31.91 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.234 -1.386 . . . . 0.0 112.174 -178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 66.8 t -80.98 137.41 49.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -78.35 141.35 18.0 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.839 1.442 . . . . 0.0 110.739 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.02 -29.98 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.72 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.06 -32.84 70.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.393 -0.817 . . . . 0.0 108.981 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.8 t -72.1 -33.63 68.01 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' MET . . . . . 0.507 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 10.4 mtp -70.03 -36.26 74.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.781 -0.574 . . . . 0.0 110.036 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.417 -0.802 . . . . 0.0 110.792 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.133 0.492 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.9 167.53 43.16 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 -70.03 -61.28 1.84 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.459 -1.024 . . . . 0.0 109.758 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 t0 48.43 49.96 17.4 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.717 -0.614 . . . . 0.0 112.612 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 67' ' ' PRO . 32.2 mttt -115.31 172.48 7.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 110.706 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 63.77 123.94 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.968 -1.083 . . . . 0.0 109.341 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -58.13 127.37 31.74 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.33 -0.856 . . . . 0.0 110.737 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -86.43 -53.27 10.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.516 0.674 . . . . 0.0 110.053 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 48.21 37.39 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.695 -0.628 . . . . 0.0 111.209 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.02 134.1 8.51 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.8 mp0 -69.92 -40.08 75.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.878 . . . . 0.0 110.166 179.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -123.52 129.98 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -116.63 127.78 54.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.688 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 98.5 t -84.33 136.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.91 174.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.534 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.1 t -138.24 136.19 36.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.093 0.949 . . . . 0.0 109.129 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 19.4 p -113.64 179.9 3.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.912 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.64 32.92 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.5 p -104.78 -36.73 7.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.302 -0.873 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.6 -169.14 0.48 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.853 -1.154 . . . . 0.0 111.957 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 68.1 m -123.71 143.76 50.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.862 -0.524 . . . . 0.0 109.601 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.2 p90 -160.26 -138.12 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.549 -0.719 . . . . 0.0 109.911 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 82.0 mt -135.4 166.64 22.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.421 -1.425 . . . . 0.0 113.653 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.05 122.81 8.66 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.243 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 32.7 m -101.14 127.21 47.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.44 -0.787 . . . . 0.0 111.729 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.3 m -74.11 123.11 23.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.825 -0.547 . . . . 0.0 109.827 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.95 130.04 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.455 -0.778 . . . . 0.0 110.096 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.67 40.01 29.45 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.476 -0.765 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.19 28.04 73.49 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.439 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 63.5 t -140.04 117.0 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.963 . . . . 0.0 109.29 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.4 t -76.28 122.99 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.294 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.439 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 95.5 m95 -113.48 130.02 56.42 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.427 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 11.8 t -133.08 -179.75 5.68 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 7.0 m -90.72 131.0 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.076 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.92 -40.04 87.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 49.8 p-80 -74.82 68.74 1.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.29 1.043 . . . . 0.0 108.829 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.0 -38.43 0.16 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.02 -66.79 0.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.792 -0.828 . . . . 0.0 109.182 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.52 -98.84 1.06 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -91.28 46.36 1.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.907 . . . . 0.0 110.629 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.6 pttt 37.54 -130.34 0.16 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.037 0.535 . . . . 0.0 111.5 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 49.8 m 47.34 54.11 9.99 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.243 -0.911 . . . . 0.0 111.919 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -86.95 -132.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -141.25 109.02 5.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.547 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -73.06 -149.51 1.15 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' CG ' ' O ' ' A' ' 26' ' ' LYS . 42.0 Cg_endo -60.18 -32.15 94.11 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 124.321 1.695 . . . . 0.0 109.259 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -153.33 -2.67 0.21 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.91 162.44 28.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.648 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.2 125.8 16.53 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.956 1.503 . . . . 0.0 111.014 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.452 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 39.8 mt -104.86 152.61 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 0.0 109.676 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -96.24 144.83 26.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.731 -0.606 . . . . 0.0 110.626 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 14.8 pt20 -75.94 151.4 37.3 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.574 -0.704 . . . . 0.0 110.784 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.6 ttt -98.78 -39.84 8.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.547 -0.721 . . . . 0.0 110.398 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.8 OUTLIER -139.97 166.75 23.82 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.417 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 24.0 m -154.68 111.06 3.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.628 -0.67 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.86 78.61 5.38 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -40.0 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.428 -0.795 . . . . 0.0 109.767 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -55.74 -26.22 44.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 0.0 109.003 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -111.66 -0.71 15.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.736 -0.602 . . . . 0.0 110.762 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.7 t70 59.95 57.75 2.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.105 -0.997 . . . . 0.0 109.553 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 52.8 tp -146.23 152.37 39.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.92 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.421 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -143.11 127.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.25 123.96 5.76 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.262 -1.446 . . . . 0.0 111.753 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.444 ' CD1' ' HA ' ' A' ' 73' ' ' GLN . 3.2 m-90 -84.72 -174.94 5.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.144 -0.621 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -110.07 73.71 0.85 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.34 130.87 88.87 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 121.791 -0.568 . . . . 0.0 111.436 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.585 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 40.6 Cg_endo -134.14 -91.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.65 0 O-C-N 123.658 1.346 . . . . 0.0 110.422 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.9 Cg_endo -81.93 8.64 4.34 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 114.855 -2.964 . . . . 0.0 111.494 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -118.5 43.58 1.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -175.43 134.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -1.048 . . . . 0.0 110.651 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -73.48 -28.49 61.96 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.545 0.688 . . . . 0.0 110.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.67 115.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.39 0.614 . . . . 0.0 111.151 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.65 167.09 15.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.661 -0.649 . . . . 0.0 110.121 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.432 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 3.8 m -89.49 135.23 31.21 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.1 -85.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.054 0 O-C-N 123.894 1.471 . . . . 0.0 110.067 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.34 114.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.081 -1.012 . . . . 0.0 110.463 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 99' ' ' CYS . 94.1 m -61.05 -40.05 92.16 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.412 -0.805 . . . . 0.0 111.848 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.6 m 61.79 117.3 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.418 -0.801 . . . . 0.0 111.754 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.98 -38.73 92.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -70.48 148.9 47.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.952 -0.734 . . . . 0.0 109.208 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -117.46 14.62 14.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 111.375 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.18 75.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 108.786 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.8 mt -84.28 176.19 8.9 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.479 0.657 . . . . 0.0 111.125 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.9 m-85 -140.96 131.89 26.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.96 148.13 35.68 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.946 0.879 . . . . 0.0 111.529 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.9 t -119.97 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.414 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 26.7 p -81.08 179.9 7.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.287 -0.883 . . . . 0.0 109.525 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -41.87 -29.9 0.23 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -116.66 -50.01 2.63 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.12 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -156.86 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.934 -1.104 . . . . 0.0 111.597 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 16.9 t70 47.08 73.67 0.18 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.088 -1.008 . . . . 0.0 111.203 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -82.56 99.99 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.189 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.8 mm -120.95 150.01 52.21 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.753 -0.592 . . . . 0.0 109.542 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 48.3 Cg_endo -90.44 133.03 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 124.015 1.534 . . . . 0.0 110.559 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.7 t -127.57 130.03 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -90.34 118.23 29.68 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.42 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.6 ttp180 -62.07 125.8 25.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.805 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -98.43 4.36 48.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.787 -0.571 . . . . 0.0 109.569 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.99 170.67 32.17 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 107.436 -2.266 . . . . 0.0 107.436 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 78.2 m-20 -60.83 -19.69 60.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -1.022 . . . . 0.0 110.122 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -121.56 15.98 11.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 0.0 111.822 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -146.08 143.27 29.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.987 -1.07 . . . . 0.0 111.431 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.51 141.85 11.81 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.4 m -90.3 111.6 22.85 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.951 -0.735 . . . . 0.0 110.326 -179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 55.5 tp -73.56 109.93 7.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.347 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.8 mm? -60.03 -30.0 68.89 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.4 m -114.25 97.75 46.6 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.516 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.91 142.18 74.34 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.909 1.478 . . . . 0.0 109.965 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -149.99 161.06 32.3 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.81 122.84 12.42 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.832 1.438 . . . . 0.0 110.92 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.98 -28.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 t -59.01 -34.9 72.4 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.66 0.743 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -70.04 -27.32 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.47 5.6 30.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.484 -0.76 . . . . 0.0 110.858 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -68.11 110.16 3.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.04 55.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.6 p -74.9 -17.93 60.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -1.04 . . . . 0.0 109.056 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.09 149.51 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 108.885 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . 91.16 -9.51 77.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -77.15 -151.52 4.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 51.7 Cg_endo -147.5 148.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 116.307 -1.996 . . . . 0.0 112.921 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.4 mp -99.89 98.43 9.21 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 135.61 34.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.425 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 84.4 m -58.82 175.6 0.32 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 40.5 Cg_endo -72.11 -5.04 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 117.215 -1.39 . . . . 0.0 110.977 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.8 t -106.14 -0.22 24.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.905 -1.122 . . . . 0.0 112.27 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.84 6.55 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.432 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 34.7 m170 -114.04 118.53 34.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.34 121.86 24.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.394 -0.816 . . . . 0.0 110.685 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.03 -4.12 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.799 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.472 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -152.79 131.08 3.22 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.279 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.411 ' CD1' ' CE ' ' A' ' 175' ' ' MET . 74.5 mt -109.91 119.14 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.098 -1.236 . . . . 0.0 108.163 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 16.9 t80 -49.99 129.29 20.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.393 -0.817 . . . . 0.0 112.362 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -117.22 -30.08 5.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.938 -0.476 . . . . 0.0 111.569 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -162.08 146.56 12.51 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.585 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.97 138.29 37.24 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 42.9 t -95.72 90.97 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.1 p -94.03 122.24 36.33 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.115 0.96 . . . . 0.0 112.111 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 80.4 m -87.1 -102.07 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.116 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 -59.98 -50.0 75.47 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.601 -1.312 . . . . 0.0 109.464 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -176.18 30.53 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.0 m -149.84 145.89 17.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -75.92 125.34 28.91 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 0.0 111.24 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -103.88 7.14 36.84 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.298 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -175.26 137.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 124' ' ' GLY . 16.0 m -105.82 134.68 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.428 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -100.41 146.59 26.82 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 40.3 p90 -152.55 162.96 40.5 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.314 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.0 t -79.82 143.76 58.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.499 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.75 141.54 9.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.747 1.393 . . . . 0.0 111.717 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.9 p -69.05 -27.67 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.08 -28.69 66.72 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.3 t -70.65 -26.28 63.38 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.411 ' CE ' ' CD1' ' A' ' 153' ' ' ILE . 66.3 mtt -69.32 -36.62 77.14 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.778 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.9 p -60.74 -40.06 90.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.011 -1.056 . . . . 0.0 109.525 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.467 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 94.4 m -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.61 -39.89 89.84 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.7 -39.73 92.52 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.742 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -163.55 121.01 1.83 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.886 -0.509 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 183' ' ' LYS . 12.9 p -72.87 87.87 1.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.956 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 182' ' ' SER . 57.7 tptt 63.58 -61.78 0.15 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.218 -0.301 . . . . 0.0 111.303 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 53.22 58.77 4.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.965 -1.084 . . . . 0.0 110.403 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -70.54 -39.93 73.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.506 0.669 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.5 mttp . . . . . 0 C--N 1.294 -1.833 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.278 -179.855 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.438 ' O4 ' ' CD2' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.168 0.509 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.9 143.15 14.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -120.03 139.98 51.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.635 -0.921 . . . . 0.0 110.391 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.414 ' HB2' ' HA ' ' A' ' 67' ' ' PRO . 83.9 m-20 -81.26 161.71 23.82 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.798 179.168 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -80.04 70.03 6.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.594 -0.691 . . . . 0.0 111.624 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 47.26 25.05 0.5 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.49 -0.756 . . . . 0.0 112.309 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.14 -69.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.544 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 44.9 39.95 4.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.61 -0.681 . . . . 0.0 112.476 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.46 143.47 11.56 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.542 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.76 -40.02 72.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.795 -0.826 . . . . 0.0 109.985 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.9 t -119.89 123.45 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -94.68 122.84 37.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.719 . . . . 0.0 111.314 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.1 t -82.78 132.83 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.79 175.13 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.756 0.788 . . . . 0.0 110.427 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -140.04 149.82 43.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 HG23 ' CE1' ' A' ' 43' ' ' PHE . 3.4 t -116.8 79.03 1.27 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.376 1.084 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.45 -52.51 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.449 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -120.7 9.28 10.73 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.585 -1.322 . . . . 0.0 113.966 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -161.73 178.07 9.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.628 -1.295 . . . . 0.0 112.236 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.7 m -129.92 150.2 51.31 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.218 0.532 . . . . 0.0 109.942 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 9.9 p90 -160.32 -148.14 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 0.0 109.414 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' O ' ' OG1' ' A' ' 54' ' ' THR . 93.5 mt -136.42 165.34 26.05 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.608 -1.308 . . . . 0.0 113.772 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.4 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -152.42 130.71 12.03 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.41 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.4 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 99.7 m -99.9 120.46 39.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.402 -0.811 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -72.15 124.58 25.31 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.14 127.66 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 50.1 39.97 20.54 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.552 -0.718 . . . . 0.0 111.432 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.35 73.6 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.419 HG13 ' CE2' ' A' ' 53' ' ' TRP . 58.9 t -137.7 115.04 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -1.111 . . . . 0.0 109.348 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 29.1 t -75.4 119.68 19.83 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.25 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.46 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 84.9 m95 -108.53 127.42 53.92 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.869 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.464 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 6.9 t -133.99 -178.6 5.1 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 21.2 m -93.24 131.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.238 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.0 -41.89 93.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.506 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 45.9 p-80 -70.0 -14.5 62.73 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.699 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.1 -47.94 2.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.02 -79.97 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.8 -0.823 . . . . 0.0 109.066 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.53 13.22 Favored Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.3 -0.875 . . . . 0.0 111.086 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 63' ' ' THR . 69.9 m -136.01 13.31 3.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.251 -1.146 . . . . 0.0 111.818 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt 60.05 -71.29 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 0.0 111.715 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' SER . 8.9 m -77.3 145.76 37.23 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.831 0.824 . . . . 0.0 111.494 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.423 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -147.05 -119.29 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.34 95.47 1.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.739 -1.225 . . . . 0.0 109.424 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -99.92 -171.1 30.0 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.639 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 44.2 Cg_endo -62.76 -21.97 73.49 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 124.154 1.607 . . . . 0.0 110.679 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -102.54 -4.52 25.17 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.054 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.65 -150.42 18.05 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -64.63 112.47 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.001 1.527 . . . . 0.0 110.477 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.421 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 55.3 mt -101.67 149.92 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.371 0.605 . . . . 0.0 109.941 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.83 153.1 17.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.681 -0.637 . . . . 0.0 110.381 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.448 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 5.4 pt20 -80.09 159.97 25.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.658 -0.652 . . . . 0.0 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.2 ttp -101.91 -32.19 10.34 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.632 -0.667 . . . . 0.0 109.592 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' CE1' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -149.99 168.98 22.29 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.483 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 91.0 m -153.84 118.55 4.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.382 -0.824 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -101.05 74.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 87.7 t -59.96 -38.65 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.52 -0.738 . . . . 0.0 109.725 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -54.34 -26.79 31.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.512 -0.743 . . . . 0.0 109.03 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.61 0.71 14.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.733 -0.605 . . . . 0.0 111.05 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 60.07 56.84 3.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.5 tp -145.96 146.57 31.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.457 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -146.06 136.62 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -122.05 123.78 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.531 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.464 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.4 m-90 -88.47 -173.72 4.29 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.16 109.97 21.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 108.628 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.51 125.31 89.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.566 -0.709 . . . . 0.0 110.753 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.02 167.97 19.44 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.833 1.438 . . . . 0.0 109.531 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -58.24 152.65 51.51 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.689 1.363 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.92 74.61 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.34 118.14 22.94 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.321 -1.105 . . . . 0.0 109.7 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -85.83 88.1 7.51 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.1 p -79.33 160.0 26.94 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.452 0.644 . . . . 0.0 110.535 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 90.9 mt -97.91 161.73 13.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.828 -0.545 . . . . 0.0 110.475 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.425 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 94.4 m -103.7 150.01 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.664 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.04 145.49 9.89 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.97 1.51 . . . . 0.0 109.957 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.407 ' HB3' ' CB ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -163.19 160.98 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.453 -0.78 . . . . 0.0 110.037 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.7 m -119.96 124.96 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.9 m -121.55 150.91 40.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 111.013 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.04 -25.93 68.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.0 t -100.04 129.19 46.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.043 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.9 m -98.55 19.78 13.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -69.95 75.56 0.47 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 84.2 mt -89.93 175.34 7.24 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.067 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 47.9 p90 -151.76 139.01 19.31 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.442 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 41.6 tp -109.82 162.92 14.01 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.774 0.797 . . . . 0.0 111.633 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.442 ' N ' ' HG ' ' A' ' 106' ' ' LEU . 75.1 t -110.01 123.99 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.803 -0.561 . . . . 0.0 110.197 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.443 ' N ' HG21 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -82.9 -179.65 7.5 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -49.18 -24.21 1.62 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.844 -0.535 . . . . 0.0 110.279 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -94.06 -71.33 0.66 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.611 -0.68 . . . . 0.0 110.383 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.91 -50.88 0.09 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -133.91 151.84 51.65 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.988 -1.07 . . . . 0.0 112.827 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.443 HG21 ' N ' ' A' ' 108' ' ' THR . 15.9 t -118.91 43.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 59.97 178.65 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.29 138.99 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.757 1.399 . . . . 0.0 110.871 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -124.3 132.94 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.094 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 tpp85 -90.28 120.04 31.09 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 6.7 ttp180 -64.15 123.37 18.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 110.16 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -100.05 4.55 44.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.621 -0.674 . . . . 0.0 109.778 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.98 172.74 38.86 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.0 m-20 -61.97 -22.5 65.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.488 -1.007 . . . . 0.0 110.218 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.2 p -123.21 17.2 9.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -144.13 139.43 28.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.887 -1.133 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -135.16 142.9 14.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 t -92.16 110.01 21.39 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.727 -0.866 . . . . 0.0 110.566 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 18.1 tp -71.59 105.79 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.06 -31.49 70.04 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.365 0.602 . . . . 0.0 110.089 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 73.5 m -115.07 94.59 39.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.637 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.61 148.06 86.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.885 1.466 . . . . 0.0 109.697 179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.01 168.76 11.63 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -59.32 125.75 18.88 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.887 1.467 . . . . 0.0 110.334 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.96 -24.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.762 -0.587 . . . . 0.0 111.387 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.4 t -52.91 -32.84 47.53 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.405 -0.809 . . . . 0.0 109.677 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -71.94 -28.87 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.49 0.09 54.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.736 . . . . 0.0 111.587 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -70.78 108.35 4.41 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.28 -0.888 . . . . 0.0 108.647 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.16 -9.42 56.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 19.3 t -76.16 -14.99 60.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.427 -1.043 . . . . 0.0 109.246 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.95 147.34 53.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.839 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.405 ' CA ' HG12 ' A' ' 55' ' ' VAL . . . 94.06 -10.84 71.53 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.23 -158.28 4.7 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 49.1 Cg_endo -144.54 144.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 116.818 -1.655 . . . . 0.0 112.467 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.0 mt -98.32 97.57 8.93 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 6.0 mp -89.47 144.71 25.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 54.6 m -63.95 -174.03 0.11 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 41.3 Cg_endo -86.01 9.9 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.573 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -107.91 -23.52 12.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.998 . . . . 0.0 110.767 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.8 36.1 1.19 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.425 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 73.0 m80 -120.09 127.73 52.81 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -1.061 . . . . 0.0 110.82 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.24 120.82 23.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.506 -0.746 . . . . 0.0 109.434 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -122.43 -4.54 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.896 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -160.06 128.58 2.0 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.281 -1.438 . . . . 0.0 111.33 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 32.5 mt -107.82 117.93 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.211 -1.17 . . . . 0.0 108.286 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.427 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 16.4 t80 -51.96 128.72 25.09 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.539 0.685 . . . . 0.0 112.402 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -117.75 -29.22 5.77 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.833 -0.542 . . . . 0.0 111.498 -179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.401 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -161.27 145.63 13.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.207 -0.933 . . . . 0.0 111.412 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.59 139.39 35.31 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -88.24 93.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 72.2 m -91.55 122.26 33.97 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.273 1.035 . . . . 0.0 112.81 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.6 m -120.06 130.06 54.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.771 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 56.16 23.46 7.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.477 -0.764 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 90.19 20.02 43.89 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.38 -0.825 . . . . 0.0 111.787 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 m -145.98 142.85 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.06 -1.259 . . . . 0.0 109.352 178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.35 129.06 34.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 111.129 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -119.77 11.3 11.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.0 110.302 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -174.33 141.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.427 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 19.0 m -113.65 135.17 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.711 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -101.6 145.14 29.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.469 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 39.3 p90 -154.4 163.81 39.59 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.033 -1.467 . . . . 0.0 112.892 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 65.3 t -86.48 130.0 51.0 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.99 147.48 21.17 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 O-C-N 123.688 1.362 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.1 p -70.0 -30.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.733 -0.604 . . . . 0.0 109.528 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.88 -32.91 71.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -75.01 -32.67 61.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.559 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.401 ' HE1' ' CD1' ' A' ' 53' ' ' TRP . 1.0 OUTLIER -65.03 -35.61 81.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.895 -0.503 . . . . 0.0 109.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -45.73 91.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.5 p -73.33 -29.89 62.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.742 -0.599 . . . . 0.0 109.389 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.49 ' CG2' ' CE1' ' A' ' 75' ' ' TYR . 66.8 m -60.06 -39.76 87.11 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 67.0 mtt -60.63 -44.89 95.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.954 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -70.56 -42.81 70.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.533 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 10.86 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.4 t -172.18 36.65 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -143.67 139.51 29.6 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.672 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -71.37 -40.0 70.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.677 -0.64 . . . . 0.0 110.113 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 81.1 tttt 54.07 86.79 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.52 -0.737 . . . . 0.0 110.614 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.3 tttt . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.101 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.443 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 162.31 46.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.51 -139.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.951 -0.735 . . . . 0.0 109.161 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.61 130.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.996 -1.065 . . . . 0.0 109.842 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.426 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 79.1 mttt -65.08 145.95 55.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.908 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 59.11 163.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 110.002 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' GLU . 89.3 mt-30 -52.7 120.2 5.43 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.389 0.614 . . . . 0.0 110.154 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.404 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 3.1 t 59.35 -73.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 28' ' ' GLN . 2.3 mt-10 -166.29 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 110.398 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.16 -164.71 23.29 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.31 -54.17 11.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.626 -0.926 . . . . 0.0 110.262 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.9 t -129.95 130.05 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.644 -0.66 . . . . 0.0 109.329 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -98.99 122.83 42.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.9 t -84.86 128.48 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -148.02 176.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.176 -0.953 . . . . 0.0 110.593 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 32.1 t -149.24 144.25 26.41 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.788 0.804 . . . . 0.0 108.895 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 t -118.83 -178.38 3.54 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.54 -17.52 1.29 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.807 -0.558 . . . . 0.0 112.227 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.8 p -96.57 -40.76 8.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.058 . . . . 0.0 112.287 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 -170.56 0.64 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.885 -1.134 . . . . 0.0 112.641 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 67.8 m -109.99 143.26 40.22 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.9 p90 -161.79 -146.38 0.12 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.152 -0.967 . . . . 0.0 110.749 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.7 mt -134.26 166.59 22.45 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.707 1.241 . . . . 0.0 113.925 -176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.423 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -151.94 118.56 5.71 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.712 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.43 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 53.9 m -91.59 123.11 34.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 0.0 111.219 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 47.3 t -74.87 110.0 8.81 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.99 130.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.538 -0.726 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.29 40.03 25.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.561 -0.712 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.33 27.39 71.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 60.6 t -139.99 117.64 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -77.23 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.54 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.501 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.4 m95 -107.14 124.39 49.62 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.139 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.479 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 9.8 t -128.61 -175.33 3.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 27.7 m -93.15 130.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.504 -1.278 . . . . 0.0 112.703 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.94 -44.17 94.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.462 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -66.81 -18.13 65.22 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.774 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -93.54 -36.12 5.98 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.87 -70.08 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.663 -0.904 . . . . 0.0 110.503 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.17 118.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.5 40.02 22.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.427 -1.043 . . . . 0.0 111.402 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 pttt 36.28 -129.57 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 122.907 0.483 . . . . 0.0 111.939 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m 49.79 73.13 0.27 Allowed 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.155 -0.965 . . . . 0.0 112.109 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.458 ' CD2' ' CZ2' ' A' ' 85' ' ' TRP . 4.5 mm? -84.2 -161.52 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.75 100.61 5.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.489 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.76 -179.48 52.36 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 49.9 Cg_endo -65.63 -11.69 31.73 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.763 1.401 . . . . 0.0 111.027 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -137.82 -1.04 2.05 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.791 -179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.23 177.97 42.1 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.09 -1.528 . . . . 0.0 111.017 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.84 131.35 19.53 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 124.14 1.6 . . . . 0.0 110.561 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -90.05 159.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.7 m -111.94 139.1 47.72 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.466 -0.771 . . . . 0.0 112.391 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.473 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 6.9 pt20 -83.99 165.06 18.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.654 . . . . 0.0 111.837 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.8 mtp -100.03 -45.45 5.67 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.564 -0.71 . . . . 0.0 109.969 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -158.84 -177.96 6.9 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.407 ' HB ' HG13 ' A' ' 83' ' ' VAL . 5.1 t -159.98 142.69 13.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.719 0.771 . . . . 0.0 110.27 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -104.96 83.09 1.94 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.96 -40.05 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -55.15 -26.16 36.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -111.74 0.35 16.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.82 -0.55 . . . . 0.0 110.836 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.0 59.55 2.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 44.5 tp -145.72 152.1 39.05 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.454 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.477 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 1.5 m -140.0 132.07 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.401 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -121.63 126.9 6.67 Favored Glycine 0 N--CA 1.508 3.459 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.852 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.479 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.1 m-90 -90.52 -169.59 2.45 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.046 -0.679 . . . . 0.0 111.243 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -113.04 95.46 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.683 -0.636 . . . . 0.0 110.42 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.23 130.0 89.95 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.419 -0.801 . . . . 0.0 109.878 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.03 157.68 34.26 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.799 1.421 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.88 152.51 68.72 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 O-C-N 123.821 1.432 . . . . 0.0 110.537 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.39 -8.27 47.99 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -86.85 -144.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.152 -1.204 . . . . 0.0 109.31 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -147.48 100.04 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -92.8 166.93 12.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.591 0.71 . . . . 0.0 111.102 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.411 ' HB2' ' HB3' ' A' ' 150' ' ' ALA . 83.2 mt -109.78 148.63 31.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -105.53 -173.91 0.3 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.189 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -117.44 154.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.992 0 O-C-N 123.847 1.446 . . . . 0.0 110.276 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.5 p -142.25 171.08 14.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.284 -0.885 . . . . 0.0 111.29 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.3 p -50.73 -25.85 4.84 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.469 -0.769 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m 59.63 51.02 6.67 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.229 -0.92 . . . . 0.0 111.66 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.04 95.99 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 m -103.18 140.57 37.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.741 -0.858 . . . . 0.0 108.869 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 m -96.49 17.12 16.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 111.217 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.56 69.22 1.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.7 mt -75.07 174.6 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.755 -0.591 . . . . 0.0 110.903 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.1 m-85 -140.52 130.01 24.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.676 -0.64 . . . . 0.0 109.519 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.2 tp -110.56 152.03 26.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.727 0.775 . . . . 0.0 111.286 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 81.1 t -108.97 132.26 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 110' ' ' HIS . 75.8 p -80.83 169.36 17.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -34.39 -32.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 108' ' ' THR . 81.7 m-70 -97.73 -85.34 0.36 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.79 16.01 0.1 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.177 -0.952 . . . . 0.0 112.327 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 47.8 t0 -68.43 130.03 41.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.835 -1.166 . . . . 0.0 110.036 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.4 p -97.37 117.43 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.698 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 3.8 tt -116.29 119.82 35.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.572 -0.705 . . . . 0.0 109.654 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.411 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.0 Cg_endo -70.2 131.32 20.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.616 1.324 . . . . 0.0 111.701 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 61.4 t -130.0 132.29 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.771 -0.581 . . . . 0.0 109.456 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -88.19 112.06 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.44 122.56 10.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 111.13 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -98.51 0.45 45.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.636 -0.665 . . . . 0.0 110.047 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.79 -174.4 46.85 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 91.0 m-20 -70.07 -22.7 63.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -1.043 . . . . 0.0 110.053 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.3 p -124.9 17.38 8.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.569 -0.707 . . . . 0.0 111.465 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.99 145.2 37.52 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.281 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.29 142.14 11.81 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.0 t -88.82 111.56 22.19 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.873 -0.781 . . . . 0.0 109.785 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.6 tp -70.38 112.37 6.63 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.08 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.95 -19.98 63.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.825 -0.547 . . . . 0.0 110.587 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 36.7 m -120.0 79.96 25.93 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.672 -0.643 . . . . 0.0 109.945 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -57.78 142.47 96.12 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.849 1.447 . . . . 0.0 110.641 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -155.33 167.15 14.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -58.9 128.02 26.46 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.746 1.393 . . . . 0.0 109.76 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.25 -25.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.683 -0.635 . . . . 0.0 111.085 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 91.0 p -58.44 -30.37 66.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.598 -0.689 . . . . 0.0 109.564 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -70.04 -29.31 66.31 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.42 3.98 25.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.5 mtpm? -66.89 111.63 3.88 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.5 55.84 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -77.81 -13.64 59.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.529 -0.983 . . . . 0.0 109.924 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.9 m -67.59 147.35 52.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.078 -1.014 . . . . 0.0 110.22 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.414 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.96 -9.99 75.44 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.87 -163.64 1.72 Allowed Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.43 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 50.0 Cg_endo -143.26 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 117.033 -1.512 . . . . 0.0 111.852 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.6 mp -91.77 96.96 10.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 mp -83.6 143.83 29.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.201 1.0 . . . . 0.0 113.132 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 12.8 m -69.4 163.75 55.62 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.39 -11.2 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.577 1.304 . . . . 0.0 111.504 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.7 m -95.71 -0.06 51.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.925 -1.11 . . . . 0.0 111.808 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.93 33.5 6.62 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -118.73 128.49 54.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -1.147 . . . . 0.0 109.968 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.411 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -91.71 116.66 29.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.78 1.28 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.648 . . . . 0.0 111.904 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.465 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -147.96 128.3 2.84 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.856 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 68.8 mt -109.97 120.83 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.018 -1.284 . . . . 0.0 108.181 177.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 12.7 t80 -50.02 129.36 20.54 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.866 0.841 . . . . 0.0 112.711 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 40.1 ttt180 -117.31 -28.51 6.12 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 149.2 8.34 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.707 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -102.69 135.86 43.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.838 -0.538 . . . . 0.0 111.209 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.0 t -85.12 86.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 27.5 p -88.09 104.05 16.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.743 1.258 . . . . 0.0 112.191 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -99.72 133.91 43.37 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.162 178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 54.8 22.88 4.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.21 17.74 49.23 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.356 -0.84 . . . . 0.0 111.836 178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.02 140.74 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.255 . . . . 0.0 109.687 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 118.85 19.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.587 -0.696 . . . . 0.0 111.763 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -111.01 10.55 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.825 -0.547 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -175.04 140.01 0.51 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.82 135.88 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.256 -178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -103.94 147.36 27.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.465 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.1 p90 -154.32 164.25 38.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.263 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.4 t -82.25 138.46 45.36 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -77.65 149.3 26.67 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.741 1.39 . . . . 0.0 110.786 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.4 -29.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.316 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -29.29 68.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.242 -0.911 . . . . 0.0 108.846 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.5 t -70.21 -32.65 70.64 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.653 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.501 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -66.52 -39.92 88.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.596 -0.69 . . . . 0.0 109.643 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.18 -43.27 96.0 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.631 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 47.7 p -70.0 -31.22 68.78 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.672 -0.642 . . . . 0.0 110.57 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -40.06 87.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.452 -0.78 . . . . 0.0 109.195 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 96.7 mtp -63.08 -36.99 85.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.914 -0.491 . . . . 0.0 109.782 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -60.04 -32.96 71.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.747 . . . . 0.0 110.59 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.98 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.721 -0.612 . . . . 0.0 110.248 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.32 42.88 31.17 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.097 -1.002 . . . . 0.0 110.239 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -83.37 144.27 29.76 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.353 0.597 . . . . 0.0 110.487 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -71.14 -39.96 71.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 110.777 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -81.64 126.72 32.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.454 -0.779 . . . . 0.0 110.317 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.107 179.523 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.455 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.071 0.462 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.12 154.29 7.64 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -108.92 138.38 45.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.959 . . . . 0.0 109.985 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -81.58 168.97 17.63 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.223 0.535 . . . . 0.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.6 154.07 22.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 0.0 110.321 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -70.05 -39.96 75.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.614 -0.679 . . . . 0.0 111.182 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -89.76 122.55 32.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.342 -0.848 . . . . 0.0 110.803 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.1 t -83.98 -45.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.359 0.6 . . . . 0.0 110.101 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 50.11 39.92 20.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.557 -0.715 . . . . 0.0 111.796 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.46 33.89 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' CA ' ' HB3' ' A' ' 92' ' ' ARG . 11.1 pt-20 -95.37 -24.0 16.91 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.647 -0.913 . . . . 0.0 111.077 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -109.96 119.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.547 -0.721 . . . . 0.0 109.343 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -102.26 125.3 48.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.639 -0.663 . . . . 0.0 110.79 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.68 128.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.73 174.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.631 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.3 p -146.92 133.63 19.98 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.703 0.763 . . . . 0.0 109.217 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -107.48 -179.93 4.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.2 5.89 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.591 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 p -99.34 -37.23 9.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 112.607 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.47 -170.0 0.77 Allowed 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.62 -1.3 . . . . 0.0 113.13 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 28.6 p -116.25 141.14 48.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 14.9 p90 -163.67 -146.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.236 -0.915 . . . . 0.0 110.638 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 79.4 mt -131.92 160.43 35.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.777 -1.202 . . . . 0.0 113.121 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.28 128.44 9.74 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.817 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.409 HG23 ' CD1' ' A' ' 153' ' ' ILE . 7.6 t -80.01 -151.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 4.8 t -160.12 106.35 1.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.425 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.2 40.01 30.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.797 -0.564 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 45.5 t -133.93 113.06 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.973 . . . . 0.0 109.745 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 t -76.07 121.87 23.43 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 96.4 m95 -108.47 127.56 54.02 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.474 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.468 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 5.4 t -135.58 -179.14 5.46 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.46 HG12 ' HB3' ' A' ' 139' ' ' SER . 14.5 m -89.69 126.81 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 C-N-CA 118.18 -1.408 . . . . 0.0 112.213 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -59.95 -42.49 94.17 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.61 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.46 ' CG ' ' CD2' ' A' ' 188' ' ' 2ZF . 30.0 p-80 -71.31 73.74 0.7 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.589 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.83 -32.72 0.56 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.24 -69.99 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.575 -0.956 . . . . 0.0 110.927 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.64 0.1 15.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m 53.43 66.72 1.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.129 -1.218 . . . . 0.0 111.266 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -165.58 -62.86 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.227 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 14.0 t -157.21 158.98 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.779 0.8 . . . . 0.0 111.839 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.424 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -149.61 -130.6 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.28 88.77 1.81 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.874 -1.141 . . . . 0.0 109.013 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -88.79 -176.28 46.82 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -58.99 -20.12 51.73 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 124.085 1.571 . . . . 0.0 110.543 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.5 0.0 20.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.416 -0.803 . . . . 0.0 111.295 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.99 -157.16 15.4 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.96 120.07 7.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.84 1.442 . . . . 0.0 111.35 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.428 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 34.9 mt -107.16 141.47 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.6 m -91.23 140.97 29.3 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.421 0.629 . . . . 0.0 110.826 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.25 147.02 49.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.783 -0.573 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.84 -29.87 12.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.467 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.4 OUTLIER -149.96 169.97 19.93 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.434 ' N ' ' CG ' ' A' ' 75' ' ' TYR . 27.3 m -154.28 112.41 3.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 110.69 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 81' ' ' ASP . 20.4 t-20 -91.12 77.85 5.95 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.02 -40.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -56.07 -25.6 45.91 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.94 -1.41 15.47 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.734 -0.604 . . . . 0.0 110.833 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.8 t0 60.78 57.36 2.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.965 -1.085 . . . . 0.0 109.152 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.0 tp -145.36 154.52 42.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.657 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.458 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -145.67 128.22 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.9 119.76 4.76 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.037 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.468 ' CZ3' HG23 ' A' ' 54' ' ' THR . 5.4 m-90 -86.45 174.61 8.86 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -95.93 91.75 6.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.009 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.92 153.83 95.15 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.587 -0.696 . . . . 0.0 111.153 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -95.54 173.01 1.16 Allowed 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.935 1.492 . . . . 0.0 109.485 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.71 136.38 32.98 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.89 1.468 . . . . 0.0 110.287 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.41 -32.28 3.77 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.38 59.13 4.42 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.719 -0.871 . . . . 0.0 110.371 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' HB3' ' CA ' ' A' ' 32' ' ' GLU . 28.5 ttm180 24.07 95.25 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 124.313 1.045 . . . . 0.0 113.022 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.9 m -85.28 107.34 17.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.259 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 159.96 20.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.6 163.34 18.09 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.379 -0.826 . . . . 0.0 111.024 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.11 160.49 49.43 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 O-C-N 124.071 1.564 . . . . 0.0 109.848 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.423 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 51.2 t -166.21 158.54 14.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 111.051 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.2 t -151.67 66.86 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.697 -0.627 . . . . 0.0 109.654 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 53.4 m -69.35 -40.05 77.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.47 -0.769 . . . . 0.0 110.203 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.22 -14.68 33.42 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.9 m -63.23 -38.36 90.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.19 -1.182 . . . . 0.0 109.492 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.17 15.48 6.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.778 -0.576 . . . . 0.0 111.399 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -84.56 79.6 9.53 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.2 mt -88.04 174.6 8.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.037 0.923 . . . . 0.0 112.368 -177.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 97.4 m-85 -145.32 129.97 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.7 144.43 34.81 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.629 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.507 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 76.0 t -90.57 120.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.7 p -91.54 178.05 6.05 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.798 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -47.13 -25.98 1.0 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.896 -0.502 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -97.28 -70.13 0.73 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.638 -0.664 . . . . 0.0 109.311 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.06 -164.99 1.99 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.95 0.881 . . . . 0.0 110.06 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 8.9 t0 -52.92 -93.96 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.598 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.9 t 57.02 156.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.139 -0.976 . . . . 0.0 110.977 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 34.3 mt 53.7 105.33 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.274 -0.892 . . . . 0.0 111.849 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 50.2 Cg_endo -90.42 150.1 4.4 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.803 1.422 . . . . 0.0 109.319 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 21.9 t -131.26 139.87 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.322 -0.862 . . . . 0.0 110.832 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -98.49 117.06 32.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.444 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 22.5 ttp85 -62.82 129.16 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.328 -0.857 . . . . 0.0 110.996 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -102.92 4.81 37.96 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.445 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.33 178.76 40.82 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.56 -26.57 68.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.451 -1.029 . . . . 0.0 109.87 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.6 p -120.07 16.86 12.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.662 -0.649 . . . . 0.0 111.868 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -140.04 139.05 35.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.011 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.59 138.7 9.15 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.2 t -89.28 110.72 21.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.909 -0.759 . . . . 0.0 110.181 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.0 tp -70.86 110.67 5.75 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.819 179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.97 -21.72 63.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.831 -0.543 . . . . 0.0 110.515 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.7 m -120.43 82.95 32.87 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.617 . . . . 0.0 110.197 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -59.42 139.81 91.31 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 O-C-N 123.803 1.423 . . . . 0.0 110.152 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -152.27 164.26 20.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -54.06 125.97 20.51 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 O-C-N 123.786 1.414 . . . . 0.0 110.93 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 p -50.08 -25.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.86 -0.525 . . . . 0.0 110.91 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.0 m -58.81 -35.36 72.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.605 -0.684 . . . . 0.0 109.496 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -68.4 -28.13 66.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.2 0.95 38.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.351 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -70.63 119.49 14.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.256 -0.903 . . . . 0.0 108.597 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.53 -10.09 66.83 Favored Glycine 0 C--N 1.286 -2.207 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.4 t -78.65 -13.5 59.79 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.56 -0.965 . . . . 0.0 109.815 178.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 55' ' ' VAL . 14.5 m -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.007 -1.058 . . . . 0.0 110.695 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.453 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.94 -9.71 76.35 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -61.66 -179.23 3.25 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -128.04 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 117.206 -1.396 . . . . 0.0 111.761 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mt -94.52 97.19 9.97 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.413 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -89.62 141.31 28.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -59.35 -167.33 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.97 16.46 1.45 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.749 1.394 . . . . 0.0 110.905 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -122.03 -51.08 2.02 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -0.95 . . . . 0.0 110.916 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.62 42.42 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.423 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 79.3 m80 -127.13 126.62 43.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -1.068 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -88.0 103.0 15.29 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.5 m -109.92 8.18 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.386 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -159.19 134.08 3.62 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.873 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.415 ' CD1' ' CB ' ' A' ' 53' ' ' TRP . 1.6 mt -118.27 120.81 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.288 -1.124 . . . . 0.0 108.309 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.408 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 19.3 t80 -54.33 128.03 29.74 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.398 0.618 . . . . 0.0 112.5 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -119.28 -24.17 6.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 111.311 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.52 148.39 12.67 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.59 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -104.88 143.81 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.291 0.567 . . . . 0.0 111.38 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 47.2 t -94.74 88.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.0 p -89.88 111.08 22.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.505 1.145 . . . . 0.0 112.454 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 162' ' ' GLY . 93.6 m -92.59 125.95 37.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.415 ' HB3' ' O ' ' A' ' 160' ' ' THR . 73.9 ttt180 62.14 -70.6 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 122.014 -0.429 . . . . 0.0 110.056 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.05 24.98 0.25 Allowed Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.178 -1.011 . . . . 0.0 110.588 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -149.65 144.85 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.086 -1.244 . . . . 0.0 109.472 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.07 123.55 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.434 0.635 . . . . 0.0 111.123 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -112.47 11.41 19.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.784 -0.573 . . . . 0.0 110.581 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.77 144.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.9 m -117.87 137.3 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.889 0.852 . . . . 0.0 112.674 -178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -104.02 146.01 29.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 33.9 p90 -154.61 160.62 41.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.17 -1.412 . . . . 0.0 112.205 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.9 t -81.2 129.98 64.63 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.6 155.87 49.65 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.749 1.394 . . . . 0.0 110.784 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.41 -24.39 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.616 -0.677 . . . . 0.0 109.49 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.87 -30.23 67.58 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -71.9 -39.97 69.19 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.496 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.408 ' HG2' ' CG ' ' A' ' 53' ' ' TRP . 1.9 mpp? -64.72 -39.69 94.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -32.21 70.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.812 -0.555 . . . . 0.0 110.334 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -37.51 79.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.442 -0.787 . . . . 0.0 109.94 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.467 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 99.0 m -60.31 -45.45 93.34 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 109.023 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 86.8 mtp -62.49 -40.11 95.63 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.248 178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -72.05 -29.36 64.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.507 -0.745 . . . . 0.0 110.005 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 183' ' ' LYS . . . 59.94 20.05 9.08 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.701 -0.624 . . . . 0.0 110.96 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.4 t 58.14 -79.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.939 -0.475 . . . . 0.0 111.47 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 181' ' ' ALA . 98.8 mttt -84.93 137.07 33.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.263 -0.898 . . . . 0.0 110.413 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -86.31 12.28 10.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.735 -0.603 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.0 -32.57 70.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.0 mttm . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.822 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.46 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.129 0.49 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.7 -174.02 52.86 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -63.22 143.45 57.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.946 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -151.38 112.78 4.37 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.007 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -83.32 62.89 6.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.874 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -83.24 -152.8 0.12 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.603 -0.685 . . . . 0.0 109.358 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -79.99 167.46 20.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.512 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 32.6 m -86.25 16.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 O-C-N 121.504 -0.748 . . . . 0.0 111.24 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' A' ' 29' ' ' VAL . 44.3 mm-40 66.21 -61.69 0.28 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.763 -0.585 . . . . 0.0 111.601 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.99 -95.63 0.51 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.33 -47.07 5.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.742 -0.858 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -110.06 120.44 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -93.02 130.16 38.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 75.5 t -77.77 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.7 m -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.961 -177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.4 p -157.89 143.93 17.38 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.409 ' CG2' ' O ' ' A' ' 58' ' ' GLY . 4.5 t -109.37 -177.7 3.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.71 -14.44 0.91 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.577 -0.702 . . . . 0.0 112.869 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.5 t -112.0 -21.27 11.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -169.65 -171.88 1.31 Allowed 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.368 -1.457 . . . . 0.0 113.174 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -125.59 146.65 49.6 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 59' ' ' ALA . 6.7 p90 -162.79 -142.58 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.414 ' O ' ' OG1' ' A' ' 54' ' ' THR . 91.3 mt -135.63 162.03 33.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.525 -1.359 . . . . 0.0 113.229 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -151.46 130.0 12.22 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.286 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.2 m -99.92 125.35 45.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.702 . . . . 0.0 111.218 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.4 t -73.0 119.46 17.28 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.18 135.44 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.469 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 52.69 39.7 28.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.69 -0.632 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.67 23.37 73.89 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 60.5 t -140.62 120.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -1.078 . . . . 0.0 110.335 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.9 m -73.99 120.61 19.81 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.433 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 96.7 m95 -107.17 125.97 51.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.481 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -132.93 -176.41 4.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 32.3 m -87.03 127.17 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 C-N-CA 118.346 -1.342 . . . . 0.0 112.83 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.61 -40.03 93.38 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.6 p-80 -72.54 68.85 0.83 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.286 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.409 ' O ' ' CG2' ' A' ' 38' ' ' THR . . . 163.14 -59.45 0.28 Allowed Glycine 0 N--CA 1.484 1.856 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 43' ' ' PHE . . . -70.5 -40.04 73.79 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.694 -0.886 . . . . 0.0 111.2 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.72 -105.71 3.31 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.6 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.252 -1.146 . . . . 0.0 110.992 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -166.69 -102.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.8 -1.187 . . . . 0.0 112.119 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.5 m -84.48 108.24 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.746 -1.221 . . . . 0.0 111.648 -178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 ' HB2' ' CE2' ' A' ' 85' ' ' TRP 0.266 2.0 tm? -94.84 -12.53 26.8 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.326 0.584 . . . . 0.0 110.462 179.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 62.77 105.23 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.344 -0.847 . . . . 0.0 109.987 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -120.51 179.41 16.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.27 -17.65 54.12 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.945 1.497 . . . . 0.0 110.65 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.46 1.7 46.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 111.14 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.51 -168.13 13.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.53 116.9 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.937 1.493 . . . . 0.0 110.022 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.412 HG23 ' CD1' ' A' ' 85' ' ' TRP . 63.4 mt -97.44 139.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.527 0.679 . . . . 0.0 109.676 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.9 m -96.24 140.01 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.417 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 4.1 pt20 -66.01 149.84 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.708 . . . . 0.0 110.627 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.3 mmm -103.55 -27.27 12.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.731 -0.606 . . . . 0.0 109.889 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.494 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.1 OUTLIER -154.95 171.15 20.17 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.516 -0.74 . . . . 0.0 109.314 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.437 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 39.9 m -154.12 115.86 4.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.632 -0.667 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.76 76.36 3.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.99 -33.06 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.686 -0.634 . . . . 0.0 109.298 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.6 -26.6 13.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.07 8.36 6.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.13 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 62.42 61.77 1.22 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.765 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.5 tp -144.19 152.56 41.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -146.32 133.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.65 121.67 5.17 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.232 -1.461 . . . . 0.0 111.767 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.481 ' CZ3' HG23 ' A' ' 54' ' ' THR . 6.2 m-90 -89.19 -169.68 2.6 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.795 -0.826 . . . . 0.0 109.359 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -94.05 107.68 19.58 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.98 148.96 96.38 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.563 -0.711 . . . . 0.0 112.522 -177.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -118.88 175.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 1.024 0 O-C-N 123.928 1.488 . . . . 0.0 109.233 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.49 152.78 60.44 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 O-C-N 123.695 1.366 . . . . 0.0 110.864 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.58 -36.37 4.45 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 14.91 2.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.992 -0.711 . . . . 0.0 112.302 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 36.56 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -80.48 124.47 28.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 4.5 mm? -85.26 173.46 10.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.844 -0.535 . . . . 0.0 110.349 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.416 ' CG2' ' CD ' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -95.19 -168.4 0.17 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.596 -0.69 . . . . 0.0 110.915 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.416 ' CD ' ' CG2' ' A' ' 95' ' ' THR . 49.6 Cg_endo -132.85 125.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.837 0 O-C-N 123.986 1.519 . . . . 0.0 109.318 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.454 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -159.97 162.46 34.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -115.35 120.01 38.18 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.5 m -105.91 129.67 54.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.037 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.22 96.4 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.6 m -60.01 -37.12 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.483 -1.01 . . . . 0.0 110.137 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 58.08 21.44 7.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.778 -0.576 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.0 71.07 10.12 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 73.0 mt -79.75 174.38 11.64 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 111.779 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 94.0 m-85 -140.47 126.44 19.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.4 tp -109.3 128.59 55.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.342 -0.849 . . . . 0.0 111.427 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.1 t -75.59 134.74 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' HIS . 45.6 p -84.42 175.94 9.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.536 -0.728 . . . . 0.0 110.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -32.92 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' THR . 4.1 p80 -112.88 -65.24 1.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.31 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -158.6 -33.99 0.07 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.956 -1.09 . . . . 0.0 113.198 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 48.4 m-20 -44.01 116.54 1.01 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.331 -0.856 . . . . 0.0 112.038 -177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.0 m -84.29 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.264 0.554 . . . . 0.0 110.665 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 48.3 mm -113.9 110.85 48.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.668 . . . . 0.0 109.454 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.415 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 46.0 Cg_endo -64.28 120.01 7.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 O-C-N 123.875 1.46 . . . . 0.0 110.688 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.6 t -127.51 133.93 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 109.219 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -87.44 118.84 27.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.216 -0.928 . . . . 0.0 108.763 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -62.31 122.17 15.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -97.46 0.16 47.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.0 176.62 44.36 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 77.7 m-20 -62.3 -24.06 67.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -1.028 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 p -123.65 17.34 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 111.962 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -141.67 141.8 33.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 111.136 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.78 142.66 13.23 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.0 t -88.64 110.69 21.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.803 -0.822 . . . . 0.0 109.563 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.8 tp -69.46 109.99 4.51 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.569 -0.853 . . . . 0.0 108.804 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.51 -25.88 64.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.854 -0.528 . . . . 0.0 110.282 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.1 t -107.04 102.42 42.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.19 130.69 11.29 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 124.077 1.567 . . . . 0.0 109.573 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -152.46 163.13 24.55 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -55.39 128.39 30.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.744 1.391 . . . . 0.0 110.508 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -51.25 -24.91 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.854 -0.529 . . . . 0.0 111.135 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.9 p -57.51 -31.33 65.92 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -70.02 -28.81 65.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.48 2.4 37.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.482 -0.761 . . . . 0.0 111.024 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -66.86 107.81 2.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.37 -8.79 58.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -72.97 -16.61 61.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -1.069 . . . . 0.0 108.427 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.46 151.29 45.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.412 ' N ' ' CG1' ' A' ' 55' ' ' VAL . . . 89.45 -10.05 74.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.53 -159.68 4.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -138.73 138.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 O-C-N 123.821 1.432 . . . . 0.0 111.977 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 3.0 mt -95.43 95.38 8.4 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.9 mp -87.21 133.6 33.64 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.411 ' HB2' ' CD ' ' A' ' 146' ' ' PRO . 32.1 p -82.51 -172.46 0.36 Allowed Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.411 ' CD ' ' HB2' ' A' ' 145' ' ' CYS . 47.9 Cg_endo -84.24 20.53 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.106 1.056 . . . . 0.0 112.453 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.1 m -100.88 -18.03 16.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.015 -1.053 . . . . 0.0 111.102 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.98 39.94 3.21 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.454 ' CE1' ' HB3' ' A' ' 97' ' ' CYS . 0.2 OUTLIER -149.93 165.57 32.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 110.871 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.51 120.2 32.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.669 -0.645 . . . . 0.0 109.425 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 149' ' ' HIS . 2.6 t -99.97 -20.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.662 -0.649 . . . . 0.0 110.888 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.489 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . -159.4 140.94 7.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 49.5 mt -107.17 118.93 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.146 -1.208 . . . . 0.0 107.792 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.418 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 20.8 t80 -52.69 127.34 22.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.579 0.704 . . . . 0.0 111.957 -178.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -116.02 -28.69 6.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.849 -0.532 . . . . 0.0 111.962 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.404 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -160.37 140.9 11.73 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.201 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -98.64 134.37 41.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.726 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.9 t -89.96 92.44 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.1 p -89.99 109.91 20.92 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.52 1.152 . . . . 0.0 112.364 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.4 m -97.14 121.76 39.4 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.779 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 59.97 19.93 8.99 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.381 -0.824 . . . . 0.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 102.02 13.61 31.06 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.395 178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.9 m -144.91 140.03 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 118.684 1.242 . . . . 0.0 109.445 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 129.94 37.48 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.833 0.825 . . . . 0.0 111.603 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.63 14.43 7.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.731 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.21 150.84 2.49 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.418 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 9.6 m -133.64 135.84 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 119.376 -0.929 . . . . 0.0 112.695 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -102.14 149.08 24.64 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.489 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 36.1 p90 -154.74 164.68 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.076 -1.45 . . . . 0.0 112.583 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.61 137.25 38.82 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.59 145.64 14.74 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.582 1.306 . . . . 0.0 111.99 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.405 ' HA ' ' HE2' ' A' ' 175' ' ' MET . 10.7 p -69.97 -27.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 109.607 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.84 -29.97 65.38 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 m -73.1 -22.9 60.47 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.151 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.405 ' HE2' ' HA ' ' A' ' 172' ' ' VAL . 66.3 mtt -68.72 -40.11 80.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.206 -0.934 . . . . 0.0 108.931 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.07 -39.21 85.25 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.89 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 68.2 p -60.06 -28.46 67.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 0.0 110.688 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.494 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 35.9 m -62.66 -52.88 61.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.309 -0.87 . . . . 0.0 108.805 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.27 -32.95 72.47 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.734 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.98 -15.63 55.7 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.449 -0.782 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -167.82 165.55 13.95 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.332 -0.855 . . . . 0.0 110.791 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.8 33.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.564 -0.71 . . . . 0.0 110.087 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.91 6.8 40.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 110.803 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt 52.55 32.62 11.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.976 -1.078 . . . . 0.0 110.698 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -80.19 159.76 25.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.624 . . . . 0.0 110.571 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.201 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.458 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.056 0.455 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.54 -82.46 0.1 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -61.76 139.99 58.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.59 -0.947 . . . . 0.0 110.12 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -79.76 159.94 26.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.566 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' GLN . 59.0 mttm -97.16 112.93 24.5 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.365 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 48.33 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' LYS . 79.8 mt-30 -106.91 158.0 17.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.123 -0.986 . . . . 0.0 111.056 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.0 t -81.15 -62.27 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.434 0.635 . . . . 0.0 109.677 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 49.99 39.94 20.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.609 -0.682 . . . . 0.0 111.809 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.44 145.51 13.2 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.815 -1.183 . . . . 0.0 111.209 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.05 -40.0 75.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.848 -0.796 . . . . 0.0 110.452 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -111.03 119.96 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.54 132.67 40.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.71 -0.619 . . . . 0.0 110.444 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -80.8 138.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 16.5 m -139.99 171.72 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.621 0.724 . . . . 0.0 110.138 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -153.29 153.42 32.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.403 HG21 ' HG2' ' A' ' 41' ' ' GLN . 2.9 t -117.82 75.86 1.03 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.546 1.165 . . . . 0.0 109.358 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.13 -48.69 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -120.7 11.08 11.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.446 -1.408 . . . . 0.0 114.007 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' HG2' HG21 ' A' ' 38' ' ' THR . 14.7 pt20 -160.01 169.96 22.33 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.593 -1.317 . . . . 0.0 111.746 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.5 m -128.8 152.25 48.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.49 0.662 . . . . 0.0 110.131 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 36' ' ' VAL . 8.3 p90 -160.5 -145.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 78.2 mt -135.27 165.54 25.21 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.36 -1.462 . . . . 0.0 113.843 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.457 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -151.99 126.84 9.63 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.25 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.408 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 53.4 m -104.94 127.46 52.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.352 -0.843 . . . . 0.0 111.44 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 44.7 t -74.55 121.36 21.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.792 -0.567 . . . . 0.0 109.517 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.47 130.18 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.912 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.77 39.98 30.95 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.479 -0.763 . . . . 0.0 110.728 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 25.5 75.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.14 122.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -1.011 . . . . 0.0 109.271 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 6.4 t -74.17 139.22 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.409 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.431 ' CZ3' ' CD2' ' A' ' 82' ' ' LEU . 78.2 m95 -136.1 130.02 32.73 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.924 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.482 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 8.8 t -139.13 -174.74 3.94 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 13.4 m -87.99 131.83 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.31 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -60.03 -41.97 93.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.467 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.4 p-80 -69.96 -13.96 62.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.735 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -97.04 -41.32 3.54 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.05 -72.62 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.606 -0.938 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.69 160.66 0.14 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 62' ' ' LYS . 4.2 m 58.08 18.69 5.4 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.489 -1.006 . . . . 0.0 111.832 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 61' ' ' SER . 96.4 mttt 62.05 -59.39 0.12 Allowed 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 121.56 0.695 . . . . 0.0 112.567 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 70' ' ' PRO . 5.5 t -72.18 159.4 34.18 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.881 0.848 . . . . 0.0 111.633 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.489 ' CD2' ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -146.98 -121.75 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -150.02 86.58 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.791 -1.193 . . . . 0.0 109.8 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -93.05 -176.4 40.84 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -56.67 -22.28 43.35 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.81 1.426 . . . . 0.0 110.556 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.18 0.02 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.599 -0.688 . . . . 0.0 110.922 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.65 -149.21 17.69 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.414 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 40.5 Cg_endo -63.85 116.95 3.99 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.892 1.469 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.42 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 64.8 mt -112.88 130.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.175 0.988 . . . . 0.0 112.001 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 m -130.76 123.59 29.53 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.97 -60.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.433 ' C ' ' CG ' ' A' ' 75' ' ' TYR . 10.8 mmt -92.91 -65.84 0.97 Allowed 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.538 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.446 ' CE1' ' CG2' ' A' ' 178' ' ' THR . 0.1 OUTLIER 174.88 -171.82 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.941 -1.099 . . . . 0.0 112.012 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.421 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 99.8 m -138.43 117.3 12.38 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -94.37 81.96 4.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.2 t -61.06 -40.07 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 109.425 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.02 -26.75 27.99 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 109.075 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -111.82 -2.2 15.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.734 -0.604 . . . . 0.0 110.706 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.94 55.09 3.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' CD2' ' CZ3' ' A' ' 53' ' ' TRP . 42.5 tp -146.95 156.43 43.05 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.903 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.476 ' HB ' ' CH2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -144.33 138.71 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' C ' ' CE3' ' A' ' 85' ' ' TRP . . . -136.66 162.28 25.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 118.632 -1.746 . . . . 0.0 113.079 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.489 ' CE2' ' CD2' ' A' ' 64' ' ' LEU . 2.6 m-90 -148.25 170.12 18.59 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 114.297 -0.951 . . . . 0.0 108.927 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.48 115.38 23.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.97 134.49 95.04 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.612 -0.68 . . . . 0.0 110.746 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.99 158.61 42.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.832 1.438 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.78 145.12 67.92 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.895 1.471 . . . . 0.0 109.953 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.42 -24.49 7.26 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.9 -152.12 0.23 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.458 -1.025 . . . . 0.0 109.095 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -152.93 106.88 3.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.638 -0.664 . . . . 0.0 109.976 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.1 p -84.72 164.61 18.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 3.2 mm? -120.86 163.83 17.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.57 -0.706 . . . . 0.0 109.673 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.447 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 26.3 m -102.01 145.1 29.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.079 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -98.45 135.62 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.178 0 O-C-N 123.751 1.395 . . . . 0.0 110.694 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.8 p -151.23 147.34 26.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.645 -0.659 . . . . 0.0 110.48 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.7 m -68.06 -39.92 82.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.428 -0.795 . . . . 0.0 111.574 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 87.1 m 55.84 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.363 -0.836 . . . . 0.0 111.062 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.83 3.3 45.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -129.66 137.41 50.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -1.225 . . . . 0.0 110.019 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -103.61 19.02 20.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.713 . . . . 0.0 110.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -72.97 67.57 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -0.788 . . . . 0.0 108.943 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -81.71 174.73 11.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.873 -0.517 . . . . 0.0 109.914 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 43.5 p90 -154.06 138.84 17.07 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 34.9 tp -113.29 153.85 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.98 0.895 . . . . 0.0 111.603 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -110.29 136.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.412 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 31.6 p -81.76 -178.94 7.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -36.33 -32.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.78 -51.14 2.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.339 -0.85 . . . . 0.0 111.291 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.28 -95.4 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.967 -1.083 . . . . 0.0 111.719 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.412 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 17.2 t0 44.07 70.23 0.34 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.095 -1.003 . . . . 0.0 111.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.41 HG21 ' CD2' ' A' ' 105' ' ' TYR . 13.7 p -71.78 64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.435 -0.791 . . . . 0.0 109.926 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.401 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 12.3 pt -70.04 150.03 96.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.522 -0.736 . . . . 0.0 110.073 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -102.05 130.16 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.715 1.376 . . . . 0.0 110.032 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 49.1 t -127.45 131.94 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -88.11 117.32 26.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 10.6 ttm180 -61.8 123.87 19.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.552 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -97.29 1.07 49.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.781 -0.574 . . . . 0.0 109.81 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.86 179.72 43.01 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.6 m-20 -64.84 -23.42 67.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.326 -1.102 . . . . 0.0 110.362 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.0 p -123.2 16.83 9.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.513 -0.742 . . . . 0.0 111.752 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -140.0 142.8 36.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -142.06 140.7 10.25 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.7 m -89.94 110.02 21.01 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.8 -0.824 . . . . 0.0 110.151 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 114' ' ' ILE . 31.9 tp -72.98 108.55 5.95 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.18 -28.03 68.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.322 0.582 . . . . 0.0 109.801 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -109.99 103.75 54.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.85 -0.531 . . . . 0.0 110.171 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.37 140.54 36.99 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.877 1.461 . . . . 0.0 109.955 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -147.09 159.26 43.18 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.18 124.41 14.77 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.898 1.473 . . . . 0.0 110.361 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.13 -26.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.328 0.585 . . . . 0.0 110.685 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -38.3 82.28 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -69.32 -27.53 65.45 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.69 2.76 36.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.783 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -68.65 109.6 3.87 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.77 -8.87 58.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.8 t -76.1 -15.69 60.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -1.005 . . . . 0.0 109.079 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.22 154.64 41.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.235 -0.916 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.415 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.99 -8.48 79.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.92 -159.04 6.89 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.408 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.96 148.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 116.588 -1.808 . . . . 0.0 112.582 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.8 mt -99.49 98.27 9.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 4.6 mm? -82.14 137.07 35.06 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.133 0.968 . . . . 0.0 113.182 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 0.5 OUTLIER -66.62 -161.48 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.017 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -92.16 17.27 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.714 1.376 . . . . 0.0 110.978 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.424 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -138.74 25.82 2.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.122 -0.986 . . . . 0.0 111.962 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.11 37.96 59.66 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.447 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 41.6 m170 -118.91 118.91 32.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.559 -0.965 . . . . 0.0 110.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.49 125.12 29.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 0.0 109.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.03 -6.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.92 130.31 2.8 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.263 -1.446 . . . . 0.0 111.509 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.25 116.06 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.401 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 18.7 t80 -51.87 128.66 24.65 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.6 -0.688 . . . . 0.0 112.272 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -119.44 -24.48 6.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.702 -0.624 . . . . 0.0 112.308 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.418 ' HA ' ' HA1' ' A' ' 188' ' ' 2ZF . . . -159.2 139.12 11.86 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.269 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -100.36 136.72 39.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.769 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.41 HG11 ' O ' ' A' ' 158' ' ' VAL . 7.3 p -102.99 98.88 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.0 p -93.47 123.53 36.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.209 1.004 . . . . 0.0 111.278 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 93.9 m -86.38 -70.02 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.119 -179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -104.19 26.18 9.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.475 -0.765 . . . . 0.0 110.206 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 107.69 10.27 27.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 32.8 m -141.26 138.93 33.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -80.1 114.11 18.77 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.667 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -96.95 11.54 35.62 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.606 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.405 ' CB ' ' CG1' ' A' ' 158' ' ' VAL . . . -167.77 154.49 8.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.401 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 17.4 m -128.58 140.02 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.947 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -107.46 146.45 31.74 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 38.7 p90 -152.98 165.09 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.999 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 58.4 t -83.37 137.64 42.15 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.831 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.94 146.22 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.78 1.411 . . . . 0.0 110.747 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.7 p -70.03 -29.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.67 . . . . 0.0 109.61 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.32 -29.54 65.99 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.7 m -73.42 -24.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.8 -0.562 . . . . 0.0 110.234 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 64.3 mtt -65.67 -46.2 80.01 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.06 -41.07 91.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.301 0.572 . . . . 0.0 109.959 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.6 p -70.22 -22.63 62.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.624 -0.673 . . . . 0.0 110.965 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.446 ' CG2' ' CE1' ' A' ' 75' ' ' TYR . 93.6 m -61.6 -50.07 74.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.296 -0.878 . . . . 0.0 109.71 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 25.5 ptm -68.55 -24.85 64.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.644 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -66.54 -16.41 64.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.754 . . . . 0.0 110.583 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 182' ' ' SER . . . -166.72 -148.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -0.846 . . . . 0.0 110.53 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 181' ' ' ALA . 1.5 p 86.1 -31.76 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 123.682 0.793 . . . . 0.0 110.967 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.09 -42.89 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.267 -0.896 . . . . 0.0 110.231 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 48.6 tptt 56.84 32.48 21.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -154.71 159.95 41.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.532 -0.73 . . . . 0.0 110.814 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.006 179.531 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.455 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.049 0.452 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 -10.02 75.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.68 140.4 30.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -1.13 . . . . 0.0 109.924 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -79.51 166.89 21.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.255 0.55 . . . . 0.0 110.096 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -140.28 160.65 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.018 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m120 51.33 53.7 12.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.506 -0.746 . . . . 0.0 111.473 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 53.23 -175.89 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.478 -0.764 . . . . 0.0 110.97 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.408 ' CG1' ' HA ' ' A' ' 91' ' ' ALA . 63.3 t -80.83 -42.91 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.181 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 48.74 39.8 14.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.673 -0.642 . . . . 0.0 111.616 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.65 176.36 47.94 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -93.85 -23.49 18.1 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.83 -0.806 . . . . 0.0 111.697 -178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.03 120.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 -178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.01 124.36 45.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.805 -0.559 . . . . 0.0 110.623 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.29 133.84 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.42 174.53 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.891 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.3 m -147.99 126.48 12.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.0 t -106.34 -179.14 3.85 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.49 -16.89 4.28 Favored 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.823 -0.548 . . . . 0.0 112.377 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 74.4 p -102.49 -34.85 8.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.036 -1.04 . . . . 0.0 113.245 -178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -172.83 -169.17 0.55 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.776 -1.203 . . . . 0.0 112.756 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.2 p -116.71 145.3 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.1 p90 -162.02 -143.86 0.09 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.21 -0.931 . . . . 0.0 110.802 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 44.1 mt -129.06 161.77 29.23 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.618 -1.301 . . . . 0.0 114.0 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.464 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.3 123.61 7.08 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.759 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 53' ' ' TRP . 9.7 t -80.47 -156.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 23.4 m -153.16 112.42 3.81 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.0 137.03 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.104 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 m120 50.58 39.45 21.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.577 -0.702 . . . . 0.0 111.163 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 26.59 74.41 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.44 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 55.6 t -137.6 118.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -1.009 . . . . 0.0 110.218 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.7 t -75.53 120.08 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.447 ' CH2' ' CE1' ' A' ' 75' ' ' TYR . 89.1 m95 -106.74 128.74 54.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.03 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.464 ' HB ' ' CB ' ' A' ' 45' ' ' ALA . 15.0 t -134.5 -177.76 4.75 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 6.4 m -89.52 125.47 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.792 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.0 -41.88 93.07 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.584 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.463 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 26.1 p-80 -66.04 -34.42 78.04 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.437 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.23 -34.23 64.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.97 -70.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.681 -0.894 . . . . 0.0 110.14 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.55 -63.02 0.32 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.611 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 p -175.77 87.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.175 -1.191 . . . . 0.0 111.349 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 57.18 -163.52 0.18 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.522 1.153 . . . . 0.0 111.404 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 49.89 70.94 0.44 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.393 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' ' CE2' ' A' ' 85' ' ' TRP 0.254 11.8 tp -91.86 -155.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.415 ' H ' ' HG ' ' A' ' 64' ' ' LEU . . . -143.01 100.01 3.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.077 -1.015 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.482 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -92.05 -169.52 41.0 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.34 -13.46 30.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.194 1.628 . . . . 0.0 111.015 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -108.21 -24.89 11.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.21 -0.931 . . . . 0.0 111.016 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.64 -151.08 22.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.37 121.19 7.27 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.93 1.489 . . . . 0.0 110.845 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.482 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 72.6 mt -100.15 150.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.9 m -93.62 127.8 39.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.644 -0.66 . . . . 0.0 110.102 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -64.88 163.9 13.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.619 -0.676 . . . . 0.0 110.146 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -93.51 -40.08 10.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -155.72 -176.65 6.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.414 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 57.6 m -152.01 123.5 7.82 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.787 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -93.77 77.84 4.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.0 -40.1 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.681 -0.637 . . . . 0.0 109.686 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -55.25 -25.8 35.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -112.41 -0.61 15.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.74 -0.6 . . . . 0.0 110.906 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 60.04 56.77 3.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.046 -1.034 . . . . 0.0 109.321 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 40.3 tp -144.37 154.53 43.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.984 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.466 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -142.05 133.26 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.93 123.21 5.54 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.319 -1.419 . . . . 0.0 112.058 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.466 ' CZ3' ' HB ' ' A' ' 83' ' ' VAL . 3.6 m-90 -88.25 -171.7 3.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.063 -0.669 . . . . 0.0 109.395 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -100.01 111.94 24.24 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 130.02 93.55 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.446 -0.784 . . . . 0.0 111.85 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.415 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_endo -90.96 175.21 2.52 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.795 1.419 . . . . 0.0 109.063 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 88' ' ' PRO . 40.6 Cg_endo -62.47 143.64 93.54 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.549 1.289 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.28 -3.55 66.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.408 ' HA ' ' CG1' ' A' ' 29' ' ' VAL . . . -87.99 22.52 2.35 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.008 -1.29 . . . . 0.0 112.207 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 31.34 96.01 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.5 t -84.59 130.04 34.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 110.036 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 4.4 mm? -115.95 170.93 8.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 164.05 37.12 Favored Pre-proline 0 N--CA 1.495 1.822 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.19 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.81 159.03 18.72 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.923 1.486 . . . . 0.0 109.436 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.438 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . 9.0 p -132.56 -40.51 0.98 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.43 -0.794 . . . . 0.0 111.829 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 48.02 36.93 6.93 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.18 -0.95 . . . . 0.0 110.731 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -65.14 -35.46 81.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.677 . . . . 0.0 111.097 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.93 -35.27 2.16 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t -68.34 130.04 41.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.979 . . . . 0.0 109.508 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -102.67 9.86 38.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.554 -0.716 . . . . 0.0 111.438 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -71.97 75.73 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 108.584 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.96 174.67 11.3 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.389 0.614 . . . . 0.0 111.138 -178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 77.5 m-85 -144.37 127.3 16.41 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 38.1 tp -115.07 153.56 30.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.923 0.868 . . . . 0.0 111.841 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 97.7 t -119.17 135.17 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.404 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 68.8 p -85.22 175.28 9.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.132 -0.98 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 63.8 ttt180 -37.16 -34.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 121.172 0.51 . . . . 0.0 112.056 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -100.15 -70.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.41 -80.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.864 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 11.4 t70 46.6 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.593 -0.692 . . . . 0.0 111.595 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.69 107.67 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.249 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 23.6 pt -130.95 159.99 68.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.7 -0.625 . . . . 0.0 109.731 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.425 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.9 Cg_endo -106.88 134.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.966 1.508 . . . . 0.0 111.224 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 46.6 t -124.23 130.07 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -89.13 115.34 26.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.421 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 28.4 ttp85 -59.91 126.18 26.57 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.237 -0.915 . . . . 0.0 110.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -103.3 8.09 38.29 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.676 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.65 43.84 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 12.0 p-10 -59.96 -36.39 77.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -1.067 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -121.09 19.18 11.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.882 -0.511 . . . . 0.0 112.091 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -131.24 141.05 49.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.974 -1.079 . . . . 0.0 110.558 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.76 143.54 13.54 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -92.06 110.12 21.48 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 122.097 -0.649 . . . . 0.0 110.02 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 45.3 tp -72.67 109.89 6.63 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.993 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.7 -31.03 69.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.457 0.646 . . . . 0.0 109.596 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -105.88 107.92 60.54 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.88 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.56 143.28 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.84 1.442 . . . . 0.0 110.357 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -148.36 160.01 37.77 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -60.36 126.24 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.842 1.443 . . . . 0.0 110.4 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.08 -26.12 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.75 -0.594 . . . . 0.0 110.675 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.403 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 68.6 m -59.31 -34.66 72.59 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.881 0.848 . . . . 0.0 109.212 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -73.82 -26.78 60.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.514 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.27 -4.82 58.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 112.939 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.88 66.59 1.55 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.647 1.213 . . . . 0.0 109.025 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 174.51 -26.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.8 t -72.57 -9.1 58.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.395 -1.062 . . . . 0.0 111.841 -178.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.458 ' HB3' HG12 ' A' ' 55' ' ' VAL . 7.1 m -58.6 142.31 49.72 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.869 -1.145 . . . . 0.0 109.559 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.426 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.47 -9.86 76.26 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.02 157.06 53.56 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -103.01 138.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.92 1.484 . . . . 0.0 112.799 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.9 mp -100.16 98.81 9.47 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.6 mp -87.64 147.81 25.1 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.028 0.918 . . . . 0.0 113.064 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -158.86 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -99.69 16.61 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.69 1.363 . . . . 0.0 110.732 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.4 p -127.42 0.14 6.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.156 -0.965 . . . . 0.0 112.271 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.94 39.97 3.21 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.438 ' CG ' ' HB3' ' A' ' 97' ' ' CYS . 79.8 m80 -125.75 121.84 34.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -1.122 . . . . 0.0 110.791 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.94 101.51 12.41 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.07 7.13 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 0.0 112.237 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.425 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -156.58 134.74 4.17 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.406 ' CD1' ' CB ' ' A' ' 53' ' ' TRP . 1.1 mt -118.66 122.63 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.385 -1.068 . . . . 0.0 108.398 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.421 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 10.3 t80 -50.86 128.56 21.35 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.894 0.854 . . . . 0.0 112.326 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.2 ttt180 -116.78 -29.77 5.95 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.872 -0.518 . . . . 0.0 110.751 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.421 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.93 153.21 10.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.15 141.49 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.812 -0.555 . . . . 0.0 111.024 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 30.5 t -94.5 93.42 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.6 p -91.8 115.78 28.34 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.383 1.087 . . . . 0.0 112.704 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 162' ' ' GLY . 22.1 m -92.02 120.28 32.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 160' ' ' THR . 14.8 ttm180 65.3 -67.67 0.12 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.986 -0.446 . . . . 0.0 109.892 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.7 24.49 0.23 Allowed Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.686 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 34.6 m -150.01 143.18 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -1.205 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -79.0 130.0 35.06 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.663 0.744 . . . . 0.0 111.547 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -125.58 16.42 8.18 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.39 150.02 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.421 HG13 ' CE1' ' A' ' 154' ' ' PHE . 13.3 m -130.29 137.67 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.27 -0.972 . . . . 0.0 113.013 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -104.32 145.51 30.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 29.5 p90 -152.98 161.9 41.98 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.243 -1.383 . . . . 0.0 112.541 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.41 139.87 55.8 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.979 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.37 156.74 12.62 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.683 1.36 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.03 -25.71 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.64 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -26.74 66.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 108.964 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.8 p -75.47 -33.07 60.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 110.348 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.418 ' HG2' ' CG ' ' A' ' 53' ' ' TRP . 1.1 mpp? -66.92 -48.46 68.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.724 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 177' ' ' THR . 12.5 pt-20 -62.4 -40.4 96.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.555 -0.715 . . . . 0.0 110.441 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.415 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 33.8 p -63.31 -37.8 88.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.602 -0.686 . . . . 0.0 109.962 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.425 HG23 ' CD1' ' A' ' 75' ' ' TYR . 94.2 m -60.56 -40.03 90.15 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.27 -39.75 93.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.662 -0.649 . . . . 0.0 109.25 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -63.58 -29.95 71.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.67 159.68 19.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.621 -0.674 . . . . 0.0 110.941 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.77 52.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.695 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -144.83 151.13 38.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.615 . . . . 0.0 109.605 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.5 tptt 53.94 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.51 -0.744 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 42.5 mttp . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.183 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.463 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.077 0.465 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.32 178.25 51.72 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -49.95 75.65 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.542 -0.975 . . . . 0.0 109.543 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 40.8 t0 50.0 50.36 18.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.794 -0.566 . . . . 0.0 112.163 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.68 -152.72 0.14 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.417 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -154.75 92.5 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 110.718 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -163.93 55.14 0.16 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 109.971 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.1 t -87.98 -50.08 13.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 49.64 39.96 18.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.554 -0.716 . . . . 0.0 111.373 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 172.02 36.48 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -98.32 -39.15 8.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.81 -0.818 . . . . 0.0 111.381 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.5 t -114.56 119.99 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 0.0 109.454 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -102.94 121.98 43.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 0.0 111.353 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.3 t -83.96 130.82 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.31 175.1 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.879 0.847 . . . . 0.0 110.818 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -138.41 129.43 26.95 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.724 0.773 . . . . 0.0 109.309 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.42 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 62.1 p -110.9 -179.08 3.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -17.22 9.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.61 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.5 p -101.33 -41.12 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 112.278 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -175.61 -162.51 0.1 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 121.033 -1.042 . . . . 0.0 111.457 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.8 m -121.76 146.93 46.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.707 -0.621 . . . . 0.0 109.371 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.42 ' CZ ' HG22 ' A' ' 38' ' ' THR . 7.4 p90 -160.71 -141.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.624 -0.673 . . . . 0.0 109.764 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.0 mt -130.79 161.0 32.72 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.489 -1.382 . . . . 0.0 114.271 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.58 120.2 4.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.693 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 HG22 ' CB ' ' A' ' 142' ' ' PRO . 0.3 OUTLIER -85.75 -159.99 0.5 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.146 -0.971 . . . . 0.0 110.162 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 39.1 t -149.98 113.14 4.89 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.04 129.95 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.058 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 51.78 40.0 26.76 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.653 -0.654 . . . . 0.0 110.715 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 26.53 74.23 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.432 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 41.5 t -133.86 111.9 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -1.077 . . . . 0.0 109.616 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 29.3 t -75.47 129.53 37.42 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.485 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 84.7 m95 -118.58 129.27 55.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.55 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.442 ' HB ' ' CB ' ' A' ' 45' ' ' ALA . 12.5 t -135.72 179.7 6.18 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.453 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 12.3 m -88.66 133.33 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.696 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.819 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -59.97 -42.5 94.29 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.453 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 46.9 p-80 -74.0 69.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.22 -35.85 0.08 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.8 -69.39 0.59 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.496 -1.003 . . . . 0.0 108.79 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.94 -92.67 1.36 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.467 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -89.06 39.24 0.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.536 -0.979 . . . . 0.0 111.816 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.0 mttp 48.21 -173.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.101 0.953 . . . . 0.0 112.144 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 60.76 135.49 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.708 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.11 -128.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.2 91.95 2.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.844 -1.16 . . . . 0.0 110.239 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -65.93 -153.42 0.18 Allowed Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.23 -20.92 24.06 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.243 1.654 . . . . 0.0 109.922 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -142.21 0.7 1.36 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.12 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.43 173.14 41.79 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.74 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -60.83 129.62 29.76 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.91 1.479 . . . . 0.0 111.324 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 40.3 mt -105.48 146.95 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 6.2 m -94.83 144.79 25.36 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.71 0.766 . . . . 0.0 111.596 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 85' ' ' TRP . 14.3 pt20 -78.45 160.34 27.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.872 -0.518 . . . . 0.0 111.2 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.9 mmm -93.34 -39.61 10.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.662 -0.649 . . . . 0.0 109.609 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 -176.37 5.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.73 . . . . 0.0 109.516 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 8.4 m -149.94 118.71 6.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.726 -0.609 . . . . 0.0 109.384 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.1 t30 -91.67 77.26 5.64 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.02 -38.14 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.734 -0.604 . . . . 0.0 109.42 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -54.73 -25.98 31.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -115.91 1.28 13.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.696 -0.627 . . . . 0.0 111.139 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t70 60.03 59.99 2.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.969 -1.082 . . . . 0.0 108.971 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.436 HD22 ' CE3' ' A' ' 53' ' ' TRP . 27.4 tp -147.04 152.5 38.66 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.597 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.42 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -140.18 130.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.35 127.07 5.94 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.12 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.436 ' CZ2' ' HB3' ' A' ' 73' ' ' GLN . 3.9 m-90 -90.4 178.47 6.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.19 84.05 2.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.299 -0.875 . . . . 0.0 108.709 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.97 158.49 87.16 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.581 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -100.01 -170.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 124.017 1.535 . . . . 0.0 108.618 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -87.36 12.06 3.04 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.62 1.327 . . . . 0.0 111.552 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -28.77 13.45 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.21 57.34 4.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.803 -0.822 . . . . 0.0 110.554 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 25.6 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.014 0.926 . . . . 0.0 112.721 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.6 m -83.17 108.14 16.22 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.051 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 91.0 mt -82.74 164.07 20.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.132 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.44 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 95.2 m -115.98 153.73 48.31 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -102.6 135.81 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 O-C-N 123.404 1.213 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 149' ' ' HIS . 26.7 p -145.68 151.76 38.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.461 -0.774 . . . . 0.0 110.703 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.4 p -86.48 103.79 15.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.3 m -99.49 137.77 37.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.09 -35.23 86.9 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.1 m -83.91 127.18 33.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.732 -0.864 . . . . 0.0 109.887 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -97.01 17.04 17.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.602 -0.686 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -71.49 73.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.72 175.12 10.23 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.33 0.586 . . . . 0.0 110.342 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -141.7 120.61 12.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 22.0 tp -100.09 140.2 34.66 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.503 0.668 . . . . 0.0 110.233 -179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 83.8 t -91.75 120.05 40.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.344 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -84.63 173.31 10.86 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -38.84 -31.73 0.07 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.983 -0.448 . . . . 0.0 112.195 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -100.26 -69.25 0.78 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.828 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 -162.35 1.53 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -60.34 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.181 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.9 t 50.87 22.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.312 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -171.27 117.05 0.44 Allowed Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.011 -1.056 . . . . 0.0 110.299 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -98.91 145.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.748 1.393 . . . . 0.0 109.357 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.5 t -133.97 139.55 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 111.073 -179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -97.06 120.26 37.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -60.02 125.2 22.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 111.063 -178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -101.68 5.37 41.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.707 -0.621 . . . . 0.0 109.419 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.07 34.77 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 26.9 t0 -58.48 -22.93 56.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.473 -1.016 . . . . 0.0 110.634 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -124.61 17.15 8.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.529 -0.732 . . . . 0.0 111.361 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -139.99 144.55 37.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.045 -1.034 . . . . 0.0 110.953 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.79 141.07 10.64 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.0 t -88.67 112.03 22.63 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.926 -0.75 . . . . 0.0 109.954 -179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.5 tp -72.89 107.36 5.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.18 -19.92 65.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.809 -0.557 . . . . 0.0 110.535 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.0 m -122.45 79.99 46.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.672 -0.643 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -58.51 150.4 68.95 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 O-C-N 123.771 1.406 . . . . 0.0 110.374 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -151.14 163.07 24.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.55 122.56 11.97 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 O-C-N 123.774 1.407 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.72 -25.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.808 -0.558 . . . . 0.0 111.524 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.3 m -59.58 -39.97 85.86 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.608 0.718 . . . . 0.0 109.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.94 -27.08 64.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.3 1.65 47.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.0 111.644 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.23 66.01 1.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.989 -1.07 . . . . 0.0 109.029 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.1 -24.4 0.08 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 83.1 p -70.59 -13.77 62.22 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.53 -0.982 . . . . 0.0 111.65 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.429 ' HB3' HG12 ' A' ' 55' ' ' VAL . 6.9 m -60.97 141.93 56.91 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.973 -1.079 . . . . 0.0 109.833 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.43 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.02 -9.98 75.51 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.35 -161.44 0.49 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.429 ' CB ' HG22 ' A' ' 46' ' ' THR . 56.1 Cg_endo -146.36 137.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 116.282 -2.012 . . . . 0.0 112.277 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 mt -95.09 96.52 9.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.7 mp -87.68 145.14 26.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.0 m -67.92 174.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.69 -2.03 11.91 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.655 1.345 . . . . 0.0 111.695 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.1 m -103.3 0.07 30.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.974 -1.079 . . . . 0.0 112.085 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.26 36.24 5.24 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.44 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 77.3 m80 -121.16 124.04 43.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -1.121 . . . . 0.0 110.902 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.41 22.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.765 -0.584 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.8 1.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 111.839 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.458 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.0 136.65 5.25 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 20.2 mt -119.83 120.05 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 12.0 t80 -50.14 127.6 17.24 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.903 0.859 . . . . 0.0 113.28 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 38.7 ttt-85 -116.67 -28.64 6.32 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.741 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.89 151.21 10.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.112 -0.993 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.59 146.73 29.27 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 58.6 t -90.06 94.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 83.5 m -91.57 119.2 31.28 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.258 1.028 . . . . 0.0 112.711 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 94.3 m -120.04 132.59 55.52 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.989 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 56.78 23.79 8.38 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.04 19.31 51.35 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.818 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.9 m -147.15 143.85 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.015 -1.285 . . . . 0.0 109.564 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.93 126.03 30.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 111.26 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -118.82 15.74 13.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.295 0.569 . . . . 0.0 110.051 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.19 149.05 1.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 15.6 m -124.01 135.42 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.03 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -106.08 149.32 26.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -154.53 163.96 39.41 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.267 -1.373 . . . . 0.0 112.791 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 63.0 t -80.27 141.56 53.71 Favored Pre-proline 0 N--CA 1.498 1.945 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.314 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.79 151.21 14.55 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.702 1.369 . . . . 0.0 110.754 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -73.16 -30.04 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.654 -0.654 . . . . 0.0 110.136 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.93 -32.95 70.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.43 -0.794 . . . . 0.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.9 m -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.884 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.485 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 4.8 mtp -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.692 -0.63 . . . . 0.0 109.911 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -61.41 -40.01 92.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.7 p -66.03 -24.03 66.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.436 -0.79 . . . . 0.0 111.592 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -62.36 -40.49 96.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.118 -0.989 . . . . 0.0 109.139 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 82.6 mmm -65.21 -38.54 90.76 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -60.91 -28.29 68.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 111.104 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 182' ' ' SER . . . -166.02 -44.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.659 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 181' ' ' ALA . 1.4 t 75.49 -55.61 0.62 Allowed 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.723 -0.611 . . . . 0.0 110.605 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 185' ' ' LYS . 36.1 mttm -142.64 101.66 3.91 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.27 -0.894 . . . . 0.0 110.264 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 59.58 -72.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.071 -0.393 . . . . 0.0 110.867 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 183' ' ' LYS . 44.9 pttt -159.84 32.8 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.239 -0.913 . . . . 0.0 110.493 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.986 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.416 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.4 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.52 -171.01 39.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -69.96 170.63 10.88 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.957 -0.731 . . . . 0.0 109.943 179.73 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 24' ' ' ARG . 3.0 t70 85.24 -174.75 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 123.791 0.837 . . . . 0.0 109.495 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.13 139.09 57.25 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.899 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 22' ' ' THR . 10.3 t-20 -159.45 139.58 11.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -63.32 140.07 58.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.793 -0.567 . . . . 0.0 110.475 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.5 m -80.81 -15.26 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.769 -0.582 . . . . 0.0 110.821 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.97 66.95 0.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.301 -0.874 . . . . 0.0 109.762 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.55 155.49 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -98.36 -40.06 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.952 . . . . 0.0 110.333 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.435 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.459 ' CG ' ' CD2' ' A' ' 188' ' ' 2ZF . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 38' ' ' THR . . . -77.06 -28.74 54.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.03 -112.16 3.57 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -162.93 40.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.94 . . . . 0.0 110.292 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -169.74 161.12 9.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 111.317 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 77.6 m 42.08 -100.09 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER 80.9 -29.32 0.12 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.697 0.799 . . . . 0.0 111.968 -178.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 73.01 99.51 0.07 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.53 -169.59 23.69 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.76 -17.6 60.03 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 124.021 1.537 . . . . 0.0 110.623 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -104.55 5.16 33.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 111.375 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.7 -155.99 15.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.61 111.07 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.782 1.411 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.5 mt -105.73 148.99 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.65 . . . . 0.0 110.108 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.438 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CZ3' HG23 ' A' ' 54' ' ' THR . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 149.91 96.27 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.61 161.3 28.01 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 124.026 1.54 . . . . 0.0 109.816 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.03 19.96 1.2 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.722 1.38 . . . . 0.0 111.119 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.34 -15.08 36.4 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.69 -160.25 0.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.329 -1.101 . . . . 0.0 108.962 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -77.86 -40.0 41.58 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.585 0.707 . . . . 0.0 110.752 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m 52.82 101.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.82 171.84 2.59 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.8 t -52.81 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.84 -0.538 . . . . 0.0 111.634 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m 49.97 55.01 10.09 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.981 -1.074 . . . . 0.0 112.089 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.75 173.95 11.91 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.02 -1.05 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.57 19.28 7.56 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m -137.5 152.63 49.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.142 -1.21 . . . . 0.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' CA ' ' CD1' ' A' ' 169' ' ' PHE . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.41 ' CD1' ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.471 ' CD1' ' CA ' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.41 ' CE ' ' CD1' ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p -59.92 -32.48 70.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.462 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 78.9 m -60.62 -44.99 95.69 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.1 mtp -61.33 -40.24 93.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.44 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -70.08 -39.97 75.29 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.896 0.855 . . . . 0.0 109.487 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 60.1 7.13 1.12 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 36.37 31.06 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.422 -0.799 . . . . 0.0 113.086 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -85.28 -47.12 10.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 50.0 41.45 23.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.442 -0.787 . . . . 0.0 111.486 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.63 130.01 34.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.47 -0.769 . . . . 0.0 109.848 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 34.7 mttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.215 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.459 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.153 0.502 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -57.97 3.76 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 30.4 ttt85 -107.44 5.0 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.532 -0.981 . . . . 0.0 111.282 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 60.13 -154.48 0.37 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.821 -1.174 . . . . 0.0 110.327 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -110.03 25.76 11.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.928 -178.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 66.41 -59.97 0.33 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.561 -0.712 . . . . 0.0 111.789 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -100.82 128.34 46.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.942 -1.099 . . . . 0.0 110.509 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.418 ' CG1' ' CB ' ' A' ' 91' ' ' ALA . 60.1 t -84.18 -56.87 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.438 0.637 . . . . 0.0 109.785 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 46.53 34.73 2.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.741 -0.599 . . . . 0.0 112.011 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.11 16.88 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.05 -25.78 63.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.73 -0.865 . . . . 0.0 110.655 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.8 t -109.89 140.01 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -0.762 . . . . 0.0 109.653 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -138.83 147.76 42.88 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.574 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -86.0 130.52 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.337 0.589 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.464 ' CG2' ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -132.67 159.99 42.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.7 -0.625 . . . . 0.0 109.603 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 m -141.56 149.93 41.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.4 t -115.42 76.77 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.498 1.142 . . . . 0.0 109.755 179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 63.3 -48.9 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -120.06 9.72 11.26 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.405 -1.434 . . . . 0.0 113.851 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.36 170.52 19.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.646 -1.284 . . . . 0.0 111.703 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -127.75 154.36 45.46 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.496 0.665 . . . . 0.0 109.825 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.464 ' CE2' ' CG2' ' A' ' 36' ' ' VAL . 10.0 p90 -162.95 -145.8 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.427 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 79.4 mt -135.69 161.71 34.77 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.488 -1.383 . . . . 0.0 112.852 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.98 130.4 13.83 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 21.8 m -112.42 125.29 54.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.364 -0.835 . . . . 0.0 111.453 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 27.5 p -74.16 130.14 39.19 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.493 0.663 . . . . 0.0 110.784 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.8 t -140.34 137.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.25 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 52.09 37.88 22.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.387 -0.821 . . . . 0.0 110.785 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.74 28.06 72.52 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.2 t -138.94 120.02 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.487 -1.008 . . . . 0.0 109.812 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 33.9 m -72.43 129.31 38.05 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 73.3 m95 -122.9 133.28 54.41 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.8 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.486 ' CG2' ' CH2' ' A' ' 85' ' ' TRP . 3.7 t -140.57 -179.21 5.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 4.8 m -88.81 128.29 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 C-N-CA 118.146 -1.422 . . . . 0.0 111.895 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CE1' HG21 ' A' ' 78' ' ' VAL . 88.3 t80 -59.98 -40.08 87.91 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.496 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 43.1 p-80 -67.8 -20.06 65.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.487 -1.285 . . . . 0.0 108.518 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -85.51 -35.25 12.13 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.196 -2.362 . . . . 0.0 107.196 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.02 -80.03 0.33 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.742 -0.858 . . . . 0.0 109.08 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.99 9.28 75.72 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.331 -0.856 . . . . 0.0 111.923 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.0 p -140.46 15.61 2.38 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.957 1.379 . . . . 0.0 111.864 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 tttt 68.34 -59.11 0.45 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 -179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 70' ' ' PRO . 64.9 p -79.67 169.98 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.455 ' CD2' ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -147.8 -128.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.556 -0.715 . . . . 0.0 109.368 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.15 84.49 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 108.285 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -106.83 -176.04 22.99 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.577 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -54.06 -24.04 31.1 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.923 1.486 . . . . 0.0 110.763 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.96 6.63 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.723 -0.611 . . . . 0.0 110.627 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.49 -144.27 17.21 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 42.9 Cg_endo -69.05 109.89 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.916 1.482 . . . . 0.0 109.084 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.404 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 72.1 mt -101.18 137.81 27.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.265 1.031 . . . . 0.0 111.821 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -137.1 126.67 25.22 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -138.3 -71.67 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.6 mtt -87.67 -64.68 1.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -174.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -171.56 -168.15 0.58 Allowed 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.182 -176.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.443 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 99.5 m -149.75 115.3 5.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.618 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 3.0 t-20 -99.04 83.58 2.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.182 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' CE1' ' A' ' 56' ' ' TYR . 61.0 t -63.96 -37.4 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.427 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.77 -27.13 27.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.593 -0.692 . . . . 0.0 109.254 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.18 -1.78 14.27 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.675 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.6 t70 61.23 54.97 3.09 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 108.672 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 16.6 tp -147.12 148.83 31.98 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.503 ' HB ' ' CH2' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -142.87 139.93 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 108.87 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -131.29 133.24 7.14 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 118.931 -1.604 . . . . 0.0 110.882 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.503 ' CH2' ' HB ' ' A' ' 83' ' ' VAL . 21.0 m-90 -106.96 -160.83 0.75 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -116.18 113.39 23.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.54 143.25 97.93 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.543 -0.723 . . . . 0.0 110.961 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -104.19 163.94 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.845 1.445 . . . . 0.0 110.006 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.26 130.21 26.38 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 123.897 1.472 . . . . 0.0 110.376 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.82 -30.16 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.418 ' CB ' ' CG1' ' A' ' 29' ' ' VAL . . . -91.91 -146.78 0.21 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.692 -0.887 . . . . 0.0 109.543 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -154.66 112.38 3.44 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 m -82.64 139.14 33.91 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.386 0.612 . . . . 0.0 110.784 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.2 mt -96.6 165.34 12.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.7 168.05 8.46 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.615 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.71 132.79 25.9 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 124.003 1.528 . . . . 0.0 109.869 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.46 ' SG ' ' CB ' ' A' ' 145' ' ' CYS . 2.2 t -70.15 -40.06 74.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.0 112.027 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m 50.77 50.01 19.85 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.384 -0.822 . . . . 0.0 112.299 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.84 169.93 21.04 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.011 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.76 16.34 58.45 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.424 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 m -75.48 120.24 20.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.006 -1.291 . . . . 0.0 109.412 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.7 m -105.02 -2.52 24.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.75 76.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.017 -1.052 . . . . 0.0 109.17 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.1 mt -84.37 174.69 9.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.744 0.783 . . . . 0.0 111.845 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 93.7 m-85 -146.39 130.96 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 43.9 tp -112.73 152.69 28.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.012 0.91 . . . . 0.0 111.759 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.6 t -109.95 131.09 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 80.0 p -81.94 169.06 17.23 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.455 -0.778 . . . . 0.0 110.283 -179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -34.0 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -98.76 -85.29 0.38 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.34 5.34 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 113.06 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.07 137.91 57.99 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.561 -1.337 . . . . 0.0 109.956 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.27 120.05 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 0.0 110.319 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 6.1 tt -120.01 112.43 34.89 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 109.577 179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 45.5 Cg_endo -62.55 132.07 36.44 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.596 1.314 . . . . 0.0 111.487 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.7 t -129.93 134.18 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -91.07 119.99 31.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 108.769 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 ttm180 -58.71 124.28 19.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.922 . . . . 0.0 110.958 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -99.58 3.44 45.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 109.634 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.31 45.96 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.5 m-20 -63.41 -27.09 69.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -1.084 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.2 p -123.49 18.67 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.6 -0.688 . . . . 0.0 111.808 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -138.52 145.83 41.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.089 -1.007 . . . . 0.0 111.378 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.53 142.17 12.11 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.7 t -90.4 110.01 21.12 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.872 -0.781 . . . . 0.0 110.227 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.0 tp -70.36 108.42 4.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.51 -35.41 75.89 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.585 0.707 . . . . 0.0 109.732 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.3 t -110.87 107.82 57.82 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.254 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.45 148.17 37.59 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 O-C-N 123.873 1.46 . . . . 0.0 109.899 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -150.02 160.96 32.54 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.91 124.3 15.67 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.858 1.451 . . . . 0.0 110.441 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.01 -27.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.268 0.556 . . . . 0.0 110.806 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.4 m -57.47 -30.88 65.42 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.823 0.82 . . . . 0.0 109.23 178.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -74.09 -29.05 61.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.383 -0.823 . . . . 0.0 109.125 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.05 -1.42 57.95 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.6 65.85 1.35 Allowed 'General case' 0 N--CA 1.513 2.68 0 O-C-N 120.8 -1.188 . . . . 0.0 109.369 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 173.6 -25.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.2 t -70.32 -12.58 61.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -1.056 . . . . 0.0 111.316 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.401 ' HB3' HG12 ' A' ' 55' ' ' VAL . 11.1 m -59.92 140.4 56.72 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 88.93 -7.98 80.83 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.06 -158.21 0.74 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.41 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 58.6 Cg_endo -143.32 140.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 116.356 -1.963 . . . . 0.0 112.077 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.93 96.25 7.43 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.401 ' CD1' ' HB2' ' A' ' 142' ' ' PRO . 7.3 mp -86.93 132.58 33.77 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.816 0.817 . . . . 0.0 112.737 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.46 ' CB ' ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -61.25 -161.44 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -98.85 15.78 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.666 1.351 . . . . 0.0 110.15 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -120.33 12.4 11.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.209 -0.932 . . . . 0.0 112.047 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.38 20.64 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.94 -1.1 . . . . 0.0 110.488 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.439 ' CG ' ' HA ' ' A' ' 97' ' ' CYS . 39.8 m80 -127.15 128.75 46.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 0.0 110.639 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.61 100.13 12.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.99 6.79 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.177 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -149.95 124.43 1.76 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.278 -1.439 . . . . 0.0 111.462 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 22.6 mt -109.98 120.07 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.24 . . . . 0.0 107.984 177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.426 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 13.5 t80 -52.56 128.83 27.29 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.673 0.749 . . . . 0.0 112.495 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 27.3 ttp180 -116.27 -28.19 6.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.851 -0.53 . . . . 0.0 110.993 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.3 151.0 9.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.2 -0.938 . . . . 0.0 111.836 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.73 145.31 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.824 -0.547 . . . . 0.0 111.331 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 49.0 t -93.43 91.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.501 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.3 p -94.59 113.84 25.72 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.667 1.222 . . . . 0.0 112.625 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 162' ' ' GLY . 62.8 m -98.57 133.31 43.1 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 63.45 -72.43 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -164.39 25.83 0.19 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -149.95 144.02 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.056 -1.261 . . . . 0.0 109.569 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.501 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -79.18 127.59 32.23 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.592 0.71 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -118.35 14.89 13.88 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.176 0.512 . . . . 0.0 110.04 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.72 146.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.422 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 14.7 m -121.12 135.39 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.729 0.776 . . . . 0.0 112.464 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -103.39 147.14 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 36.2 p90 -156.14 161.26 40.37 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.306 -1.358 . . . . 0.0 112.757 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -87.55 130.34 47.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.863 178.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -79.23 156.69 26.01 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 14.1 p -70.06 -29.94 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -59.47 -27.63 66.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -75.04 -25.99 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.706 -0.621 . . . . 0.0 110.236 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' MET . . . . . . . . . . . . . 55.4 mtt -64.65 -50.07 68.52 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.306 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.91 -45.11 94.05 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.5 p -69.77 -40.74 75.88 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.41 ' CG2' ' OH ' ' A' ' 75' ' ' TYR . 85.9 m -68.96 -40.06 79.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 85.0 mmm -66.84 -25.57 66.49 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.66 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -59.15 -22.5 61.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.304 -0.872 . . . . 0.0 110.657 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.92 18.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 111.221 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -173.17 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.472 -0.767 . . . . 0.0 109.749 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.1 mttp 49.99 -139.97 0.82 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.501 -0.749 . . . . 0.0 110.43 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 47.5 tptt 56.56 36.95 28.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.648 -1.283 . . . . 0.0 109.388 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -70.0 -40.05 75.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.804 0.811 . . . . 0.0 109.68 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.47 179.182 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.459 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.58 -9.92 73.31 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -103.7 4.6 35.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.041 -1.27 . . . . 0.0 111.231 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.2 t0 47.83 76.98 0.1 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.336 -0.852 . . . . 0.0 111.643 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -73.85 65.82 1.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.917 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -159.6 136.61 9.48 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.86 141.99 58.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.289 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.428 ' CG1' ' CB ' ' A' ' 91' ' ' ALA . 39.1 t -79.99 -70.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.393 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 43.71 38.94 2.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.783 -0.573 . . . . 0.0 112.533 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.88 158.76 27.78 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.628 -1.272 . . . . 0.0 111.174 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 24.7 mp0 -70.0 -35.66 74.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.99 -0.712 . . . . 0.0 110.318 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.58 121.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.673 -0.642 . . . . 0.0 109.755 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -91.61 127.96 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.71 127.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.49 173.99 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.36 -0.838 . . . . 0.0 110.38 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 8.2 t -150.1 141.99 23.81 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.822 0.82 . . . . 0.0 109.081 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 6.2 t -117.48 179.34 4.08 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -18.48 1.51 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 67.5 p -104.55 -31.09 9.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.995 -1.066 . . . . 0.0 113.595 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -171.88 -169.14 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.588 -1.32 . . . . 0.0 113.183 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 53.6 m -118.4 145.71 44.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 10.2 p90 -161.12 -145.2 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.384 -0.822 . . . . 0.0 110.71 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.434 ' O ' ' OG1' ' A' ' 54' ' ' THR . 88.9 mt -134.08 160.66 37.11 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.629 -1.294 . . . . 0.0 113.287 -176.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.18 126.72 10.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.068 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 59.3 m -96.74 127.28 42.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.115 -0.99 . . . . 0.0 111.743 -178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 22.3 m -76.32 123.82 26.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.854 -0.529 . . . . 0.0 110.434 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.52 130.01 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.54 -0.725 . . . . 0.0 110.19 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 50.37 39.92 21.55 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.355 -0.84 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.34 26.16 74.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.411 HG13 ' CE2' ' A' ' 53' ' ' TRP . 53.2 t -136.19 113.86 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -1.029 . . . . 0.0 109.556 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.461 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 47.5 t -75.65 119.97 20.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.73 -0.606 . . . . 0.0 109.399 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.449 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 86.7 m95 -107.68 123.45 48.53 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.471 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -127.62 -179.87 5.15 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.459 HG12 ' HB3' ' A' ' 139' ' ' SER . 10.5 m -90.22 124.99 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 C-N-CA 118.194 -1.403 . . . . 0.0 111.999 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.412 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.444 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.4 p-80 -73.02 68.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.119 0.962 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 168.57 -49.31 0.22 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.39 -78.61 0.25 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.71 -0.876 . . . . 0.0 109.753 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 43.56 28.39 1.01 Allowed Glycine 0 N--CA 1.503 3.16 0 O-C-N 121.521 -0.737 . . . . 0.0 111.688 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 63' ' ' THR . 27.3 p -131.89 10.08 4.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.264 -1.139 . . . . 0.0 112.31 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 61' ' ' SER . 20.3 ttmt 62.51 -64.63 0.09 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 118.581 0.628 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 61' ' ' SER . 90.7 m -81.0 138.13 36.05 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.845 0.831 . . . . 0.0 111.683 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.43 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -142.26 -135.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.85 100.03 4.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.743 -1.223 . . . . 0.0 110.712 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -96.45 172.92 29.38 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -63.75 -12.98 34.18 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.934 1.492 . . . . 0.0 110.996 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -112.51 -13.72 13.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.926 . . . . 0.0 111.873 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.6 -163.64 29.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.59 121.33 8.55 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.944 1.497 . . . . 0.0 109.597 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.42 HG23 ' CD1' ' A' ' 85' ' ' TRP . 27.0 mt -94.35 143.79 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.666 0.746 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -99.94 140.34 34.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.922 -0.486 . . . . 0.0 110.534 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -72.19 156.05 39.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.524 -0.735 . . . . 0.0 110.416 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -95.35 -35.51 11.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.499 0.666 . . . . 0.0 109.27 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -159.26 -177.02 6.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 89.4 m -150.48 122.49 8.22 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.653 -0.654 . . . . 0.0 109.565 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.79 76.41 2.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.04 -39.91 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.651 -0.655 . . . . 0.0 109.71 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -54.95 -26.09 33.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -110.48 -2.58 16.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.703 -0.623 . . . . 0.0 110.794 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 60.01 54.97 3.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.907 -1.121 . . . . 0.0 108.372 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 8.1 tp -147.33 153.57 39.86 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.839 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.442 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -144.18 141.2 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -124.14 122.01 4.65 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.094 -1.527 . . . . 0.0 111.877 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.471 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 6.9 m-90 -90.99 -170.24 2.61 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -101.83 112.72 25.43 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.27 138.39 97.41 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.421 -0.799 . . . . 0.0 110.48 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -114.36 167.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 123.751 1.395 . . . . 0.0 110.674 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -61.05 146.16 98.08 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.846 1.445 . . . . 0.0 110.631 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.88 -45.44 1.15 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.428 ' CB ' ' CG1' ' A' ' 29' ' ' VAL . . . -88.37 -152.71 0.22 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.87 -0.783 . . . . 0.0 109.828 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -154.27 114.47 3.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.1 m -84.48 157.48 21.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.46 0.648 . . . . 0.0 111.12 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.4 mt -109.37 158.61 17.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.919 -0.488 . . . . 0.0 109.927 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.2 p -101.1 149.98 36.71 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.475 -0.766 . . . . 0.0 110.662 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.27 170.49 11.94 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 O-C-N 123.834 1.439 . . . . 0.0 110.637 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 20.0 t -167.16 152.82 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.6 m -136.53 111.93 9.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.2 p -150.07 169.95 20.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 110.862 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.55 3.63 81.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 m -89.33 109.97 20.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.794 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.0 m -98.42 4.88 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.586 -0.696 . . . . 0.0 111.439 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -70.56 73.8 0.54 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.8 mt -83.53 175.56 9.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.584 0.707 . . . . 0.0 111.085 -178.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 89.6 m-85 -143.54 123.96 13.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -100.6 141.07 33.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 110.925 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -89.89 120.27 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.919 -0.488 . . . . 0.0 109.693 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 p -85.27 176.74 8.14 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.622 -0.674 . . . . 0.0 109.221 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -42.73 -29.19 0.29 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.052 0.453 . . . . 0.0 111.654 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.52 -67.92 0.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.552 -0.717 . . . . 0.0 110.091 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.31 -163.09 1.7 Allowed 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.474 -0.766 . . . . 0.0 109.546 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -55.55 -71.95 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.668 -0.645 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 33.6 t 65.41 -52.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.7 pt -118.9 149.96 47.66 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.72 -1.237 . . . . 0.0 112.087 -178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.417 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 53.8 Cg_endo -111.07 156.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.721 1.379 . . . . 0.0 109.736 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -139.05 139.97 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -95.68 116.02 28.27 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 ttm180 -58.06 125.51 23.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.946 . . . . 0.0 111.379 -178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -96.89 -2.67 43.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.42 -176.28 44.71 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 94.1 m-20 -70.01 -18.5 63.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.293 -1.122 . . . . 0.0 110.243 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.6 p -120.17 14.23 12.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.493 -0.754 . . . . 0.0 111.916 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -148.98 147.57 28.74 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.059 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.37 138.57 9.12 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.4 t -88.89 109.98 20.69 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.833 -0.804 . . . . 0.0 110.265 -178.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.8 tp -73.67 109.01 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.64 -19.75 65.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.693 -0.63 . . . . 0.0 110.392 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -119.96 79.97 25.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.669 -0.644 . . . . 0.0 110.212 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -57.68 146.99 82.51 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.681 1.359 . . . . 0.0 110.087 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -154.13 168.5 11.69 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.696 -0.627 . . . . 0.0 109.659 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.39 124.93 15.68 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.943 1.496 . . . . 0.0 110.077 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.75 -24.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.813 -0.555 . . . . 0.0 111.923 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.3 p -57.5 -34.25 68.88 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.398 -0.814 . . . . 0.0 109.514 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -69.92 -29.59 66.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.85 4.14 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.857 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.41 114.13 7.37 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.146 0.974 . . . . 0.0 109.039 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.66 -7.91 61.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.6 t -73.81 -17.14 61.12 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.504 -0.998 . . . . 0.0 109.569 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.459 ' HB3' HG12 ' A' ' 55' ' ' VAL . 2.9 m -65.3 148.7 51.24 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.052 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.438 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.92 -10.0 75.35 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -69.36 -167.22 5.31 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -139.58 147.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 117.087 -1.476 . . . . 0.0 111.734 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.1 mt -97.55 102.29 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.456 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -81.32 130.04 34.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -176.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.96 -160.18 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -95.21 16.24 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.635 1.334 . . . . 0.0 110.712 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.0 p -130.77 19.93 5.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.245 -0.909 . . . . 0.0 111.691 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.41 30.47 64.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 50.8 m170 -115.92 118.64 33.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.486 -1.008 . . . . 0.0 109.907 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.66 124.69 27.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.906 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 33.3 m -125.58 -2.54 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 111.559 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.474 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.18 128.63 2.42 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.487 -1.34 . . . . 0.0 111.317 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 23.3 mt -110.07 119.98 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.06 -1.259 . . . . 0.0 107.866 177.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 14.0 t80 -52.0 127.31 20.99 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.808 0.813 . . . . 0.0 112.909 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -115.68 -28.13 6.85 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.947 -0.471 . . . . 0.0 110.82 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.53 148.92 9.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.918 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -101.91 141.98 33.92 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.4 t -89.65 92.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 77.2 m -88.49 117.89 27.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.33 1.062 . . . . 0.0 112.218 -176.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 88.6 m -120.04 131.96 55.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.725 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 57.6 mmt-85 58.3 21.25 8.03 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.401 -0.812 . . . . 0.0 110.224 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 89.83 18.86 49.9 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.532 178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.1 m -145.98 143.91 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.235 -1.156 . . . . 0.0 109.4 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.56 121.29 23.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.476 -0.765 . . . . 0.0 110.854 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -111.11 11.14 21.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.714 -0.617 . . . . 0.0 110.51 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -175.25 139.46 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.43 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 17.1 m -110.09 137.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.155 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -106.55 148.09 28.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -155.21 164.57 38.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.616 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 50.2 t -84.23 135.68 41.45 Favored Pre-proline 0 N--CA 1.497 1.902 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 148.83 46.36 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.843 1.444 . . . . 0.0 110.099 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 173' ' ' GLU . 7.3 p -71.68 -28.53 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 0.0 109.922 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.414 ' N ' HG11 ' A' ' 172' ' ' VAL . 98.9 mt-10 -59.95 -30.62 69.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.465 -0.772 . . . . 0.0 109.128 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.4 t -72.12 -33.68 68.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.786 -0.571 . . . . 0.0 110.159 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.449 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 3.4 mtp -68.26 -40.08 82.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.5 -40.05 95.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 109.843 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 69.8 p -69.86 -31.96 70.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 111.78 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -60.02 -50.03 75.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.0 109.701 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 27.4 ptm -70.04 -26.37 64.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.634 -0.666 . . . . 0.0 109.837 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -70.04 -17.48 63.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.464 -0.772 . . . . 0.0 111.211 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.66 -54.13 44.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.392 -0.818 . . . . 0.0 110.162 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.0 p 39.07 60.33 1.48 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.94 -67.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.425 -0.797 . . . . 0.0 110.662 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -151.78 22.02 0.69 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.601 -0.687 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -156.02 131.04 9.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.294 -0.879 . . . . 0.0 110.648 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.1 mttp . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.126 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.441 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.73 12.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -79.99 -70.0 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.531 -0.982 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 41.78 31.9 0.23 Allowed 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.291 0.567 . . . . 0.0 111.295 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -134.83 76.97 1.66 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.908 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -161.02 39.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.596 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 54.65 102.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.432 -0.793 . . . . 0.0 111.01 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 90.5 t -81.28 -59.34 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.037 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 48.42 36.92 7.88 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.585 -0.697 . . . . 0.0 111.447 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.15 149.83 19.28 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.41 -47.69 19.13 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.843 -0.798 . . . . 0.0 110.522 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -125.55 130.04 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -94.85 120.44 35.07 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 61.6 t -84.01 130.26 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 30.4 m -146.32 171.26 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.641 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.0 p -142.21 127.91 19.21 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.699 0.762 . . . . 0.0 109.183 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 69.2 p -107.76 179.94 4.09 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -17.11 7.56 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.51 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -96.55 -41.41 8.56 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.273 -0.892 . . . . 0.0 112.019 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -173.47 -170.27 0.59 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.869 -1.144 . . . . 0.0 112.511 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 55.4 m -112.58 141.32 46.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 17.0 p90 -163.64 -145.72 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 0.0 110.628 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 54' ' ' THR . 92.0 mt -137.75 169.04 18.47 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.714 -1.241 . . . . 0.0 112.54 -177.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -150.25 127.35 11.23 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 62.6 m -99.13 127.81 45.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 111.526 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -74.6 124.29 26.39 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.8 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.56 126.79 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.482 -0.761 . . . . 0.0 109.992 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.8 40.05 26.89 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.621 -0.675 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.71 26.78 72.17 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG13 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -139.81 115.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.396 -1.061 . . . . 0.0 109.409 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.2 t -76.63 121.83 23.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.287 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.513 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 94.2 m95 -109.75 126.87 54.19 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.671 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.459 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 1.4 t -132.21 176.83 8.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.479 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 15.6 m -87.31 126.01 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 118.307 -1.357 . . . . 0.0 111.649 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.619 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.479 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 31.9 p-80 -66.85 -19.99 65.84 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.144 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.418 ' O ' ' CE1' ' A' ' 43' ' ' PHE . . . -81.75 -39.27 12.2 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.97 -69.96 0.55 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.681 -0.894 . . . . 0.0 109.166 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.25 -61.07 0.59 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.617 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 31.6 m -98.9 14.31 29.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.34 -1.094 . . . . 0.0 111.946 -178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 51.48 -164.72 0.06 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.016 -1.053 . . . . 0.0 110.56 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 95.6 m 51.25 71.71 0.42 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.377 0.608 . . . . 0.0 111.342 178.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -87.52 -137.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.73 109.46 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.901 -1.124 . . . . 0.0 110.518 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.432 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -75.42 -159.3 7.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.07 -22.35 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.215 1.64 . . . . 0.0 109.877 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -143.23 -1.52 1.05 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.122 -1.031 . . . . 0.0 113.166 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.64 169.97 42.96 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.938 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.46 121.86 9.8 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 124.09 1.574 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.432 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 42.9 mt -97.16 143.74 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -98.14 145.33 26.69 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.492 0.663 . . . . 0.0 111.553 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 2.4 pp0? -77.27 155.24 32.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.774 -0.579 . . . . 0.0 109.933 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.2 ttm -102.58 -29.14 11.74 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.536 -0.727 . . . . 0.0 110.501 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.487 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.1 OUTLIER -147.72 164.73 32.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.235 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 31.3 m -150.86 116.95 5.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.608 -0.683 . . . . 0.0 110.137 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 78.05 4.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.97 -33.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 0.0 109.929 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -53.1 -26.59 16.99 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.55 3.97 8.98 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.867 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.22 61.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.94 -1.1 . . . . 0.0 109.883 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.6 tp -142.41 151.74 42.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 109.535 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.423 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -143.86 129.15 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.401 -0.812 . . . . 0.0 109.58 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.07 122.49 5.48 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.192 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.459 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.1 m-90 -85.9 -171.74 3.74 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.988 -0.713 . . . . 0.0 110.12 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -102.57 95.26 6.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.13 145.1 98.98 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.44 -0.787 . . . . 0.0 110.853 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -92.61 156.25 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 124.062 1.559 . . . . 0.0 109.68 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.85 119.86 7.26 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 O-C-N 123.751 1.395 . . . . 0.0 110.561 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.13 -15.32 6.17 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.501 ' O ' ' N ' ' A' ' 93' ' ' SER . . . -89.45 97.33 11.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -1.135 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? 24.22 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.861 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER 63.33 75.86 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.737 0.779 . . . . 0.0 109.88 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.0 mt -71.15 163.96 26.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.24 155.48 37.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.836 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.82 172.3 11.95 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.969 1.51 . . . . 0.0 110.242 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.42 ' HB2' ' CB ' ' A' ' 149' ' ' HIS . 24.7 t -160.88 160.02 30.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 0.0 110.515 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 p -142.53 41.62 1.6 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.752 -0.592 . . . . 0.0 110.693 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.5 p -76.28 154.45 35.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.283 -0.886 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.95 -8.44 86.64 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.914 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.5 m -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.916 -1.344 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m 54.26 20.38 2.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.531 -0.731 . . . . 0.0 111.254 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -86.45 79.59 8.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 96.5 mt -89.53 170.61 10.35 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.381 0.61 . . . . 0.0 110.678 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 45.1 p90 -155.86 140.75 17.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.13 153.17 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.07 0.938 . . . . 0.0 111.748 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.0 t -109.99 130.01 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.434 ' O ' ' N ' ' A' ' 110' ' ' HIS . 60.1 p -81.35 171.6 14.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.412 -0.805 . . . . 0.0 110.284 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -32.26 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 108' ' ' THR . 83.3 m-70 -98.87 -87.19 0.35 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.108 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.2 26.37 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.124 -0.985 . . . . 0.0 111.226 179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.2 158.28 14.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.066 -1.021 . . . . 0.0 110.694 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.11 120.03 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.421 ' CG2' ' CD1' ' A' ' 126' ' ' LEU . 85.9 mt -130.01 83.86 62.29 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 110.259 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.68 120.61 7.83 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.982 1.517 . . . . 0.0 110.744 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.6 t -124.48 132.95 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.684 . . . . 0.0 109.422 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -84.86 120.09 26.07 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -60.82 123.51 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 110.569 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.743 -0.598 . . . . 0.0 109.491 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.72 -179.94 43.89 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.422 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 30.1 p-10 -62.04 -29.32 70.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.98 . . . . 0.0 110.564 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 m -121.52 18.55 11.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.831 -0.543 . . . . 0.0 112.056 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -139.31 144.33 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 111.04 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.41 140.4 10.24 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.3 t -87.59 109.97 20.04 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.782 -0.834 . . . . 0.0 109.821 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.421 ' CD1' ' CG2' ' A' ' 114' ' ' ILE . 22.8 tp -69.33 105.78 2.68 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.51 -25.34 66.64 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.202 0.525 . . . . 0.0 110.055 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 p -106.41 100.71 31.37 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.764 -0.585 . . . . 0.0 110.158 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.88 134.25 16.19 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 124.024 1.539 . . . . 0.0 109.55 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.67 167.22 14.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -57.98 128.71 29.93 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.824 1.434 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.69 -26.43 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.628 -0.67 . . . . 0.0 110.616 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 75.3 m -57.86 -31.36 66.61 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.719 0.771 . . . . 0.0 109.274 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -70.86 -30.89 67.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 98.3 mt -89.98 -0.02 57.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.539 -0.725 . . . . 0.0 112.557 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -75.7 124.81 27.88 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 120.837 -1.164 . . . . 0.0 109.001 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 99.66 -11.4 61.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 -177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 p -78.55 -10.24 59.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.34 -1.094 . . . . 0.0 109.669 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.41 ' HB3' HG12 ' A' ' 55' ' ' VAL . 1.5 m -60.45 143.86 52.43 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.81 -9.94 75.47 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.11 -163.53 0.89 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.424 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.19 135.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 116.624 -1.784 . . . . 0.0 112.145 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 3.9 mp -94.82 97.11 9.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 7.2 mp -88.76 141.48 28.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.953 0.882 . . . . 0.0 113.33 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 1.3 m -74.01 -172.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.0 Cg_endo -82.02 5.28 6.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.739 1.389 . . . . 0.0 111.446 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.42 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 14.1 m -110.2 17.8 20.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.996 -1.065 . . . . 0.0 111.883 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.72 38.31 61.09 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.42 ' CB ' ' HB2' ' A' ' 97' ' ' CYS . 46.4 m170 -122.97 123.64 41.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.465 -1.021 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -87.16 102.76 14.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.04 7.4 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.912 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.61 133.94 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.575 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 40.1 mt -116.52 120.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.276 -1.132 . . . . 0.0 108.072 177.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.411 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 13.0 t80 -49.96 127.71 17.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.857 0.837 . . . . 0.0 112.978 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -114.28 -30.33 6.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.942 -0.474 . . . . 0.0 111.059 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.411 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.16 150.42 9.38 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.684 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -101.62 140.77 35.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 57.3 t -93.12 88.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.509 -0.744 . . . . 0.0 109.006 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.2 p -92.84 115.72 28.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.273 1.035 . . . . 0.0 111.103 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.5 m -90.01 -80.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.502 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -97.71 61.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.172 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 70.03 19.13 75.21 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.3 m -147.74 140.18 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 121.282 -1.128 . . . . 0.0 108.956 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.24 128.27 33.33 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.546 0.688 . . . . 0.0 111.325 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -122.22 16.14 10.65 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -171.55 154.13 3.68 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.4 m -135.27 138.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.885 0.85 . . . . 0.0 112.237 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -107.23 148.34 29.06 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 35.7 p90 -153.45 163.95 39.05 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.713 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.02 141.63 54.83 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.994 -0.442 . . . . 0.0 110.714 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.42 150.87 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.523 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.69 -28.13 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.689 . . . . 0.0 110.355 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -59.95 -32.49 70.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.1 t -75.52 -29.71 59.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.987 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.513 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 7.3 mtp -69.92 -37.93 76.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.96 -36.4 77.03 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.265 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.2 p -60.44 -30.66 69.79 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.399 -0.813 . . . . 0.0 110.624 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.487 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 47.3 m -60.08 -46.02 90.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.096 -1.003 . . . . 0.0 108.901 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.53 -39.33 87.47 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -83.5 -13.7 54.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 50.71 -165.72 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.175 -0.953 . . . . 0.0 110.941 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.23 -47.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.448 -0.783 . . . . 0.0 110.563 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -151.39 159.98 43.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.456 -0.777 . . . . 0.0 110.589 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -74.18 -26.3 60.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.7 -0.625 . . . . 0.0 110.66 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 63.1 tttm 55.44 85.63 0.06 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.44 -0.788 . . . . 0.0 110.422 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 65.2 pttt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.435 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.408 HB31 ' CD2' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -9.98 75.48 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -80.26 133.88 36.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.104 -1.233 . . . . 0.0 110.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t0 49.36 37.79 12.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.822 -0.549 . . . . 0.0 111.332 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -134.94 29.98 3.4 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.368 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -157.99 173.97 15.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.584 0.707 . . . . 0.0 109.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.97 -160.6 0.06 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.955 -0.466 . . . . 0.0 110.516 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 33.7 m -87.04 16.39 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.532 -0.73 . . . . 0.0 111.763 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 29' ' ' VAL . 57.4 mm-40 63.47 -67.37 0.09 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.031 0.533 . . . . 0.0 111.771 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.44 -123.66 6.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -66.31 -40.0 89.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.612 -0.934 . . . . 0.0 111.48 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.1 t -125.08 129.96 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.858 . . . . 0.0 110.658 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -99.24 123.77 43.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.622 -0.674 . . . . 0.0 110.623 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 62.7 t -81.69 131.22 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.91 174.03 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.094 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 88.0 p -145.49 125.78 13.89 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.718 0.77 . . . . 0.0 108.98 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 47.6 p -103.52 -179.54 3.98 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.34 -15.03 8.83 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.528 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -100.42 -39.21 8.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 112.572 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -172.02 -170.0 0.71 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.798 -1.189 . . . . 0.0 112.694 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.414 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 73.6 m -115.21 141.54 47.88 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.6 p90 -162.61 -147.33 0.12 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 110.499 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.0 mt -132.07 166.01 22.72 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.602 -1.311 . . . . 0.0 113.342 -176.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -152.86 131.86 12.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.837 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 94.1 m -96.75 123.65 40.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 84.2 m -73.78 127.22 32.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.68 -0.637 . . . . 0.0 109.805 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 38.7 t -140.42 127.24 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.796 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 49.98 40.7 21.76 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.585 -0.697 . . . . 0.0 111.619 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.54 26.93 68.59 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.439 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 59.9 t -139.94 117.37 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -1.04 . . . . 0.0 109.572 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 13.6 t -75.68 119.62 19.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 96.2 m95 -106.86 125.74 51.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.902 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.474 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 7.2 t -132.52 -179.26 5.34 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 139' ' ' SER . 24.0 m -90.22 125.57 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 118.193 -1.403 . . . . 0.0 112.242 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.03 -39.99 87.81 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CG ' ' CD2' ' A' ' 188' ' ' 2ZF . 30.5 p-80 -73.42 68.64 1.12 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.139 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.09 -38.13 0.31 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.02 -69.99 0.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.597 -0.943 . . . . 0.0 110.224 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.95 16.4 33.32 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.04 88.02 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.024 -1.28 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -150.62 -171.26 3.88 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.923 0.868 . . . . 0.0 110.662 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.404 ' HB ' ' CB ' ' A' ' 70' ' ' PRO . 2.6 p -79.74 -6.43 57.24 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.422 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 HD23 ' CZ2' ' A' ' 85' ' ' TRP . 4.3 mm? 49.48 -159.95 0.06 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.163 -0.961 . . . . 0.0 110.572 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.4 91.84 2.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.437 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -85.52 174.82 48.89 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.81 -14.93 43.74 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 124.043 1.549 . . . . 0.0 110.204 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -105.97 -15.14 14.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 110.891 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.59 -156.84 24.91 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' CB ' ' HB ' ' A' ' 63' ' ' THR . 44.4 Cg_endo -63.81 117.04 4.05 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.047 1.551 . . . . 0.0 110.834 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.437 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 68.0 mt -89.56 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 137.61 32.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 0.0 111.742 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -70.03 141.54 52.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.734 -0.604 . . . . 0.0 109.899 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.8 ttp -105.33 -34.36 7.89 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.427 -0.796 . . . . 0.0 110.693 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.488 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.1 OUTLIER -153.33 170.47 20.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.467 -0.771 . . . . 0.0 109.755 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.437 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 71.5 m -153.4 115.94 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.69 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 76.6 3.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.6 t -60.06 -39.99 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.451 -0.781 . . . . 0.0 109.553 -179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -55.65 -26.64 45.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -110.86 -0.4 16.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.751 -0.593 . . . . 0.0 110.751 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 60.17 56.31 3.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.947 -1.096 . . . . 0.0 109.393 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 49.1 tp -145.57 153.19 40.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.46 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -146.03 130.68 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 109.415 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.78 121.01 5.11 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.625 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.474 ' CZ3' HG23 ' A' ' 54' ' ' THR . 5.3 m-90 -87.07 -170.28 2.99 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.88 -0.777 . . . . 0.0 109.314 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -100.01 112.22 24.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.6 133.83 95.66 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -96.13 154.82 1.38 Allowed 'Trans proline' 0 N--CA 1.485 1.002 0 O-C-N 123.943 1.496 . . . . 0.0 110.048 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.05 144.27 95.94 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.753 1.396 . . . . 0.0 110.499 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.86 -49.73 0.91 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.44 -137.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 122.045 -0.679 . . . . 0.0 109.954 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -151.84 -29.65 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.865 -1.147 . . . . 0.0 112.77 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.7 t 60.64 154.81 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.457 -0.777 . . . . 0.0 110.768 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.451 ' N ' ' CD2' ' A' ' 94' ' ' LEU . 3.7 mm? -114.32 150.62 34.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.532 -0.73 . . . . 0.0 109.846 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.406 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 2.9 p -98.46 151.06 37.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.434 -0.791 . . . . 0.0 110.93 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.77 153.81 29.93 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.865 1.455 . . . . 0.0 110.037 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 44.3 t -160.48 159.97 31.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.516 -0.74 . . . . 0.0 110.857 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -150.07 67.7 0.98 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 109.69 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -70.05 -33.79 72.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.86 -16.54 9.45 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.1 m -88.72 139.29 30.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -1.203 . . . . 0.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -106.65 15.87 25.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.704 . . . . 0.0 110.971 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -73.1 78.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 68.3 mt -99.12 175.09 6.02 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.395 0.616 . . . . 0.0 110.32 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.3 p90 -150.27 131.75 14.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 21.9 tp -92.99 147.25 22.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.846 0.831 . . . . 0.0 110.897 -178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 80.9 t -90.07 110.0 21.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.4 p -81.38 177.58 8.89 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.216 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -43.74 -25.51 0.18 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.817 -0.552 . . . . 0.0 111.744 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -90.16 -79.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.573 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -151.38 -44.07 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.291 -0.881 . . . . 0.0 111.183 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -163.84 -65.33 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.746 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.6 t 64.42 -58.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.6 pt -125.41 150.96 69.26 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.951 -1.093 . . . . 0.0 111.737 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -106.65 163.87 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.804 1.423 . . . . 0.0 109.788 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.8 t -136.1 140.08 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.834 . . . . 0.0 110.856 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -95.0 115.81 27.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.99 124.8 21.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 -178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -99.26 -0.05 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 0.0 109.766 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.83 44.35 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 34.4 m-20 -65.12 -22.89 67.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.931 . . . . 0.0 110.251 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.2 p -124.96 17.41 8.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 111.46 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -140.66 140.83 35.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.068 -1.02 . . . . 0.0 111.088 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.73 141.25 11.47 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.3 t -89.9 112.19 23.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.834 -0.803 . . . . 0.0 110.161 -179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 21.9 tp -71.2 104.47 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.3 mt -60.04 -32.67 71.13 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 110.079 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -112.89 99.92 49.62 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.28 145.97 74.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.908 1.478 . . . . 0.0 109.018 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -154.29 163.17 25.01 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.599 -0.688 . . . . 0.0 109.685 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -60.52 122.8 11.85 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.064 1.56 . . . . 0.0 109.88 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -46.5 -25.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.928 -0.482 . . . . 0.0 111.724 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.4 p -58.23 -34.32 70.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.0 108.992 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -69.99 -30.03 67.26 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.25 2.02 33.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.763 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -72.21 112.44 8.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.234 -0.916 . . . . 0.0 108.603 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 -10.1 58.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.5 t -76.69 -12.86 60.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 110.111 178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.449 ' HB3' HG12 ' A' ' 55' ' ' VAL . 2.7 m -66.53 150.99 48.16 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.001 -1.062 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.423 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 89.9 -9.91 75.66 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.93 -167.7 4.03 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -141.48 140.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 116.956 -1.563 . . . . 0.0 112.143 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 mp -94.2 94.02 8.11 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 6.0 mp -85.65 150.24 24.76 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -162.89 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 16.57 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.645 1.339 . . . . 0.0 110.504 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.1 m -124.78 -51.98 1.69 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.06 40.64 0.02 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.44 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 77.4 m80 -119.99 129.42 54.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -70.26 121.16 17.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.563 -0.711 . . . . 0.0 110.001 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.24 -29.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.803 -0.561 . . . . 0.0 110.112 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.48 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -155.12 150.38 21.86 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.985 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 16.7 mt -119.37 120.86 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.341 -1.093 . . . . 0.0 108.073 177.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.404 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 12.9 t80 -50.01 128.94 19.86 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.948 0.88 . . . . 0.0 113.044 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 29.9 ttt180 -117.06 -27.88 6.4 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.723 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.415 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -165.39 147.59 7.7 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.08 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -98.42 140.43 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.7 t -91.19 92.66 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 86.1 m -94.49 123.32 37.84 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.77 0.795 . . . . 0.0 111.479 -177.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 75.9 m -85.37 -97.51 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.773 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -69.77 -55.5 9.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.782 -1.199 . . . . 0.0 109.119 179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . -163.96 28.32 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -148.83 146.01 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -81.34 129.25 34.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.568 -0.708 . . . . 0.0 111.168 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.82 15.22 13.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.266 0.555 . . . . 0.0 109.999 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.39 153.02 2.29 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 11.7 m -130.1 138.22 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.513 -178.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -105.3 147.63 27.91 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 36.6 p90 -153.2 165.61 35.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.169 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.15 130.07 51.39 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.86 157.52 51.49 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.759 1.4 . . . . 0.0 110.487 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.466 ' HA ' ' CE ' ' A' ' 175' ' ' MET . 7.2 p -76.03 -23.28 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.644 . . . . 0.0 109.653 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.52 -30.83 67.37 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.6 m -73.31 -36.8 66.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.36 0.6 . . . . 0.0 109.631 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.466 ' CE ' ' HA ' ' A' ' 172' ' ' VAL . 0.4 OUTLIER -67.96 -36.6 80.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.522 -0.737 . . . . 0.0 109.019 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -33.1 71.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.885 -0.509 . . . . 0.0 110.33 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 181' ' ' ALA . 30.5 p -63.27 -28.88 70.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.173 -0.954 . . . . 0.0 110.453 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.488 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 53.6 m -65.4 -51.5 59.92 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.202 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 25.1 ptm -66.75 -27.88 67.96 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.691 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -89.42 -15.7 32.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.891 . . . . 0.0 110.728 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 177' ' ' THR . . . 56.92 118.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.901 0.858 . . . . 0.0 111.125 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.8 p -65.2 78.73 0.05 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.462 -0.774 . . . . 0.0 111.073 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -89.04 140.33 29.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.477 -0.764 . . . . 0.0 110.019 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -160.03 59.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.255 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -77.8 134.49 38.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.594 -0.691 . . . . 0.0 109.711 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.0 mttt . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.935 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.457 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.178 0.513 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.06 -178.03 50.88 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -114.15 129.51 56.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.554 -0.969 . . . . 0.0 110.785 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.67 -42.76 33.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.647 0.737 . . . . 0.0 110.045 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -149.95 -172.34 4.13 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.881 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -158.26 51.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -117.54 123.52 46.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 110.289 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.3 m -97.42 18.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.907 -0.496 . . . . 0.0 111.332 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.93 -46.69 34.02 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 32' ' ' GLU . . . 151.11 -154.57 25.65 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 97.8 mt-10 75.23 -106.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.148 1.379 . . . . 0.0 114.558 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.6 t -140.01 140.69 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.945 -1.097 . . . . 0.0 111.268 -175.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.01 121.39 32.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.309 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.44 138.89 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.75 169.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.088 0.946 . . . . 0.0 111.544 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -142.76 120.0 11.52 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.428 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 62.6 p -107.15 -179.07 3.82 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.66 -16.48 16.39 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.659 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.3 p -102.69 -39.68 6.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.268 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -174.64 -168.91 0.39 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.064 -1.023 . . . . 0.0 111.855 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 m -116.57 147.43 41.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 38' ' ' THR . 11.7 p90 -161.76 -142.97 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.443 ' O ' ' OG1' ' A' ' 54' ' ' THR . 85.5 mt -134.33 161.48 34.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.675 -1.265 . . . . 0.0 113.352 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.408 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -147.84 123.43 10.45 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.143 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.443 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 25.1 m -97.9 120.04 37.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.486 -0.759 . . . . 0.0 110.674 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 21.5 m -76.79 125.99 30.21 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.123 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -123.16 124.61 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 52.67 45.3 28.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.307 -0.87 . . . . 0.0 110.625 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.05 22.64 77.28 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.168 -1.015 . . . . 0.0 110.74 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' NE1' ' A' ' 53' ' ' TRP . 61.9 t -130.01 111.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.261 -1.141 . . . . 0.0 109.24 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 15.6 t -74.61 121.85 22.25 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 87.0 m95 -112.84 126.21 55.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.475 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 2.1 t -131.51 178.96 6.33 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 16.6 m -89.57 123.84 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.705 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.02 -39.97 87.66 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 34.6 p-80 -71.31 74.42 0.72 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.872 0.844 . . . . 0.0 109.069 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.07 -25.51 0.71 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.405 ' HA ' ' CG2' ' A' ' 38' ' ' THR . . . -88.24 -80.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -1.055 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 47.77 24.32 2.88 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.252 -0.905 . . . . 0.0 111.741 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.409 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 26.4 p -111.63 -19.81 12.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.98 -1.306 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 61' ' ' SER . 83.5 tttt 67.82 -60.54 0.4 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.572 -0.705 . . . . 0.0 111.684 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.402 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 24.5 p -83.84 -32.1 25.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 113.053 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 44.14 -142.89 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 O-C-N 121.985 -0.447 . . . . 0.0 111.284 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.433 ' N ' ' HG ' ' A' ' 64' ' ' LEU . . . -150.71 102.07 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 109.947 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -90.3 -178.71 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.85 -16.44 54.85 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 124.001 1.527 . . . . 0.0 110.396 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -112.49 2.35 16.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.32 -0.863 . . . . 0.0 111.117 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.6 -160.91 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -57.97 123.52 13.88 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.638 1.336 . . . . 0.0 110.264 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.43 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 8.6 mt -87.57 -25.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.643 -0.661 . . . . 0.0 111.455 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 10.1 m 60.52 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.488 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 3.8 pt20 -80.06 159.29 26.21 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.335 -0.853 . . . . 0.0 112.167 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.6 mmm -108.77 -30.01 8.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.058 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 1.3 t80 -140.37 164.22 30.69 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.525 -0.734 . . . . 0.0 109.248 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.44 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 39.8 m -154.35 115.33 4.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 0.0 110.304 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -99.15 74.03 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.431 -0.793 . . . . 0.0 109.168 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.05 -39.97 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.272 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -55.19 -26.08 36.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -111.99 -2.59 15.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.682 -0.636 . . . . 0.0 110.589 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t0 62.56 55.18 2.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 109.249 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 18.6 tp -147.14 151.75 37.31 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.449 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -147.1 139.34 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.068 -1.02 . . . . 0.0 109.296 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.45 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -124.69 122.14 4.62 Favored Glycine 0 N--CA 1.5 2.933 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.656 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.475 ' CD1' ' HA ' ' A' ' 73' ' ' GLN . 9.4 m-90 -90.36 -166.72 1.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.076 -0.661 . . . . 0.0 109.387 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -112.55 96.96 6.28 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 160.03 82.01 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.498 -0.751 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -101.42 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.936 1.493 . . . . 0.0 110.324 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -60.11 109.52 0.63 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.785 1.413 . . . . 0.0 112.664 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.49 -63.09 0.31 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 29' ' ' VAL . . . -61.03 105.11 0.44 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.214 1.007 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' A' ' 47' ' ' CYS . 8.5 mpt_? 52.7 108.94 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 122.105 0.955 . . . . 0.0 112.446 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 m -165.02 107.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -110.01 160.59 16.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.34 -0.85 . . . . 0.0 111.133 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.417 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.1 p -112.12 157.12 40.71 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.611 -0.68 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.84 151.59 7.27 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.874 1.46 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.505 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 49.8 t -155.25 -71.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.521 -0.737 . . . . 0.0 110.767 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.0 m 51.62 59.09 4.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.693 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -140.0 152.15 46.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.193 -0.942 . . . . 0.0 112.04 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.57 -46.77 3.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 t -168.92 169.94 9.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 110.752 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.8 m -105.09 18.85 21.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.725 -0.609 . . . . 0.0 109.989 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -70.47 76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.0 mt -94.11 174.32 7.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.283 0.563 . . . . 0.0 109.664 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.6 p90 -152.4 136.1 16.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 40.8 tp -103.83 141.25 36.44 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.724 0.774 . . . . 0.0 111.146 -177.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -86.31 119.92 35.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.4 p -80.44 179.98 7.44 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.097 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -43.02 -27.92 0.23 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.756 -0.59 . . . . 0.0 112.24 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -115.27 -50.92 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.865 . . . . 0.0 111.571 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.62 -179.0 7.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.89 -1.131 . . . . 0.0 110.338 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 57.7 t0 -60.09 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.163 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.4 t 51.67 25.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.392 -0.817 . . . . 0.0 110.726 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.402 ' CD1' ' CD1' ' A' ' 126' ' ' LEU . 6.5 tp -164.83 100.07 0.83 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.874 . . . . 0.0 111.024 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.82 136.41 2.11 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.571 1.301 . . . . 0.0 109.761 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -130.4 140.32 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.324 -0.86 . . . . 0.0 111.027 -179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -93.77 119.47 32.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.421 ' NH2' ' CZ ' ' A' ' 169' ' ' PHE . 10.9 ttm-85 -60.59 127.38 31.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.802 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -99.77 -0.01 40.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.666 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.75 -177.37 43.86 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 82.8 m-20 -69.23 -20.02 63.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -1.03 . . . . 0.0 110.171 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 p -123.47 15.15 9.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.409 -0.807 . . . . 0.0 111.642 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -143.25 144.59 32.2 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.14 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.14 140.99 10.79 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.6 t -88.69 111.37 21.87 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.759 -0.848 . . . . 0.0 109.67 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.402 ' CD1' ' CD1' ' A' ' 114' ' ' ILE . 23.6 tp -70.31 110.23 5.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.01 -18.88 65.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.852 -0.53 . . . . 0.0 110.655 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 47.4 t -129.95 82.25 66.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 110.399 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -61.19 143.84 98.71 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.856 1.45 . . . . 0.0 109.907 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -154.99 168.36 12.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.643 -0.661 . . . . 0.0 109.345 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.86 125.37 18.43 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.842 1.443 . . . . 0.0 110.354 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.05 -27.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 121.516 0.674 . . . . 0.0 110.534 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.477 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 39.7 t -61.42 -15.08 33.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.785 -0.572 . . . . 0.0 110.135 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -86.75 -31.79 20.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 136' ' ' LYS . 84.4 mt -76.7 -55.85 5.13 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.79 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 133' ' ' SER . 4.5 pttt 7.12 104.74 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.22 -4.2 55.14 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.3 p -76.07 -14.78 60.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.534 -0.98 . . . . 0.0 109.261 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.425 ' HB3' HG12 ' A' ' 55' ' ' VAL . 4.0 m -61.97 142.23 57.58 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.161 -0.962 . . . . 0.0 110.143 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.428 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.06 -10.11 75.13 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.05 -162.02 0.68 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.443 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 55.5 Cg_endo -146.69 138.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 116.605 -1.796 . . . . 0.0 112.469 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 3.4 mp -96.0 97.84 9.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 7.3 mp -87.29 151.68 22.93 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.414 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -64.42 -159.62 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.215 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 51.2 Cg_endo -96.8 17.34 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.503 1.265 . . . . 0.0 110.098 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.5 p -130.54 11.06 5.27 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.273 -0.892 . . . . 0.0 112.066 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.52 32.0 10.84 Favored Glycine 0 N--CA 1.502 3.039 0 O-C-N 120.917 -1.114 . . . . 0.0 110.558 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.505 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 77.7 m80 -113.91 118.45 34.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -1.19 . . . . 0.0 110.536 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.22 123.41 24.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.505 -0.747 . . . . 0.0 110.222 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.2 m -123.35 -5.56 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.551 -0.718 . . . . 0.0 111.572 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.479 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -160.04 127.67 1.84 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.791 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.58 120.71 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -1.082 . . . . 0.0 108.555 177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 15.8 t80 -50.75 128.61 21.2 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.621 0.724 . . . . 0.0 112.601 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -116.78 -26.45 6.95 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.867 -0.521 . . . . 0.0 110.835 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.96 149.18 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.957 . . . . 0.0 111.751 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.98 141.59 32.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.718 -0.614 . . . . 0.0 110.889 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 49.1 t -95.15 93.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -89.43 117.78 28.6 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.13 0.967 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.8 m -83.92 -69.96 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.16 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -117.36 57.57 0.8 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.057 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.04 16.35 76.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.4 m -146.84 139.9 19.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 121.374 -1.074 . . . . 0.0 108.27 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.98 129.92 35.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.732 0.777 . . . . 0.0 111.338 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -123.86 17.28 9.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.272 0.558 . . . . 0.0 110.077 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -174.33 139.93 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.3 m -113.31 138.67 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.148 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -108.5 143.33 37.63 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.479 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 39.2 p90 -150.96 166.02 31.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.12 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 52.4 t -87.3 130.53 47.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.996 -0.44 . . . . 0.0 110.326 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.7 135.82 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 O-C-N 123.722 1.38 . . . . 0.0 110.195 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 11.6 p -70.21 -29.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.588 -0.695 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.08 -31.09 69.69 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 18.8 m -72.6 -35.28 67.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.609 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.423 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 1.4 mtp -64.68 -47.16 79.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.75 -44.46 96.15 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.937 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 13.8 t -72.92 -40.02 65.82 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 110.683 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.422 ' CG2' ' OH ' ' A' ' 75' ' ' TYR . 83.6 m -64.29 -42.12 96.54 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.057 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 24.6 ptm -67.24 -26.67 66.7 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.247 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -63.85 -23.63 67.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 0.0 109.987 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -166.76 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.9 t 50.01 69.88 0.56 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.147 -0.971 . . . . 0.0 111.468 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -143.2 140.69 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 110.555 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.01 -38.84 69.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.618 -0.676 . . . . 0.0 109.767 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.27 129.97 35.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.691 -0.631 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.473 179.93 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.455 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.114 0.483 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.68 91.04 0.14 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -69.98 -59.92 2.62 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.583 -0.951 . . . . 0.0 110.332 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 36.21 62.06 0.73 Allowed 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -139.99 146.39 39.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.989 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 67.69 139.04 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.437 -0.789 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 58.85 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.498 0.666 . . . . 0.0 110.789 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 33.8 m -86.43 0.84 5.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.847 -0.533 . . . . 0.0 111.439 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 56.67 20.04 4.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.118 -0.989 . . . . 0.0 111.612 179.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.68 -120.79 23.99 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -98.43 -34.87 10.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.728 -0.866 . . . . 0.0 111.536 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.08 129.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.391 -178.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.59 117.65 30.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -84.81 131.66 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 43' ' ' PHE . 33.9 m -140.43 178.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.493 -0.754 . . . . 0.0 109.268 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 m -140.91 126.94 19.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.718 0.771 . . . . 0.0 109.209 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.498 HG23 ' CE1' ' A' ' 43' ' ' PHE . 14.7 t -113.0 -168.57 1.34 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.36 5.04 0.82 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -120.89 -39.35 2.73 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.701 -1.25 . . . . 0.0 111.941 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -173.08 -155.38 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.098 -1.001 . . . . 0.0 112.348 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 m -102.71 119.01 38.09 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.498 ' CE1' HG23 ' A' ' 38' ' ' THR 0.27 3.3 m-85 -90.25 -174.67 4.26 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 117.398 2.369 . . . . 0.0 117.398 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' O ' ' OG1' ' A' ' 54' ' ' THR . 26.5 mt -142.55 136.07 28.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.378 -2.192 . . . . 0.0 106.842 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -145.78 136.66 24.48 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.6 m -101.69 125.77 48.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.583 -0.698 . . . . 0.0 111.586 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -72.45 119.98 17.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.72 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.83 129.97 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.456 -0.777 . . . . 0.0 109.994 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 50.12 40.14 21.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.472 -0.768 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.96 26.57 74.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 58.5 t -138.75 115.97 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.267 -1.137 . . . . 0.0 109.658 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 35.2 t -76.72 118.61 19.52 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.433 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 91.8 m95 -106.27 124.24 49.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.0 111.189 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -130.65 179.98 5.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 140' ' ' GLY . 2.8 m -84.32 123.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 C-N-CA 117.195 -1.802 . . . . 0.0 113.373 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.98 -40.31 88.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.802 . . . . 0.0 109.9 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.479 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.6 p-80 -69.2 101.9 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.701 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.16 -41.72 1.42 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -76.71 0.16 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.947 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.52 22.72 8.28 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -129.02 -2.4 5.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.25 -1.147 . . . . 0.0 111.786 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 tttp 66.71 -65.66 0.2 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.378 -0.826 . . . . 0.0 110.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.8 p -81.93 159.94 23.49 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.744 0.783 . . . . 0.0 110.888 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -149.46 -126.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.21 83.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 109.505 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' CA ' ' CD1' ' A' ' 71' ' ' ILE . . . -63.76 -166.68 0.95 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -59.48 -21.0 59.65 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 124.043 1.549 . . . . 0.0 110.785 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -145.02 4.28 1.09 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.991 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.98 -176.25 40.77 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.158 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -56.7 130.21 38.75 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.799 1.42 . . . . 0.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.409 ' CD1' ' CA ' ' A' ' 66' ' ' GLY . 4.5 mt -89.37 -14.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.714 -0.616 . . . . 0.0 111.441 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.6 m 58.7 136.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.955 0.883 . . . . 0.0 112.175 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.482 ' HG2' ' CE2' ' A' ' 85' ' ' TRP . 16.1 mt-30 -80.28 157.19 26.5 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.531 -0.731 . . . . 0.0 112.564 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 88.8 mtp -100.56 -38.23 8.45 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.21 -176.46 4.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 69.7 m -153.49 127.42 8.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.559 -0.713 . . . . 0.0 109.59 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.16 76.96 2.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.95 -40.06 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.643 -0.66 . . . . 0.0 110.009 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.41 -26.17 40.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.476 -0.765 . . . . 0.0 108.972 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -112.59 0.02 15.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.643 . . . . 0.0 110.735 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.03 59.71 2.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.045 -1.034 . . . . 0.0 109.189 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.454 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 24.3 tp -145.99 154.01 41.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.171 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.41 135.83 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.76 121.99 4.7 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.949 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.482 ' CE2' ' HG2' ' A' ' 73' ' ' GLN . 11.1 m-90 -89.92 -173.11 3.77 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -104.05 91.66 4.05 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.96 131.97 92.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.805 -0.56 . . . . 0.0 110.28 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 148.83 78.37 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.952 1.501 . . . . 0.0 109.426 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.36 114.4 2.34 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.913 1.481 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.04 -32.77 1.27 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.32 60.42 0.44 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.6 -0.941 . . . . 0.0 111.291 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 tpt85 29.59 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.3 t -83.45 123.79 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.4 mt -106.61 159.68 16.01 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.086 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.64 166.1 11.42 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.97 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.29 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 O-C-N 124.054 1.555 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.461 ' CB ' ' CD2' ' A' ' 149' ' ' HIS . 0.5 OUTLIER 56.11 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.051 -1.031 . . . . 0.0 110.195 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.8 m -83.51 89.31 7.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.222 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 51.0 m -71.33 144.47 49.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.694 -0.629 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -62.47 -39.93 98.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 t -74.62 130.01 38.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.882 -0.775 . . . . 0.0 109.406 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -103.72 18.33 22.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 111.19 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.51 78.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.5 mt -89.75 174.19 7.85 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.477 0.656 . . . . 0.0 110.546 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.9 113.49 9.02 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.52 146.64 24.47 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.127 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -92.97 119.42 40.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.159 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 66.0 p -85.94 175.24 8.73 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -42.86 -28.61 0.26 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.796 -0.565 . . . . 0.0 111.954 -178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -100.07 -69.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.12 -163.27 1.74 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.438 -0.789 . . . . 0.0 109.506 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 73.9 m-20 -57.29 -66.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.741 -0.599 . . . . 0.0 110.585 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.7 t 56.58 -85.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.99 -0.444 . . . . 0.0 111.298 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 44.0 pt -76.51 145.28 75.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.078 -1.013 . . . . 0.0 112.006 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -112.63 153.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 O-C-N 123.756 1.398 . . . . 0.0 108.657 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.2 t -136.42 139.64 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.074 -1.016 . . . . 0.0 111.66 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.32 118.49 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.8 ttm180 -63.37 122.2 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.0 110.219 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -101.05 7.43 43.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.688 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.32 173.59 42.09 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.446 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 75.5 m-20 -60.3 -25.83 66.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.379 -1.071 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.7 18.58 7.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.548 -0.72 . . . . 0.0 111.85 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.41 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 92.7 mtt180 -138.12 143.41 40.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.833 -1.167 . . . . 0.0 111.012 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -140.11 142.17 12.26 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.1 t -89.64 110.99 21.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.971 -0.723 . . . . 0.0 109.814 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 61.4 tp -69.96 113.74 7.47 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.174 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.99 -20.96 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.874 -0.516 . . . . 0.0 110.756 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 m -126.77 80.86 70.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.43 139.79 91.21 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 O-C-N 123.754 1.397 . . . . 0.0 110.346 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -146.96 163.15 30.14 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -55.47 124.49 16.42 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.808 1.425 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.8 p -51.61 -23.46 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.888 -0.507 . . . . 0.0 111.639 -178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -57.19 -34.34 68.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.312 -0.868 . . . . 0.0 109.28 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -74.22 -21.87 59.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -85.02 -0.49 54.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 0.0 111.194 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.77 109.89 2.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.108 -0.995 . . . . 0.0 108.81 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.94 -6.73 64.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.41 ' HA ' ' CD1' ' A' ' 44' ' ' LEU . 12.7 t -74.27 -13.32 60.75 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.562 -0.963 . . . . 0.0 108.686 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.3 147.68 39.98 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.372 -0.83 . . . . 0.0 109.384 179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.482 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 95.25 -12.16 68.37 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -64.3 -157.6 0.22 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -144.12 132.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 116.514 -1.857 . . . . 0.0 113.426 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.3 mp -89.24 85.79 6.7 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 175.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.422 ' CD1' ' N ' ' A' ' 149' ' ' HIS . 0.7 OUTLIER -92.57 138.32 31.61 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 0.0 112.524 -175.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 61.3 m -56.48 -177.17 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -91.18 3.6 4.36 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.553 1.291 . . . . 0.0 110.536 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.4 m -103.63 -15.97 15.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.82 28.64 3.11 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.461 ' CD2' ' CB ' ' A' ' 97' ' ' CYS . 74.2 m80 -116.65 109.98 17.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.103 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.74 121.97 22.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 26.8 m -122.65 -1.35 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 112.077 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.46 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -158.68 138.01 5.5 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.334 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.418 ' CG2' ' HA2' ' A' ' 140' ' ' GLY . 25.7 mt -120.09 118.42 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.436 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 13.7 t80 -49.92 127.31 16.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.873 0.844 . . . . 0.0 112.9 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 61.7 ttt-85 -121.58 -21.53 6.18 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.619 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' HA ' ' HA1' ' A' ' 188' ' ' 2ZF . . . -162.82 138.96 7.25 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.917 -1.114 . . . . 0.0 112.148 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -100.01 138.97 36.35 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 39.9 t -89.91 94.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 77.2 m -89.99 110.02 21.02 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.104 0.954 . . . . 0.0 112.793 -175.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 30.3 m -100.48 125.18 46.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.3 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 56.3 22.81 6.59 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -0.827 . . . . 0.0 111.31 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.23 17.71 36.13 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.019 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.8 m -144.3 139.99 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.117 -1.225 . . . . 0.0 109.0 178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -78.12 122.09 25.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.274 -0.891 . . . . 0.0 111.552 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -116.24 15.95 15.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.794 -0.566 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.33 150.89 2.42 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 17.3 m -128.6 136.77 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.633 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.7 m-20 -105.43 150.45 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.46 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -154.51 161.09 41.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.914 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.3 t -80.34 139.93 52.27 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.1 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -82.17 148.24 14.91 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.779 1.41 . . . . 0.0 110.525 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.22 -30.06 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.644 -0.66 . . . . 0.0 110.007 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.85 -31.48 69.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 109.014 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 35.0 t -73.06 -31.04 64.14 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.438 0.637 . . . . 0.0 109.559 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.454 ' HG3' ' CD2' ' A' ' 82' ' ' LEU . 2.7 mtp -70.03 -39.39 75.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.658 -0.651 . . . . 0.0 109.461 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -59.99 -41.46 92.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.655 -0.653 . . . . 0.0 109.433 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 32.7 p -69.73 -33.92 73.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.497 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.7 m -63.16 -40.03 96.38 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -63.04 -32.41 73.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.844 -0.535 . . . . 0.0 109.687 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -59.97 -40.01 87.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.407 -0.808 . . . . 0.0 109.595 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.89 150.02 46.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.2 t -170.64 76.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.5 -0.75 . . . . 0.0 110.159 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 56.74 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.823 -0.548 . . . . 0.0 110.809 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -160.22 -49.86 0.05 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -1.0 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 50.05 -144.24 0.52 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.353 -0.842 . . . . 0.0 110.451 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.43 HB31 ' CD2' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.037 0.446 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.26 -57.47 1.2 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 60.08 129.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.031 0.92 . . . . 0.0 110.895 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.97 157.29 26.87 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.871 -0.518 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.62 173.97 12.21 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.677 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 53.27 50.06 18.45 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 56.3 169.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.475 -0.766 . . . . 0.0 110.797 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 66.8 t -80.47 -48.97 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.48 0.657 . . . . 0.0 110.591 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLY . 98.2 mt-10 49.93 40.03 19.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.635 -0.665 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.57 171.81 40.15 Favored Glycine 0 N--CA 1.5 2.954 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.172 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.418 ' HG3' ' CD ' ' A' ' 92' ' ' ARG . 99.5 mt-10 -85.41 -47.05 10.34 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.831 -0.805 . . . . 0.0 111.663 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.25 124.28 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -94.59 124.2 38.48 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.2 t -80.29 131.17 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.7 175.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.414 -0.803 . . . . 0.0 110.262 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.5 p -146.32 133.24 20.18 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.837 0.827 . . . . 0.0 109.206 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 HG22 ' HA ' ' A' ' 59' ' ' ALA . 24.3 p -108.25 -179.73 3.97 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.69 -14.92 23.82 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 p -107.92 -32.34 7.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 113.185 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.88 -169.98 0.72 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.705 -1.247 . . . . 0.0 112.769 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 m -121.43 148.79 43.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.7 p90 -164.3 -145.55 0.09 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.525 -0.734 . . . . 0.0 110.299 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' O ' ' OG1' ' A' ' 54' ' ' THR . 82.9 mt -134.87 159.99 39.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.644 -1.285 . . . . 0.0 112.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -143.72 128.79 18.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 98.1 m -96.8 132.84 42.11 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.0 111.799 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.19 117.31 20.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.44 129.93 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.041 -1.037 . . . . 0.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 54.05 40.05 31.22 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.534 -0.729 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.95 24.95 74.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.424 HG13 ' CZ2' ' A' ' 53' ' ' TRP . 60.0 t -138.58 123.02 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.544 -0.974 . . . . 0.0 109.099 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.0 m -75.3 143.34 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.563 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CG ' ' HG2' ' A' ' 175' ' ' MET . 91.2 m95 -136.0 125.51 25.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.732 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -128.79 -174.21 3.19 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.466 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 35.1 m -86.41 131.52 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.312 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -60.43 -40.09 89.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.776 -0.577 . . . . 0.0 109.641 178.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 37.8 p-80 -73.41 72.43 1.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.391 1.091 . . . . 0.0 108.745 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.36 -36.07 0.81 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.404 ' HA ' HG22 ' A' ' 38' ' ' THR . . . -83.18 0.47 45.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.808 -0.819 . . . . 0.0 111.143 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.54 -23.91 5.08 Favored Glycine 0 N--CA 1.502 3.041 0 O-C-N 121.077 -1.014 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.431 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 63.6 m -66.23 -9.81 35.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.358 -1.083 . . . . 0.0 111.185 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 61' ' ' SER . 40.0 ttpt 64.42 -71.91 0.07 Allowed 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.563 -0.71 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -80.06 100.08 8.01 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.473 0.654 . . . . 0.0 110.402 -179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.41 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -92.03 -126.93 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.35 97.39 2.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.766 -1.209 . . . . 0.0 110.202 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -89.09 -179.95 45.49 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.99 -17.84 54.06 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 O-C-N 123.933 1.491 . . . . 0.0 110.46 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -109.74 3.91 21.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.331 -0.856 . . . . 0.0 111.3 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.82 -159.66 14.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -58.39 123.49 13.73 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.648 1.341 . . . . 0.0 110.621 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.429 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 8.3 mt -88.05 -22.81 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.736 -0.602 . . . . 0.0 111.527 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 50.9 m 60.06 124.64 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.562 0.696 . . . . 0.0 110.913 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.555 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 95.3 mt-30 -59.94 137.71 58.01 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.271 -0.893 . . . . 0.0 112.547 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.4 ttm -97.08 -27.63 14.5 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -147.04 167.65 23.52 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.421 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 19.0 m -154.61 116.7 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 110.398 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -95.02 75.2 3.5 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.01 -40.04 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -55.8 -26.27 45.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -111.02 0.09 16.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.706 -0.621 . . . . 0.0 110.832 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 60.17 57.4 2.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.499 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.9 tp -148.06 151.53 35.84 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.652 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.453 ' CG2' HG21 ' A' ' 54' ' ' THR . 14.6 m -139.74 140.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' HA2' ' CE3' ' A' ' 85' ' ' TRP . . . -125.47 171.21 17.38 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.151 -1.499 . . . . 0.0 112.102 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.555 ' CD1' ' HA ' ' A' ' 73' ' ' GLN . 0.2 OUTLIER -148.67 -162.08 1.48 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.258 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -100.36 111.31 23.57 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -68.19 134.2 91.45 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 111.542 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.55 176.3 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.974 1.512 . . . . 0.0 109.443 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.13 149.73 32.57 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.847 1.446 . . . . 0.0 110.651 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 30' ' ' GLU . . . 94.67 -9.98 70.9 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.267 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.28 39.95 0.93 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.853 -1.381 . . . . 0.0 111.546 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.418 ' CD ' ' HG3' ' A' ' 32' ' ' GLU . 49.9 mtt-85 27.96 96.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 t -83.49 129.74 34.99 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.411 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -109.98 149.91 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 7.6 p -105.38 157.56 34.16 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.339 -178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.62 163.06 5.28 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 O-C-N 123.824 1.434 . . . . 0.0 110.604 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 p -155.82 169.2 24.93 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.391 -0.818 . . . . 0.0 111.488 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m -61.18 -40.1 92.62 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.72 -0.613 . . . . 0.0 110.583 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 98' ' ' THR . 74.2 m 64.59 79.23 0.26 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.235 0.54 . . . . 0.0 112.353 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.41 -33.2 86.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -111.85 144.2 41.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.797 -0.825 . . . . 0.0 108.948 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.3 m -98.4 16.38 21.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 111.268 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -67.81 86.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.9 mt -99.02 176.64 5.5 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.616 0.722 . . . . 0.0 111.28 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -144.45 111.13 5.68 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.6 tp -86.36 143.93 27.6 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.465 0.65 . . . . 0.0 110.315 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 80.5 t -88.97 114.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.4 p -84.21 174.87 9.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -41.55 -29.33 0.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.816 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -100.04 -70.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.541 -0.724 . . . . 0.0 109.654 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.92 -162.92 1.66 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.523 -0.736 . . . . 0.0 109.023 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 87.9 m-20 -57.81 -63.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.632 -0.667 . . . . 0.0 110.08 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.8 t 54.02 -86.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.008 -0.433 . . . . 0.0 111.617 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.9 pp -76.23 134.63 70.42 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.101 -0.999 . . . . 0.0 111.731 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -104.67 148.1 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.604 1.318 . . . . 0.0 109.13 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 40.5 t -134.06 138.61 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.275 -0.891 . . . . 0.0 110.803 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.83 124.17 39.73 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -62.62 121.56 13.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.409 -0.807 . . . . 0.0 110.356 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.02 7.4 44.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.631 -0.668 . . . . 0.0 109.574 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.97 173.81 43.73 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 16.8 t0 -61.33 -25.28 67.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -125.71 18.59 7.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.551 -0.718 . . . . 0.0 111.757 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.415 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 95.2 mtt-85 -138.26 145.37 41.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.884 -1.135 . . . . 0.0 111.161 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -141.29 141.2 10.93 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 55.3 p -89.21 113.1 24.27 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.951 -0.735 . . . . 0.0 109.858 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.1 tp -71.06 110.06 5.52 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.687 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.95 -18.0 63.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 110.738 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.0 m -119.95 79.96 25.52 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.615 -0.678 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.72 137.75 78.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.807 1.425 . . . . 0.0 109.903 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -154.11 169.8 9.43 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.699 -0.626 . . . . 0.0 109.344 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.56 124.38 15.34 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.963 1.507 . . . . 0.0 110.335 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.36 -23.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.794 -0.566 . . . . 0.0 111.635 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.324 -0.86 . . . . 0.0 109.356 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -70.67 -28.03 64.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.8 mt -84.25 -0.32 51.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.557 -0.714 . . . . 0.0 111.271 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -70.31 110.84 5.49 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.76 -10.57 57.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 p -74.65 -15.24 60.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 109.159 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.405 ' HA ' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -71.29 151.33 44.32 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 179.233 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.92 -10.74 72.86 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -72.23 -157.92 3.62 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.422 ' HB3' ' CG2' ' A' ' 46' ' ' THR . 49.6 Cg_endo -142.35 137.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 116.982 -1.546 . . . . 0.0 112.212 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.2 mt -95.06 99.16 11.21 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.426 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.2 mp -90.86 146.41 23.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -59.86 -164.8 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 49.0 Cg_endo -90.14 17.98 1.43 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.521 1.274 . . . . 0.0 111.022 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.3 m -126.51 -55.42 1.43 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.096 -1.002 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.0 43.32 0.02 OUTLIER Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.6 m80 -125.19 120.99 32.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -1.037 . . . . 0.0 110.797 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.61 124.3 29.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.266 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.21 -1.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.724 . . . . 0.0 111.901 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.86 125.46 1.65 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.168 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.0 mt -105.8 117.48 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.297 -1.119 . . . . 0.0 108.156 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 16.2 t80 -50.14 126.8 15.43 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.601 0.715 . . . . 0.0 112.529 -177.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -119.85 -22.48 6.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.82 -0.55 . . . . 0.0 112.224 -178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.96 136.62 6.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.894 -1.129 . . . . 0.0 111.974 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.0 133.25 40.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 122.001 -0.437 . . . . 0.0 111.375 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -84.66 91.08 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 64.2 m -94.23 119.73 33.45 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.824 0.821 . . . . 0.0 111.352 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -89.95 -79.96 0.33 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.075 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -106.41 64.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.404 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 72.93 18.79 79.23 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 27.6 m -146.67 137.94 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.29 -1.123 . . . . 0.0 109.016 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.454 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -83.14 129.98 35.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.549 -0.72 . . . . 0.0 111.072 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -119.94 14.82 12.46 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.215 0.531 . . . . 0.0 110.089 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.06 152.15 2.84 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.428 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 9.1 m -132.18 137.3 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.461 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -104.71 152.0 23.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.467 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -153.71 166.66 32.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.644 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 57.8 t -80.7 130.88 62.5 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.094 179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.04 148.61 45.18 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.744 1.392 . . . . 0.0 109.863 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.41 ' HA ' ' HE3' ' A' ' 175' ' ' MET . 7.2 p -72.33 -25.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.917 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.98 -29.69 68.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.312 -0.867 . . . . 0.0 108.72 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 30.9 m -71.08 -32.79 69.52 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.409 0.623 . . . . 0.0 109.395 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.471 ' HG2' ' CG ' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -69.37 -38.45 78.07 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.8 0.81 . . . . 0.0 108.937 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.01 -39.24 85.13 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.589 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 3.9 t -60.28 -25.78 65.99 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.27 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.445 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 95.2 m -63.97 -49.93 70.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.156 -0.965 . . . . 0.0 108.765 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 78.1 mtm -63.36 -40.0 96.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -70.07 -31.42 69.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.703 . . . . 0.0 109.854 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 59.49 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.492 0.663 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 33.4 t -172.86 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.07 -39.96 54.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.748 -0.595 . . . . 0.0 110.497 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 57.23 35.34 26.05 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.414 -0.804 . . . . 0.0 109.422 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 57.2 162.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.613 -0.679 . . . . 0.0 110.417 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.1 mttm . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.029 -179.654 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.456 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.077 0.465 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.75 179.95 44.8 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -140.95 165.33 27.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.012 -0.699 . . . . 0.0 109.296 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -74.26 139.25 44.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -130.1 155.14 46.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.953 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 62.3 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.525 -0.734 . . . . 0.0 111.079 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 56.03 111.28 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.696 0.76 . . . . 0.0 111.353 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 65.8 t -79.92 -40.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.118 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 45.44 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.44 0.638 . . . . 0.0 111.34 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' N ' ' HB1' ' A' ' 91' ' ' ALA . . . -91.08 96.26 2.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -151.11 -78.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.0 t -138.14 129.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -140.08 141.36 36.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.27 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.47 139.02 18.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.54 159.98 42.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.57 0.7 . . . . 0.0 110.215 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.7 m -137.28 121.39 17.88 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.8 0.81 . . . . 0.0 108.897 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 24.5 p -107.48 -179.87 4.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -14.92 18.45 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.213 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.6 p -99.14 -40.95 7.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 112.191 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -173.55 -168.52 0.45 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.926 -1.109 . . . . 0.0 112.098 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 p -118.4 144.66 45.76 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 8.4 p90 -161.4 -143.35 0.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.738 . . . . 0.0 110.132 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 80.9 mt -134.64 162.96 30.83 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.615 -1.303 . . . . 0.0 112.833 -177.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -151.89 129.84 11.76 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.648 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 75.5 m -103.07 127.7 50.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 0.0 111.418 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 86.9 m -74.82 122.56 23.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.746 -0.596 . . . . 0.0 109.568 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.55 129.48 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.4 t30 49.99 39.99 20.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.584 -0.698 . . . . 0.0 111.264 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.42 26.19 73.84 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.414 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 62.9 t -137.82 113.02 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -1.038 . . . . 0.0 109.611 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 7.9 t -74.47 121.28 21.23 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.454 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 87.6 m95 -110.01 129.96 55.6 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.493 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.474 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 4.5 t -136.74 179.99 6.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.442 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 30.3 m -90.2 126.37 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.138 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -60.08 -40.89 91.15 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -74.64 67.06 1.51 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.13 0.967 . . . . 0.0 108.64 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.1 -36.6 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.03 -79.96 0.33 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.875 . . . . 0.0 109.366 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.41 25.27 4.28 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.368 -0.833 . . . . 0.0 111.218 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 63' ' ' THR . 26.4 p -132.14 1.72 3.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -1.132 . . . . 0.0 112.02 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 61' ' ' SER . 96.3 mttt 61.17 -66.81 0.06 Allowed 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.945 0.879 . . . . 0.0 110.733 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 61' ' ' SER . 11.5 m -79.13 139.97 37.91 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.663 0.744 . . . . 0.0 110.363 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -143.74 -130.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.21 93.33 2.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.109 . . . . 0.0 109.034 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.412 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -100.0 -171.74 30.01 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.6 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -61.07 -18.8 60.12 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 O-C-N 124.105 1.582 . . . . 0.0 110.649 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -108.83 7.43 26.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 110.955 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.09 -153.3 16.85 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.88 116.16 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.007 1.53 . . . . 0.0 111.18 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.412 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 66.7 mt -104.97 140.0 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.462 0.648 . . . . 0.0 109.751 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -95.37 145.25 25.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.791 -0.568 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 11.5 pt20 -75.27 157.41 34.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.669 -0.645 . . . . 0.0 111.101 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.3 mmm -96.88 -39.97 9.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.706 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.33 -178.18 7.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.598 -0.689 . . . . 0.0 109.333 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.4 ' CG2' ' CG1' ' A' ' 83' ' ' VAL . 88.2 m -150.9 125.55 9.63 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.81 76.69 4.24 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.93 -39.23 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 109.466 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -53.84 -26.2 23.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -115.66 0.64 13.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.656 -0.653 . . . . 0.0 110.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t0 60.37 56.82 3.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.893 -1.129 . . . . 0.0 108.591 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.408 ' CD2' ' HG3' ' A' ' 175' ' ' MET . 22.6 tp -142.77 155.47 44.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.869 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.465 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.1 OUTLIER -145.1 137.55 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.435 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.52 125.99 5.19 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.44 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.474 ' CZ3' ' CG2' ' A' ' 54' ' ' THR . 4.5 m-90 -90.04 -170.04 2.64 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -108.44 109.84 21.22 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.27 147.91 98.29 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.508 -0.745 . . . . 0.0 110.556 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -104.11 167.29 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.727 1.383 . . . . 0.0 110.354 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.64 169.6 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.876 1.461 . . . . 0.0 110.406 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.97 -9.97 75.5 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' HB1' ' N ' ' A' ' 31' ' ' GLY . . . -98.01 -147.96 0.32 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.362 -1.081 . . . . 0.0 108.899 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -153.0 -39.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.279 -0.888 . . . . 0.0 111.108 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.5 131.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.464 0.65 . . . . 0.0 110.553 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -75.44 153.89 37.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.99 161.49 22.65 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.364 -0.835 . . . . 0.0 110.8 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -61.09 165.32 12.62 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.797 1.42 . . . . 0.0 110.083 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.403 ' SG ' ' CB ' ' A' ' 145' ' ' CYS . 4.0 t -108.17 120.26 41.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.519 -0.738 . . . . 0.0 111.736 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.2 m -70.06 -41.32 74.32 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.36 142.54 53.95 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.86 14.8 55.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.3 m -59.99 136.98 58.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.952 -1.322 . . . . 0.0 109.568 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.2 m -101.66 7.84 41.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.426 -0.796 . . . . 0.0 111.511 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.88 76.1 1.16 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 108.618 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 53.9 mt -95.26 172.42 8.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.753 -0.592 . . . . 0.0 109.808 -179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 53.0 p90 -152.06 142.2 22.29 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 38.9 tp -115.03 155.8 26.31 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.98 0.895 . . . . 0.0 111.908 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.402 ' N ' ' HG ' ' A' ' 106' ' ' LEU . 92.4 t -109.97 135.7 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 45.1 p -83.25 175.79 9.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -41.95 -31.29 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.296 0.57 . . . . 0.0 111.422 -179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -99.99 -70.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.77 -82.44 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.566 -0.709 . . . . 0.0 110.328 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 23.2 t0 46.86 90.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.389 -0.82 . . . . 0.0 111.4 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.19 49.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.685 . . . . 0.0 110.439 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 13.1 pt -70.06 156.03 92.49 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 0.0 109.88 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -103.31 141.11 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.982 1.517 . . . . 0.0 111.523 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.02 130.06 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 21.5 mmm180 -90.26 116.59 28.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.3 ttp180 -60.39 123.48 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.93 -178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -100.01 4.51 44.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 109.935 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.76 176.99 41.78 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 92.5 m-20 -65.64 -21.54 66.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -1.059 . . . . 0.0 110.119 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -124.49 17.0 8.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -140.3 139.93 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.975 -1.078 . . . . 0.0 110.774 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -139.19 144.02 14.77 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 t -90.9 111.97 23.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.789 -0.83 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 44.3 tp -73.49 104.64 4.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.02 -27.43 66.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.225 0.536 . . . . 0.0 110.387 -179.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 t -112.39 105.49 56.12 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.713 -0.617 . . . . 0.0 110.76 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.78 141.74 19.6 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.911 1.479 . . . . 0.0 109.442 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.88 165.23 18.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.573 -0.704 . . . . 0.0 109.258 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.12 125.19 16.93 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.895 1.471 . . . . 0.0 109.935 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -49.64 -25.14 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.799 -0.563 . . . . 0.0 111.254 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 25.3 t -55.5 -38.12 68.76 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.654 0.74 . . . . 0.0 109.434 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -70.02 -29.18 66.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.87 2.0 50.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.583 -0.698 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -70.5 113.01 7.21 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.152 -0.967 . . . . 0.0 108.56 178.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.7 -9.05 56.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.6 t -75.27 -17.13 60.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.0 109.083 177.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -65.14 146.21 55.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 179.367 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.422 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 96.85 -14.98 63.39 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.54 -158.08 0.61 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.405 ' HB2' ' CD1' ' A' ' 144' ' ' LEU . 56.8 Cg_endo -142.74 140.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 116.683 -1.745 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 4.5 mp -97.08 97.33 9.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 7.3 mp -90.01 138.13 31.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.403 ' CB ' ' SG ' ' A' ' 97' ' ' CYS . 0.0 OUTLIER -64.03 -154.89 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.469 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -104.16 15.04 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.453 1.238 . . . . 0.0 110.365 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 m -117.14 16.9 14.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.44 37.59 46.8 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -125.2 132.08 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.85 119.97 37.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.18 -1.56 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.269 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.89 126.85 2.35 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.506 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 48.3 mt -109.94 117.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.105 -1.232 . . . . 0.0 108.283 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CE1' ' HB ' ' A' ' 167' ' ' VAL . 15.2 t80 -50.92 128.67 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -119.34 -25.56 6.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.722 -0.612 . . . . 0.0 111.648 179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.409 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -160.06 141.44 12.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 111.827 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -95.99 140.1 31.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.4 t -89.95 92.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . . . . . . . . . 61.8 m -92.59 118.17 30.73 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.696 0.76 . . . . 0.0 111.028 -177.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 96.7 m -89.94 -78.38 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.489 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -105.99 54.58 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 81.79 16.57 72.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.1 m -146.36 141.31 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.353 -1.086 . . . . 0.0 108.335 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.484 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -84.52 128.29 34.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.545 -0.722 . . . . 0.0 111.047 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -120.0 15.83 12.48 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.163 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -171.31 145.87 2.23 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.431 ' HB ' ' CE1' ' A' ' 154' ' ' PHE . 16.0 m -121.65 135.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.698 -177.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -102.57 147.34 26.9 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 41.5 p90 -152.65 165.16 36.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.089 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 67.3 t -81.65 131.81 56.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.09 143.1 31.88 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.887 1.467 . . . . 0.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.77 -29.94 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 109.659 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.98 -33.09 70.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 m -75.54 -29.65 59.48 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.855 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.454 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 3.5 mtp -69.95 -39.88 75.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 109.586 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.04 -39.92 87.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.73 -0.606 . . . . 0.0 110.069 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 64.6 p -64.59 -36.05 82.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.453 -0.78 . . . . 0.0 109.823 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -61.55 -40.06 93.36 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 94.4 mtp -65.34 -35.47 81.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -59.99 -36.01 76.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.677 -0.639 . . . . 0.0 110.446 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.07 92.27 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.743 -0.598 . . . . 0.0 110.217 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.15 -69.0 0.14 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.551 -0.718 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 185' ' ' LYS . 80.5 tttt -150.79 80.07 1.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.374 -0.829 . . . . 0.0 110.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.9 tptm 60.01 -68.14 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.174 -0.329 . . . . 0.0 111.465 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 183' ' ' LYS . 16.5 ptpt -159.49 169.98 22.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 0.0 110.539 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.19 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.418 HB31 ' CD2' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.105 0.478 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.35 101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 1.6 tmm_? -138.96 157.5 45.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.888 -0.771 . . . . 0.0 110.046 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.414 ' HB2' ' CD ' ' A' ' 24' ' ' ARG . 56.1 t0 54.78 47.15 23.05 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.797 -0.564 . . . . 0.0 110.56 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -149.84 161.31 42.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.677 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 60.47 119.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.518 -0.739 . . . . 0.0 111.07 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -58.35 169.25 0.9 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.185 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -79.98 -6.06 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.583 -0.698 . . . . 0.0 111.765 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.06 66.87 0.62 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.005 -1.06 . . . . 0.0 110.0 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.8 156.58 27.01 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.39 -52.07 6.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.731 -0.864 . . . . 0.0 111.078 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.3 t -111.26 126.32 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.0 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -96.25 139.85 31.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.417 0.627 . . . . 0.0 110.341 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.0 t -80.33 140.16 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.92 159.97 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 122.346 1.069 . . . . 0.0 112.0 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 78.2 p -148.5 116.93 6.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 30.2 p -108.71 179.98 4.03 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.396 0.617 . . . . 0.0 109.651 -178.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.65 -16.27 15.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -111.29 -27.35 8.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 113.166 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -170.93 -170.01 0.83 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.582 -1.324 . . . . 0.0 112.54 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 75.3 m -127.84 140.79 51.82 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.7 p90 -159.69 -141.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 109.996 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 84.4 mt -136.82 171.16 14.92 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.594 -1.316 . . . . 0.0 113.39 -176.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -148.11 122.91 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.389 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 ' CG2' ' HB3' ' A' ' 142' ' ' PRO . 93.5 m -85.89 120.83 27.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.592 -0.693 . . . . 0.0 110.541 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.46 119.7 19.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.362 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.5 t -140.89 131.88 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.37 -0.831 . . . . 0.0 110.465 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 52.86 40.03 30.05 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.508 -0.745 . . . . 0.0 111.025 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.59 27.36 73.58 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.401 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 84.0 t -140.0 118.87 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.542 -0.976 . . . . 0.0 109.675 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -74.04 129.01 37.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.493 ' CD2' ' HB2' ' A' ' 175' ' ' MET . 90.2 m95 -117.33 120.06 37.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.813 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.454 ' HB ' ' CB ' ' A' ' 45' ' ' ALA . 6.5 t -129.15 -178.16 4.53 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 24.1 m -88.42 134.54 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 C-N-CA 118.942 -1.103 . . . . 0.0 113.359 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -64.37 -40.0 94.98 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.366 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.472 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.8 p-80 -71.65 75.07 0.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.09 0.948 . . . . 0.0 109.326 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.55 -42.61 0.49 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.2 -69.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.671 -0.9 . . . . 0.0 110.915 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.42 -89.9 0.81 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.9 p -175.18 86.91 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.485 -1.009 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.83 -159.17 0.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.516 -0.74 . . . . 0.0 111.162 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.6 p -77.56 -32.94 54.13 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.732 -0.605 . . . . 0.0 110.932 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 63' ' ' THR . 0.3 OUTLIER 78.84 -28.13 0.16 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.831 0.852 . . . . 0.0 112.377 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 69.84 92.45 0.08 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.709 -0.619 . . . . 0.0 109.6 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.76 -179.65 49.03 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -62.81 -14.81 42.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.963 1.507 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -104.8 -22.45 13.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 111.199 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.79 -164.82 30.46 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.05 114.66 3.27 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.873 1.459 . . . . 0.0 110.606 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.4 mt -97.14 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -88.1 136.49 32.95 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 111.436 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 19.4 pt20 -73.3 146.47 45.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.812 -0.555 . . . . 0.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.11 -37.71 8.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.517 -0.739 . . . . 0.0 109.955 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.96 -177.56 1.95 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 5.0 t -159.99 143.6 14.16 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.732 0.777 . . . . 0.0 110.13 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.92 80.67 1.46 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.93 -39.99 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.74 . . . . 0.0 110.056 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -56.58 -26.55 55.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.288 -0.883 . . . . 0.0 108.853 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -110.39 2.44 19.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.717 -0.614 . . . . 0.0 110.706 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 60.56 56.38 3.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 111.336 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.3 mt -144.54 150.56 37.73 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.527 -0.733 . . . . 0.0 110.261 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.445 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 1.0 OUTLIER -136.95 128.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 179.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.27 123.56 5.7 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 118.876 -1.63 . . . . 0.0 113.222 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.445 ' CZ3' ' HB ' ' A' ' 83' ' ' VAL . 5.8 m-90 -92.69 -170.78 2.55 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 122.025 -0.691 . . . . 0.0 109.676 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.2 100.99 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.4 130.02 91.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 111.091 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.3 158.55 48.41 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.925 1.487 . . . . 0.0 109.504 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.62 119.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.773 1.407 . . . . 0.0 110.405 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.39 -30.18 2.73 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 29' ' ' VAL . . . -72.84 58.58 0.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.534 -0.98 . . . . 0.0 111.481 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 25.73 96.99 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.7 m -81.5 107.3 14.15 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.822 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 68.2 mt -91.37 154.38 19.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.834 -0.541 . . . . 0.0 110.088 -178.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.51 164.51 17.03 Favored Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.555 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -98.49 153.42 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 O-C-N 123.87 1.458 . . . . 0.0 110.324 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.5 p -159.96 159.93 32.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.753 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.6 p -99.97 118.9 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.0 m -119.99 141.39 49.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.888 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -64.05 -26.25 70.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -99.98 127.12 46.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.529 -0.983 . . . . 0.0 110.181 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.2 m -95.4 20.43 9.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.629 -0.669 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -69.97 73.7 0.44 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.611 -0.681 . . . . 0.0 109.188 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.5 mt -90.17 174.48 7.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -153.14 144.53 23.24 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' PRO . 28.1 tp -116.35 142.53 46.73 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.705 0.764 . . . . 0.0 111.297 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -91.66 125.08 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.44 ' O ' ' N ' ' A' ' 110' ' ' HIS . 72.0 p -85.82 170.66 12.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.731 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -28.89 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.892 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 108' ' ' THR . 73.6 m-70 -99.99 -86.32 0.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.132 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.64 22.33 0.12 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.191 -0.943 . . . . 0.0 111.358 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -66.43 129.07 38.61 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.052 -1.03 . . . . 0.0 110.466 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -69.97 -53.38 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.686 -0.634 . . . . 0.0 110.514 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 126' ' ' LEU . 83.1 mt 46.46 73.69 0.94 Allowed Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.526 -0.734 . . . . 0.0 111.083 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -59.74 130.52 35.47 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.864 1.455 . . . . 0.0 111.187 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 60.9 t -127.95 131.98 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 109.532 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -87.64 124.59 33.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 108.708 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -63.93 123.01 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.549 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -97.88 1.45 48.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.4 170.23 38.08 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.1 m-20 -58.7 -23.74 60.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.158 -1.201 . . . . 0.0 110.365 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 93.0 p -121.67 17.6 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 112.331 -179.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -144.07 142.39 30.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.03 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -138.43 142.71 13.4 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.0 p -88.77 114.84 25.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.839 -0.8 . . . . 0.0 109.477 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.413 ' CD1' ' CG2' ' A' ' 114' ' ' ILE . 20.5 tp -72.26 109.98 6.38 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.92 -20.58 65.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.86 -0.525 . . . . 0.0 110.375 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -117.67 84.23 19.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.744 -0.597 . . . . 0.0 109.962 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -58.34 138.29 85.04 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.761 1.4 . . . . 0.0 110.381 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -152.99 164.69 19.53 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.55 127.43 24.59 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.77 1.405 . . . . 0.0 110.473 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -50.11 -25.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.814 -0.554 . . . . 0.0 110.702 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -59.91 -37.63 79.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.577 -0.702 . . . . 0.0 109.469 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -69.01 -25.86 64.72 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.76 -1.73 44.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.46 -0.775 . . . . 0.0 110.406 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -70.17 122.1 18.82 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.152 -0.968 . . . . 0.0 108.563 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.92 -11.41 64.23 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.1 t -79.03 -16.23 57.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.443 -1.034 . . . . 0.0 109.672 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.436 ' HB3' HG12 ' A' ' 55' ' ' VAL . 14.9 m -62.26 147.42 48.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.451 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.09 -9.91 75.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -68.9 -169.56 5.97 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.412 ' N ' ' CD1' ' A' ' 106' ' ' LEU . 48.1 Cg_endo -140.34 142.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 116.974 -1.551 . . . . 0.0 112.396 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.5 mp -96.59 96.35 8.59 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 7.2 mp -87.39 141.55 28.55 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 85.2 m -63.71 -173.0 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.2 Cg_endo -87.79 17.27 1.74 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 117.249 -1.368 . . . . 0.0 111.6 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -122.03 18.11 10.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.07 -1.018 . . . . 0.0 111.764 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.14 35.74 37.42 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -122.87 123.38 40.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.374 -1.074 . . . . 0.0 110.34 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.95 123.33 34.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.621 -0.674 . . . . 0.0 110.179 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.02 -2.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.638 -0.664 . . . . 0.0 111.694 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.451 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -145.45 126.66 2.63 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.419 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 18.1 mt -110.07 121.76 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.188 -1.184 . . . . 0.0 108.407 177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.424 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 8.0 t80 -51.76 122.83 8.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.841 0.829 . . . . 0.0 112.442 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.406 ' HD2' ' CG1' ' A' ' 170' ' ' VAL . 39.6 ttt-85 -115.9 -29.41 6.37 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -166.07 169.43 14.56 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.926 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -139.48 155.12 47.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.402 ' CG2' ' CB ' ' A' ' 166' ' ' ALA . 15.5 m -107.6 105.39 18.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.742 0.782 . . . . 0.0 109.501 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.5 p -95.36 121.84 37.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 110.36 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 91.0 m -89.98 -79.89 0.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.567 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -96.96 52.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.96 15.94 77.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.2 m -144.67 140.01 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.386 -1.067 . . . . 0.0 108.35 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -81.56 116.93 21.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.657 0.741 . . . . 0.0 111.675 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.57 8.12 45.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.722 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.402 ' CB ' ' CG2' ' A' ' 158' ' ' VAL . . . -171.53 141.83 1.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.286 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.62 143.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.713 0.768 . . . . 0.0 112.687 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -111.19 142.07 43.88 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.451 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 34.2 p90 -152.83 165.04 36.65 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.276 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.406 ' CG1' ' HD2' ' A' ' 155' ' ' ARG . 26.9 m -90.68 133.03 33.33 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.908 -0.495 . . . . 0.0 110.015 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.63 157.2 56.35 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.719 1.378 . . . . 0.0 109.936 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 175' ' ' MET . 7.1 p -64.36 -27.23 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.49 -0.756 . . . . 0.0 109.594 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.59 -25.39 62.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 108.547 177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.3 m -74.15 -40.1 62.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.596 -0.69 . . . . 0.0 111.934 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.493 ' HB2' ' CD2' ' A' ' 53' ' ' TRP . 16.7 ptp -69.85 -41.06 75.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.667 -1.271 . . . . 0.0 108.815 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 175' ' ' MET . 98.9 mt-10 -59.98 -39.97 87.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.793 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.4 p -61.69 -23.32 66.02 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.179 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 45.0 m -65.06 -39.92 93.98 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 67.6 mtt -62.44 -34.74 77.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -60.0 -27.5 66.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.748 -0.595 . . . . 0.0 110.527 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.0 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.531 -0.731 . . . . 0.0 111.568 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 31.2 t 41.28 49.99 3.4 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.246 -0.908 . . . . 0.0 112.293 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -86.44 131.62 34.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.414 -0.804 . . . . 0.0 110.222 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -77.13 -22.58 52.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 111.145 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -157.73 160.04 37.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.198 179.835 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.448 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.4 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.52 -171.01 39.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER -69.96 170.63 10.88 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.957 -0.731 . . . . 0.0 109.943 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 24' ' ' ARG . 3.0 t70 85.24 -174.75 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 123.791 0.837 . . . . 0.0 109.495 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.13 139.09 57.25 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.899 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 22' ' ' THR . 10.3 t-20 -159.45 139.58 11.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -63.32 140.07 58.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.793 -0.567 . . . . 0.0 110.475 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 34.5 m -80.81 -15.26 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.769 -0.582 . . . . 0.0 110.821 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.97 66.95 0.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.301 -0.874 . . . . 0.0 109.762 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.55 155.49 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -98.36 -40.06 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.952 . . . . 0.0 110.333 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.403 ' CG2' ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.407 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.435 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.435 ' CZ2' HG12 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.451 HG23 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.459 ' CG ' ' CD2' ' A' ' 188' ' ' 2ZF . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 38' ' ' THR . . . -77.06 -28.74 54.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.03 -112.16 3.57 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -162.93 40.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.94 . . . . 0.0 110.292 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -169.74 161.12 9.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 111.317 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.425 ' O ' ' CB ' ' A' ' 64' ' ' LEU . 77.6 m 42.08 -100.09 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.425 ' CB ' ' O ' ' A' ' 63' ' ' THR . 0.2 OUTLIER 80.9 -29.32 0.12 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.697 0.799 . . . . 0.0 111.968 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 73.01 99.51 0.07 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.53 -169.59 23.69 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.76 -17.6 60.03 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 124.021 1.537 . . . . 0.0 110.623 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -104.55 5.16 33.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 111.375 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.7 -155.99 15.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -70.61 111.07 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.782 1.411 . . . . 0.0 110.143 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 94.5 mt -105.73 148.99 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.65 . . . . 0.0 110.108 -179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CG ' ' CG2' ' A' ' 178' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.438 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.451 ' CZ3' HG23 ' A' ' 54' ' ' THR . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.02 149.91 96.27 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.61 161.3 28.01 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 124.026 1.54 . . . . 0.0 109.816 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.03 19.96 1.2 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.722 1.38 . . . . 0.0 111.119 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.34 -15.08 36.4 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -76.69 -160.25 0.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.329 -1.101 . . . . 0.0 108.962 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -77.86 -40.0 41.58 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.585 0.707 . . . . 0.0 110.752 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m 52.82 101.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.82 171.84 2.59 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.8 t -52.81 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.84 -0.538 . . . . 0.0 111.634 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m 49.97 55.01 10.09 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.981 -1.074 . . . . 0.0 112.089 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.75 173.95 11.91 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.02 -1.05 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.57 19.28 7.56 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m -137.5 152.63 49.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.142 -1.21 . . . . 0.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.411 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 154' ' ' PHE . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.429 ' N ' HG12 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' CA ' ' CD1' ' A' ' 169' ' ' PHE . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.41 ' CD1' ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.402 ' CB ' HD13 ' A' ' 188' ' ' 2ZF . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.471 ' CD1' ' CA ' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.41 ' CE ' ' CD1' ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p -59.92 -32.48 70.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.462 ' CG2' ' CG ' ' A' ' 75' ' ' TYR . 78.9 m -60.62 -44.99 95.69 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.1 mtp -61.33 -40.24 93.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.44 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 84.7 mtt85 -70.08 -39.97 75.29 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.896 0.855 . . . . 0.0 109.487 178.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 60.1 7.13 1.12 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 36.37 31.06 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.422 -0.799 . . . . 0.0 113.086 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -85.28 -47.12 10.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 50.0 41.45 23.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.442 -0.787 . . . . 0.0 111.486 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.63 130.01 34.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.47 -0.769 . . . . 0.0 109.848 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 34.7 mttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.215 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.459 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.123 0.487 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.67 149.37 41.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.89 151.04 50.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.778 -0.836 . . . . 0.0 109.838 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 51.6 t0 59.2 72.56 0.52 Allowed 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.449 0.643 . . . . 0.0 110.33 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.99 17.63 20.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.883 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 68.44 -61.22 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -60.76 151.34 29.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -76.18 -40.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.623 -0.673 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -169.07 -33.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.574 -0.704 . . . . 0.0 111.284 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.97 -157.25 51.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -90.03 -54.63 3.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.935 . . . . 0.0 110.157 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.8 t -130.02 133.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -139.96 151.96 45.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.5 t -82.77 137.82 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.1 m -143.95 170.16 9.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -150.63 149.26 29.63 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.928 0.87 . . . . 0.0 109.603 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.7 t -119.69 -180.0 4.06 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.62 -16.25 2.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.612 -0.68 . . . . 0.0 112.274 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 76.3 p -98.27 -37.21 9.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.902 -1.124 . . . . 0.0 112.887 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -171.48 -174.21 1.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.805 -1.184 . . . . 0.0 112.313 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.3 p -116.76 143.74 45.29 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 6.9 p90 -162.52 -139.09 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.416 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 76.1 mt -134.57 164.61 27.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 113.363 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.45 125.29 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.315 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.421 HG23 ' CD1' ' A' ' 153' ' ' ILE . 5.9 t -83.55 -152.0 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 0.0 110.745 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.412 ' N ' HG22 ' A' ' 46' ' ' THR . 13.6 t -159.35 113.52 2.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 57.1 t -138.71 135.52 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.299 -0.961 . . . . 0.0 111.371 -177.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 49.99 39.98 20.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.667 -0.645 . . . . 0.0 110.935 179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.28 24.93 74.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.417 HG12 ' CZ2' ' A' ' 53' ' ' TRP . 61.0 t -133.7 113.66 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.831 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 130.08 38.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.507 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.1 m95 -118.46 133.93 55.48 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.453 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.483 ' CG2' ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -139.01 -178.47 5.35 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.463 ' HB ' ' CE1' ' A' ' 57' ' ' HIS . 21.2 m -82.77 134.26 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.671 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.422 ' CE2' HG12 ' A' ' 78' ' ' VAL . 49.7 t80 -64.22 -39.96 95.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.463 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 11.5 p-80 -63.11 -16.27 59.43 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.531 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -90.7 -82.7 1.4 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' N ' ' CZ ' ' A' ' 43' ' ' PHE . . . -92.15 40.73 1.05 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.397 -1.061 . . . . 0.0 111.19 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.63 63.21 0.45 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.5 t -173.98 -85.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.297 -1.119 . . . . 0.0 109.84 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -175.19 -174.36 0.74 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 0.0 108.847 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.414 ' HA ' ' HB2' ' A' ' 70' ' ' PRO . 64.2 m 48.8 75.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.0 0.905 . . . . 0.0 111.337 178.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 70' ' ' PRO . 20.2 tp -89.53 -98.82 0.1 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.898 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -171.17 116.46 0.44 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.876 -1.14 . . . . 0.0 110.565 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.44 ' HA3' HG13 ' A' ' 71' ' ' ILE . . . -137.45 176.35 20.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.01 -15.79 51.23 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 124.077 1.567 . . . . 0.0 110.506 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -101.07 -20.4 15.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.105 -0.997 . . . . 0.0 111.416 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.31 -122.2 1.03 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' O ' ' N ' ' A' ' 64' ' ' LEU . 50.3 Cg_endo -98.06 9.15 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 O-C-N 123.635 1.334 . . . . 0.0 111.584 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.49 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.2 OUTLIER 52.98 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.882 -1.136 . . . . 0.0 110.198 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 70.0 m -139.32 132.86 30.34 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.467 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 8.1 pt20 -76.22 153.22 36.25 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.444 -0.785 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.5 ttp -107.88 -30.05 8.71 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -148.84 167.71 24.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.45 ' N ' ' CD1' ' A' ' 75' ' ' TYR . 29.7 m -154.03 114.15 3.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.636 -0.665 . . . . 0.0 110.428 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 76.98 4.22 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 HG12 ' CE2' ' A' ' 56' ' ' TYR . 98.3 t -59.95 -40.0 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.405 -0.809 . . . . 0.0 109.724 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.55 -25.85 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.68 -1.23 16.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.792 -0.567 . . . . 0.0 110.703 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.92 57.72 3.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.1 -1.0 . . . . 0.0 109.332 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 42.9 tp -147.77 153.55 39.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.691 -179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.469 ' HB ' ' CZ3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -143.09 131.78 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.73 124.79 5.79 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.768 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CD1' ' CG2' ' A' ' 71' ' ' ILE . 3.3 m-90 -84.69 170.01 13.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 122.049 -0.677 . . . . 0.0 109.771 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.28 89.29 4.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 109.352 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.08 144.19 92.41 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.552 -0.717 . . . . 0.0 110.532 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.42 179.89 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.809 1.426 . . . . 0.0 109.864 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -87.98 13.39 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.789 1.415 . . . . 0.0 111.539 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.95 -25.44 31.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.42 -143.12 0.13 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.713 -0.875 . . . . 0.0 109.84 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -154.07 108.63 3.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.2 m -87.71 157.07 19.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.7 -0.625 . . . . 0.0 110.582 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -90.14 170.03 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 110.161 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.434 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 92.6 m -111.94 164.18 15.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -119.45 142.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.639 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.407 ' SG ' ' CG ' ' A' ' 149' ' ' HIS . 18.0 p -160.52 160.0 31.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.453 -0.78 . . . . 0.0 110.77 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 100' ' ' GLY . 12.8 t -74.85 -38.65 61.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.633 -0.667 . . . . 0.0 111.842 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 92.9 m 59.37 -79.65 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.711 -0.618 . . . . 0.0 111.035 -178.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' THR . . . 137.72 -28.16 2.77 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.1 t -101.75 130.04 48.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -1.024 . . . . 0.0 109.812 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -89.95 11.76 19.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.0 111.386 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -70.01 80.08 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 108.694 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.62 176.73 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.66 . . . . 0.0 110.95 -178.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -146.24 100.89 3.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 35.0 tp -76.24 139.95 41.39 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.513 0.673 . . . . 0.0 110.013 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 78.3 t -85.32 111.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' ALA . 55.5 p -81.38 172.39 13.61 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -42.6 -27.95 0.2 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.712 -0.618 . . . . 0.0 112.149 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -100.01 -68.91 0.79 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.407 -0.808 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 108' ' ' THR . . . -146.53 -161.71 1.38 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 26.8 p-10 -60.0 -44.69 94.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.535 -0.728 . . . . 0.0 110.244 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.7 t 46.28 -89.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 50.1 pt -74.84 142.82 77.2 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 112.712 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -105.81 141.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 O-C-N 123.777 1.409 . . . . 0.0 108.718 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 41.8 t -133.93 133.13 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.028 -1.045 . . . . 0.0 111.447 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -92.61 119.25 31.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 13.4 ttm180 -61.06 126.02 25.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 110.798 -177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -99.1 1.4 45.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.803 -0.56 . . . . 0.0 109.698 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.13 43.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 86.4 m-20 -67.19 -21.87 65.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.7 p -123.38 16.33 9.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.513 -0.742 . . . . 0.0 111.46 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.39 143.56 35.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.072 -1.018 . . . . 0.0 111.244 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -143.34 139.21 8.71 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 17.6 t -88.84 110.51 21.11 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.909 -0.76 . . . . 0.0 110.125 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 59.6 tp -71.03 114.58 9.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.782 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.5 mm? -68.87 -25.0 64.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.234 0.54 . . . . 0.0 110.335 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.8 m -120.82 84.54 38.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.763 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -61.69 143.26 96.31 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.919 1.483 . . . . 0.0 110.039 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -152.96 167.78 12.72 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -57.54 125.29 18.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.773 1.407 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.9 -25.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.749 -0.594 . . . . 0.0 110.931 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.1 t -57.93 -34.95 70.42 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 179.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 109.496 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.87 1.52 38.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.549 -0.719 . . . . 0.0 110.913 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -72.33 68.92 0.78 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.129 0.966 . . . . 0.0 109.173 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 157.05 -21.28 0.43 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.8 t -75.0 -11.45 60.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.506 -0.997 . . . . 0.0 110.367 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . 0.401 ' HA ' ' CD2' ' A' ' 154' ' ' PHE . 0.8 OUTLIER -68.71 150.9 47.37 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.314 -0.866 . . . . 0.0 109.216 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.416 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 87.31 -11.49 65.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -70.54 -167.41 6.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -139.98 140.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 116.866 -1.623 . . . . 0.0 111.622 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.67 99.2 11.94 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.415 ' CD1' ' N ' ' A' ' 144' ' ' LEU . 7.4 mp -86.47 142.39 28.41 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.797 0.808 . . . . 0.0 112.759 -176.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.04 -170.15 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.36 12.55 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.62 1.326 . . . . 0.0 111.031 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -119.86 -18.95 8.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 111.36 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 39.12 0.81 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 55.9 m80 -122.96 118.65 28.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -1.043 . . . . 0.0 110.538 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.08 120.29 24.64 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 109.354 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.18 -3.89 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 112.068 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.462 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.6 124.41 1.85 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.362 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.421 ' CD1' HG23 ' A' ' 46' ' ' THR . 14.9 mt -106.12 121.75 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.014 -1.286 . . . . 0.0 109.009 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 10.5 t80 -51.36 124.53 12.09 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.76 0.791 . . . . 0.0 111.978 -178.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 27.0 ttt180 -114.63 -34.13 5.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.843 -0.535 . . . . 0.0 110.818 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.54 164.41 26.89 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.488 -0.757 . . . . 0.0 110.326 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -126.78 158.06 37.55 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 2.7 t -99.96 98.79 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' CYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.9 p -96.23 118.27 32.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.432 1.11 . . . . 0.0 112.32 -177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 162' ' ' GLY . 90.9 m -93.45 119.52 32.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.0 ttm105 65.51 -64.4 0.19 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.958 -0.464 . . . . 0.0 110.135 -178.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -165.1 25.54 0.18 Allowed Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.819 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.2 m -148.9 139.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -1.186 . . . . 0.0 109.494 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -82.26 123.01 28.65 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.596 0.712 . . . . 0.0 111.679 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -113.83 17.65 17.89 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.25 0.548 . . . . 0.0 109.851 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -172.43 149.34 2.16 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 13.8 m -127.4 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.64 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -107.39 149.5 27.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.3 p90 -152.13 166.36 31.91 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.234 -1.386 . . . . 0.0 112.174 -178.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 66.8 t -80.98 137.41 49.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -78.35 141.35 18.0 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.839 1.442 . . . . 0.0 110.739 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.02 -29.98 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.72 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.06 -32.84 70.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.393 -0.817 . . . . 0.0 108.981 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.8 t -72.1 -33.63 68.01 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' MET . . . . . 0.507 ' HG2' ' CD2' ' A' ' 53' ' ' TRP . 10.4 mtp -70.03 -36.26 74.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.781 -0.574 . . . . 0.0 110.036 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 -19.91 65.8 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.417 -0.802 . . . . 0.0 110.792 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.497 HG22 ' CD1' ' A' ' 75' ' ' TYR . 94.4 m -60.79 -53.66 54.68 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 109.894 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 17.1 ptm -60.66 -33.76 73.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -70.28 -25.81 63.51 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.537 0.684 . . . . 0.0 109.311 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' LYS . . . 52.92 32.95 13.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.564 -0.71 . . . . 0.0 111.014 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.1 t 55.91 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.202 -0.311 . . . . 0.0 111.236 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 181' ' ' ALA . 35.0 ttmt -152.86 29.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 110.082 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 50.55 43.98 27.29 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.267 -0.896 . . . . 0.0 111.282 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -151.95 137.2 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.608 -0.682 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.311 -179.806 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' 2ZF . . . . . 0.462 ' CD2' ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HG2' HD21 ' A' ' 94' ' ' LEU . 57.8 mp0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.297 0.57 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -123.52 129.98 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -116.63 127.78 54.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.688 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.766 HG22 HD21 ' A' ' 44' ' ' LEU . 98.5 t -84.33 136.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.91 174.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.534 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -138.24 136.19 36.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.093 0.949 . . . . 0.0 109.129 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 59' ' ' ALA . 19.4 p -113.64 179.9 3.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.912 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.64 32.92 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.5 p -104.78 -36.73 7.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.302 -0.873 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.6 -169.14 0.48 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.853 -1.154 . . . . 0.0 111.957 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.1 m -123.71 143.76 50.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.862 -0.524 . . . . 0.0 109.601 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.2 p90 -160.26 -138.12 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.549 -0.719 . . . . 0.0 109.911 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.766 HD21 HG22 ' A' ' 35' ' ' VAL . 82.0 mt -135.4 166.64 22.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.421 -1.425 . . . . 0.0 113.653 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -150.05 122.81 8.66 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.243 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 142' ' ' PRO . 32.7 m -101.14 127.21 47.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.44 -0.787 . . . . 0.0 111.729 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.3 m -74.11 123.11 23.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.825 -0.547 . . . . 0.0 109.827 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.95 130.04 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.455 -0.778 . . . . 0.0 110.096 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.67 40.01 29.45 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.476 -0.765 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.19 28.04 73.49 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 63.5 t -140.04 117.0 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.963 . . . . 0.0 109.29 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 8.4 t -76.28 122.99 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.294 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.49 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 95.5 m95 -113.48 130.02 56.42 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.607 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 11.8 t -133.08 -179.75 5.68 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 140' ' ' GLY . 7.0 m -90.72 131.0 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.076 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.92 -40.04 87.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 49.8 p-80 -74.82 68.74 1.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.29 1.043 . . . . 0.0 108.829 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.0 -38.43 0.16 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.8 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.792 -0.828 . . . . 0.0 109.182 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD21 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.547 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.42 HG22 ' HD1' ' A' ' 85' ' ' TRP . 39.8 mt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -96.24 144.83 26.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.731 -0.606 . . . . 0.0 110.626 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 14.8 pt20 -75.94 151.4 37.3 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.574 -0.704 . . . . 0.0 110.784 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.6 ttt -98.78 -39.84 8.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.547 -0.721 . . . . 0.0 110.398 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -139.97 166.75 23.82 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.918 HG23 ' CG1' ' A' ' 83' ' ' VAL . 24.0 m -154.68 111.06 3.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.628 -0.67 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.86 78.61 5.38 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -40.0 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.428 -0.795 . . . . 0.0 109.767 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -55.74 -26.22 44.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 0.0 109.003 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -111.66 -0.71 15.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.736 -0.602 . . . . 0.0 110.762 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.7 t70 59.95 57.75 2.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.105 -0.997 . . . . 0.0 109.553 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.713 HD13 HG11 ' A' ' 170' ' ' VAL . 52.8 tp -146.23 152.37 39.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.92 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.918 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -143.11 127.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.25 123.96 5.76 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.262 -1.446 . . . . 0.0 111.753 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.2 m-90 -84.72 -174.94 5.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.144 -0.621 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -110.07 73.71 0.85 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.175 0 O-C-N 121.791 -0.568 . . . . 0.0 111.436 -179.543 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 121.39 0.614 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.986 HD13 HD11 ' A' ' 144' ' ' LEU . 85.1 mt -85.65 167.09 15.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.661 -0.649 . . . . 0.0 110.121 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 3.8 m -89.49 135.23 31.21 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.506 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.318 -1.054 0 O-C-N 123.894 1.471 . . . . 0.0 110.067 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -117.46 14.62 14.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 111.375 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.18 75.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 108.786 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 145' ' ' CYS . 79.8 mt -84.28 176.19 8.9 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.479 0.657 . . . . 0.0 111.125 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.9 m-85 -140.96 131.89 26.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.96 148.13 35.68 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.946 0.879 . . . . 0.0 111.529 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 111' ' ' ALA . 83.9 t -119.97 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 112' ' ' ASP . 26.7 p -81.08 179.9 7.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.287 -0.883 . . . . 0.0 109.525 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.552 ' O ' HG21 ' A' ' 35' ' ' VAL . 13.0 ptm180 -41.87 -29.9 0.23 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -116.66 -50.01 2.63 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.12 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -156.86 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.934 -1.104 . . . . 0.0 111.597 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 108' ' ' THR . 16.9 t70 47.08 73.67 0.18 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.088 -1.008 . . . . 0.0 111.203 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -82.56 99.99 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.189 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.8 mm -120.95 150.01 52.21 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.753 -0.592 . . . . 0.0 109.542 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 48.3 Cg_endo -90.44 133.03 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 124.015 1.534 . . . . 0.0 110.559 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 167' ' ' VAL . 61.7 t -127.57 130.03 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -90.34 118.23 29.68 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.496 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.6 ttp180 -62.07 125.8 25.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.805 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -98.43 4.36 48.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.787 -0.571 . . . . 0.0 109.569 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.99 170.67 32.17 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 107.436 -2.266 . . . . 0.0 107.436 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 78.2 m-20 -60.83 -19.69 60.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -1.022 . . . . 0.0 110.122 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -121.56 15.98 11.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 0.0 111.822 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -146.08 143.27 29.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.987 -1.07 . . . . 0.0 111.431 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.51 141.85 11.81 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.4 ' C ' HG13 ' A' ' 116' ' ' VAL . 3.4 m -90.3 111.6 22.85 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.951 -0.735 . . . . 0.0 110.326 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 116' ' ' VAL . 55.5 tp -73.56 109.93 7.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.347 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.8 mm? -60.03 -30.0 68.89 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.4 m -114.25 97.75 46.6 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.516 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.91 142.18 74.34 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.909 1.478 . . . . 0.0 109.965 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -149.99 161.06 32.3 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.81 122.84 12.42 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.832 1.438 . . . . 0.0 110.92 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.98 -28.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 t -59.01 -34.9 72.4 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.66 0.743 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 108' ' ' THR . 72.7 t80 -70.04 -27.32 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.47 5.6 30.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.484 -0.76 . . . . 0.0 110.858 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -68.11 110.16 3.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.04 55.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.6 p -74.9 -17.93 60.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -1.04 . . . . 0.0 109.056 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.09 149.51 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 108.885 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 55' ' ' VAL . . . 91.16 -9.51 77.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -77.15 -151.52 4.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.693 ' HG3' HG22 ' A' ' 33' ' ' VAL . 51.7 Cg_endo -147.5 148.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 116.307 -1.996 . . . . 0.0 112.921 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.4 mp -99.89 98.43 9.21 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.986 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -83.43 135.61 34.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.553 ' HA ' HD23 ' A' ' 104' ' ' LEU . 84.4 m -58.82 175.6 0.32 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 40.5 Cg_endo -72.11 -5.04 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 117.215 -1.39 . . . . 0.0 110.977 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.447 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 9.8 t -106.14 -0.22 24.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.905 -1.122 . . . . 0.0 112.27 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.84 6.55 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.447 ' CD2' ' HB3' ' A' ' 147' ' ' SER . 9.2 m-70 -114.04 118.53 34.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.34 121.86 24.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.394 -0.816 . . . . 0.0 110.685 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.03 -4.12 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.799 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.472 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -152.79 131.08 3.22 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.279 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.504 HD12 ' CE ' ' A' ' 175' ' ' MET . 74.5 mt -109.91 119.14 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.098 -1.236 . . . . 0.0 108.163 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 16.9 t80 -49.99 129.29 20.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.393 -0.817 . . . . 0.0 112.362 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.409 ' HB2' HG23 ' A' ' 170' ' ' VAL . 41.8 ttt180 -117.22 -30.08 5.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.938 -0.476 . . . . 0.0 111.569 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.08 146.56 12.51 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.585 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.97 138.29 37.24 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 166' ' ' ALA . 42.9 t -95.72 90.97 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 29.1 p -94.03 122.24 36.33 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.115 0.96 . . . . 0.0 112.111 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 161' ' ' ARG . 80.4 m -87.1 -102.07 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.116 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 160' ' ' THR . 12.8 tpt180 -59.98 -50.0 75.47 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.601 -1.312 . . . . 0.0 109.464 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.443 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -176.18 30.53 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.762 HG23 ' HD3' ' A' ' 165' ' ' LYS . 33.0 m -149.84 145.89 17.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -75.92 125.34 28.91 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 0.0 111.24 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.762 ' HD3' HG23 ' A' ' 163' ' ' VAL . 4.2 mmmm -103.88 7.14 36.84 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.298 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.26 137.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.552 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -105.82 134.68 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.428 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -100.41 146.59 26.82 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 40.3 p90 -152.55 162.96 40.5 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.314 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 82' ' ' LEU . 61.0 t -79.82 143.76 58.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.499 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.75 141.54 9.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.747 1.393 . . . . 0.0 111.717 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.499 HG23 ' SD ' ' A' ' 175' ' ' MET . 14.9 p -69.05 -27.67 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.08 -28.69 66.72 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.3 t -70.65 -26.28 63.38 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 153' ' ' ILE . 66.3 mtt -69.32 -36.62 77.14 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.778 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.011 -1.056 . . . . 0.0 109.525 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.483 0.659 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -119.89 123.45 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -94.68 122.84 37.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.719 . . . . 0.0 111.314 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.1 t -82.78 132.83 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.79 175.13 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.756 0.788 . . . . 0.0 110.427 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 58.1 m -140.04 149.82 43.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.4 t -116.8 79.03 1.27 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.376 1.084 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.45 -52.51 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.449 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -120.7 9.28 10.73 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.585 -1.322 . . . . 0.0 113.966 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' SER . 16.6 pt20 -161.73 178.07 9.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.628 -1.295 . . . . 0.0 112.236 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.7 m -129.92 150.2 51.31 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.218 0.532 . . . . 0.0 109.942 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 9.9 p90 -160.32 -148.14 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 0.0 109.414 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' SER . 93.5 mt -136.42 165.34 26.05 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.608 -1.308 . . . . 0.0 113.772 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -152.42 130.71 12.03 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.41 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 142' ' ' PRO . 99.7 m -99.9 120.46 39.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.402 -0.811 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -72.15 124.58 25.31 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.14 127.66 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 50.1 39.97 20.54 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.552 -0.718 . . . . 0.0 111.432 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.35 73.6 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.9 t -137.7 115.04 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -1.111 . . . . 0.0 109.348 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 29.1 t -75.4 119.68 19.83 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.25 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 84.9 m95 -108.53 127.42 53.92 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.869 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 6.9 t -133.99 -178.6 5.1 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.638 HG23 ' HA3' ' A' ' 58' ' ' GLY . 21.2 m -93.24 131.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.238 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.0 -41.89 93.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.52 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 45.9 p-80 -70.0 -14.5 62.73 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.699 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 38' ' ' THR . . . -93.1 -47.94 2.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.8 -0.823 . . . . 0.0 109.066 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.748 0 O-C-N 120.739 -1.225 . . . . 0.0 109.424 179.127 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.371 0.605 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.83 153.1 17.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.681 -0.637 . . . . 0.0 110.381 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 22.3 pt20 -80.09 159.97 25.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.658 -0.652 . . . . 0.0 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.2 ttp -101.91 -32.19 10.34 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.632 -0.667 . . . . 0.0 109.592 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -149.99 168.98 22.29 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 91.0 m -153.84 118.55 4.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.382 -0.824 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -101.05 74.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 76' ' ' THR . 87.7 t -59.96 -38.65 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.52 -0.738 . . . . 0.0 109.725 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -54.34 -26.79 31.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.512 -0.743 . . . . 0.0 109.03 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.61 0.71 14.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.733 -0.605 . . . . 0.0 111.05 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 60.07 56.84 3.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.577 HD21 ' HG3' ' A' ' 175' ' ' MET . 35.5 tp -145.96 146.57 31.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.06 136.62 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -122.05 123.78 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.531 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.4 m-90 -88.47 -173.72 4.29 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.16 109.97 21.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 108.628 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.566 -0.709 . . . . 0.0 110.753 -179.016 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.1 p . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.452 0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.985 HD13 HD21 ' A' ' 144' ' ' LEU . 90.9 mt -97.91 161.73 13.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.828 -0.545 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 94.4 m -103.7 150.01 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.664 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 O-C-N 123.97 1.51 . . . . 0.0 109.957 179.534 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.221 0.534 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 5.9 m -98.55 19.78 13.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -69.95 75.56 0.47 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 118' ' ' ARG . 84.2 mt -89.93 175.34 7.24 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.067 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 47.9 p90 -151.76 139.01 19.31 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 41.6 tp -109.82 162.92 14.01 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.774 0.797 . . . . 0.0 111.633 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 111' ' ' ALA . 75.1 t -110.01 123.99 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.803 -0.561 . . . . 0.0 110.197 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.959 ' CG2' HG22 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -82.9 -179.65 7.5 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -49.18 -24.21 1.62 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.844 -0.535 . . . . 0.0 110.279 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -94.06 -71.33 0.66 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.611 -0.68 . . . . 0.0 110.383 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.91 -50.88 0.09 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 84.0 m-20 -133.91 151.84 51.65 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.988 -1.07 . . . . 0.0 112.827 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 108' ' ' THR . 15.9 t -118.91 43.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 128' ' ' SER . 0.1 OUTLIER 59.97 178.65 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.29 138.99 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.757 1.399 . . . . 0.0 110.871 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.886 HG22 HD12 ' A' ' 126' ' ' LEU . 49.1 t -124.3 132.94 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.094 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.4 tpp85 -90.28 120.04 31.09 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' LEU . 6.7 ttp180 -64.15 123.37 18.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 110.16 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -100.05 4.55 44.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.621 -0.674 . . . . 0.0 109.778 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.98 172.74 38.86 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.0 m-20 -61.97 -22.5 65.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.488 -1.007 . . . . 0.0 110.218 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.2 p -123.21 17.2 9.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -144.13 139.43 28.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.887 -1.133 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -135.16 142.9 14.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 t -92.16 110.01 21.39 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.727 -0.866 . . . . 0.0 110.566 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.886 HD12 HG22 ' A' ' 116' ' ' VAL . 18.1 tp -71.59 105.79 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.06 -31.49 70.04 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.365 0.602 . . . . 0.0 110.089 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 114' ' ' ILE . 73.5 m -115.07 94.59 39.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.5 Cg_endo -65.61 148.06 86.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.885 1.466 . . . . 0.0 109.697 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.01 168.76 11.63 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -59.32 125.75 18.88 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.887 1.467 . . . . 0.0 110.334 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.96 -24.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.762 -0.587 . . . . 0.0 111.387 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 17.4 t -52.91 -32.84 47.53 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.405 -0.809 . . . . 0.0 109.677 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.742 ' CE2' HG21 ' A' ' 108' ' ' THR . 71.1 t80 -71.94 -28.87 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.49 0.09 54.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.736 . . . . 0.0 111.587 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.409 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 58.1 mtpt -70.78 108.35 4.41 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.28 -0.888 . . . . 0.0 108.647 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.16 -9.42 56.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' ' 108' ' ' THR . 19.3 t -76.16 -14.99 60.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.427 -1.043 . . . . 0.0 109.246 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.95 147.34 53.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.839 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 94.06 -10.84 71.53 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -73.23 -158.28 4.7 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.576 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.1 Cg_endo -144.54 144.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 116.818 -1.655 . . . . 0.0 112.467 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.637 ' O ' HG22 ' A' ' 151' ' ' VAL . 2.0 mt -98.32 97.57 8.93 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.985 HD21 HD13 ' A' ' 94' ' ' LEU . 6.0 mp -89.47 144.71 25.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 54.6 m -63.95 -174.03 0.11 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 41.3 Cg_endo -86.01 9.9 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.573 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -107.91 -23.52 12.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.998 . . . . 0.0 110.767 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.8 36.1 1.19 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 73.0 m80 -120.09 127.73 52.81 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -1.061 . . . . 0.0 110.82 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.24 120.82 23.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.506 -0.746 . . . . 0.0 109.434 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 143' ' ' LEU . 36.0 m -122.43 -4.54 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.896 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 169' ' ' PHE . . . -160.06 128.58 2.0 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.281 -1.438 . . . . 0.0 111.33 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 32.5 mt -107.82 117.93 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.211 -1.17 . . . . 0.0 108.286 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.469 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.4 t80 -51.96 128.72 25.09 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.539 0.685 . . . . 0.0 112.402 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 70.9 ttt180 -117.75 -29.22 5.77 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.833 -0.542 . . . . 0.0 111.498 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.27 145.63 13.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.207 -0.933 . . . . 0.0 111.412 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -99.59 139.39 35.31 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -88.24 93.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 72.2 m -91.55 122.26 33.97 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.273 1.035 . . . . 0.0 112.81 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.6 m -120.06 130.06 54.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.771 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 56.16 23.46 7.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.477 -0.764 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 90.19 20.02 43.89 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.38 -0.825 . . . . 0.0 111.787 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -145.98 142.85 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.06 -1.259 . . . . 0.0 109.352 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.35 129.06 34.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 111.129 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -119.77 11.3 11.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.0 110.302 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -174.33 141.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.701 HG21 HG11 ' A' ' 116' ' ' VAL . 19.0 m -113.65 135.17 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.711 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -101.6 145.14 29.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.3 p90 -154.4 163.81 39.59 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.033 -1.467 . . . . 0.0 112.892 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 82' ' ' LEU . 65.3 t -86.48 130.0 51.0 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.99 147.48 21.17 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 O-C-N 123.688 1.362 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 11.1 p -70.0 -30.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.733 -0.604 . . . . 0.0 109.528 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.88 -32.91 71.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -75.01 -32.67 61.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.559 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.577 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -65.03 -35.61 81.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.895 -0.503 . . . . 0.0 109.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -45.73 91.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.742 -0.599 . . . . 0.0 109.389 177.721 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 121.316 0.579 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -129.95 130.05 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.644 -0.66 . . . . 0.0 109.329 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -98.99 122.83 42.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 ' C ' HG13 ' A' ' 36' ' ' VAL . 60.9 t -84.86 128.48 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 64' ' ' LEU . 26.9 m -148.02 176.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.176 -0.953 . . . . 0.0 110.593 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.1 t -149.24 144.25 26.41 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.788 0.804 . . . . 0.0 108.895 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' HE1' ' A' ' 43' ' ' PHE . 5.7 t -118.83 -178.38 3.54 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.54 -17.52 1.29 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.807 -0.558 . . . . 0.0 112.227 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.563 ' H ' HG23 ' A' ' 38' ' ' THR . 73.8 p -96.57 -40.76 8.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.058 . . . . 0.0 112.287 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 -170.56 0.64 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.885 -1.134 . . . . 0.0 112.641 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.8 m -109.99 143.26 40.22 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HE1' HG22 ' A' ' 38' ' ' THR . 12.9 p90 -161.79 -146.38 0.12 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.152 -0.967 . . . . 0.0 110.749 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 88.7 mt -134.26 166.59 22.45 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.707 1.241 . . . . 0.0 113.925 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.94 118.56 5.71 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.712 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.9 m -91.59 123.11 34.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 0.0 111.219 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 47.3 t -74.87 110.0 8.81 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.99 130.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.538 -0.726 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.29 40.03 25.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.561 -0.712 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.33 27.39 71.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.6 t -139.99 117.64 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -77.23 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.54 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.54 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.4 m95 -107.14 124.39 49.62 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.139 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.615 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 9.8 t -128.61 -175.33 3.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.603 HG23 ' HA3' ' A' ' 58' ' ' GLY . 27.7 m -93.15 130.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.504 -1.278 . . . . 0.0 112.703 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.94 -44.17 94.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -66.81 -18.13 65.22 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.774 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.603 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -93.54 -36.12 5.98 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.663 -0.904 . . . . 0.0 110.503 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 36' ' ' VAL . 4.5 mm? . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.489 179.394 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.7 m -111.94 139.1 47.72 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.466 -0.771 . . . . 0.0 112.391 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 6.9 pt20 -83.99 165.06 18.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.654 . . . . 0.0 111.837 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.8 mtp -100.03 -45.45 5.67 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.564 -0.71 . . . . 0.0 109.969 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -158.84 -177.96 6.9 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.54 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.1 t -159.98 142.69 13.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.719 0.771 . . . . 0.0 110.27 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -104.96 83.09 1.94 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.96 -40.05 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -55.15 -26.16 36.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -111.74 0.35 16.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.82 -0.55 . . . . 0.0 110.836 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.0 59.55 2.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 175' ' ' MET . 44.5 tp -145.72 152.1 39.05 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.454 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' THR . 1.5 m -140.0 132.07 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -121.63 126.9 6.67 Favored Glycine 0 N--CA 1.508 3.459 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.852 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.615 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -90.52 -169.59 2.45 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.046 -0.679 . . . . 0.0 111.243 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -113.04 95.46 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.683 -0.636 . . . . 0.0 110.42 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.419 -0.801 . . . . 0.0 109.878 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.591 0.71 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 144' ' ' LEU . 83.2 mt -109.78 148.63 31.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -105.53 -173.91 0.3 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.189 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.485 0.992 0 O-C-N 123.847 1.446 . . . . 0.0 110.276 179.572 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 m -96.49 17.12 16.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 111.217 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.56 69.22 1.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 145' ' ' CYS . 92.7 mt -75.07 174.6 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.755 -0.591 . . . . 0.0 110.903 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.1 m-85 -140.52 130.01 24.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.676 -0.64 . . . . 0.0 109.519 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.2 tp -110.56 152.03 26.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.727 0.775 . . . . 0.0 111.286 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.516 HG13 ' HA ' ' A' ' 111' ' ' ALA . 81.1 t -108.97 132.26 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 75.8 p -80.83 169.36 17.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -34.39 -32.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 108' ' ' THR . 81.7 m-70 -97.73 -85.34 0.36 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -161.79 16.01 0.1 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.177 -0.952 . . . . 0.0 112.327 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 47.8 t0 -68.43 130.03 41.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.835 -1.166 . . . . 0.0 110.036 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -97.37 117.43 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.698 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 128' ' ' SER . 3.8 tt -116.29 119.82 35.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.572 -0.705 . . . . 0.0 109.654 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 127' ' ' LEU . 49.0 Cg_endo -70.2 131.32 20.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.616 1.324 . . . . 0.0 111.701 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 167' ' ' VAL . 61.4 t -130.0 132.29 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.771 -0.581 . . . . 0.0 109.456 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -88.19 112.06 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -54.44 122.56 10.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 111.13 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -98.51 0.45 45.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.636 -0.665 . . . . 0.0 110.047 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.79 -174.4 46.85 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 91.0 m-20 -70.07 -22.7 63.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -1.043 . . . . 0.0 110.053 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.3 p -124.9 17.38 8.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.569 -0.707 . . . . 0.0 111.465 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.99 145.2 37.52 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.281 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.29 142.14 11.81 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.0 t -88.82 111.56 22.19 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.873 -0.781 . . . . 0.0 109.785 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 114' ' ' ILE . 44.6 tp -70.38 112.37 6.63 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.08 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 115' ' ' PRO . 87.3 mt -69.95 -19.98 63.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.825 -0.547 . . . . 0.0 110.587 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 114' ' ' ILE . 36.7 m -120.0 79.96 25.93 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.672 -0.643 . . . . 0.0 109.945 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.2 Cg_endo -57.78 142.47 96.12 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.849 1.447 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -155.33 167.15 14.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -58.9 128.02 26.46 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.746 1.393 . . . . 0.0 109.76 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.25 -25.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.683 -0.635 . . . . 0.0 111.085 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 91.0 p -58.44 -30.37 66.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.598 -0.689 . . . . 0.0 109.564 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -70.04 -29.31 66.31 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.42 3.98 25.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.416 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 4.5 mtpm? -66.89 111.63 3.88 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.5 55.84 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -77.81 -13.64 59.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.529 -0.983 . . . . 0.0 109.924 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.531 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -67.59 147.35 52.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.078 -1.014 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.553 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.96 -9.99 75.44 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -66.87 -163.64 1.72 Allowed Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.0 Cg_endo -143.26 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 117.033 -1.512 . . . . 0.0 111.852 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.6 mp -91.77 96.96 10.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -83.6 143.83 29.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.201 1.0 . . . . 0.0 113.132 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.498 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.8 m -69.4 163.75 55.62 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.39 -11.2 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.577 1.304 . . . . 0.0 111.504 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.7 m -95.71 -0.06 51.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.925 -1.11 . . . . 0.0 111.808 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.93 33.5 6.62 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -118.73 128.49 54.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -1.147 . . . . 0.0 109.968 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.66 29.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.78 1.28 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.648 . . . . 0.0 111.904 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -147.96 128.3 2.84 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.856 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 68.8 mt -109.97 120.83 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.018 -1.284 . . . . 0.0 108.181 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.462 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.7 t80 -50.02 129.36 20.54 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.866 0.841 . . . . 0.0 112.711 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.492 ' HB2' HG23 ' A' ' 170' ' ' VAL . 40.1 ttt180 -117.31 -28.51 6.12 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 149.2 8.34 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.707 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -102.69 135.86 43.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.838 -0.538 . . . . 0.0 111.209 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.0 t -85.12 86.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 27.5 p -88.09 104.05 16.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.743 1.258 . . . . 0.0 112.191 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.607 ' O ' HG22 ' A' ' 163' ' ' VAL . 8.2 m -99.72 133.91 43.37 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.162 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 54.8 22.88 4.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.431 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 91.21 17.74 49.23 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.356 -0.84 . . . . 0.0 111.836 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 160' ' ' THR . 34.2 m -146.02 140.74 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.255 . . . . 0.0 109.687 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 118.85 19.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.587 -0.696 . . . . 0.0 111.763 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -111.01 10.55 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.825 -0.547 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.04 140.01 0.51 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.637 HG21 HG11 ' A' ' 116' ' ' VAL . 17.8 m -112.82 135.88 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.256 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -103.94 147.36 27.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.465 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.1 p90 -154.32 164.25 38.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.263 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 82' ' ' LEU . 61.4 t -82.25 138.46 45.36 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -77.65 149.3 26.67 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.741 1.39 . . . . 0.0 110.786 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.4 -29.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.316 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -29.29 68.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.242 -0.911 . . . . 0.0 108.846 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.5 t -70.21 -32.65 70.64 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.653 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.711 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -66.52 -39.92 88.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.596 -0.69 . . . . 0.0 109.643 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.18 -43.27 96.0 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.631 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 47.7 p . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.672 -0.642 . . . . 0.0 110.57 179.583 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 33' ' ' VAL . 11.1 pt-20 . . . . . 0 N--CA 1.5 2.043 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 107' ' ' VAL . 62.1 t -109.96 119.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.547 -0.721 . . . . 0.0 109.343 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -102.26 125.3 48.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.639 -0.663 . . . . 0.0 110.79 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 36' ' ' VAL . 59.0 t -83.68 128.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 35' ' ' VAL . 32.5 m -146.73 174.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.631 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.3 p -146.92 133.63 19.98 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.703 0.763 . . . . 0.0 109.217 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 59' ' ' ALA . 41.5 p -107.48 -179.93 4.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.2 5.89 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.591 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 p -99.34 -37.23 9.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 112.607 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -171.47 -170.0 0.77 Allowed 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.62 -1.3 . . . . 0.0 113.13 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 28.6 p -116.25 141.14 48.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 14.9 p90 -163.67 -146.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.236 -0.915 . . . . 0.0 110.638 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.851 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -131.92 160.43 35.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.777 -1.202 . . . . 0.0 113.121 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.28 128.44 9.74 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.817 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.87 ' CG2' HD11 ' A' ' 153' ' ' ILE . 7.6 t -80.01 -151.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG23 ' A' ' 46' ' ' THR . 4.8 t -160.12 106.35 1.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.425 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.2 40.01 30.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.797 -0.564 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 45.5 t -133.93 113.06 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.973 . . . . 0.0 109.745 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 t -76.07 121.87 23.43 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.546 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.4 m95 -108.47 127.56 54.02 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.474 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.685 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 5.4 t -135.58 -179.14 5.46 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG13 ' CA ' ' A' ' 140' ' ' GLY . 14.5 m -89.69 126.81 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 C-N-CA 118.18 -1.408 . . . . 0.0 112.213 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -59.95 -42.49 94.17 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.61 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -71.31 73.74 0.7 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.589 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.83 -32.72 0.56 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.575 -0.956 . . . . 0.0 110.927 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 120.874 -1.141 . . . . 0.0 109.013 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.718 HG22 ' HD1' ' A' ' 85' ' ' TRP . 34.9 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.6 m -91.23 140.97 29.3 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.421 0.629 . . . . 0.0 110.826 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.25 147.02 49.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.783 -0.573 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.84 -29.87 12.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.434 ' CG ' ' N ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -149.96 169.97 19.93 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 27.3 m -154.28 112.41 3.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 110.69 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 20.4 t-20 -91.12 77.85 5.95 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.02 -40.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -56.07 -25.6 45.91 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.94 -1.41 15.47 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.734 -0.604 . . . . 0.0 110.833 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.8 t0 60.78 57.36 2.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.965 -1.085 . . . . 0.0 109.152 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 170' ' ' VAL . 17.0 tp -145.36 154.52 42.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.657 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -145.67 128.22 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.407 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -114.9 119.76 4.76 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.037 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.718 ' HD1' HG22 ' A' ' 71' ' ' ILE . 5.4 m-90 -86.45 174.61 8.86 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -95.93 91.75 6.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.009 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.587 -0.696 . . . . 0.0 111.153 -179.071 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.366 0.603 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 144' ' ' LEU . 73.3 mt -84.25 159.96 20.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.6 163.34 18.09 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.379 -0.826 . . . . 0.0 111.024 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.491 1.33 0 O-C-N 124.071 1.564 . . . . 0.0 109.848 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.757 0.789 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.17 15.48 6.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.778 -0.576 . . . . 0.0 111.399 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -84.56 79.6 9.53 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 118' ' ' ARG . 92.2 mt -88.04 174.6 8.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.037 0.923 . . . . 0.0 112.368 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 97.4 m-85 -145.32 129.97 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 143' ' ' LEU . 25.0 tp -107.7 144.43 34.81 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.629 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 33' ' ' VAL . 76.0 t -90.57 120.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.7 p -91.54 178.05 6.05 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.798 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -47.13 -25.98 1.0 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.896 -0.502 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -97.28 -70.13 0.73 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.638 -0.664 . . . . 0.0 109.311 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.06 -164.99 1.99 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.95 0.881 . . . . 0.0 110.06 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 8.9 t0 -52.92 -93.96 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.598 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 114' ' ' ILE . 32.9 t 57.02 156.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.139 -0.976 . . . . 0.0 110.977 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 126' ' ' LEU . 34.3 mt 53.7 105.33 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.274 -0.892 . . . . 0.0 111.849 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 50.2 Cg_endo -90.42 150.1 4.4 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.803 1.422 . . . . 0.0 109.319 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 126' ' ' LEU . 21.9 t -131.26 139.87 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.322 -0.862 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -98.49 117.06 32.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 22.5 ttp85 -62.82 129.16 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.328 -0.857 . . . . 0.0 110.996 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -102.92 4.81 37.96 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.445 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.33 178.76 40.82 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.56 -26.57 68.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.451 -1.029 . . . . 0.0 109.87 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.6 p -120.07 16.86 12.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.662 -0.649 . . . . 0.0 111.868 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -140.04 139.05 35.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.011 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.59 138.7 9.15 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 116' ' ' VAL . 23.2 t -89.28 110.72 21.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.909 -0.759 . . . . 0.0 110.181 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 116' ' ' VAL . 21.0 tp -70.86 110.67 5.75 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.819 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.97 -21.72 63.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.831 -0.543 . . . . 0.0 110.515 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.693 ' HB2' HG23 ' A' ' 114' ' ' ILE . 70.7 m -120.43 82.95 32.87 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.617 . . . . 0.0 110.197 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.1 Cg_endo -59.42 139.81 91.31 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 O-C-N 123.803 1.423 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -152.27 164.26 20.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -54.06 125.97 20.51 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 O-C-N 123.786 1.414 . . . . 0.0 110.93 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 p -50.08 -25.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.86 -0.525 . . . . 0.0 110.91 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.0 m -58.81 -35.36 72.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.605 -0.684 . . . . 0.0 109.496 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -68.4 -28.13 66.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.2 0.95 38.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.351 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -70.63 119.49 14.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.256 -0.903 . . . . 0.0 108.597 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.53 -10.09 66.83 Favored Glycine 0 C--N 1.286 -2.207 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.851 ' HA ' HD12 ' A' ' 44' ' ' LEU . 27.4 t -78.65 -13.5 59.79 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.56 -0.965 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.513 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.5 m -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.007 -1.058 . . . . 0.0 110.695 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.598 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.94 -9.71 76.35 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -61.66 -179.23 3.25 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.6 ' CG ' HG22 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -128.04 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 117.206 -1.396 . . . . 0.0 111.761 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.5 mt -94.52 97.19 9.97 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 94' ' ' LEU . 7.3 mp -89.62 141.31 28.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.425 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -59.35 -167.33 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.97 16.46 1.45 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.749 1.394 . . . . 0.0 110.905 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -122.03 -51.08 2.02 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -0.95 . . . . 0.0 110.916 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.62 42.42 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -127.13 126.62 43.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -1.068 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -88.0 103.0 15.29 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' HB ' ' A' ' 172' ' ' VAL . 35.5 m -109.92 8.18 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.386 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -159.19 134.08 3.62 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.873 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.87 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.6 mt -118.27 120.81 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.288 -1.124 . . . . 0.0 108.309 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 19.3 t80 -54.33 128.03 29.74 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.398 0.618 . . . . 0.0 112.5 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 170' ' ' VAL . 7.2 ptm180 -119.28 -24.17 6.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 111.311 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.52 148.39 12.67 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.59 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -104.88 143.81 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.291 0.567 . . . . 0.0 111.38 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 47.2 t -94.74 88.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.0 p -89.88 111.08 22.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.505 1.145 . . . . 0.0 112.454 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLY . 93.6 m -92.59 125.95 37.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 160' ' ' THR . 73.9 ttt180 62.14 -70.6 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 122.014 -0.429 . . . . 0.0 110.056 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.05 24.98 0.25 Allowed Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.178 -1.011 . . . . 0.0 110.588 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.65 144.85 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.086 -1.244 . . . . 0.0 109.472 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.07 123.55 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.434 0.635 . . . . 0.0 111.123 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -112.47 11.41 19.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.784 -0.573 . . . . 0.0 110.581 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 158' ' ' VAL . . . -173.77 144.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 116' ' ' VAL . 15.9 m -117.87 137.3 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.889 0.852 . . . . 0.0 112.674 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -104.02 146.01 29.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 33.9 p90 -154.61 160.62 41.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.17 -1.412 . . . . 0.0 112.205 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 82' ' ' LEU . 59.9 t -81.2 129.98 64.63 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.6 155.87 49.65 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.749 1.394 . . . . 0.0 110.784 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 151' ' ' VAL . 7.5 p -71.41 -24.39 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.616 -0.677 . . . . 0.0 109.49 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.87 -30.23 67.58 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -71.9 -39.97 69.19 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.496 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.9 mpp? -64.72 -39.69 94.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -32.21 70.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.812 -0.555 . . . . 0.0 110.334 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 121.442 -0.787 . . . . 0.0 109.94 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.569 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.0 t -110.06 120.44 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -93.02 130.16 38.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 44' ' ' LEU . 75.5 t -77.77 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 64' ' ' LEU . 34.7 m -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.961 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.4 p -157.89 143.93 17.38 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.829 HG21 ' O ' ' A' ' 58' ' ' GLY . 4.5 t -109.37 -177.7 3.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.71 -14.44 0.91 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.577 -0.702 . . . . 0.0 112.869 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.764 HG22 HG23 ' A' ' 38' ' ' THR . 9.5 t -112.0 -21.27 11.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HG2' HG23 ' A' ' 40' ' ' THR . 4.8 pt20 -169.65 -171.88 1.31 Allowed 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.368 -1.457 . . . . 0.0 113.174 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -125.59 146.65 49.6 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.7 p90 -162.79 -142.58 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.3 mt -135.63 162.03 33.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.525 -1.359 . . . . 0.0 113.229 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.46 130.0 12.22 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.286 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 142' ' ' PRO . 57.2 m -99.92 125.35 45.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.702 . . . . 0.0 111.218 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.4 t -73.0 119.46 17.28 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.18 135.44 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.469 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 52.69 39.7 28.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.69 -0.632 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.67 23.37 73.89 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.604 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.5 t -140.62 120.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -1.078 . . . . 0.0 110.335 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.9 m -73.99 120.61 19.81 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.604 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.7 m95 -107.17 125.97 51.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.752 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -132.93 -176.41 4.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.729 HG11 ' HB2' ' A' ' 139' ' ' SER . 32.3 m -87.03 127.17 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 C-N-CA 118.346 -1.342 . . . . 0.0 112.83 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.61 -40.03 93.38 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.6 p-80 -72.54 68.85 0.83 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.286 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.829 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.14 -59.45 0.28 Allowed Glycine 0 N--CA 1.484 1.856 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.694 -0.886 . . . . 0.0 111.2 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 64' ' ' LEU 0.266 2.0 tm? . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.326 0.584 . . . . 0.0 110.462 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.502 2.156 0 O-C-N 121.344 -0.847 . . . . 0.0 109.987 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.776 HG22 ' HD1' ' A' ' 85' ' ' TRP . 63.4 mt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.527 0.679 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.9 m -96.24 140.01 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.01 149.84 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.708 . . . . 0.0 110.627 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.3 mmm -103.55 -27.27 12.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.731 -0.606 . . . . 0.0 109.889 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -154.95 171.15 20.17 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.516 -0.74 . . . . 0.0 109.314 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.847 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.9 m -154.12 115.86 4.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.632 -0.667 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.76 76.36 3.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.99 -33.06 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.686 -0.634 . . . . 0.0 109.298 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.6 -26.6 13.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.07 8.36 6.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.13 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 62.42 61.77 1.22 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.765 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.855 HD22 HG11 ' A' ' 170' ' ' VAL . 36.5 tp -144.19 152.56 41.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.847 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.32 133.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.65 121.67 5.17 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.232 -1.461 . . . . 0.0 111.767 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.776 ' HD1' HG22 ' A' ' 71' ' ' ILE . 6.2 m-90 -89.19 -169.68 2.6 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.795 -0.826 . . . . 0.0 109.359 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -94.05 107.68 19.58 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.026 0 O-C-N 121.563 -0.711 . . . . 0.0 112.522 -177.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.5 mm? -85.26 173.46 10.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.844 -0.535 . . . . 0.0 110.349 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.804 HG22 ' CD ' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -95.19 -168.4 0.17 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.596 -0.69 . . . . 0.0 110.915 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.804 ' CD ' HG22 ' A' ' 95' ' ' THR . 49.6 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 O-C-N 123.986 1.519 . . . . 0.0 109.318 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.313 0.578 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 58.08 21.44 7.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.778 -0.576 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.0 71.07 10.12 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.484 HD23 ' CA ' ' A' ' 145' ' ' CYS . 73.0 mt -79.75 174.38 11.64 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 111.779 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 94.0 m-85 -140.47 126.44 19.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.673 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.4 tp -109.3 128.59 55.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.342 -0.849 . . . . 0.0 111.427 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 111' ' ' ALA . 76.1 t -75.59 134.74 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 112' ' ' ASP . 45.6 p -84.42 175.94 9.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.536 -0.728 . . . . 0.0 110.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -32.92 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' THR . 4.1 p80 -112.88 -65.24 1.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.31 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -158.6 -33.99 0.07 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.956 -1.09 . . . . 0.0 113.198 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 48.4 m-20 -44.01 116.54 1.01 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.331 -0.856 . . . . 0.0 112.038 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' LEU . 34.0 m -84.29 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.264 0.554 . . . . 0.0 110.665 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 126' ' ' LEU . 48.3 mm -113.9 110.85 48.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.668 . . . . 0.0 109.454 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 46.0 Cg_endo -64.28 120.01 7.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 O-C-N 123.875 1.46 . . . . 0.0 110.688 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.674 HG22 HD12 ' A' ' 126' ' ' LEU . 48.6 t -127.51 133.93 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 109.219 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -87.44 118.84 27.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.216 -0.928 . . . . 0.0 108.763 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.1 ttm180 -62.31 122.17 15.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -97.46 0.16 47.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.0 176.62 44.36 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 77.7 m-20 -62.3 -24.06 67.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -1.028 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 p -123.65 17.34 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 111.962 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -141.67 141.8 33.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 111.136 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.78 142.66 13.23 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.496 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.0 t -88.64 110.69 21.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.803 -0.822 . . . . 0.0 109.563 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.803 HD11 HG21 ' A' ' 114' ' ' ILE . 23.8 tp -69.46 109.99 4.51 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.569 -0.853 . . . . 0.0 108.804 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.51 -25.88 64.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.854 -0.528 . . . . 0.0 110.282 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.1 t -107.04 102.42 42.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.19 130.69 11.29 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 124.077 1.567 . . . . 0.0 109.573 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -152.46 163.13 24.55 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -55.39 128.39 30.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.744 1.391 . . . . 0.0 110.508 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -51.25 -24.91 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.854 -0.529 . . . . 0.0 111.135 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 79.9 p -57.51 -31.33 65.92 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -70.02 -28.81 65.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.48 2.4 37.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.482 -0.761 . . . . 0.0 111.024 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.3 mtpt -66.86 107.81 2.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.37 -8.79 58.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -72.97 -16.61 61.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -1.069 . . . . 0.0 108.427 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.729 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -70.46 151.29 45.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.672 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.45 -10.05 74.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.53 -159.68 4.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.4 Cg_endo -138.73 138.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 O-C-N 123.821 1.432 . . . . 0.0 111.977 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.673 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.0 mt -95.43 95.38 8.4 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 144' ' ' LEU . 6.9 mp -87.21 133.6 33.64 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.629 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.1 p -82.51 -172.46 0.36 Allowed Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.9 Cg_endo -84.24 20.53 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.106 1.056 . . . . 0.0 112.453 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.1 m -100.88 -18.03 16.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.015 -1.053 . . . . 0.0 111.102 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.98 39.94 3.21 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.766 ' CE1' HG22 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -149.93 165.57 32.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 110.871 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.51 120.2 32.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.669 -0.645 . . . . 0.0 109.425 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.766 HG22 ' CE1' ' A' ' 149' ' ' HIS . 2.6 t -99.97 -20.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.662 -0.649 . . . . 0.0 110.888 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . -159.4 140.94 7.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 ' HE1' ' A' ' 175' ' ' MET . 49.5 mt -107.17 118.93 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.146 -1.208 . . . . 0.0 107.792 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.456 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 20.8 t80 -52.69 127.34 22.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.579 0.704 . . . . 0.0 111.957 -178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -116.02 -28.69 6.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.849 -0.532 . . . . 0.0 111.962 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.37 140.9 11.73 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.201 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.456 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.64 134.37 41.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.726 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 38.9 t -89.96 92.44 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.1 p -89.99 109.91 20.92 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.52 1.152 . . . . 0.0 112.364 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.516 ' O ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -97.14 121.76 39.4 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.779 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 59.97 19.93 8.99 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.381 -0.824 . . . . 0.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 102.02 13.61 31.06 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.395 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -144.91 140.03 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 118.684 1.242 . . . . 0.0 109.445 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 129.94 37.48 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.833 0.825 . . . . 0.0 111.603 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.63 14.43 7.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.731 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.21 150.84 2.49 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 116' ' ' VAL . 9.6 m -133.64 135.84 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 119.376 -0.929 . . . . 0.0 112.695 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -102.14 149.08 24.64 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 36.1 p90 -154.74 164.68 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.076 -1.45 . . . . 0.0 112.583 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.855 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -84.61 137.25 38.82 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.59 145.64 14.74 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.582 1.306 . . . . 0.0 111.99 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.58 HG23 ' SD ' ' A' ' 175' ' ' MET . 10.7 p -69.97 -27.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 109.607 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.84 -29.97 65.38 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 m -73.1 -22.9 60.47 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.151 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 172' ' ' VAL . 66.3 mtt -68.72 -40.11 80.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.206 -0.934 . . . . 0.0 108.931 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.07 -39.21 85.25 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.89 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 0.0 110.688 -178.829 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.129 0.49 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.7 t -111.03 119.96 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.54 132.67 40.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.71 -0.619 . . . . 0.0 110.444 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -80.8 138.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.667 HG23 ' CE2' ' A' ' 43' ' ' PHE . 16.5 m -139.99 171.72 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.621 0.724 . . . . 0.0 110.138 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -153.29 153.42 32.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 2.9 t -117.82 75.86 1.03 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.546 1.165 . . . . 0.0 109.358 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.13 -48.69 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -120.7 11.08 11.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.446 -1.408 . . . . 0.0 114.007 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG2' HG23 ' A' ' 38' ' ' THR . 14.7 pt20 -160.01 169.96 22.33 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.593 -1.317 . . . . 0.0 111.746 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.5 m -128.8 152.25 48.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.49 0.662 . . . . 0.0 110.131 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.667 ' CE2' HG23 ' A' ' 36' ' ' VAL . 8.3 p90 -160.5 -145.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 78.2 mt -135.27 165.54 25.21 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.36 -1.462 . . . . 0.0 113.843 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.99 126.84 9.63 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.25 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.4 m -104.94 127.46 52.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.352 -0.843 . . . . 0.0 111.44 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 44.7 t -74.55 121.36 21.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.792 -0.567 . . . . 0.0 109.517 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 172' ' ' VAL . 48.8 t -131.47 130.18 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.912 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.77 39.98 30.95 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.479 -0.763 . . . . 0.0 110.728 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 25.5 75.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.14 122.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -1.011 . . . . 0.0 109.271 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 6.4 t -74.17 139.22 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.409 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.465 ' CE3' HD21 ' A' ' 82' ' ' LEU . 78.2 m95 -136.1 130.02 32.73 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.924 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 8.8 t -139.13 -174.74 3.94 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.635 HG23 ' HA3' ' A' ' 58' ' ' GLY . 13.4 m -87.99 131.83 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.31 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 33.7 t80 -60.03 -41.97 93.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.4 p-80 -69.96 -13.96 62.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.735 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.635 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -97.04 -41.32 3.54 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 83' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.606 -0.938 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.513 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.791 -1.193 . . . . 0.0 109.8 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 122.175 0.988 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 m -130.76 123.59 29.53 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.97 -60.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.433 ' C ' ' CG ' ' A' ' 75' ' ' TYR . 10.8 mmt -92.91 -65.84 0.97 Allowed 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.538 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CG ' ' C ' ' A' ' 74' ' ' MET . 0.1 OUTLIER 174.88 -171.82 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.941 -1.099 . . . . 0.0 112.012 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.895 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.8 m -138.43 117.3 12.38 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -94.37 81.96 4.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 90.2 t -61.06 -40.07 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 109.425 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.02 -26.75 27.99 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 109.075 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -111.82 -2.2 15.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.734 -0.604 . . . . 0.0 110.706 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.94 55.09 3.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 170' ' ' VAL . 42.5 tp -146.95 156.43 43.05 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.903 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.895 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER -144.33 138.71 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' C ' ' CE3' ' A' ' 85' ' ' TRP . . . -136.66 162.28 25.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 118.632 -1.746 . . . . 0.0 113.079 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.76 ' CZ3' HG22 ' A' ' 54' ' ' THR . 2.6 m-90 -148.25 170.12 18.59 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 114.297 -0.951 . . . . 0.0 108.927 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.48 115.38 23.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.984 0 O-C-N 121.612 -0.68 . . . . 0.0 110.746 -179.2 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.732 ' C ' HD22 ' A' ' 94' ' ' LEU . 40.1 p . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.187 0.518 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 93' ' ' SER . 3.2 mm? -120.86 163.83 17.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.57 -0.706 . . . . 0.0 109.673 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 26.3 m -102.01 145.1 29.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.079 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 172' ' ' VAL . 52.5 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 O-C-N 123.751 1.395 . . . . 0.0 110.694 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.045 0.45 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -103.61 19.02 20.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.713 . . . . 0.0 110.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -72.97 67.57 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -0.788 . . . . 0.0 108.943 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 145' ' ' CYS . 88.3 mt -81.71 174.73 11.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.873 -0.517 . . . . 0.0 109.914 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 43.5 p90 -154.06 138.84 17.07 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 142' ' ' PRO . 34.9 tp -113.29 153.85 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.98 0.895 . . . . 0.0 111.603 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 111' ' ' ALA . 98.3 t -110.29 136.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 112' ' ' ASP . 31.6 p -81.76 -178.94 7.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -36.33 -32.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.78 -51.14 2.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.339 -0.85 . . . . 0.0 111.291 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.28 -95.4 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.967 -1.083 . . . . 0.0 111.719 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 108' ' ' THR . 17.2 t0 44.07 70.23 0.34 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.095 -1.003 . . . . 0.0 111.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.7 p -71.78 64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.435 -0.791 . . . . 0.0 109.926 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 126' ' ' LEU . 12.3 pt -70.04 150.03 96.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.522 -0.736 . . . . 0.0 110.073 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -102.05 130.16 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.715 1.376 . . . . 0.0 110.032 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 167' ' ' VAL . 49.1 t -127.45 131.94 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -88.11 117.32 26.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.6 ttm180 -61.8 123.87 19.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.552 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -97.29 1.07 49.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.781 -0.574 . . . . 0.0 109.81 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.86 179.72 43.01 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.6 m-20 -64.84 -23.42 67.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.326 -1.102 . . . . 0.0 110.362 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.0 p -123.2 16.83 9.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.513 -0.742 . . . . 0.0 111.752 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -140.0 142.8 36.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -142.06 140.7 10.25 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.434 ' C ' HG13 ' A' ' 116' ' ' VAL . 5.7 m -89.94 110.02 21.01 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.8 -0.824 . . . . 0.0 110.151 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.749 ' CD1' HD12 ' A' ' 114' ' ' ILE . 31.9 tp -72.98 108.55 5.95 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.18 -28.03 68.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.322 0.582 . . . . 0.0 109.801 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -109.99 103.75 54.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.85 -0.531 . . . . 0.0 110.171 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.37 140.54 36.99 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.877 1.461 . . . . 0.0 109.955 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -147.09 159.26 43.18 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.18 124.41 14.77 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.898 1.473 . . . . 0.0 110.361 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.13 -26.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.328 0.585 . . . . 0.0 110.685 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -38.3 82.28 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 108' ' ' THR . 48.7 t80 -69.32 -27.53 65.45 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.69 2.76 36.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.783 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -68.65 109.6 3.87 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.77 -8.87 58.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.8 t -76.1 -15.69 60.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -1.005 . . . . 0.0 109.079 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.22 154.64 41.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.235 -0.916 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.99 -8.48 79.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.92 -159.04 6.89 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.637 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.96 148.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 116.588 -1.808 . . . . 0.0 112.582 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 1.8 mt -99.49 98.27 9.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 4.6 mm? -82.14 137.07 35.06 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.133 0.968 . . . . 0.0 113.182 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.565 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -66.62 -161.48 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.017 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -92.16 17.27 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.714 1.376 . . . . 0.0 110.978 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -138.74 25.82 2.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.122 -0.986 . . . . 0.0 111.962 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.11 37.96 59.66 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.42 ' HB2' ' HB2' ' A' ' 145' ' ' CYS . 12.0 m-70 -118.91 118.91 32.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.559 -0.965 . . . . 0.0 110.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.49 125.12 29.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 0.0 109.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.03 -6.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.92 130.31 2.8 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.263 -1.446 . . . . 0.0 111.509 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.574 HD12 ' CE ' ' A' ' 175' ' ' MET . 70.3 mt -109.25 116.06 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.436 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 18.7 t80 -51.87 128.66 24.65 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.6 -0.688 . . . . 0.0 112.272 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' VAL . 35.3 ptt180 -119.44 -24.48 6.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.702 -0.624 . . . . 0.0 112.308 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.2 139.12 11.86 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.269 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.36 136.72 39.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.769 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.979 HG11 ' HB3' ' A' ' 166' ' ' ALA . 7.3 p -102.99 98.88 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.0 p -93.47 123.53 36.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.209 1.004 . . . . 0.0 111.278 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 161' ' ' ARG . 93.9 m -86.38 -70.02 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.119 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.535 ' HG3' HG22 ' A' ' 160' ' ' THR . 89.9 mtt180 -104.19 26.18 9.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.475 -0.765 . . . . 0.0 110.206 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 107.69 10.27 27.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.8 m -141.26 138.93 33.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.515 ' O ' HD23 ' A' ' 126' ' ' LEU . . . -80.1 114.11 18.77 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.667 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -96.95 11.54 35.62 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.606 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.979 ' HB3' HG11 ' A' ' 158' ' ' VAL . . . -167.77 154.49 8.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 116' ' ' VAL . 17.4 m -128.58 140.02 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.947 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -107.46 146.45 31.74 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 38.7 p90 -152.98 165.09 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.999 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 82' ' ' LEU . 58.4 t -83.37 137.64 42.15 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.831 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.94 146.22 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.78 1.411 . . . . 0.0 110.747 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 96' ' ' PRO . 14.7 p -70.03 -29.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.67 . . . . 0.0 109.61 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.32 -29.54 65.99 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.7 m -73.42 -24.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.8 -0.562 . . . . 0.0 110.234 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.574 ' CE ' HD12 ' A' ' 153' ' ' ILE . 64.3 mtt -65.67 -46.2 80.01 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.06 -41.07 91.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.301 0.572 . . . . 0.0 109.959 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.624 -0.673 . . . . 0.0 110.965 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.1 t -110.03 120.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.424 ' NE2' ' SG ' ' A' ' 47' ' ' CYS . 78.7 mt-30 -100.01 124.36 45.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.805 -0.559 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.29 133.84 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.42 174.53 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.891 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.3 m -147.99 126.48 12.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.741 HG21 ' O ' ' A' ' 59' ' ' ALA . 10.0 t -106.34 -179.14 3.85 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.49 -16.89 4.28 Favored 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.823 -0.548 . . . . 0.0 112.377 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.616 ' H ' HG23 ' A' ' 38' ' ' THR . 74.4 p -102.49 -34.85 8.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.036 -1.04 . . . . 0.0 113.245 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -172.83 -169.17 0.55 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.776 -1.203 . . . . 0.0 112.756 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.2 p -116.71 145.3 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HE1' HG22 ' A' ' 38' ' ' THR . 11.1 p90 -162.02 -143.86 0.09 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.21 -0.931 . . . . 0.0 110.802 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 109' ' ' ARG . 44.1 mt -129.06 161.77 29.23 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.618 -1.301 . . . . 0.0 114.0 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.3 123.61 7.08 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.759 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.905 ' CG2' HD11 ' A' ' 153' ' ' ILE . 9.7 t -80.47 -156.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.424 ' SG ' ' NE2' ' A' ' 34' ' ' GLN . 23.4 m -153.16 112.42 3.81 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.0 137.03 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.104 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 m120 50.58 39.45 21.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.577 -0.702 . . . . 0.0 111.163 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 26.59 74.41 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.587 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 55.6 t -137.6 118.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -1.009 . . . . 0.0 110.218 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 27.7 t -75.53 120.08 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 89.1 m95 -106.74 128.74 54.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.03 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.73 ' O ' HD12 ' A' ' 82' ' ' LEU . 15.0 t -134.5 -177.76 4.75 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.658 HG23 ' HA3' ' A' ' 58' ' ' GLY . 6.4 m -89.52 125.47 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.792 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.0 -41.88 93.07 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.584 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 26.1 p-80 -66.04 -34.42 78.04 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.437 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -71.23 -34.23 64.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.741 ' O ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.681 -0.894 . . . . 0.0 110.14 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' CE2' ' A' ' 85' ' ' TRP 0.254 11.8 tp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.077 -1.015 . . . . 0.0 109.607 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.441 HG22 ' HD1' ' A' ' 85' ' ' TRP . 72.6 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.9 m -93.62 127.8 39.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.644 -0.66 . . . . 0.0 110.102 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 4.0 pt20 -64.88 163.9 13.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.619 -0.676 . . . . 0.0 110.146 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -93.51 -40.08 10.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -155.72 -176.65 6.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.862 HG23 ' CG1' ' A' ' 83' ' ' VAL . 57.6 m -152.01 123.5 7.82 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.787 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 27.8 t-20 -93.77 77.84 4.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.0 -40.1 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.681 -0.637 . . . . 0.0 109.686 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -55.25 -25.8 35.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -112.41 -0.61 15.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.74 -0.6 . . . . 0.0 110.906 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 60.04 56.77 3.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.046 -1.034 . . . . 0.0 109.321 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 54' ' ' THR . 40.3 tp -144.37 154.53 43.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.984 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.862 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -142.05 133.26 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.93 123.21 5.54 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.319 -1.419 . . . . 0.0 112.058 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.897 ' CE2' HD22 ' A' ' 64' ' ' LEU . 3.6 m-90 -88.25 -171.7 3.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.063 -0.669 . . . . 0.0 109.395 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -100.01 111.94 24.24 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.948 0 O-C-N 121.446 -0.784 . . . . 0.0 111.85 -178.052 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.695 ' C ' HD22 ' A' ' 94' ' ' LEU . 41.5 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.575 0.702 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 148' ' ' GLY . 4.4 mm? -115.95 170.93 8.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 164.05 37.12 Favored Pre-proline 0 N--CA 1.495 1.822 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.19 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.316 -1.176 0 O-C-N 123.923 1.486 . . . . 0.0 109.436 179.416 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -102.67 9.86 38.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.554 -0.716 . . . . 0.0 111.438 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -71.97 75.73 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 108.584 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 97.8 mt -78.96 174.67 11.3 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.389 0.614 . . . . 0.0 111.138 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 77.5 m-85 -144.37 127.3 16.41 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.479 HD13 ' HG ' ' A' ' 143' ' ' LEU . 38.1 tp -115.07 153.56 30.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.923 0.868 . . . . 0.0 111.841 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 111' ' ' ALA . 97.7 t -119.17 135.17 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.595 ' C ' HD11 ' A' ' 44' ' ' LEU . 68.8 p -85.22 175.28 9.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.132 -0.98 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 44' ' ' LEU . 63.8 ttt180 -37.16 -34.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 121.172 0.51 . . . . 0.0 112.056 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -100.15 -70.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.41 -80.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.864 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.568 ' HB3' HG23 ' A' ' 108' ' ' THR . 11.4 t70 46.6 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.593 -0.692 . . . . 0.0 111.595 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.69 107.67 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.249 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 126' ' ' LEU . 23.6 pt -130.95 159.99 68.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.7 -0.625 . . . . 0.0 109.731 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.431 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.9 Cg_endo -106.88 134.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.966 1.508 . . . . 0.0 111.224 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 167' ' ' VAL . 46.6 t -124.23 130.07 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -89.13 115.34 26.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.494 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 28.4 ttp85 -59.91 126.18 26.57 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.237 -0.915 . . . . 0.0 110.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -103.3 8.09 38.29 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.676 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.65 43.84 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 12.0 p-10 -59.96 -36.39 77.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -1.067 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -121.09 19.18 11.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.882 -0.511 . . . . 0.0 112.091 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -131.24 141.05 49.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.974 -1.079 . . . . 0.0 110.558 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.76 143.54 13.54 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -92.06 110.12 21.48 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 122.097 -0.649 . . . . 0.0 110.02 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 114' ' ' ILE . 45.3 tp -72.67 109.89 6.63 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.993 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.7 -31.03 69.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.457 0.646 . . . . 0.0 109.596 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -105.88 107.92 60.54 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.88 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.56 143.28 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.84 1.442 . . . . 0.0 110.357 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -148.36 160.01 37.77 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -60.36 126.24 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.842 1.443 . . . . 0.0 110.4 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.08 -26.12 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.75 -0.594 . . . . 0.0 110.675 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.6 m -59.31 -34.66 72.59 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.881 0.848 . . . . 0.0 109.212 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -73.82 -26.78 60.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.514 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.27 -4.82 58.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 112.939 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.88 66.59 1.55 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.647 1.213 . . . . 0.0 109.025 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 174.51 -26.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.683 ' HA ' HD12 ' A' ' 44' ' ' LEU . 3.8 t -72.57 -9.1 58.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.395 -1.062 . . . . 0.0 111.841 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.524 ' HB3' HG11 ' A' ' 55' ' ' VAL . 7.1 m -58.6 142.31 49.72 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.869 -1.145 . . . . 0.0 109.559 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.59 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 90.47 -9.86 76.26 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.02 157.06 53.56 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.4 Cg_endo -103.01 138.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.92 1.484 . . . . 0.0 112.799 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.479 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.9 mp -100.16 98.81 9.47 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.6 mp -87.64 147.81 25.1 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.028 0.918 . . . . 0.0 113.064 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -158.86 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -99.69 16.61 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.69 1.363 . . . . 0.0 110.732 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.4 p -127.42 0.14 6.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.156 -0.965 . . . . 0.0 112.271 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 94' ' ' LEU . . . 99.94 39.97 3.21 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -125.75 121.84 34.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -1.122 . . . . 0.0 110.791 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.94 101.51 12.41 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.07 7.13 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 0.0 112.237 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -156.58 134.74 4.17 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.905 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.1 mt -118.66 122.63 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.385 -1.068 . . . . 0.0 108.398 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -50.86 128.56 21.35 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.894 0.854 . . . . 0.0 112.326 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.55 ' HB2' HG23 ' A' ' 170' ' ' VAL . 34.2 ttt180 -116.78 -29.77 5.95 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.872 -0.518 . . . . 0.0 110.751 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.421 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.93 153.21 10.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -107.15 141.49 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.812 -0.555 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 30.5 t -94.5 93.42 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.6 p -91.8 115.78 28.34 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.383 1.087 . . . . 0.0 112.704 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 162' ' ' GLY . 22.1 m -92.02 120.28 32.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 160' ' ' THR . 14.8 ttm180 65.3 -67.67 0.12 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.986 -0.446 . . . . 0.0 109.892 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.452 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -161.7 24.49 0.23 Allowed Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.686 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 34.6 m -150.01 143.18 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -1.205 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.0 130.0 35.06 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.663 0.744 . . . . 0.0 111.547 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -125.58 16.42 8.18 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.39 150.02 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 116' ' ' VAL . 13.3 m -130.29 137.67 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.27 -0.972 . . . . 0.0 113.013 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -104.32 145.51 30.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 29.5 p90 -152.98 161.9 41.98 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.243 -1.383 . . . . 0.0 112.541 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.583 HG11 HD22 ' A' ' 82' ' ' LEU . 75.7 t -79.41 139.87 55.8 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.979 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.37 156.74 12.62 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.683 1.36 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.03 -25.71 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.64 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.89 -26.74 66.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 108.964 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.8 p -75.47 -33.07 60.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 110.348 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.571 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.1 mpp? -66.92 -48.46 68.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.724 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 177' ' ' THR . 12.5 pt-20 -62.4 -40.4 96.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.555 -0.715 . . . . 0.0 110.441 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 173' ' ' GLU . 33.8 p . . . . . 0 N--CA 1.498 1.937 0 O-C-N 121.602 -0.686 . . . . 0.0 109.962 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.87 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.3 pt-20 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 120.718 0.294 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' A' ' 32' ' ' GLU . 62.5 t -114.56 119.99 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 0.0 109.454 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -102.94 121.98 43.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 0.0 111.353 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 44' ' ' LEU . 78.3 t -83.96 130.82 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.31 175.1 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.879 0.847 . . . . 0.0 110.818 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -138.41 129.43 26.95 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.724 0.773 . . . . 0.0 109.309 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.1 p -110.9 -179.08 3.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -17.22 9.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.61 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.5 p -101.33 -41.12 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 112.278 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -175.61 -162.51 0.1 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 121.033 -1.042 . . . . 0.0 111.457 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.8 m -121.76 146.93 46.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.707 -0.621 . . . . 0.0 109.371 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.4 p90 -160.71 -141.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.624 -0.673 . . . . 0.0 109.764 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 138' ' ' SER . 61.0 mt -130.79 161.0 32.72 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.489 -1.382 . . . . 0.0 114.271 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.446 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.58 120.2 4.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.693 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER -85.75 -159.99 0.5 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.146 -0.971 . . . . 0.0 110.162 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' H ' HG22 ' A' ' 46' ' ' THR . 39.1 t -149.98 113.14 4.89 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.04 129.95 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.058 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 51.78 40.0 26.76 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.653 -0.654 . . . . 0.0 110.715 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 26.53 74.23 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 41.5 t -133.86 111.9 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -1.077 . . . . 0.0 109.616 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 29.3 t -75.47 129.53 37.42 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 84.7 m95 -118.58 129.27 55.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.55 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.585 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 12.5 t -135.72 179.7 6.18 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 140' ' ' GLY . 12.3 m -88.66 133.33 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.696 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.819 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -59.97 -42.5 94.29 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 46.9 p-80 -74.0 69.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.22 -35.85 0.08 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.496 -1.003 . . . . 0.0 108.79 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.434 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.844 -1.16 . . . . 0.0 110.239 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.685 HG22 ' HD1' ' A' ' 85' ' ' TRP . 40.3 mt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 6.2 m -94.83 144.79 25.36 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.71 0.766 . . . . 0.0 111.596 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 85' ' ' TRP . 3.6 pt20 -78.45 160.34 27.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.872 -0.518 . . . . 0.0 111.2 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.9 mmm -93.34 -39.61 10.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.662 -0.649 . . . . 0.0 109.609 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 -176.37 5.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.73 . . . . 0.0 109.516 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.897 HG23 ' CG1' ' A' ' 83' ' ' VAL . 8.4 m -149.94 118.71 6.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.726 -0.609 . . . . 0.0 109.384 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.1 t30 -91.67 77.26 5.64 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.02 -38.14 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.734 -0.604 . . . . 0.0 109.42 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -54.73 -25.98 31.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -115.91 1.28 13.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.696 -0.627 . . . . 0.0 111.139 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t70 60.03 59.99 2.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.969 -1.082 . . . . 0.0 108.971 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 175' ' ' MET . 27.4 tp -147.04 152.5 38.66 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.597 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.897 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.18 130.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.35 127.07 5.94 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.12 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.685 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.9 m-90 -90.4 178.47 6.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.19 84.05 2.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.299 -0.875 . . . . 0.0 108.709 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.418 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.581 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.375 0.607 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 144' ' ' LEU . 91.0 mt -82.74 164.07 20.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 95.2 m -115.98 153.73 48.31 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 O-C-N 123.404 1.213 . . . . 0.0 111.023 -179.653 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -97.01 17.04 17.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.602 -0.686 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -71.49 73.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.72 175.12 10.23 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.33 0.586 . . . . 0.0 110.342 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -141.7 120.61 12.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 154' ' ' PHE . 22.0 tp -100.09 140.2 34.66 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.503 0.668 . . . . 0.0 110.233 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.669 HG21 HG21 ' A' ' 33' ' ' VAL . 83.8 t -91.75 120.05 40.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.344 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -84.63 173.31 10.86 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -38.84 -31.73 0.07 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.983 -0.448 . . . . 0.0 112.195 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -100.26 -69.25 0.78 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.828 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 -162.35 1.53 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' HG22 ' A' ' 107' ' ' VAL . 84.6 m-20 -60.34 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.181 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 113' ' ' VAL . 48.9 t 50.87 22.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.312 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -171.27 117.05 0.44 Allowed Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.011 -1.056 . . . . 0.0 110.299 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -98.91 145.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.748 1.393 . . . . 0.0 109.357 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 126' ' ' LEU . 47.5 t -133.97 139.55 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 111.073 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -97.06 120.26 37.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 8.4 ttp180 -60.02 125.2 22.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 111.063 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -101.68 5.37 41.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.707 -0.621 . . . . 0.0 109.419 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.07 34.77 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 26.9 t0 -58.48 -22.93 56.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.473 -1.016 . . . . 0.0 110.634 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -124.61 17.15 8.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.529 -0.732 . . . . 0.0 111.361 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -139.99 144.55 37.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.045 -1.034 . . . . 0.0 110.953 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.79 141.07 10.64 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.0 t -88.67 112.03 22.63 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.926 -0.75 . . . . 0.0 109.954 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 129' ' ' PRO . 38.5 tp -72.89 107.36 5.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.18 -19.92 65.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.809 -0.557 . . . . 0.0 110.535 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.0 m -122.45 79.99 46.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.672 -0.643 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.655 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.0 Cg_endo -58.51 150.4 68.95 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 O-C-N 123.771 1.406 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -151.14 163.07 24.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.55 122.56 11.97 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 O-C-N 123.774 1.407 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.72 -25.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.808 -0.558 . . . . 0.0 111.524 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.3 m -59.58 -39.97 85.86 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.608 0.718 . . . . 0.0 109.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.94 -27.08 64.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.3 1.65 47.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.0 111.644 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.23 66.01 1.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.989 -1.07 . . . . 0.0 109.029 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.1 -24.4 0.08 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' LEU . 83.1 p -70.59 -13.77 62.22 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.53 -0.982 . . . . 0.0 111.65 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.545 ' HB3' HG11 ' A' ' 55' ' ' VAL . 6.9 m -60.97 141.93 56.91 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.973 -1.079 . . . . 0.0 109.833 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.622 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.02 -9.98 75.51 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.35 -161.44 0.49 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.509 ' HB2' HD11 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -146.36 137.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 116.282 -2.012 . . . . 0.0 112.277 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.4 mt -95.09 96.52 9.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.7 mp -87.68 145.14 26.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.0 m -67.92 174.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.69 -2.03 11.91 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.655 1.345 . . . . 0.0 111.695 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.1 m -103.3 0.07 30.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.974 -1.079 . . . . 0.0 112.085 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.26 36.24 5.24 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 77.3 m80 -121.16 124.04 43.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -1.121 . . . . 0.0 110.902 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.41 22.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.765 -0.584 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.8 1.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 111.839 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -155.0 136.65 5.25 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 20.2 mt -119.83 120.05 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.0 t80 -50.14 127.6 17.24 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.903 0.859 . . . . 0.0 113.28 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 170' ' ' VAL . 38.7 ttt-85 -116.67 -28.64 6.32 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.741 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.89 151.21 10.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.112 -0.993 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.59 146.73 29.27 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.669 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 58.6 t -90.06 94.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 83.5 m -91.57 119.2 31.28 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.258 1.028 . . . . 0.0 112.711 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.625 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.3 m -120.04 132.59 55.52 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.989 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 56.78 23.79 8.38 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.04 19.31 51.35 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.818 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 160' ' ' THR . 34.9 m -147.15 143.85 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.015 -1.285 . . . . 0.0 109.564 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.93 126.03 30.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 111.26 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -118.82 15.74 13.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.295 0.569 . . . . 0.0 110.051 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.669 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.19 149.05 1.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.607 ' CG2' HG11 ' A' ' 116' ' ' VAL . 15.6 m -124.01 135.42 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.03 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -106.08 149.32 26.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.9 p90 -154.53 163.96 39.41 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.267 -1.373 . . . . 0.0 112.791 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 155' ' ' ARG . 63.0 t -80.27 141.56 53.71 Favored Pre-proline 0 N--CA 1.498 1.945 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.79 151.21 14.55 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.702 1.369 . . . . 0.0 110.754 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -73.16 -30.04 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.654 -0.654 . . . . 0.0 110.136 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.93 -32.95 70.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.43 -0.794 . . . . 0.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.9 m -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.884 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.532 ' CG ' HD21 ' A' ' 82' ' ' LEU . 4.8 mtp -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.692 -0.63 . . . . 0.0 109.911 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -61.41 -40.01 92.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.436 -0.79 . . . . 0.0 111.592 -179.091 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.218 0.532 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG22 ' HD1' ' A' ' 85' ' ' TRP . 94.5 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.136 0.493 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 4.4 pp0? -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.093 0.473 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.4 pt-20 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.153 0.502 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 ' HG3' ' A' ' 142' ' ' PRO . 46.8 t -109.89 140.01 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -0.762 . . . . 0.0 109.653 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -138.83 147.76 42.88 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.574 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -86.0 130.52 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.337 0.589 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.68 HG23 ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -132.67 159.99 42.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.7 -0.625 . . . . 0.0 109.603 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 m -141.56 149.93 41.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 2.4 t -115.42 76.77 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.498 1.142 . . . . 0.0 109.755 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.3 -48.9 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -120.06 9.72 11.26 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.405 -1.434 . . . . 0.0 113.851 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.36 170.52 19.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.646 -1.284 . . . . 0.0 111.703 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -127.75 154.36 45.46 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.496 0.665 . . . . 0.0 109.825 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.68 ' CE2' HG23 ' A' ' 36' ' ' VAL . 10.0 p90 -162.95 -145.8 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -135.69 161.71 34.77 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.488 -1.383 . . . . 0.0 112.852 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.98 130.4 13.83 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 21.8 m -112.42 125.29 54.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.364 -0.835 . . . . 0.0 111.453 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 27.5 p -74.16 130.14 39.19 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.493 0.663 . . . . 0.0 110.784 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.658 HG11 HG23 ' A' ' 172' ' ' VAL . 44.8 t -140.34 137.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 52.09 37.88 22.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.387 -0.821 . . . . 0.0 110.785 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.74 28.06 72.52 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG22 ' SD ' ' A' ' 74' ' ' MET . 89.2 t -138.94 120.02 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.487 -1.008 . . . . 0.0 109.812 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 33.9 m -72.43 129.31 38.05 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 73.3 m95 -122.9 133.28 54.41 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.8 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.821 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 3.7 t -140.57 -179.21 5.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.734 HG23 ' HA3' ' A' ' 58' ' ' GLY . 4.8 m -88.81 128.29 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 C-N-CA 118.146 -1.422 . . . . 0.0 111.895 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.705 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 88.3 t80 -59.98 -40.08 87.91 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.501 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 43.1 p-80 -67.8 -20.06 65.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.487 -1.285 . . . . 0.0 108.518 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.734 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -85.51 -35.25 12.13 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.196 -2.362 . . . . 0.0 107.196 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.742 -0.858 . . . . 0.0 109.08 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 108.285 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.421 ' O ' HD23 ' A' ' 64' ' ' LEU . 72.1 mt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 122.265 1.031 . . . . 0.0 111.821 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -137.1 126.67 25.22 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 85' ' ' TRP . 97.7 mm-40 -138.3 -71.67 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 51' ' ' VAL . 29.6 mtt -87.67 -64.68 1.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -171.56 -168.15 0.58 Allowed 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.182 -176.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.875 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.5 m -149.75 115.3 5.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.618 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 3.0 t-20 -99.04 83.58 2.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.182 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.705 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 61.0 t -63.96 -37.4 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.427 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.77 -27.13 27.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.593 -0.692 . . . . 0.0 109.254 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.18 -1.78 14.27 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.675 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.6 t70 61.23 54.97 3.09 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 108.672 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 170' ' ' VAL . 16.6 tp -147.12 148.83 31.98 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.875 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -142.87 139.93 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 108.87 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 74' ' ' MET . . . -131.29 133.24 7.14 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 118.931 -1.604 . . . . 0.0 110.882 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.821 ' CZ3' HG22 ' A' ' 54' ' ' THR . 21.0 m-90 -106.96 -160.83 0.75 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 73' ' ' GLN . 66.7 tt0 -116.18 113.39 23.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.038 0 O-C-N 121.543 -0.723 . . . . 0.0 110.961 -178.691 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.386 0.612 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 150' ' ' ALA . 68.2 mt -96.6 165.34 12.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.7 168.05 8.46 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.615 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.486 1.039 0 O-C-N 124.003 1.528 . . . . 0.0 109.869 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.7 m -105.02 -2.52 24.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.75 76.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.017 -1.052 . . . . 0.0 109.17 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.1 mt -84.37 174.69 9.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.744 0.783 . . . . 0.0 111.845 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 93.7 m-85 -146.39 130.96 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 138' ' ' SER . 43.9 tp -112.73 152.69 28.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.012 0.91 . . . . 0.0 111.759 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.6 t -109.95 131.09 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.448 ' C ' HD11 ' A' ' 44' ' ' LEU . 80.0 p -81.94 169.06 17.23 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.455 -0.778 . . . . 0.0 110.283 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.531 ' HA ' HD21 ' A' ' 44' ' ' LEU . 58.6 ttp180 -34.0 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -98.76 -85.29 0.38 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.34 5.34 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 113.06 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.07 137.91 57.99 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.561 -1.337 . . . . 0.0 109.956 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.27 120.05 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 0.0 110.319 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 128' ' ' SER . 6.1 tt -120.01 112.43 34.89 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 109.577 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 45.5 Cg_endo -62.55 132.07 36.44 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.596 1.314 . . . . 0.0 111.487 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.692 HG22 HD12 ' A' ' 126' ' ' LEU . 48.7 t -129.93 134.18 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -91.07 119.99 31.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 108.769 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 ttm180 -58.71 124.28 19.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.922 . . . . 0.0 110.958 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -99.58 3.44 45.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 109.634 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.31 45.96 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.5 m-20 -63.41 -27.09 69.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -1.084 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.2 p -123.49 18.67 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.6 -0.688 . . . . 0.0 111.808 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -138.52 145.83 41.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.089 -1.007 . . . . 0.0 111.378 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.53 142.17 12.11 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.455 ' C ' HG13 ' A' ' 116' ' ' VAL . 13.7 t -90.4 110.01 21.12 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.872 -0.781 . . . . 0.0 110.227 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.692 HD12 HG22 ' A' ' 116' ' ' VAL . 31.0 tp -70.36 108.42 4.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.51 -35.41 75.89 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.585 0.707 . . . . 0.0 109.732 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 114' ' ' ILE . 47.3 t -110.87 107.82 57.82 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.254 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.45 148.17 37.59 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 O-C-N 123.873 1.46 . . . . 0.0 109.899 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -150.02 160.96 32.54 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.91 124.3 15.67 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.858 1.451 . . . . 0.0 110.441 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.01 -27.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.268 0.556 . . . . 0.0 110.806 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.4 m -57.47 -30.88 65.42 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.823 0.82 . . . . 0.0 109.23 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -74.09 -29.05 61.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.383 -0.823 . . . . 0.0 109.125 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.05 -1.42 57.95 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.6 65.85 1.35 Allowed 'General case' 0 N--CA 1.513 2.68 0 O-C-N 120.8 -1.188 . . . . 0.0 109.369 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 173.6 -25.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 44' ' ' LEU . 8.2 t -70.32 -12.58 61.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -1.056 . . . . 0.0 111.316 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.442 ' HB3' HG11 ' A' ' 55' ' ' VAL . 11.1 m -59.92 140.4 56.72 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.621 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 88.93 -7.98 80.83 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.06 -158.21 0.74 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.799 ' HG3' HG22 ' A' ' 33' ' ' VAL . 58.6 Cg_endo -143.32 140.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 116.356 -1.963 . . . . 0.0 112.077 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' HD22 ' A' ' 104' ' ' LEU . 2.5 mt -99.93 96.25 7.43 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -86.93 132.58 33.77 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.816 0.817 . . . . 0.0 112.737 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.25 -161.44 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -98.85 15.78 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.666 1.351 . . . . 0.0 110.15 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.434 ' HB3' ' CD2' ' A' ' 149' ' ' HIS . 2.0 m -120.33 12.4 11.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.209 -0.932 . . . . 0.0 112.047 -179.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.38 20.64 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.94 -1.1 . . . . 0.0 110.488 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.434 ' CD2' ' HB3' ' A' ' 147' ' ' SER . 90.8 m-70 -127.15 128.75 46.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 0.0 110.639 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -92.61 100.13 12.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.99 6.79 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.177 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -149.95 124.43 1.76 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.278 -1.439 . . . . 0.0 111.462 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.619 HD12 ' CE ' ' A' ' 175' ' ' MET . 22.6 mt -109.98 120.07 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.24 . . . . 0.0 107.984 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.485 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.5 t80 -52.56 128.83 27.29 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.673 0.749 . . . . 0.0 112.495 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.3 ttp180 -116.27 -28.19 6.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.851 -0.53 . . . . 0.0 110.993 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.3 151.0 9.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.2 -0.938 . . . . 0.0 111.836 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.485 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.73 145.31 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.824 -0.547 . . . . 0.0 111.331 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 49.0 t -93.43 91.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.3 p -94.59 113.84 25.72 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.667 1.222 . . . . 0.0 112.625 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' GLY . 62.8 m -98.57 133.31 43.1 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 160' ' ' THR . 19.8 ttp180 63.45 -72.43 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -164.39 25.83 0.19 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.95 144.02 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.056 -1.261 . . . . 0.0 109.569 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.18 127.59 32.23 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.592 0.71 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -118.35 14.89 13.88 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.176 0.512 . . . . 0.0 110.04 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.72 146.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.686 HG21 HG11 ' A' ' 116' ' ' VAL . 14.7 m -121.12 135.39 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.729 0.776 . . . . 0.0 112.464 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -103.39 147.14 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 36.2 p90 -156.14 161.26 40.37 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.306 -1.358 . . . . 0.0 112.757 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 155' ' ' ARG . 62.9 t -87.55 130.34 47.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.863 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -79.23 156.69 26.01 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.658 HG23 HG11 ' A' ' 48' ' ' VAL . 14.1 p -70.06 -29.94 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -59.47 -27.63 66.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -75.04 -25.99 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.706 -0.621 . . . . 0.0 110.236 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 153' ' ' ILE . 55.4 mtt -64.65 -50.07 68.52 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.91 -45.11 94.05 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.495 1.814 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.756 -179.495 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.845 ' HG2' HD21 ' A' ' 94' ' ' LEU . 24.7 mp0 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.156 0.503 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.3 t -107.58 121.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.673 -0.642 . . . . 0.0 109.755 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -91.61 127.96 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.71 127.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.49 173.99 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.36 -0.838 . . . . 0.0 110.38 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 8.2 t -150.1 141.99 23.81 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.822 0.82 . . . . 0.0 109.081 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 58' ' ' GLY . 6.2 t -117.48 179.34 4.08 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -18.48 1.51 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.505 ' H ' HG23 ' A' ' 38' ' ' THR . 67.5 p -104.55 -31.09 9.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.995 -1.066 . . . . 0.0 113.595 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -171.88 -169.14 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.588 -1.32 . . . . 0.0 113.183 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 53.6 m -118.4 145.71 44.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.668 ' HE1' HG22 ' A' ' 38' ' ' THR . 10.2 p90 -161.12 -145.2 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.384 -0.822 . . . . 0.0 110.71 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt -134.08 160.66 37.11 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.629 -1.294 . . . . 0.0 113.287 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.484 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -150.18 126.72 10.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.068 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.581 HG21 ' HB3' ' A' ' 142' ' ' PRO . 59.3 m -96.74 127.28 42.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.115 -0.99 . . . . 0.0 111.743 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 22.3 m -76.32 123.82 26.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.854 -0.529 . . . . 0.0 110.434 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.52 130.01 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.54 -0.725 . . . . 0.0 110.19 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 m120 50.37 39.92 21.55 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.355 -0.84 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.34 26.16 74.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.19 113.86 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -1.029 . . . . 0.0 109.556 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.5 t -75.65 119.97 20.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.73 -0.606 . . . . 0.0 109.399 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 86.7 m95 -107.68 123.45 48.53 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.88 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -127.62 -179.87 5.15 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 139' ' ' SER . 10.5 m -90.22 124.99 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 C-N-CA 118.194 -1.403 . . . . 0.0 111.999 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.412 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.438 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.4 p-80 -73.02 68.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.119 0.962 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 38' ' ' THR . . . 168.57 -49.31 0.22 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.71 -0.876 . . . . 0.0 109.753 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.466 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.762 0 O-C-N 120.743 -1.223 . . . . 0.0 110.712 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.748 HG22 ' HD1' ' A' ' 85' ' ' TRP . 27.0 mt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.666 0.746 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -99.94 140.34 34.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.922 -0.486 . . . . 0.0 110.534 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.3 pt20 -72.19 156.05 39.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.524 -0.735 . . . . 0.0 110.416 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -95.35 -35.51 11.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.499 0.666 . . . . 0.0 109.27 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -159.26 -177.02 6.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.906 HG23 HG13 ' A' ' 83' ' ' VAL . 89.4 m -150.48 122.49 8.22 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.653 -0.654 . . . . 0.0 109.565 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.79 76.41 2.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.04 -39.91 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.651 -0.655 . . . . 0.0 109.71 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -54.95 -26.09 33.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -110.48 -2.58 16.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.703 -0.623 . . . . 0.0 110.794 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 60.01 54.97 3.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.907 -1.121 . . . . 0.0 108.372 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD21 ' CG ' ' A' ' 175' ' ' MET . 8.1 tp -147.33 153.57 39.86 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.839 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -144.18 141.2 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -124.14 122.01 4.65 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.094 -1.527 . . . . 0.0 111.877 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.88 ' CZ3' HG22 ' A' ' 54' ' ' THR . 6.9 m-90 -90.99 -170.24 2.61 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -101.83 112.72 25.43 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.421 -0.799 . . . . 0.0 110.48 -179.336 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.46 0.648 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 144' ' ' LEU . 73.4 mt -109.37 158.61 17.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.919 -0.488 . . . . 0.0 109.927 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.2 p -101.1 149.98 36.71 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.475 -0.766 . . . . 0.0 110.662 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.49 1.283 0 O-C-N 123.834 1.439 . . . . 0.0 110.637 -179.393 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.114 0.483 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.0 m -98.42 4.88 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.586 -0.696 . . . . 0.0 111.439 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -70.56 73.8 0.54 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 145' ' ' CYS . 89.8 mt -83.53 175.56 9.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.584 0.707 . . . . 0.0 111.085 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 89.6 m-85 -143.54 123.96 13.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -100.6 141.07 33.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 110.925 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.424 ' CB ' HG21 ' A' ' 33' ' ' VAL . 53.5 t -89.89 120.27 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.919 -0.488 . . . . 0.0 109.693 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 p -85.27 176.74 8.14 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.622 -0.674 . . . . 0.0 109.221 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -42.73 -29.19 0.29 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.052 0.453 . . . . 0.0 111.654 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.52 -67.92 0.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.552 -0.717 . . . . 0.0 110.091 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.31 -163.09 1.7 Allowed 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.474 -0.766 . . . . 0.0 109.546 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -55.55 -71.95 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.668 -0.645 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.736 HG11 ' OH ' ' A' ' 134' ' ' TYR . 33.6 t 65.41 -52.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 126' ' ' LEU . 44.7 pt -118.9 149.96 47.66 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.72 -1.237 . . . . 0.0 112.087 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 53.8 Cg_endo -111.07 156.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.721 1.379 . . . . 0.0 109.736 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.656 HG11 ' CG2' ' A' ' 167' ' ' VAL . 39.4 t -139.05 139.97 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -95.68 116.02 28.27 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.9 ttm180 -58.06 125.51 23.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.946 . . . . 0.0 111.379 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -96.89 -2.67 43.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.42 -176.28 44.71 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 94.1 m-20 -70.01 -18.5 63.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.293 -1.122 . . . . 0.0 110.243 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.6 p -120.17 14.23 12.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.493 -0.754 . . . . 0.0 111.916 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -148.98 147.57 28.74 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.059 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.37 138.57 9.12 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.4 t -88.89 109.98 20.69 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.833 -0.804 . . . . 0.0 110.265 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.549 HD11 HD12 ' A' ' 114' ' ' ILE . 51.8 tp -73.67 109.01 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.64 -19.75 65.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.693 -0.63 . . . . 0.0 110.392 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -119.96 79.97 25.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.669 -0.644 . . . . 0.0 110.212 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.9 Cg_endo -57.68 146.99 82.51 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.681 1.359 . . . . 0.0 110.087 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -154.13 168.5 11.69 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.696 -0.627 . . . . 0.0 109.659 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.39 124.93 15.68 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.943 1.496 . . . . 0.0 110.077 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.75 -24.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.813 -0.555 . . . . 0.0 111.923 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.3 p -57.5 -34.25 68.88 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.398 -0.814 . . . . 0.0 109.514 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.736 ' OH ' HG11 ' A' ' 113' ' ' VAL . 69.2 t80 -69.92 -29.59 66.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.85 4.14 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.857 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.41 114.13 7.37 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.146 0.974 . . . . 0.0 109.039 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.66 -7.91 61.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.6 t -73.81 -17.14 61.12 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.504 -0.998 . . . . 0.0 109.569 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.619 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -65.3 148.7 51.24 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.052 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.586 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.0 75.35 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.36 -167.22 5.31 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.6 Cg_endo -139.58 147.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 117.087 -1.476 . . . . 0.0 111.734 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' A' ' 104' ' ' LEU . 3.1 mt -97.55 102.29 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -81.32 130.04 34.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -176.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.546 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -65.96 -160.18 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -95.21 16.24 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.635 1.334 . . . . 0.0 110.712 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.0 p -130.77 19.93 5.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.245 -0.909 . . . . 0.0 111.691 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.41 30.47 64.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 50.8 m170 -115.92 118.64 33.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.486 -1.008 . . . . 0.0 109.907 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.66 124.69 27.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.906 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' CG1' ' A' ' 172' ' ' VAL . 33.3 m -125.58 -2.54 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 111.559 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.474 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.18 128.63 2.42 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.487 -1.34 . . . . 0.0 111.317 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.3 mt -110.07 119.98 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.06 -1.259 . . . . 0.0 107.866 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 14.0 t80 -52.0 127.31 20.99 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.808 0.813 . . . . 0.0 112.909 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.449 ' HB2' HG23 ' A' ' 170' ' ' VAL . 57.3 ttp180 -115.68 -28.13 6.85 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.947 -0.471 . . . . 0.0 110.82 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.53 148.92 9.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.918 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.91 141.98 33.92 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.4 t -89.65 92.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -88.49 117.89 27.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.33 1.062 . . . . 0.0 112.218 -176.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.627 ' O ' HG22 ' A' ' 163' ' ' VAL . 88.6 m -120.04 131.96 55.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.725 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' A' ' 160' ' ' THR . 57.6 mmt-85 58.3 21.25 8.03 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.401 -0.812 . . . . 0.0 110.224 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.423 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.83 18.86 49.9 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.532 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' THR . 34.1 m -145.98 143.91 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.235 -1.156 . . . . 0.0 109.4 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.56 121.29 23.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.476 -0.765 . . . . 0.0 110.854 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -111.11 11.14 21.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.714 -0.617 . . . . 0.0 110.51 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.25 139.46 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.656 ' CG2' HG11 ' A' ' 116' ' ' VAL . 17.1 m -110.09 137.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.155 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -106.55 148.09 28.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -155.21 164.57 38.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.616 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.607 HG11 HD22 ' A' ' 82' ' ' LEU . 50.2 t -84.23 135.68 41.45 Favored Pre-proline 0 N--CA 1.497 1.902 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 148.83 46.36 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.843 1.444 . . . . 0.0 110.099 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 7.3 p -71.68 -28.53 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 0.0 109.922 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.95 -30.62 69.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.465 -0.772 . . . . 0.0 109.128 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.4 t -72.12 -33.68 68.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.786 -0.571 . . . . 0.0 110.159 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.63 ' CG ' HD21 ' A' ' 82' ' ' LEU . 3.4 mtp -68.26 -40.08 82.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.5 -40.05 95.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 109.843 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 173' ' ' GLU . 69.8 p . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 111.78 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.287 0.565 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.6 t -125.55 130.04 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -94.85 120.44 35.07 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.65 HG22 ' CD2' ' A' ' 44' ' ' LEU . 61.6 t -84.01 130.26 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 35' ' ' VAL . 30.4 m -146.32 171.26 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.641 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.0 p -142.21 127.91 19.21 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.699 0.762 . . . . 0.0 109.183 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 59' ' ' ALA . 69.2 p -107.76 179.94 4.09 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -17.11 7.56 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.51 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -96.55 -41.41 8.56 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.273 -0.892 . . . . 0.0 112.019 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -173.47 -170.27 0.59 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.869 -1.144 . . . . 0.0 112.511 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 55.4 m -112.58 141.32 46.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 17.0 p90 -163.64 -145.72 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 0.0 110.628 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 109' ' ' ARG . 92.0 mt -137.75 169.04 18.47 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.714 -1.241 . . . . 0.0 112.54 -177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB2' ' OG1' ' A' ' 54' ' ' THR . . . -150.25 127.35 11.23 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 62.6 m -99.13 127.81 45.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 111.526 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -74.6 124.29 26.39 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.8 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.56 126.79 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.482 -0.761 . . . . 0.0 109.992 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.8 40.05 26.89 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.621 -0.675 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.756 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.71 26.78 72.17 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -139.81 115.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.396 -1.061 . . . . 0.0 109.409 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.2 t -76.63 121.83 23.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.287 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.522 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 94.2 m95 -109.75 126.87 54.19 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.671 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.775 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 1.4 t -132.21 176.83 8.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 140' ' ' GLY . 15.6 m -87.31 126.01 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 118.307 -1.357 . . . . 0.0 111.649 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.619 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 31.9 p-80 -66.85 -19.99 65.84 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.144 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -81.75 -39.27 12.2 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.681 -0.894 . . . . 0.0 109.166 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.46 HD21 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 120.901 -1.124 . . . . 0.0 110.518 -179.696 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.632 HG22 ' HD1' ' A' ' 85' ' ' TRP . 42.9 mt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -98.14 145.33 26.69 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.492 0.663 . . . . 0.0 111.553 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 2.4 pp0? -77.27 155.24 32.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.774 -0.579 . . . . 0.0 109.933 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.2 ttm -102.58 -29.14 11.74 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.536 -0.727 . . . . 0.0 110.501 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -147.72 164.73 32.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.235 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.857 HG23 ' CG1' ' A' ' 83' ' ' VAL . 31.3 m -150.86 116.95 5.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.608 -0.683 . . . . 0.0 110.137 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 78.05 4.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.97 -33.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 0.0 109.929 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -53.1 -26.59 16.99 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.55 3.97 8.98 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.867 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.22 61.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.94 -1.1 . . . . 0.0 109.883 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.707 HD13 HG11 ' A' ' 170' ' ' VAL . 17.6 tp -142.41 151.74 42.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 109.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.857 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -143.86 129.15 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.401 -0.812 . . . . 0.0 109.58 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.07 122.49 5.48 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.192 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -85.9 -171.74 3.74 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.988 -0.713 . . . . 0.0 110.12 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -102.57 95.26 6.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.756 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.44 -0.787 . . . . 0.0 110.853 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.737 0.779 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 144' ' ' LEU . 85.0 mt -71.15 163.96 26.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.24 155.48 37.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.836 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.49 1.288 0 O-C-N 123.969 1.51 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.272 0.558 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m 54.26 20.38 2.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.531 -0.731 . . . . 0.0 111.254 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -86.45 79.59 8.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 143' ' ' LEU . 96.5 mt -89.53 170.61 10.35 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.381 0.61 . . . . 0.0 110.678 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 45.1 p90 -155.86 140.75 17.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.13 153.17 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.07 0.938 . . . . 0.0 111.748 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 111' ' ' ALA . 86.0 t -109.99 130.01 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.536 ' CG2' HD11 ' A' ' 114' ' ' ILE . 60.1 p -81.35 171.6 14.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.412 -0.805 . . . . 0.0 110.284 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HD21 ' A' ' 44' ' ' LEU . 26.4 ttp180 -32.26 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 108' ' ' THR . 83.3 m-70 -98.87 -87.19 0.35 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.108 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -164.2 26.37 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.124 -0.985 . . . . 0.0 111.226 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.2 158.28 14.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.066 -1.021 . . . . 0.0 110.694 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.11 120.03 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 126' ' ' LEU . 85.9 mt -130.01 83.86 62.29 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 110.259 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.68 120.61 7.83 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.982 1.517 . . . . 0.0 110.744 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 167' ' ' VAL . 62.6 t -124.48 132.95 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.684 . . . . 0.0 109.422 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -84.86 120.09 26.07 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.449 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.1 ttm180 -60.82 123.51 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 110.569 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.743 -0.598 . . . . 0.0 109.491 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.72 -179.94 43.89 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.422 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 30.1 p-10 -62.04 -29.32 70.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.98 . . . . 0.0 110.564 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 m -121.52 18.55 11.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.831 -0.543 . . . . 0.0 112.056 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -139.31 144.33 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 111.04 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.41 140.4 10.24 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.62 ' C ' HG13 ' A' ' 116' ' ' VAL . 18.3 t -87.59 109.97 20.04 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.782 -0.834 . . . . 0.0 109.821 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 116' ' ' VAL . 22.8 tp -69.33 105.78 2.68 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.51 -25.34 66.64 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.202 0.525 . . . . 0.0 110.055 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 p -106.41 100.71 31.37 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.764 -0.585 . . . . 0.0 110.158 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.88 134.25 16.19 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 124.024 1.539 . . . . 0.0 109.55 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.67 167.22 14.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -57.98 128.71 29.93 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.824 1.434 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.69 -26.43 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.628 -0.67 . . . . 0.0 110.616 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 75.3 m -57.86 -31.36 66.61 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.719 0.771 . . . . 0.0 109.274 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -70.86 -30.89 67.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.482 HD12 ' CB ' ' A' ' 164' ' ' ALA . 98.3 mt -89.98 -0.02 57.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.539 -0.725 . . . . 0.0 112.557 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -75.7 124.81 27.88 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 120.837 -1.164 . . . . 0.0 109.001 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 99.66 -11.4 61.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 p -78.55 -10.24 59.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.34 -1.094 . . . . 0.0 109.669 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 55' ' ' VAL . 1.5 m -60.45 143.86 52.43 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.81 -9.94 75.47 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.11 -163.53 0.89 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.66 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.19 135.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 116.624 -1.784 . . . . 0.0 112.145 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 104' ' ' LEU . 3.9 mp -94.82 97.11 9.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -88.76 141.48 28.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.953 0.882 . . . . 0.0 113.33 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 1.3 m -74.01 -172.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.0 Cg_endo -82.02 5.28 6.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.739 1.389 . . . . 0.0 111.446 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.1 m -110.2 17.8 20.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.996 -1.065 . . . . 0.0 111.883 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.72 38.31 61.09 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -122.97 123.64 41.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.465 -1.021 . . . . 0.0 110.883 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -87.16 102.76 14.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.04 7.4 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.912 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.61 133.94 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.575 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 175' ' ' MET . 40.1 mt -116.52 120.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.276 -1.132 . . . . 0.0 108.072 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.457 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.0 t80 -49.96 127.71 17.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.857 0.837 . . . . 0.0 112.978 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 170' ' ' VAL . 59.5 ttp180 -114.28 -30.33 6.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.942 -0.474 . . . . 0.0 111.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.411 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.16 150.42 9.38 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.684 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.62 140.77 35.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.694 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 57.3 t -93.12 88.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.509 -0.744 . . . . 0.0 109.006 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.2 p -92.84 115.72 28.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.273 1.035 . . . . 0.0 111.103 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.5 m -90.01 -80.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.502 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -97.71 61.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.172 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.438 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 70.03 19.13 75.21 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.3 m -147.74 140.18 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 121.282 -1.128 . . . . 0.0 108.956 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.24 128.27 33.33 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.546 0.688 . . . . 0.0 111.325 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -122.22 16.14 10.65 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.694 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.55 154.13 3.68 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 116' ' ' VAL . 11.4 m -135.27 138.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.885 0.85 . . . . 0.0 112.237 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -107.23 148.34 29.06 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 35.7 p90 -153.45 163.95 39.05 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.713 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 82' ' ' LEU . 99.0 t -80.02 141.63 54.83 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.994 -0.442 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.42 150.87 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.523 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.69 -28.13 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.689 . . . . 0.0 110.355 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -59.95 -32.49 70.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.1 t -75.52 -29.71 59.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.987 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.594 ' CG ' HD21 ' A' ' 82' ' ' LEU . 7.3 mtp -69.92 -37.93 76.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.96 -36.4 77.03 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.265 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.399 -0.813 . . . . 0.0 110.624 -179.268 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HA ' HD21 ' A' ' 94' ' ' LEU . 50.1 mt-10 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 120.829 0.347 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -125.08 129.96 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.858 . . . . 0.0 110.658 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -99.24 123.77 43.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.622 -0.674 . . . . 0.0 110.623 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 44' ' ' LEU . 62.7 t -81.69 131.22 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.91 174.03 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.094 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.0 p -145.49 125.78 13.89 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.718 0.77 . . . . 0.0 108.98 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.536 HG21 ' HA ' ' A' ' 59' ' ' ALA . 47.6 p -103.52 -179.54 3.98 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.34 -15.03 8.83 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.528 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -100.42 -39.21 8.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 112.572 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -172.02 -170.0 0.71 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.798 -1.189 . . . . 0.0 112.694 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -115.21 141.54 47.88 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.6 p90 -162.61 -147.33 0.12 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 110.499 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 138' ' ' SER . 74.0 mt -132.07 166.01 22.72 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.602 -1.311 . . . . 0.0 113.342 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -152.86 131.86 12.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.837 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.563 HG21 ' HB3' ' A' ' 142' ' ' PRO . 94.1 m -96.75 123.65 40.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 84.2 m -73.78 127.22 32.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.68 -0.637 . . . . 0.0 109.805 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 38.7 t -140.42 127.24 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.796 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 49.98 40.7 21.76 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.585 -0.697 . . . . 0.0 111.619 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 73.54 26.93 68.59 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 59.9 t -139.94 117.37 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -1.04 . . . . 0.0 109.572 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 t -75.68 119.62 19.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.561 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.2 m95 -106.86 125.74 51.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.902 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.67 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.2 t -132.52 -179.26 5.34 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 139' ' ' SER . 24.0 m -90.22 125.57 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 118.193 -1.403 . . . . 0.0 112.242 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.03 -39.99 87.81 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.447 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.5 p-80 -73.42 68.64 1.12 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.139 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.09 -38.13 0.31 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.597 -0.943 . . . . 0.0 110.224 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.473 HD13 HG22 ' A' ' 38' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.163 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 137.61 32.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 0.0 111.742 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -70.03 141.54 52.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.734 -0.604 . . . . 0.0 109.899 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.8 ttp -105.33 -34.36 7.89 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.427 -0.796 . . . . 0.0 110.693 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -153.33 170.47 20.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.467 -0.771 . . . . 0.0 109.755 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.883 HG23 ' CG1' ' A' ' 83' ' ' VAL . 71.5 m -153.4 115.94 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.69 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 76.6 3.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 76' ' ' THR . 93.6 t -60.06 -39.99 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.451 -0.781 . . . . 0.0 109.553 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -55.65 -26.64 45.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -110.86 -0.4 16.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.751 -0.593 . . . . 0.0 110.751 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 60.17 56.31 3.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.947 -1.096 . . . . 0.0 109.393 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 170' ' ' VAL . 49.1 tp -145.57 153.19 40.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.883 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.03 130.68 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 109.415 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.78 121.01 5.11 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.625 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.67 ' CZ3' HG22 ' A' ' 54' ' ' THR . 5.3 m-90 -87.07 -170.28 2.99 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.88 -0.777 . . . . 0.0 109.314 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -100.01 112.22 24.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . 10.7 t . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.342 0.592 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 93' ' ' SER . 3.7 mm? -114.32 150.62 34.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.532 -0.73 . . . . 0.0 109.846 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -98.46 151.06 37.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.434 -0.791 . . . . 0.0 110.93 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 O-C-N 123.865 1.455 . . . . 0.0 110.037 179.72 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -106.65 15.87 25.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.704 . . . . 0.0 110.971 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -73.1 78.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.3 mt -99.12 175.09 6.02 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.395 0.616 . . . . 0.0 110.32 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' PRO . 51.3 p90 -150.27 131.75 14.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 143' ' ' LEU . 21.9 tp -92.99 147.25 22.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.846 0.831 . . . . 0.0 110.897 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 111' ' ' ALA . 80.9 t -90.07 110.0 21.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.4 p -81.38 177.58 8.89 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.216 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -43.74 -25.51 0.18 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.817 -0.552 . . . . 0.0 111.744 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -90.16 -79.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.573 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -151.38 -44.07 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.291 -0.881 . . . . 0.0 111.183 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -163.84 -65.33 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.746 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.611 HG11 ' OH ' ' A' ' 134' ' ' TYR . 38.6 t 64.42 -58.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 126' ' ' LEU . 46.6 pt -125.41 150.96 69.26 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.951 -1.093 . . . . 0.0 111.737 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 105' ' ' TYR . 54.0 Cg_endo -106.65 163.87 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.804 1.423 . . . . 0.0 109.788 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HD12 ' A' ' 126' ' ' LEU . 48.8 t -136.1 140.08 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.834 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -95.0 115.81 27.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.463 ' CZ ' HG12 ' A' ' 151' ' ' VAL . 1.7 ttm180 -59.99 124.8 21.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -99.26 -0.05 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 0.0 109.766 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.83 44.35 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 34.4 m-20 -65.12 -22.89 67.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.931 . . . . 0.0 110.251 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.2 p -124.96 17.41 8.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 111.46 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -140.66 140.83 35.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.068 -1.02 . . . . 0.0 111.088 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -139.73 141.25 11.47 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.471 ' C ' HG13 ' A' ' 116' ' ' VAL . 7.3 t -89.9 112.19 23.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.834 -0.803 . . . . 0.0 110.161 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 114' ' ' ILE . 21.9 tp -71.2 104.47 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 115' ' ' PRO . 98.3 mt -60.04 -32.67 71.13 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 110.079 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -112.89 99.92 49.62 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.28 145.97 74.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.908 1.478 . . . . 0.0 109.018 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -154.29 163.17 25.01 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.599 -0.688 . . . . 0.0 109.685 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -60.52 122.8 11.85 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.064 1.56 . . . . 0.0 109.88 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -46.5 -25.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.928 -0.482 . . . . 0.0 111.724 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.4 p -58.23 -34.32 70.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.0 108.992 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.611 ' OH ' HG11 ' A' ' 113' ' ' VAL . 46.6 t80 -69.99 -30.03 67.26 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.25 2.02 33.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.763 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -72.21 112.44 8.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.234 -0.916 . . . . 0.0 108.603 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 -10.1 58.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.647 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.5 t -76.69 -12.86 60.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 110.111 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.603 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.7 m -66.53 150.99 48.16 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.001 -1.062 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.554 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.9 -9.91 75.66 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -67.93 -167.7 4.03 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.563 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.0 Cg_endo -141.48 140.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 116.956 -1.563 . . . . 0.0 112.143 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.427 HD12 HD13 ' A' ' 106' ' ' LEU . 4.1 mp -94.2 94.02 8.11 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 94' ' ' LEU . 6.0 mp -85.65 150.24 24.76 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.411 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -59.51 -162.89 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.098 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 16.57 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.645 1.339 . . . . 0.0 110.504 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.1 m -124.78 -51.98 1.69 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.06 40.64 0.02 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -119.99 129.42 54.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.449 ' HB2' ' CB ' ' A' ' 94' ' ' LEU . . . -70.26 121.16 17.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.563 -0.711 . . . . 0.0 110.001 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 118' ' ' ARG . 5.0 t -110.24 -29.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.803 -0.561 . . . . 0.0 110.112 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -155.12 150.38 21.86 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.985 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 16.7 mt -119.37 120.86 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.341 -1.093 . . . . 0.0 108.073 177.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.9 t80 -50.01 128.94 19.86 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.948 0.88 . . . . 0.0 113.044 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 170' ' ' VAL . 29.9 ttt180 -117.06 -27.88 6.4 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.723 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.404 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 147.59 7.7 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.08 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.426 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.42 140.43 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.583 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 52.7 t -91.19 92.66 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 86.1 m -94.49 123.32 37.84 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.77 0.795 . . . . 0.0 111.479 -177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 161' ' ' ARG . 75.9 m -85.37 -97.51 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.773 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.451 ' N ' HG22 ' A' ' 160' ' ' THR . 39.7 ttm180 -69.77 -55.5 9.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.782 -1.199 . . . . 0.0 109.119 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.424 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -163.96 28.32 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.424 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.8 m -148.83 146.01 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -81.34 129.25 34.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.568 -0.708 . . . . 0.0 111.168 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.82 15.22 13.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.266 0.555 . . . . 0.0 109.999 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.39 153.02 2.29 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.687 HG21 HG11 ' A' ' 116' ' ' VAL . 11.7 m -130.1 138.22 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.513 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -105.3 147.63 27.91 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 36.6 p90 -153.2 165.61 35.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.169 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 82' ' ' LEU . 59.6 t -86.15 130.07 51.39 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.86 157.52 51.49 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.759 1.4 . . . . 0.0 110.487 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.474 ' HA ' ' CE ' ' A' ' 175' ' ' MET . 7.2 p -76.03 -23.28 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.644 . . . . 0.0 109.653 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 177' ' ' THR . 53.5 tp10 -58.52 -30.83 67.37 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.6 m -73.31 -36.8 66.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.36 0.6 . . . . 0.0 109.631 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.685 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -67.96 -36.6 80.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.522 -0.737 . . . . 0.0 109.019 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -33.1 71.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.885 -0.509 . . . . 0.0 110.33 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 173' ' ' GLU . 30.5 p . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.173 -0.954 . . . . 0.0 110.453 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 45' ' ' ALA . 61.6 t -140.01 140.69 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.945 -1.097 . . . . 0.0 111.268 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.01 121.39 32.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.309 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.44 138.89 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.75 169.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.088 0.946 . . . . 0.0 111.544 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -142.76 120.0 11.52 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.787 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.6 p -107.15 -179.07 3.82 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.66 -16.48 16.39 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.659 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.3 p -102.69 -39.68 6.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.268 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -174.64 -168.91 0.39 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.064 -1.023 . . . . 0.0 111.855 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 m -116.57 147.43 41.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.7 p90 -161.76 -142.97 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 85.5 mt -134.33 161.48 34.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.675 -1.265 . . . . 0.0 113.352 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -147.84 123.43 10.45 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.143 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 142' ' ' PRO . 25.1 m -97.9 120.04 37.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.486 -0.759 . . . . 0.0 110.674 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 21.5 m -76.79 125.99 30.21 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.123 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -123.16 124.61 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 52.67 45.3 28.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.307 -0.87 . . . . 0.0 110.625 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.6 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 70.05 22.64 77.28 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.168 -1.015 . . . . 0.0 110.74 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' NE1' ' A' ' 53' ' ' TRP . 61.9 t -130.01 111.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.261 -1.141 . . . . 0.0 109.24 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 15.6 t -74.61 121.85 22.25 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 87.0 m95 -112.84 126.21 55.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.901 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.1 t -131.51 178.96 6.33 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 140' ' ' GLY . 16.6 m -89.57 123.84 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.705 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.02 -39.97 87.66 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 34.6 p-80 -71.31 74.42 0.72 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.872 0.844 . . . . 0.0 109.069 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.07 -25.51 0.71 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.407 -1.055 . . . . 0.0 110.859 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.596 HD22 ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.514 2.77 0 CA-C-O 120.59 0.234 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 109.947 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.6 mt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.928 0.394 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 10.1 m 60.52 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.488 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 3.8 pt20 -80.06 159.29 26.21 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.335 -0.853 . . . . 0.0 112.167 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' GLN . 96.6 mmm -108.77 -30.01 8.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.058 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 1.3 t80 -140.37 164.22 30.69 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.525 -0.734 . . . . 0.0 109.248 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.901 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.8 m -154.35 115.33 4.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 0.0 110.304 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.405 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 14.4 t-20 -99.15 74.03 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.431 -0.793 . . . . 0.0 109.168 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 76' ' ' THR . 79.1 t -60.05 -39.97 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.272 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -55.19 -26.08 36.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -111.99 -2.59 15.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.682 -0.636 . . . . 0.0 110.589 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t0 62.56 55.18 2.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 109.249 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 175' ' ' MET . 18.6 tp -147.14 151.75 37.31 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.901 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -147.1 139.34 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.068 -1.02 . . . . 0.0 109.296 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.45 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -124.69 122.14 4.62 Favored Glycine 0 N--CA 1.5 2.933 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.656 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.901 ' CZ3' HG22 ' A' ' 54' ' ' THR . 9.4 m-90 -90.36 -166.72 1.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.076 -0.661 . . . . 0.0 109.387 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 74' ' ' MET . 30.1 tt0 -112.55 96.96 6.28 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.501 2.075 0 O-C-N 121.498 -0.751 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.581 ' C ' HD22 ' A' ' 94' ' ' LEU . 11.1 m . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 93' ' ' SER . 4.6 mm? -110.01 160.59 16.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.34 -0.85 . . . . 0.0 111.133 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.417 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.1 p -112.12 157.12 40.71 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.611 -0.68 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.315 -1.192 0 O-C-N 123.874 1.46 . . . . 0.0 109.592 179.118 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.363 0.602 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.8 m -105.09 18.85 21.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.725 -0.609 . . . . 0.0 109.989 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -70.47 76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 118' ' ' ARG . 82.0 mt -94.11 174.32 7.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.283 0.563 . . . . 0.0 109.664 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.6 p90 -152.4 136.1 16.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 142' ' ' PRO . 40.8 tp -103.83 141.25 36.44 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.724 0.774 . . . . 0.0 111.146 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -86.31 119.92 35.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.4 p -80.44 179.98 7.44 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.097 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -43.02 -27.92 0.23 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.756 -0.59 . . . . 0.0 112.24 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -115.27 -50.92 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.865 . . . . 0.0 111.571 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.62 -179.0 7.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.89 -1.131 . . . . 0.0 110.338 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 114' ' ' ILE . 57.7 t0 -60.09 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.163 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 113' ' ' VAL . 48.4 t 51.67 25.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.392 -0.817 . . . . 0.0 110.726 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 126' ' ' LEU . 6.5 tp -164.83 100.07 0.83 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.874 . . . . 0.0 111.024 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.82 136.41 2.11 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.571 1.301 . . . . 0.0 109.761 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.802 HG22 HD12 ' A' ' 126' ' ' LEU . 48.9 t -130.4 140.32 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.324 -0.86 . . . . 0.0 111.027 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -93.77 119.47 32.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.9 ttm-85 -60.59 127.38 31.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.802 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -99.77 -0.01 40.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.666 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.75 -177.37 43.86 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 82.8 m-20 -69.23 -20.02 63.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -1.03 . . . . 0.0 110.171 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 p -123.47 15.15 9.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.409 -0.807 . . . . 0.0 111.642 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -143.25 144.59 32.2 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.14 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.14 140.99 10.79 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.71 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.6 t -88.69 111.37 21.87 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.759 -0.848 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 114' ' ' ILE . 23.6 tp -70.31 110.23 5.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.01 -18.88 65.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.852 -0.53 . . . . 0.0 110.655 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' ILE . 47.4 t -129.95 82.25 66.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 110.399 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.8 Cg_endo -61.19 143.84 98.71 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.856 1.45 . . . . 0.0 109.907 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -154.99 168.36 12.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.643 -0.661 . . . . 0.0 109.345 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.86 125.37 18.43 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.842 1.443 . . . . 0.0 110.354 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.05 -27.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 121.516 0.674 . . . . 0.0 110.534 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 39.7 t -61.42 -15.08 33.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.785 -0.572 . . . . 0.0 110.135 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -86.75 -31.79 20.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 136' ' ' LYS . 84.4 mt -76.7 -55.85 5.13 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.79 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 133' ' ' SER . 4.5 pttt 7.12 104.74 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.22 -4.2 55.14 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.3 p -76.07 -14.78 60.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.534 -0.98 . . . . 0.0 109.261 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.559 ' HB2' HG21 ' A' ' 55' ' ' VAL . 4.0 m -61.97 142.23 57.58 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.161 -0.962 . . . . 0.0 110.143 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.06 -10.11 75.13 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -65.05 -162.02 0.68 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.668 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.5 Cg_endo -146.69 138.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 116.605 -1.796 . . . . 0.0 112.469 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 151' ' ' VAL . 3.4 mp -96.0 97.84 9.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -87.29 151.68 22.93 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.414 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -64.42 -159.62 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.215 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 51.2 Cg_endo -96.8 17.34 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.503 1.265 . . . . 0.0 110.098 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.5 p -130.54 11.06 5.27 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.273 -0.892 . . . . 0.0 112.066 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.52 32.0 10.84 Favored Glycine 0 N--CA 1.502 3.039 0 O-C-N 120.917 -1.114 . . . . 0.0 110.558 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.7 m80 -113.91 118.45 34.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -1.19 . . . . 0.0 110.536 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.22 123.41 24.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.505 -0.747 . . . . 0.0 110.222 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.2 m -123.35 -5.56 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.551 -0.718 . . . . 0.0 111.572 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -160.04 127.67 1.84 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.791 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 66.4 mt -105.58 120.71 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -1.082 . . . . 0.0 108.555 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 15.8 t80 -50.75 128.61 21.2 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.621 0.724 . . . . 0.0 112.601 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 170' ' ' VAL . 64.6 ttt180 -116.78 -26.45 6.95 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.867 -0.521 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.96 149.18 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.957 . . . . 0.0 111.751 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.98 141.59 32.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.718 -0.614 . . . . 0.0 110.889 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.536 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 49.1 t -95.15 93.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -89.43 117.78 28.6 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.13 0.967 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.8 m -83.92 -69.96 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.16 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -117.36 57.57 0.8 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.057 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.42 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 80.04 16.35 76.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.4 m -146.84 139.9 19.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 121.374 -1.074 . . . . 0.0 108.27 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.98 129.92 35.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.732 0.777 . . . . 0.0 111.338 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -123.86 17.28 9.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.272 0.558 . . . . 0.0 110.077 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -174.33 139.93 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.717 HG21 HG11 ' A' ' 116' ' ' VAL . 22.3 m -113.31 138.67 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.148 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -108.5 143.33 37.63 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.2 p90 -150.96 166.02 31.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.12 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 155' ' ' ARG . 52.4 t -87.3 130.53 47.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.996 -0.44 . . . . 0.0 110.326 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.7 135.82 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 O-C-N 123.722 1.38 . . . . 0.0 110.195 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 151' ' ' VAL . 11.6 p -70.21 -29.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.588 -0.695 . . . . 0.0 110.129 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.08 -31.09 69.69 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 177' ' ' THR . 18.8 m -72.6 -35.28 67.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.609 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.599 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.4 mtp -64.68 -47.16 79.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.75 -44.46 96.15 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.937 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 174' ' ' SER . 13.8 t . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 110.683 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.868 0.366 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 107' ' ' VAL . 62.7 t -110.08 129.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.391 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.59 117.65 30.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -84.81 131.66 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 43' ' ' PHE . 33.9 m -140.43 178.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.493 -0.754 . . . . 0.0 109.268 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 m -140.91 126.94 19.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.718 0.771 . . . . 0.0 109.209 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 40' ' ' THR . 14.7 t -113.0 -168.57 1.34 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.36 5.04 0.82 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 24.1 p -120.89 -39.35 2.73 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.701 -1.25 . . . . 0.0 111.941 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -173.08 -155.38 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.098 -1.001 . . . . 0.0 112.348 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 m -102.71 119.01 38.09 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 36' ' ' VAL 0.27 3.3 m-85 -90.25 -174.67 4.26 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 117.398 2.369 . . . . 0.0 117.398 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' A' ' 138' ' ' SER . 26.5 mt -142.55 136.07 28.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.378 -2.192 . . . . 0.0 106.842 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 54' ' ' THR . . . -145.78 136.66 24.48 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 142' ' ' PRO . 34.6 m -101.69 125.77 48.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.583 -0.698 . . . . 0.0 111.586 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -72.45 119.98 17.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.72 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.83 129.97 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.456 -0.777 . . . . 0.0 109.994 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 50.12 40.14 21.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.472 -0.768 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.96 26.57 74.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.5 t -138.75 115.97 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.267 -1.137 . . . . 0.0 109.658 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 35.2 t -76.72 118.61 19.52 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.521 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 91.8 m95 -106.27 124.24 49.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.0 111.189 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.892 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -130.65 179.98 5.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 139' ' ' SER . 2.8 m -84.32 123.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 C-N-CA 117.195 -1.802 . . . . 0.0 113.373 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' CA ' HG22 ' A' ' 83' ' ' VAL . 25.5 t80 -59.98 -40.31 88.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.802 . . . . 0.0 109.9 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.473 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.6 p-80 -69.2 101.9 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.701 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.16 -41.72 1.42 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.947 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 109.505 179.322 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.408 ' HB ' HD21 ' A' ' 64' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.086 0.47 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.6 m 58.7 136.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.955 0.883 . . . . 0.0 112.175 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.517 ' HG2' ' CE2' ' A' ' 85' ' ' TRP . 16.1 mt-30 -80.28 157.19 26.5 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.531 -0.731 . . . . 0.0 112.564 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 88.8 mtp -100.56 -38.23 8.45 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.21 -176.46 4.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.837 HG23 HG13 ' A' ' 83' ' ' VAL . 69.7 m -153.49 127.42 8.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.559 -0.713 . . . . 0.0 109.59 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.16 76.96 2.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.95 -40.06 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.643 -0.66 . . . . 0.0 110.009 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.41 -26.17 40.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.476 -0.765 . . . . 0.0 108.972 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -112.59 0.02 15.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.643 . . . . 0.0 110.735 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.03 59.71 2.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.045 -1.034 . . . . 0.0 109.189 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.534 HD21 ' CG ' ' A' ' 175' ' ' MET . 24.3 tp -145.99 154.01 41.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.171 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.837 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -141.41 135.83 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.76 121.99 4.7 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.949 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.892 ' CZ3' HG22 ' A' ' 54' ' ' THR . 11.1 m-90 -89.92 -173.11 3.77 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -104.05 91.66 4.05 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 52' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.805 -0.56 . . . . 0.0 110.28 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 144' ' ' LEU . 88.4 mt -106.61 159.68 16.01 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.086 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.64 166.1 11.42 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.97 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 151' ' ' VAL . 39.4 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 124.054 1.555 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -103.72 18.33 22.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 111.19 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.51 78.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 143' ' ' LEU . 88.5 mt -89.75 174.19 7.85 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.477 0.656 . . . . 0.0 110.546 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.9 113.49 9.02 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.52 146.64 24.47 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.127 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 33' ' ' VAL . 74.0 t -92.97 119.42 40.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.159 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 44' ' ' LEU . 66.0 p -85.94 175.24 8.73 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' N ' HD11 ' A' ' 44' ' ' LEU . 32.2 ttp180 -42.86 -28.61 0.26 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.796 -0.565 . . . . 0.0 111.954 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -100.07 -69.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.12 -163.27 1.74 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.438 -0.789 . . . . 0.0 109.506 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' HG22 ' A' ' 107' ' ' VAL . 73.9 m-20 -57.29 -66.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.741 -0.599 . . . . 0.0 110.585 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.7 t 56.58 -85.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.99 -0.444 . . . . 0.0 111.298 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 126' ' ' LEU . 44.0 pt -76.51 145.28 75.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.078 -1.013 . . . . 0.0 112.006 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 53.3 Cg_endo -112.63 153.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 O-C-N 123.756 1.398 . . . . 0.0 108.657 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 167' ' ' VAL . 38.2 t -136.42 139.64 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.074 -1.016 . . . . 0.0 111.66 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.32 118.49 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.8 ttm180 -63.37 122.2 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.0 110.219 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -101.05 7.43 43.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.688 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.32 173.59 42.09 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.446 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 75.5 m-20 -60.3 -25.83 66.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.379 -1.071 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.7 18.58 7.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.548 -0.72 . . . . 0.0 111.85 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.41 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 92.7 mtt180 -138.12 143.41 40.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.833 -1.167 . . . . 0.0 111.012 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -140.11 142.17 12.26 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.421 ' C ' HG13 ' A' ' 116' ' ' VAL . 20.1 t -89.64 110.99 21.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.971 -0.723 . . . . 0.0 109.814 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 129' ' ' PRO . 61.4 tp -69.96 113.74 7.47 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.99 -20.96 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.874 -0.516 . . . . 0.0 110.756 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 m -126.77 80.86 70.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.3 Cg_endo -57.43 139.79 91.21 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 O-C-N 123.754 1.397 . . . . 0.0 110.346 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -146.96 163.15 30.14 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -55.47 124.49 16.42 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.808 1.425 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' VAL . . . . . 0.653 ' HA ' HD12 ' A' ' 135' ' ' LEU . 14.8 p -51.61 -23.46 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.888 -0.507 . . . . 0.0 111.639 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -57.19 -34.34 68.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.312 -0.868 . . . . 0.0 109.28 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -74.22 -21.87 59.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 132' ' ' VAL . 95.5 mt -85.02 -0.49 54.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.77 109.89 2.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.108 -0.995 . . . . 0.0 108.81 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.94 -6.73 64.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.875 ' HA ' HD12 ' A' ' 44' ' ' LEU . 12.7 t -74.27 -13.32 60.75 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.562 -0.963 . . . . 0.0 108.686 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.3 147.68 39.98 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.372 -0.83 . . . . 0.0 109.384 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.455 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.25 -12.16 68.37 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.3 -157.6 0.22 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 46' ' ' THR . 47.9 Cg_endo -144.12 132.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 116.514 -1.857 . . . . 0.0 113.426 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.3 mp -89.24 85.79 6.7 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 175.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 145' ' ' CYS . 0.7 OUTLIER -92.57 138.32 31.61 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 0.0 112.524 -175.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.854 ' N ' HD12 ' A' ' 144' ' ' LEU . 61.3 m -56.48 -177.17 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -91.18 3.6 4.36 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.553 1.291 . . . . 0.0 110.536 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.4 m -103.63 -15.97 15.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.82 28.64 3.11 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 90.9 m-70 -116.65 109.98 17.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.103 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.74 121.97 22.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 96' ' ' PRO . 26.8 m -122.65 -1.35 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 112.077 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -158.68 138.01 5.5 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.334 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.455 HG23 ' C ' ' A' ' 140' ' ' GLY . 25.7 mt -120.09 118.42 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.7 t80 -49.92 127.31 16.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.873 0.844 . . . . 0.0 112.9 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.697 ' HB2' HG23 ' A' ' 170' ' ' VAL . 61.7 ttt-85 -121.58 -21.53 6.18 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.619 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 168' ' ' ASP . . . -162.82 138.96 7.25 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.917 -1.114 . . . . 0.0 112.148 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.01 138.97 36.35 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.641 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 39.9 t -89.91 94.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -89.99 110.02 21.02 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.104 0.954 . . . . 0.0 112.793 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 163' ' ' VAL . 30.3 m -100.48 125.18 46.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.3 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 56.3 22.81 6.59 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -0.827 . . . . 0.0 111.31 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.23 17.71 36.13 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.019 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 160' ' ' THR . 34.8 m -144.3 139.99 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.117 -1.225 . . . . 0.0 109.0 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -78.12 122.09 25.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.274 -0.891 . . . . 0.0 111.552 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -116.24 15.95 15.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.794 -0.566 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.33 150.89 2.42 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.702 HG21 HG11 ' A' ' 116' ' ' VAL . 17.3 m -128.6 136.77 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.633 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 156' ' ' ALA . 84.7 m-20 -105.43 150.45 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.7 p90 -154.51 161.09 41.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.914 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 155' ' ' ARG . 60.3 t -80.34 139.93 52.27 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 174' ' ' SER . 47.4 Cg_endo -82.17 148.24 14.91 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.779 1.41 . . . . 0.0 110.525 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.22 -30.06 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.644 -0.66 . . . . 0.0 110.007 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.85 -31.48 69.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 109.014 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 171' ' ' PRO . 35.0 t -73.06 -31.04 64.14 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.438 0.637 . . . . 0.0 109.559 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.534 ' CG ' HD21 ' A' ' 82' ' ' LEU . 2.7 mtp -70.03 -39.39 75.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.658 -0.651 . . . . 0.0 109.461 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -59.99 -41.46 92.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.655 -0.653 . . . . 0.0 109.433 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.495 1.783 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.497 178.844 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 121.023 0.44 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.25 124.28 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -94.59 124.2 38.48 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.2 t -80.29 131.17 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.7 175.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.414 -0.803 . . . . 0.0 110.262 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.5 p -146.32 133.24 20.18 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.837 0.827 . . . . 0.0 109.206 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.3 p -108.25 -179.73 3.97 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.69 -14.92 23.82 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 p -107.92 -32.34 7.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 113.185 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.88 -169.98 0.72 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.705 -1.247 . . . . 0.0 112.769 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 m -121.43 148.79 43.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.7 p90 -164.3 -145.55 0.09 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.525 -0.734 . . . . 0.0 110.299 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 54' ' ' THR . 82.9 mt -134.87 159.99 39.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.644 -1.285 . . . . 0.0 112.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -143.72 128.79 18.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 142' ' ' PRO . 98.1 m -96.8 132.84 42.11 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.0 111.799 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.19 117.31 20.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.44 129.93 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.041 -1.037 . . . . 0.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 54.05 40.05 31.22 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.534 -0.729 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.95 24.95 74.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.58 123.02 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.544 -0.974 . . . . 0.0 109.099 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.0 m -75.3 143.34 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.563 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.504 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 91.2 m95 -136.0 125.51 25.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.732 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -128.79 -174.21 3.19 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 139' ' ' SER . 35.1 m -86.41 131.52 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.312 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.409 ' HB2' ' N ' ' A' ' 82' ' ' LEU . 19.0 t80 -60.43 -40.09 89.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.776 -0.577 . . . . 0.0 109.641 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 37.8 p-80 -73.41 72.43 1.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.391 1.091 . . . . 0.0 108.745 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.36 -36.07 0.81 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 83' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.808 -0.819 . . . . 0.0 111.143 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.766 -1.209 . . . . 0.0 110.202 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.468 HG22 ' CD1' ' A' ' 85' ' ' TRP . 8.3 mt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 50.9 m 60.06 124.64 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.562 0.696 . . . . 0.0 110.913 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.569 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 26.6 mt-30 -59.94 137.71 58.01 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.271 -0.893 . . . . 0.0 112.547 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.4 ttm -97.08 -27.63 14.5 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -147.04 167.65 23.52 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 1.033 HG23 HG12 ' A' ' 83' ' ' VAL . 19.0 m -154.61 116.7 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 110.398 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 15.7 t-20 -95.02 75.2 3.5 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.01 -40.04 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -55.8 -26.27 45.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -111.02 0.09 16.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.706 -0.621 . . . . 0.0 110.832 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 60.17 57.4 2.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.499 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.798 HD22 HG11 ' A' ' 170' ' ' VAL . 36.9 tp -148.06 151.53 35.84 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.652 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 1.033 HG12 HG23 ' A' ' 76' ' ' THR . 14.6 m -139.74 140.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 85' ' ' TRP . . . -125.47 171.21 17.38 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.151 -1.499 . . . . 0.0 112.102 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.58 ' HH2' HG22 ' A' ' 54' ' ' THR . 0.2 OUTLIER -148.67 -162.08 1.48 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.258 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -100.36 111.31 23.57 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.559 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 111.542 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.468 0.652 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.956 HD13 HD21 ' A' ' 144' ' ' LEU . 83.1 mt -109.98 149.91 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 p -105.38 157.56 34.16 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.339 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 N--CA 1.493 1.484 0 O-C-N 123.824 1.434 . . . . 0.0 110.604 179.719 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.3 m -98.4 16.38 21.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 111.268 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -67.81 86.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 86.9 mt -99.02 176.64 5.5 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.616 0.722 . . . . 0.0 111.28 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 96.2 m-85 -144.45 111.13 5.68 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.504 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.6 tp -86.36 143.93 27.6 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.465 0.65 . . . . 0.0 110.315 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' OD1' ' A' ' 112' ' ' ASP . 80.5 t -88.97 114.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.4 p -84.21 174.87 9.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -41.55 -29.33 0.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.816 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -100.04 -70.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.541 -0.724 . . . . 0.0 109.654 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.92 -162.92 1.66 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.523 -0.736 . . . . 0.0 109.023 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.645 ' OD1' HG22 ' A' ' 107' ' ' VAL . 87.9 m-20 -57.81 -63.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.632 -0.667 . . . . 0.0 110.08 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.8 t 54.02 -86.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.008 -0.433 . . . . 0.0 111.617 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 126' ' ' LEU . 1.9 pp -76.23 134.63 70.42 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.101 -0.999 . . . . 0.0 111.731 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 105' ' ' TYR . 52.5 Cg_endo -104.67 148.1 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.604 1.318 . . . . 0.0 109.13 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 167' ' ' VAL . 40.5 t -134.06 138.61 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.275 -0.891 . . . . 0.0 110.803 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.83 124.17 39.73 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.456 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.3 ttm180 -62.62 121.56 13.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.409 -0.807 . . . . 0.0 110.356 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.02 7.4 44.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.631 -0.668 . . . . 0.0 109.574 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.97 173.81 43.73 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 16.8 t0 -61.33 -25.28 67.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -125.71 18.59 7.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.551 -0.718 . . . . 0.0 111.757 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.415 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 95.2 mtt-85 -138.26 145.37 41.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.884 -1.135 . . . . 0.0 111.161 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.29 141.2 10.93 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 116' ' ' VAL . 55.3 p -89.21 113.1 24.27 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.951 -0.735 . . . . 0.0 109.858 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 116' ' ' VAL . 41.1 tp -71.06 110.06 5.52 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.95 -18.0 63.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 110.738 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.0 m -119.95 79.96 25.52 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.615 -0.678 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.72 137.75 78.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.807 1.425 . . . . 0.0 109.903 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -154.11 169.8 9.43 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.699 -0.626 . . . . 0.0 109.344 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.56 124.38 15.34 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.963 1.507 . . . . 0.0 110.335 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.36 -23.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.794 -0.566 . . . . 0.0 111.635 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.324 -0.86 . . . . 0.0 109.356 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -70.67 -28.03 64.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 164' ' ' ALA . 96.8 mt -84.25 -0.32 51.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.557 -0.714 . . . . 0.0 111.271 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -70.31 110.84 5.49 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.76 -10.57 57.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 p -74.65 -15.24 60.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 109.159 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -71.29 151.33 44.32 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 179.233 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.673 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.74 72.86 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.23 -157.92 3.62 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.6 Cg_endo -142.35 137.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 116.982 -1.546 . . . . 0.0 112.212 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.504 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.2 mt -95.06 99.16 11.21 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.956 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -90.86 146.41 23.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -59.86 -164.8 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 49.0 Cg_endo -90.14 17.98 1.43 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.521 1.274 . . . . 0.0 111.022 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.3 m -126.51 -55.42 1.43 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.096 -1.002 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.0 43.32 0.02 OUTLIER Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -125.19 120.99 32.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -1.037 . . . . 0.0 110.797 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.61 124.3 29.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.266 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.21 -1.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.724 . . . . 0.0 111.901 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.467 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.86 125.46 1.65 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.168 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.453 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.0 mt -105.8 117.48 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.297 -1.119 . . . . 0.0 108.156 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.2 t80 -50.14 126.8 15.43 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.601 0.715 . . . . 0.0 112.529 -177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HB2' HG23 ' A' ' 170' ' ' VAL . 51.7 ttp180 -119.85 -22.48 6.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.82 -0.55 . . . . 0.0 112.224 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.96 136.62 6.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.894 -1.129 . . . . 0.0 111.974 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.0 133.25 40.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 122.001 -0.437 . . . . 0.0 111.375 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.608 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 54.1 t -84.66 91.08 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 64.2 m -94.23 119.73 33.45 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.824 0.821 . . . . 0.0 111.352 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -89.95 -79.96 0.33 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.075 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -106.41 64.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.404 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 72.93 18.79 79.23 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 27.6 m -146.67 137.94 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.29 -1.123 . . . . 0.0 109.016 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -83.14 129.98 35.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.549 -0.72 . . . . 0.0 111.072 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -119.94 14.82 12.46 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.215 0.531 . . . . 0.0 110.089 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.06 152.15 2.84 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 116' ' ' VAL . 9.1 m -132.18 137.3 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.461 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -104.71 152.0 23.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.467 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -153.71 166.66 32.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.644 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.798 HG11 HD22 ' A' ' 82' ' ' LEU . 57.8 t -80.7 130.88 62.5 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.04 148.61 45.18 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.744 1.392 . . . . 0.0 109.863 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.33 -25.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.917 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.98 -29.69 68.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.312 -0.867 . . . . 0.0 108.72 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.903 ' O ' HG22 ' A' ' 177' ' ' THR . 30.9 m -71.08 -32.79 69.52 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.409 0.623 . . . . 0.0 109.395 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.696 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -69.37 -38.45 78.07 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.8 0.81 . . . . 0.0 108.937 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.01 -39.24 85.13 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.589 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 174' ' ' SER . 3.9 t . . . . . 0 N--CA 1.496 1.864 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.27 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.558 ' HA ' HD23 ' A' ' 94' ' ' LEU . 97.4 mt-10 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.747 HG22 ' HG3' ' A' ' 142' ' ' PRO . 63.0 t -138.14 129.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -140.08 141.36 36.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.27 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.47 139.02 18.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.54 159.98 42.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.57 0.7 . . . . 0.0 110.215 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.7 m -137.28 121.39 17.88 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.8 0.81 . . . . 0.0 108.897 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.5 p -107.48 -179.87 4.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -14.92 18.45 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.213 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.6 p -99.14 -40.95 7.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 112.191 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -173.55 -168.52 0.45 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.926 -1.109 . . . . 0.0 112.098 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 p -118.4 144.66 45.76 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 8.4 p90 -161.4 -143.35 0.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.738 . . . . 0.0 110.132 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.559 HD11 ' N ' ' A' ' 109' ' ' ARG . 80.9 mt -134.64 162.96 30.83 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.615 -1.303 . . . . 0.0 112.833 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -151.89 129.84 11.76 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.648 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 75.5 m -103.07 127.7 50.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 0.0 111.418 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 86.9 m -74.82 122.56 23.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.746 -0.596 . . . . 0.0 109.568 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.55 129.48 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.4 t30 49.99 39.99 20.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.584 -0.698 . . . . 0.0 111.264 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.42 26.19 73.84 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 62.9 t -137.82 113.02 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -1.038 . . . . 0.0 109.611 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 7.9 t -74.47 121.28 21.23 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.464 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 87.6 m95 -110.01 129.96 55.6 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.493 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.839 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 4.5 t -136.74 179.99 6.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 139' ' ' SER . 30.3 m -90.2 126.37 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.138 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -60.08 -40.89 91.15 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.451 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -74.64 67.06 1.51 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.13 0.967 . . . . 0.0 108.64 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.1 -36.6 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.875 . . . . 0.0 109.366 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.109 . . . . 0.0 109.034 179.324 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.674 HG22 ' HD1' ' A' ' 85' ' ' TRP . 66.7 mt . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.462 0.648 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -95.37 145.25 25.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.791 -0.568 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 11.5 pt20 -75.27 157.41 34.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.669 -0.645 . . . . 0.0 111.101 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.3 mmm -96.88 -39.97 9.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.706 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.33 -178.18 7.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.598 -0.689 . . . . 0.0 109.333 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.852 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.2 m -150.9 125.55 9.63 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.81 76.69 4.24 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.93 -39.23 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 109.466 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -53.84 -26.2 23.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -115.66 0.64 13.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.656 -0.653 . . . . 0.0 110.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t0 60.37 56.82 3.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.893 -1.129 . . . . 0.0 108.591 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.718 HD22 HG11 ' A' ' 170' ' ' VAL . 22.6 tp -142.77 155.47 44.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.869 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.852 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -145.1 137.55 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.435 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.52 125.99 5.19 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.44 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.839 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.5 m-90 -90.04 -170.04 2.64 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -108.44 109.84 21.22 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.965 0 O-C-N 121.508 -0.745 . . . . 0.0 110.556 -179.343 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 121.464 0.65 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 32' ' ' GLU . 4.6 mm? -75.44 153.89 37.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.99 161.49 22.65 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.364 -0.835 . . . . 0.0 110.8 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.492 1.42 0 O-C-N 123.797 1.42 . . . . 0.0 110.083 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.2 m -101.66 7.84 41.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.426 -0.796 . . . . 0.0 111.511 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.88 76.1 1.16 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 108.618 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 145' ' ' CYS . 53.9 mt -95.26 172.42 8.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.753 -0.592 . . . . 0.0 109.808 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 53.0 p90 -152.06 142.2 22.29 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 38.9 tp -115.03 155.8 26.31 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.98 0.895 . . . . 0.0 111.908 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 111' ' ' ALA . 92.4 t -109.97 135.7 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 112' ' ' ASP . 45.1 p -83.25 175.79 9.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.559 ' N ' HD11 ' A' ' 44' ' ' LEU . 70.3 ttt-85 -41.95 -31.29 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.296 0.57 . . . . 0.0 111.422 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -99.99 -70.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.77 -82.44 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.566 -0.709 . . . . 0.0 110.328 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.604 ' HB3' HG23 ' A' ' 108' ' ' THR . 23.2 t0 46.86 90.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.389 -0.82 . . . . 0.0 111.4 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.19 49.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.685 . . . . 0.0 110.439 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.639 HD12 ' CD1' ' A' ' 126' ' ' LEU . 13.1 pt -70.06 156.03 92.49 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.668 ' O ' HD22 ' A' ' 127' ' ' LEU . 43.4 Cg_endo -103.31 141.11 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.982 1.517 . . . . 0.0 111.523 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 167' ' ' VAL . 62.8 t -130.02 130.06 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG2' HD21 ' A' ' 127' ' ' LEU . 21.5 mmm180 -90.26 116.59 28.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 7.3 ttp180 -60.39 123.48 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.93 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -100.01 4.51 44.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 109.935 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.76 176.99 41.78 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 92.5 m-20 -65.64 -21.54 66.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -1.059 . . . . 0.0 110.119 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -124.49 17.0 8.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -140.3 139.93 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.975 -1.078 . . . . 0.0 110.774 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -139.19 144.02 14.77 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 t -90.9 111.97 23.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.789 -0.83 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.639 ' CD1' HD12 ' A' ' 114' ' ' ILE . 44.3 tp -73.49 104.64 4.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.668 HD22 ' O ' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -60.02 -27.43 66.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.225 0.536 . . . . 0.0 110.387 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 t -112.39 105.49 56.12 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.713 -0.617 . . . . 0.0 110.76 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.78 141.74 19.6 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.911 1.479 . . . . 0.0 109.442 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.88 165.23 18.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.573 -0.704 . . . . 0.0 109.258 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.12 125.19 16.93 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.895 1.471 . . . . 0.0 109.935 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -49.64 -25.14 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.799 -0.563 . . . . 0.0 111.254 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.402 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 25.3 t -55.5 -38.12 68.76 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.654 0.74 . . . . 0.0 109.434 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 108' ' ' THR . 53.8 t80 -70.02 -29.18 66.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.87 2.0 50.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.583 -0.698 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 51.9 mttm -70.5 113.01 7.21 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.152 -0.967 . . . . 0.0 108.56 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.7 -9.05 56.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.6 t -75.27 -17.13 60.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.0 109.083 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.693 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -65.14 146.21 55.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 179.367 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.562 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 96.85 -14.98 63.39 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.54 -158.08 0.61 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.747 ' HG3' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -142.74 140.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 116.683 -1.745 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 4.5 mp -97.08 97.33 9.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -90.01 138.13 31.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.689 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.03 -154.89 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.469 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -104.16 15.04 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.453 1.238 . . . . 0.0 110.365 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 m -117.14 16.9 14.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.44 37.59 46.8 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.0 m-70 -125.2 132.08 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.85 119.97 37.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.18 -1.56 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.269 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.89 126.85 2.35 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.506 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.443 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.3 mt -109.94 117.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.105 -1.232 . . . . 0.0 108.283 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.433 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 15.2 t80 -50.92 128.67 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.419 ' HB3' HG23 ' A' ' 170' ' ' VAL . 34.5 ptt180 -119.34 -25.56 6.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.722 -0.612 . . . . 0.0 111.648 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.44 12.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 111.827 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.433 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -95.99 140.1 31.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.4 t -89.95 92.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 61.8 m -92.59 118.17 30.73 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.696 0.76 . . . . 0.0 111.028 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.648 HG22 ' HG3' ' A' ' 161' ' ' ARG . 96.7 m -89.94 -78.38 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 160' ' ' THR . 59.6 mtp85 -105.99 54.58 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 81.79 16.57 72.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -146.36 141.31 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.353 -1.086 . . . . 0.0 108.335 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -84.52 128.29 34.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.545 -0.722 . . . . 0.0 111.047 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -120.0 15.83 12.48 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.163 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.31 145.87 2.23 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -121.65 135.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.698 -177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -102.57 147.34 26.9 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 41.5 p90 -152.65 165.16 36.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.089 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.718 HG11 HD22 ' A' ' 82' ' ' LEU . 67.3 t -81.65 131.81 56.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.09 143.1 31.88 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.887 1.467 . . . . 0.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.77 -29.94 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 109.659 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 177' ' ' THR . 86.4 tt0 -58.98 -33.09 70.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 m -75.54 -29.65 59.48 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.855 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.595 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.5 mtp -69.95 -39.88 75.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 109.586 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.04 -39.92 87.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.73 -0.606 . . . . 0.0 110.069 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 173' ' ' GLU . 64.6 p . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.453 -0.78 . . . . 0.0 109.823 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 121.157 0.503 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.3 t -111.26 126.32 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.0 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -96.25 139.85 31.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.417 0.627 . . . . 0.0 110.341 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.639 ' HA ' HD23 ' A' ' 44' ' ' LEU . 99.0 t -80.33 140.16 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.92 159.97 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 122.346 1.069 . . . . 0.0 112.0 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 78.2 p -148.5 116.93 6.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 59' ' ' ALA . 30.2 p -108.71 179.98 4.03 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.396 0.617 . . . . 0.0 109.651 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.65 -16.27 15.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -111.29 -27.35 8.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 113.166 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -170.93 -170.01 0.83 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.582 -1.324 . . . . 0.0 112.54 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 75.3 m -127.84 140.79 51.82 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.7 p90 -159.69 -141.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 109.996 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 35' ' ' VAL . 84.4 mt -136.82 171.16 14.92 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.594 -1.316 . . . . 0.0 113.39 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -148.11 122.91 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.389 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 142' ' ' PRO . 93.5 m -85.89 120.83 27.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.592 -0.693 . . . . 0.0 110.541 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.46 119.7 19.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.362 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' CG2' HG22 ' A' ' 46' ' ' THR . 41.5 t -140.89 131.88 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.37 -0.831 . . . . 0.0 110.465 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 52.86 40.03 30.05 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.508 -0.745 . . . . 0.0 111.025 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.625 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.59 27.36 73.58 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.487 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 84.0 t -140.0 118.87 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.542 -0.976 . . . . 0.0 109.675 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -74.04 129.01 37.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.516 ' CD2' ' HB2' ' A' ' 175' ' ' MET . 90.2 m95 -117.33 120.06 37.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.813 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.661 ' O ' HD23 ' A' ' 82' ' ' LEU . 6.5 t -129.15 -178.16 4.53 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.565 HG13 ' CA ' ' A' ' 140' ' ' GLY . 24.1 m -88.42 134.54 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 C-N-CA 118.942 -1.103 . . . . 0.0 113.359 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -64.37 -40.0 94.98 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.366 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.478 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.8 p-80 -71.65 75.07 0.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.09 0.948 . . . . 0.0 109.326 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.55 -42.61 0.49 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.774 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.671 -0.9 . . . . 0.0 110.915 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.522 3.148 0 CA-C-O 121.181 0.515 . . . . 0.0 112.377 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.709 -0.619 . . . . 0.0 109.6 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -88.1 136.49 32.95 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 111.436 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 19.4 pt20 -73.3 146.47 45.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.812 -0.555 . . . . 0.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.11 -37.71 8.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.517 -0.739 . . . . 0.0 109.955 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.96 -177.56 1.95 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.503 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.0 t -159.99 143.6 14.16 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.732 0.777 . . . . 0.0 110.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.92 80.67 1.46 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.93 -39.99 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.74 . . . . 0.0 110.056 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -56.58 -26.55 55.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.288 -0.883 . . . . 0.0 108.853 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -110.39 2.44 19.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.717 -0.614 . . . . 0.0 110.706 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 60.56 56.38 3.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 111.336 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 54' ' ' THR . 2.3 mt -144.54 150.56 37.73 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.527 -0.733 . . . . 0.0 110.261 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -136.95 128.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.27 123.56 5.7 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 118.876 -1.63 . . . . 0.0 113.222 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.491 ' CD1' HD23 ' A' ' 64' ' ' LEU . 5.8 m-90 -92.69 -170.78 2.55 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 122.025 -0.691 . . . . 0.0 109.676 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.2 100.99 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 111.091 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.901 HD13 HD21 ' A' ' 144' ' ' LEU . 68.2 mt -91.37 154.38 19.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.834 -0.541 . . . . 0.0 110.088 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.51 164.51 17.03 Favored Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.555 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.67 ' HB3' HG11 ' A' ' 172' ' ' VAL . 51.5 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 123.87 1.458 . . . . 0.0 110.324 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.2 m -95.4 20.43 9.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.629 -0.669 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -69.97 73.7 0.44 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.611 -0.681 . . . . 0.0 109.188 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 118' ' ' ARG . 76.5 mt -90.17 174.48 7.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.2 p90 -153.14 144.53 23.24 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' PRO . 28.1 tp -116.35 142.53 46.73 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.705 0.764 . . . . 0.0 111.297 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -91.66 125.08 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HD12 ' A' ' 114' ' ' ILE . 72.0 p -85.82 170.66 12.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.731 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -28.89 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.892 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 108' ' ' THR . 73.6 m-70 -99.99 -86.32 0.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.132 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.64 22.33 0.12 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.191 -0.943 . . . . 0.0 111.358 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -66.43 129.07 38.61 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.052 -1.03 . . . . 0.0 110.466 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -69.97 -53.38 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.686 -0.634 . . . . 0.0 110.514 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.741 ' CG2' HD11 ' A' ' 126' ' ' LEU . 83.1 mt 46.46 73.69 0.94 Allowed Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.526 -0.734 . . . . 0.0 111.083 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -59.74 130.52 35.47 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.864 1.455 . . . . 0.0 111.187 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HD12 ' A' ' 126' ' ' LEU . 60.9 t -127.95 131.98 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -87.64 124.59 33.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 108.708 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.652 ' HB2' HD12 ' A' ' 104' ' ' LEU . 3.1 ttm180 -63.93 123.01 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.549 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -97.88 1.45 48.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.4 170.23 38.08 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.1 m-20 -58.7 -23.74 60.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.158 -1.201 . . . . 0.0 110.365 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 93.0 p -121.67 17.6 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 112.331 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -144.07 142.39 30.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.03 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.43 142.71 13.4 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 116' ' ' VAL . 25.0 p -88.77 114.84 25.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.839 -0.8 . . . . 0.0 109.477 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 116' ' ' VAL . 20.5 tp -72.26 109.98 6.38 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.92 -20.58 65.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.86 -0.525 . . . . 0.0 110.375 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -117.67 84.23 19.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.744 -0.597 . . . . 0.0 109.962 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -58.34 138.29 85.04 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.761 1.4 . . . . 0.0 110.381 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -152.99 164.69 19.53 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.55 127.43 24.59 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.77 1.405 . . . . 0.0 110.473 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -50.11 -25.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.814 -0.554 . . . . 0.0 110.702 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -59.91 -37.63 79.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.577 -0.702 . . . . 0.0 109.469 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -69.01 -25.86 64.72 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.76 -1.73 44.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.46 -0.775 . . . . 0.0 110.406 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -70.17 122.1 18.82 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.152 -0.968 . . . . 0.0 108.563 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.92 -11.41 64.23 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.1 t -79.03 -16.23 57.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.443 -1.034 . . . . 0.0 109.672 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.552 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.9 m -62.26 147.42 48.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.565 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.09 -9.91 75.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -68.9 -169.56 5.97 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.1 Cg_endo -140.34 142.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 116.974 -1.551 . . . . 0.0 112.396 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.5 mp -96.59 96.35 8.59 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.901 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -87.39 141.55 28.55 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.575 ' HA ' HD23 ' A' ' 104' ' ' LEU . 85.2 m -63.71 -173.0 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.2 Cg_endo -87.79 17.27 1.74 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 117.249 -1.368 . . . . 0.0 111.6 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -122.03 18.11 10.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.07 -1.018 . . . . 0.0 111.764 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.14 35.74 37.42 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -122.87 123.38 40.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.374 -1.074 . . . . 0.0 110.34 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.95 123.33 34.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.621 -0.674 . . . . 0.0 110.179 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.02 -2.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.638 -0.664 . . . . 0.0 111.694 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -145.45 126.66 2.63 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.419 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 170' ' ' VAL . 18.1 mt -110.07 121.76 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.188 -1.184 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.834 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 8.0 t80 -51.76 122.83 8.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.841 0.829 . . . . 0.0 112.442 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.499 ' HB2' HG13 ' A' ' 170' ' ' VAL . 39.6 ttt-85 -115.9 -29.41 6.37 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -166.07 169.43 14.56 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.926 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.834 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -139.48 155.12 47.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 15.5 m -107.6 105.39 18.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.742 0.782 . . . . 0.0 109.501 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.5 p -95.36 121.84 37.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 110.36 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.548 HG22 ' HG3' ' A' ' 161' ' ' ARG . 91.0 m -89.98 -79.89 0.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.567 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.548 ' HG3' HG22 ' A' ' 160' ' ' THR . 99.6 mtt180 -96.96 52.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.96 15.94 77.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.2 m -144.67 140.01 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.386 -1.067 . . . . 0.0 108.35 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -81.56 116.93 21.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.657 0.741 . . . . 0.0 111.675 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.57 8.12 45.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.722 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -171.53 141.83 1.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.286 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.645 HG21 HG11 ' A' ' 116' ' ' VAL . 20.1 m -109.62 143.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.713 0.768 . . . . 0.0 112.687 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -111.19 142.07 43.88 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 34.2 p90 -152.83 165.04 36.65 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.276 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 155' ' ' ARG . 26.9 m -90.68 133.03 33.33 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.908 -0.495 . . . . 0.0 110.015 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.63 157.2 56.35 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.719 1.378 . . . . 0.0 109.936 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.711 HG23 ' HE3' ' A' ' 175' ' ' MET . 7.1 p -64.36 -27.23 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.49 -0.756 . . . . 0.0 109.594 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 177' ' ' THR . 86.2 tt0 -58.59 -25.39 62.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 108.547 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.3 m -74.15 -40.1 62.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.596 -0.69 . . . . 0.0 111.934 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.711 ' HE3' HG23 ' A' ' 172' ' ' VAL . 16.7 ptp -69.85 -41.06 75.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.667 -1.271 . . . . 0.0 108.815 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 175' ' ' MET . 98.9 mt-10 -59.98 -39.97 87.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.793 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 173' ' ' GLU . 43.4 p . . . . . 0 N--CA 1.498 1.966 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.179 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.218 0.532 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG22 ' HD1' ' A' ' 85' ' ' TRP . 94.5 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.136 0.493 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 4.4 pp0? -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.093 0.473 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.0 m-70 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.537 ' CG ' HD21 ' A' ' 94' ' ' LEU . 94.9 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.411 0.624 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.8 t -130.02 133.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -139.96 151.96 45.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 44' ' ' LEU . 63.5 t -82.77 137.82 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 65' ' ' ALA . 9.1 m -143.95 170.16 9.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -150.63 149.26 29.63 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.928 0.87 . . . . 0.0 109.603 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.7 t -119.69 -180.0 4.06 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.62 -16.25 2.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.612 -0.68 . . . . 0.0 112.274 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 38' ' ' THR . 76.3 p -98.27 -37.21 9.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.902 -1.124 . . . . 0.0 112.887 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -171.48 -174.21 1.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.805 -1.184 . . . . 0.0 112.313 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.3 p -116.76 143.74 45.29 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.663 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.9 p90 -162.52 -139.09 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 35' ' ' VAL . 76.1 mt -134.57 164.61 27.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 113.363 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.45 125.29 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.315 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.776 ' CG2' HD11 ' A' ' 153' ' ' ILE . 5.9 t -83.55 -152.0 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 0.0 110.745 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.521 ' N ' HG23 ' A' ' 46' ' ' THR . 13.6 t -159.35 113.52 2.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.417 HG12 ' OD1' ' A' ' 49' ' ' ASN . 57.1 t -138.71 135.52 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.299 -0.961 . . . . 0.0 111.371 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' HG12 ' A' ' 48' ' ' VAL . 27.7 m120 49.99 39.98 20.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.667 -0.645 . . . . 0.0 110.935 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.729 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.28 24.93 74.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.0 t -133.7 113.66 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.831 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 130.08 38.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.1 m95 -118.46 133.93 55.48 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.453 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.814 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -139.01 -178.47 5.35 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.677 HG13 ' CA ' ' A' ' 140' ' ' GLY . 21.2 m -82.77 134.26 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.671 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 49.7 t80 -64.22 -39.96 95.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 11.5 p-80 -63.11 -16.27 59.43 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.531 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 38' ' ' THR . . . -90.7 -82.7 1.4 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.397 -1.061 . . . . 0.0 111.19 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD22 ' CZ2' ' A' ' 85' ' ' TRP . 20.2 tp . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.316 0.103 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.057 0 O-C-N 120.876 -1.14 . . . . 0.0 110.565 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 120.869 0.366 . . . . 0.0 110.198 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 70.0 m -139.32 132.86 30.34 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 8.1 pt20 -76.22 153.22 36.25 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.444 -0.785 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.5 ttp -107.88 -30.05 8.71 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -148.84 167.71 24.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.891 HG23 ' CG1' ' A' ' 83' ' ' VAL . 29.7 m -154.03 114.15 3.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.636 -0.665 . . . . 0.0 110.428 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 76.98 4.22 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.746 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 98.3 t -59.95 -40.0 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.405 -0.809 . . . . 0.0 109.724 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.55 -25.85 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.68 -1.23 16.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.792 -0.567 . . . . 0.0 110.703 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.92 57.72 3.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.1 -1.0 . . . . 0.0 109.332 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 170' ' ' VAL . 42.9 tp -147.77 153.55 39.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.691 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.891 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -143.09 131.78 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.73 124.79 5.79 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.768 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.3 m-90 -84.69 170.01 13.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 122.049 -0.677 . . . . 0.0 109.771 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.28 89.29 4.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 109.352 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.552 -0.717 . . . . 0.0 110.532 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.231 0.539 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 ' CG ' ' A' ' 32' ' ' GLU . 97.1 mt -90.14 170.03 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 110.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 92.6 m -111.94 164.18 15.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 52.6 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.639 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.136 0.493 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -89.95 11.76 19.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.0 111.386 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -70.01 80.08 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 108.694 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 143' ' ' LEU . 96.0 mt -86.62 176.73 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.66 . . . . 0.0 110.95 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -146.24 100.89 3.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HG ' ' A' ' 143' ' ' LEU . 35.0 tp -76.24 139.95 41.39 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.513 0.673 . . . . 0.0 110.013 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 33' ' ' VAL . 78.3 t -85.32 111.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' ALA . 55.5 p -81.38 172.39 13.61 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -42.6 -27.95 0.2 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.712 -0.618 . . . . 0.0 112.149 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -100.01 -68.91 0.79 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.407 -0.808 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 108' ' ' THR . . . -146.53 -161.71 1.38 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 26.8 p-10 -60.0 -44.69 94.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.535 -0.728 . . . . 0.0 110.244 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.7 t 46.28 -89.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.625 HD12 ' CD1' ' A' ' 126' ' ' LEU . 50.1 pt -74.84 142.82 77.2 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 112.712 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 44.1 Cg_endo -105.81 141.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 O-C-N 123.777 1.409 . . . . 0.0 108.718 177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 167' ' ' VAL . 41.8 t -133.93 133.13 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.028 -1.045 . . . . 0.0 111.447 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -92.61 119.25 31.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.4 ttm180 -61.06 126.02 25.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 110.798 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -99.1 1.4 45.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.803 -0.56 . . . . 0.0 109.698 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.13 43.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 86.4 m-20 -67.19 -21.87 65.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.7 p -123.38 16.33 9.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.513 -0.742 . . . . 0.0 111.46 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.39 143.56 35.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.072 -1.018 . . . . 0.0 111.244 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -143.34 139.21 8.71 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.48 ' C ' HG13 ' A' ' 116' ' ' VAL . 17.6 t -88.84 110.51 21.11 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.909 -0.76 . . . . 0.0 110.125 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.625 ' CD1' HD12 ' A' ' 114' ' ' ILE . 59.6 tp -71.03 114.58 9.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.782 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.5 mm? -68.87 -25.0 64.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.234 0.54 . . . . 0.0 110.335 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.8 m -120.82 84.54 38.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.763 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.2 Cg_endo -61.69 143.26 96.31 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.919 1.483 . . . . 0.0 110.039 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -152.96 167.78 12.72 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -57.54 125.29 18.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.773 1.407 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.9 -25.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.749 -0.594 . . . . 0.0 110.931 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.411 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 21.1 t -57.93 -34.95 70.42 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 109.496 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.87 1.52 38.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.549 -0.719 . . . . 0.0 110.913 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.0 mtpt -72.33 68.92 0.78 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.129 0.966 . . . . 0.0 109.173 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 157.05 -21.28 0.43 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.536 ' HA ' HD12 ' A' ' 44' ' ' LEU . 16.8 t -75.0 -11.45 60.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.506 -0.997 . . . . 0.0 110.367 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -68.71 150.9 47.37 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.314 -0.866 . . . . 0.0 109.216 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . 0.677 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 87.31 -11.49 65.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -70.54 -167.41 6.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PRO . . . . . 0.517 ' HG3' HG22 ' A' ' 33' ' ' VAL . 49.0 Cg_endo -139.98 140.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 116.866 -1.623 . . . . 0.0 111.622 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.482 ' HB3' HD13 ' A' ' 104' ' ' LEU . 2.5 mt -92.67 99.2 11.94 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.4 mp -86.47 142.39 28.41 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.797 0.808 . . . . 0.0 112.759 -176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.04 -170.15 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.36 12.55 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.62 1.326 . . . . 0.0 111.031 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -119.86 -18.95 8.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 111.36 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 39.12 0.81 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 55.9 m80 -122.96 118.65 28.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -1.043 . . . . 0.0 110.538 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -81.08 120.29 24.64 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 109.354 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.18 -3.89 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 112.068 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.462 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.6 124.41 1.85 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.362 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.776 HD11 ' CG2' ' A' ' 46' ' ' THR . 14.9 mt -106.12 121.75 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.014 -1.286 . . . . 0.0 109.009 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.839 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.5 t80 -51.36 124.53 12.09 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.76 0.791 . . . . 0.0 111.978 -178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.0 ttt180 -114.63 -34.13 5.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.843 -0.535 . . . . 0.0 110.818 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.54 164.41 26.89 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.488 -0.757 . . . . 0.0 110.326 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.839 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.78 158.06 37.55 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 2.7 t -99.96 98.79 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.9 p -96.23 118.27 32.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.432 1.11 . . . . 0.0 112.32 -177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 162' ' ' GLY . 90.9 m -93.45 119.52 32.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' THR . 32.0 ttm105 65.51 -64.4 0.19 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.958 -0.464 . . . . 0.0 110.135 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.449 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -165.1 25.54 0.18 Allowed Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.819 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.2 m -148.9 139.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -1.186 . . . . 0.0 109.494 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -82.26 123.01 28.65 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.596 0.712 . . . . 0.0 111.679 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -113.83 17.65 17.89 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.25 0.548 . . . . 0.0 109.851 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -172.43 149.34 2.16 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 116' ' ' VAL . 13.8 m -127.4 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.64 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -107.39 149.5 27.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.3 p90 -152.13 166.36 31.91 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.234 -1.386 . . . . 0.0 112.174 -178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 82' ' ' LEU . 66.8 t -80.98 137.41 49.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -78.35 141.35 18.0 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.839 1.442 . . . . 0.0 110.739 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.02 -29.98 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.72 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.06 -32.84 70.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.393 -0.817 . . . . 0.0 108.981 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.8 t -72.1 -33.63 68.01 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' MET . . . . . 0.595 ' CG ' HD21 ' A' ' 82' ' ' LEU . 10.4 mtp -70.03 -36.26 74.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.781 -0.574 . . . . 0.0 110.036 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.417 -0.802 . . . . 0.0 110.792 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.133 0.492 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.9 167.53 43.16 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 18.9 tpt180 -70.03 -61.28 1.84 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.459 -1.024 . . . . 0.0 109.758 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 t0 48.43 49.96 17.4 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.717 -0.614 . . . . 0.0 112.612 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 67' ' ' PRO . 32.2 mttt -115.31 172.48 7.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 110.706 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 63.77 123.94 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.968 -1.083 . . . . 0.0 109.341 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -58.13 127.37 31.74 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.33 -0.856 . . . . 0.0 110.737 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 90' ' ' GLY . 93.8 t -86.43 -53.27 10.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.516 0.674 . . . . 0.0 110.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 48.21 37.39 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.695 -0.628 . . . . 0.0 111.209 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.02 134.1 8.51 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HG2' HD21 ' A' ' 94' ' ' LEU . 57.8 mp0 -69.92 -40.08 75.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.878 . . . . 0.0 110.166 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -123.52 129.98 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -116.63 127.78 54.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.688 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.766 HG22 HD21 ' A' ' 44' ' ' LEU . 98.5 t -84.33 136.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.91 174.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.534 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -138.24 136.19 36.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.093 0.949 . . . . 0.0 109.129 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 59' ' ' ALA . 19.4 p -113.64 179.9 3.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.912 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.64 32.92 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.5 p -104.78 -36.73 7.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.302 -0.873 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.6 -169.14 0.48 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.853 -1.154 . . . . 0.0 111.957 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.1 m -123.71 143.76 50.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.862 -0.524 . . . . 0.0 109.601 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.2 p90 -160.26 -138.12 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.549 -0.719 . . . . 0.0 109.911 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.766 HD21 HG22 ' A' ' 35' ' ' VAL . 82.0 mt -135.4 166.64 22.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.421 -1.425 . . . . 0.0 113.653 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -150.05 122.81 8.66 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.243 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 142' ' ' PRO . 32.7 m -101.14 127.21 47.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.44 -0.787 . . . . 0.0 111.729 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.618 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 93.3 m -74.11 123.11 23.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.825 -0.547 . . . . 0.0 109.827 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.95 130.04 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.455 -0.778 . . . . 0.0 110.096 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.67 40.01 29.45 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.476 -0.765 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.19 28.04 73.49 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 63.5 t -140.04 117.0 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.963 . . . . 0.0 109.29 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 8.4 t -76.28 122.99 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.294 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.49 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 95.5 m95 -113.48 130.02 56.42 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.607 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 11.8 t -133.08 -179.75 5.68 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 140' ' ' GLY . 7.0 m -90.72 131.0 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.076 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.92 -40.04 87.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.722 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 49.8 p-80 -74.82 68.74 1.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.29 1.043 . . . . 0.0 108.829 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.0 -38.43 0.16 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.8 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -80.02 -66.79 0.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.792 -0.828 . . . . 0.0 109.182 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.52 -98.84 1.06 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -91.28 46.36 1.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.907 . . . . 0.0 110.629 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HD2' HG23 ' A' ' 72' ' ' THR . 16.6 pttt 37.54 -130.34 0.16 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.037 0.535 . . . . 0.0 111.5 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 63' ' ' THR . 49.8 m 47.34 54.11 9.99 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.243 -0.911 . . . . 0.0 111.919 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.468 ' H ' HD23 ' A' ' 64' ' ' LEU . 0.6 OUTLIER -86.95 -132.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -141.25 109.02 5.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -73.06 -149.51 1.15 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' CG ' ' O ' ' A' ' 26' ' ' LYS . 42.0 Cg_endo -60.18 -32.15 94.11 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 124.321 1.695 . . . . 0.0 109.259 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 24' ' ' ARG . 19.9 ptmt -153.33 -2.67 0.21 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.91 162.44 28.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.648 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.2 125.8 16.53 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.956 1.503 . . . . 0.0 111.014 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 39.8 mt -104.86 152.61 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 0.0 109.676 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 62' ' ' LYS . 91.3 m -96.24 144.83 26.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.731 -0.606 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 14.8 pt20 -75.94 151.4 37.3 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.574 -0.704 . . . . 0.0 110.784 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.6 ttt -98.78 -39.84 8.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.547 -0.721 . . . . 0.0 110.398 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.552 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.8 OUTLIER -139.97 166.75 23.82 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.918 HG23 ' CG1' ' A' ' 83' ' ' VAL . 24.0 m -154.68 111.06 3.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.628 -0.67 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.86 78.61 5.38 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -40.0 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.428 -0.795 . . . . 0.0 109.767 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -55.74 -26.22 44.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 0.0 109.003 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -111.66 -0.71 15.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.736 -0.602 . . . . 0.0 110.762 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.7 t70 59.95 57.75 2.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.105 -0.997 . . . . 0.0 109.553 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.713 HD13 HG11 ' A' ' 170' ' ' VAL . 52.8 tp -146.23 152.37 39.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.92 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.918 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -143.11 127.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.25 123.96 5.76 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.262 -1.446 . . . . 0.0 111.753 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.2 m-90 -84.72 -174.94 5.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.144 -0.621 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -110.07 73.71 0.85 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.34 130.87 88.87 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 121.791 -0.568 . . . . 0.0 111.436 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.615 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 40.6 Cg_endo -134.14 -91.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.65 0 O-C-N 123.658 1.346 . . . . 0.0 110.422 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.9 Cg_endo -81.93 8.64 4.34 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 114.855 -2.964 . . . . 0.0 111.494 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 29' ' ' VAL . . . -118.5 43.58 1.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.618 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -175.43 134.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -1.048 . . . . 0.0 110.651 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -73.48 -28.49 61.96 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.545 0.688 . . . . 0.0 110.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.67 115.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.39 0.614 . . . . 0.0 111.151 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.986 HD13 HD11 ' A' ' 144' ' ' LEU . 85.1 mt -85.65 167.09 15.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.661 -0.649 . . . . 0.0 110.121 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.444 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 3.8 m -89.49 135.23 31.21 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.1 -85.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.054 0 O-C-N 123.894 1.471 . . . . 0.0 110.067 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.34 114.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.081 -1.012 . . . . 0.0 110.463 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 99' ' ' CYS . 94.1 m -61.05 -40.05 92.16 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.412 -0.805 . . . . 0.0 111.848 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.6 m 61.79 117.3 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.418 -0.801 . . . . 0.0 111.754 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.98 -38.73 92.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -70.48 148.9 47.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.952 -0.734 . . . . 0.0 109.208 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -117.46 14.62 14.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 111.375 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.18 75.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 108.786 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 145' ' ' CYS . 79.8 mt -84.28 176.19 8.9 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.479 0.657 . . . . 0.0 111.125 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.9 m-85 -140.96 131.89 26.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.96 148.13 35.68 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.946 0.879 . . . . 0.0 111.529 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 111' ' ' ALA . 83.9 t -119.97 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 112' ' ' ASP . 26.7 p -81.08 179.9 7.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.287 -0.883 . . . . 0.0 109.525 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.552 ' O ' HG21 ' A' ' 35' ' ' VAL . 13.0 ptm180 -41.87 -29.9 0.23 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -116.66 -50.01 2.63 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.12 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -156.86 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.934 -1.104 . . . . 0.0 111.597 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 108' ' ' THR . 16.9 t70 47.08 73.67 0.18 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.088 -1.008 . . . . 0.0 111.203 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -82.56 99.99 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.189 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.8 mm -120.95 150.01 52.21 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.753 -0.592 . . . . 0.0 109.542 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 48.3 Cg_endo -90.44 133.03 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 124.015 1.534 . . . . 0.0 110.559 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 167' ' ' VAL . 61.7 t -127.57 130.03 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -90.34 118.23 29.68 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.496 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.6 ttp180 -62.07 125.8 25.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.805 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -98.43 4.36 48.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.787 -0.571 . . . . 0.0 109.569 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.99 170.67 32.17 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 107.436 -2.266 . . . . 0.0 107.436 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 78.2 m-20 -60.83 -19.69 60.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -1.022 . . . . 0.0 110.122 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -121.56 15.98 11.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 0.0 111.822 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -146.08 143.27 29.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.987 -1.07 . . . . 0.0 111.431 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.51 141.85 11.81 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.4 ' C ' HG13 ' A' ' 116' ' ' VAL . 3.4 m -90.3 111.6 22.85 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.951 -0.735 . . . . 0.0 110.326 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 116' ' ' VAL . 55.5 tp -73.56 109.93 7.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.347 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.8 mm? -60.03 -30.0 68.89 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.4 m -114.25 97.75 46.6 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.516 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.91 142.18 74.34 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.909 1.478 . . . . 0.0 109.965 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -149.99 161.06 32.3 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.81 122.84 12.42 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.832 1.438 . . . . 0.0 110.92 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.98 -28.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 t -59.01 -34.9 72.4 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.66 0.743 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 108' ' ' THR . 72.7 t80 -70.04 -27.32 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.47 5.6 30.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.484 -0.76 . . . . 0.0 110.858 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -68.11 110.16 3.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.04 55.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.6 p -74.9 -17.93 60.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -1.04 . . . . 0.0 109.056 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.09 149.51 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 108.885 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 55' ' ' VAL . . . 91.16 -9.51 77.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -77.15 -151.52 4.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.693 ' HG3' HG22 ' A' ' 33' ' ' VAL . 51.7 Cg_endo -147.5 148.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 116.307 -1.996 . . . . 0.0 112.921 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.451 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.4 mp -99.89 98.43 9.21 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.986 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -83.43 135.61 34.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.553 ' HA ' HD23 ' A' ' 104' ' ' LEU . 84.4 m -58.82 175.6 0.32 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 40.5 Cg_endo -72.11 -5.04 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 117.215 -1.39 . . . . 0.0 110.977 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.402 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 9.8 t -106.14 -0.22 24.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.905 -1.122 . . . . 0.0 112.27 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.84 6.55 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 34.7 m170 -114.04 118.53 34.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.34 121.86 24.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.394 -0.816 . . . . 0.0 110.685 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.03 -4.12 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.799 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.472 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -152.79 131.08 3.22 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.279 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.504 HD12 ' CE ' ' A' ' 175' ' ' MET . 74.5 mt -109.91 119.14 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.098 -1.236 . . . . 0.0 108.163 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 16.9 t80 -49.99 129.29 20.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.393 -0.817 . . . . 0.0 112.362 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.409 ' HB2' HG23 ' A' ' 170' ' ' VAL . 41.8 ttt180 -117.22 -30.08 5.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.938 -0.476 . . . . 0.0 111.569 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.82 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.08 146.56 12.51 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.585 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.97 138.29 37.24 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 166' ' ' ALA . 42.9 t -95.72 90.97 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 29.1 p -94.03 122.24 36.33 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.115 0.96 . . . . 0.0 112.111 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 161' ' ' ARG . 80.4 m -87.1 -102.07 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.116 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 160' ' ' THR . 12.8 tpt180 -59.98 -50.0 75.47 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.601 -1.312 . . . . 0.0 109.464 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.443 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -176.18 30.53 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.762 HG23 ' HD3' ' A' ' 165' ' ' LYS . 33.0 m -149.84 145.89 17.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -75.92 125.34 28.91 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 0.0 111.24 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.762 ' HD3' HG23 ' A' ' 163' ' ' VAL . 4.2 mmmm -103.88 7.14 36.84 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.298 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.26 137.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.552 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -105.82 134.68 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.428 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -100.41 146.59 26.82 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 40.3 p90 -152.55 162.96 40.5 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.314 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 82' ' ' LEU . 61.0 t -79.82 143.76 58.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.499 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.75 141.54 9.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.747 1.393 . . . . 0.0 111.717 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.499 HG23 ' SD ' ' A' ' 175' ' ' MET . 14.9 p -69.05 -27.67 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.08 -28.69 66.72 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.3 t -70.65 -26.28 63.38 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 153' ' ' ILE . 66.3 mtt -69.32 -36.62 77.14 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.778 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.9 p -60.74 -40.06 90.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.011 -1.056 . . . . 0.0 109.525 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.552 HG23 ' CG ' ' A' ' 75' ' ' TYR . 94.4 m -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.61 -39.89 89.84 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.7 -39.73 92.52 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.742 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -163.55 121.01 1.83 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.886 -0.509 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 184' ' ' LYS . 12.9 p -72.87 87.87 1.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.956 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 182' ' ' SER . 57.7 tptt 63.58 -61.78 0.15 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.218 -0.301 . . . . 0.0 111.303 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 182' ' ' SER . 84.0 tttt 53.22 58.77 4.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.965 -1.084 . . . . 0.0 110.403 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -70.54 -39.93 73.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.506 0.669 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.5 mttp . . . . . 0 C--N 1.294 -1.833 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.278 -179.855 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.82 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.168 0.509 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.9 143.15 14.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -120.03 139.98 51.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.635 -0.921 . . . . 0.0 110.391 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -81.26 161.71 23.82 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.798 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -80.04 70.03 6.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.594 -0.691 . . . . 0.0 111.624 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 67' ' ' PRO . 17.4 t-20 47.26 25.05 0.5 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.49 -0.756 . . . . 0.0 112.309 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.441 HG13 ' CD ' ' A' ' 34' ' ' GLN . 42.4 t -85.14 -69.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.544 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 44.9 39.95 4.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.61 -0.681 . . . . 0.0 112.476 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.46 143.47 11.56 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.542 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.76 -40.02 72.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.795 -0.826 . . . . 0.0 109.985 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -119.89 123.45 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.441 ' CD ' HG13 ' A' ' 29' ' ' VAL . 28.2 mm100 -94.68 122.84 37.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.719 . . . . 0.0 111.314 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.1 t -82.78 132.83 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.79 175.13 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.756 0.788 . . . . 0.0 110.427 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 58.1 m -140.04 149.82 43.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.4 t -116.8 79.03 1.27 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.376 1.084 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.45 -52.51 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.449 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -120.7 9.28 10.73 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.585 -1.322 . . . . 0.0 113.966 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' SER . 16.6 pt20 -161.73 178.07 9.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.628 -1.295 . . . . 0.0 112.236 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.7 m -129.92 150.2 51.31 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.218 0.532 . . . . 0.0 109.942 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 9.9 p90 -160.32 -148.14 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 0.0 109.414 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' SER . 93.5 mt -136.42 165.34 26.05 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.608 -1.308 . . . . 0.0 113.772 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -152.42 130.71 12.03 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.41 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 142' ' ' PRO . 99.7 m -99.9 120.46 39.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.402 -0.811 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -72.15 124.58 25.31 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.14 127.66 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 50.1 39.97 20.54 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.552 -0.718 . . . . 0.0 111.432 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.35 73.6 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.9 t -137.7 115.04 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -1.111 . . . . 0.0 109.348 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 29.1 t -75.4 119.68 19.83 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.25 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 84.9 m95 -108.53 127.42 53.92 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.869 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 6.9 t -133.99 -178.6 5.1 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.638 HG23 ' HA3' ' A' ' 58' ' ' GLY . 21.2 m -93.24 131.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.238 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.0 -41.89 93.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.764 ' CG ' HD22 ' A' ' 188' ' ' 2ZF . 45.9 p-80 -70.0 -14.5 62.73 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.699 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 38' ' ' THR . . . -93.1 -47.94 2.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . -90.02 -79.97 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.8 -0.823 . . . . 0.0 109.066 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.53 13.22 Favored Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.3 -0.875 . . . . 0.0 111.086 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 63' ' ' THR . 69.9 m -136.01 13.31 3.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.251 -1.146 . . . . 0.0 111.818 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' SER . 26.9 ttpt 60.05 -71.29 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 0.0 111.715 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' SER . 8.9 m -77.3 145.76 37.23 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.831 0.824 . . . . 0.0 111.494 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.427 ' N ' HD23 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -147.05 -119.29 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.34 95.47 1.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.739 -1.225 . . . . 0.0 109.424 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -99.92 -171.1 30.0 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.639 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 27' ' ' ASN . 44.2 Cg_endo -62.76 -21.97 73.49 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 124.154 1.607 . . . . 0.0 110.679 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HG2' HD11 ' A' ' 71' ' ' ILE . 17.1 ptpt -102.54 -4.52 25.17 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.054 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.65 -150.42 18.05 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.428 ' HB2' ' CG2' ' A' ' 63' ' ' THR . 42.3 Cg_endo -64.63 112.47 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.001 1.527 . . . . 0.0 110.477 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.605 HD12 ' HA3' ' A' ' 66' ' ' GLY . 55.3 mt -101.67 149.92 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.371 0.605 . . . . 0.0 109.941 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.83 153.1 17.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.681 -0.637 . . . . 0.0 110.381 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 22.3 pt20 -80.09 159.97 25.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.658 -0.652 . . . . 0.0 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.2 ttp -101.91 -32.19 10.34 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.632 -0.667 . . . . 0.0 109.592 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' CE1' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -149.99 168.98 22.29 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 91.0 m -153.84 118.55 4.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.382 -0.824 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -101.05 74.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 76' ' ' THR . 87.7 t -59.96 -38.65 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.52 -0.738 . . . . 0.0 109.725 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -54.34 -26.79 31.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.512 -0.743 . . . . 0.0 109.03 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.61 0.71 14.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.733 -0.605 . . . . 0.0 111.05 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 60.07 56.84 3.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.577 HD21 ' HG3' ' A' ' 175' ' ' MET . 35.5 tp -145.96 146.57 31.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.06 136.62 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -122.05 123.78 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.531 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.4 m-90 -88.47 -173.72 4.29 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.16 109.97 21.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 108.628 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.51 125.31 89.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.566 -0.709 . . . . 0.0 110.753 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.02 167.97 19.44 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.833 1.438 . . . . 0.0 109.531 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -58.24 152.65 51.51 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.689 1.363 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.92 74.61 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.34 118.14 22.94 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.321 -1.105 . . . . 0.0 109.7 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -85.83 88.1 7.51 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.1 p -79.33 160.0 26.94 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.452 0.644 . . . . 0.0 110.535 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.985 HD13 HD21 ' A' ' 144' ' ' LEU . 90.9 mt -97.91 161.73 13.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.828 -0.545 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 94.4 m -103.7 150.01 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.664 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.04 145.49 9.89 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.97 1.51 . . . . 0.0 109.957 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -163.19 160.98 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.453 -0.78 . . . . 0.0 110.037 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.7 m -119.96 124.96 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.9 m -121.55 150.91 40.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 111.013 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.04 -25.93 68.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.0 t -100.04 129.19 46.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.043 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 5.9 m -98.55 19.78 13.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -69.95 75.56 0.47 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 118' ' ' ARG . 84.2 mt -89.93 175.34 7.24 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.067 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 47.9 p90 -151.76 139.01 19.31 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 41.6 tp -109.82 162.92 14.01 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.774 0.797 . . . . 0.0 111.633 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 111' ' ' ALA . 75.1 t -110.01 123.99 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.803 -0.561 . . . . 0.0 110.197 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.959 ' CG2' HG22 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -82.9 -179.65 7.5 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -49.18 -24.21 1.62 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.844 -0.535 . . . . 0.0 110.279 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -94.06 -71.33 0.66 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.611 -0.68 . . . . 0.0 110.383 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.91 -50.88 0.09 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 84.0 m-20 -133.91 151.84 51.65 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.988 -1.07 . . . . 0.0 112.827 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 108' ' ' THR . 15.9 t -118.91 43.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 128' ' ' SER . 0.1 OUTLIER 59.97 178.65 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.29 138.99 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.757 1.399 . . . . 0.0 110.871 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.886 HG22 HD12 ' A' ' 126' ' ' LEU . 49.1 t -124.3 132.94 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.094 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.4 tpp85 -90.28 120.04 31.09 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' LEU . 6.7 ttp180 -64.15 123.37 18.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 110.16 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -100.05 4.55 44.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.621 -0.674 . . . . 0.0 109.778 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.98 172.74 38.86 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.0 m-20 -61.97 -22.5 65.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.488 -1.007 . . . . 0.0 110.218 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.2 p -123.21 17.2 9.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -144.13 139.43 28.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.887 -1.133 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -135.16 142.9 14.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 t -92.16 110.01 21.39 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.727 -0.866 . . . . 0.0 110.566 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.886 HD12 HG22 ' A' ' 116' ' ' VAL . 18.1 tp -71.59 105.79 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.06 -31.49 70.04 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.365 0.602 . . . . 0.0 110.089 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 114' ' ' ILE . 73.5 m -115.07 94.59 39.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.5 Cg_endo -65.61 148.06 86.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.885 1.466 . . . . 0.0 109.697 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.01 168.76 11.63 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -59.32 125.75 18.88 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.887 1.467 . . . . 0.0 110.334 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.96 -24.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.762 -0.587 . . . . 0.0 111.387 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 17.4 t -52.91 -32.84 47.53 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.405 -0.809 . . . . 0.0 109.677 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.742 ' CE2' HG21 ' A' ' 108' ' ' THR . 71.1 t80 -71.94 -28.87 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.49 0.09 54.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.736 . . . . 0.0 111.587 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.409 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 58.1 mtpt -70.78 108.35 4.41 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.28 -0.888 . . . . 0.0 108.647 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.16 -9.42 56.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' ' 108' ' ' THR . 19.3 t -76.16 -14.99 60.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.427 -1.043 . . . . 0.0 109.246 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.95 147.34 53.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.839 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 94.06 -10.84 71.53 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -73.23 -158.28 4.7 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.576 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.1 Cg_endo -144.54 144.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 116.818 -1.655 . . . . 0.0 112.467 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.637 ' O ' HG22 ' A' ' 151' ' ' VAL . 2.0 mt -98.32 97.57 8.93 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.985 HD21 HD13 ' A' ' 94' ' ' LEU . 6.0 mp -89.47 144.71 25.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 54.6 m -63.95 -174.03 0.11 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 41.3 Cg_endo -86.01 9.9 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.573 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -107.91 -23.52 12.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.998 . . . . 0.0 110.767 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.8 36.1 1.19 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 73.0 m80 -120.09 127.73 52.81 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -1.061 . . . . 0.0 110.82 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.24 120.82 23.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.506 -0.746 . . . . 0.0 109.434 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 143' ' ' LEU . 36.0 m -122.43 -4.54 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.896 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 169' ' ' PHE . . . -160.06 128.58 2.0 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.281 -1.438 . . . . 0.0 111.33 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 32.5 mt -107.82 117.93 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.211 -1.17 . . . . 0.0 108.286 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.469 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.4 t80 -51.96 128.72 25.09 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.539 0.685 . . . . 0.0 112.402 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 70.9 ttt180 -117.75 -29.22 5.77 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.833 -0.542 . . . . 0.0 111.498 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.665 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -161.27 145.63 13.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.207 -0.933 . . . . 0.0 111.412 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -99.59 139.39 35.31 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -88.24 93.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 72.2 m -91.55 122.26 33.97 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.273 1.035 . . . . 0.0 112.81 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.6 m -120.06 130.06 54.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.771 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 56.16 23.46 7.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.477 -0.764 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 90.19 20.02 43.89 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.38 -0.825 . . . . 0.0 111.787 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -145.98 142.85 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.06 -1.259 . . . . 0.0 109.352 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.35 129.06 34.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 111.129 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -119.77 11.3 11.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.0 110.302 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -174.33 141.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.701 HG21 HG11 ' A' ' 116' ' ' VAL . 19.0 m -113.65 135.17 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.711 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -101.6 145.14 29.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.3 p90 -154.4 163.81 39.59 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.033 -1.467 . . . . 0.0 112.892 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 82' ' ' LEU . 65.3 t -86.48 130.0 51.0 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.99 147.48 21.17 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 O-C-N 123.688 1.362 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 11.1 p -70.0 -30.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.733 -0.604 . . . . 0.0 109.528 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.88 -32.91 71.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -75.01 -32.67 61.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.559 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.577 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -65.03 -35.61 81.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.895 -0.503 . . . . 0.0 109.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -45.73 91.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.5 p -73.33 -29.89 62.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.742 -0.599 . . . . 0.0 109.389 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.49 ' CG2' ' CE1' ' A' ' 75' ' ' TYR . 66.8 m -60.06 -39.76 87.11 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 67.0 mtt -60.63 -44.89 95.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.954 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -70.56 -42.81 70.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.533 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 10.86 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.4 t -172.18 36.65 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -143.67 139.51 29.6 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.672 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -71.37 -40.0 70.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.677 -0.64 . . . . 0.0 110.113 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 81.1 tttt 54.07 86.79 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.52 -0.737 . . . . 0.0 110.614 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.3 tttt . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.101 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.764 HD22 ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 162.31 46.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HD2' HG13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -147.51 -139.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.951 -0.735 . . . . 0.0 109.161 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.61 130.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.996 -1.065 . . . . 0.0 109.842 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 79.1 mttt -65.08 145.95 55.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.908 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 59.11 163.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 110.002 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' GLU . 89.3 mt-30 -52.7 120.2 5.43 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.389 0.614 . . . . 0.0 110.154 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 3.1 t 59.35 -73.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 28' ' ' GLN . 2.3 mt-10 -166.29 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 110.398 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' H ' ' HB1' ' A' ' 91' ' ' ALA . . . 131.16 -164.71 23.29 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.31 -54.17 11.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.626 -0.926 . . . . 0.0 110.262 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -129.95 130.05 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.644 -0.66 . . . . 0.0 109.329 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -98.99 122.83 42.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 ' C ' HG13 ' A' ' 36' ' ' VAL . 60.9 t -84.86 128.48 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 64' ' ' LEU . 26.9 m -148.02 176.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.176 -0.953 . . . . 0.0 110.593 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.1 t -149.24 144.25 26.41 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.788 0.804 . . . . 0.0 108.895 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' HE1' ' A' ' 43' ' ' PHE . 5.7 t -118.83 -178.38 3.54 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.54 -17.52 1.29 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.807 -0.558 . . . . 0.0 112.227 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.563 ' H ' HG23 ' A' ' 38' ' ' THR . 73.8 p -96.57 -40.76 8.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.058 . . . . 0.0 112.287 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 -170.56 0.64 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.885 -1.134 . . . . 0.0 112.641 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.8 m -109.99 143.26 40.22 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HE1' HG22 ' A' ' 38' ' ' THR . 12.9 p90 -161.79 -146.38 0.12 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.152 -0.967 . . . . 0.0 110.749 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 88.7 mt -134.26 166.59 22.45 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.707 1.241 . . . . 0.0 113.925 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.94 118.56 5.71 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.712 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.9 m -91.59 123.11 34.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 0.0 111.219 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 47.3 t -74.87 110.0 8.81 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.99 130.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.538 -0.726 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.29 40.03 25.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.561 -0.712 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.33 27.39 71.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.6 t -139.99 117.64 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -77.23 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.54 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.54 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.4 m95 -107.14 124.39 49.62 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.139 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.615 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 9.8 t -128.61 -175.33 3.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.603 HG23 ' HA3' ' A' ' 58' ' ' GLY . 27.7 m -93.15 130.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.504 -1.278 . . . . 0.0 112.703 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.94 -44.17 94.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.782 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 30.0 p-80 -66.81 -18.13 65.22 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.774 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.603 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -93.54 -36.12 5.98 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 38' ' ' THR . . . -79.87 -70.08 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.663 -0.904 . . . . 0.0 110.503 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.17 118.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.5 40.02 22.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.427 -1.043 . . . . 0.0 111.402 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 pttt 36.28 -129.57 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 122.907 0.483 . . . . 0.0 111.939 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m 49.79 73.13 0.27 Allowed 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.155 -0.965 . . . . 0.0 112.109 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 36' ' ' VAL . 4.5 mm? -84.2 -161.52 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.75 100.61 5.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.489 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.76 -179.48 52.36 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 49.9 Cg_endo -65.63 -11.69 31.73 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.763 1.401 . . . . 0.0 111.027 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 89.1 mttt -137.82 -1.04 2.05 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.791 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.23 177.97 42.1 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.09 -1.528 . . . . 0.0 111.017 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.84 131.35 19.53 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 124.14 1.6 . . . . 0.0 110.561 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -90.05 159.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.7 m -111.94 139.1 47.72 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.466 -0.771 . . . . 0.0 112.391 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 6.9 pt20 -83.99 165.06 18.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.654 . . . . 0.0 111.837 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.8 mtp -100.03 -45.45 5.67 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.564 -0.71 . . . . 0.0 109.969 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -158.84 -177.96 6.9 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.54 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.1 t -159.98 142.69 13.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.719 0.771 . . . . 0.0 110.27 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -104.96 83.09 1.94 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.96 -40.05 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -55.15 -26.16 36.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -111.74 0.35 16.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.82 -0.55 . . . . 0.0 110.836 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.0 59.55 2.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 175' ' ' MET . 44.5 tp -145.72 152.1 39.05 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.454 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' THR . 1.5 m -140.0 132.07 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -121.63 126.9 6.67 Favored Glycine 0 N--CA 1.508 3.459 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.852 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.615 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -90.52 -169.59 2.45 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.046 -0.679 . . . . 0.0 111.243 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -113.04 95.46 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.683 -0.636 . . . . 0.0 110.42 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.23 130.0 89.95 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.419 -0.801 . . . . 0.0 109.878 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.03 157.68 34.26 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.799 1.421 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.88 152.51 68.72 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 O-C-N 123.821 1.432 . . . . 0.0 110.537 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.39 -8.27 47.99 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.62 ' HB1' ' H ' ' A' ' 31' ' ' GLY . . . -86.85 -144.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.152 -1.204 . . . . 0.0 109.31 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -147.48 100.04 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -92.8 166.93 12.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.591 0.71 . . . . 0.0 111.102 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 144' ' ' LEU . 83.2 mt -109.78 148.63 31.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -105.53 -173.91 0.3 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.189 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -117.44 154.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.992 0 O-C-N 123.847 1.446 . . . . 0.0 110.276 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.5 p -142.25 171.08 14.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.284 -0.885 . . . . 0.0 111.29 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.3 p -50.73 -25.85 4.84 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.469 -0.769 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m 59.63 51.02 6.67 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.229 -0.92 . . . . 0.0 111.66 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.04 95.99 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 m -103.18 140.57 37.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.741 -0.858 . . . . 0.0 108.869 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 m -96.49 17.12 16.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 111.217 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.56 69.22 1.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 145' ' ' CYS . 92.7 mt -75.07 174.6 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.755 -0.591 . . . . 0.0 110.903 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.1 m-85 -140.52 130.01 24.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.676 -0.64 . . . . 0.0 109.519 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.2 tp -110.56 152.03 26.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.727 0.775 . . . . 0.0 111.286 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.516 HG13 ' HA ' ' A' ' 111' ' ' ALA . 81.1 t -108.97 132.26 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 75.8 p -80.83 169.36 17.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -34.39 -32.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 108' ' ' THR . 81.7 m-70 -97.73 -85.34 0.36 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -161.79 16.01 0.1 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.177 -0.952 . . . . 0.0 112.327 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 47.8 t0 -68.43 130.03 41.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.835 -1.166 . . . . 0.0 110.036 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -97.37 117.43 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.698 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 128' ' ' SER . 3.8 tt -116.29 119.82 35.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.572 -0.705 . . . . 0.0 109.654 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 127' ' ' LEU . 49.0 Cg_endo -70.2 131.32 20.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.616 1.324 . . . . 0.0 111.701 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 167' ' ' VAL . 61.4 t -130.0 132.29 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.771 -0.581 . . . . 0.0 109.456 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -88.19 112.06 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -54.44 122.56 10.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 111.13 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -98.51 0.45 45.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.636 -0.665 . . . . 0.0 110.047 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.79 -174.4 46.85 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 91.0 m-20 -70.07 -22.7 63.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -1.043 . . . . 0.0 110.053 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.3 p -124.9 17.38 8.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.569 -0.707 . . . . 0.0 111.465 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.99 145.2 37.52 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.281 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.29 142.14 11.81 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.0 t -88.82 111.56 22.19 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.873 -0.781 . . . . 0.0 109.785 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 114' ' ' ILE . 44.6 tp -70.38 112.37 6.63 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.08 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 115' ' ' PRO . 87.3 mt -69.95 -19.98 63.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.825 -0.547 . . . . 0.0 110.587 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 114' ' ' ILE . 36.7 m -120.0 79.96 25.93 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.672 -0.643 . . . . 0.0 109.945 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.2 Cg_endo -57.78 142.47 96.12 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.849 1.447 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -155.33 167.15 14.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -58.9 128.02 26.46 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.746 1.393 . . . . 0.0 109.76 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.25 -25.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.683 -0.635 . . . . 0.0 111.085 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 91.0 p -58.44 -30.37 66.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.598 -0.689 . . . . 0.0 109.564 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -70.04 -29.31 66.31 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.42 3.98 25.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 4.5 mtpm? -66.89 111.63 3.88 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.5 55.84 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -77.81 -13.64 59.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.529 -0.983 . . . . 0.0 109.924 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.531 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -67.59 147.35 52.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.078 -1.014 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.553 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.96 -9.99 75.44 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -66.87 -163.64 1.72 Allowed Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.0 Cg_endo -143.26 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 117.033 -1.512 . . . . 0.0 111.852 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.6 mp -91.77 96.96 10.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -83.6 143.83 29.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.201 1.0 . . . . 0.0 113.132 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.498 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.8 m -69.4 163.75 55.62 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.39 -11.2 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.577 1.304 . . . . 0.0 111.504 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.7 m -95.71 -0.06 51.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.925 -1.11 . . . . 0.0 111.808 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.93 33.5 6.62 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -118.73 128.49 54.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -1.147 . . . . 0.0 109.968 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.66 29.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.78 1.28 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.648 . . . . 0.0 111.904 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -147.96 128.3 2.84 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.856 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 68.8 mt -109.97 120.83 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.018 -1.284 . . . . 0.0 108.181 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.462 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.7 t80 -50.02 129.36 20.54 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.866 0.841 . . . . 0.0 112.711 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.492 ' HB2' HG23 ' A' ' 170' ' ' VAL . 40.1 ttt180 -117.31 -28.51 6.12 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.39 149.2 8.34 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.707 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -102.69 135.86 43.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.838 -0.538 . . . . 0.0 111.209 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.0 t -85.12 86.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 27.5 p -88.09 104.05 16.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.743 1.258 . . . . 0.0 112.191 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.607 ' O ' HG22 ' A' ' 163' ' ' VAL . 8.2 m -99.72 133.91 43.37 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.162 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 54.8 22.88 4.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.431 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 91.21 17.74 49.23 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.356 -0.84 . . . . 0.0 111.836 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 160' ' ' THR . 34.2 m -146.02 140.74 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.255 . . . . 0.0 109.687 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 118.85 19.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.587 -0.696 . . . . 0.0 111.763 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -111.01 10.55 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.825 -0.547 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.04 140.01 0.51 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.637 HG21 HG11 ' A' ' 116' ' ' VAL . 17.8 m -112.82 135.88 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.256 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -103.94 147.36 27.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.465 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.1 p90 -154.32 164.25 38.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.263 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 82' ' ' LEU . 61.4 t -82.25 138.46 45.36 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -77.65 149.3 26.67 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.741 1.39 . . . . 0.0 110.786 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.4 -29.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.316 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -29.29 68.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.242 -0.911 . . . . 0.0 108.846 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.5 t -70.21 -32.65 70.64 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.653 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.711 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -66.52 -39.92 88.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.596 -0.69 . . . . 0.0 109.643 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.18 -43.27 96.0 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.631 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 47.7 p -70.0 -31.22 68.78 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.672 -0.642 . . . . 0.0 110.57 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -40.06 87.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.452 -0.78 . . . . 0.0 109.195 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 96.7 mtp -63.08 -36.99 85.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.914 -0.491 . . . . 0.0 109.782 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -60.04 -32.96 71.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.747 . . . . 0.0 110.59 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.98 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.721 -0.612 . . . . 0.0 110.248 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.32 42.88 31.17 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.097 -1.002 . . . . 0.0 110.239 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -83.37 144.27 29.76 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.353 0.597 . . . . 0.0 110.487 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -71.14 -39.96 71.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 110.777 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -81.64 126.72 32.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.454 -0.779 . . . . 0.0 110.317 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.107 179.523 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.782 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.071 0.462 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.12 154.29 7.64 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -108.92 138.38 45.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.959 . . . . 0.0 109.985 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -81.58 168.97 17.63 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.223 0.535 . . . . 0.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.6 154.07 22.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 0.0 110.321 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 67' ' ' PRO . 21.5 t-20 -70.05 -39.96 75.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.614 -0.679 . . . . 0.0 111.182 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -89.76 122.55 32.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.342 -0.848 . . . . 0.0 110.803 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.1 t -83.98 -45.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.359 0.6 . . . . 0.0 110.101 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 50.11 39.92 20.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.557 -0.715 . . . . 0.0 111.796 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.46 33.89 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 33' ' ' VAL . 11.1 pt-20 -95.37 -24.0 16.91 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.647 -0.913 . . . . 0.0 111.077 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 107' ' ' VAL . 62.1 t -109.96 119.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.547 -0.721 . . . . 0.0 109.343 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -102.26 125.3 48.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.639 -0.663 . . . . 0.0 110.79 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 36' ' ' VAL . 59.0 t -83.68 128.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 35' ' ' VAL . 32.5 m -146.73 174.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.631 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.3 p -146.92 133.63 19.98 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.703 0.763 . . . . 0.0 109.217 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 59' ' ' ALA . 41.5 p -107.48 -179.93 4.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.2 5.89 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.591 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 p -99.34 -37.23 9.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 112.607 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -171.47 -170.0 0.77 Allowed 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.62 -1.3 . . . . 0.0 113.13 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 28.6 p -116.25 141.14 48.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 14.9 p90 -163.67 -146.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.236 -0.915 . . . . 0.0 110.638 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.851 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -131.92 160.43 35.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.777 -1.202 . . . . 0.0 113.121 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.28 128.44 9.74 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.817 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.87 ' CG2' HD11 ' A' ' 153' ' ' ILE . 7.6 t -80.01 -151.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG23 ' A' ' 46' ' ' THR . 4.8 t -160.12 106.35 1.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.425 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.2 40.01 30.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.797 -0.564 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 45.5 t -133.93 113.06 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.973 . . . . 0.0 109.745 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 t -76.07 121.87 23.43 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.546 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.4 m95 -108.47 127.56 54.02 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.474 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.685 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 5.4 t -135.58 -179.14 5.46 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG13 ' CA ' ' A' ' 140' ' ' GLY . 14.5 m -89.69 126.81 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 C-N-CA 118.18 -1.408 . . . . 0.0 112.213 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -59.95 -42.49 94.17 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.61 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.804 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 30.0 p-80 -71.31 73.74 0.7 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.589 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 156.83 -32.72 0.56 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -82.24 -69.99 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.575 -0.956 . . . . 0.0 110.927 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.64 0.1 15.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m 53.43 66.72 1.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.129 -1.218 . . . . 0.0 111.266 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -165.58 -62.86 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.227 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 14.0 t -157.21 158.98 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.779 0.8 . . . . 0.0 111.839 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -149.61 -130.6 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -146.28 88.77 1.81 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.874 -1.141 . . . . 0.0 109.013 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -88.79 -176.28 46.82 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HB2' ' HA ' ' A' ' 27' ' ' ASN . 47.6 Cg_endo -58.99 -20.12 51.73 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 124.085 1.571 . . . . 0.0 110.543 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.5 0.0 20.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.416 -0.803 . . . . 0.0 111.295 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.99 -157.16 15.4 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.96 120.07 7.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.84 1.442 . . . . 0.0 111.35 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.718 HG22 ' HD1' ' A' ' 85' ' ' TRP . 34.9 mt -107.16 141.47 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.6 m -91.23 140.97 29.3 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.421 0.629 . . . . 0.0 110.826 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.25 147.02 49.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.783 -0.573 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.84 -29.87 12.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -149.96 169.97 19.93 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 27.3 m -154.28 112.41 3.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 110.69 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 20.4 t-20 -91.12 77.85 5.95 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.02 -40.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -56.07 -25.6 45.91 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.94 -1.41 15.47 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.734 -0.604 . . . . 0.0 110.833 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.8 t0 60.78 57.36 2.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.965 -1.085 . . . . 0.0 109.152 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 170' ' ' VAL . 17.0 tp -145.36 154.52 42.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.657 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -145.67 128.22 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.407 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -114.9 119.76 4.76 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.037 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.718 ' HD1' HG22 ' A' ' 71' ' ' ILE . 5.4 m-90 -86.45 174.61 8.86 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -95.93 91.75 6.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.009 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.92 153.83 95.15 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.587 -0.696 . . . . 0.0 111.153 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -95.54 173.01 1.16 Allowed 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.935 1.492 . . . . 0.0 109.485 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.71 136.38 32.98 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.89 1.468 . . . . 0.0 110.287 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.41 -32.28 3.77 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . . . -82.38 59.13 4.42 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.719 -0.871 . . . . 0.0 110.371 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' HB3' ' CA ' ' A' ' 32' ' ' GLU . 28.5 ttm180 24.07 95.25 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 124.313 1.045 . . . . 0.0 113.022 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.9 m -85.28 107.34 17.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.259 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 144' ' ' LEU . 73.3 mt -84.25 159.96 20.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.6 163.34 18.09 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.379 -0.826 . . . . 0.0 111.024 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.11 160.49 49.43 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 O-C-N 124.071 1.564 . . . . 0.0 109.848 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.445 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 51.2 t -166.21 158.54 14.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 111.051 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 98' ' ' THR . 6.2 t -151.67 66.86 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.697 -0.627 . . . . 0.0 109.654 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 53.4 m -69.35 -40.05 77.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.47 -0.769 . . . . 0.0 110.203 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.22 -14.68 33.42 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.9 m -63.23 -38.36 90.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.19 -1.182 . . . . 0.0 109.492 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.17 15.48 6.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.778 -0.576 . . . . 0.0 111.399 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -84.56 79.6 9.53 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 118' ' ' ARG . 92.2 mt -88.04 174.6 8.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.037 0.923 . . . . 0.0 112.368 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 97.4 m-85 -145.32 129.97 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 143' ' ' LEU . 25.0 tp -107.7 144.43 34.81 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.629 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 33' ' ' VAL . 76.0 t -90.57 120.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.7 p -91.54 178.05 6.05 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.798 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -47.13 -25.98 1.0 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.896 -0.502 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -97.28 -70.13 0.73 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.638 -0.664 . . . . 0.0 109.311 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.06 -164.99 1.99 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.95 0.881 . . . . 0.0 110.06 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 8.9 t0 -52.92 -93.96 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.598 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 114' ' ' ILE . 32.9 t 57.02 156.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.139 -0.976 . . . . 0.0 110.977 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 126' ' ' LEU . 34.3 mt 53.7 105.33 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.274 -0.892 . . . . 0.0 111.849 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 50.2 Cg_endo -90.42 150.1 4.4 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.803 1.422 . . . . 0.0 109.319 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 126' ' ' LEU . 21.9 t -131.26 139.87 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.322 -0.862 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -98.49 117.06 32.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 22.5 ttp85 -62.82 129.16 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.328 -0.857 . . . . 0.0 110.996 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -102.92 4.81 37.96 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.445 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.33 178.76 40.82 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.56 -26.57 68.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.451 -1.029 . . . . 0.0 109.87 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.6 p -120.07 16.86 12.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.662 -0.649 . . . . 0.0 111.868 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -140.04 139.05 35.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.011 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.59 138.7 9.15 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 116' ' ' VAL . 23.2 t -89.28 110.72 21.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.909 -0.759 . . . . 0.0 110.181 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 116' ' ' VAL . 21.0 tp -70.86 110.67 5.75 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.819 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.97 -21.72 63.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.831 -0.543 . . . . 0.0 110.515 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.693 ' HB2' HG23 ' A' ' 114' ' ' ILE . 70.7 m -120.43 82.95 32.87 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.617 . . . . 0.0 110.197 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.1 Cg_endo -59.42 139.81 91.31 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 O-C-N 123.803 1.423 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -152.27 164.26 20.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -54.06 125.97 20.51 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 O-C-N 123.786 1.414 . . . . 0.0 110.93 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 p -50.08 -25.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.86 -0.525 . . . . 0.0 110.91 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.0 m -58.81 -35.36 72.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.605 -0.684 . . . . 0.0 109.496 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -68.4 -28.13 66.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.2 0.95 38.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.351 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -70.63 119.49 14.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.256 -0.903 . . . . 0.0 108.597 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.53 -10.09 66.83 Favored Glycine 0 C--N 1.286 -2.207 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.851 ' HA ' HD12 ' A' ' 44' ' ' LEU . 27.4 t -78.65 -13.5 59.79 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.56 -0.965 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.513 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.5 m -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.007 -1.058 . . . . 0.0 110.695 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.598 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.94 -9.71 76.35 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -61.66 -179.23 3.25 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.6 ' CG ' HG22 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -128.04 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 117.206 -1.396 . . . . 0.0 111.761 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.5 mt -94.52 97.19 9.97 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 94' ' ' LEU . 7.3 mp -89.62 141.31 28.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.425 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -59.35 -167.33 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.97 16.46 1.45 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.749 1.394 . . . . 0.0 110.905 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -122.03 -51.08 2.02 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -0.95 . . . . 0.0 110.916 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.62 42.42 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 82.8 m-70 -127.13 126.62 43.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -1.068 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -88.0 103.0 15.29 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' HB ' ' A' ' 172' ' ' VAL . 35.5 m -109.92 8.18 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.386 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -159.19 134.08 3.62 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.873 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.87 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.6 mt -118.27 120.81 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.288 -1.124 . . . . 0.0 108.309 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 19.3 t80 -54.33 128.03 29.74 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.398 0.618 . . . . 0.0 112.5 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 170' ' ' VAL . 7.2 ptm180 -119.28 -24.17 6.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 111.311 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.52 148.39 12.67 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.59 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -104.88 143.81 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.291 0.567 . . . . 0.0 111.38 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 47.2 t -94.74 88.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.0 p -89.88 111.08 22.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.505 1.145 . . . . 0.0 112.454 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLY . 93.6 m -92.59 125.95 37.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 160' ' ' THR . 73.9 ttt180 62.14 -70.6 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 122.014 -0.429 . . . . 0.0 110.056 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.05 24.98 0.25 Allowed Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.178 -1.011 . . . . 0.0 110.588 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.65 144.85 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.086 -1.244 . . . . 0.0 109.472 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.07 123.55 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.434 0.635 . . . . 0.0 111.123 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -112.47 11.41 19.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.784 -0.573 . . . . 0.0 110.581 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 158' ' ' VAL . . . -173.77 144.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 116' ' ' VAL . 15.9 m -117.87 137.3 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.889 0.852 . . . . 0.0 112.674 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -104.02 146.01 29.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 33.9 p90 -154.61 160.62 41.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.17 -1.412 . . . . 0.0 112.205 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 82' ' ' LEU . 59.9 t -81.2 129.98 64.63 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.6 155.87 49.65 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.749 1.394 . . . . 0.0 110.784 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 151' ' ' VAL . 7.5 p -71.41 -24.39 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.616 -0.677 . . . . 0.0 109.49 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.87 -30.23 67.58 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -71.9 -39.97 69.19 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.496 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.9 mpp? -64.72 -39.69 94.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -32.21 70.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.812 -0.555 . . . . 0.0 110.334 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -37.51 79.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.442 -0.787 . . . . 0.0 109.94 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.529 HG23 ' CG ' ' A' ' 75' ' ' TYR . 99.0 m -60.31 -45.45 93.34 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 109.023 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 179' ' ' MET . 86.8 mtp -62.49 -40.11 95.63 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.248 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 53.4 mtm180 -72.05 -29.36 64.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.507 -0.745 . . . . 0.0 110.005 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 59.94 20.05 9.08 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.701 -0.624 . . . . 0.0 110.96 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.4 t 58.14 -79.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.939 -0.475 . . . . 0.0 111.47 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 181' ' ' ALA . 98.8 mttt -84.93 137.07 33.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.263 -0.898 . . . . 0.0 110.413 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -86.31 12.28 10.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.735 -0.603 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.0 -32.57 70.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.0 mttm . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.822 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.804 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.129 0.49 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.7 -174.02 52.86 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -63.22 143.45 57.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.946 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -151.38 112.78 4.37 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.007 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -83.32 62.89 6.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.874 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -83.24 -152.8 0.12 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.603 -0.685 . . . . 0.0 109.358 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -79.99 167.46 20.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.512 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 29' ' ' VAL . 32.6 m -86.25 16.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 O-C-N 121.504 -0.748 . . . . 0.0 111.24 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 44.3 mm-40 66.21 -61.69 0.28 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.763 -0.585 . . . . 0.0 111.601 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.99 -95.63 0.51 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.33 -47.07 5.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.742 -0.858 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.569 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.0 t -110.06 120.44 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 34.6 mt-30 -93.02 130.16 38.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.752 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 44' ' ' LEU . 75.5 t -77.77 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 64' ' ' LEU . 34.7 m -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.961 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.4 p -157.89 143.93 17.38 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.829 HG21 ' O ' ' A' ' 58' ' ' GLY . 4.5 t -109.37 -177.7 3.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.71 -14.44 0.91 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.577 -0.702 . . . . 0.0 112.869 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.764 HG22 HG23 ' A' ' 38' ' ' THR . 9.5 t -112.0 -21.27 11.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HG2' HG23 ' A' ' 40' ' ' THR . 4.8 pt20 -169.65 -171.88 1.31 Allowed 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.368 -1.457 . . . . 0.0 113.174 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -125.59 146.65 49.6 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.7 p90 -162.79 -142.58 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.3 mt -135.63 162.03 33.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.525 -1.359 . . . . 0.0 113.229 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.46 130.0 12.22 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.286 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 142' ' ' PRO . 57.2 m -99.92 125.35 45.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.702 . . . . 0.0 111.218 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.4 t -73.0 119.46 17.28 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.18 135.44 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.469 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 52.69 39.7 28.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.69 -0.632 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.67 23.37 73.89 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.5 t -140.62 120.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -1.078 . . . . 0.0 110.335 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.9 m -73.99 120.61 19.81 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.604 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.7 m95 -107.17 125.97 51.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.752 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -132.93 -176.41 4.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.729 HG11 ' HB2' ' A' ' 139' ' ' SER . 32.3 m -87.03 127.17 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 C-N-CA 118.346 -1.342 . . . . 0.0 112.83 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.61 -40.03 93.38 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.818 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 41.6 p-80 -72.54 68.85 0.83 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.286 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.829 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.14 -59.45 0.28 Allowed Glycine 0 N--CA 1.484 1.856 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . -70.5 -40.04 73.79 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.694 -0.886 . . . . 0.0 111.2 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.72 -105.71 3.31 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.6 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.252 -1.146 . . . . 0.0 110.992 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -166.69 -102.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.8 -1.187 . . . . 0.0 112.119 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 70' ' ' PRO . 20.5 m -84.48 108.24 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.746 -1.221 . . . . 0.0 111.648 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 64' ' ' LEU 0.266 2.0 tm? -94.84 -12.53 26.8 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.326 0.584 . . . . 0.0 110.462 179.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 62.77 105.23 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.344 -0.847 . . . . 0.0 109.987 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -120.51 179.41 16.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.27 -17.65 54.12 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.945 1.497 . . . . 0.0 110.65 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.46 1.7 46.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 111.14 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.51 -168.13 13.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' CB ' HG23 ' A' ' 63' ' ' THR . 47.5 Cg_endo -65.53 116.9 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.937 1.493 . . . . 0.0 110.022 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.776 HG22 ' HD1' ' A' ' 85' ' ' TRP . 63.4 mt -97.44 139.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.527 0.679 . . . . 0.0 109.676 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.9 m -96.24 140.01 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.01 149.84 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.708 . . . . 0.0 110.627 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.3 mmm -103.55 -27.27 12.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.731 -0.606 . . . . 0.0 109.889 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.786 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -154.95 171.15 20.17 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.516 -0.74 . . . . 0.0 109.314 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.847 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.9 m -154.12 115.86 4.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.632 -0.667 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.76 76.36 3.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.99 -33.06 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.686 -0.634 . . . . 0.0 109.298 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.6 -26.6 13.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.07 8.36 6.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.13 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 62.42 61.77 1.22 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.765 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.855 HD22 HG11 ' A' ' 170' ' ' VAL . 36.5 tp -144.19 152.56 41.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.847 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.32 133.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.65 121.67 5.17 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.232 -1.461 . . . . 0.0 111.767 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.776 ' HD1' HG22 ' A' ' 71' ' ' ILE . 6.2 m-90 -89.19 -169.68 2.6 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.795 -0.826 . . . . 0.0 109.359 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -94.05 107.68 19.58 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . . . -69.98 148.96 96.38 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.563 -0.711 . . . . 0.0 112.522 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 54.7 Cg_endo -118.88 175.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 1.024 0 O-C-N 123.928 1.488 . . . . 0.0 109.233 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.49 152.78 60.44 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 O-C-N 123.695 1.366 . . . . 0.0 110.864 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.58 -36.37 4.45 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.74 14.91 2.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.992 -0.711 . . . . 0.0 112.302 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 36.56 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -80.48 124.47 28.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 94' ' ' LEU . 4.5 mm? -85.26 173.46 10.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.844 -0.535 . . . . 0.0 110.349 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.804 HG22 ' CD ' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -95.19 -168.4 0.17 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.596 -0.69 . . . . 0.0 110.915 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.804 ' CD ' HG22 ' A' ' 95' ' ' THR . 49.6 Cg_endo -132.85 125.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.837 0 O-C-N 123.986 1.519 . . . . 0.0 109.318 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -159.97 162.46 34.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -115.35 120.01 38.18 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.5 m -105.91 129.67 54.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.037 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.22 96.4 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.6 m -60.01 -37.12 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.483 -1.01 . . . . 0.0 110.137 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 58.08 21.44 7.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.778 -0.576 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.0 71.07 10.12 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.484 HD23 ' CA ' ' A' ' 145' ' ' CYS . 73.0 mt -79.75 174.38 11.64 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 111.779 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 94.0 m-85 -140.47 126.44 19.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.673 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.4 tp -109.3 128.59 55.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.342 -0.849 . . . . 0.0 111.427 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 111' ' ' ALA . 76.1 t -75.59 134.74 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 112' ' ' ASP . 45.6 p -84.42 175.94 9.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.536 -0.728 . . . . 0.0 110.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -32.92 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' THR . 4.1 p80 -112.88 -65.24 1.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.31 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -158.6 -33.99 0.07 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.956 -1.09 . . . . 0.0 113.198 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 48.4 m-20 -44.01 116.54 1.01 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.331 -0.856 . . . . 0.0 112.038 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' LEU . 34.0 m -84.29 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.264 0.554 . . . . 0.0 110.665 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 126' ' ' LEU . 48.3 mm -113.9 110.85 48.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.668 . . . . 0.0 109.454 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 46.0 Cg_endo -64.28 120.01 7.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 O-C-N 123.875 1.46 . . . . 0.0 110.688 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.674 HG22 HD12 ' A' ' 126' ' ' LEU . 48.6 t -127.51 133.93 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 109.219 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -87.44 118.84 27.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.216 -0.928 . . . . 0.0 108.763 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.1 ttm180 -62.31 122.17 15.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -97.46 0.16 47.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.0 176.62 44.36 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 77.7 m-20 -62.3 -24.06 67.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -1.028 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 p -123.65 17.34 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 111.962 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -141.67 141.8 33.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 111.136 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.78 142.66 13.23 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.496 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.0 t -88.64 110.69 21.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.803 -0.822 . . . . 0.0 109.563 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.803 HD11 HG21 ' A' ' 114' ' ' ILE . 23.8 tp -69.46 109.99 4.51 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.569 -0.853 . . . . 0.0 108.804 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.51 -25.88 64.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.854 -0.528 . . . . 0.0 110.282 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.1 t -107.04 102.42 42.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.19 130.69 11.29 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 124.077 1.567 . . . . 0.0 109.573 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -152.46 163.13 24.55 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -55.39 128.39 30.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.744 1.391 . . . . 0.0 110.508 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -51.25 -24.91 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.854 -0.529 . . . . 0.0 111.135 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 79.9 p -57.51 -31.33 65.92 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -70.02 -28.81 65.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.48 2.4 37.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.482 -0.761 . . . . 0.0 111.024 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.3 mtpt -66.86 107.81 2.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.37 -8.79 58.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -72.97 -16.61 61.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -1.069 . . . . 0.0 108.427 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.729 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -70.46 151.29 45.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.672 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.45 -10.05 74.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.53 -159.68 4.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.4 Cg_endo -138.73 138.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 O-C-N 123.821 1.432 . . . . 0.0 111.977 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.673 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.0 mt -95.43 95.38 8.4 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.603 HD12 ' N ' ' A' ' 144' ' ' LEU . 6.9 mp -87.21 133.6 33.64 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.629 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.1 p -82.51 -172.46 0.36 Allowed Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.9 Cg_endo -84.24 20.53 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.106 1.056 . . . . 0.0 112.453 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.1 m -100.88 -18.03 16.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.015 -1.053 . . . . 0.0 111.102 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.98 39.94 3.21 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -149.93 165.57 32.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 110.871 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.51 120.2 32.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.669 -0.645 . . . . 0.0 109.425 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 149' ' ' HIS . 2.6 t -99.97 -20.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.662 -0.649 . . . . 0.0 110.888 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . -159.4 140.94 7.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 ' HE1' ' A' ' 175' ' ' MET . 49.5 mt -107.17 118.93 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.146 -1.208 . . . . 0.0 107.792 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.456 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 20.8 t80 -52.69 127.34 22.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.579 0.704 . . . . 0.0 111.957 -178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -116.02 -28.69 6.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.849 -0.532 . . . . 0.0 111.962 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -160.37 140.9 11.73 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.201 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.456 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.64 134.37 41.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.726 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 38.9 t -89.96 92.44 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.1 p -89.99 109.91 20.92 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.52 1.152 . . . . 0.0 112.364 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.516 ' O ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -97.14 121.76 39.4 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.779 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 59.97 19.93 8.99 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.381 -0.824 . . . . 0.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 102.02 13.61 31.06 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.395 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -144.91 140.03 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 118.684 1.242 . . . . 0.0 109.445 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 129.94 37.48 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.833 0.825 . . . . 0.0 111.603 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.63 14.43 7.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.731 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.21 150.84 2.49 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 116' ' ' VAL . 9.6 m -133.64 135.84 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 119.376 -0.929 . . . . 0.0 112.695 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -102.14 149.08 24.64 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 36.1 p90 -154.74 164.68 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.076 -1.45 . . . . 0.0 112.583 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.855 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -84.61 137.25 38.82 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.59 145.64 14.74 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.582 1.306 . . . . 0.0 111.99 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.58 HG23 ' SD ' ' A' ' 175' ' ' MET . 10.7 p -69.97 -27.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 109.607 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.84 -29.97 65.38 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 m -73.1 -22.9 60.47 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.151 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 172' ' ' VAL . 66.3 mtt -68.72 -40.11 80.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.206 -0.934 . . . . 0.0 108.931 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.07 -39.21 85.25 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.89 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 68.2 p -60.06 -28.46 67.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 0.0 110.688 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.786 HG23 ' CG ' ' A' ' 75' ' ' TYR . 35.9 m -62.66 -52.88 61.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.309 -0.87 . . . . 0.0 108.805 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.27 -32.95 72.47 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.734 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.98 -15.63 55.7 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.449 -0.782 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -167.82 165.55 13.95 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.332 -0.855 . . . . 0.0 110.791 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.8 33.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.564 -0.71 . . . . 0.0 110.087 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.91 6.8 40.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 110.803 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt 52.55 32.62 11.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.976 -1.078 . . . . 0.0 110.698 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -80.19 159.76 25.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.624 . . . . 0.0 110.571 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.201 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.818 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.056 0.455 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.54 -82.46 0.1 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -61.76 139.99 58.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.59 -0.947 . . . . 0.0 110.12 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -79.76 159.94 26.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.566 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' GLN . 59.0 mttm -97.16 112.93 24.5 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.365 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 48.33 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' LYS . 79.8 mt-30 -106.91 158.0 17.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.123 -0.986 . . . . 0.0 111.056 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 62.0 t -81.15 -62.27 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.434 0.635 . . . . 0.0 109.677 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 49.99 39.94 20.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.609 -0.682 . . . . 0.0 111.809 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.44 145.51 13.2 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.815 -1.183 . . . . 0.0 111.209 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.05 -40.0 75.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.848 -0.796 . . . . 0.0 110.452 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.7 t -111.03 119.96 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.54 132.67 40.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.71 -0.619 . . . . 0.0 110.444 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -80.8 138.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.667 HG23 ' CE2' ' A' ' 43' ' ' PHE . 16.5 m -139.99 171.72 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.621 0.724 . . . . 0.0 110.138 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -153.29 153.42 32.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 2.9 t -117.82 75.86 1.03 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.546 1.165 . . . . 0.0 109.358 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.13 -48.69 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -120.7 11.08 11.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.446 -1.408 . . . . 0.0 114.007 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG2' HG23 ' A' ' 38' ' ' THR . 14.7 pt20 -160.01 169.96 22.33 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.593 -1.317 . . . . 0.0 111.746 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.5 m -128.8 152.25 48.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.49 0.662 . . . . 0.0 110.131 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.667 ' CE2' HG23 ' A' ' 36' ' ' VAL . 8.3 p90 -160.5 -145.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 78.2 mt -135.27 165.54 25.21 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.36 -1.462 . . . . 0.0 113.843 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.99 126.84 9.63 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.25 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.4 m -104.94 127.46 52.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.352 -0.843 . . . . 0.0 111.44 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 44.7 t -74.55 121.36 21.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.792 -0.567 . . . . 0.0 109.517 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 172' ' ' VAL . 48.8 t -131.47 130.18 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.912 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.77 39.98 30.95 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.479 -0.763 . . . . 0.0 110.728 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 25.5 75.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.14 122.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -1.011 . . . . 0.0 109.271 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 6.4 t -74.17 139.22 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.409 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.465 ' CE3' HD21 ' A' ' 82' ' ' LEU . 78.2 m95 -136.1 130.02 32.73 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.924 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 8.8 t -139.13 -174.74 3.94 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.635 HG23 ' HA3' ' A' ' 58' ' ' GLY . 13.4 m -87.99 131.83 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.31 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 33.7 t80 -60.03 -41.97 93.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.78 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 29.4 p-80 -69.96 -13.96 62.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.735 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.635 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -97.04 -41.32 3.54 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 83' ' ' VAL . . . -85.05 -72.62 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.606 -0.938 . . . . 0.0 110.358 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.69 160.66 0.14 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.551 ' O ' HG22 ' A' ' 63' ' ' THR . 4.2 m 58.08 18.69 5.4 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.489 -1.006 . . . . 0.0 111.832 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' SER . 96.4 mttt 62.05 -59.39 0.12 Allowed 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 121.56 0.695 . . . . 0.0 112.567 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 61' ' ' SER . 5.5 t -72.18 159.4 34.18 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.881 0.848 . . . . 0.0 111.633 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -146.98 -121.75 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.513 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -150.02 86.58 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.791 -1.193 . . . . 0.0 109.8 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -93.05 -176.4 40.84 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -56.67 -22.28 43.35 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.81 1.426 . . . . 0.0 110.556 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.18 0.02 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.599 -0.688 . . . . 0.0 110.922 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.65 -149.21 17.69 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 40.5 Cg_endo -63.85 116.95 3.99 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.892 1.469 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.593 HD12 ' HA3' ' A' ' 66' ' ' GLY . 64.8 mt -112.88 130.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.175 0.988 . . . . 0.0 112.001 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 m -130.76 123.59 29.53 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.97 -60.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.433 ' C ' ' CG ' ' A' ' 75' ' ' TYR . 10.8 mmt -92.91 -65.84 0.97 Allowed 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.538 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.446 ' CE1' ' CG2' ' A' ' 178' ' ' THR . 0.1 OUTLIER 174.88 -171.82 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.941 -1.099 . . . . 0.0 112.012 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.895 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.8 m -138.43 117.3 12.38 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -94.37 81.96 4.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 90.2 t -61.06 -40.07 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 109.425 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.02 -26.75 27.99 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 109.075 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -111.82 -2.2 15.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.734 -0.604 . . . . 0.0 110.706 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.94 55.09 3.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 170' ' ' VAL . 42.5 tp -146.95 156.43 43.05 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.903 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.895 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER -144.33 138.71 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' C ' ' CE3' ' A' ' 85' ' ' TRP . . . -136.66 162.28 25.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 118.632 -1.746 . . . . 0.0 113.079 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.76 ' CZ3' HG22 ' A' ' 54' ' ' THR . 2.6 m-90 -148.25 170.12 18.59 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 114.297 -0.951 . . . . 0.0 108.927 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.48 115.38 23.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.97 134.49 95.04 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.612 -0.68 . . . . 0.0 110.746 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.99 158.61 42.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.832 1.438 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.78 145.12 67.92 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.895 1.471 . . . . 0.0 109.953 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.42 -24.49 7.26 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -88.9 -152.12 0.23 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.458 -1.025 . . . . 0.0 109.095 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -152.93 106.88 3.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.638 -0.664 . . . . 0.0 109.976 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.732 ' C ' HD22 ' A' ' 94' ' ' LEU . 40.1 p -84.72 164.61 18.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 93' ' ' SER . 3.2 mm? -120.86 163.83 17.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.57 -0.706 . . . . 0.0 109.673 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 26.3 m -102.01 145.1 29.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.079 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 172' ' ' VAL . 52.5 Cg_endo -98.45 135.62 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.178 0 O-C-N 123.751 1.395 . . . . 0.0 110.694 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.8 p -151.23 147.34 26.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.645 -0.659 . . . . 0.0 110.48 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.7 m -68.06 -39.92 82.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.428 -0.795 . . . . 0.0 111.574 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 87.1 m 55.84 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.363 -0.836 . . . . 0.0 111.062 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.83 3.3 45.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -129.66 137.41 50.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -1.225 . . . . 0.0 110.019 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -103.61 19.02 20.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.713 . . . . 0.0 110.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -72.97 67.57 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -0.788 . . . . 0.0 108.943 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 145' ' ' CYS . 88.3 mt -81.71 174.73 11.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.873 -0.517 . . . . 0.0 109.914 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 43.5 p90 -154.06 138.84 17.07 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 142' ' ' PRO . 34.9 tp -113.29 153.85 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.98 0.895 . . . . 0.0 111.603 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 111' ' ' ALA . 98.3 t -110.29 136.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 112' ' ' ASP . 31.6 p -81.76 -178.94 7.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -36.33 -32.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.78 -51.14 2.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.339 -0.85 . . . . 0.0 111.291 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.28 -95.4 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.967 -1.083 . . . . 0.0 111.719 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 108' ' ' THR . 17.2 t0 44.07 70.23 0.34 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.095 -1.003 . . . . 0.0 111.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.7 p -71.78 64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.435 -0.791 . . . . 0.0 109.926 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 126' ' ' LEU . 12.3 pt -70.04 150.03 96.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.522 -0.736 . . . . 0.0 110.073 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -102.05 130.16 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.715 1.376 . . . . 0.0 110.032 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 167' ' ' VAL . 49.1 t -127.45 131.94 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -88.11 117.32 26.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.6 ttm180 -61.8 123.87 19.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.552 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -97.29 1.07 49.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.781 -0.574 . . . . 0.0 109.81 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.86 179.72 43.01 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.6 m-20 -64.84 -23.42 67.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.326 -1.102 . . . . 0.0 110.362 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.0 p -123.2 16.83 9.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.513 -0.742 . . . . 0.0 111.752 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -140.0 142.8 36.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -142.06 140.7 10.25 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.434 ' C ' HG13 ' A' ' 116' ' ' VAL . 5.7 m -89.94 110.02 21.01 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.8 -0.824 . . . . 0.0 110.151 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.749 ' CD1' HD12 ' A' ' 114' ' ' ILE . 31.9 tp -72.98 108.55 5.95 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.18 -28.03 68.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.322 0.582 . . . . 0.0 109.801 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -109.99 103.75 54.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.85 -0.531 . . . . 0.0 110.171 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.37 140.54 36.99 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.877 1.461 . . . . 0.0 109.955 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -147.09 159.26 43.18 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.18 124.41 14.77 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.898 1.473 . . . . 0.0 110.361 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.13 -26.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.328 0.585 . . . . 0.0 110.685 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -38.3 82.28 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 108' ' ' THR . 48.7 t80 -69.32 -27.53 65.45 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.69 2.76 36.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.783 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -68.65 109.6 3.87 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.77 -8.87 58.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.8 t -76.1 -15.69 60.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -1.005 . . . . 0.0 109.079 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.22 154.64 41.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.235 -0.916 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.99 -8.48 79.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.92 -159.04 6.89 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.637 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.96 148.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 116.588 -1.808 . . . . 0.0 112.582 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 1.8 mt -99.49 98.27 9.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 4.6 mm? -82.14 137.07 35.06 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.133 0.968 . . . . 0.0 113.182 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.565 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -66.62 -161.48 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.017 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -92.16 17.27 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.714 1.376 . . . . 0.0 110.978 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.44 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -138.74 25.82 2.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.122 -0.986 . . . . 0.0 111.962 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.11 37.96 59.66 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 41.6 m170 -118.91 118.91 32.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.559 -0.965 . . . . 0.0 110.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.49 125.12 29.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 0.0 109.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.03 -6.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.92 130.31 2.8 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.263 -1.446 . . . . 0.0 111.509 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.574 HD12 ' CE ' ' A' ' 175' ' ' MET . 70.3 mt -109.25 116.06 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.436 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 18.7 t80 -51.87 128.66 24.65 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.6 -0.688 . . . . 0.0 112.272 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' VAL . 35.3 ptt180 -119.44 -24.48 6.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.702 -0.624 . . . . 0.0 112.308 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -159.2 139.12 11.86 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.269 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.36 136.72 39.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.769 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.979 HG11 ' HB3' ' A' ' 166' ' ' ALA . 7.3 p -102.99 98.88 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.0 p -93.47 123.53 36.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.209 1.004 . . . . 0.0 111.278 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 161' ' ' ARG . 93.9 m -86.38 -70.02 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.119 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.535 ' HG3' HG22 ' A' ' 160' ' ' THR . 89.9 mtt180 -104.19 26.18 9.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.475 -0.765 . . . . 0.0 110.206 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 107.69 10.27 27.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.8 m -141.26 138.93 33.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.515 ' O ' HD23 ' A' ' 126' ' ' LEU . . . -80.1 114.11 18.77 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.667 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -96.95 11.54 35.62 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.606 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.979 ' HB3' HG11 ' A' ' 158' ' ' VAL . . . -167.77 154.49 8.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 116' ' ' VAL . 17.4 m -128.58 140.02 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.947 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -107.46 146.45 31.74 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 38.7 p90 -152.98 165.09 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.999 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 82' ' ' LEU . 58.4 t -83.37 137.64 42.15 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.831 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.94 146.22 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.78 1.411 . . . . 0.0 110.747 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 96' ' ' PRO . 14.7 p -70.03 -29.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.67 . . . . 0.0 109.61 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.32 -29.54 65.99 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.7 m -73.42 -24.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.8 -0.562 . . . . 0.0 110.234 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.574 ' CE ' HD12 ' A' ' 153' ' ' ILE . 64.3 mtt -65.67 -46.2 80.01 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.06 -41.07 91.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.301 0.572 . . . . 0.0 109.959 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.6 p -70.22 -22.63 62.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.624 -0.673 . . . . 0.0 110.965 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.446 ' CG2' ' CE1' ' A' ' 75' ' ' TYR . 93.6 m -61.6 -50.07 74.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.296 -0.878 . . . . 0.0 109.71 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 25.5 ptm -68.55 -24.85 64.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.644 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -66.54 -16.41 64.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.754 . . . . 0.0 110.583 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 182' ' ' SER . . . -166.72 -148.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -0.846 . . . . 0.0 110.53 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 181' ' ' ALA . 1.5 p 86.1 -31.76 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 123.682 0.793 . . . . 0.0 110.967 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.09 -42.89 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.267 -0.896 . . . . 0.0 110.231 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 48.6 tptt 56.84 32.48 21.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -154.71 159.95 41.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.532 -0.73 . . . . 0.0 110.814 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.006 179.531 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.78 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.049 0.452 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 -10.02 75.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.68 140.4 30.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -1.13 . . . . 0.0 109.924 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 12.0 t70 -79.51 166.89 21.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.255 0.55 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -140.28 160.65 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.018 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m120 51.33 53.7 12.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.506 -0.746 . . . . 0.0 111.473 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 53.23 -175.89 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.478 -0.764 . . . . 0.0 110.97 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.614 HG13 ' HG2' ' A' ' 34' ' ' GLN . 63.3 t -80.83 -42.91 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.181 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 48.74 39.8 14.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.673 -0.642 . . . . 0.0 111.616 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.65 176.36 47.94 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CA ' ' HB3' ' A' ' 92' ' ' ARG . 86.3 tt0 -93.85 -23.49 18.1 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.83 -0.806 . . . . 0.0 111.697 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.1 t -110.03 120.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.614 ' HG2' HG13 ' A' ' 29' ' ' VAL . 78.7 mt-30 -100.01 124.36 45.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.805 -0.559 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.29 133.84 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.42 174.53 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.891 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.3 m -147.99 126.48 12.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.741 HG21 ' O ' ' A' ' 59' ' ' ALA . 10.0 t -106.34 -179.14 3.85 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.49 -16.89 4.28 Favored 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.823 -0.548 . . . . 0.0 112.377 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.616 ' H ' HG23 ' A' ' 38' ' ' THR . 74.4 p -102.49 -34.85 8.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.036 -1.04 . . . . 0.0 113.245 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -172.83 -169.17 0.55 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.776 -1.203 . . . . 0.0 112.756 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.2 p -116.71 145.3 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HE1' HG22 ' A' ' 38' ' ' THR . 11.1 p90 -162.02 -143.86 0.09 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.21 -0.931 . . . . 0.0 110.802 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 109' ' ' ARG . 44.1 mt -129.06 161.77 29.23 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.618 -1.301 . . . . 0.0 114.0 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.3 123.61 7.08 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.759 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.905 ' CG2' HD11 ' A' ' 153' ' ' ILE . 9.7 t -80.47 -156.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 23.4 m -153.16 112.42 3.81 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.0 137.03 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.104 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 m120 50.58 39.45 21.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.577 -0.702 . . . . 0.0 111.163 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 26.59 74.41 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.587 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 55.6 t -137.6 118.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -1.009 . . . . 0.0 110.218 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 27.7 t -75.53 120.08 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 89.1 m95 -106.74 128.74 54.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.03 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.73 ' O ' HD12 ' A' ' 82' ' ' LEU . 15.0 t -134.5 -177.76 4.75 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.658 HG23 ' HA3' ' A' ' 58' ' ' GLY . 6.4 m -89.52 125.47 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.792 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.0 -41.88 93.07 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.584 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.827 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 26.1 p-80 -66.04 -34.42 78.04 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.437 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -71.23 -34.23 64.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.741 ' O ' HG21 ' A' ' 38' ' ' THR . . . -79.97 -70.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.681 -0.894 . . . . 0.0 110.14 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.55 -63.02 0.32 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.611 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 p -175.77 87.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.175 -1.191 . . . . 0.0 111.349 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 57.18 -163.52 0.18 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.522 1.153 . . . . 0.0 111.404 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 49.89 70.94 0.44 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.393 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' CE2' ' A' ' 85' ' ' TRP 0.254 11.8 tp -91.86 -155.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 64' ' ' LEU . . . -143.01 100.01 3.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.077 -1.015 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -92.05 -169.52 41.0 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 25' ' ' ASP . 48.4 Cg_endo -71.34 -13.46 30.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.194 1.628 . . . . 0.0 111.015 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -108.21 -24.89 11.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.21 -0.931 . . . . 0.0 111.016 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.64 -151.08 22.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.37 121.19 7.27 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.93 1.489 . . . . 0.0 110.845 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.509 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 72.6 mt -100.15 150.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.9 m -93.62 127.8 39.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.644 -0.66 . . . . 0.0 110.102 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 4.0 pt20 -64.88 163.9 13.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.619 -0.676 . . . . 0.0 110.146 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -93.51 -40.08 10.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -155.72 -176.65 6.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.862 HG23 ' CG1' ' A' ' 83' ' ' VAL . 57.6 m -152.01 123.5 7.82 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.787 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 27.8 t-20 -93.77 77.84 4.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.0 -40.1 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.681 -0.637 . . . . 0.0 109.686 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -55.25 -25.8 35.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -112.41 -0.61 15.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.74 -0.6 . . . . 0.0 110.906 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 60.04 56.77 3.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.046 -1.034 . . . . 0.0 109.321 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 54' ' ' THR . 40.3 tp -144.37 154.53 43.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.984 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.862 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -142.05 133.26 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.93 123.21 5.54 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.319 -1.419 . . . . 0.0 112.058 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.897 ' CE2' HD22 ' A' ' 64' ' ' LEU . 3.6 m-90 -88.25 -171.7 3.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.063 -0.669 . . . . 0.0 109.395 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -100.01 111.94 24.24 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 130.02 93.55 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.446 -0.784 . . . . 0.0 111.85 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_endo -90.96 175.21 2.52 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.795 1.419 . . . . 0.0 109.063 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 88' ' ' PRO . 40.6 Cg_endo -62.47 143.64 93.54 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.549 1.289 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.28 -3.55 66.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.619 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -87.99 22.52 2.35 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.008 -1.29 . . . . 0.0 112.207 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HG2' HD21 ' A' ' 94' ' ' LEU . 40.3 ttt180 31.34 96.01 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.695 ' C ' HD22 ' A' ' 94' ' ' LEU . 41.5 t -84.59 130.04 34.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 110.036 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 148' ' ' GLY . 4.4 mm? -115.95 170.93 8.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 164.05 37.12 Favored Pre-proline 0 N--CA 1.495 1.822 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.19 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.81 159.03 18.72 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.923 1.486 . . . . 0.0 109.436 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . 9.0 p -132.56 -40.51 0.98 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.43 -0.794 . . . . 0.0 111.829 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 48.02 36.93 6.93 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.18 -0.95 . . . . 0.0 110.731 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -65.14 -35.46 81.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.677 . . . . 0.0 111.097 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.93 -35.27 2.16 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t -68.34 130.04 41.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.979 . . . . 0.0 109.508 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -102.67 9.86 38.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.554 -0.716 . . . . 0.0 111.438 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -71.97 75.73 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 108.584 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 97.8 mt -78.96 174.67 11.3 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.389 0.614 . . . . 0.0 111.138 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 77.5 m-85 -144.37 127.3 16.41 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.479 HD13 ' HG ' ' A' ' 143' ' ' LEU . 38.1 tp -115.07 153.56 30.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.923 0.868 . . . . 0.0 111.841 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 111' ' ' ALA . 97.7 t -119.17 135.17 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.595 ' C ' HD11 ' A' ' 44' ' ' LEU . 68.8 p -85.22 175.28 9.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.132 -0.98 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 44' ' ' LEU . 63.8 ttt180 -37.16 -34.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 121.172 0.51 . . . . 0.0 112.056 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -100.15 -70.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.41 -80.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.864 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.568 ' HB3' HG23 ' A' ' 108' ' ' THR . 11.4 t70 46.6 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.593 -0.692 . . . . 0.0 111.595 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.69 107.67 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.249 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 126' ' ' LEU . 23.6 pt -130.95 159.99 68.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.7 -0.625 . . . . 0.0 109.731 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.431 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.9 Cg_endo -106.88 134.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.966 1.508 . . . . 0.0 111.224 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 167' ' ' VAL . 46.6 t -124.23 130.07 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -89.13 115.34 26.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.494 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 28.4 ttp85 -59.91 126.18 26.57 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.237 -0.915 . . . . 0.0 110.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -103.3 8.09 38.29 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.676 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.65 43.84 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 12.0 p-10 -59.96 -36.39 77.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -1.067 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -121.09 19.18 11.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.882 -0.511 . . . . 0.0 112.091 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -131.24 141.05 49.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.974 -1.079 . . . . 0.0 110.558 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.76 143.54 13.54 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -92.06 110.12 21.48 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 122.097 -0.649 . . . . 0.0 110.02 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 114' ' ' ILE . 45.3 tp -72.67 109.89 6.63 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.993 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.7 -31.03 69.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.457 0.646 . . . . 0.0 109.596 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -105.88 107.92 60.54 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.88 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.56 143.28 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.84 1.442 . . . . 0.0 110.357 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -148.36 160.01 37.77 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -60.36 126.24 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.842 1.443 . . . . 0.0 110.4 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.08 -26.12 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.75 -0.594 . . . . 0.0 110.675 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.6 m -59.31 -34.66 72.59 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.881 0.848 . . . . 0.0 109.212 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -73.82 -26.78 60.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.514 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.27 -4.82 58.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 112.939 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.88 66.59 1.55 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.647 1.213 . . . . 0.0 109.025 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 174.51 -26.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.683 ' HA ' HD12 ' A' ' 44' ' ' LEU . 3.8 t -72.57 -9.1 58.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.395 -1.062 . . . . 0.0 111.841 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.524 ' HB3' HG11 ' A' ' 55' ' ' VAL . 7.1 m -58.6 142.31 49.72 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.869 -1.145 . . . . 0.0 109.559 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.59 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 90.47 -9.86 76.26 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.02 157.06 53.56 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.4 Cg_endo -103.01 138.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.92 1.484 . . . . 0.0 112.799 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.479 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.9 mp -100.16 98.81 9.47 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.626 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.6 mp -87.64 147.81 25.1 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.028 0.918 . . . . 0.0 113.064 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -158.86 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -99.69 16.61 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.69 1.363 . . . . 0.0 110.732 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.4 p -127.42 0.14 6.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.156 -0.965 . . . . 0.0 112.271 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 94' ' ' LEU . . . 99.94 39.97 3.21 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 97' ' ' CYS . 79.8 m80 -125.75 121.84 34.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -1.122 . . . . 0.0 110.791 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.94 101.51 12.41 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.07 7.13 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 0.0 112.237 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -156.58 134.74 4.17 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.905 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.1 mt -118.66 122.63 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.385 -1.068 . . . . 0.0 108.398 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -50.86 128.56 21.35 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.894 0.854 . . . . 0.0 112.326 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.55 ' HB2' HG23 ' A' ' 170' ' ' VAL . 34.2 ttt180 -116.78 -29.77 5.95 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.872 -0.518 . . . . 0.0 110.751 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.859 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.93 153.21 10.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -107.15 141.49 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.812 -0.555 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 30.5 t -94.5 93.42 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.6 p -91.8 115.78 28.34 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.383 1.087 . . . . 0.0 112.704 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 162' ' ' GLY . 22.1 m -92.02 120.28 32.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 160' ' ' THR . 14.8 ttm180 65.3 -67.67 0.12 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.986 -0.446 . . . . 0.0 109.892 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.452 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -161.7 24.49 0.23 Allowed Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.686 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 34.6 m -150.01 143.18 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -1.205 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.0 130.0 35.06 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.663 0.744 . . . . 0.0 111.547 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -125.58 16.42 8.18 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.39 150.02 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 116' ' ' VAL . 13.3 m -130.29 137.67 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.27 -0.972 . . . . 0.0 113.013 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -104.32 145.51 30.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 29.5 p90 -152.98 161.9 41.98 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.243 -1.383 . . . . 0.0 112.541 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.583 HG11 HD22 ' A' ' 82' ' ' LEU . 75.7 t -79.41 139.87 55.8 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.979 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.37 156.74 12.62 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.683 1.36 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.03 -25.71 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.64 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.89 -26.74 66.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 108.964 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.8 p -75.47 -33.07 60.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 110.348 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.571 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.1 mpp? -66.92 -48.46 68.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.724 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 177' ' ' THR . 12.5 pt-20 -62.4 -40.4 96.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.555 -0.715 . . . . 0.0 110.441 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 173' ' ' GLU . 33.8 p -63.31 -37.8 88.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.602 -0.686 . . . . 0.0 109.962 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.2 m -60.56 -40.03 90.15 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.27 -39.75 93.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.662 -0.649 . . . . 0.0 109.25 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -63.58 -29.95 71.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.67 159.68 19.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.621 -0.674 . . . . 0.0 110.941 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.77 52.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.695 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -144.83 151.13 38.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.615 . . . . 0.0 109.605 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.5 tptt 53.94 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.51 -0.744 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 42.5 mttp . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.183 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.859 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.077 0.465 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.32 178.25 51.72 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -49.95 75.65 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.542 -0.975 . . . . 0.0 109.543 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 40.8 t0 50.0 50.36 18.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.794 -0.566 . . . . 0.0 112.163 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.68 -152.72 0.14 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.417 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -154.75 92.5 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 110.718 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -163.93 55.14 0.16 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 109.971 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG11 ' CB ' ' A' ' 91' ' ' ALA . 80.1 t -87.98 -50.08 13.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.399 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 49.64 39.96 18.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.554 -0.716 . . . . 0.0 111.373 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 172.02 36.48 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.87 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.3 pt-20 -98.32 -39.15 8.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.81 -0.818 . . . . 0.0 111.381 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' A' ' 32' ' ' GLU . 62.5 t -114.56 119.99 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 0.0 109.454 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.444 ' CG ' HG13 ' A' ' 29' ' ' VAL . 6.5 mm100 -102.94 121.98 43.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 0.0 111.353 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 44' ' ' LEU . 78.3 t -83.96 130.82 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.31 175.1 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.879 0.847 . . . . 0.0 110.818 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -138.41 129.43 26.95 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.724 0.773 . . . . 0.0 109.309 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.1 p -110.9 -179.08 3.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -17.22 9.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.61 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.5 p -101.33 -41.12 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 112.278 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -175.61 -162.51 0.1 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 121.033 -1.042 . . . . 0.0 111.457 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.8 m -121.76 146.93 46.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.707 -0.621 . . . . 0.0 109.371 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.4 p90 -160.71 -141.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.624 -0.673 . . . . 0.0 109.764 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 138' ' ' SER . 61.0 mt -130.79 161.0 32.72 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.489 -1.382 . . . . 0.0 114.271 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.446 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.58 120.2 4.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.693 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER -85.75 -159.99 0.5 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.146 -0.971 . . . . 0.0 110.162 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' H ' HG22 ' A' ' 46' ' ' THR . 39.1 t -149.98 113.14 4.89 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.04 129.95 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.058 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 51.78 40.0 26.76 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.653 -0.654 . . . . 0.0 110.715 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 26.53 74.23 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 41.5 t -133.86 111.9 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -1.077 . . . . 0.0 109.616 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 29.3 t -75.47 129.53 37.42 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 84.7 m95 -118.58 129.27 55.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.55 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.585 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 12.5 t -135.72 179.7 6.18 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 140' ' ' GLY . 12.3 m -88.66 133.33 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.696 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.819 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -59.97 -42.5 94.29 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.728 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 46.9 p-80 -74.0 69.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.22 -35.85 0.08 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -79.8 -69.39 0.59 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.496 -1.003 . . . . 0.0 108.79 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.94 -92.67 1.36 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.467 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -89.06 39.24 0.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.536 -0.979 . . . . 0.0 111.816 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.0 mttp 48.21 -173.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.101 0.953 . . . . 0.0 112.144 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 60.76 135.49 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.708 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -144.11 -128.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.434 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -145.2 91.95 2.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.844 -1.16 . . . . 0.0 110.239 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -65.93 -153.42 0.18 Allowed Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.23 -20.92 24.06 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.243 1.654 . . . . 0.0 109.922 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -142.21 0.7 1.36 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.12 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.43 173.14 41.79 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.74 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -60.83 129.62 29.76 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.91 1.479 . . . . 0.0 111.324 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.685 HG22 ' HD1' ' A' ' 85' ' ' TRP . 40.3 mt -105.48 146.95 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 6.2 m -94.83 144.79 25.36 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.71 0.766 . . . . 0.0 111.596 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 85' ' ' TRP . 3.6 pt20 -78.45 160.34 27.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.872 -0.518 . . . . 0.0 111.2 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.9 mmm -93.34 -39.61 10.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.662 -0.649 . . . . 0.0 109.609 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 -176.37 5.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.73 . . . . 0.0 109.516 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.897 HG23 ' CG1' ' A' ' 83' ' ' VAL . 8.4 m -149.94 118.71 6.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.726 -0.609 . . . . 0.0 109.384 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.1 t30 -91.67 77.26 5.64 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.02 -38.14 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.734 -0.604 . . . . 0.0 109.42 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -54.73 -25.98 31.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -115.91 1.28 13.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.696 -0.627 . . . . 0.0 111.139 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t70 60.03 59.99 2.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.969 -1.082 . . . . 0.0 108.971 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 175' ' ' MET . 27.4 tp -147.04 152.5 38.66 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.597 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.897 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.18 130.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.35 127.07 5.94 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.12 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.685 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.9 m-90 -90.4 178.47 6.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.19 84.05 2.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.299 -0.875 . . . . 0.0 108.709 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.418 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -69.97 158.49 87.16 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.581 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -100.01 -170.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 124.017 1.535 . . . . 0.0 108.618 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -87.36 12.06 3.04 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.62 1.327 . . . . 0.0 111.552 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -28.77 13.45 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 29' ' ' VAL . . . -85.21 57.34 4.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.803 -0.822 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 25.6 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.014 0.926 . . . . 0.0 112.721 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.6 m -83.17 108.14 16.22 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.051 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 144' ' ' LEU . 91.0 mt -82.74 164.07 20.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 95.2 m -115.98 153.73 48.31 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -102.6 135.81 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 O-C-N 123.404 1.213 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 149' ' ' HIS . 26.7 p -145.68 151.76 38.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.461 -0.774 . . . . 0.0 110.703 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.4 p -86.48 103.79 15.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.3 m -99.49 137.77 37.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.09 -35.23 86.9 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.1 m -83.91 127.18 33.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.732 -0.864 . . . . 0.0 109.887 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -97.01 17.04 17.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.602 -0.686 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -71.49 73.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.72 175.12 10.23 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.33 0.586 . . . . 0.0 110.342 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -141.7 120.61 12.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 154' ' ' PHE . 22.0 tp -100.09 140.2 34.66 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.503 0.668 . . . . 0.0 110.233 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.669 HG21 HG21 ' A' ' 33' ' ' VAL . 83.8 t -91.75 120.05 40.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.344 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -84.63 173.31 10.86 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -38.84 -31.73 0.07 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.983 -0.448 . . . . 0.0 112.195 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -100.26 -69.25 0.78 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.828 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 -162.35 1.53 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' HG22 ' A' ' 107' ' ' VAL . 84.6 m-20 -60.34 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.181 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.634 ' O ' HG12 ' A' ' 113' ' ' VAL . 48.9 t 50.87 22.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.312 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -171.27 117.05 0.44 Allowed Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.011 -1.056 . . . . 0.0 110.299 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -98.91 145.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.748 1.393 . . . . 0.0 109.357 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 126' ' ' LEU . 47.5 t -133.97 139.55 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 111.073 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -97.06 120.26 37.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 8.4 ttp180 -60.02 125.2 22.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 111.063 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -101.68 5.37 41.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.707 -0.621 . . . . 0.0 109.419 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.07 34.77 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 26.9 t0 -58.48 -22.93 56.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.473 -1.016 . . . . 0.0 110.634 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -124.61 17.15 8.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.529 -0.732 . . . . 0.0 111.361 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -139.99 144.55 37.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.045 -1.034 . . . . 0.0 110.953 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.79 141.07 10.64 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.0 t -88.67 112.03 22.63 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.926 -0.75 . . . . 0.0 109.954 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 129' ' ' PRO . 38.5 tp -72.89 107.36 5.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.18 -19.92 65.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.809 -0.557 . . . . 0.0 110.535 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.0 m -122.45 79.99 46.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.672 -0.643 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.655 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.0 Cg_endo -58.51 150.4 68.95 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 O-C-N 123.771 1.406 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -151.14 163.07 24.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.55 122.56 11.97 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 O-C-N 123.774 1.407 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.72 -25.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.808 -0.558 . . . . 0.0 111.524 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.3 m -59.58 -39.97 85.86 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.608 0.718 . . . . 0.0 109.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.94 -27.08 64.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.3 1.65 47.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.0 111.644 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.23 66.01 1.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.989 -1.07 . . . . 0.0 109.029 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.1 -24.4 0.08 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' LEU . 83.1 p -70.59 -13.77 62.22 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.53 -0.982 . . . . 0.0 111.65 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.545 ' HB3' HG11 ' A' ' 55' ' ' VAL . 6.9 m -60.97 141.93 56.91 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.973 -1.079 . . . . 0.0 109.833 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.622 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.02 -9.98 75.51 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.35 -161.44 0.49 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.509 ' HB2' HD11 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -146.36 137.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 116.282 -2.012 . . . . 0.0 112.277 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.4 mt -95.09 96.52 9.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.619 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.7 mp -87.68 145.14 26.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.0 m -67.92 174.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.69 -2.03 11.91 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.655 1.345 . . . . 0.0 111.695 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.1 m -103.3 0.07 30.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.974 -1.079 . . . . 0.0 112.085 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.26 36.24 5.24 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 77.3 m80 -121.16 124.04 43.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -1.121 . . . . 0.0 110.902 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.41 22.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.765 -0.584 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.8 1.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 111.839 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -155.0 136.65 5.25 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 20.2 mt -119.83 120.05 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.0 t80 -50.14 127.6 17.24 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.903 0.859 . . . . 0.0 113.28 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 170' ' ' VAL . 38.7 ttt-85 -116.67 -28.64 6.32 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.741 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.715 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -164.89 151.21 10.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.112 -0.993 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.59 146.73 29.27 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.669 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 58.6 t -90.06 94.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 83.5 m -91.57 119.2 31.28 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.258 1.028 . . . . 0.0 112.711 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.625 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.3 m -120.04 132.59 55.52 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.989 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 56.78 23.79 8.38 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.04 19.31 51.35 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.818 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 160' ' ' THR . 34.9 m -147.15 143.85 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.015 -1.285 . . . . 0.0 109.564 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.93 126.03 30.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 111.26 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -118.82 15.74 13.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.295 0.569 . . . . 0.0 110.051 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.669 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.19 149.05 1.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.607 ' CG2' HG11 ' A' ' 116' ' ' VAL . 15.6 m -124.01 135.42 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.03 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -106.08 149.32 26.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.9 p90 -154.53 163.96 39.41 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.267 -1.373 . . . . 0.0 112.791 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 155' ' ' ARG . 63.0 t -80.27 141.56 53.71 Favored Pre-proline 0 N--CA 1.498 1.945 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.79 151.21 14.55 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.702 1.369 . . . . 0.0 110.754 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -73.16 -30.04 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.654 -0.654 . . . . 0.0 110.136 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.93 -32.95 70.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.43 -0.794 . . . . 0.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.9 m -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.884 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.532 ' CG ' HD21 ' A' ' 82' ' ' LEU . 4.8 mtp -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.692 -0.63 . . . . 0.0 109.911 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -61.41 -40.01 92.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.7 p -66.03 -24.03 66.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.436 -0.79 . . . . 0.0 111.592 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -62.36 -40.49 96.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.118 -0.989 . . . . 0.0 109.139 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 82.6 mmm -65.21 -38.54 90.76 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -60.91 -28.29 68.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 111.104 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 182' ' ' SER . . . -166.02 -44.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.659 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 181' ' ' ALA . 1.4 t 75.49 -55.61 0.62 Allowed 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.723 -0.611 . . . . 0.0 110.605 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 185' ' ' LYS . 36.1 mttm -142.64 101.66 3.91 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.27 -0.894 . . . . 0.0 110.264 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 59.58 -72.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.071 -0.393 . . . . 0.0 110.867 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 183' ' ' LYS . 44.9 pttt -159.84 32.8 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.239 -0.913 . . . . 0.0 110.493 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.986 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.728 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.4 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.52 -171.01 39.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.96 170.63 10.88 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.957 -0.731 . . . . 0.0 109.943 179.73 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 24' ' ' ARG . 3.0 t70 85.24 -174.75 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 123.791 0.837 . . . . 0.0 109.495 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.13 139.09 57.25 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.899 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 22' ' ' THR . 10.3 t-20 -159.45 139.58 11.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -63.32 140.07 58.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.793 -0.567 . . . . 0.0 110.475 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 ' O ' ' HB1' ' A' ' 91' ' ' ALA . 34.5 m -80.81 -15.26 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.769 -0.582 . . . . 0.0 110.821 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.97 66.95 0.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.301 -0.874 . . . . 0.0 109.762 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.55 155.49 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -98.36 -40.06 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.952 . . . . 0.0 110.333 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.785 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -77.06 -28.74 54.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.03 -112.16 3.57 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -162.93 40.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.94 . . . . 0.0 110.292 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -169.74 161.12 9.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 111.317 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 70' ' ' PRO . 77.6 m 42.08 -100.09 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER 80.9 -29.32 0.12 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.697 0.799 . . . . 0.0 111.968 -178.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 73.01 99.51 0.07 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.619 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -105.53 -169.59 23.69 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.76 -17.6 60.03 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 124.021 1.537 . . . . 0.0 110.623 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -104.55 5.16 33.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 111.375 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.7 -155.99 15.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' THR . 46.5 Cg_endo -70.61 111.07 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.782 1.411 . . . . 0.0 110.143 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.619 HD12 ' HA3' ' A' ' 66' ' ' GLY . 94.5 mt -105.73 148.99 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.65 . . . . 0.0 110.108 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 4.4 pp0? -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.859 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.02 149.91 96.27 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.61 161.3 28.01 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 124.026 1.54 . . . . 0.0 109.816 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.03 19.96 1.2 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.722 1.38 . . . . 0.0 111.119 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.34 -15.08 36.4 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -76.69 -160.25 0.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.329 -1.101 . . . . 0.0 108.962 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -77.86 -40.0 41.58 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.585 0.707 . . . . 0.0 110.752 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m 52.82 101.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.82 171.84 2.59 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.54 ' O ' ' HD2' ' A' ' 149' ' ' HIS . 14.8 t -52.81 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.84 -0.538 . . . . 0.0 111.634 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m 49.97 55.01 10.09 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.981 -1.074 . . . . 0.0 112.089 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.75 173.95 11.91 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.02 -1.05 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.57 19.28 7.56 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m -137.5 152.63 49.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.142 -1.21 . . . . 0.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.54 ' HD2' ' O ' ' A' ' 97' ' ' CYS . 5.0 m-70 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p -59.92 -32.48 70.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.859 HG23 ' CG ' ' A' ' 75' ' ' TYR . 78.9 m -60.62 -44.99 95.69 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.1 mtp -61.33 -40.24 93.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.44 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.7 mtt85 -70.08 -39.97 75.29 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.896 0.855 . . . . 0.0 109.487 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 60.1 7.13 1.12 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 36.37 31.06 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.422 -0.799 . . . . 0.0 113.086 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -85.28 -47.12 10.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 50.0 41.45 23.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.442 -0.787 . . . . 0.0 111.486 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.63 130.01 34.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.47 -0.769 . . . . 0.0 109.848 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 34.7 mttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.215 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.787 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.153 0.502 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -57.97 3.76 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 30.4 ttt85 -107.44 5.0 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.532 -0.981 . . . . 0.0 111.282 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 60.13 -154.48 0.37 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.821 -1.174 . . . . 0.0 110.327 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 33.9 mttp -110.03 25.76 11.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.928 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 17.0 t-20 66.41 -59.97 0.33 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.561 -0.712 . . . . 0.0 111.789 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -100.82 128.34 46.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.942 -1.099 . . . . 0.0 110.509 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 91' ' ' ALA . 60.1 t -84.18 -56.87 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.438 0.637 . . . . 0.0 109.785 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 46.53 34.73 2.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.741 -0.599 . . . . 0.0 112.011 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.11 16.88 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.4 pt-20 -70.05 -25.78 63.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.73 -0.865 . . . . 0.0 110.655 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 ' HG3' ' A' ' 142' ' ' PRO . 46.8 t -109.89 140.01 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -0.762 . . . . 0.0 109.653 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -138.83 147.76 42.88 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.574 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -86.0 130.52 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.337 0.589 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.68 HG23 ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -132.67 159.99 42.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.7 -0.625 . . . . 0.0 109.603 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 m -141.56 149.93 41.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 2.4 t -115.42 76.77 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.498 1.142 . . . . 0.0 109.755 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.3 -48.9 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -120.06 9.72 11.26 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.405 -1.434 . . . . 0.0 113.851 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.36 170.52 19.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.646 -1.284 . . . . 0.0 111.703 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -127.75 154.36 45.46 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.496 0.665 . . . . 0.0 109.825 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.68 ' CE2' HG23 ' A' ' 36' ' ' VAL . 10.0 p90 -162.95 -145.8 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -135.69 161.71 34.77 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.488 -1.383 . . . . 0.0 112.852 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.98 130.4 13.83 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 21.8 m -112.42 125.29 54.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.364 -0.835 . . . . 0.0 111.453 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 27.5 p -74.16 130.14 39.19 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.493 0.663 . . . . 0.0 110.784 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.658 HG11 HG23 ' A' ' 172' ' ' VAL . 44.8 t -140.34 137.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 52.09 37.88 22.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.387 -0.821 . . . . 0.0 110.785 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.74 28.06 72.52 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG22 ' SD ' ' A' ' 74' ' ' MET . 89.2 t -138.94 120.02 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.487 -1.008 . . . . 0.0 109.812 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 33.9 m -72.43 129.31 38.05 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 73.3 m95 -122.9 133.28 54.41 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.8 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.821 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 3.7 t -140.57 -179.21 5.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.734 HG23 ' HA3' ' A' ' 58' ' ' GLY . 4.8 m -88.81 128.29 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 C-N-CA 118.146 -1.422 . . . . 0.0 111.895 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.705 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 88.3 t80 -59.98 -40.08 87.91 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.831 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 43.1 p-80 -67.8 -20.06 65.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.487 -1.285 . . . . 0.0 108.518 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.734 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -85.51 -35.25 12.13 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.196 -2.362 . . . . 0.0 107.196 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -90.02 -80.03 0.33 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.742 -0.858 . . . . 0.0 109.08 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.99 9.28 75.72 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.331 -0.856 . . . . 0.0 111.923 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.0 p -140.46 15.61 2.38 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.957 1.379 . . . . 0.0 111.864 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HG2' HG23 ' A' ' 72' ' ' THR . 40.0 tttt 68.34 -59.11 0.45 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.849 HG22 ' OG1' ' A' ' 72' ' ' THR . 64.9 p -79.67 169.98 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -147.8 -128.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.556 -0.715 . . . . 0.0 109.368 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -146.15 84.49 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 108.285 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.694 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -106.83 -176.04 22.99 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.577 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 27' ' ' ASN . 47.1 Cg_endo -54.06 -24.04 31.1 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.923 1.486 . . . . 0.0 110.763 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.96 6.63 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.723 -0.611 . . . . 0.0 110.627 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.49 -144.27 17.21 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 42.9 Cg_endo -69.05 109.89 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.916 1.482 . . . . 0.0 109.084 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.694 HD12 ' HA3' ' A' ' 66' ' ' GLY . 72.1 mt -101.18 137.81 27.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.265 1.031 . . . . 0.0 111.821 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.849 ' OG1' HG22 ' A' ' 63' ' ' THR . 96.6 m -137.1 126.67 25.22 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 85' ' ' TRP . 97.7 mm-40 -138.3 -71.67 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 51' ' ' VAL . 29.6 mtt -87.67 -64.68 1.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -171.56 -168.15 0.58 Allowed 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.182 -176.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.875 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.5 m -149.75 115.3 5.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.618 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 3.0 t-20 -99.04 83.58 2.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.182 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.705 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 61.0 t -63.96 -37.4 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.427 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.77 -27.13 27.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.593 -0.692 . . . . 0.0 109.254 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.18 -1.78 14.27 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.675 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.6 t70 61.23 54.97 3.09 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 108.672 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 170' ' ' VAL . 16.6 tp -147.12 148.83 31.98 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.875 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -142.87 139.93 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 108.87 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 74' ' ' MET . . . -131.29 133.24 7.14 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 118.931 -1.604 . . . . 0.0 110.882 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.821 ' CZ3' HG22 ' A' ' 54' ' ' THR . 21.0 m-90 -106.96 -160.83 0.75 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 73' ' ' GLN . 66.7 tt0 -116.18 113.39 23.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.54 143.25 97.93 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.543 -0.723 . . . . 0.0 110.961 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -104.19 163.94 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.845 1.445 . . . . 0.0 110.006 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.26 130.21 26.38 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 123.897 1.472 . . . . 0.0 110.376 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.82 -30.16 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -91.91 -146.78 0.21 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.692 -0.887 . . . . 0.0 109.543 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -154.66 112.38 3.44 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 m -82.64 139.14 33.91 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.386 0.612 . . . . 0.0 110.784 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 150' ' ' ALA . 68.2 mt -96.6 165.34 12.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.7 168.05 8.46 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.615 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.71 132.79 25.9 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 124.003 1.528 . . . . 0.0 109.869 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.46 ' SG ' ' CB ' ' A' ' 145' ' ' CYS . 2.2 t -70.15 -40.06 74.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.0 112.027 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m 50.77 50.01 19.85 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.384 -0.822 . . . . 0.0 112.299 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.84 169.93 21.04 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.011 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.76 16.34 58.45 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.424 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 m -75.48 120.24 20.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.006 -1.291 . . . . 0.0 109.412 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.7 m -105.02 -2.52 24.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.75 76.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.017 -1.052 . . . . 0.0 109.17 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.1 mt -84.37 174.69 9.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.744 0.783 . . . . 0.0 111.845 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 93.7 m-85 -146.39 130.96 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 138' ' ' SER . 43.9 tp -112.73 152.69 28.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.012 0.91 . . . . 0.0 111.759 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.6 t -109.95 131.09 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.448 ' C ' HD11 ' A' ' 44' ' ' LEU . 80.0 p -81.94 169.06 17.23 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.455 -0.778 . . . . 0.0 110.283 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.531 ' HA ' HD21 ' A' ' 44' ' ' LEU . 58.6 ttp180 -34.0 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -98.76 -85.29 0.38 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.34 5.34 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 113.06 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.07 137.91 57.99 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.561 -1.337 . . . . 0.0 109.956 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.27 120.05 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 0.0 110.319 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 128' ' ' SER . 6.1 tt -120.01 112.43 34.89 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 109.577 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 45.5 Cg_endo -62.55 132.07 36.44 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.596 1.314 . . . . 0.0 111.487 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.692 HG22 HD12 ' A' ' 126' ' ' LEU . 48.7 t -129.93 134.18 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -91.07 119.99 31.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 108.769 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 ttm180 -58.71 124.28 19.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.922 . . . . 0.0 110.958 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -99.58 3.44 45.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 109.634 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.31 45.96 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.5 m-20 -63.41 -27.09 69.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -1.084 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.2 p -123.49 18.67 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.6 -0.688 . . . . 0.0 111.808 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -138.52 145.83 41.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.089 -1.007 . . . . 0.0 111.378 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.53 142.17 12.11 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.455 ' C ' HG13 ' A' ' 116' ' ' VAL . 13.7 t -90.4 110.01 21.12 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.872 -0.781 . . . . 0.0 110.227 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.692 HD12 HG22 ' A' ' 116' ' ' VAL . 31.0 tp -70.36 108.42 4.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.51 -35.41 75.89 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.585 0.707 . . . . 0.0 109.732 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 114' ' ' ILE . 47.3 t -110.87 107.82 57.82 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.254 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.45 148.17 37.59 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 O-C-N 123.873 1.46 . . . . 0.0 109.899 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -150.02 160.96 32.54 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.91 124.3 15.67 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.858 1.451 . . . . 0.0 110.441 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.01 -27.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.268 0.556 . . . . 0.0 110.806 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.4 m -57.47 -30.88 65.42 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.823 0.82 . . . . 0.0 109.23 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -74.09 -29.05 61.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.383 -0.823 . . . . 0.0 109.125 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.05 -1.42 57.95 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.6 65.85 1.35 Allowed 'General case' 0 N--CA 1.513 2.68 0 O-C-N 120.8 -1.188 . . . . 0.0 109.369 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 173.6 -25.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 44' ' ' LEU . 8.2 t -70.32 -12.58 61.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -1.056 . . . . 0.0 111.316 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.442 ' HB3' HG11 ' A' ' 55' ' ' VAL . 11.1 m -59.92 140.4 56.72 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.621 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 88.93 -7.98 80.83 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.06 -158.21 0.74 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.799 ' HG3' HG22 ' A' ' 33' ' ' VAL . 58.6 Cg_endo -143.32 140.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 116.356 -1.963 . . . . 0.0 112.077 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' HD22 ' A' ' 104' ' ' LEU . 2.5 mt -99.93 96.25 7.43 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -86.93 132.58 33.77 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.816 0.817 . . . . 0.0 112.737 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.25 -161.44 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -98.85 15.78 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.666 1.351 . . . . 0.0 110.15 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -120.33 12.4 11.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.209 -0.932 . . . . 0.0 112.047 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.38 20.64 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.94 -1.1 . . . . 0.0 110.488 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -127.15 128.75 46.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 0.0 110.639 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -92.61 100.13 12.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.99 6.79 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.177 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -149.95 124.43 1.76 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.278 -1.439 . . . . 0.0 111.462 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.619 HD12 ' CE ' ' A' ' 175' ' ' MET . 22.6 mt -109.98 120.07 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.24 . . . . 0.0 107.984 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.485 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.5 t80 -52.56 128.83 27.29 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.673 0.749 . . . . 0.0 112.495 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.3 ttp180 -116.27 -28.19 6.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.851 -0.53 . . . . 0.0 110.993 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.797 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.3 151.0 9.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.2 -0.938 . . . . 0.0 111.836 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.485 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.73 145.31 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.824 -0.547 . . . . 0.0 111.331 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 49.0 t -93.43 91.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.3 p -94.59 113.84 25.72 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.667 1.222 . . . . 0.0 112.625 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' GLY . 62.8 m -98.57 133.31 43.1 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 160' ' ' THR . 19.8 ttp180 63.45 -72.43 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -164.39 25.83 0.19 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.95 144.02 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.056 -1.261 . . . . 0.0 109.569 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.18 127.59 32.23 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.592 0.71 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -118.35 14.89 13.88 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.176 0.512 . . . . 0.0 110.04 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.72 146.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.686 HG21 HG11 ' A' ' 116' ' ' VAL . 14.7 m -121.12 135.39 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.729 0.776 . . . . 0.0 112.464 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -103.39 147.14 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 36.2 p90 -156.14 161.26 40.37 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.306 -1.358 . . . . 0.0 112.757 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 155' ' ' ARG . 62.9 t -87.55 130.34 47.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.863 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -79.23 156.69 26.01 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.658 HG23 HG11 ' A' ' 48' ' ' VAL . 14.1 p -70.06 -29.94 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -59.47 -27.63 66.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -75.04 -25.99 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.706 -0.621 . . . . 0.0 110.236 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 153' ' ' ILE . 55.4 mtt -64.65 -50.07 68.52 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.91 -45.11 94.05 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.5 p -69.77 -40.74 75.88 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.41 ' CG2' ' OH ' ' A' ' 75' ' ' TYR . 85.9 m -68.96 -40.06 79.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 85.0 mmm -66.84 -25.57 66.49 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.66 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -59.15 -22.5 61.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.304 -0.872 . . . . 0.0 110.657 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.92 18.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 111.221 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -173.17 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.472 -0.767 . . . . 0.0 109.749 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.1 mttp 49.99 -139.97 0.82 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.501 -0.749 . . . . 0.0 110.43 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 47.5 tptt 56.56 36.95 28.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.648 -1.283 . . . . 0.0 109.388 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -70.0 -40.05 75.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.804 0.811 . . . . 0.0 109.68 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.47 179.182 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.831 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.58 -9.92 73.31 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -103.7 4.6 35.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.041 -1.27 . . . . 0.0 111.231 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.2 t0 47.83 76.98 0.1 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.336 -0.852 . . . . 0.0 111.643 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -73.85 65.82 1.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.917 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -159.6 136.61 9.48 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.86 141.99 58.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.289 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG11 ' HB2' ' A' ' 91' ' ' ALA . 39.1 t -79.99 -70.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.393 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 43.71 38.94 2.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.783 -0.573 . . . . 0.0 112.533 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.88 158.76 27.78 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.628 -1.272 . . . . 0.0 111.174 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.845 ' HG2' HD21 ' A' ' 94' ' ' LEU . 24.7 mp0 -70.0 -35.66 74.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.99 -0.712 . . . . 0.0 110.318 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.3 t -107.58 121.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.673 -0.642 . . . . 0.0 109.755 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -91.61 127.96 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.71 127.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.49 173.99 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.36 -0.838 . . . . 0.0 110.38 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 8.2 t -150.1 141.99 23.81 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.822 0.82 . . . . 0.0 109.081 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 58' ' ' GLY . 6.2 t -117.48 179.34 4.08 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -18.48 1.51 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.505 ' H ' HG23 ' A' ' 38' ' ' THR . 67.5 p -104.55 -31.09 9.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.995 -1.066 . . . . 0.0 113.595 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -171.88 -169.14 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.588 -1.32 . . . . 0.0 113.183 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 53.6 m -118.4 145.71 44.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.668 ' HE1' HG22 ' A' ' 38' ' ' THR . 10.2 p90 -161.12 -145.2 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.384 -0.822 . . . . 0.0 110.71 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt -134.08 160.66 37.11 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.629 -1.294 . . . . 0.0 113.287 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.484 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -150.18 126.72 10.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.068 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.581 HG21 ' HB3' ' A' ' 142' ' ' PRO . 59.3 m -96.74 127.28 42.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.115 -0.99 . . . . 0.0 111.743 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 22.3 m -76.32 123.82 26.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.854 -0.529 . . . . 0.0 110.434 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.52 130.01 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.54 -0.725 . . . . 0.0 110.19 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.8 m120 50.37 39.92 21.55 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.355 -0.84 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.34 26.16 74.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.19 113.86 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -1.029 . . . . 0.0 109.556 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.5 t -75.65 119.97 20.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.73 -0.606 . . . . 0.0 109.399 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 86.7 m95 -107.68 123.45 48.53 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.88 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -127.62 -179.87 5.15 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 139' ' ' SER . 10.5 m -90.22 124.99 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 C-N-CA 118.194 -1.403 . . . . 0.0 111.999 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.412 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.819 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 41.4 p-80 -73.02 68.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.119 0.962 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 38' ' ' THR . . . 168.57 -49.31 0.22 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -85.39 -78.61 0.25 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.71 -0.876 . . . . 0.0 109.753 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 43.56 28.39 1.01 Allowed Glycine 0 N--CA 1.503 3.16 0 O-C-N 121.521 -0.737 . . . . 0.0 111.688 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 63' ' ' THR . 27.3 p -131.89 10.08 4.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.264 -1.139 . . . . 0.0 112.31 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 61' ' ' SER . 20.3 ttmt 62.51 -64.63 0.09 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 118.581 0.628 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 70' ' ' PRO . 90.7 m -81.0 138.13 36.05 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.845 0.831 . . . . 0.0 111.683 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -142.26 -135.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.466 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -137.85 100.03 4.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.743 -1.223 . . . . 0.0 110.712 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -96.45 172.92 29.38 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -63.75 -12.98 34.18 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.934 1.492 . . . . 0.0 110.996 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -112.51 -13.72 13.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.926 . . . . 0.0 111.873 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.6 -163.64 29.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.864 ' HB2' HG23 ' A' ' 63' ' ' THR . 47.6 Cg_endo -66.59 121.33 8.55 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.944 1.497 . . . . 0.0 109.597 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.748 HG22 ' HD1' ' A' ' 85' ' ' TRP . 27.0 mt -94.35 143.79 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.666 0.746 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.409 HG23 ' HD3' ' A' ' 62' ' ' LYS . 31.7 m -99.94 140.34 34.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.922 -0.486 . . . . 0.0 110.534 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.3 pt20 -72.19 156.05 39.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.524 -0.735 . . . . 0.0 110.416 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -95.35 -35.51 11.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.499 0.666 . . . . 0.0 109.27 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -159.26 -177.02 6.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.906 HG23 HG13 ' A' ' 83' ' ' VAL . 89.4 m -150.48 122.49 8.22 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.653 -0.654 . . . . 0.0 109.565 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.79 76.41 2.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.04 -39.91 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.651 -0.655 . . . . 0.0 109.71 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -54.95 -26.09 33.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -110.48 -2.58 16.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.703 -0.623 . . . . 0.0 110.794 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 60.01 54.97 3.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.907 -1.121 . . . . 0.0 108.372 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD21 ' CG ' ' A' ' 175' ' ' MET . 8.1 tp -147.33 153.57 39.86 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.839 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -144.18 141.2 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -124.14 122.01 4.65 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.094 -1.527 . . . . 0.0 111.877 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.88 ' CZ3' HG22 ' A' ' 54' ' ' THR . 6.9 m-90 -90.99 -170.24 2.61 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -101.83 112.72 25.43 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . . . -64.27 138.39 97.41 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.421 -0.799 . . . . 0.0 110.48 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 53.8 Cg_endo -114.36 167.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 123.751 1.395 . . . . 0.0 110.674 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -61.05 146.16 98.08 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.846 1.445 . . . . 0.0 110.631 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.88 -45.44 1.15 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.851 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -88.37 -152.71 0.22 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.87 -0.783 . . . . 0.0 109.828 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -154.27 114.47 3.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.1 m -84.48 157.48 21.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.46 0.648 . . . . 0.0 111.12 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 144' ' ' LEU . 73.4 mt -109.37 158.61 17.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.919 -0.488 . . . . 0.0 109.927 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.2 p -101.1 149.98 36.71 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.475 -0.766 . . . . 0.0 110.662 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.27 170.49 11.94 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 O-C-N 123.834 1.439 . . . . 0.0 110.637 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 149' ' ' HIS . 20.0 t -167.16 152.82 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.6 m -136.53 111.93 9.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.2 p -150.07 169.95 20.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 110.862 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.55 3.63 81.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 m -89.33 109.97 20.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.794 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.0 m -98.42 4.88 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.586 -0.696 . . . . 0.0 111.439 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -70.56 73.8 0.54 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 145' ' ' CYS . 89.8 mt -83.53 175.56 9.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.584 0.707 . . . . 0.0 111.085 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 89.6 m-85 -143.54 123.96 13.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -100.6 141.07 33.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 110.925 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.424 ' CB ' HG21 ' A' ' 33' ' ' VAL . 53.5 t -89.89 120.27 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.919 -0.488 . . . . 0.0 109.693 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 p -85.27 176.74 8.14 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.622 -0.674 . . . . 0.0 109.221 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -42.73 -29.19 0.29 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.052 0.453 . . . . 0.0 111.654 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.52 -67.92 0.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.552 -0.717 . . . . 0.0 110.091 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.31 -163.09 1.7 Allowed 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.474 -0.766 . . . . 0.0 109.546 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -55.55 -71.95 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.668 -0.645 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.736 HG11 ' OH ' ' A' ' 134' ' ' TYR . 33.6 t 65.41 -52.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 126' ' ' LEU . 44.7 pt -118.9 149.96 47.66 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.72 -1.237 . . . . 0.0 112.087 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 53.8 Cg_endo -111.07 156.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.721 1.379 . . . . 0.0 109.736 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.656 HG11 ' CG2' ' A' ' 167' ' ' VAL . 39.4 t -139.05 139.97 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -95.68 116.02 28.27 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.9 ttm180 -58.06 125.51 23.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.946 . . . . 0.0 111.379 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -96.89 -2.67 43.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.42 -176.28 44.71 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 94.1 m-20 -70.01 -18.5 63.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.293 -1.122 . . . . 0.0 110.243 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.6 p -120.17 14.23 12.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.493 -0.754 . . . . 0.0 111.916 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -148.98 147.57 28.74 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.059 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.37 138.57 9.12 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.4 t -88.89 109.98 20.69 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.833 -0.804 . . . . 0.0 110.265 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.549 HD11 HD12 ' A' ' 114' ' ' ILE . 51.8 tp -73.67 109.01 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.64 -19.75 65.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.693 -0.63 . . . . 0.0 110.392 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -119.96 79.97 25.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.669 -0.644 . . . . 0.0 110.212 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.9 Cg_endo -57.68 146.99 82.51 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.681 1.359 . . . . 0.0 110.087 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -154.13 168.5 11.69 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.696 -0.627 . . . . 0.0 109.659 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.39 124.93 15.68 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.943 1.496 . . . . 0.0 110.077 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.75 -24.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.813 -0.555 . . . . 0.0 111.923 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.3 p -57.5 -34.25 68.88 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.398 -0.814 . . . . 0.0 109.514 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.736 ' OH ' HG11 ' A' ' 113' ' ' VAL . 69.2 t80 -69.92 -29.59 66.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.85 4.14 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.857 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.41 114.13 7.37 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.146 0.974 . . . . 0.0 109.039 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.66 -7.91 61.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.6 t -73.81 -17.14 61.12 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.504 -0.998 . . . . 0.0 109.569 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.619 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -65.3 148.7 51.24 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.052 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.586 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.0 75.35 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.36 -167.22 5.31 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.6 Cg_endo -139.58 147.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 117.087 -1.476 . . . . 0.0 111.734 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' A' ' 104' ' ' LEU . 3.1 mt -97.55 102.29 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -81.32 130.04 34.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -176.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.546 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -65.96 -160.18 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -95.21 16.24 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.635 1.334 . . . . 0.0 110.712 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.0 p -130.77 19.93 5.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.245 -0.909 . . . . 0.0 111.691 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.41 30.47 64.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 50.8 m170 -115.92 118.64 33.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.486 -1.008 . . . . 0.0 109.907 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.66 124.69 27.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.906 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' CG1' ' A' ' 172' ' ' VAL . 33.3 m -125.58 -2.54 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 111.559 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.474 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.18 128.63 2.42 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.487 -1.34 . . . . 0.0 111.317 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.3 mt -110.07 119.98 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.06 -1.259 . . . . 0.0 107.866 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 14.0 t80 -52.0 127.31 20.99 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.808 0.813 . . . . 0.0 112.909 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.449 ' HB2' HG23 ' A' ' 170' ' ' VAL . 57.3 ttp180 -115.68 -28.13 6.85 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.947 -0.471 . . . . 0.0 110.82 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.835 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -164.53 148.92 9.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.918 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.91 141.98 33.92 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.4 t -89.65 92.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -88.49 117.89 27.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.33 1.062 . . . . 0.0 112.218 -176.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.627 ' O ' HG22 ' A' ' 163' ' ' VAL . 88.6 m -120.04 131.96 55.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.725 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' A' ' 160' ' ' THR . 57.6 mmt-85 58.3 21.25 8.03 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.401 -0.812 . . . . 0.0 110.224 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.423 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.83 18.86 49.9 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.532 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' THR . 34.1 m -145.98 143.91 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.235 -1.156 . . . . 0.0 109.4 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.56 121.29 23.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.476 -0.765 . . . . 0.0 110.854 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -111.11 11.14 21.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.714 -0.617 . . . . 0.0 110.51 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.25 139.46 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.656 ' CG2' HG11 ' A' ' 116' ' ' VAL . 17.1 m -110.09 137.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.155 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -106.55 148.09 28.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -155.21 164.57 38.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.616 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.607 HG11 HD22 ' A' ' 82' ' ' LEU . 50.2 t -84.23 135.68 41.45 Favored Pre-proline 0 N--CA 1.497 1.902 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 148.83 46.36 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.843 1.444 . . . . 0.0 110.099 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 7.3 p -71.68 -28.53 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 0.0 109.922 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.95 -30.62 69.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.465 -0.772 . . . . 0.0 109.128 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.4 t -72.12 -33.68 68.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.786 -0.571 . . . . 0.0 110.159 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.63 ' CG ' HD21 ' A' ' 82' ' ' LEU . 3.4 mtp -68.26 -40.08 82.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.5 -40.05 95.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 109.843 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 173' ' ' GLU . 69.8 p -69.86 -31.96 70.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 111.78 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -60.02 -50.03 75.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.0 109.701 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 27.4 ptm -70.04 -26.37 64.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.634 -0.666 . . . . 0.0 109.837 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -70.04 -17.48 63.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.464 -0.772 . . . . 0.0 111.211 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.66 -54.13 44.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.392 -0.818 . . . . 0.0 110.162 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.0 p 39.07 60.33 1.48 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.94 -67.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.425 -0.797 . . . . 0.0 110.662 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -151.78 22.02 0.69 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.601 -0.687 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -156.02 131.04 9.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.294 -0.879 . . . . 0.0 110.648 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.1 mttp . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.126 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.835 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 6.7 t . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.73 12.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -79.99 -70.0 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.531 -0.982 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 41.78 31.9 0.23 Allowed 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.291 0.567 . . . . 0.0 111.295 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -134.83 76.97 1.66 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.908 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -161.02 39.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.596 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 54.65 102.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.432 -0.793 . . . . 0.0 111.01 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' CB ' ' HB2' ' A' ' 91' ' ' ALA . 90.5 t -81.28 -59.34 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.037 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 48.42 36.92 7.88 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.585 -0.697 . . . . 0.0 111.447 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.15 149.83 19.28 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.41 -47.69 19.13 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.843 -0.798 . . . . 0.0 110.522 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.6 t -125.55 130.04 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -94.85 120.44 35.07 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG22 ' CD2' ' A' ' 44' ' ' LEU . 61.6 t -84.01 130.26 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 35' ' ' VAL . 30.4 m -146.32 171.26 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.641 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.0 p -142.21 127.91 19.21 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.699 0.762 . . . . 0.0 109.183 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 59' ' ' ALA . 69.2 p -107.76 179.94 4.09 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 61' ' ' SER . . . -56.62 -17.11 7.56 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.51 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -96.55 -41.41 8.56 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.273 -0.892 . . . . 0.0 112.019 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -173.47 -170.27 0.59 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.869 -1.144 . . . . 0.0 112.511 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 55.4 m -112.58 141.32 46.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 17.0 p90 -163.64 -145.72 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 0.0 110.628 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 109' ' ' ARG . 92.0 mt -137.75 169.04 18.47 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.714 -1.241 . . . . 0.0 112.54 -177.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB2' ' OG1' ' A' ' 54' ' ' THR . . . -150.25 127.35 11.23 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 62.6 m -99.13 127.81 45.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 111.526 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -74.6 124.29 26.39 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.8 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.56 126.79 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.482 -0.761 . . . . 0.0 109.992 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.8 40.05 26.89 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.621 -0.675 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.756 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.71 26.78 72.17 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -139.81 115.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.396 -1.061 . . . . 0.0 109.409 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.2 t -76.63 121.83 23.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.287 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.522 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 94.2 m95 -109.75 126.87 54.19 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.671 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.775 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 1.4 t -132.21 176.83 8.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 140' ' ' GLY . 15.6 m -87.31 126.01 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 118.307 -1.357 . . . . 0.0 111.649 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.619 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.725 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 31.9 p-80 -66.85 -19.99 65.84 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.144 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -81.75 -39.27 12.2 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -79.97 -69.96 0.55 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.681 -0.894 . . . . 0.0 109.166 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.25 -61.07 0.59 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.617 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 31.6 m -98.9 14.31 29.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.34 -1.094 . . . . 0.0 111.946 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 51.48 -164.72 0.06 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.016 -1.053 . . . . 0.0 110.56 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 63' ' ' THR . 95.6 m 51.25 71.71 0.42 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.377 0.608 . . . . 0.0 111.342 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.46 HD21 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -87.52 -137.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.73 109.46 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.901 -1.124 . . . . 0.0 110.518 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -75.42 -159.3 7.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.07 -22.35 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.215 1.64 . . . . 0.0 109.877 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -143.23 -1.52 1.05 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.122 -1.031 . . . . 0.0 113.166 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.64 169.97 42.96 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.938 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.46 121.86 9.8 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 124.09 1.574 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.632 HG22 ' HD1' ' A' ' 85' ' ' TRP . 42.9 mt -97.16 143.74 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -98.14 145.33 26.69 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.492 0.663 . . . . 0.0 111.553 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 2.4 pp0? -77.27 155.24 32.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.774 -0.579 . . . . 0.0 109.933 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.2 ttm -102.58 -29.14 11.74 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.536 -0.727 . . . . 0.0 110.501 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.702 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -147.72 164.73 32.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.235 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.857 HG23 ' CG1' ' A' ' 83' ' ' VAL . 31.3 m -150.86 116.95 5.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.608 -0.683 . . . . 0.0 110.137 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 78.05 4.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.97 -33.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 0.0 109.929 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -53.1 -26.59 16.99 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.55 3.97 8.98 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.867 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.22 61.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.94 -1.1 . . . . 0.0 109.883 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.707 HD13 HG11 ' A' ' 170' ' ' VAL . 17.6 tp -142.41 151.74 42.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 109.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.857 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -143.86 129.15 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.401 -0.812 . . . . 0.0 109.58 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.07 122.49 5.48 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.192 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -85.9 -171.74 3.74 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.988 -0.713 . . . . 0.0 110.12 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -102.57 95.26 6.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.756 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -66.13 145.1 98.98 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.44 -0.787 . . . . 0.0 110.853 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -92.61 156.25 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 124.062 1.559 . . . . 0.0 109.68 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.85 119.86 7.26 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 O-C-N 123.751 1.395 . . . . 0.0 110.561 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.13 -15.32 6.17 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.535 ' HB2' ' CB ' ' A' ' 29' ' ' VAL . . . -89.45 97.33 11.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -1.135 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? 24.22 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.861 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER 63.33 75.86 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.737 0.779 . . . . 0.0 109.88 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 144' ' ' LEU . 85.0 mt -71.15 163.96 26.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.24 155.48 37.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.836 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.82 172.3 11.95 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.969 1.51 . . . . 0.0 110.242 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.597 ' HB2' ' CD2' ' A' ' 149' ' ' HIS . 24.7 t -160.88 160.02 30.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 0.0 110.515 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 p -142.53 41.62 1.6 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.752 -0.592 . . . . 0.0 110.693 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.5 p -76.28 154.45 35.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.283 -0.886 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.95 -8.44 86.64 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.914 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.5 m -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.916 -1.344 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m 54.26 20.38 2.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.531 -0.731 . . . . 0.0 111.254 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -86.45 79.59 8.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 143' ' ' LEU . 96.5 mt -89.53 170.61 10.35 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.381 0.61 . . . . 0.0 110.678 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 45.1 p90 -155.86 140.75 17.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.13 153.17 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.07 0.938 . . . . 0.0 111.748 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 111' ' ' ALA . 86.0 t -109.99 130.01 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.536 ' CG2' HD11 ' A' ' 114' ' ' ILE . 60.1 p -81.35 171.6 14.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.412 -0.805 . . . . 0.0 110.284 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HD21 ' A' ' 44' ' ' LEU . 26.4 ttp180 -32.26 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 108' ' ' THR . 83.3 m-70 -98.87 -87.19 0.35 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.108 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -164.2 26.37 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.124 -0.985 . . . . 0.0 111.226 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.2 158.28 14.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.066 -1.021 . . . . 0.0 110.694 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.11 120.03 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 126' ' ' LEU . 85.9 mt -130.01 83.86 62.29 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 110.259 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.68 120.61 7.83 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.982 1.517 . . . . 0.0 110.744 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 167' ' ' VAL . 62.6 t -124.48 132.95 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.684 . . . . 0.0 109.422 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -84.86 120.09 26.07 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.449 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.1 ttm180 -60.82 123.51 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 110.569 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.743 -0.598 . . . . 0.0 109.491 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.72 -179.94 43.89 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.422 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 30.1 p-10 -62.04 -29.32 70.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.98 . . . . 0.0 110.564 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 m -121.52 18.55 11.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.831 -0.543 . . . . 0.0 112.056 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -139.31 144.33 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 111.04 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.41 140.4 10.24 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.62 ' C ' HG13 ' A' ' 116' ' ' VAL . 18.3 t -87.59 109.97 20.04 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.782 -0.834 . . . . 0.0 109.821 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 116' ' ' VAL . 22.8 tp -69.33 105.78 2.68 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.51 -25.34 66.64 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.202 0.525 . . . . 0.0 110.055 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 p -106.41 100.71 31.37 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.764 -0.585 . . . . 0.0 110.158 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.88 134.25 16.19 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 124.024 1.539 . . . . 0.0 109.55 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.67 167.22 14.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -57.98 128.71 29.93 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.824 1.434 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.69 -26.43 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.628 -0.67 . . . . 0.0 110.616 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 75.3 m -57.86 -31.36 66.61 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.719 0.771 . . . . 0.0 109.274 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -70.86 -30.89 67.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.482 HD12 ' CB ' ' A' ' 164' ' ' ALA . 98.3 mt -89.98 -0.02 57.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.539 -0.725 . . . . 0.0 112.557 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -75.7 124.81 27.88 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 120.837 -1.164 . . . . 0.0 109.001 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 99.66 -11.4 61.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 p -78.55 -10.24 59.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.34 -1.094 . . . . 0.0 109.669 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 55' ' ' VAL . 1.5 m -60.45 143.86 52.43 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.81 -9.94 75.47 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.11 -163.53 0.89 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.66 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.19 135.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 116.624 -1.784 . . . . 0.0 112.145 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 104' ' ' LEU . 3.9 mp -94.82 97.11 9.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -88.76 141.48 28.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.953 0.882 . . . . 0.0 113.33 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 1.3 m -74.01 -172.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.0 Cg_endo -82.02 5.28 6.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.739 1.389 . . . . 0.0 111.446 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 14.1 m -110.2 17.8 20.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.996 -1.065 . . . . 0.0 111.883 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.72 38.31 61.09 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.597 ' CD2' ' HB2' ' A' ' 97' ' ' CYS . 9.2 m-70 -122.97 123.64 41.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.465 -1.021 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -87.16 102.76 14.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.04 7.4 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.912 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.61 133.94 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.575 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 175' ' ' MET . 40.1 mt -116.52 120.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.276 -1.132 . . . . 0.0 108.072 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.457 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.0 t80 -49.96 127.71 17.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.857 0.837 . . . . 0.0 112.978 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 170' ' ' VAL . 59.5 ttp180 -114.28 -30.33 6.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.942 -0.474 . . . . 0.0 111.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.81 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.16 150.42 9.38 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.684 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.62 140.77 35.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.694 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 57.3 t -93.12 88.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.509 -0.744 . . . . 0.0 109.006 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.2 p -92.84 115.72 28.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.273 1.035 . . . . 0.0 111.103 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.5 m -90.01 -80.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.502 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -97.71 61.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.172 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.438 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 70.03 19.13 75.21 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.3 m -147.74 140.18 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 121.282 -1.128 . . . . 0.0 108.956 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.24 128.27 33.33 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.546 0.688 . . . . 0.0 111.325 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -122.22 16.14 10.65 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.694 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.55 154.13 3.68 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 116' ' ' VAL . 11.4 m -135.27 138.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.885 0.85 . . . . 0.0 112.237 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -107.23 148.34 29.06 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 35.7 p90 -153.45 163.95 39.05 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.713 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 82' ' ' LEU . 99.0 t -80.02 141.63 54.83 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.994 -0.442 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.42 150.87 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.523 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.69 -28.13 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.689 . . . . 0.0 110.355 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -59.95 -32.49 70.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.1 t -75.52 -29.71 59.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.987 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.594 ' CG ' HD21 ' A' ' 82' ' ' LEU . 7.3 mtp -69.92 -37.93 76.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.96 -36.4 77.03 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.265 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.2 p -60.44 -30.66 69.79 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.399 -0.813 . . . . 0.0 110.624 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.702 HG23 ' CG ' ' A' ' 75' ' ' TYR . 47.3 m -60.08 -46.02 90.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.096 -1.003 . . . . 0.0 108.901 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.53 -39.33 87.47 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -83.5 -13.7 54.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 50.71 -165.72 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.175 -0.953 . . . . 0.0 110.941 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.23 -47.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.448 -0.783 . . . . 0.0 110.563 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -151.39 159.98 43.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.456 -0.777 . . . . 0.0 110.589 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -74.18 -26.3 60.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.7 -0.625 . . . . 0.0 110.66 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 63.1 tttm 55.44 85.63 0.06 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.44 -0.788 . . . . 0.0 110.422 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 65.2 pttt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.435 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.81 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -9.98 75.48 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -80.26 133.88 36.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.104 -1.233 . . . . 0.0 110.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t0 49.36 37.79 12.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.822 -0.549 . . . . 0.0 111.332 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -134.94 29.98 3.4 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.368 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -157.99 173.97 15.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.584 0.707 . . . . 0.0 109.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.97 -160.6 0.06 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.955 -0.466 . . . . 0.0 110.516 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 29' ' ' VAL . 33.7 m -87.04 16.39 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.532 -0.73 . . . . 0.0 111.763 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.4 mm-40 63.47 -67.37 0.09 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.031 0.533 . . . . 0.0 111.771 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.44 -123.66 6.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HA ' HD21 ' A' ' 94' ' ' LEU . 50.1 mt-10 -66.31 -40.0 89.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.612 -0.934 . . . . 0.0 111.48 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -125.08 129.96 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.858 . . . . 0.0 110.658 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 96.7 mt-30 -99.24 123.77 43.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.622 -0.674 . . . . 0.0 110.623 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 44' ' ' LEU . 62.7 t -81.69 131.22 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.91 174.03 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.094 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.0 p -145.49 125.78 13.89 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.718 0.77 . . . . 0.0 108.98 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.536 HG21 ' HA ' ' A' ' 59' ' ' ALA . 47.6 p -103.52 -179.54 3.98 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.34 -15.03 8.83 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.528 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -100.42 -39.21 8.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 112.572 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -172.02 -170.0 0.71 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.798 -1.189 . . . . 0.0 112.694 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -115.21 141.54 47.88 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.6 p90 -162.61 -147.33 0.12 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 110.499 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 138' ' ' SER . 74.0 mt -132.07 166.01 22.72 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.602 -1.311 . . . . 0.0 113.342 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -152.86 131.86 12.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.837 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.563 HG21 ' HB3' ' A' ' 142' ' ' PRO . 94.1 m -96.75 123.65 40.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 84.2 m -73.78 127.22 32.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.68 -0.637 . . . . 0.0 109.805 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 38.7 t -140.42 127.24 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.796 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 49.98 40.7 21.76 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.585 -0.697 . . . . 0.0 111.619 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 73.54 26.93 68.59 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 59.9 t -139.94 117.37 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -1.04 . . . . 0.0 109.572 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 t -75.68 119.62 19.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.561 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.2 m95 -106.86 125.74 51.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.902 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.67 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.2 t -132.52 -179.26 5.34 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 139' ' ' SER . 24.0 m -90.22 125.57 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 118.193 -1.403 . . . . 0.0 112.242 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.03 -39.99 87.81 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.833 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 30.5 p-80 -73.42 68.64 1.12 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.139 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.09 -38.13 0.31 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -80.02 -69.99 0.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.597 -0.943 . . . . 0.0 110.224 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.95 16.4 33.32 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.04 88.02 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.024 -1.28 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -150.62 -171.26 3.88 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.923 0.868 . . . . 0.0 110.662 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.432 ' HB ' ' CB ' ' A' ' 70' ' ' PRO . 2.6 p -79.74 -6.43 57.24 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.422 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.473 HD13 HG22 ' A' ' 38' ' ' THR . 4.3 mm? 49.48 -159.95 0.06 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.163 -0.961 . . . . 0.0 110.572 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.4 91.84 2.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -85.52 174.82 48.89 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.81 -14.93 43.74 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 124.043 1.549 . . . . 0.0 110.204 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -105.97 -15.14 14.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 110.891 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.59 -156.84 24.91 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' CB ' ' HB ' ' A' ' 63' ' ' THR . 44.4 Cg_endo -63.81 117.04 4.05 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.047 1.551 . . . . 0.0 110.834 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.486 HD11 ' HA3' ' A' ' 66' ' ' GLY . 68.0 mt -89.56 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 137.61 32.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 0.0 111.742 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -70.03 141.54 52.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.734 -0.604 . . . . 0.0 109.899 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.8 ttp -105.33 -34.36 7.89 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.427 -0.796 . . . . 0.0 110.693 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -153.33 170.47 20.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.467 -0.771 . . . . 0.0 109.755 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.883 HG23 ' CG1' ' A' ' 83' ' ' VAL . 71.5 m -153.4 115.94 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.69 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 76.6 3.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 76' ' ' THR . 93.6 t -60.06 -39.99 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.451 -0.781 . . . . 0.0 109.553 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -55.65 -26.64 45.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -110.86 -0.4 16.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.751 -0.593 . . . . 0.0 110.751 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 60.17 56.31 3.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.947 -1.096 . . . . 0.0 109.393 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 170' ' ' VAL . 49.1 tp -145.57 153.19 40.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.883 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.03 130.68 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 109.415 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.78 121.01 5.11 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.625 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.67 ' CZ3' HG22 ' A' ' 54' ' ' THR . 5.3 m-90 -87.07 -170.28 2.99 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.88 -0.777 . . . . 0.0 109.314 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -100.01 112.22 24.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -63.6 133.83 95.66 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.973 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -96.13 154.82 1.38 Allowed 'Trans proline' 0 N--CA 1.485 1.002 0 O-C-N 123.943 1.496 . . . . 0.0 110.048 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.05 144.27 95.94 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.753 1.396 . . . . 0.0 110.499 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.86 -49.73 0.91 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.44 -137.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 122.045 -0.679 . . . . 0.0 109.954 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -151.84 -29.65 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.865 -1.147 . . . . 0.0 112.77 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . 10.7 t 60.64 154.81 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.457 -0.777 . . . . 0.0 110.768 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 93' ' ' SER . 3.7 mm? -114.32 150.62 34.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.532 -0.73 . . . . 0.0 109.846 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.9 p -98.46 151.06 37.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.434 -0.791 . . . . 0.0 110.93 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.77 153.81 29.93 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.865 1.455 . . . . 0.0 110.037 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 44.3 t -160.48 159.97 31.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.516 -0.74 . . . . 0.0 110.857 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -150.07 67.7 0.98 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 109.69 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -70.05 -33.79 72.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.86 -16.54 9.45 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.1 m -88.72 139.29 30.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -1.203 . . . . 0.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -106.65 15.87 25.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.704 . . . . 0.0 110.971 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -73.1 78.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.3 mt -99.12 175.09 6.02 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.395 0.616 . . . . 0.0 110.32 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' PRO . 51.3 p90 -150.27 131.75 14.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 143' ' ' LEU . 21.9 tp -92.99 147.25 22.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.846 0.831 . . . . 0.0 110.897 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 111' ' ' ALA . 80.9 t -90.07 110.0 21.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.4 p -81.38 177.58 8.89 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.216 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -43.74 -25.51 0.18 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.817 -0.552 . . . . 0.0 111.744 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -90.16 -79.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.573 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -151.38 -44.07 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.291 -0.881 . . . . 0.0 111.183 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -163.84 -65.33 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.746 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.611 HG11 ' OH ' ' A' ' 134' ' ' TYR . 38.6 t 64.42 -58.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 126' ' ' LEU . 46.6 pt -125.41 150.96 69.26 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.951 -1.093 . . . . 0.0 111.737 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 105' ' ' TYR . 54.0 Cg_endo -106.65 163.87 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.804 1.423 . . . . 0.0 109.788 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HD12 ' A' ' 126' ' ' LEU . 48.8 t -136.1 140.08 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.834 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -95.0 115.81 27.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.463 ' CZ ' HG12 ' A' ' 151' ' ' VAL . 1.7 ttm180 -59.99 124.8 21.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -99.26 -0.05 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 0.0 109.766 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.83 44.35 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 34.4 m-20 -65.12 -22.89 67.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.931 . . . . 0.0 110.251 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.2 p -124.96 17.41 8.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 111.46 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -140.66 140.83 35.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.068 -1.02 . . . . 0.0 111.088 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -139.73 141.25 11.47 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.471 ' C ' HG13 ' A' ' 116' ' ' VAL . 7.3 t -89.9 112.19 23.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.834 -0.803 . . . . 0.0 110.161 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 114' ' ' ILE . 21.9 tp -71.2 104.47 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 115' ' ' PRO . 98.3 mt -60.04 -32.67 71.13 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 110.079 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -112.89 99.92 49.62 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.28 145.97 74.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.908 1.478 . . . . 0.0 109.018 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -154.29 163.17 25.01 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.599 -0.688 . . . . 0.0 109.685 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -60.52 122.8 11.85 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.064 1.56 . . . . 0.0 109.88 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -46.5 -25.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.928 -0.482 . . . . 0.0 111.724 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.4 p -58.23 -34.32 70.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.0 108.992 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.611 ' OH ' HG11 ' A' ' 113' ' ' VAL . 46.6 t80 -69.99 -30.03 67.26 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.25 2.02 33.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.763 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -72.21 112.44 8.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.234 -0.916 . . . . 0.0 108.603 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 -10.1 58.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.647 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.5 t -76.69 -12.86 60.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 110.111 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.603 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.7 m -66.53 150.99 48.16 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.001 -1.062 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.554 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.9 -9.91 75.66 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -67.93 -167.7 4.03 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.563 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.0 Cg_endo -141.48 140.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 116.956 -1.563 . . . . 0.0 112.143 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.427 HD12 HD13 ' A' ' 106' ' ' LEU . 4.1 mp -94.2 94.02 8.11 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 94' ' ' LEU . 6.0 mp -85.65 150.24 24.76 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.411 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -59.51 -162.89 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.098 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 16.57 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.645 1.339 . . . . 0.0 110.504 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.1 m -124.78 -51.98 1.69 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.06 40.64 0.02 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.467 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 73.2 m-70 -119.99 129.42 54.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.449 ' HB2' ' CB ' ' A' ' 94' ' ' LEU . . . -70.26 121.16 17.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.563 -0.711 . . . . 0.0 110.001 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 118' ' ' ARG . 5.0 t -110.24 -29.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.803 -0.561 . . . . 0.0 110.112 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -155.12 150.38 21.86 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.985 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 16.7 mt -119.37 120.86 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.341 -1.093 . . . . 0.0 108.073 177.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.9 t80 -50.01 128.94 19.86 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.948 0.88 . . . . 0.0 113.044 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 170' ' ' VAL . 29.9 ttt180 -117.06 -27.88 6.4 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.723 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.833 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.39 147.59 7.7 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.08 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.426 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.42 140.43 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.583 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 52.7 t -91.19 92.66 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 86.1 m -94.49 123.32 37.84 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.77 0.795 . . . . 0.0 111.479 -177.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 161' ' ' ARG . 75.9 m -85.37 -97.51 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.773 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.451 ' N ' HG22 ' A' ' 160' ' ' THR . 39.7 ttm180 -69.77 -55.5 9.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.782 -1.199 . . . . 0.0 109.119 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.424 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -163.96 28.32 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.424 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.8 m -148.83 146.01 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -81.34 129.25 34.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.568 -0.708 . . . . 0.0 111.168 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.82 15.22 13.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.266 0.555 . . . . 0.0 109.999 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.39 153.02 2.29 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.687 HG21 HG11 ' A' ' 116' ' ' VAL . 11.7 m -130.1 138.22 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.513 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -105.3 147.63 27.91 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 36.6 p90 -153.2 165.61 35.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.169 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 82' ' ' LEU . 59.6 t -86.15 130.07 51.39 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.86 157.52 51.49 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.759 1.4 . . . . 0.0 110.487 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.474 ' HA ' ' CE ' ' A' ' 175' ' ' MET . 7.2 p -76.03 -23.28 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.644 . . . . 0.0 109.653 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 177' ' ' THR . 53.5 tp10 -58.52 -30.83 67.37 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.6 m -73.31 -36.8 66.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.36 0.6 . . . . 0.0 109.631 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.685 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -67.96 -36.6 80.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.522 -0.737 . . . . 0.0 109.019 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 179' ' ' MET . 98.9 mt-10 -59.98 -33.1 71.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.885 -0.509 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 173' ' ' GLU . 30.5 p -63.27 -28.88 70.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.173 -0.954 . . . . 0.0 110.453 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.664 HG23 ' CG ' ' A' ' 75' ' ' TYR . 53.6 m -65.4 -51.5 59.92 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.202 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 176' ' ' GLU . 25.1 ptm -66.75 -27.88 67.96 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.691 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.401 ' HG3' ' HG3' ' A' ' 179' ' ' MET . 99.1 mtt180 -89.42 -15.7 32.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.891 . . . . 0.0 110.728 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 177' ' ' THR . . . 56.92 118.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.901 0.858 . . . . 0.0 111.125 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.8 p -65.2 78.73 0.05 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.462 -0.774 . . . . 0.0 111.073 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -89.04 140.33 29.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.477 -0.764 . . . . 0.0 110.019 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -160.03 59.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.255 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -77.8 134.49 38.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.594 -0.691 . . . . 0.0 109.711 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.0 mttt . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.935 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.833 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.178 0.513 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.06 -178.03 50.88 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -114.15 129.51 56.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.554 -0.969 . . . . 0.0 110.785 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.67 -42.76 33.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.647 0.737 . . . . 0.0 110.045 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HE3' HG21 ' A' ' 35' ' ' VAL . 62.0 mttt -149.95 -172.34 4.13 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.881 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -158.26 51.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -117.54 123.52 46.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 110.289 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.3 m -97.42 18.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.907 -0.496 . . . . 0.0 111.332 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.93 -46.69 34.02 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' N ' ' A' ' 92' ' ' ARG . . . 151.11 -154.57 25.65 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 97.8 mt-10 75.23 -106.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.148 1.379 . . . . 0.0 114.558 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 45' ' ' ALA . 61.6 t -140.01 140.69 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.945 -1.097 . . . . 0.0 111.268 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HG3' ' HG2' ' A' ' 92' ' ' ARG . 87.9 mt-30 -91.01 121.39 32.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.309 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 ' HE3' ' A' ' 26' ' ' LYS . 77.9 t -80.44 138.89 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.75 169.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.088 0.946 . . . . 0.0 111.544 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -142.76 120.0 11.52 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.787 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.6 p -107.15 -179.07 3.82 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.66 -16.48 16.39 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.659 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.3 p -102.69 -39.68 6.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.268 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -174.64 -168.91 0.39 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.064 -1.023 . . . . 0.0 111.855 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 m -116.57 147.43 41.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.7 p90 -161.76 -142.97 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 85.5 mt -134.33 161.48 34.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.675 -1.265 . . . . 0.0 113.352 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -147.84 123.43 10.45 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.143 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 142' ' ' PRO . 25.1 m -97.9 120.04 37.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.486 -0.759 . . . . 0.0 110.674 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 21.5 m -76.79 125.99 30.21 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.123 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -123.16 124.61 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 52.67 45.3 28.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.307 -0.87 . . . . 0.0 110.625 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.6 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 70.05 22.64 77.28 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.168 -1.015 . . . . 0.0 110.74 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' NE1' ' A' ' 53' ' ' TRP . 61.9 t -130.01 111.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.261 -1.141 . . . . 0.0 109.24 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 15.6 t -74.61 121.85 22.25 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 87.0 m95 -112.84 126.21 55.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.901 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.1 t -131.51 178.96 6.33 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 140' ' ' GLY . 16.6 m -89.57 123.84 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.705 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.02 -39.97 87.66 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.748 ' CG ' HD22 ' A' ' 188' ' ' 2ZF . 34.6 p-80 -71.31 74.42 0.72 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.872 0.844 . . . . 0.0 109.069 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.07 -25.51 0.71 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -88.24 -80.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -1.055 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 47.77 24.32 2.88 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.252 -0.905 . . . . 0.0 111.741 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.615 ' OG ' HG22 ' A' ' 38' ' ' THR . 26.4 p -111.63 -19.81 12.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.98 -1.306 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 61' ' ' SER . 83.5 tttt 67.82 -60.54 0.4 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.572 -0.705 . . . . 0.0 111.684 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.639 ' C ' HD23 ' A' ' 64' ' ' LEU . 24.5 p -83.84 -32.1 25.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 113.053 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD23 ' C ' ' A' ' 63' ' ' THR . 0.5 OUTLIER 44.14 -142.89 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 O-C-N 121.985 -0.447 . . . . 0.0 111.284 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 64' ' ' LEU . . . -150.71 102.07 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 109.947 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -90.3 -178.71 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.85 -16.44 54.85 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 124.001 1.527 . . . . 0.0 110.396 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -112.49 2.35 16.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.32 -0.863 . . . . 0.0 111.117 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.6 -160.91 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -57.97 123.52 13.88 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.638 1.336 . . . . 0.0 110.264 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.6 mt -87.57 -25.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.643 -0.661 . . . . 0.0 111.455 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 10.1 m 60.52 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.488 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 3.8 pt20 -80.06 159.29 26.21 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.335 -0.853 . . . . 0.0 112.167 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' GLN . 96.6 mmm -108.77 -30.01 8.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.058 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 1.3 t80 -140.37 164.22 30.69 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.525 -0.734 . . . . 0.0 109.248 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.901 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.8 m -154.35 115.33 4.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 0.0 110.304 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.405 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 14.4 t-20 -99.15 74.03 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.431 -0.793 . . . . 0.0 109.168 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 76' ' ' THR . 79.1 t -60.05 -39.97 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.272 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -55.19 -26.08 36.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -111.99 -2.59 15.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.682 -0.636 . . . . 0.0 110.589 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t0 62.56 55.18 2.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 109.249 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 175' ' ' MET . 18.6 tp -147.14 151.75 37.31 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.901 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -147.1 139.34 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.068 -1.02 . . . . 0.0 109.296 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.45 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -124.69 122.14 4.62 Favored Glycine 0 N--CA 1.5 2.933 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.656 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.901 ' CZ3' HG22 ' A' ' 54' ' ' THR . 9.4 m-90 -90.36 -166.72 1.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.076 -0.661 . . . . 0.0 109.387 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 74' ' ' MET . 30.1 tt0 -112.55 96.96 6.28 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.02 160.03 82.01 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.498 -0.751 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.748 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 47.0 Cg_endo -101.42 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.936 1.493 . . . . 0.0 110.324 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -60.11 109.52 0.63 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.785 1.413 . . . . 0.0 112.664 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.49 -63.09 0.31 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.748 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -61.03 105.11 0.44 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.214 1.007 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 47' ' ' CYS . 8.5 mpt_? 52.7 108.94 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 122.105 0.955 . . . . 0.0 112.446 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.581 ' C ' HD22 ' A' ' 94' ' ' LEU . 11.1 m -165.02 107.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 93' ' ' SER . 4.6 mm? -110.01 160.59 16.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.34 -0.85 . . . . 0.0 111.133 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.417 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.1 p -112.12 157.12 40.71 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.611 -0.68 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.84 151.59 7.27 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.874 1.46 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 49.8 t -155.25 -71.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.521 -0.737 . . . . 0.0 110.767 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.0 m 51.62 59.09 4.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.693 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -140.0 152.15 46.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.193 -0.942 . . . . 0.0 112.04 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.57 -46.77 3.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 t -168.92 169.94 9.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 110.752 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.8 m -105.09 18.85 21.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.725 -0.609 . . . . 0.0 109.989 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -70.47 76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 118' ' ' ARG . 82.0 mt -94.11 174.32 7.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.283 0.563 . . . . 0.0 109.664 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.6 p90 -152.4 136.1 16.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 142' ' ' PRO . 40.8 tp -103.83 141.25 36.44 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.724 0.774 . . . . 0.0 111.146 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -86.31 119.92 35.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.4 p -80.44 179.98 7.44 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.097 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -43.02 -27.92 0.23 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.756 -0.59 . . . . 0.0 112.24 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -115.27 -50.92 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.865 . . . . 0.0 111.571 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.62 -179.0 7.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.89 -1.131 . . . . 0.0 110.338 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 114' ' ' ILE . 57.7 t0 -60.09 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.163 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.628 ' O ' HG12 ' A' ' 113' ' ' VAL . 48.4 t 51.67 25.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.392 -0.817 . . . . 0.0 110.726 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 126' ' ' LEU . 6.5 tp -164.83 100.07 0.83 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.874 . . . . 0.0 111.024 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.82 136.41 2.11 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.571 1.301 . . . . 0.0 109.761 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.802 HG22 HD12 ' A' ' 126' ' ' LEU . 48.9 t -130.4 140.32 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.324 -0.86 . . . . 0.0 111.027 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -93.77 119.47 32.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.9 ttm-85 -60.59 127.38 31.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.802 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -99.77 -0.01 40.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.666 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.75 -177.37 43.86 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 82.8 m-20 -69.23 -20.02 63.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -1.03 . . . . 0.0 110.171 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 p -123.47 15.15 9.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.409 -0.807 . . . . 0.0 111.642 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -143.25 144.59 32.2 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.14 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.14 140.99 10.79 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.71 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.6 t -88.69 111.37 21.87 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.759 -0.848 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 114' ' ' ILE . 23.6 tp -70.31 110.23 5.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.01 -18.88 65.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.852 -0.53 . . . . 0.0 110.655 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' ILE . 47.4 t -129.95 82.25 66.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 110.399 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.8 Cg_endo -61.19 143.84 98.71 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.856 1.45 . . . . 0.0 109.907 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -154.99 168.36 12.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.643 -0.661 . . . . 0.0 109.345 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.86 125.37 18.43 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.842 1.443 . . . . 0.0 110.354 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.05 -27.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 121.516 0.674 . . . . 0.0 110.534 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 39.7 t -61.42 -15.08 33.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.785 -0.572 . . . . 0.0 110.135 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -86.75 -31.79 20.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 136' ' ' LYS . 84.4 mt -76.7 -55.85 5.13 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.79 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 133' ' ' SER . 4.5 pttt 7.12 104.74 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.22 -4.2 55.14 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.3 p -76.07 -14.78 60.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.534 -0.98 . . . . 0.0 109.261 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.559 ' HB2' HG21 ' A' ' 55' ' ' VAL . 4.0 m -61.97 142.23 57.58 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.161 -0.962 . . . . 0.0 110.143 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.06 -10.11 75.13 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -65.05 -162.02 0.68 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.668 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.5 Cg_endo -146.69 138.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 116.605 -1.796 . . . . 0.0 112.469 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 151' ' ' VAL . 3.4 mp -96.0 97.84 9.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.607 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -87.29 151.68 22.93 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.414 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -64.42 -159.62 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.215 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 51.2 Cg_endo -96.8 17.34 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.503 1.265 . . . . 0.0 110.098 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.5 p -130.54 11.06 5.27 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.273 -0.892 . . . . 0.0 112.066 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.52 32.0 10.84 Favored Glycine 0 N--CA 1.502 3.039 0 O-C-N 120.917 -1.114 . . . . 0.0 110.558 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.538 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 77.7 m80 -113.91 118.45 34.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -1.19 . . . . 0.0 110.536 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.22 123.41 24.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.505 -0.747 . . . . 0.0 110.222 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.2 m -123.35 -5.56 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.551 -0.718 . . . . 0.0 111.572 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -160.04 127.67 1.84 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.791 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 66.4 mt -105.58 120.71 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -1.082 . . . . 0.0 108.555 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 15.8 t80 -50.75 128.61 21.2 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.621 0.724 . . . . 0.0 112.601 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 170' ' ' VAL . 64.6 ttt180 -116.78 -26.45 6.95 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.867 -0.521 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -164.96 149.18 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.957 . . . . 0.0 111.751 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.98 141.59 32.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.718 -0.614 . . . . 0.0 110.889 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.536 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 49.1 t -95.15 93.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -89.43 117.78 28.6 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.13 0.967 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.8 m -83.92 -69.96 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.16 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -117.36 57.57 0.8 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.057 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.42 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 80.04 16.35 76.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.4 m -146.84 139.9 19.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 121.374 -1.074 . . . . 0.0 108.27 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.98 129.92 35.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.732 0.777 . . . . 0.0 111.338 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -123.86 17.28 9.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.272 0.558 . . . . 0.0 110.077 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -174.33 139.93 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.717 HG21 HG11 ' A' ' 116' ' ' VAL . 22.3 m -113.31 138.67 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.148 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -108.5 143.33 37.63 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.2 p90 -150.96 166.02 31.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.12 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 155' ' ' ARG . 52.4 t -87.3 130.53 47.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.996 -0.44 . . . . 0.0 110.326 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.7 135.82 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 O-C-N 123.722 1.38 . . . . 0.0 110.195 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 151' ' ' VAL . 11.6 p -70.21 -29.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.588 -0.695 . . . . 0.0 110.129 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.08 -31.09 69.69 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 177' ' ' THR . 18.8 m -72.6 -35.28 67.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.609 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.599 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.4 mtp -64.68 -47.16 79.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 179' ' ' MET . 80.6 mm-40 -62.75 -44.46 96.15 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.937 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 174' ' ' SER . 13.8 t -72.92 -40.02 65.82 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 110.683 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.424 ' N ' HG23 ' A' ' 177' ' ' THR . 83.6 m -64.29 -42.12 96.54 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.057 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 176' ' ' GLU . 24.6 ptm -67.24 -26.67 66.7 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.247 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -63.85 -23.63 67.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 0.0 109.987 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -166.76 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 178' ' ' THR . 44.9 t 50.01 69.88 0.56 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.147 -0.971 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -143.2 140.69 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 110.555 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.01 -38.84 69.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.618 -0.676 . . . . 0.0 109.767 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.27 129.97 35.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.691 -0.631 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.473 179.93 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.748 HD22 ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.114 0.483 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.68 91.04 0.14 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -69.98 -59.92 2.62 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.583 -0.951 . . . . 0.0 110.332 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 36.21 62.06 0.73 Allowed 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -139.99 146.39 39.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.989 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 67.69 139.04 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.437 -0.789 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 58.85 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.498 0.666 . . . . 0.0 110.789 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 31' ' ' GLY . 33.8 m -86.43 0.84 5.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.847 -0.533 . . . . 0.0 111.439 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 78.6 mm-40 56.67 20.04 4.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.118 -0.989 . . . . 0.0 111.612 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' H ' HG23 ' A' ' 29' ' ' VAL . . . 58.68 -120.79 23.99 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 92' ' ' ARG . 94.7 mt-10 -98.43 -34.87 10.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.728 -0.866 . . . . 0.0 111.536 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 107' ' ' VAL . 62.7 t -110.08 129.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.391 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 19.4 mp0 -95.59 117.65 30.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.523 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -84.81 131.66 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 43' ' ' PHE . 33.9 m -140.43 178.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.493 -0.754 . . . . 0.0 109.268 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 m -140.91 126.94 19.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.718 0.771 . . . . 0.0 109.209 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 40' ' ' THR . 14.7 t -113.0 -168.57 1.34 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.36 5.04 0.82 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 24.1 p -120.89 -39.35 2.73 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.701 -1.25 . . . . 0.0 111.941 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -173.08 -155.38 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.098 -1.001 . . . . 0.0 112.348 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 m -102.71 119.01 38.09 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 36' ' ' VAL 0.27 3.3 m-85 -90.25 -174.67 4.26 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 117.398 2.369 . . . . 0.0 117.398 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' A' ' 138' ' ' SER . 26.5 mt -142.55 136.07 28.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.378 -2.192 . . . . 0.0 106.842 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 54' ' ' THR . . . -145.78 136.66 24.48 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 142' ' ' PRO . 34.6 m -101.69 125.77 48.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.583 -0.698 . . . . 0.0 111.586 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -72.45 119.98 17.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.72 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.83 129.97 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.456 -0.777 . . . . 0.0 109.994 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 50.12 40.14 21.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.472 -0.768 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.96 26.57 74.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.5 t -138.75 115.97 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.267 -1.137 . . . . 0.0 109.658 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 35.2 t -76.72 118.61 19.52 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.521 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 91.8 m95 -106.27 124.24 49.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.0 111.189 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.892 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -130.65 179.98 5.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 139' ' ' SER . 2.8 m -84.32 123.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 C-N-CA 117.195 -1.802 . . . . 0.0 113.373 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' CA ' HG22 ' A' ' 83' ' ' VAL . 25.5 t80 -59.98 -40.31 88.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.802 . . . . 0.0 109.9 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.716 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 29.6 p-80 -69.2 101.9 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.701 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.16 -41.72 1.42 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -76.8 -76.71 0.16 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.947 . . . . 0.0 109.997 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.52 22.72 8.28 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -129.02 -2.4 5.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.25 -1.147 . . . . 0.0 111.786 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 tttp 66.71 -65.66 0.2 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.378 -0.826 . . . . 0.0 110.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.8 p -81.93 159.94 23.49 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.744 0.783 . . . . 0.0 110.888 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -149.46 -126.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.21 83.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 109.505 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' CA ' ' CD1' ' A' ' 71' ' ' ILE . . . -63.76 -166.68 0.95 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -59.48 -21.0 59.65 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 124.043 1.549 . . . . 0.0 110.785 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -145.02 4.28 1.09 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.991 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.98 -176.25 40.77 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.158 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -56.7 130.21 38.75 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.799 1.42 . . . . 0.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.409 ' CD1' ' CA ' ' A' ' 66' ' ' GLY . 4.5 mt -89.37 -14.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.714 -0.616 . . . . 0.0 111.441 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.6 m 58.7 136.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.955 0.883 . . . . 0.0 112.175 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.517 ' HG2' ' CE2' ' A' ' 85' ' ' TRP . 16.1 mt-30 -80.28 157.19 26.5 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.531 -0.731 . . . . 0.0 112.564 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 88.8 mtp -100.56 -38.23 8.45 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.21 -176.46 4.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.837 HG23 HG13 ' A' ' 83' ' ' VAL . 69.7 m -153.49 127.42 8.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.559 -0.713 . . . . 0.0 109.59 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.16 76.96 2.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.95 -40.06 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.643 -0.66 . . . . 0.0 110.009 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.41 -26.17 40.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.476 -0.765 . . . . 0.0 108.972 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -112.59 0.02 15.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.643 . . . . 0.0 110.735 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.03 59.71 2.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.045 -1.034 . . . . 0.0 109.189 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.534 HD21 ' CG ' ' A' ' 175' ' ' MET . 24.3 tp -145.99 154.01 41.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.171 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.837 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -141.41 135.83 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.76 121.99 4.7 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.949 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.892 ' CZ3' HG22 ' A' ' 54' ' ' THR . 11.1 m-90 -89.92 -173.11 3.77 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -104.05 91.66 4.05 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 52' ' ' CYS . . . -67.96 131.97 92.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.805 -0.56 . . . . 0.0 110.28 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 148.83 78.37 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.952 1.501 . . . . 0.0 109.426 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.36 114.4 2.34 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.913 1.481 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.04 -32.77 1.27 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.32 60.42 0.44 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.6 -0.941 . . . . 0.0 111.291 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 2.8 tpt85 29.59 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.3 t -83.45 123.79 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 144' ' ' LEU . 88.4 mt -106.61 159.68 16.01 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.086 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.64 166.1 11.42 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.97 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 151' ' ' VAL . 39.4 Cg_endo -65.29 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 O-C-N 124.054 1.555 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 0.5 OUTLIER 56.11 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.051 -1.031 . . . . 0.0 110.195 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.8 m -83.51 89.31 7.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.222 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 51.0 m -71.33 144.47 49.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.694 -0.629 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -62.47 -39.93 98.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 t -74.62 130.01 38.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.882 -0.775 . . . . 0.0 109.406 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -103.72 18.33 22.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 111.19 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.51 78.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 143' ' ' LEU . 88.5 mt -89.75 174.19 7.85 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.477 0.656 . . . . 0.0 110.546 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.9 113.49 9.02 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.52 146.64 24.47 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.127 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 33' ' ' VAL . 74.0 t -92.97 119.42 40.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.159 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 44' ' ' LEU . 66.0 p -85.94 175.24 8.73 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' N ' HD11 ' A' ' 44' ' ' LEU . 32.2 ttp180 -42.86 -28.61 0.26 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.796 -0.565 . . . . 0.0 111.954 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -100.07 -69.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.12 -163.27 1.74 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.438 -0.789 . . . . 0.0 109.506 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' HG22 ' A' ' 107' ' ' VAL . 73.9 m-20 -57.29 -66.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.741 -0.599 . . . . 0.0 110.585 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.7 t 56.58 -85.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.99 -0.444 . . . . 0.0 111.298 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 126' ' ' LEU . 44.0 pt -76.51 145.28 75.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.078 -1.013 . . . . 0.0 112.006 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 53.3 Cg_endo -112.63 153.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 O-C-N 123.756 1.398 . . . . 0.0 108.657 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 167' ' ' VAL . 38.2 t -136.42 139.64 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.074 -1.016 . . . . 0.0 111.66 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.32 118.49 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.8 ttm180 -63.37 122.2 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.0 110.219 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -101.05 7.43 43.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.688 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.32 173.59 42.09 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.446 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 75.5 m-20 -60.3 -25.83 66.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.379 -1.071 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.7 18.58 7.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.548 -0.72 . . . . 0.0 111.85 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.41 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 92.7 mtt180 -138.12 143.41 40.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.833 -1.167 . . . . 0.0 111.012 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -140.11 142.17 12.26 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.421 ' C ' HG13 ' A' ' 116' ' ' VAL . 20.1 t -89.64 110.99 21.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.971 -0.723 . . . . 0.0 109.814 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 129' ' ' PRO . 61.4 tp -69.96 113.74 7.47 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.99 -20.96 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.874 -0.516 . . . . 0.0 110.756 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 m -126.77 80.86 70.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.3 Cg_endo -57.43 139.79 91.21 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 O-C-N 123.754 1.397 . . . . 0.0 110.346 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -146.96 163.15 30.14 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -55.47 124.49 16.42 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.808 1.425 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.653 ' HA ' HD12 ' A' ' 135' ' ' LEU . 14.8 p -51.61 -23.46 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.888 -0.507 . . . . 0.0 111.639 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -57.19 -34.34 68.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.312 -0.868 . . . . 0.0 109.28 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -74.22 -21.87 59.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 132' ' ' VAL . 95.5 mt -85.02 -0.49 54.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.77 109.89 2.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.108 -0.995 . . . . 0.0 108.81 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.94 -6.73 64.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.875 ' HA ' HD12 ' A' ' 44' ' ' LEU . 12.7 t -74.27 -13.32 60.75 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.562 -0.963 . . . . 0.0 108.686 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.3 147.68 39.98 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.372 -0.83 . . . . 0.0 109.384 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.455 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.25 -12.16 68.37 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.3 -157.6 0.22 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 46' ' ' THR . 47.9 Cg_endo -144.12 132.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 116.514 -1.857 . . . . 0.0 113.426 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.522 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.3 mp -89.24 85.79 6.7 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 175.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 145' ' ' CYS . 0.7 OUTLIER -92.57 138.32 31.61 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 0.0 112.524 -175.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.854 ' N ' HD12 ' A' ' 144' ' ' LEU . 61.3 m -56.48 -177.17 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -91.18 3.6 4.36 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.553 1.291 . . . . 0.0 110.536 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.4 m -103.63 -15.97 15.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.82 28.64 3.11 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 97' ' ' CYS . 90.9 m-70 -116.65 109.98 17.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.103 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.74 121.97 22.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 96' ' ' PRO . 26.8 m -122.65 -1.35 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 112.077 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -158.68 138.01 5.5 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.334 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.455 HG23 ' C ' ' A' ' 140' ' ' GLY . 25.7 mt -120.09 118.42 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.7 t80 -49.92 127.31 16.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.873 0.844 . . . . 0.0 112.9 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.697 ' HB2' HG23 ' A' ' 170' ' ' VAL . 61.7 ttt-85 -121.58 -21.53 6.18 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.619 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.59 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.82 138.96 7.25 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.917 -1.114 . . . . 0.0 112.148 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.01 138.97 36.35 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.641 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 39.9 t -89.91 94.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -89.99 110.02 21.02 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.104 0.954 . . . . 0.0 112.793 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 163' ' ' VAL . 30.3 m -100.48 125.18 46.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.3 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 56.3 22.81 6.59 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -0.827 . . . . 0.0 111.31 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.23 17.71 36.13 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.019 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 160' ' ' THR . 34.8 m -144.3 139.99 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.117 -1.225 . . . . 0.0 109.0 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -78.12 122.09 25.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.274 -0.891 . . . . 0.0 111.552 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -116.24 15.95 15.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.794 -0.566 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.33 150.89 2.42 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.702 HG21 HG11 ' A' ' 116' ' ' VAL . 17.3 m -128.6 136.77 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.633 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 156' ' ' ALA . 84.7 m-20 -105.43 150.45 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.7 p90 -154.51 161.09 41.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.914 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 155' ' ' ARG . 60.3 t -80.34 139.93 52.27 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 174' ' ' SER . 47.4 Cg_endo -82.17 148.24 14.91 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.779 1.41 . . . . 0.0 110.525 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.22 -30.06 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.644 -0.66 . . . . 0.0 110.007 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.85 -31.48 69.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 109.014 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 171' ' ' PRO . 35.0 t -73.06 -31.04 64.14 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.438 0.637 . . . . 0.0 109.559 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.534 ' CG ' HD21 ' A' ' 82' ' ' LEU . 2.7 mtp -70.03 -39.39 75.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.658 -0.651 . . . . 0.0 109.461 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -59.99 -41.46 92.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.655 -0.653 . . . . 0.0 109.433 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 32.7 p -69.73 -33.92 73.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.497 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.7 m -63.16 -40.03 96.38 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -63.04 -32.41 73.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.844 -0.535 . . . . 0.0 109.687 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -59.97 -40.01 87.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.407 -0.808 . . . . 0.0 109.595 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.89 150.02 46.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.2 t -170.64 76.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.5 -0.75 . . . . 0.0 110.159 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 56.74 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.823 -0.548 . . . . 0.0 110.809 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -160.22 -49.86 0.05 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -1.0 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 50.05 -144.24 0.52 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.353 -0.842 . . . . 0.0 110.451 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.716 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.037 0.446 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.26 -57.47 1.2 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 60.08 129.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.031 0.92 . . . . 0.0 110.895 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.97 157.29 26.87 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.871 -0.518 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.62 173.97 12.21 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.677 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 53.27 50.06 18.45 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 56.3 169.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.475 -0.766 . . . . 0.0 110.797 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG13 ' HG2' ' A' ' 34' ' ' GLN . 66.8 t -80.47 -48.97 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.48 0.657 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLY . 98.2 mt-10 49.93 40.03 19.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.635 -0.665 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.57 171.81 40.15 Favored Glycine 0 N--CA 1.5 2.954 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.172 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' HG3' ' CD ' ' A' ' 92' ' ' ARG . 99.5 mt-10 -85.41 -47.05 10.34 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.831 -0.805 . . . . 0.0 111.663 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.25 124.28 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.507 ' HG2' HG13 ' A' ' 29' ' ' VAL . 29.6 mt-30 -94.59 124.2 38.48 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.2 t -80.29 131.17 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.7 175.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.414 -0.803 . . . . 0.0 110.262 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.5 p -146.32 133.24 20.18 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.837 0.827 . . . . 0.0 109.206 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.3 p -108.25 -179.73 3.97 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.69 -14.92 23.82 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 p -107.92 -32.34 7.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 113.185 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.88 -169.98 0.72 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.705 -1.247 . . . . 0.0 112.769 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 m -121.43 148.79 43.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.7 p90 -164.3 -145.55 0.09 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.525 -0.734 . . . . 0.0 110.299 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 54' ' ' THR . 82.9 mt -134.87 159.99 39.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.644 -1.285 . . . . 0.0 112.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -143.72 128.79 18.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 142' ' ' PRO . 98.1 m -96.8 132.84 42.11 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.0 111.799 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.19 117.31 20.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.44 129.93 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.041 -1.037 . . . . 0.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 54.05 40.05 31.22 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.534 -0.729 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.95 24.95 74.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.58 123.02 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.544 -0.974 . . . . 0.0 109.099 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.0 m -75.3 143.34 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.563 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 91.2 m95 -136.0 125.51 25.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.732 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -128.79 -174.21 3.19 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 139' ' ' SER . 35.1 m -86.41 131.52 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.312 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.409 ' HB2' ' N ' ' A' ' 82' ' ' LEU . 19.0 t80 -60.43 -40.09 89.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.776 -0.577 . . . . 0.0 109.641 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.849 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 37.8 p-80 -73.41 72.43 1.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.391 1.091 . . . . 0.0 108.745 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.36 -36.07 0.81 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 83' ' ' VAL . . . -83.18 0.47 45.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.808 -0.819 . . . . 0.0 111.143 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.54 -23.91 5.08 Favored Glycine 0 N--CA 1.502 3.041 0 O-C-N 121.077 -1.014 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 63.6 m -66.23 -9.81 35.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.358 -1.083 . . . . 0.0 111.185 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 61' ' ' SER . 40.0 ttpt 64.42 -71.91 0.07 Allowed 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.563 -0.71 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -80.06 100.08 8.01 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.473 0.654 . . . . 0.0 110.402 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -92.03 -126.93 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -146.35 97.39 2.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.766 -1.209 . . . . 0.0 110.202 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -89.09 -179.95 45.49 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.99 -17.84 54.06 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 O-C-N 123.933 1.491 . . . . 0.0 110.46 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -109.74 3.91 21.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.331 -0.856 . . . . 0.0 111.3 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.82 -159.66 14.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -58.39 123.49 13.73 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.648 1.341 . . . . 0.0 110.621 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.468 HG22 ' CD1' ' A' ' 85' ' ' TRP . 8.3 mt -88.05 -22.81 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.736 -0.602 . . . . 0.0 111.527 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 63' ' ' THR . 50.9 m 60.06 124.64 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.562 0.696 . . . . 0.0 110.913 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.569 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 26.6 mt-30 -59.94 137.71 58.01 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.271 -0.893 . . . . 0.0 112.547 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.4 ttm -97.08 -27.63 14.5 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.739 ' CD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -147.04 167.65 23.52 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 1.033 HG23 HG12 ' A' ' 83' ' ' VAL . 19.0 m -154.61 116.7 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 110.398 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 15.7 t-20 -95.02 75.2 3.5 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.01 -40.04 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -55.8 -26.27 45.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -111.02 0.09 16.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.706 -0.621 . . . . 0.0 110.832 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 60.17 57.4 2.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.499 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.798 HD22 HG11 ' A' ' 170' ' ' VAL . 36.9 tp -148.06 151.53 35.84 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.652 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 1.033 HG12 HG23 ' A' ' 76' ' ' THR . 14.6 m -139.74 140.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 85' ' ' TRP . . . -125.47 171.21 17.38 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.151 -1.499 . . . . 0.0 112.102 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.58 ' HH2' HG22 ' A' ' 54' ' ' THR . 0.2 OUTLIER -148.67 -162.08 1.48 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.258 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -100.36 111.31 23.57 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.559 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -68.19 134.2 91.45 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 111.542 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.55 176.3 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.974 1.512 . . . . 0.0 109.443 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.13 149.73 32.57 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.847 1.446 . . . . 0.0 110.651 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 30' ' ' GLU . . . 94.67 -9.98 70.9 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.267 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.28 39.95 0.93 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.853 -1.381 . . . . 0.0 111.546 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CD ' ' HG3' ' A' ' 32' ' ' GLU . 49.9 mtt-85 27.96 96.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 t -83.49 129.74 34.99 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.411 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.956 HD13 HD21 ' A' ' 144' ' ' LEU . 83.1 mt -109.98 149.91 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 7.6 p -105.38 157.56 34.16 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.339 -178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.62 163.06 5.28 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 O-C-N 123.824 1.434 . . . . 0.0 110.604 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 p -155.82 169.2 24.93 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.391 -0.818 . . . . 0.0 111.488 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m -61.18 -40.1 92.62 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.72 -0.613 . . . . 0.0 110.583 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 98' ' ' THR . 74.2 m 64.59 79.23 0.26 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.235 0.54 . . . . 0.0 112.353 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.41 -33.2 86.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -111.85 144.2 41.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.797 -0.825 . . . . 0.0 108.948 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.3 m -98.4 16.38 21.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 111.268 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -67.81 86.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 86.9 mt -99.02 176.64 5.5 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.616 0.722 . . . . 0.0 111.28 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 96.2 m-85 -144.45 111.13 5.68 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.504 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.6 tp -86.36 143.93 27.6 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.465 0.65 . . . . 0.0 110.315 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' OD1' ' A' ' 112' ' ' ASP . 80.5 t -88.97 114.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.4 p -84.21 174.87 9.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -41.55 -29.33 0.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.816 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -100.04 -70.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.541 -0.724 . . . . 0.0 109.654 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.92 -162.92 1.66 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.523 -0.736 . . . . 0.0 109.023 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.645 ' OD1' HG22 ' A' ' 107' ' ' VAL . 87.9 m-20 -57.81 -63.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.632 -0.667 . . . . 0.0 110.08 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.8 t 54.02 -86.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.008 -0.433 . . . . 0.0 111.617 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 126' ' ' LEU . 1.9 pp -76.23 134.63 70.42 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.101 -0.999 . . . . 0.0 111.731 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 105' ' ' TYR . 52.5 Cg_endo -104.67 148.1 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.604 1.318 . . . . 0.0 109.13 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 167' ' ' VAL . 40.5 t -134.06 138.61 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.275 -0.891 . . . . 0.0 110.803 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.83 124.17 39.73 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.456 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.3 ttm180 -62.62 121.56 13.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.409 -0.807 . . . . 0.0 110.356 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.02 7.4 44.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.631 -0.668 . . . . 0.0 109.574 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.97 173.81 43.73 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 16.8 t0 -61.33 -25.28 67.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -125.71 18.59 7.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.551 -0.718 . . . . 0.0 111.757 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.415 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 95.2 mtt-85 -138.26 145.37 41.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.884 -1.135 . . . . 0.0 111.161 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.29 141.2 10.93 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 116' ' ' VAL . 55.3 p -89.21 113.1 24.27 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.951 -0.735 . . . . 0.0 109.858 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 116' ' ' VAL . 41.1 tp -71.06 110.06 5.52 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.95 -18.0 63.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 110.738 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.0 m -119.95 79.96 25.52 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.615 -0.678 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.72 137.75 78.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.807 1.425 . . . . 0.0 109.903 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -154.11 169.8 9.43 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.699 -0.626 . . . . 0.0 109.344 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.56 124.38 15.34 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.963 1.507 . . . . 0.0 110.335 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 159' ' ' CYS . 15.0 p -49.36 -23.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.794 -0.566 . . . . 0.0 111.635 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.324 -0.86 . . . . 0.0 109.356 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -70.67 -28.03 64.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 164' ' ' ALA . 96.8 mt -84.25 -0.32 51.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.557 -0.714 . . . . 0.0 111.271 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -70.31 110.84 5.49 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.76 -10.57 57.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 p -74.65 -15.24 60.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 109.159 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -71.29 151.33 44.32 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 179.233 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.673 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.74 72.86 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.23 -157.92 3.62 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.6 Cg_endo -142.35 137.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 116.982 -1.546 . . . . 0.0 112.212 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.504 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.2 mt -95.06 99.16 11.21 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.956 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -90.86 146.41 23.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -59.86 -164.8 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 49.0 Cg_endo -90.14 17.98 1.43 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.521 1.274 . . . . 0.0 111.022 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.3 m -126.51 -55.42 1.43 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.096 -1.002 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.0 43.32 0.02 OUTLIER Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -125.19 120.99 32.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -1.037 . . . . 0.0 110.797 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.61 124.3 29.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.266 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.21 -1.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.724 . . . . 0.0 111.901 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.86 125.46 1.65 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.168 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.453 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.0 mt -105.8 117.48 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.297 -1.119 . . . . 0.0 108.156 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.2 t80 -50.14 126.8 15.43 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.601 0.715 . . . . 0.0 112.529 -177.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HB2' HG23 ' A' ' 170' ' ' VAL . 51.7 ttp180 -119.85 -22.48 6.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.82 -0.55 . . . . 0.0 112.224 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.96 136.62 6.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.894 -1.129 . . . . 0.0 111.974 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.0 133.25 40.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 122.001 -0.437 . . . . 0.0 111.375 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.608 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 54.1 t -84.66 91.08 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.454 ' HG ' HG21 ' A' ' 132' ' ' VAL . 64.2 m -94.23 119.73 33.45 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.824 0.821 . . . . 0.0 111.352 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -89.95 -79.96 0.33 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.075 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -106.41 64.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.404 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 72.93 18.79 79.23 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 27.6 m -146.67 137.94 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.29 -1.123 . . . . 0.0 109.016 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -83.14 129.98 35.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.549 -0.72 . . . . 0.0 111.072 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -119.94 14.82 12.46 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.215 0.531 . . . . 0.0 110.089 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.06 152.15 2.84 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 116' ' ' VAL . 9.1 m -132.18 137.3 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.461 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -104.71 152.0 23.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.467 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -153.71 166.66 32.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.644 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.798 HG11 HD22 ' A' ' 82' ' ' LEU . 57.8 t -80.7 130.88 62.5 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.04 148.61 45.18 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.744 1.392 . . . . 0.0 109.863 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.33 -25.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.917 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.98 -29.69 68.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.312 -0.867 . . . . 0.0 108.72 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.903 ' O ' HG22 ' A' ' 177' ' ' THR . 30.9 m -71.08 -32.79 69.52 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.409 0.623 . . . . 0.0 109.395 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.696 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -69.37 -38.45 78.07 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.8 0.81 . . . . 0.0 108.937 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.01 -39.24 85.13 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.589 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 174' ' ' SER . 3.9 t -60.28 -25.78 65.99 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.27 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.739 HG23 ' CD2' ' A' ' 75' ' ' TYR . 95.2 m -63.97 -49.93 70.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.156 -0.965 . . . . 0.0 108.765 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 78.1 mtm -63.36 -40.0 96.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -70.07 -31.42 69.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.703 . . . . 0.0 109.854 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 59.49 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.492 0.663 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 33.4 t -172.86 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.07 -39.96 54.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.748 -0.595 . . . . 0.0 110.497 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 57.23 35.34 26.05 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.414 -0.804 . . . . 0.0 109.422 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 57.2 162.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.613 -0.679 . . . . 0.0 110.417 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.1 mttm . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.029 -179.654 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.849 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' THR . 7.8 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.077 0.465 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.75 179.95 44.8 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -140.95 165.33 27.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.012 -0.699 . . . . 0.0 109.296 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 84.6 m-20 -74.26 139.25 44.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -130.1 155.14 46.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.953 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 62.3 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.525 -0.734 . . . . 0.0 111.079 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 56.03 111.28 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.696 0.76 . . . . 0.0 111.353 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 65.8 t -79.92 -40.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.118 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 45.44 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.44 0.638 . . . . 0.0 111.34 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.597 ' CA ' ' HB1' ' A' ' 91' ' ' ALA . . . -91.08 96.26 2.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.558 ' HA ' HD23 ' A' ' 94' ' ' LEU . 97.4 mt-10 -151.11 -78.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.747 HG22 ' HG3' ' A' ' 142' ' ' PRO . 63.0 t -138.14 129.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -140.08 141.36 36.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.27 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.47 139.02 18.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.54 159.98 42.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.57 0.7 . . . . 0.0 110.215 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.7 m -137.28 121.39 17.88 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.8 0.81 . . . . 0.0 108.897 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.5 p -107.48 -179.87 4.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -14.92 18.45 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.213 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.6 p -99.14 -40.95 7.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 112.191 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -173.55 -168.52 0.45 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.926 -1.109 . . . . 0.0 112.098 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 p -118.4 144.66 45.76 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 8.4 p90 -161.4 -143.35 0.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.738 . . . . 0.0 110.132 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD11 ' N ' ' A' ' 109' ' ' ARG . 80.9 mt -134.64 162.96 30.83 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.615 -1.303 . . . . 0.0 112.833 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -151.89 129.84 11.76 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.648 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 75.5 m -103.07 127.7 50.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 0.0 111.418 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 86.9 m -74.82 122.56 23.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.746 -0.596 . . . . 0.0 109.568 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.55 129.48 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.4 t30 49.99 39.99 20.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.584 -0.698 . . . . 0.0 111.264 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.42 26.19 73.84 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.577 HG21 ' SD ' ' A' ' 179' ' ' MET . 62.9 t -137.82 113.02 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -1.038 . . . . 0.0 109.611 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 7.9 t -74.47 121.28 21.23 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.464 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 87.6 m95 -110.01 129.96 55.6 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.493 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.839 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 4.5 t -136.74 179.99 6.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 139' ' ' SER . 30.3 m -90.2 126.37 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.138 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -60.08 -40.89 91.15 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.701 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 36.8 p-80 -74.64 67.06 1.51 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.13 0.967 . . . . 0.0 108.64 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.1 -36.6 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -90.03 -79.96 0.33 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.875 . . . . 0.0 109.366 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.41 25.27 4.28 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.368 -0.833 . . . . 0.0 111.218 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 63' ' ' THR . 26.4 p -132.14 1.72 3.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -1.132 . . . . 0.0 112.02 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' SER . 96.3 mttt 61.17 -66.81 0.06 Allowed 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.945 0.879 . . . . 0.0 110.733 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 61' ' ' SER . 11.5 m -79.13 139.97 37.91 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.663 0.744 . . . . 0.0 110.363 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -143.74 -130.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.21 93.33 2.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.109 . . . . 0.0 109.034 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -100.0 -171.74 30.01 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.6 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HG3' HG13 ' A' ' 29' ' ' VAL . 44.3 Cg_endo -61.07 -18.8 60.12 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 O-C-N 124.105 1.582 . . . . 0.0 110.649 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -108.83 7.43 26.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 110.955 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.09 -153.3 16.85 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HB2' HG23 ' A' ' 63' ' ' THR . 44.0 Cg_endo -64.88 116.16 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.007 1.53 . . . . 0.0 111.18 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.674 HG22 ' HD1' ' A' ' 85' ' ' TRP . 66.7 mt -104.97 140.0 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.462 0.648 . . . . 0.0 109.751 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -95.37 145.25 25.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.791 -0.568 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 11.5 pt20 -75.27 157.41 34.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.669 -0.645 . . . . 0.0 111.101 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.3 mmm -96.88 -39.97 9.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.706 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.33 -178.18 7.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.598 -0.689 . . . . 0.0 109.333 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.852 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.2 m -150.9 125.55 9.63 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.81 76.69 4.24 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.93 -39.23 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 109.466 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -53.84 -26.2 23.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -115.66 0.64 13.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.656 -0.653 . . . . 0.0 110.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t0 60.37 56.82 3.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.893 -1.129 . . . . 0.0 108.591 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.718 HD22 HG11 ' A' ' 170' ' ' VAL . 22.6 tp -142.77 155.47 44.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.869 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.852 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -145.1 137.55 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.435 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.52 125.99 5.19 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.44 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.839 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.5 m-90 -90.04 -170.04 2.64 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -108.44 109.84 21.22 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.27 147.91 98.29 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.508 -0.745 . . . . 0.0 110.556 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -104.11 167.29 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.727 1.383 . . . . 0.0 110.354 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 29' ' ' VAL . 46.9 Cg_endo -63.64 169.6 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.876 1.461 . . . . 0.0 110.406 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.97 -9.97 75.5 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.628 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -98.01 -147.96 0.32 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.362 -1.081 . . . . 0.0 108.899 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -153.0 -39.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.279 -0.888 . . . . 0.0 111.108 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.5 131.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.464 0.65 . . . . 0.0 110.553 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 32' ' ' GLU . 4.6 mm? -75.44 153.89 37.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.99 161.49 22.65 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.364 -0.835 . . . . 0.0 110.8 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -61.09 165.32 12.62 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.797 1.42 . . . . 0.0 110.083 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.403 ' SG ' ' CB ' ' A' ' 145' ' ' CYS . 4.0 t -108.17 120.26 41.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.519 -0.738 . . . . 0.0 111.736 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.2 m -70.06 -41.32 74.32 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.36 142.54 53.95 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.86 14.8 55.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.3 m -59.99 136.98 58.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.952 -1.322 . . . . 0.0 109.568 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.2 m -101.66 7.84 41.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.426 -0.796 . . . . 0.0 111.511 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.88 76.1 1.16 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 108.618 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 145' ' ' CYS . 53.9 mt -95.26 172.42 8.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.753 -0.592 . . . . 0.0 109.808 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 53.0 p90 -152.06 142.2 22.29 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 38.9 tp -115.03 155.8 26.31 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.98 0.895 . . . . 0.0 111.908 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 111' ' ' ALA . 92.4 t -109.97 135.7 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 112' ' ' ASP . 45.1 p -83.25 175.79 9.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.559 ' N ' HD11 ' A' ' 44' ' ' LEU . 70.3 ttt-85 -41.95 -31.29 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.296 0.57 . . . . 0.0 111.422 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -99.99 -70.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.77 -82.44 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.566 -0.709 . . . . 0.0 110.328 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.604 ' HB3' HG23 ' A' ' 108' ' ' THR . 23.2 t0 46.86 90.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.389 -0.82 . . . . 0.0 111.4 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.19 49.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.685 . . . . 0.0 110.439 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.639 HD12 ' CD1' ' A' ' 126' ' ' LEU . 13.1 pt -70.06 156.03 92.49 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.668 ' O ' HD22 ' A' ' 127' ' ' LEU . 43.4 Cg_endo -103.31 141.11 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.982 1.517 . . . . 0.0 111.523 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 167' ' ' VAL . 62.8 t -130.02 130.06 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG2' HD21 ' A' ' 127' ' ' LEU . 21.5 mmm180 -90.26 116.59 28.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 7.3 ttp180 -60.39 123.48 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.93 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -100.01 4.51 44.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 109.935 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.76 176.99 41.78 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 92.5 m-20 -65.64 -21.54 66.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -1.059 . . . . 0.0 110.119 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -124.49 17.0 8.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -140.3 139.93 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.975 -1.078 . . . . 0.0 110.774 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -139.19 144.02 14.77 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 t -90.9 111.97 23.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.789 -0.83 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.639 ' CD1' HD12 ' A' ' 114' ' ' ILE . 44.3 tp -73.49 104.64 4.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.668 HD22 ' O ' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -60.02 -27.43 66.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.225 0.536 . . . . 0.0 110.387 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 t -112.39 105.49 56.12 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.713 -0.617 . . . . 0.0 110.76 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.78 141.74 19.6 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.911 1.479 . . . . 0.0 109.442 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.88 165.23 18.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.573 -0.704 . . . . 0.0 109.258 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.12 125.19 16.93 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.895 1.471 . . . . 0.0 109.935 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -49.64 -25.14 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.799 -0.563 . . . . 0.0 111.254 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.402 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 25.3 t -55.5 -38.12 68.76 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.654 0.74 . . . . 0.0 109.434 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 108' ' ' THR . 53.8 t80 -70.02 -29.18 66.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.87 2.0 50.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.583 -0.698 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 51.9 mttm -70.5 113.01 7.21 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.152 -0.967 . . . . 0.0 108.56 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.7 -9.05 56.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.6 t -75.27 -17.13 60.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.0 109.083 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.693 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -65.14 146.21 55.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 179.367 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.562 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 96.85 -14.98 63.39 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.54 -158.08 0.61 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.747 ' HG3' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -142.74 140.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 116.683 -1.745 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 4.5 mp -97.08 97.33 9.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.614 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.3 mp -90.01 138.13 31.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.689 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.03 -154.89 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.469 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -104.16 15.04 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.453 1.238 . . . . 0.0 110.365 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 m -117.14 16.9 14.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.44 37.59 46.8 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -125.2 132.08 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.85 119.97 37.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.18 -1.56 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.269 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.89 126.85 2.35 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.506 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.443 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.3 mt -109.94 117.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.105 -1.232 . . . . 0.0 108.283 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.433 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 15.2 t80 -50.92 128.67 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.419 ' HB3' HG23 ' A' ' 170' ' ' VAL . 34.5 ptt180 -119.34 -25.56 6.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.722 -0.612 . . . . 0.0 111.648 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -160.06 141.44 12.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 111.827 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.433 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -95.99 140.1 31.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.4 t -89.95 92.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 61.8 m -92.59 118.17 30.73 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.696 0.76 . . . . 0.0 111.028 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.648 HG22 ' HG3' ' A' ' 161' ' ' ARG . 96.7 m -89.94 -78.38 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 160' ' ' THR . 59.6 mtp85 -105.99 54.58 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 81.79 16.57 72.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -146.36 141.31 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.353 -1.086 . . . . 0.0 108.335 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -84.52 128.29 34.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.545 -0.722 . . . . 0.0 111.047 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -120.0 15.83 12.48 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.163 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.31 145.87 2.23 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -121.65 135.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.698 -177.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -102.57 147.34 26.9 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 41.5 p90 -152.65 165.16 36.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.089 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.718 HG11 HD22 ' A' ' 82' ' ' LEU . 67.3 t -81.65 131.81 56.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.09 143.1 31.88 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.887 1.467 . . . . 0.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.77 -29.94 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 109.659 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 177' ' ' THR . 86.4 tt0 -58.98 -33.09 70.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 m -75.54 -29.65 59.48 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.855 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.595 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.5 mtp -69.95 -39.88 75.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 109.586 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.04 -39.92 87.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.73 -0.606 . . . . 0.0 110.069 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 173' ' ' GLU . 64.6 p -64.59 -36.05 82.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.453 -0.78 . . . . 0.0 109.823 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.447 HG21 ' HH2' ' A' ' 53' ' ' TRP . 94.4 m -61.55 -40.06 93.36 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.577 ' SD ' HG21 ' A' ' 51' ' ' VAL . 94.4 mtp -65.34 -35.47 81.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -59.99 -36.01 76.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.677 -0.639 . . . . 0.0 110.446 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.07 92.27 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.743 -0.598 . . . . 0.0 110.217 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.15 -69.0 0.14 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.551 -0.718 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 185' ' ' LYS . 80.5 tttt -150.79 80.07 1.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.374 -0.829 . . . . 0.0 110.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.9 tptm 60.01 -68.14 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.174 -0.329 . . . . 0.0 111.465 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 183' ' ' LYS . 16.5 ptpt -159.49 169.98 22.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 0.0 110.539 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.19 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.724 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.105 0.478 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.35 101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 1.6 tmm_? -138.96 157.5 45.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.888 -0.771 . . . . 0.0 110.046 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.433 ' HB2' ' CD ' ' A' ' 24' ' ' ARG . 56.1 t0 54.78 47.15 23.05 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.797 -0.564 . . . . 0.0 110.56 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -149.84 161.31 42.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.677 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 60.47 119.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.518 -0.739 . . . . 0.0 111.07 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -58.35 169.25 0.9 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.185 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -79.98 -6.06 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.583 -0.698 . . . . 0.0 111.765 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.06 66.87 0.62 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.005 -1.06 . . . . 0.0 110.0 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.8 156.58 27.01 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.39 -52.07 6.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.731 -0.864 . . . . 0.0 111.078 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.3 t -111.26 126.32 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.0 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -96.25 139.85 31.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.417 0.627 . . . . 0.0 110.341 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.639 ' HA ' HD23 ' A' ' 44' ' ' LEU . 99.0 t -80.33 140.16 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.92 159.97 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 122.346 1.069 . . . . 0.0 112.0 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 78.2 p -148.5 116.93 6.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 59' ' ' ALA . 30.2 p -108.71 179.98 4.03 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.396 0.617 . . . . 0.0 109.651 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.65 -16.27 15.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -111.29 -27.35 8.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 113.166 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -170.93 -170.01 0.83 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.582 -1.324 . . . . 0.0 112.54 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 75.3 m -127.84 140.79 51.82 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.7 p90 -159.69 -141.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 109.996 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 35' ' ' VAL . 84.4 mt -136.82 171.16 14.92 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.594 -1.316 . . . . 0.0 113.39 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -148.11 122.91 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.389 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 142' ' ' PRO . 93.5 m -85.89 120.83 27.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.592 -0.693 . . . . 0.0 110.541 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.761 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 85.3 m -74.46 119.7 19.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.362 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' CG2' HG22 ' A' ' 46' ' ' THR . 41.5 t -140.89 131.88 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.37 -0.831 . . . . 0.0 110.465 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 52.86 40.03 30.05 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.508 -0.745 . . . . 0.0 111.025 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.625 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.59 27.36 73.58 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.702 HG21 ' HE1' ' A' ' 179' ' ' MET . 84.0 t -140.0 118.87 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.542 -0.976 . . . . 0.0 109.675 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -74.04 129.01 37.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.516 ' CD2' ' HB2' ' A' ' 175' ' ' MET . 90.2 m95 -117.33 120.06 37.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.813 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.661 ' O ' HD23 ' A' ' 82' ' ' LEU . 6.5 t -129.15 -178.16 4.53 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.565 HG13 ' CA ' ' A' ' 140' ' ' GLY . 24.1 m -88.42 134.54 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 C-N-CA 118.942 -1.103 . . . . 0.0 113.359 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -64.37 -40.0 94.98 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.366 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.794 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 41.8 p-80 -71.65 75.07 0.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.09 0.948 . . . . 0.0 109.326 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 158.55 -42.61 0.49 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.774 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -80.2 -69.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.671 -0.9 . . . . 0.0 110.915 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.42 -89.9 0.81 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.9 p -175.18 86.91 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.485 -1.009 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.83 -159.17 0.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.516 -0.74 . . . . 0.0 111.162 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.6 p -77.56 -32.94 54.13 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.732 -0.605 . . . . 0.0 110.932 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER 78.84 -28.13 0.16 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.831 0.852 . . . . 0.0 112.377 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 69.84 92.45 0.08 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.709 -0.619 . . . . 0.0 109.6 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.76 -179.65 49.03 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -62.81 -14.81 42.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.963 1.507 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -104.8 -22.45 13.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 111.199 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.79 -164.82 30.46 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.05 114.66 3.27 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.873 1.459 . . . . 0.0 110.606 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 63' ' ' THR . 91.4 mt -97.14 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -88.1 136.49 32.95 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 111.436 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 19.4 pt20 -73.3 146.47 45.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.812 -0.555 . . . . 0.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.11 -37.71 8.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.517 -0.739 . . . . 0.0 109.955 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' CG ' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -171.96 -177.56 1.95 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.503 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.0 t -159.99 143.6 14.16 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.732 0.777 . . . . 0.0 110.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.92 80.67 1.46 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.93 -39.99 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.74 . . . . 0.0 110.056 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -56.58 -26.55 55.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.288 -0.883 . . . . 0.0 108.853 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -110.39 2.44 19.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.717 -0.614 . . . . 0.0 110.706 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 60.56 56.38 3.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 111.336 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 54' ' ' THR . 2.3 mt -144.54 150.56 37.73 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.527 -0.733 . . . . 0.0 110.261 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -136.95 128.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 179.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.27 123.56 5.7 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 118.876 -1.63 . . . . 0.0 113.222 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.491 ' CD1' HD23 ' A' ' 64' ' ' LEU . 5.8 m-90 -92.69 -170.78 2.55 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 122.025 -0.691 . . . . 0.0 109.676 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.2 100.99 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -69.4 130.02 91.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 111.091 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.3 158.55 48.41 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.925 1.487 . . . . 0.0 109.504 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.62 119.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.773 1.407 . . . . 0.0 110.405 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.39 -30.18 2.73 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.761 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -72.84 58.58 0.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.534 -0.98 . . . . 0.0 111.481 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 25.73 96.99 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.7 m -81.5 107.3 14.15 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.822 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.901 HD13 HD21 ' A' ' 144' ' ' LEU . 68.2 mt -91.37 154.38 19.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.834 -0.541 . . . . 0.0 110.088 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.51 164.51 17.03 Favored Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.555 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.67 ' HB3' HG11 ' A' ' 172' ' ' VAL . 51.5 Cg_endo -98.49 153.42 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 O-C-N 123.87 1.458 . . . . 0.0 110.324 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.5 p -159.96 159.93 32.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.753 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.6 p -99.97 118.9 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.0 m -119.99 141.39 49.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.888 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -64.05 -26.25 70.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -99.98 127.12 46.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.529 -0.983 . . . . 0.0 110.181 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.2 m -95.4 20.43 9.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.629 -0.669 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -69.97 73.7 0.44 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.611 -0.681 . . . . 0.0 109.188 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 118' ' ' ARG . 76.5 mt -90.17 174.48 7.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.2 p90 -153.14 144.53 23.24 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' PRO . 28.1 tp -116.35 142.53 46.73 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.705 0.764 . . . . 0.0 111.297 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -91.66 125.08 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HD12 ' A' ' 114' ' ' ILE . 72.0 p -85.82 170.66 12.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.731 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -28.89 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.892 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 108' ' ' THR . 73.6 m-70 -99.99 -86.32 0.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.132 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.64 22.33 0.12 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.191 -0.943 . . . . 0.0 111.358 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -66.43 129.07 38.61 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.052 -1.03 . . . . 0.0 110.466 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -69.97 -53.38 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.686 -0.634 . . . . 0.0 110.514 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.741 ' CG2' HD11 ' A' ' 126' ' ' LEU . 83.1 mt 46.46 73.69 0.94 Allowed Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.526 -0.734 . . . . 0.0 111.083 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -59.74 130.52 35.47 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.864 1.455 . . . . 0.0 111.187 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HD12 ' A' ' 126' ' ' LEU . 60.9 t -127.95 131.98 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -87.64 124.59 33.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 108.708 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.652 ' HB2' HD12 ' A' ' 104' ' ' LEU . 3.1 ttm180 -63.93 123.01 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.549 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -97.88 1.45 48.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.4 170.23 38.08 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.1 m-20 -58.7 -23.74 60.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.158 -1.201 . . . . 0.0 110.365 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 93.0 p -121.67 17.6 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 112.331 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -144.07 142.39 30.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.03 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.43 142.71 13.4 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 116' ' ' VAL . 25.0 p -88.77 114.84 25.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.839 -0.8 . . . . 0.0 109.477 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 116' ' ' VAL . 20.5 tp -72.26 109.98 6.38 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.92 -20.58 65.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.86 -0.525 . . . . 0.0 110.375 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -117.67 84.23 19.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.744 -0.597 . . . . 0.0 109.962 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -58.34 138.29 85.04 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.761 1.4 . . . . 0.0 110.381 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -152.99 164.69 19.53 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.55 127.43 24.59 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.77 1.405 . . . . 0.0 110.473 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -50.11 -25.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.814 -0.554 . . . . 0.0 110.702 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -59.91 -37.63 79.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.577 -0.702 . . . . 0.0 109.469 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -69.01 -25.86 64.72 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.76 -1.73 44.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.46 -0.775 . . . . 0.0 110.406 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -70.17 122.1 18.82 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.152 -0.968 . . . . 0.0 108.563 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.92 -11.41 64.23 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.1 t -79.03 -16.23 57.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.443 -1.034 . . . . 0.0 109.672 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.552 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.9 m -62.26 147.42 48.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.565 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.09 -9.91 75.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -68.9 -169.56 5.97 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.1 Cg_endo -140.34 142.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 116.974 -1.551 . . . . 0.0 112.396 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.475 HD12 ' N ' ' A' ' 143' ' ' LEU . 5.5 mp -96.59 96.35 8.59 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.901 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -87.39 141.55 28.55 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.575 ' HA ' HD23 ' A' ' 104' ' ' LEU . 85.2 m -63.71 -173.0 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.2 Cg_endo -87.79 17.27 1.74 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 117.249 -1.368 . . . . 0.0 111.6 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -122.03 18.11 10.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.07 -1.018 . . . . 0.0 111.764 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.14 35.74 37.42 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -122.87 123.38 40.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.374 -1.074 . . . . 0.0 110.34 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.95 123.33 34.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.621 -0.674 . . . . 0.0 110.179 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.02 -2.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.638 -0.664 . . . . 0.0 111.694 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -145.45 126.66 2.63 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.419 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 170' ' ' VAL . 18.1 mt -110.07 121.76 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.188 -1.184 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.834 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 8.0 t80 -51.76 122.83 8.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.841 0.829 . . . . 0.0 112.442 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.499 ' HB2' HG13 ' A' ' 170' ' ' VAL . 39.6 ttt-85 -115.9 -29.41 6.37 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.874 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -166.07 169.43 14.56 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.926 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.834 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -139.48 155.12 47.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 15.5 m -107.6 105.39 18.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.742 0.782 . . . . 0.0 109.501 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.5 p -95.36 121.84 37.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 110.36 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.548 HG22 ' HG3' ' A' ' 161' ' ' ARG . 91.0 m -89.98 -79.89 0.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.567 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.548 ' HG3' HG22 ' A' ' 160' ' ' THR . 99.6 mtt180 -96.96 52.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.96 15.94 77.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.2 m -144.67 140.01 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.386 -1.067 . . . . 0.0 108.35 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -81.56 116.93 21.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.657 0.741 . . . . 0.0 111.675 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.57 8.12 45.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.722 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -171.53 141.83 1.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.286 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.645 HG21 HG11 ' A' ' 116' ' ' VAL . 20.1 m -109.62 143.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.713 0.768 . . . . 0.0 112.687 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -111.19 142.07 43.88 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 34.2 p90 -152.83 165.04 36.65 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.276 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 155' ' ' ARG . 26.9 m -90.68 133.03 33.33 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.908 -0.495 . . . . 0.0 110.015 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.63 157.2 56.35 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.719 1.378 . . . . 0.0 109.936 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.711 HG23 ' HE3' ' A' ' 175' ' ' MET . 7.1 p -64.36 -27.23 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.49 -0.756 . . . . 0.0 109.594 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 177' ' ' THR . 86.2 tt0 -58.59 -25.39 62.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 108.547 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.3 m -74.15 -40.1 62.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.596 -0.69 . . . . 0.0 111.934 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.711 ' HE3' HG23 ' A' ' 172' ' ' VAL . 16.7 ptp -69.85 -41.06 75.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.667 -1.271 . . . . 0.0 108.815 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 175' ' ' MET . 98.9 mt-10 -59.98 -39.97 87.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.793 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 173' ' ' GLU . 43.4 p -61.69 -23.32 66.02 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.179 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 182' ' ' SER . 45.0 m -65.06 -39.92 93.98 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.702 ' HE1' HG21 ' A' ' 51' ' ' VAL . 67.6 mtt -62.44 -34.74 77.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -60.0 -27.5 66.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.748 -0.595 . . . . 0.0 110.527 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.0 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.531 -0.731 . . . . 0.0 111.568 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 178' ' ' THR . 31.2 t 41.28 49.99 3.4 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.246 -0.908 . . . . 0.0 112.293 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -86.44 131.62 34.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.414 -0.804 . . . . 0.0 110.222 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -77.13 -22.58 52.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 111.145 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -157.73 160.04 37.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.198 179.835 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.874 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.4 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.52 -171.01 39.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.96 170.63 10.88 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.957 -0.731 . . . . 0.0 109.943 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 24' ' ' ARG . 3.0 t70 85.24 -174.75 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 123.791 0.837 . . . . 0.0 109.495 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.13 139.09 57.25 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.899 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 22' ' ' THR . 10.3 t-20 -159.45 139.58 11.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -63.32 140.07 58.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.793 -0.567 . . . . 0.0 110.475 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.443 ' O ' ' HB1' ' A' ' 91' ' ' ALA . 34.5 m -80.81 -15.26 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.769 -0.582 . . . . 0.0 110.821 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.97 66.95 0.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.301 -0.874 . . . . 0.0 109.762 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.55 155.49 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -98.36 -40.06 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.952 . . . . 0.0 110.333 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.785 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -77.06 -28.74 54.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.03 -112.16 3.57 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -162.93 40.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.94 . . . . 0.0 110.292 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -169.74 161.12 9.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 111.317 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 70' ' ' PRO . 77.6 m 42.08 -100.09 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER 80.9 -29.32 0.12 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.697 0.799 . . . . 0.0 111.968 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 73.01 99.51 0.07 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.619 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -105.53 -169.59 23.69 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.76 -17.6 60.03 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 124.021 1.537 . . . . 0.0 110.623 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -104.55 5.16 33.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 111.375 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.7 -155.99 15.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' THR . 46.5 Cg_endo -70.61 111.07 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.782 1.411 . . . . 0.0 110.143 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.619 HD12 ' HA3' ' A' ' 66' ' ' GLY . 94.5 mt -105.73 148.99 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.65 . . . . 0.0 110.108 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 4.4 pp0? -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.859 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.02 149.91 96.27 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.61 161.3 28.01 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 124.026 1.54 . . . . 0.0 109.816 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.03 19.96 1.2 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.722 1.38 . . . . 0.0 111.119 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.34 -15.08 36.4 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -76.69 -160.25 0.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.329 -1.101 . . . . 0.0 108.962 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -77.86 -40.0 41.58 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.585 0.707 . . . . 0.0 110.752 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m 52.82 101.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.82 171.84 2.59 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.54 ' O ' ' HD2' ' A' ' 149' ' ' HIS . 14.8 t -52.81 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.84 -0.538 . . . . 0.0 111.634 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m 49.97 55.01 10.09 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.981 -1.074 . . . . 0.0 112.089 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.75 173.95 11.91 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.02 -1.05 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.57 19.28 7.56 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m -137.5 152.63 49.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.142 -1.21 . . . . 0.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.54 ' HD2' ' O ' ' A' ' 97' ' ' CYS . 5.0 m-70 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p -59.92 -32.48 70.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.859 HG23 ' CG ' ' A' ' 75' ' ' TYR . 78.9 m -60.62 -44.99 95.69 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.1 mtp -61.33 -40.24 93.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.44 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.7 mtt85 -70.08 -39.97 75.29 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.896 0.855 . . . . 0.0 109.487 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 60.1 7.13 1.12 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 36.37 31.06 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.422 -0.799 . . . . 0.0 113.086 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -85.28 -47.12 10.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 50.0 41.45 23.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.442 -0.787 . . . . 0.0 111.486 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.63 130.01 34.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.47 -0.769 . . . . 0.0 109.848 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 34.7 mttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.215 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.787 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.427 HG23 ' CB ' ' A' ' 37' ' ' SER . 3.0 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.123 0.487 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.67 149.37 41.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -129.89 151.04 50.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.778 -0.836 . . . . 0.0 109.838 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 51.6 t0 59.2 72.56 0.52 Allowed 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.449 0.643 . . . . 0.0 110.33 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.99 17.63 20.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.883 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 68.44 -61.22 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -60.76 151.34 29.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -76.18 -40.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.623 -0.673 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 10.9 tp10 -169.07 -33.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.574 -0.704 . . . . 0.0 111.284 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.97 -157.25 51.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.537 ' CG ' HD21 ' A' ' 94' ' ' LEU . 94.9 mt-10 -90.03 -54.63 3.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.935 . . . . 0.0 110.157 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.8 t -130.02 133.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -139.96 151.96 45.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 44' ' ' LEU . 63.5 t -82.77 137.82 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 65' ' ' ALA . 9.1 m -143.95 170.16 9.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.427 ' CB ' HG23 ' A' ' 22' ' ' THR . 47.6 t -150.63 149.26 29.63 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.928 0.87 . . . . 0.0 109.603 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.7 t -119.69 -180.0 4.06 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.62 -16.25 2.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.612 -0.68 . . . . 0.0 112.274 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 38' ' ' THR . 76.3 p -98.27 -37.21 9.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.902 -1.124 . . . . 0.0 112.887 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -171.48 -174.21 1.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.805 -1.184 . . . . 0.0 112.313 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.3 p -116.76 143.74 45.29 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.663 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.9 p90 -162.52 -139.09 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 35' ' ' VAL . 76.1 mt -134.57 164.61 27.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 113.363 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.45 125.29 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.315 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.776 ' CG2' HD11 ' A' ' 153' ' ' ILE . 5.9 t -83.55 -152.0 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 0.0 110.745 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.521 ' N ' HG23 ' A' ' 46' ' ' THR . 13.6 t -159.35 113.52 2.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.417 HG12 ' OD1' ' A' ' 49' ' ' ASN . 57.1 t -138.71 135.52 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.299 -0.961 . . . . 0.0 111.371 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' OD1' HG12 ' A' ' 48' ' ' VAL . 27.7 m120 49.99 39.98 20.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.667 -0.645 . . . . 0.0 110.935 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.729 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.28 24.93 74.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.0 t -133.7 113.66 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.831 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 130.08 38.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.529 ' HH2' HG21 ' A' ' 178' ' ' THR . 93.1 m95 -118.46 133.93 55.48 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.453 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.814 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -139.01 -178.47 5.35 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.677 HG13 ' CA ' ' A' ' 140' ' ' GLY . 21.2 m -82.77 134.26 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.671 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 49.7 t80 -64.22 -39.96 95.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.824 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 11.5 p-80 -63.11 -16.27 59.43 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.531 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 38' ' ' THR . . . -90.7 -82.7 1.4 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -92.15 40.73 1.05 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.397 -1.061 . . . . 0.0 111.19 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.63 63.21 0.45 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.5 t -173.98 -85.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.297 -1.119 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -175.19 -174.36 0.74 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 0.0 108.847 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.611 HG23 ' CB ' ' A' ' 70' ' ' PRO . 64.2 m 48.8 75.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.0 0.905 . . . . 0.0 111.337 178.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 70' ' ' PRO . 20.2 tp -89.53 -98.82 0.1 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.898 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -171.17 116.46 0.44 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.876 -1.14 . . . . 0.0 110.565 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.601 ' CA ' HD12 ' A' ' 71' ' ' ILE . . . -137.45 176.35 20.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.01 -15.79 51.23 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 124.077 1.567 . . . . 0.0 110.506 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -101.07 -20.4 15.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.105 -0.997 . . . . 0.0 111.416 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.31 -122.2 1.03 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.611 ' CB ' HG23 ' A' ' 63' ' ' THR . 50.3 Cg_endo -98.06 9.15 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 O-C-N 123.635 1.334 . . . . 0.0 111.584 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.601 HD12 ' CA ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER 52.98 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.882 -1.136 . . . . 0.0 110.198 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 70.0 m -139.32 132.86 30.34 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 8.1 pt20 -76.22 153.22 36.25 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.444 -0.785 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.5 ttp -107.88 -30.05 8.71 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TYR . . . . . 0.681 ' CD2' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -148.84 167.71 24.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.891 HG23 ' CG1' ' A' ' 83' ' ' VAL . 29.7 m -154.03 114.15 3.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.636 -0.665 . . . . 0.0 110.428 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 76.98 4.22 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.746 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 98.3 t -59.95 -40.0 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.405 -0.809 . . . . 0.0 109.724 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.55 -25.85 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.68 -1.23 16.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.792 -0.567 . . . . 0.0 110.703 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.92 57.72 3.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.1 -1.0 . . . . 0.0 109.332 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 170' ' ' VAL . 42.9 tp -147.77 153.55 39.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.691 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.891 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -143.09 131.78 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.73 124.79 5.79 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.768 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.3 m-90 -84.69 170.01 13.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 122.049 -0.677 . . . . 0.0 109.771 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.28 89.29 4.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 109.352 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.08 144.19 92.41 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.552 -0.717 . . . . 0.0 110.532 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.42 179.89 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.809 1.426 . . . . 0.0 109.864 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -87.98 13.39 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.789 1.415 . . . . 0.0 111.539 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.95 -25.44 31.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 30' ' ' GLU . . . -88.42 -143.12 0.13 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.713 -0.875 . . . . 0.0 109.84 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -154.07 108.63 3.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.2 m -87.71 157.07 19.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.7 -0.625 . . . . 0.0 110.582 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 ' CG ' ' A' ' 32' ' ' GLU . 97.1 mt -90.14 170.03 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 110.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 92.6 m -111.94 164.18 15.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 52.6 Cg_endo -119.45 142.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.639 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.407 ' SG ' ' CG ' ' A' ' 149' ' ' HIS . 18.0 p -160.52 160.0 31.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.453 -0.78 . . . . 0.0 110.77 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 99' ' ' CYS . 12.8 t -74.85 -38.65 61.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.633 -0.667 . . . . 0.0 111.842 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' CYS . . . . . 0.421 ' N ' HG23 ' A' ' 98' ' ' THR . 92.9 m 59.37 -79.65 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.711 -0.618 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' THR . . . 137.72 -28.16 2.77 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.1 t -101.75 130.04 48.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -1.024 . . . . 0.0 109.812 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -89.95 11.76 19.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.0 111.386 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -70.01 80.08 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 108.694 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 143' ' ' LEU . 96.0 mt -86.62 176.73 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.66 . . . . 0.0 110.95 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -146.24 100.89 3.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HG ' ' A' ' 143' ' ' LEU . 35.0 tp -76.24 139.95 41.39 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.513 0.673 . . . . 0.0 110.013 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 33' ' ' VAL . 78.3 t -85.32 111.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' ALA . 55.5 p -81.38 172.39 13.61 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -42.6 -27.95 0.2 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.712 -0.618 . . . . 0.0 112.149 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -100.01 -68.91 0.79 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.407 -0.808 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 108' ' ' THR . . . -146.53 -161.71 1.38 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 26.8 p-10 -60.0 -44.69 94.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.535 -0.728 . . . . 0.0 110.244 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.7 t 46.28 -89.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.625 HD12 ' CD1' ' A' ' 126' ' ' LEU . 50.1 pt -74.84 142.82 77.2 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 112.712 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 44.1 Cg_endo -105.81 141.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 O-C-N 123.777 1.409 . . . . 0.0 108.718 177.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 167' ' ' VAL . 41.8 t -133.93 133.13 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.028 -1.045 . . . . 0.0 111.447 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -92.61 119.25 31.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.4 ttm180 -61.06 126.02 25.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 110.798 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -99.1 1.4 45.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.803 -0.56 . . . . 0.0 109.698 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.13 43.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 86.4 m-20 -67.19 -21.87 65.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.7 p -123.38 16.33 9.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.513 -0.742 . . . . 0.0 111.46 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.39 143.56 35.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.072 -1.018 . . . . 0.0 111.244 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -143.34 139.21 8.71 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.48 ' C ' HG13 ' A' ' 116' ' ' VAL . 17.6 t -88.84 110.51 21.11 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.909 -0.76 . . . . 0.0 110.125 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.625 ' CD1' HD12 ' A' ' 114' ' ' ILE . 59.6 tp -71.03 114.58 9.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.782 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' N ' ' CD2' ' A' ' 127' ' ' LEU . 3.5 mm? -68.87 -25.0 64.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.234 0.54 . . . . 0.0 110.335 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.8 m -120.82 84.54 38.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.763 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.2 Cg_endo -61.69 143.26 96.31 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.919 1.483 . . . . 0.0 110.039 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -152.96 167.78 12.72 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -57.54 125.29 18.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.773 1.407 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.9 -25.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.749 -0.594 . . . . 0.0 110.931 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.411 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 21.1 t -57.93 -34.95 70.42 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 109.496 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.87 1.52 38.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.549 -0.719 . . . . 0.0 110.913 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.0 mtpt -72.33 68.92 0.78 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.129 0.966 . . . . 0.0 109.173 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 157.05 -21.28 0.43 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.536 ' HA ' HD12 ' A' ' 44' ' ' LEU . 16.8 t -75.0 -11.45 60.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.506 -0.997 . . . . 0.0 110.367 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -68.71 150.9 47.37 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.314 -0.866 . . . . 0.0 109.216 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.677 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 87.31 -11.49 65.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -70.54 -167.41 6.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.517 ' HG3' HG22 ' A' ' 33' ' ' VAL . 49.0 Cg_endo -139.98 140.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 116.866 -1.623 . . . . 0.0 111.622 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.482 ' HB3' HD13 ' A' ' 104' ' ' LEU . 2.5 mt -92.67 99.2 11.94 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.615 HD12 ' N ' ' A' ' 144' ' ' LEU . 7.4 mp -86.47 142.39 28.41 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.797 0.808 . . . . 0.0 112.759 -176.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.04 -170.15 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.36 12.55 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.62 1.326 . . . . 0.0 111.031 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -119.86 -18.95 8.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 111.36 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 39.12 0.81 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 55.9 m80 -122.96 118.65 28.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -1.043 . . . . 0.0 110.538 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -81.08 120.29 24.64 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 109.354 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.18 -3.89 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 112.068 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.462 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.6 124.41 1.85 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.362 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.776 HD11 ' CG2' ' A' ' 46' ' ' THR . 14.9 mt -106.12 121.75 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.014 -1.286 . . . . 0.0 109.009 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.839 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.5 t80 -51.36 124.53 12.09 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.76 0.791 . . . . 0.0 111.978 -178.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.0 ttt180 -114.63 -34.13 5.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.843 -0.535 . . . . 0.0 110.818 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.728 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.54 164.41 26.89 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.488 -0.757 . . . . 0.0 110.326 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.839 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.78 158.06 37.55 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 2.7 t -99.96 98.79 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.9 p -96.23 118.27 32.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.432 1.11 . . . . 0.0 112.32 -177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 162' ' ' GLY . 90.9 m -93.45 119.52 32.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' THR . 32.0 ttm105 65.51 -64.4 0.19 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.958 -0.464 . . . . 0.0 110.135 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.449 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -165.1 25.54 0.18 Allowed Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.819 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.2 m -148.9 139.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -1.186 . . . . 0.0 109.494 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -82.26 123.01 28.65 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.596 0.712 . . . . 0.0 111.679 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -113.83 17.65 17.89 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.25 0.548 . . . . 0.0 109.851 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -172.43 149.34 2.16 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 116' ' ' VAL . 13.8 m -127.4 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.64 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -107.39 149.5 27.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.3 p90 -152.13 166.36 31.91 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.234 -1.386 . . . . 0.0 112.174 -178.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 82' ' ' LEU . 66.8 t -80.98 137.41 49.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -78.35 141.35 18.0 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.839 1.442 . . . . 0.0 110.739 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.02 -29.98 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.72 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.06 -32.84 70.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.393 -0.817 . . . . 0.0 108.981 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.8 t -72.1 -33.63 68.01 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' MET . . . . . 0.595 ' CG ' HD21 ' A' ' 82' ' ' LEU . 10.4 mtp -70.03 -36.26 74.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 179' ' ' MET . 98.9 mt-10 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.781 -0.574 . . . . 0.0 110.036 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 -19.91 65.8 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.417 -0.802 . . . . 0.0 110.792 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.681 HG23 ' CD2' ' A' ' 75' ' ' TYR . 94.4 m -60.79 -53.66 54.68 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 109.894 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 176' ' ' GLU . 17.1 ptm -60.66 -33.76 73.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -70.28 -25.81 63.51 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.537 0.684 . . . . 0.0 109.311 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' LYS . . . 52.92 32.95 13.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.564 -0.71 . . . . 0.0 111.014 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.1 t 55.91 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.202 -0.311 . . . . 0.0 111.236 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 181' ' ' ALA . 35.0 ttmt -152.86 29.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 110.082 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 50.55 43.98 27.29 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.267 -0.896 . . . . 0.0 111.282 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -151.95 137.2 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.608 -0.682 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.311 -179.806 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' 2ZF . . . . . 0.824 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HG2' HD21 ' A' ' 94' ' ' LEU . 57.8 mp0 . . . . . 0 N--CA 1.496 1.827 0 CA-C-O 121.297 0.57 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -123.52 129.98 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -116.63 127.78 54.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.688 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.766 HG22 HD21 ' A' ' 44' ' ' LEU . 98.5 t -84.33 136.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.91 174.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.534 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -138.24 136.19 36.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.093 0.949 . . . . 0.0 109.129 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 59' ' ' ALA . 19.4 p -113.64 179.9 3.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.912 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.64 32.92 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.5 p -104.78 -36.73 7.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.302 -0.873 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.6 -169.14 0.48 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.853 -1.154 . . . . 0.0 111.957 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.1 m -123.71 143.76 50.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.862 -0.524 . . . . 0.0 109.601 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.2 p90 -160.26 -138.12 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.549 -0.719 . . . . 0.0 109.911 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.766 HD21 HG22 ' A' ' 35' ' ' VAL . 82.0 mt -135.4 166.64 22.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.421 -1.425 . . . . 0.0 113.653 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -150.05 122.81 8.66 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.243 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 142' ' ' PRO . 32.7 m -101.14 127.21 47.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.44 -0.787 . . . . 0.0 111.729 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.3 m -74.11 123.11 23.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.825 -0.547 . . . . 0.0 109.827 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.95 130.04 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.455 -0.778 . . . . 0.0 110.096 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.67 40.01 29.45 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.476 -0.765 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.19 28.04 73.49 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 63.5 t -140.04 117.0 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.963 . . . . 0.0 109.29 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 8.4 t -76.28 122.99 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.294 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.49 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 95.5 m95 -113.48 130.02 56.42 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.607 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 11.8 t -133.08 -179.75 5.68 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 140' ' ' GLY . 7.0 m -90.72 131.0 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.076 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.92 -40.04 87.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.49 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 49.8 p-80 -74.82 68.74 1.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.29 1.043 . . . . 0.0 108.829 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.0 -38.43 0.16 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.8 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.792 -0.828 . . . . 0.0 109.182 178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD21 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.441 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.547 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.42 HG22 ' HD1' ' A' ' 85' ' ' TRP . 39.8 mt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 91.3 m -96.24 144.83 26.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.731 -0.606 . . . . 0.0 110.626 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 14.8 pt20 -75.94 151.4 37.3 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.574 -0.704 . . . . 0.0 110.784 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.6 ttt -98.78 -39.84 8.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.547 -0.721 . . . . 0.0 110.398 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.436 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.8 OUTLIER -139.97 166.75 23.82 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.918 HG23 ' CG1' ' A' ' 83' ' ' VAL . 24.0 m -154.68 111.06 3.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.628 -0.67 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.86 78.61 5.38 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -40.0 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.428 -0.795 . . . . 0.0 109.767 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -55.74 -26.22 44.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 0.0 109.003 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -111.66 -0.71 15.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.736 -0.602 . . . . 0.0 110.762 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.7 t70 59.95 57.75 2.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.105 -0.997 . . . . 0.0 109.553 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.713 HD13 HG11 ' A' ' 170' ' ' VAL . 52.8 tp -146.23 152.37 39.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.92 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.918 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -143.11 127.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.25 123.96 5.76 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.262 -1.446 . . . . 0.0 111.753 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.2 m-90 -84.72 -174.94 5.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.144 -0.621 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -110.07 73.71 0.85 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.175 0 O-C-N 121.791 -0.568 . . . . 0.0 111.436 -179.543 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 121.39 0.614 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.986 HD13 HD11 ' A' ' 144' ' ' LEU . 85.1 mt -85.65 167.09 15.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.661 -0.649 . . . . 0.0 110.121 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.444 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 3.8 m -89.49 135.23 31.21 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo . . . . . 0 C--N 1.318 -1.054 0 O-C-N 123.894 1.471 . . . . 0.0 110.067 179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m . . . . . 0 N--CA 1.493 1.7 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -117.46 14.62 14.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 111.375 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.18 75.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 108.786 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 145' ' ' CYS . 79.8 mt -84.28 176.19 8.9 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.479 0.657 . . . . 0.0 111.125 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.9 m-85 -140.96 131.89 26.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.96 148.13 35.68 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.946 0.879 . . . . 0.0 111.529 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 111' ' ' ALA . 83.9 t -119.97 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 112' ' ' ASP . 26.7 p -81.08 179.9 7.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.287 -0.883 . . . . 0.0 109.525 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.552 ' O ' HG21 ' A' ' 35' ' ' VAL . 13.0 ptm180 -41.87 -29.9 0.23 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -116.66 -50.01 2.63 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.12 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -156.86 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.934 -1.104 . . . . 0.0 111.597 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 108' ' ' THR . 16.9 t70 47.08 73.67 0.18 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.088 -1.008 . . . . 0.0 111.203 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -82.56 99.99 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.189 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.8 mm -120.95 150.01 52.21 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.753 -0.592 . . . . 0.0 109.542 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 48.3 Cg_endo -90.44 133.03 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 124.015 1.534 . . . . 0.0 110.559 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 167' ' ' VAL . 61.7 t -127.57 130.03 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -90.34 118.23 29.68 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.496 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.6 ttp180 -62.07 125.8 25.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.805 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -98.43 4.36 48.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.787 -0.571 . . . . 0.0 109.569 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.99 170.67 32.17 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 107.436 -2.266 . . . . 0.0 107.436 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 78.2 m-20 -60.83 -19.69 60.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -1.022 . . . . 0.0 110.122 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -121.56 15.98 11.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 0.0 111.822 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -146.08 143.27 29.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.987 -1.07 . . . . 0.0 111.431 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.51 141.85 11.81 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.4 ' C ' HG13 ' A' ' 116' ' ' VAL . 3.4 m -90.3 111.6 22.85 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.951 -0.735 . . . . 0.0 110.326 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 116' ' ' VAL . 55.5 tp -73.56 109.93 7.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.347 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 3.8 mm? -60.03 -30.0 68.89 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.4 m -114.25 97.75 46.6 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.516 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.91 142.18 74.34 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.909 1.478 . . . . 0.0 109.965 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -149.99 161.06 32.3 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.81 122.84 12.42 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.832 1.438 . . . . 0.0 110.92 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.98 -28.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 t -59.01 -34.9 72.4 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.66 0.743 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 108' ' ' THR . 72.7 t80 -70.04 -27.32 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.47 5.6 30.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.484 -0.76 . . . . 0.0 110.858 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -68.11 110.16 3.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.04 55.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.6 p -74.9 -17.93 60.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -1.04 . . . . 0.0 109.056 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.09 149.51 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 108.885 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 55' ' ' VAL . . . 91.16 -9.51 77.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -77.15 -151.52 4.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.693 ' HG3' HG22 ' A' ' 33' ' ' VAL . 51.7 Cg_endo -147.5 148.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 116.307 -1.996 . . . . 0.0 112.921 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.4 mp -99.89 98.43 9.21 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.986 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -83.43 135.61 34.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.553 ' HA ' HD23 ' A' ' 104' ' ' LEU . 84.4 m -58.82 175.6 0.32 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 40.5 Cg_endo -72.11 -5.04 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 117.215 -1.39 . . . . 0.0 110.977 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.402 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 9.8 t -106.14 -0.22 24.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.905 -1.122 . . . . 0.0 112.27 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.84 6.55 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 34.7 m170 -114.04 118.53 34.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.34 121.86 24.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.394 -0.816 . . . . 0.0 110.685 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.03 -4.12 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.799 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.472 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -152.79 131.08 3.22 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.279 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.504 HD12 ' CE ' ' A' ' 175' ' ' MET . 74.5 mt -109.91 119.14 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.098 -1.236 . . . . 0.0 108.163 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 16.9 t80 -49.99 129.29 20.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.393 -0.817 . . . . 0.0 112.362 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.409 ' HB2' HG23 ' A' ' 170' ' ' VAL . 41.8 ttt180 -117.22 -30.08 5.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.938 -0.476 . . . . 0.0 111.569 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.407 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.08 146.56 12.51 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.585 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.97 138.29 37.24 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 166' ' ' ALA . 42.9 t -95.72 90.97 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 29.1 p -94.03 122.24 36.33 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.115 0.96 . . . . 0.0 112.111 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 161' ' ' ARG . 80.4 m -87.1 -102.07 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.116 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 160' ' ' THR . 12.8 tpt180 -59.98 -50.0 75.47 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.601 -1.312 . . . . 0.0 109.464 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.443 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -176.18 30.53 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.762 HG23 ' HD3' ' A' ' 165' ' ' LYS . 33.0 m -149.84 145.89 17.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -75.92 125.34 28.91 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 0.0 111.24 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.762 ' HD3' HG23 ' A' ' 163' ' ' VAL . 4.2 mmmm -103.88 7.14 36.84 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.298 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.26 137.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.552 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -105.82 134.68 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.428 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -100.41 146.59 26.82 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 40.3 p90 -152.55 162.96 40.5 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.314 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 82' ' ' LEU . 61.0 t -79.82 143.76 58.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.499 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.75 141.54 9.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.747 1.393 . . . . 0.0 111.717 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.499 HG23 ' SD ' ' A' ' 175' ' ' MET . 14.9 p -69.05 -27.67 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.08 -28.69 66.72 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.3 t -70.65 -26.28 63.38 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 153' ' ' ILE . 66.3 mtt -69.32 -36.62 77.14 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.778 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.9 p . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.011 -1.056 . . . . 0.0 109.525 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.483 0.659 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -119.89 123.45 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -94.68 122.84 37.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.719 . . . . 0.0 111.314 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.1 t -82.78 132.83 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.79 175.13 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.756 0.788 . . . . 0.0 110.427 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 58.1 m -140.04 149.82 43.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.4 t -116.8 79.03 1.27 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.376 1.084 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.45 -52.51 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.449 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -120.7 9.28 10.73 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.585 -1.322 . . . . 0.0 113.966 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' SER . 16.6 pt20 -161.73 178.07 9.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.628 -1.295 . . . . 0.0 112.236 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.7 m -129.92 150.2 51.31 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.218 0.532 . . . . 0.0 109.942 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 9.9 p90 -160.32 -148.14 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 0.0 109.414 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' SER . 93.5 mt -136.42 165.34 26.05 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.608 -1.308 . . . . 0.0 113.772 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -152.42 130.71 12.03 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.41 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 142' ' ' PRO . 99.7 m -99.9 120.46 39.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.402 -0.811 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -72.15 124.58 25.31 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.14 127.66 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 50.1 39.97 20.54 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.552 -0.718 . . . . 0.0 111.432 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.35 73.6 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.9 t -137.7 115.04 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -1.111 . . . . 0.0 109.348 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 29.1 t -75.4 119.68 19.83 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.25 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 84.9 m95 -108.53 127.42 53.92 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.869 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 6.9 t -133.99 -178.6 5.1 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.638 HG23 ' HA3' ' A' ' 58' ' ' GLY . 21.2 m -93.24 131.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.238 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.0 -41.89 93.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.52 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 45.9 p-80 -70.0 -14.5 62.73 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.699 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 38' ' ' THR . . . -93.1 -47.94 2.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . . . . . . 0 N--CA 1.494 1.773 0 O-C-N 121.8 -0.823 . . . . 0.0 109.066 178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.748 0 O-C-N 120.739 -1.225 . . . . 0.0 109.424 179.127 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 55.3 mt . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.371 0.605 . . . . 0.0 109.941 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.83 153.1 17.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.681 -0.637 . . . . 0.0 110.381 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 5.4 pt20 -80.09 159.97 25.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.658 -0.652 . . . . 0.0 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.2 ttp -101.91 -32.19 10.34 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.632 -0.667 . . . . 0.0 109.592 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.483 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -149.99 168.98 22.29 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 91.0 m -153.84 118.55 4.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.382 -0.824 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -101.05 74.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 76' ' ' THR . 87.7 t -59.96 -38.65 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.52 -0.738 . . . . 0.0 109.725 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -54.34 -26.79 31.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.512 -0.743 . . . . 0.0 109.03 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.61 0.71 14.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.733 -0.605 . . . . 0.0 111.05 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 60.07 56.84 3.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.577 HD21 ' HG3' ' A' ' 175' ' ' MET . 35.5 tp -145.96 146.57 31.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.06 136.62 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -122.05 123.78 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.531 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.4 m-90 -88.47 -173.72 4.29 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.16 109.97 21.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 108.628 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.857 0 O-C-N 121.566 -0.709 . . . . 0.0 110.753 -179.016 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.1 p . . . . . 0 N--CA 1.493 1.695 0 CA-C-O 121.452 0.644 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.985 HD13 HD21 ' A' ' 144' ' ' LEU . 90.9 mt -97.91 161.73 13.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.828 -0.545 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 94.4 m -103.7 150.01 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.664 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo . . . . . 0 N--CA 1.49 1.295 0 O-C-N 123.97 1.51 . . . . 0.0 109.957 179.534 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.221 0.534 . . . . 0.0 110.043 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 5.9 m -98.55 19.78 13.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -69.95 75.56 0.47 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 118' ' ' ARG . 84.2 mt -89.93 175.34 7.24 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.067 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 47.9 p90 -151.76 139.01 19.31 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 41.6 tp -109.82 162.92 14.01 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.774 0.797 . . . . 0.0 111.633 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 111' ' ' ALA . 75.1 t -110.01 123.99 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.803 -0.561 . . . . 0.0 110.197 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.959 ' CG2' HG22 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -82.9 -179.65 7.5 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -49.18 -24.21 1.62 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.844 -0.535 . . . . 0.0 110.279 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -94.06 -71.33 0.66 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.611 -0.68 . . . . 0.0 110.383 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.91 -50.88 0.09 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 84.0 m-20 -133.91 151.84 51.65 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.988 -1.07 . . . . 0.0 112.827 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 108' ' ' THR . 15.9 t -118.91 43.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 128' ' ' SER . 0.1 OUTLIER 59.97 178.65 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.29 138.99 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.757 1.399 . . . . 0.0 110.871 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.886 HG22 HD12 ' A' ' 126' ' ' LEU . 49.1 t -124.3 132.94 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.094 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.4 tpp85 -90.28 120.04 31.09 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' LEU . 6.7 ttp180 -64.15 123.37 18.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 110.16 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -100.05 4.55 44.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.621 -0.674 . . . . 0.0 109.778 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.98 172.74 38.86 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.0 m-20 -61.97 -22.5 65.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.488 -1.007 . . . . 0.0 110.218 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.2 p -123.21 17.2 9.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -144.13 139.43 28.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.887 -1.133 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -135.16 142.9 14.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 t -92.16 110.01 21.39 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.727 -0.866 . . . . 0.0 110.566 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.886 HD12 HG22 ' A' ' 116' ' ' VAL . 18.1 tp -71.59 105.79 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.06 -31.49 70.04 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.365 0.602 . . . . 0.0 110.089 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 114' ' ' ILE . 73.5 m -115.07 94.59 39.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.5 Cg_endo -65.61 148.06 86.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.885 1.466 . . . . 0.0 109.697 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.01 168.76 11.63 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -59.32 125.75 18.88 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.887 1.467 . . . . 0.0 110.334 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.96 -24.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.762 -0.587 . . . . 0.0 111.387 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 17.4 t -52.91 -32.84 47.53 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.405 -0.809 . . . . 0.0 109.677 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.742 ' CE2' HG21 ' A' ' 108' ' ' THR . 71.1 t80 -71.94 -28.87 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.49 0.09 54.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.736 . . . . 0.0 111.587 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.409 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 58.1 mtpt -70.78 108.35 4.41 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.28 -0.888 . . . . 0.0 108.647 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.16 -9.42 56.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' ' 108' ' ' THR . 19.3 t -76.16 -14.99 60.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.427 -1.043 . . . . 0.0 109.246 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.95 147.34 53.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.839 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 94.06 -10.84 71.53 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -73.23 -158.28 4.7 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.576 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.1 Cg_endo -144.54 144.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 116.818 -1.655 . . . . 0.0 112.467 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.637 ' O ' HG22 ' A' ' 151' ' ' VAL . 2.0 mt -98.32 97.57 8.93 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.985 HD21 HD13 ' A' ' 94' ' ' LEU . 6.0 mp -89.47 144.71 25.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 54.6 m -63.95 -174.03 0.11 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 41.3 Cg_endo -86.01 9.9 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.573 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -107.91 -23.52 12.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.998 . . . . 0.0 110.767 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.8 36.1 1.19 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 73.0 m80 -120.09 127.73 52.81 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -1.061 . . . . 0.0 110.82 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.24 120.82 23.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.506 -0.746 . . . . 0.0 109.434 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 143' ' ' LEU . 36.0 m -122.43 -4.54 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.896 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 169' ' ' PHE . . . -160.06 128.58 2.0 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.281 -1.438 . . . . 0.0 111.33 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 32.5 mt -107.82 117.93 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.211 -1.17 . . . . 0.0 108.286 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.469 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.4 t80 -51.96 128.72 25.09 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.539 0.685 . . . . 0.0 112.402 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 70.9 ttt180 -117.75 -29.22 5.77 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.833 -0.542 . . . . 0.0 111.498 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.27 145.63 13.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.207 -0.933 . . . . 0.0 111.412 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -99.59 139.39 35.31 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -88.24 93.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 72.2 m -91.55 122.26 33.97 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.273 1.035 . . . . 0.0 112.81 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.6 m -120.06 130.06 54.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.771 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 56.16 23.46 7.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.477 -0.764 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.43 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 90.19 20.02 43.89 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.38 -0.825 . . . . 0.0 111.787 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -145.98 142.85 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.06 -1.259 . . . . 0.0 109.352 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.35 129.06 34.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 111.129 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -119.77 11.3 11.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.0 110.302 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -174.33 141.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.701 HG21 HG11 ' A' ' 116' ' ' VAL . 19.0 m -113.65 135.17 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.711 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -101.6 145.14 29.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.3 p90 -154.4 163.81 39.59 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.033 -1.467 . . . . 0.0 112.892 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 82' ' ' LEU . 65.3 t -86.48 130.0 51.0 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.99 147.48 21.17 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 O-C-N 123.688 1.362 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 11.1 p -70.0 -30.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.733 -0.604 . . . . 0.0 109.528 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.88 -32.91 71.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -75.01 -32.67 61.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.559 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.577 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -65.03 -35.61 81.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.895 -0.503 . . . . 0.0 109.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -45.73 91.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.742 -0.599 . . . . 0.0 109.389 177.721 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 . . . . . 0 N--CA 1.498 1.973 0 CA-C-O 121.316 0.579 . . . . 0.0 110.262 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -129.95 130.05 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.644 -0.66 . . . . 0.0 109.329 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -98.99 122.83 42.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 ' C ' HG13 ' A' ' 36' ' ' VAL . 60.9 t -84.86 128.48 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 64' ' ' LEU . 26.9 m -148.02 176.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.176 -0.953 . . . . 0.0 110.593 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.1 t -149.24 144.25 26.41 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.788 0.804 . . . . 0.0 108.895 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' HE1' ' A' ' 43' ' ' PHE . 5.7 t -118.83 -178.38 3.54 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.54 -17.52 1.29 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.807 -0.558 . . . . 0.0 112.227 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.563 ' H ' HG23 ' A' ' 38' ' ' THR . 73.8 p -96.57 -40.76 8.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.058 . . . . 0.0 112.287 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 -170.56 0.64 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.885 -1.134 . . . . 0.0 112.641 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.8 m -109.99 143.26 40.22 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HE1' HG22 ' A' ' 38' ' ' THR . 12.9 p90 -161.79 -146.38 0.12 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.152 -0.967 . . . . 0.0 110.749 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 88.7 mt -134.26 166.59 22.45 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.707 1.241 . . . . 0.0 113.925 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.94 118.56 5.71 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.712 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.9 m -91.59 123.11 34.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 0.0 111.219 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 47.3 t -74.87 110.0 8.81 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.99 130.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.538 -0.726 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.29 40.03 25.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.561 -0.712 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.33 27.39 71.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.6 t -139.99 117.64 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -77.23 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.54 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.54 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.4 m95 -107.14 124.39 49.62 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.139 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.615 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 9.8 t -128.61 -175.33 3.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.603 HG23 ' HA3' ' A' ' 58' ' ' GLY . 27.7 m -93.15 130.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.504 -1.278 . . . . 0.0 112.703 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.94 -44.17 94.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -66.81 -18.13 65.22 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.774 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.603 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -93.54 -36.12 5.98 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.663 -0.904 . . . . 0.0 110.503 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 36' ' ' VAL . 4.5 mm? . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.489 179.394 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.7 m -111.94 139.1 47.72 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.466 -0.771 . . . . 0.0 112.391 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 6.9 pt20 -83.99 165.06 18.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.654 . . . . 0.0 111.837 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.8 mtp -100.03 -45.45 5.67 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.564 -0.71 . . . . 0.0 109.969 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -158.84 -177.96 6.9 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.54 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.1 t -159.98 142.69 13.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.719 0.771 . . . . 0.0 110.27 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -104.96 83.09 1.94 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.96 -40.05 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -55.15 -26.16 36.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -111.74 0.35 16.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.82 -0.55 . . . . 0.0 110.836 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.0 59.55 2.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 175' ' ' MET . 44.5 tp -145.72 152.1 39.05 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.454 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' THR . 1.5 m -140.0 132.07 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -121.63 126.9 6.67 Favored Glycine 0 N--CA 1.508 3.459 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.852 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.615 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -90.52 -169.59 2.45 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.046 -0.679 . . . . 0.0 111.243 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -113.04 95.46 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.683 -0.636 . . . . 0.0 110.42 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.497 1.913 0 O-C-N 121.419 -0.801 . . . . 0.0 109.878 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.591 0.71 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 144' ' ' LEU . 83.2 mt -109.78 148.63 31.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -105.53 -173.91 0.3 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.189 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo . . . . . 0 N--CA 1.485 0.992 0 O-C-N 123.847 1.446 . . . . 0.0 110.276 179.572 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 m -96.49 17.12 16.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 111.217 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.56 69.22 1.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 145' ' ' CYS . 92.7 mt -75.07 174.6 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.755 -0.591 . . . . 0.0 110.903 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.1 m-85 -140.52 130.01 24.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.676 -0.64 . . . . 0.0 109.519 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.2 tp -110.56 152.03 26.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.727 0.775 . . . . 0.0 111.286 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.516 HG13 ' HA ' ' A' ' 111' ' ' ALA . 81.1 t -108.97 132.26 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 75.8 p -80.83 169.36 17.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -34.39 -32.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 108' ' ' THR . 81.7 m-70 -97.73 -85.34 0.36 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -161.79 16.01 0.1 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.177 -0.952 . . . . 0.0 112.327 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 47.8 t0 -68.43 130.03 41.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.835 -1.166 . . . . 0.0 110.036 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -97.37 117.43 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.698 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 128' ' ' SER . 3.8 tt -116.29 119.82 35.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.572 -0.705 . . . . 0.0 109.654 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 127' ' ' LEU . 49.0 Cg_endo -70.2 131.32 20.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.616 1.324 . . . . 0.0 111.701 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 167' ' ' VAL . 61.4 t -130.0 132.29 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.771 -0.581 . . . . 0.0 109.456 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -88.19 112.06 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -54.44 122.56 10.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 111.13 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -98.51 0.45 45.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.636 -0.665 . . . . 0.0 110.047 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.79 -174.4 46.85 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 91.0 m-20 -70.07 -22.7 63.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -1.043 . . . . 0.0 110.053 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.3 p -124.9 17.38 8.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.569 -0.707 . . . . 0.0 111.465 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.99 145.2 37.52 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.281 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.29 142.14 11.81 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.0 t -88.82 111.56 22.19 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.873 -0.781 . . . . 0.0 109.785 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 114' ' ' ILE . 44.6 tp -70.38 112.37 6.63 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.08 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 115' ' ' PRO . 87.3 mt -69.95 -19.98 63.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.825 -0.547 . . . . 0.0 110.587 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 114' ' ' ILE . 36.7 m -120.0 79.96 25.93 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.672 -0.643 . . . . 0.0 109.945 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.2 Cg_endo -57.78 142.47 96.12 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.849 1.447 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -155.33 167.15 14.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -58.9 128.02 26.46 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.746 1.393 . . . . 0.0 109.76 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.25 -25.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.683 -0.635 . . . . 0.0 111.085 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 91.0 p -58.44 -30.37 66.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.598 -0.689 . . . . 0.0 109.564 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -70.04 -29.31 66.31 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.42 3.98 25.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.416 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 4.5 mtpm? -66.89 111.63 3.88 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.5 55.84 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -77.81 -13.64 59.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.529 -0.983 . . . . 0.0 109.924 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.531 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -67.59 147.35 52.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.078 -1.014 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.553 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.96 -9.99 75.44 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -66.87 -163.64 1.72 Allowed Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.0 Cg_endo -143.26 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 117.033 -1.512 . . . . 0.0 111.852 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.6 mp -91.77 96.96 10.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -83.6 143.83 29.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.201 1.0 . . . . 0.0 113.132 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.498 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.8 m -69.4 163.75 55.62 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.39 -11.2 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.577 1.304 . . . . 0.0 111.504 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.7 m -95.71 -0.06 51.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.925 -1.11 . . . . 0.0 111.808 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.93 33.5 6.62 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -118.73 128.49 54.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -1.147 . . . . 0.0 109.968 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.66 29.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.78 1.28 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.648 . . . . 0.0 111.904 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -147.96 128.3 2.84 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.856 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 68.8 mt -109.97 120.83 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.018 -1.284 . . . . 0.0 108.181 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.462 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.7 t80 -50.02 129.36 20.54 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.866 0.841 . . . . 0.0 112.711 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.492 ' HB2' HG23 ' A' ' 170' ' ' VAL . 40.1 ttt180 -117.31 -28.51 6.12 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 149.2 8.34 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.707 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -102.69 135.86 43.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.838 -0.538 . . . . 0.0 111.209 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.0 t -85.12 86.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 27.5 p -88.09 104.05 16.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.743 1.258 . . . . 0.0 112.191 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.607 ' O ' HG22 ' A' ' 163' ' ' VAL . 8.2 m -99.72 133.91 43.37 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.162 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 54.8 22.88 4.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.431 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 91.21 17.74 49.23 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.356 -0.84 . . . . 0.0 111.836 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 160' ' ' THR . 34.2 m -146.02 140.74 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.255 . . . . 0.0 109.687 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 118.85 19.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.587 -0.696 . . . . 0.0 111.763 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -111.01 10.55 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.825 -0.547 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.04 140.01 0.51 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.637 HG21 HG11 ' A' ' 116' ' ' VAL . 17.8 m -112.82 135.88 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.256 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -103.94 147.36 27.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.465 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.1 p90 -154.32 164.25 38.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.263 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 82' ' ' LEU . 61.4 t -82.25 138.46 45.36 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -77.65 149.3 26.67 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.741 1.39 . . . . 0.0 110.786 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.4 -29.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.316 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -29.29 68.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.242 -0.911 . . . . 0.0 108.846 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.5 t -70.21 -32.65 70.64 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.653 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.711 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -66.52 -39.92 88.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.596 -0.69 . . . . 0.0 109.643 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.18 -43.27 96.0 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.631 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 47.7 p . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.672 -0.642 . . . . 0.0 110.57 179.583 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 33' ' ' VAL . 11.1 pt-20 . . . . . 0 N--CA 1.5 2.043 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 107' ' ' VAL . 62.1 t -109.96 119.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.547 -0.721 . . . . 0.0 109.343 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -102.26 125.3 48.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.639 -0.663 . . . . 0.0 110.79 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 36' ' ' VAL . 59.0 t -83.68 128.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 35' ' ' VAL . 32.5 m -146.73 174.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.631 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.3 p -146.92 133.63 19.98 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.703 0.763 . . . . 0.0 109.217 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 59' ' ' ALA . 41.5 p -107.48 -179.93 4.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.2 5.89 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.591 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 p -99.34 -37.23 9.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 112.607 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.4 ' NE2' ' HA3' ' A' ' 58' ' ' GLY . 14.9 pt20 -171.47 -170.0 0.77 Allowed 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.62 -1.3 . . . . 0.0 113.13 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 28.6 p -116.25 141.14 48.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 14.9 p90 -163.67 -146.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.236 -0.915 . . . . 0.0 110.638 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.851 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -131.92 160.43 35.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.777 -1.202 . . . . 0.0 113.121 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.28 128.44 9.74 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.817 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.87 ' CG2' HD11 ' A' ' 153' ' ' ILE . 7.6 t -80.01 -151.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG23 ' A' ' 46' ' ' THR . 4.8 t -160.12 106.35 1.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.425 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.2 40.01 30.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.797 -0.564 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 45.5 t -133.93 113.06 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.973 . . . . 0.0 109.745 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 t -76.07 121.87 23.43 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.546 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.4 m95 -108.47 127.56 54.02 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.474 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.685 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 5.4 t -135.58 -179.14 5.46 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.598 HG13 ' CA ' ' A' ' 140' ' ' GLY . 14.5 m -89.69 126.81 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 C-N-CA 118.18 -1.408 . . . . 0.0 112.213 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -59.95 -42.49 94.17 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.61 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.423 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.0 p-80 -71.31 73.74 0.7 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.589 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.4 ' HA3' ' NE2' ' A' ' 41' ' ' GLN . . . 156.83 -32.72 0.56 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.575 -0.956 . . . . 0.0 110.927 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 120.874 -1.141 . . . . 0.0 109.013 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.718 HG22 ' HD1' ' A' ' 85' ' ' TRP . 34.9 mt . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.6 m -91.23 140.97 29.3 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.421 0.629 . . . . 0.0 110.826 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.25 147.02 49.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.783 -0.573 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.84 -29.87 12.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.434 ' CG ' ' N ' ' A' ' 76' ' ' THR . 0.4 OUTLIER -149.96 169.97 19.93 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 27.3 m -154.28 112.41 3.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 110.69 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 20.4 t-20 -91.12 77.85 5.95 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.02 -40.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -56.07 -25.6 45.91 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.94 -1.41 15.47 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.734 -0.604 . . . . 0.0 110.833 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.8 t0 60.78 57.36 2.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.965 -1.085 . . . . 0.0 109.152 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 170' ' ' VAL . 17.0 tp -145.36 154.52 42.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.657 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -145.67 128.22 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.407 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -114.9 119.76 4.76 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.037 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.718 ' HD1' HG22 ' A' ' 71' ' ' ILE . 5.4 m-90 -86.45 174.61 8.86 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -95.93 91.75 6.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.009 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.587 -0.696 . . . . 0.0 111.153 -179.071 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.9 m . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.366 0.603 . . . . 0.0 110.259 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 144' ' ' LEU . 73.3 mt -84.25 159.96 20.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.6 163.34 18.09 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.379 -0.826 . . . . 0.0 111.024 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.491 1.33 0 O-C-N 124.071 1.564 . . . . 0.0 109.848 179.765 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.9 m . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.757 0.789 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.17 15.48 6.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.778 -0.576 . . . . 0.0 111.399 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -84.56 79.6 9.53 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 118' ' ' ARG . 92.2 mt -88.04 174.6 8.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.037 0.923 . . . . 0.0 112.368 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 97.4 m-85 -145.32 129.97 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 143' ' ' LEU . 25.0 tp -107.7 144.43 34.81 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.629 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 33' ' ' VAL . 76.0 t -90.57 120.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.7 p -91.54 178.05 6.05 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.798 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -47.13 -25.98 1.0 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.896 -0.502 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -97.28 -70.13 0.73 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.638 -0.664 . . . . 0.0 109.311 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.06 -164.99 1.99 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.95 0.881 . . . . 0.0 110.06 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 8.9 t0 -52.92 -93.96 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.598 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 114' ' ' ILE . 32.9 t 57.02 156.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.139 -0.976 . . . . 0.0 110.977 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 126' ' ' LEU . 34.3 mt 53.7 105.33 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.274 -0.892 . . . . 0.0 111.849 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 50.2 Cg_endo -90.42 150.1 4.4 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.803 1.422 . . . . 0.0 109.319 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 126' ' ' LEU . 21.9 t -131.26 139.87 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.322 -0.862 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -98.49 117.06 32.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 22.5 ttp85 -62.82 129.16 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.328 -0.857 . . . . 0.0 110.996 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -102.92 4.81 37.96 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.445 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.33 178.76 40.82 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.56 -26.57 68.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.451 -1.029 . . . . 0.0 109.87 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.6 p -120.07 16.86 12.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.662 -0.649 . . . . 0.0 111.868 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -140.04 139.05 35.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.011 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.59 138.7 9.15 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 116' ' ' VAL . 23.2 t -89.28 110.72 21.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.909 -0.759 . . . . 0.0 110.181 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 116' ' ' VAL . 21.0 tp -70.86 110.67 5.75 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.819 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.97 -21.72 63.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.831 -0.543 . . . . 0.0 110.515 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.693 ' HB2' HG23 ' A' ' 114' ' ' ILE . 70.7 m -120.43 82.95 32.87 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.617 . . . . 0.0 110.197 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.1 Cg_endo -59.42 139.81 91.31 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 O-C-N 123.803 1.423 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -152.27 164.26 20.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -54.06 125.97 20.51 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 O-C-N 123.786 1.414 . . . . 0.0 110.93 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 p -50.08 -25.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.86 -0.525 . . . . 0.0 110.91 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.0 m -58.81 -35.36 72.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.605 -0.684 . . . . 0.0 109.496 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -68.4 -28.13 66.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.2 0.95 38.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.351 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -70.63 119.49 14.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.256 -0.903 . . . . 0.0 108.597 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.53 -10.09 66.83 Favored Glycine 0 C--N 1.286 -2.207 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.851 ' HA ' HD12 ' A' ' 44' ' ' LEU . 27.4 t -78.65 -13.5 59.79 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.56 -0.965 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.513 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.5 m -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.007 -1.058 . . . . 0.0 110.695 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.598 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.94 -9.71 76.35 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -61.66 -179.23 3.25 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.6 ' CG ' HG22 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -128.04 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 117.206 -1.396 . . . . 0.0 111.761 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.5 mt -94.52 97.19 9.97 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 94' ' ' LEU . 7.3 mp -89.62 141.31 28.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.425 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -59.35 -167.33 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.97 16.46 1.45 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.749 1.394 . . . . 0.0 110.905 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -122.03 -51.08 2.02 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -0.95 . . . . 0.0 110.916 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.62 42.42 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -127.13 126.62 43.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -1.068 . . . . 0.0 110.507 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -88.0 103.0 15.29 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' HB ' ' A' ' 172' ' ' VAL . 35.5 m -109.92 8.18 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.386 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.444 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -159.19 134.08 3.62 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.873 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.87 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.6 mt -118.27 120.81 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.288 -1.124 . . . . 0.0 108.309 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 19.3 t80 -54.33 128.03 29.74 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.398 0.618 . . . . 0.0 112.5 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 170' ' ' VAL . 7.2 ptm180 -119.28 -24.17 6.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 111.311 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.52 148.39 12.67 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.59 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -104.88 143.81 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.291 0.567 . . . . 0.0 111.38 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 47.2 t -94.74 88.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.0 p -89.88 111.08 22.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.505 1.145 . . . . 0.0 112.454 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLY . 93.6 m -92.59 125.95 37.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 160' ' ' THR . 73.9 ttt180 62.14 -70.6 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 122.014 -0.429 . . . . 0.0 110.056 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.05 24.98 0.25 Allowed Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.178 -1.011 . . . . 0.0 110.588 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.65 144.85 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.086 -1.244 . . . . 0.0 109.472 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.07 123.55 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.434 0.635 . . . . 0.0 111.123 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -112.47 11.41 19.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.784 -0.573 . . . . 0.0 110.581 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 158' ' ' VAL . . . -173.77 144.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 116' ' ' VAL . 15.9 m -117.87 137.3 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.889 0.852 . . . . 0.0 112.674 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -104.02 146.01 29.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 33.9 p90 -154.61 160.62 41.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.17 -1.412 . . . . 0.0 112.205 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 82' ' ' LEU . 59.9 t -81.2 129.98 64.63 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.6 155.87 49.65 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.749 1.394 . . . . 0.0 110.784 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 151' ' ' VAL . 7.5 p -71.41 -24.39 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.616 -0.677 . . . . 0.0 109.49 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.87 -30.23 67.58 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -71.9 -39.97 69.19 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.496 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.9 mpp? -64.72 -39.69 94.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -32.21 70.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.812 -0.555 . . . . 0.0 110.334 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.972 0 O-C-N 121.442 -0.787 . . . . 0.0 109.94 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.5 2.064 0 CA-C-O 121.253 0.549 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.569 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.0 t -110.06 120.44 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -93.02 130.16 38.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.752 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 44' ' ' LEU . 75.5 t -77.77 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 64' ' ' LEU . 34.7 m -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.961 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.4 p -157.89 143.93 17.38 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.829 HG21 ' O ' ' A' ' 58' ' ' GLY . 4.5 t -109.37 -177.7 3.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.71 -14.44 0.91 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.577 -0.702 . . . . 0.0 112.869 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.764 HG22 HG23 ' A' ' 38' ' ' THR . 9.5 t -112.0 -21.27 11.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HG2' HG23 ' A' ' 40' ' ' THR . 4.8 pt20 -169.65 -171.88 1.31 Allowed 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.368 -1.457 . . . . 0.0 113.174 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -125.59 146.65 49.6 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.7 p90 -162.79 -142.58 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.3 mt -135.63 162.03 33.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.525 -1.359 . . . . 0.0 113.229 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.46 130.0 12.22 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.286 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 142' ' ' PRO . 57.2 m -99.92 125.35 45.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.702 . . . . 0.0 111.218 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.4 t -73.0 119.46 17.28 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.18 135.44 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.469 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 52.69 39.7 28.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.69 -0.632 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.67 23.37 73.89 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.604 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.5 t -140.62 120.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -1.078 . . . . 0.0 110.335 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.9 m -73.99 120.61 19.81 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.604 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.7 m95 -107.17 125.97 51.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.752 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -132.93 -176.41 4.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.729 HG11 ' HB2' ' A' ' 139' ' ' SER . 32.3 m -87.03 127.17 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 C-N-CA 118.346 -1.342 . . . . 0.0 112.83 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.61 -40.03 93.38 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.6 p-80 -72.54 68.85 0.83 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.286 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.829 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.14 -59.45 0.28 Allowed Glycine 0 N--CA 1.484 1.856 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . . . . . . 0 N--CA 1.501 2.087 0 O-C-N 121.694 -0.886 . . . . 0.0 111.2 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 64' ' ' LEU 0.266 2.0 tm? . . . . . 0 N--CA 1.484 1.227 0 CA-C-O 121.326 0.584 . . . . 0.0 110.462 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.502 2.156 0 O-C-N 121.344 -0.847 . . . . 0.0 109.987 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.776 HG22 ' HD1' ' A' ' 85' ' ' TRP . 63.4 mt . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.527 0.679 . . . . 0.0 109.676 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.9 m -96.24 140.01 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.01 149.84 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.708 . . . . 0.0 110.627 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.3 mmm -103.55 -27.27 12.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.731 -0.606 . . . . 0.0 109.889 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.445 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -154.95 171.15 20.17 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.516 -0.74 . . . . 0.0 109.314 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.847 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.9 m -154.12 115.86 4.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.632 -0.667 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.76 76.36 3.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.99 -33.06 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.686 -0.634 . . . . 0.0 109.298 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.6 -26.6 13.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.07 8.36 6.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.13 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 62.42 61.77 1.22 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.765 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.855 HD22 HG11 ' A' ' 170' ' ' VAL . 36.5 tp -144.19 152.56 41.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.847 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.32 133.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.65 121.67 5.17 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.232 -1.461 . . . . 0.0 111.767 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.776 ' HD1' HG22 ' A' ' 71' ' ' ILE . 6.2 m-90 -89.19 -169.68 2.6 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.795 -0.826 . . . . 0.0 109.359 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -94.05 107.68 19.58 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.026 0 O-C-N 121.563 -0.711 . . . . 0.0 112.522 -177.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.5 mm? -85.26 173.46 10.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.844 -0.535 . . . . 0.0 110.349 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.804 HG22 ' CD ' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -95.19 -168.4 0.17 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.596 -0.69 . . . . 0.0 110.915 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.804 ' CD ' HG22 ' A' ' 95' ' ' THR . 49.6 Cg_endo . . . . . 0 N--CA 1.482 0.837 0 O-C-N 123.986 1.519 . . . . 0.0 109.318 177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.6 m . . . . . 0 N--CA 1.499 2.006 0 CA-C-O 121.313 0.578 . . . . 0.0 110.137 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 58.08 21.44 7.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.778 -0.576 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.0 71.07 10.12 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.484 HD23 ' CA ' ' A' ' 145' ' ' CYS . 73.0 mt -79.75 174.38 11.64 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 111.779 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 94.0 m-85 -140.47 126.44 19.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.673 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.4 tp -109.3 128.59 55.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.342 -0.849 . . . . 0.0 111.427 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 111' ' ' ALA . 76.1 t -75.59 134.74 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 112' ' ' ASP . 45.6 p -84.42 175.94 9.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.536 -0.728 . . . . 0.0 110.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -32.92 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' THR . 4.1 p80 -112.88 -65.24 1.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.31 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -158.6 -33.99 0.07 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.956 -1.09 . . . . 0.0 113.198 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 48.4 m-20 -44.01 116.54 1.01 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.331 -0.856 . . . . 0.0 112.038 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' LEU . 34.0 m -84.29 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.264 0.554 . . . . 0.0 110.665 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 126' ' ' LEU . 48.3 mm -113.9 110.85 48.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.668 . . . . 0.0 109.454 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 46.0 Cg_endo -64.28 120.01 7.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 O-C-N 123.875 1.46 . . . . 0.0 110.688 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.674 HG22 HD12 ' A' ' 126' ' ' LEU . 48.6 t -127.51 133.93 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 109.219 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -87.44 118.84 27.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.216 -0.928 . . . . 0.0 108.763 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.1 ttm180 -62.31 122.17 15.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -97.46 0.16 47.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.0 176.62 44.36 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 77.7 m-20 -62.3 -24.06 67.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -1.028 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 p -123.65 17.34 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 111.962 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -141.67 141.8 33.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 111.136 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.78 142.66 13.23 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.496 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.0 t -88.64 110.69 21.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.803 -0.822 . . . . 0.0 109.563 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.803 HD11 HG21 ' A' ' 114' ' ' ILE . 23.8 tp -69.46 109.99 4.51 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.569 -0.853 . . . . 0.0 108.804 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.51 -25.88 64.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.854 -0.528 . . . . 0.0 110.282 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.1 t -107.04 102.42 42.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.19 130.69 11.29 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 124.077 1.567 . . . . 0.0 109.573 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -152.46 163.13 24.55 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -55.39 128.39 30.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.744 1.391 . . . . 0.0 110.508 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -51.25 -24.91 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.854 -0.529 . . . . 0.0 111.135 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 79.9 p -57.51 -31.33 65.92 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -70.02 -28.81 65.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.48 2.4 37.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.482 -0.761 . . . . 0.0 111.024 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.3 mtpt -66.86 107.81 2.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.37 -8.79 58.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -72.97 -16.61 61.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -1.069 . . . . 0.0 108.427 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.729 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -70.46 151.29 45.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.672 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.45 -10.05 74.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.53 -159.68 4.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.4 Cg_endo -138.73 138.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 O-C-N 123.821 1.432 . . . . 0.0 111.977 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.673 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.0 mt -95.43 95.38 8.4 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 144' ' ' LEU . 6.9 mp -87.21 133.6 33.64 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.629 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.1 p -82.51 -172.46 0.36 Allowed Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.9 Cg_endo -84.24 20.53 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.106 1.056 . . . . 0.0 112.453 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.1 m -100.88 -18.03 16.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.015 -1.053 . . . . 0.0 111.102 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.98 39.94 3.21 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -149.93 165.57 32.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 110.871 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.51 120.2 32.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.669 -0.645 . . . . 0.0 109.425 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 149' ' ' HIS . 2.6 t -99.97 -20.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.662 -0.649 . . . . 0.0 110.888 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . -159.4 140.94 7.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 ' HE1' ' A' ' 175' ' ' MET . 49.5 mt -107.17 118.93 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.146 -1.208 . . . . 0.0 107.792 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.456 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 20.8 t80 -52.69 127.34 22.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.579 0.704 . . . . 0.0 111.957 -178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -116.02 -28.69 6.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.849 -0.532 . . . . 0.0 111.962 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.37 140.9 11.73 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.201 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.456 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.64 134.37 41.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.726 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 38.9 t -89.96 92.44 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.1 p -89.99 109.91 20.92 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.52 1.152 . . . . 0.0 112.364 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.516 ' O ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -97.14 121.76 39.4 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.779 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 59.97 19.93 8.99 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.381 -0.824 . . . . 0.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 102.02 13.61 31.06 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.395 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -144.91 140.03 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 118.684 1.242 . . . . 0.0 109.445 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 129.94 37.48 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.833 0.825 . . . . 0.0 111.603 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.63 14.43 7.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.731 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.21 150.84 2.49 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 116' ' ' VAL . 9.6 m -133.64 135.84 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 119.376 -0.929 . . . . 0.0 112.695 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -102.14 149.08 24.64 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 36.1 p90 -154.74 164.68 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.076 -1.45 . . . . 0.0 112.583 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.855 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -84.61 137.25 38.82 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.59 145.64 14.74 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.582 1.306 . . . . 0.0 111.99 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.58 HG23 ' SD ' ' A' ' 175' ' ' MET . 10.7 p -69.97 -27.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 109.607 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.84 -29.97 65.38 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 m -73.1 -22.9 60.47 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.151 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 172' ' ' VAL . 66.3 mtt -68.72 -40.11 80.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.206 -0.934 . . . . 0.0 108.931 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.07 -39.21 85.25 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.89 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 0.0 110.688 -178.829 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 . . . . . 0 N--CA 1.495 1.776 0 CA-C-O 121.129 0.49 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.7 t -111.03 119.96 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.54 132.67 40.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.71 -0.619 . . . . 0.0 110.444 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -80.8 138.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.667 HG23 ' CE2' ' A' ' 43' ' ' PHE . 16.5 m -139.99 171.72 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.621 0.724 . . . . 0.0 110.138 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -153.29 153.42 32.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 2.9 t -117.82 75.86 1.03 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.546 1.165 . . . . 0.0 109.358 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.13 -48.69 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -120.7 11.08 11.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.446 -1.408 . . . . 0.0 114.007 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG2' HG23 ' A' ' 38' ' ' THR . 14.7 pt20 -160.01 169.96 22.33 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.593 -1.317 . . . . 0.0 111.746 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.5 m -128.8 152.25 48.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.49 0.662 . . . . 0.0 110.131 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.667 ' CE2' HG23 ' A' ' 36' ' ' VAL . 8.3 p90 -160.5 -145.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.435 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 78.2 mt -135.27 165.54 25.21 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.36 -1.462 . . . . 0.0 113.843 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.99 126.84 9.63 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.25 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.4 m -104.94 127.46 52.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.352 -0.843 . . . . 0.0 111.44 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 44.7 t -74.55 121.36 21.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.792 -0.567 . . . . 0.0 109.517 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 172' ' ' VAL . 48.8 t -131.47 130.18 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.912 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.77 39.98 30.95 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.479 -0.763 . . . . 0.0 110.728 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 25.5 75.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.14 122.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -1.011 . . . . 0.0 109.271 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 6.4 t -74.17 139.22 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.409 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.465 ' CE3' HD21 ' A' ' 82' ' ' LEU . 78.2 m95 -136.1 130.02 32.73 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.924 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 8.8 t -139.13 -174.74 3.94 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.635 HG23 ' HA3' ' A' ' 58' ' ' GLY . 13.4 m -87.99 131.83 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.31 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 33.7 t80 -60.03 -41.97 93.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.466 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.4 p-80 -69.96 -13.96 62.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.735 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.635 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -97.04 -41.32 3.54 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 83' ' ' VAL . . . . . . . . 0 N--CA 1.497 1.885 0 O-C-N 121.606 -0.938 . . . . 0.0 110.358 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.513 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 120.791 -1.193 . . . . 0.0 109.8 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 64.8 mt . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 122.175 0.988 . . . . 0.0 112.001 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 m -130.76 123.59 29.53 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.97 -60.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.433 ' C ' ' CG ' ' A' ' 75' ' ' TYR . 10.8 mmt -92.91 -65.84 0.97 Allowed 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.538 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.433 ' CG ' ' C ' ' A' ' 74' ' ' MET . 0.1 OUTLIER 174.88 -171.82 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.941 -1.099 . . . . 0.0 112.012 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.895 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.8 m -138.43 117.3 12.38 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -94.37 81.96 4.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 90.2 t -61.06 -40.07 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 109.425 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.02 -26.75 27.99 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 109.075 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -111.82 -2.2 15.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.734 -0.604 . . . . 0.0 110.706 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.94 55.09 3.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 170' ' ' VAL . 42.5 tp -146.95 156.43 43.05 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.903 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.895 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER -144.33 138.71 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.448 ' C ' ' CE3' ' A' ' 85' ' ' TRP . . . -136.66 162.28 25.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 118.632 -1.746 . . . . 0.0 113.079 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.76 ' CZ3' HG22 ' A' ' 54' ' ' THR . 2.6 m-90 -148.25 170.12 18.59 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 114.297 -0.951 . . . . 0.0 108.927 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.48 115.38 23.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.984 0 O-C-N 121.612 -0.68 . . . . 0.0 110.746 -179.2 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.732 ' C ' HD22 ' A' ' 94' ' ' LEU . 40.1 p . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.187 0.518 . . . . 0.0 110.385 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 93' ' ' SER . 3.2 mm? -120.86 163.83 17.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.57 -0.706 . . . . 0.0 109.673 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 26.3 m -102.01 145.1 29.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.079 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 172' ' ' VAL . 52.5 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 O-C-N 123.751 1.395 . . . . 0.0 110.694 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.045 0.45 . . . . 0.0 110.019 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -103.61 19.02 20.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.713 . . . . 0.0 110.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -72.97 67.57 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -0.788 . . . . 0.0 108.943 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 145' ' ' CYS . 88.3 mt -81.71 174.73 11.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.873 -0.517 . . . . 0.0 109.914 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 43.5 p90 -154.06 138.84 17.07 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 142' ' ' PRO . 34.9 tp -113.29 153.85 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.98 0.895 . . . . 0.0 111.603 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 111' ' ' ALA . 98.3 t -110.29 136.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 112' ' ' ASP . 31.6 p -81.76 -178.94 7.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -36.33 -32.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.78 -51.14 2.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.339 -0.85 . . . . 0.0 111.291 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.28 -95.4 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.967 -1.083 . . . . 0.0 111.719 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 108' ' ' THR . 17.2 t0 44.07 70.23 0.34 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.095 -1.003 . . . . 0.0 111.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.7 p -71.78 64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.435 -0.791 . . . . 0.0 109.926 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 126' ' ' LEU . 12.3 pt -70.04 150.03 96.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.522 -0.736 . . . . 0.0 110.073 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -102.05 130.16 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.715 1.376 . . . . 0.0 110.032 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 167' ' ' VAL . 49.1 t -127.45 131.94 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -88.11 117.32 26.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.6 ttm180 -61.8 123.87 19.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.552 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -97.29 1.07 49.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.781 -0.574 . . . . 0.0 109.81 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.86 179.72 43.01 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.6 m-20 -64.84 -23.42 67.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.326 -1.102 . . . . 0.0 110.362 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.0 p -123.2 16.83 9.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.513 -0.742 . . . . 0.0 111.752 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -140.0 142.8 36.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -142.06 140.7 10.25 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.434 ' C ' HG13 ' A' ' 116' ' ' VAL . 5.7 m -89.94 110.02 21.01 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.8 -0.824 . . . . 0.0 110.151 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.749 ' CD1' HD12 ' A' ' 114' ' ' ILE . 31.9 tp -72.98 108.55 5.95 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.18 -28.03 68.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.322 0.582 . . . . 0.0 109.801 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -109.99 103.75 54.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.85 -0.531 . . . . 0.0 110.171 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.37 140.54 36.99 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.877 1.461 . . . . 0.0 109.955 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -147.09 159.26 43.18 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.18 124.41 14.77 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.898 1.473 . . . . 0.0 110.361 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.13 -26.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.328 0.585 . . . . 0.0 110.685 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -38.3 82.28 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 108' ' ' THR . 48.7 t80 -69.32 -27.53 65.45 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.69 2.76 36.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.783 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -68.65 109.6 3.87 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.77 -8.87 58.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.8 t -76.1 -15.69 60.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -1.005 . . . . 0.0 109.079 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.22 154.64 41.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.235 -0.916 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.99 -8.48 79.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.92 -159.04 6.89 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.637 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.96 148.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 116.588 -1.808 . . . . 0.0 112.582 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 1.8 mt -99.49 98.27 9.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 4.6 mm? -82.14 137.07 35.06 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.133 0.968 . . . . 0.0 113.182 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.565 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -66.62 -161.48 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -92.16 17.27 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.714 1.376 . . . . 0.0 110.978 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.44 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -138.74 25.82 2.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.122 -0.986 . . . . 0.0 111.962 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.11 37.96 59.66 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 41.6 m170 -118.91 118.91 32.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.559 -0.965 . . . . 0.0 110.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.49 125.12 29.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 0.0 109.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.03 -6.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.92 130.31 2.8 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.263 -1.446 . . . . 0.0 111.509 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.574 HD12 ' CE ' ' A' ' 175' ' ' MET . 70.3 mt -109.25 116.06 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.436 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 18.7 t80 -51.87 128.66 24.65 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.6 -0.688 . . . . 0.0 112.272 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' VAL . 35.3 ptt180 -119.44 -24.48 6.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.702 -0.624 . . . . 0.0 112.308 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -159.2 139.12 11.86 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.269 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.36 136.72 39.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.769 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.979 HG11 ' HB3' ' A' ' 166' ' ' ALA . 7.3 p -102.99 98.88 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.0 p -93.47 123.53 36.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.209 1.004 . . . . 0.0 111.278 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 161' ' ' ARG . 93.9 m -86.38 -70.02 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.119 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.535 ' HG3' HG22 ' A' ' 160' ' ' THR . 89.9 mtt180 -104.19 26.18 9.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.475 -0.765 . . . . 0.0 110.206 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 107.69 10.27 27.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.8 m -141.26 138.93 33.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.515 ' O ' HD23 ' A' ' 126' ' ' LEU . . . -80.1 114.11 18.77 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.667 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -96.95 11.54 35.62 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.606 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.979 ' HB3' HG11 ' A' ' 158' ' ' VAL . . . -167.77 154.49 8.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 116' ' ' VAL . 17.4 m -128.58 140.02 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.947 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -107.46 146.45 31.74 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 38.7 p90 -152.98 165.09 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.999 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 82' ' ' LEU . 58.4 t -83.37 137.64 42.15 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.831 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.94 146.22 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.78 1.411 . . . . 0.0 110.747 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 96' ' ' PRO . 14.7 p -70.03 -29.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.67 . . . . 0.0 109.61 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.32 -29.54 65.99 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.7 m -73.42 -24.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.8 -0.562 . . . . 0.0 110.234 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.574 ' CE ' HD12 ' A' ' 153' ' ' ILE . 64.3 mtt -65.67 -46.2 80.01 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.06 -41.07 91.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.301 0.572 . . . . 0.0 109.959 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 N--CA 1.494 1.769 0 O-C-N 121.624 -0.673 . . . . 0.0 110.965 179.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 . . . . . 0 N--CA 1.498 1.953 0 N-CA-C 111.697 0.258 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.1 t -110.03 120.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -100.01 124.36 45.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.805 -0.559 . . . . 0.0 110.623 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.29 133.84 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.42 174.53 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.891 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.3 m -147.99 126.48 12.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.741 HG21 ' O ' ' A' ' 59' ' ' ALA . 10.0 t -106.34 -179.14 3.85 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.49 -16.89 4.28 Favored 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.823 -0.548 . . . . 0.0 112.377 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.616 ' H ' HG23 ' A' ' 38' ' ' THR . 74.4 p -102.49 -34.85 8.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.036 -1.04 . . . . 0.0 113.245 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -172.83 -169.17 0.55 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.776 -1.203 . . . . 0.0 112.756 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.2 p -116.71 145.3 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HE1' HG22 ' A' ' 38' ' ' THR . 11.1 p90 -162.02 -143.86 0.09 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.21 -0.931 . . . . 0.0 110.802 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 109' ' ' ARG . 44.1 mt -129.06 161.77 29.23 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.618 -1.301 . . . . 0.0 114.0 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.3 123.61 7.08 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.759 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.905 ' CG2' HD11 ' A' ' 153' ' ' ILE . 9.7 t -80.47 -156.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.409 ' N ' HG23 ' A' ' 46' ' ' THR . 23.4 m -153.16 112.42 3.81 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.0 137.03 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.104 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 m120 50.58 39.45 21.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.577 -0.702 . . . . 0.0 111.163 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 26.59 74.41 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.587 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 55.6 t -137.6 118.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -1.009 . . . . 0.0 110.218 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 27.7 t -75.53 120.08 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 89.1 m95 -106.74 128.74 54.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.03 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.73 ' O ' HD12 ' A' ' 82' ' ' LEU . 15.0 t -134.5 -177.76 4.75 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.658 HG23 ' HA3' ' A' ' 58' ' ' GLY . 6.4 m -89.52 125.47 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.792 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.0 -41.88 93.07 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.584 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.461 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 26.1 p-80 -66.04 -34.42 78.04 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.437 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -71.23 -34.23 64.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.741 ' O ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.498 1.958 0 O-C-N 121.681 -0.894 . . . . 0.0 110.14 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' CE2' ' A' ' 85' ' ' TRP 0.254 11.8 tp . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.077 -1.015 . . . . 0.0 109.607 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.441 HG22 ' HD1' ' A' ' 85' ' ' TRP . 72.6 mt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.9 m -93.62 127.8 39.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.644 -0.66 . . . . 0.0 110.102 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 4.0 pt20 -64.88 163.9 13.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.619 -0.676 . . . . 0.0 110.146 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -93.51 -40.08 10.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -155.72 -176.65 6.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.862 HG23 ' CG1' ' A' ' 83' ' ' VAL . 57.6 m -152.01 123.5 7.82 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.787 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 27.8 t-20 -93.77 77.84 4.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.0 -40.1 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.681 -0.637 . . . . 0.0 109.686 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -55.25 -25.8 35.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -112.41 -0.61 15.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.74 -0.6 . . . . 0.0 110.906 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 60.04 56.77 3.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.046 -1.034 . . . . 0.0 109.321 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 54' ' ' THR . 40.3 tp -144.37 154.53 43.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.984 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.862 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -142.05 133.26 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.93 123.21 5.54 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.319 -1.419 . . . . 0.0 112.058 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.897 ' CE2' HD22 ' A' ' 64' ' ' LEU . 3.6 m-90 -88.25 -171.7 3.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.063 -0.669 . . . . 0.0 109.395 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -100.01 111.94 24.24 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.948 0 O-C-N 121.446 -0.784 . . . . 0.0 111.85 -178.052 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.695 ' C ' HD22 ' A' ' 94' ' ' LEU . 41.5 t . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.575 0.702 . . . . 0.0 110.036 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 148' ' ' GLY . 4.4 mm? -115.95 170.93 8.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 164.05 37.12 Favored Pre-proline 0 N--CA 1.495 1.822 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.19 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo . . . . . 0 C--N 1.316 -1.176 0 O-C-N 123.923 1.486 . . . . 0.0 109.436 179.416 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -102.67 9.86 38.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.554 -0.716 . . . . 0.0 111.438 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -71.97 75.73 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 108.584 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 97.8 mt -78.96 174.67 11.3 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.389 0.614 . . . . 0.0 111.138 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 77.5 m-85 -144.37 127.3 16.41 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.479 HD13 ' HG ' ' A' ' 143' ' ' LEU . 38.1 tp -115.07 153.56 30.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.923 0.868 . . . . 0.0 111.841 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 111' ' ' ALA . 97.7 t -119.17 135.17 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.595 ' C ' HD11 ' A' ' 44' ' ' LEU . 68.8 p -85.22 175.28 9.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.132 -0.98 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 44' ' ' LEU . 63.8 ttt180 -37.16 -34.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 121.172 0.51 . . . . 0.0 112.056 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -100.15 -70.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.41 -80.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.864 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.568 ' HB3' HG23 ' A' ' 108' ' ' THR . 11.4 t70 46.6 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.593 -0.692 . . . . 0.0 111.595 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.69 107.67 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.249 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 126' ' ' LEU . 23.6 pt -130.95 159.99 68.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.7 -0.625 . . . . 0.0 109.731 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.431 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.9 Cg_endo -106.88 134.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.966 1.508 . . . . 0.0 111.224 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 167' ' ' VAL . 46.6 t -124.23 130.07 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -89.13 115.34 26.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.494 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 28.4 ttp85 -59.91 126.18 26.57 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.237 -0.915 . . . . 0.0 110.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -103.3 8.09 38.29 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.676 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.65 43.84 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 12.0 p-10 -59.96 -36.39 77.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -1.067 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -121.09 19.18 11.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.882 -0.511 . . . . 0.0 112.091 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -131.24 141.05 49.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.974 -1.079 . . . . 0.0 110.558 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.76 143.54 13.54 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -92.06 110.12 21.48 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 122.097 -0.649 . . . . 0.0 110.02 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 114' ' ' ILE . 45.3 tp -72.67 109.89 6.63 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.993 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.7 -31.03 69.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.457 0.646 . . . . 0.0 109.596 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -105.88 107.92 60.54 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.88 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.56 143.28 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.84 1.442 . . . . 0.0 110.357 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -148.36 160.01 37.77 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -60.36 126.24 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.842 1.443 . . . . 0.0 110.4 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.08 -26.12 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.75 -0.594 . . . . 0.0 110.675 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.6 m -59.31 -34.66 72.59 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.881 0.848 . . . . 0.0 109.212 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -73.82 -26.78 60.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.514 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.27 -4.82 58.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 112.939 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.88 66.59 1.55 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.647 1.213 . . . . 0.0 109.025 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 174.51 -26.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.683 ' HA ' HD12 ' A' ' 44' ' ' LEU . 3.8 t -72.57 -9.1 58.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.395 -1.062 . . . . 0.0 111.841 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.524 ' HB3' HG11 ' A' ' 55' ' ' VAL . 7.1 m -58.6 142.31 49.72 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.869 -1.145 . . . . 0.0 109.559 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.59 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 90.47 -9.86 76.26 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.02 157.06 53.56 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.4 Cg_endo -103.01 138.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.92 1.484 . . . . 0.0 112.799 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.479 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.9 mp -100.16 98.81 9.47 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.6 mp -87.64 147.81 25.1 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.028 0.918 . . . . 0.0 113.064 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -158.86 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -99.69 16.61 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.69 1.363 . . . . 0.0 110.732 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.4 p -127.42 0.14 6.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.156 -0.965 . . . . 0.0 112.271 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 94' ' ' LEU . . . 99.94 39.97 3.21 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -125.75 121.84 34.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -1.122 . . . . 0.0 110.791 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.94 101.51 12.41 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.07 7.13 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 0.0 112.237 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -156.58 134.74 4.17 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.905 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.1 mt -118.66 122.63 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.385 -1.068 . . . . 0.0 108.398 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -50.86 128.56 21.35 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.894 0.854 . . . . 0.0 112.326 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.55 ' HB2' HG23 ' A' ' 170' ' ' VAL . 34.2 ttt180 -116.78 -29.77 5.95 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.872 -0.518 . . . . 0.0 110.751 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.421 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.93 153.21 10.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -107.15 141.49 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.812 -0.555 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 30.5 t -94.5 93.42 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.6 p -91.8 115.78 28.34 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.383 1.087 . . . . 0.0 112.704 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 162' ' ' GLY . 22.1 m -92.02 120.28 32.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 160' ' ' THR . 14.8 ttm180 65.3 -67.67 0.12 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.986 -0.446 . . . . 0.0 109.892 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.452 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -161.7 24.49 0.23 Allowed Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.686 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 34.6 m -150.01 143.18 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -1.205 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.0 130.0 35.06 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.663 0.744 . . . . 0.0 111.547 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -125.58 16.42 8.18 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.39 150.02 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 116' ' ' VAL . 13.3 m -130.29 137.67 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.27 -0.972 . . . . 0.0 113.013 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -104.32 145.51 30.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 29.5 p90 -152.98 161.9 41.98 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.243 -1.383 . . . . 0.0 112.541 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.583 HG11 HD22 ' A' ' 82' ' ' LEU . 75.7 t -79.41 139.87 55.8 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.979 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.37 156.74 12.62 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.683 1.36 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.03 -25.71 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.64 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.89 -26.74 66.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 108.964 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.8 p -75.47 -33.07 60.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 110.348 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.571 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.1 mpp? -66.92 -48.46 68.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.724 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 177' ' ' THR . 12.5 pt-20 -62.4 -40.4 96.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.555 -0.715 . . . . 0.0 110.441 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 173' ' ' GLU . 33.8 p . . . . . 0 N--CA 1.498 1.937 0 O-C-N 121.602 -0.686 . . . . 0.0 109.962 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.87 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.3 pt-20 . . . . . 0 N--CA 1.5 2.048 0 CA-C-O 120.718 0.294 . . . . 0.0 111.381 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' A' ' 32' ' ' GLU . 62.5 t -114.56 119.99 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 0.0 109.454 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -102.94 121.98 43.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 0.0 111.353 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 44' ' ' LEU . 78.3 t -83.96 130.82 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.31 175.1 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.879 0.847 . . . . 0.0 110.818 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -138.41 129.43 26.95 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.724 0.773 . . . . 0.0 109.309 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.1 p -110.9 -179.08 3.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -17.22 9.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.61 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.5 p -101.33 -41.12 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 112.278 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -175.61 -162.51 0.1 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 121.033 -1.042 . . . . 0.0 111.457 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.8 m -121.76 146.93 46.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.707 -0.621 . . . . 0.0 109.371 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.4 p90 -160.71 -141.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.624 -0.673 . . . . 0.0 109.764 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 138' ' ' SER . 61.0 mt -130.79 161.0 32.72 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.489 -1.382 . . . . 0.0 114.271 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.446 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.58 120.2 4.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.693 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER -85.75 -159.99 0.5 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.146 -0.971 . . . . 0.0 110.162 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.564 ' H ' HG22 ' A' ' 46' ' ' THR . 39.1 t -149.98 113.14 4.89 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.04 129.95 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.058 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 51.78 40.0 26.76 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.653 -0.654 . . . . 0.0 110.715 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 26.53 74.23 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 41.5 t -133.86 111.9 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -1.077 . . . . 0.0 109.616 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 29.3 t -75.47 129.53 37.42 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 84.7 m95 -118.58 129.27 55.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.55 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.585 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 12.5 t -135.72 179.7 6.18 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 140' ' ' GLY . 12.3 m -88.66 133.33 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.696 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.819 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -59.97 -42.5 94.29 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.457 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 46.9 p-80 -74.0 69.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.22 -35.85 0.08 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.496 -1.003 . . . . 0.0 108.79 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.434 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.844 -1.16 . . . . 0.0 110.239 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.685 HG22 ' HD1' ' A' ' 85' ' ' TRP . 40.3 mt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 6.2 m -94.83 144.79 25.36 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.71 0.766 . . . . 0.0 111.596 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 85' ' ' TRP . 14.3 pt20 -78.45 160.34 27.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.872 -0.518 . . . . 0.0 111.2 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.9 mmm -93.34 -39.61 10.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.662 -0.649 . . . . 0.0 109.609 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 -176.37 5.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.73 . . . . 0.0 109.516 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.897 HG23 ' CG1' ' A' ' 83' ' ' VAL . 8.4 m -149.94 118.71 6.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.726 -0.609 . . . . 0.0 109.384 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.1 t30 -91.67 77.26 5.64 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.02 -38.14 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.734 -0.604 . . . . 0.0 109.42 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -54.73 -25.98 31.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -115.91 1.28 13.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.696 -0.627 . . . . 0.0 111.139 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t70 60.03 59.99 2.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.969 -1.082 . . . . 0.0 108.971 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 175' ' ' MET . 27.4 tp -147.04 152.5 38.66 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.597 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.897 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.18 130.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.35 127.07 5.94 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.12 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.685 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.9 m-90 -90.4 178.47 6.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.19 84.05 2.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.299 -0.875 . . . . 0.0 108.709 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.418 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.581 -178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.6 m . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.375 0.607 . . . . 0.0 110.051 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 144' ' ' LEU . 91.0 mt -82.74 164.07 20.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 95.2 m -115.98 153.73 48.31 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.493 1.481 0 O-C-N 123.404 1.213 . . . . 0.0 111.023 -179.653 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.1 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 120.994 0.426 . . . . 0.0 109.887 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -97.01 17.04 17.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.602 -0.686 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -71.49 73.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.72 175.12 10.23 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.33 0.586 . . . . 0.0 110.342 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -141.7 120.61 12.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 154' ' ' PHE . 22.0 tp -100.09 140.2 34.66 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.503 0.668 . . . . 0.0 110.233 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.669 HG21 HG21 ' A' ' 33' ' ' VAL . 83.8 t -91.75 120.05 40.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.344 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -84.63 173.31 10.86 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -38.84 -31.73 0.07 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.983 -0.448 . . . . 0.0 112.195 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -100.26 -69.25 0.78 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.828 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 -162.35 1.53 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' HG22 ' A' ' 107' ' ' VAL . 84.6 m-20 -60.34 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.181 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.9 t 50.87 22.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.312 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -171.27 117.05 0.44 Allowed Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.011 -1.056 . . . . 0.0 110.299 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -98.91 145.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.748 1.393 . . . . 0.0 109.357 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 126' ' ' LEU . 47.5 t -133.97 139.55 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 111.073 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -97.06 120.26 37.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 8.4 ttp180 -60.02 125.2 22.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 111.063 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -101.68 5.37 41.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.707 -0.621 . . . . 0.0 109.419 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.07 34.77 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.428 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 26.9 t0 -58.48 -22.93 56.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.473 -1.016 . . . . 0.0 110.634 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -124.61 17.15 8.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.529 -0.732 . . . . 0.0 111.361 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -139.99 144.55 37.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.045 -1.034 . . . . 0.0 110.953 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.79 141.07 10.64 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.0 t -88.67 112.03 22.63 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.926 -0.75 . . . . 0.0 109.954 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 129' ' ' PRO . 38.5 tp -72.89 107.36 5.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.18 -19.92 65.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.809 -0.557 . . . . 0.0 110.535 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.0 m -122.45 79.99 46.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.672 -0.643 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.655 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.0 Cg_endo -58.51 150.4 68.95 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 O-C-N 123.771 1.406 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -151.14 163.07 24.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.55 122.56 11.97 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 O-C-N 123.774 1.407 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.72 -25.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.808 -0.558 . . . . 0.0 111.524 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.3 m -59.58 -39.97 85.86 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.608 0.718 . . . . 0.0 109.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.94 -27.08 64.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.3 1.65 47.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.0 111.644 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.23 66.01 1.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.989 -1.07 . . . . 0.0 109.029 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.1 -24.4 0.08 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' LEU . 83.1 p -70.59 -13.77 62.22 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.53 -0.982 . . . . 0.0 111.65 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.545 ' HB3' HG11 ' A' ' 55' ' ' VAL . 6.9 m -60.97 141.93 56.91 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.973 -1.079 . . . . 0.0 109.833 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.622 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.02 -9.98 75.51 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.35 -161.44 0.49 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.509 ' HB2' HD11 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -146.36 137.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 116.282 -2.012 . . . . 0.0 112.277 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.4 mt -95.09 96.52 9.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.7 mp -87.68 145.14 26.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.0 m -67.92 174.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.69 -2.03 11.91 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.655 1.345 . . . . 0.0 111.695 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.1 m -103.3 0.07 30.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.974 -1.079 . . . . 0.0 112.085 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.26 36.24 5.24 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 77.3 m80 -121.16 124.04 43.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -1.121 . . . . 0.0 110.902 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.41 22.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.765 -0.584 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.8 1.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 111.839 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -155.0 136.65 5.25 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 20.2 mt -119.83 120.05 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.0 t80 -50.14 127.6 17.24 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.903 0.859 . . . . 0.0 113.28 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 170' ' ' VAL . 38.7 ttt-85 -116.67 -28.64 6.32 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.741 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.89 151.21 10.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.112 -0.993 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.59 146.73 29.27 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.669 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 58.6 t -90.06 94.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 83.5 m -91.57 119.2 31.28 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.258 1.028 . . . . 0.0 112.711 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.625 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.3 m -120.04 132.59 55.52 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.989 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 56.78 23.79 8.38 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.04 19.31 51.35 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.818 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 160' ' ' THR . 34.9 m -147.15 143.85 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.015 -1.285 . . . . 0.0 109.564 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.93 126.03 30.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 111.26 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -118.82 15.74 13.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.295 0.569 . . . . 0.0 110.051 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.669 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.19 149.05 1.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.607 ' CG2' HG11 ' A' ' 116' ' ' VAL . 15.6 m -124.01 135.42 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.03 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -106.08 149.32 26.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.9 p90 -154.53 163.96 39.41 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.267 -1.373 . . . . 0.0 112.791 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 155' ' ' ARG . 63.0 t -80.27 141.56 53.71 Favored Pre-proline 0 N--CA 1.498 1.945 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.79 151.21 14.55 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.702 1.369 . . . . 0.0 110.754 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -73.16 -30.04 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.654 -0.654 . . . . 0.0 110.136 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.93 -32.95 70.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.43 -0.794 . . . . 0.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.9 m -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.884 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.532 ' CG ' HD21 ' A' ' 82' ' ' LEU . 4.8 mtp -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.692 -0.63 . . . . 0.0 109.911 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -61.41 -40.01 92.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.7 p . . . . . 0 N--CA 1.499 1.991 0 O-C-N 121.436 -0.79 . . . . 0.0 111.592 -179.091 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.218 0.532 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG22 ' HD1' ' A' ' 85' ' ' TRP . 94.5 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.136 0.493 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.093 0.473 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.4 pt-20 . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 121.153 0.502 . . . . 0.0 110.655 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 ' HG3' ' A' ' 142' ' ' PRO . 46.8 t -109.89 140.01 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -0.762 . . . . 0.0 109.653 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -138.83 147.76 42.88 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.574 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -86.0 130.52 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.337 0.589 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.68 HG23 ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -132.67 159.99 42.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.7 -0.625 . . . . 0.0 109.603 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 m -141.56 149.93 41.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 2.4 t -115.42 76.77 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.498 1.142 . . . . 0.0 109.755 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.3 -48.9 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -120.06 9.72 11.26 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.405 -1.434 . . . . 0.0 113.851 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.36 170.52 19.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.646 -1.284 . . . . 0.0 111.703 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -127.75 154.36 45.46 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.496 0.665 . . . . 0.0 109.825 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.68 ' CE2' HG23 ' A' ' 36' ' ' VAL . 10.0 p90 -162.95 -145.8 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -135.69 161.71 34.77 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.488 -1.383 . . . . 0.0 112.852 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.98 130.4 13.83 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 21.8 m -112.42 125.29 54.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.364 -0.835 . . . . 0.0 111.453 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 27.5 p -74.16 130.14 39.19 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.493 0.663 . . . . 0.0 110.784 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.658 HG11 HG23 ' A' ' 172' ' ' VAL . 44.8 t -140.34 137.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 52.09 37.88 22.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.387 -0.821 . . . . 0.0 110.785 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.74 28.06 72.52 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG22 ' SD ' ' A' ' 74' ' ' MET . 89.2 t -138.94 120.02 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.487 -1.008 . . . . 0.0 109.812 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 33.9 m -72.43 129.31 38.05 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 73.3 m95 -122.9 133.28 54.41 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.8 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.821 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 3.7 t -140.57 -179.21 5.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.734 HG23 ' HA3' ' A' ' 58' ' ' GLY . 4.8 m -88.81 128.29 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 C-N-CA 118.146 -1.422 . . . . 0.0 111.895 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.705 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 88.3 t80 -59.98 -40.08 87.91 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.501 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 43.1 p-80 -67.8 -20.06 65.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.487 -1.285 . . . . 0.0 108.518 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.734 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -85.51 -35.25 12.13 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.196 -2.362 . . . . 0.0 107.196 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.499 1.976 0 O-C-N 121.742 -0.858 . . . . 0.0 109.08 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.709 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 108.285 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.421 ' O ' HD23 ' A' ' 64' ' ' LEU . 72.1 mt . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 122.265 1.031 . . . . 0.0 111.821 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 96.6 m -137.1 126.67 25.22 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 85' ' ' TRP . 97.7 mm-40 -138.3 -71.67 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 51' ' ' VAL . 29.6 mtt -87.67 -64.68 1.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -171.56 -168.15 0.58 Allowed 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.182 -176.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.875 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.5 m -149.75 115.3 5.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.618 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 3.0 t-20 -99.04 83.58 2.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.182 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.705 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 61.0 t -63.96 -37.4 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.427 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.77 -27.13 27.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.593 -0.692 . . . . 0.0 109.254 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.18 -1.78 14.27 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.675 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.6 t70 61.23 54.97 3.09 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 108.672 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 170' ' ' VAL . 16.6 tp -147.12 148.83 31.98 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.875 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -142.87 139.93 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 108.87 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 74' ' ' MET . . . -131.29 133.24 7.14 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 118.931 -1.604 . . . . 0.0 110.882 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.821 ' CZ3' HG22 ' A' ' 54' ' ' THR . 21.0 m-90 -106.96 -160.83 0.75 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 73' ' ' GLN . 66.7 tt0 -116.18 113.39 23.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.038 0 O-C-N 121.543 -0.723 . . . . 0.0 110.961 -178.691 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 m . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.386 0.612 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 150' ' ' ALA . 68.2 mt -96.6 165.34 12.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.7 168.05 8.46 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.615 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo . . . . . 0 N--CA 1.486 1.039 0 O-C-N 124.003 1.528 . . . . 0.0 109.869 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.496 1.845 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.7 m -105.02 -2.52 24.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.75 76.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.017 -1.052 . . . . 0.0 109.17 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.1 mt -84.37 174.69 9.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.744 0.783 . . . . 0.0 111.845 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 93.7 m-85 -146.39 130.96 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 138' ' ' SER . 43.9 tp -112.73 152.69 28.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.012 0.91 . . . . 0.0 111.759 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.6 t -109.95 131.09 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.448 ' C ' HD11 ' A' ' 44' ' ' LEU . 80.0 p -81.94 169.06 17.23 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.455 -0.778 . . . . 0.0 110.283 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.531 ' HA ' HD21 ' A' ' 44' ' ' LEU . 58.6 ttp180 -34.0 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -98.76 -85.29 0.38 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.34 5.34 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 113.06 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.07 137.91 57.99 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.561 -1.337 . . . . 0.0 109.956 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.27 120.05 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 0.0 110.319 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 128' ' ' SER . 6.1 tt -120.01 112.43 34.89 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 109.577 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 45.5 Cg_endo -62.55 132.07 36.44 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.596 1.314 . . . . 0.0 111.487 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.692 HG22 HD12 ' A' ' 126' ' ' LEU . 48.7 t -129.93 134.18 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -91.07 119.99 31.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 108.769 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 ttm180 -58.71 124.28 19.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.922 . . . . 0.0 110.958 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -99.58 3.44 45.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 109.634 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.31 45.96 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.5 m-20 -63.41 -27.09 69.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -1.084 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.2 p -123.49 18.67 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.6 -0.688 . . . . 0.0 111.808 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -138.52 145.83 41.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.089 -1.007 . . . . 0.0 111.378 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.53 142.17 12.11 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.455 ' C ' HG13 ' A' ' 116' ' ' VAL . 13.7 t -90.4 110.01 21.12 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.872 -0.781 . . . . 0.0 110.227 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.692 HD12 HG22 ' A' ' 116' ' ' VAL . 31.0 tp -70.36 108.42 4.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.51 -35.41 75.89 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.585 0.707 . . . . 0.0 109.732 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 114' ' ' ILE . 47.3 t -110.87 107.82 57.82 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.254 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.45 148.17 37.59 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 O-C-N 123.873 1.46 . . . . 0.0 109.899 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -150.02 160.96 32.54 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.91 124.3 15.67 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.858 1.451 . . . . 0.0 110.441 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.01 -27.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.268 0.556 . . . . 0.0 110.806 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.4 m -57.47 -30.88 65.42 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.823 0.82 . . . . 0.0 109.23 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -74.09 -29.05 61.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.383 -0.823 . . . . 0.0 109.125 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.05 -1.42 57.95 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.6 65.85 1.35 Allowed 'General case' 0 N--CA 1.513 2.68 0 O-C-N 120.8 -1.188 . . . . 0.0 109.369 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 173.6 -25.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 44' ' ' LEU . 8.2 t -70.32 -12.58 61.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -1.056 . . . . 0.0 111.316 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.442 ' HB3' HG11 ' A' ' 55' ' ' VAL . 11.1 m -59.92 140.4 56.72 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.621 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 88.93 -7.98 80.83 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.06 -158.21 0.74 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.799 ' HG3' HG22 ' A' ' 33' ' ' VAL . 58.6 Cg_endo -143.32 140.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 116.356 -1.963 . . . . 0.0 112.077 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' HD22 ' A' ' 104' ' ' LEU . 2.5 mt -99.93 96.25 7.43 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.3 mp -86.93 132.58 33.77 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.816 0.817 . . . . 0.0 112.737 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.25 -161.44 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -98.85 15.78 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.666 1.351 . . . . 0.0 110.15 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -120.33 12.4 11.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.209 -0.932 . . . . 0.0 112.047 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.38 20.64 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.94 -1.1 . . . . 0.0 110.488 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -127.15 128.75 46.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 0.0 110.639 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -92.61 100.13 12.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.99 6.79 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.177 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -149.95 124.43 1.76 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.278 -1.439 . . . . 0.0 111.462 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.619 HD12 ' CE ' ' A' ' 175' ' ' MET . 22.6 mt -109.98 120.07 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.24 . . . . 0.0 107.984 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.485 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.5 t80 -52.56 128.83 27.29 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.673 0.749 . . . . 0.0 112.495 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.3 ttp180 -116.27 -28.19 6.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.851 -0.53 . . . . 0.0 110.993 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.3 151.0 9.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.2 -0.938 . . . . 0.0 111.836 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.485 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.73 145.31 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.824 -0.547 . . . . 0.0 111.331 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 49.0 t -93.43 91.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.3 p -94.59 113.84 25.72 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.667 1.222 . . . . 0.0 112.625 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' GLY . 62.8 m -98.57 133.31 43.1 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 160' ' ' THR . 19.8 ttp180 63.45 -72.43 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -164.39 25.83 0.19 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.95 144.02 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.056 -1.261 . . . . 0.0 109.569 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.18 127.59 32.23 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.592 0.71 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -118.35 14.89 13.88 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.176 0.512 . . . . 0.0 110.04 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.72 146.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.686 HG21 HG11 ' A' ' 116' ' ' VAL . 14.7 m -121.12 135.39 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.729 0.776 . . . . 0.0 112.464 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -103.39 147.14 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 36.2 p90 -156.14 161.26 40.37 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.306 -1.358 . . . . 0.0 112.757 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 155' ' ' ARG . 62.9 t -87.55 130.34 47.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.863 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -79.23 156.69 26.01 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.658 HG23 HG11 ' A' ' 48' ' ' VAL . 14.1 p -70.06 -29.94 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -59.47 -27.63 66.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -75.04 -25.99 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.706 -0.621 . . . . 0.0 110.236 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 153' ' ' ILE . 55.4 mtt -64.65 -50.07 68.52 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.91 -45.11 94.05 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.5 p . . . . . 0 N--CA 1.495 1.814 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.756 -179.495 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.845 ' HG2' HD21 ' A' ' 94' ' ' LEU . 24.7 mp0 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 121.156 0.503 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.3 t -107.58 121.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.673 -0.642 . . . . 0.0 109.755 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -91.61 127.96 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.71 127.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.49 173.99 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.36 -0.838 . . . . 0.0 110.38 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 8.2 t -150.1 141.99 23.81 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.822 0.82 . . . . 0.0 109.081 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 58' ' ' GLY . 6.2 t -117.48 179.34 4.08 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -18.48 1.51 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.505 ' H ' HG23 ' A' ' 38' ' ' THR . 67.5 p -104.55 -31.09 9.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.995 -1.066 . . . . 0.0 113.595 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -171.88 -169.14 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.588 -1.32 . . . . 0.0 113.183 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 53.6 m -118.4 145.71 44.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.668 ' HE1' HG22 ' A' ' 38' ' ' THR . 10.2 p90 -161.12 -145.2 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.384 -0.822 . . . . 0.0 110.71 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt -134.08 160.66 37.11 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.629 -1.294 . . . . 0.0 113.287 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.484 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -150.18 126.72 10.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.068 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.581 HG21 ' HB3' ' A' ' 142' ' ' PRO . 59.3 m -96.74 127.28 42.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.115 -0.99 . . . . 0.0 111.743 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 22.3 m -76.32 123.82 26.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.854 -0.529 . . . . 0.0 110.434 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.52 130.01 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.54 -0.725 . . . . 0.0 110.19 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 50.37 39.92 21.55 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.355 -0.84 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.34 26.16 74.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.19 113.86 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -1.029 . . . . 0.0 109.556 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.5 t -75.65 119.97 20.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.73 -0.606 . . . . 0.0 109.399 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 86.7 m95 -107.68 123.45 48.53 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.88 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -127.62 -179.87 5.15 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 139' ' ' SER . 10.5 m -90.22 124.99 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 C-N-CA 118.194 -1.403 . . . . 0.0 111.999 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.412 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.438 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.4 p-80 -73.02 68.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.119 0.962 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 38' ' ' THR . . . 168.57 -49.31 0.22 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.71 -0.876 . . . . 0.0 109.753 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.466 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.762 0 O-C-N 120.743 -1.223 . . . . 0.0 110.712 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.748 HG22 ' HD1' ' A' ' 85' ' ' TRP . 27.0 mt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.666 0.746 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.7 m -99.94 140.34 34.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.922 -0.486 . . . . 0.0 110.534 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.3 pt20 -72.19 156.05 39.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.524 -0.735 . . . . 0.0 110.416 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -95.35 -35.51 11.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.499 0.666 . . . . 0.0 109.27 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -159.26 -177.02 6.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.906 HG23 HG13 ' A' ' 83' ' ' VAL . 89.4 m -150.48 122.49 8.22 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.653 -0.654 . . . . 0.0 109.565 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.79 76.41 2.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.04 -39.91 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.651 -0.655 . . . . 0.0 109.71 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -54.95 -26.09 33.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -110.48 -2.58 16.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.703 -0.623 . . . . 0.0 110.794 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 60.01 54.97 3.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.907 -1.121 . . . . 0.0 108.372 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.63 HD21 ' CG ' ' A' ' 175' ' ' MET . 8.1 tp -147.33 153.57 39.86 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.839 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -144.18 141.2 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -124.14 122.01 4.65 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.094 -1.527 . . . . 0.0 111.877 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.88 ' CZ3' HG22 ' A' ' 54' ' ' THR . 6.9 m-90 -90.99 -170.24 2.61 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -101.83 112.72 25.43 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.93 0 O-C-N 121.421 -0.799 . . . . 0.0 110.48 -179.336 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 121.46 0.648 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 144' ' ' LEU . 73.4 mt -109.37 158.61 17.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.919 -0.488 . . . . 0.0 109.927 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.2 p -101.1 149.98 36.71 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.475 -0.766 . . . . 0.0 110.662 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo . . . . . 0 N--CA 1.49 1.283 0 O-C-N 123.834 1.439 . . . . 0.0 110.637 -179.393 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.494 1.729 0 CA-C-O 121.114 0.483 . . . . 0.0 109.794 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.0 m -98.42 4.88 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.586 -0.696 . . . . 0.0 111.439 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -70.56 73.8 0.54 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 145' ' ' CYS . 89.8 mt -83.53 175.56 9.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.584 0.707 . . . . 0.0 111.085 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 89.6 m-85 -143.54 123.96 13.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -100.6 141.07 33.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 110.925 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.424 ' CB ' HG21 ' A' ' 33' ' ' VAL . 53.5 t -89.89 120.27 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.919 -0.488 . . . . 0.0 109.693 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 p -85.27 176.74 8.14 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.622 -0.674 . . . . 0.0 109.221 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -42.73 -29.19 0.29 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.052 0.453 . . . . 0.0 111.654 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.52 -67.92 0.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.552 -0.717 . . . . 0.0 110.091 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.31 -163.09 1.7 Allowed 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.474 -0.766 . . . . 0.0 109.546 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -55.55 -71.95 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.668 -0.645 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.736 HG11 ' OH ' ' A' ' 134' ' ' TYR . 33.6 t 65.41 -52.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 126' ' ' LEU . 44.7 pt -118.9 149.96 47.66 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.72 -1.237 . . . . 0.0 112.087 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 53.8 Cg_endo -111.07 156.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.721 1.379 . . . . 0.0 109.736 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.656 HG11 ' CG2' ' A' ' 167' ' ' VAL . 39.4 t -139.05 139.97 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -95.68 116.02 28.27 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.9 ttm180 -58.06 125.51 23.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.946 . . . . 0.0 111.379 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -96.89 -2.67 43.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.42 -176.28 44.71 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 94.1 m-20 -70.01 -18.5 63.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.293 -1.122 . . . . 0.0 110.243 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.6 p -120.17 14.23 12.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.493 -0.754 . . . . 0.0 111.916 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -148.98 147.57 28.74 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.059 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.37 138.57 9.12 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.4 t -88.89 109.98 20.69 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.833 -0.804 . . . . 0.0 110.265 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.549 HD11 HD12 ' A' ' 114' ' ' ILE . 51.8 tp -73.67 109.01 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.64 -19.75 65.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.693 -0.63 . . . . 0.0 110.392 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -119.96 79.97 25.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.669 -0.644 . . . . 0.0 110.212 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.9 Cg_endo -57.68 146.99 82.51 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.681 1.359 . . . . 0.0 110.087 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -154.13 168.5 11.69 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.696 -0.627 . . . . 0.0 109.659 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.39 124.93 15.68 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.943 1.496 . . . . 0.0 110.077 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.75 -24.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.813 -0.555 . . . . 0.0 111.923 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.3 p -57.5 -34.25 68.88 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.398 -0.814 . . . . 0.0 109.514 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.736 ' OH ' HG11 ' A' ' 113' ' ' VAL . 69.2 t80 -69.92 -29.59 66.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.85 4.14 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.857 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.41 114.13 7.37 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.146 0.974 . . . . 0.0 109.039 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.66 -7.91 61.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.6 t -73.81 -17.14 61.12 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.504 -0.998 . . . . 0.0 109.569 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.619 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -65.3 148.7 51.24 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.052 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.586 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.0 75.35 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.36 -167.22 5.31 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.6 Cg_endo -139.58 147.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 117.087 -1.476 . . . . 0.0 111.734 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' A' ' 104' ' ' LEU . 3.1 mt -97.55 102.29 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -81.32 130.04 34.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -176.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.546 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -65.96 -160.18 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -95.21 16.24 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.635 1.334 . . . . 0.0 110.712 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.0 p -130.77 19.93 5.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.245 -0.909 . . . . 0.0 111.691 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.41 30.47 64.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 50.8 m170 -115.92 118.64 33.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.486 -1.008 . . . . 0.0 109.907 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.66 124.69 27.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.906 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' CG1' ' A' ' 172' ' ' VAL . 33.3 m -125.58 -2.54 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 111.559 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.474 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.18 128.63 2.42 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.487 -1.34 . . . . 0.0 111.317 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.3 mt -110.07 119.98 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.06 -1.259 . . . . 0.0 107.866 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 14.0 t80 -52.0 127.31 20.99 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.808 0.813 . . . . 0.0 112.909 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.449 ' HB2' HG23 ' A' ' 170' ' ' VAL . 57.3 ttp180 -115.68 -28.13 6.85 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.947 -0.471 . . . . 0.0 110.82 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.419 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.53 148.92 9.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.918 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.91 141.98 33.92 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.4 t -89.65 92.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -88.49 117.89 27.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.33 1.062 . . . . 0.0 112.218 -176.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.627 ' O ' HG22 ' A' ' 163' ' ' VAL . 88.6 m -120.04 131.96 55.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.725 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' A' ' 160' ' ' THR . 57.6 mmt-85 58.3 21.25 8.03 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.401 -0.812 . . . . 0.0 110.224 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.423 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.83 18.86 49.9 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.532 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' THR . 34.1 m -145.98 143.91 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.235 -1.156 . . . . 0.0 109.4 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.56 121.29 23.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.476 -0.765 . . . . 0.0 110.854 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -111.11 11.14 21.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.714 -0.617 . . . . 0.0 110.51 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.25 139.46 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.656 ' CG2' HG11 ' A' ' 116' ' ' VAL . 17.1 m -110.09 137.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.155 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -106.55 148.09 28.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -155.21 164.57 38.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.616 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.607 HG11 HD22 ' A' ' 82' ' ' LEU . 50.2 t -84.23 135.68 41.45 Favored Pre-proline 0 N--CA 1.497 1.902 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 148.83 46.36 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.843 1.444 . . . . 0.0 110.099 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 7.3 p -71.68 -28.53 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 0.0 109.922 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.95 -30.62 69.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.465 -0.772 . . . . 0.0 109.128 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.4 t -72.12 -33.68 68.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.786 -0.571 . . . . 0.0 110.159 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.63 ' CG ' HD21 ' A' ' 82' ' ' LEU . 3.4 mtp -68.26 -40.08 82.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.5 -40.05 95.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 109.843 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 173' ' ' GLU . 69.8 p . . . . . 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 111.78 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.287 0.565 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.6 t -125.55 130.04 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -94.85 120.44 35.07 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.65 HG22 ' CD2' ' A' ' 44' ' ' LEU . 61.6 t -84.01 130.26 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 35' ' ' VAL . 30.4 m -146.32 171.26 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.641 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.0 p -142.21 127.91 19.21 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.699 0.762 . . . . 0.0 109.183 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 59' ' ' ALA . 69.2 p -107.76 179.94 4.09 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.62 -17.11 7.56 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.51 -179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -96.55 -41.41 8.56 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.273 -0.892 . . . . 0.0 112.019 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -173.47 -170.27 0.59 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.869 -1.144 . . . . 0.0 112.511 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 55.4 m -112.58 141.32 46.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 17.0 p90 -163.64 -145.72 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 0.0 110.628 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 109' ' ' ARG . 92.0 mt -137.75 169.04 18.47 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.714 -1.241 . . . . 0.0 112.54 -177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB2' ' OG1' ' A' ' 54' ' ' THR . . . -150.25 127.35 11.23 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 62.6 m -99.13 127.81 45.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 111.526 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -74.6 124.29 26.39 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.8 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.56 126.79 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.482 -0.761 . . . . 0.0 109.992 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.8 40.05 26.89 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.621 -0.675 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.756 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.71 26.78 72.17 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -139.81 115.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.396 -1.061 . . . . 0.0 109.409 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.2 t -76.63 121.83 23.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.287 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.522 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 94.2 m95 -109.75 126.87 54.19 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.671 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.775 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 1.4 t -132.21 176.83 8.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 140' ' ' GLY . 15.6 m -87.31 126.01 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 118.307 -1.357 . . . . 0.0 111.649 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.619 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.482 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 31.9 p-80 -66.85 -19.99 65.84 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.144 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -81.75 -39.27 12.2 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.498 1.954 0 O-C-N 121.681 -0.894 . . . . 0.0 109.166 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.46 HD21 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 120.901 -1.124 . . . . 0.0 110.518 -179.696 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.632 HG22 ' HD1' ' A' ' 85' ' ' TRP . 42.9 mt . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -98.14 145.33 26.69 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.492 0.663 . . . . 0.0 111.553 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 2.4 pp0? -77.27 155.24 32.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.774 -0.579 . . . . 0.0 109.933 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.2 ttm -102.58 -29.14 11.74 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.536 -0.727 . . . . 0.0 110.501 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -147.72 164.73 32.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.235 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.857 HG23 ' CG1' ' A' ' 83' ' ' VAL . 31.3 m -150.86 116.95 5.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.608 -0.683 . . . . 0.0 110.137 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 78.05 4.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.97 -33.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 0.0 109.929 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -53.1 -26.59 16.99 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.55 3.97 8.98 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.867 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.22 61.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.94 -1.1 . . . . 0.0 109.883 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.707 HD13 HG11 ' A' ' 170' ' ' VAL . 17.6 tp -142.41 151.74 42.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 109.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.857 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -143.86 129.15 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.401 -0.812 . . . . 0.0 109.58 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.07 122.49 5.48 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.192 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -85.9 -171.74 3.74 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.988 -0.713 . . . . 0.0 110.12 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -102.57 95.26 6.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.756 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.871 0 O-C-N 121.44 -0.787 . . . . 0.0 110.853 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.879 0 CA-C-O 121.737 0.779 . . . . 0.0 109.88 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 144' ' ' LEU . 85.0 mt -71.15 163.96 26.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.24 155.48 37.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.836 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.49 1.288 0 O-C-N 123.969 1.51 . . . . 0.0 110.242 -179.925 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.5 m . . . . . 0 N--CA 1.498 1.947 0 CA-C-O 121.272 0.558 . . . . 0.0 110.604 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m 54.26 20.38 2.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.531 -0.731 . . . . 0.0 111.254 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -86.45 79.59 8.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 143' ' ' LEU . 96.5 mt -89.53 170.61 10.35 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.381 0.61 . . . . 0.0 110.678 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 45.1 p90 -155.86 140.75 17.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.13 153.17 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.07 0.938 . . . . 0.0 111.748 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 111' ' ' ALA . 86.0 t -109.99 130.01 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.536 ' CG2' HD11 ' A' ' 114' ' ' ILE . 60.1 p -81.35 171.6 14.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.412 -0.805 . . . . 0.0 110.284 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HD21 ' A' ' 44' ' ' LEU . 26.4 ttp180 -32.26 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 108' ' ' THR . 83.3 m-70 -98.87 -87.19 0.35 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.108 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -164.2 26.37 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.124 -0.985 . . . . 0.0 111.226 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.2 158.28 14.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.066 -1.021 . . . . 0.0 110.694 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.11 120.03 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 126' ' ' LEU . 85.9 mt -130.01 83.86 62.29 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 110.259 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.68 120.61 7.83 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.982 1.517 . . . . 0.0 110.744 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 167' ' ' VAL . 62.6 t -124.48 132.95 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.684 . . . . 0.0 109.422 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -84.86 120.09 26.07 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.449 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.1 ttm180 -60.82 123.51 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 110.569 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.743 -0.598 . . . . 0.0 109.491 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.72 -179.94 43.89 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.422 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 30.1 p-10 -62.04 -29.32 70.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.98 . . . . 0.0 110.564 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 m -121.52 18.55 11.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.831 -0.543 . . . . 0.0 112.056 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -139.31 144.33 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 111.04 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.41 140.4 10.24 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.62 ' C ' HG13 ' A' ' 116' ' ' VAL . 18.3 t -87.59 109.97 20.04 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.782 -0.834 . . . . 0.0 109.821 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 116' ' ' VAL . 22.8 tp -69.33 105.78 2.68 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.51 -25.34 66.64 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.202 0.525 . . . . 0.0 110.055 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 p -106.41 100.71 31.37 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.764 -0.585 . . . . 0.0 110.158 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.88 134.25 16.19 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 124.024 1.539 . . . . 0.0 109.55 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.67 167.22 14.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -57.98 128.71 29.93 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.824 1.434 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.69 -26.43 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.628 -0.67 . . . . 0.0 110.616 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 75.3 m -57.86 -31.36 66.61 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.719 0.771 . . . . 0.0 109.274 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -70.86 -30.89 67.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.482 HD12 ' CB ' ' A' ' 164' ' ' ALA . 98.3 mt -89.98 -0.02 57.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.539 -0.725 . . . . 0.0 112.557 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -75.7 124.81 27.88 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 120.837 -1.164 . . . . 0.0 109.001 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 99.66 -11.4 61.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 p -78.55 -10.24 59.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.34 -1.094 . . . . 0.0 109.669 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 55' ' ' VAL . 1.5 m -60.45 143.86 52.43 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.81 -9.94 75.47 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.11 -163.53 0.89 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.66 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.19 135.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 116.624 -1.784 . . . . 0.0 112.145 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 104' ' ' LEU . 3.9 mp -94.82 97.11 9.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -88.76 141.48 28.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.953 0.882 . . . . 0.0 113.33 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 1.3 m -74.01 -172.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.0 Cg_endo -82.02 5.28 6.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.739 1.389 . . . . 0.0 111.446 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 14.1 m -110.2 17.8 20.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.996 -1.065 . . . . 0.0 111.883 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.72 38.31 61.09 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.439 ' CE1' ' HB3' ' A' ' 147' ' ' SER . 46.4 m170 -122.97 123.64 41.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.465 -1.021 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -87.16 102.76 14.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.04 7.4 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.912 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.61 133.94 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.575 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 175' ' ' MET . 40.1 mt -116.52 120.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.276 -1.132 . . . . 0.0 108.072 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.457 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.0 t80 -49.96 127.71 17.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.857 0.837 . . . . 0.0 112.978 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 170' ' ' VAL . 59.5 ttp180 -114.28 -30.33 6.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.942 -0.474 . . . . 0.0 111.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.411 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.16 150.42 9.38 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.684 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.62 140.77 35.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.694 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 57.3 t -93.12 88.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.509 -0.744 . . . . 0.0 109.006 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.2 p -92.84 115.72 28.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.273 1.035 . . . . 0.0 111.103 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.5 m -90.01 -80.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.502 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -97.71 61.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.172 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.438 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 70.03 19.13 75.21 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.3 m -147.74 140.18 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 121.282 -1.128 . . . . 0.0 108.956 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.24 128.27 33.33 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.546 0.688 . . . . 0.0 111.325 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -122.22 16.14 10.65 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.694 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.55 154.13 3.68 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 116' ' ' VAL . 11.4 m -135.27 138.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.885 0.85 . . . . 0.0 112.237 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -107.23 148.34 29.06 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 35.7 p90 -153.45 163.95 39.05 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.713 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 82' ' ' LEU . 99.0 t -80.02 141.63 54.83 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.994 -0.442 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.42 150.87 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.523 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.69 -28.13 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.689 . . . . 0.0 110.355 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -59.95 -32.49 70.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.1 t -75.52 -29.71 59.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.987 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.594 ' CG ' HD21 ' A' ' 82' ' ' LEU . 7.3 mtp -69.92 -37.93 76.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.96 -36.4 77.03 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.265 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.2 p . . . . . 0 N--CA 1.5 2.049 0 O-C-N 121.399 -0.813 . . . . 0.0 110.624 -179.268 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HA ' HD21 ' A' ' 94' ' ' LEU . 50.1 mt-10 . . . . . 0 N--CA 1.499 2.012 0 CA-C-O 120.829 0.347 . . . . 0.0 111.48 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -125.08 129.96 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.858 . . . . 0.0 110.658 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -99.24 123.77 43.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.622 -0.674 . . . . 0.0 110.623 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 44' ' ' LEU . 62.7 t -81.69 131.22 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.91 174.03 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.094 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.0 p -145.49 125.78 13.89 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.718 0.77 . . . . 0.0 108.98 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.536 HG21 ' HA ' ' A' ' 59' ' ' ALA . 47.6 p -103.52 -179.54 3.98 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.34 -15.03 8.83 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.528 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -100.42 -39.21 8.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 112.572 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -172.02 -170.0 0.71 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.798 -1.189 . . . . 0.0 112.694 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -115.21 141.54 47.88 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.6 p90 -162.61 -147.33 0.12 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 110.499 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 138' ' ' SER . 74.0 mt -132.07 166.01 22.72 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.602 -1.311 . . . . 0.0 113.342 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -152.86 131.86 12.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.837 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.563 HG21 ' HB3' ' A' ' 142' ' ' PRO . 94.1 m -96.75 123.65 40.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 84.2 m -73.78 127.22 32.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.68 -0.637 . . . . 0.0 109.805 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 38.7 t -140.42 127.24 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.796 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 49.98 40.7 21.76 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.585 -0.697 . . . . 0.0 111.619 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 73.54 26.93 68.59 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.561 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 59.9 t -139.94 117.37 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -1.04 . . . . 0.0 109.572 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 t -75.68 119.62 19.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.561 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.2 m95 -106.86 125.74 51.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.902 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.67 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.2 t -132.52 -179.26 5.34 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 139' ' ' SER . 24.0 m -90.22 125.57 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 118.193 -1.403 . . . . 0.0 112.242 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.03 -39.99 87.81 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.447 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 30.5 p-80 -73.42 68.64 1.12 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.139 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.09 -38.13 0.31 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.805 0 O-C-N 121.597 -0.943 . . . . 0.0 110.224 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.473 HD13 HG22 ' A' ' 38' ' ' THR . 4.3 mm? . . . . . 0 N--CA 1.503 2.201 0 CA-C-O 121.224 0.535 . . . . 0.0 110.572 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.163 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 137.61 32.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 0.0 111.742 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -70.03 141.54 52.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.734 -0.604 . . . . 0.0 109.899 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.8 ttp -105.33 -34.36 7.89 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.427 -0.796 . . . . 0.0 110.693 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.45 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -153.33 170.47 20.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.467 -0.771 . . . . 0.0 109.755 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.883 HG23 ' CG1' ' A' ' 83' ' ' VAL . 71.5 m -153.4 115.94 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.69 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 76.6 3.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 76' ' ' THR . 93.6 t -60.06 -39.99 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.451 -0.781 . . . . 0.0 109.553 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -55.65 -26.64 45.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -110.86 -0.4 16.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.751 -0.593 . . . . 0.0 110.751 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 60.17 56.31 3.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.947 -1.096 . . . . 0.0 109.393 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 170' ' ' VAL . 49.1 tp -145.57 153.19 40.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.883 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.03 130.68 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 109.415 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.78 121.01 5.11 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.625 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.67 ' CZ3' HG22 ' A' ' 54' ' ' THR . 5.3 m-90 -87.07 -170.28 2.99 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.88 -0.777 . . . . 0.0 109.314 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -100.01 112.22 24.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.973 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . 10.7 t . . . . . 0 N--CA 1.501 2.101 0 CA-C-O 121.342 0.592 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 93' ' ' SER . 3.7 mm? -114.32 150.62 34.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.532 -0.73 . . . . 0.0 109.846 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.406 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 2.9 p -98.46 151.06 37.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.434 -0.791 . . . . 0.0 110.93 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.491 1.351 0 O-C-N 123.865 1.455 . . . . 0.0 110.037 179.72 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.1 m . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -106.65 15.87 25.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.704 . . . . 0.0 110.971 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -73.1 78.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.3 mt -99.12 175.09 6.02 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.395 0.616 . . . . 0.0 110.32 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' PRO . 51.3 p90 -150.27 131.75 14.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 143' ' ' LEU . 21.9 tp -92.99 147.25 22.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.846 0.831 . . . . 0.0 110.897 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 111' ' ' ALA . 80.9 t -90.07 110.0 21.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.4 p -81.38 177.58 8.89 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.216 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -43.74 -25.51 0.18 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.817 -0.552 . . . . 0.0 111.744 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -90.16 -79.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.573 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -151.38 -44.07 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.291 -0.881 . . . . 0.0 111.183 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -163.84 -65.33 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.746 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.611 HG11 ' OH ' ' A' ' 134' ' ' TYR . 38.6 t 64.42 -58.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 126' ' ' LEU . 46.6 pt -125.41 150.96 69.26 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.951 -1.093 . . . . 0.0 111.737 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 105' ' ' TYR . 54.0 Cg_endo -106.65 163.87 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.804 1.423 . . . . 0.0 109.788 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HD12 ' A' ' 126' ' ' LEU . 48.8 t -136.1 140.08 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.834 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -95.0 115.81 27.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.463 ' CZ ' HG12 ' A' ' 151' ' ' VAL . 1.7 ttm180 -59.99 124.8 21.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -99.26 -0.05 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 0.0 109.766 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.83 44.35 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.441 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 34.4 m-20 -65.12 -22.89 67.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.931 . . . . 0.0 110.251 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.2 p -124.96 17.41 8.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 111.46 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -140.66 140.83 35.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.068 -1.02 . . . . 0.0 111.088 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -139.73 141.25 11.47 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.471 ' C ' HG13 ' A' ' 116' ' ' VAL . 7.3 t -89.9 112.19 23.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.834 -0.803 . . . . 0.0 110.161 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 114' ' ' ILE . 21.9 tp -71.2 104.47 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 115' ' ' PRO . 98.3 mt -60.04 -32.67 71.13 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 110.079 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -112.89 99.92 49.62 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.28 145.97 74.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.908 1.478 . . . . 0.0 109.018 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -154.29 163.17 25.01 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.599 -0.688 . . . . 0.0 109.685 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -60.52 122.8 11.85 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.064 1.56 . . . . 0.0 109.88 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -46.5 -25.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.928 -0.482 . . . . 0.0 111.724 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.4 p -58.23 -34.32 70.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.0 108.992 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.611 ' OH ' HG11 ' A' ' 113' ' ' VAL . 46.6 t80 -69.99 -30.03 67.26 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.25 2.02 33.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.763 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -72.21 112.44 8.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.234 -0.916 . . . . 0.0 108.603 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 -10.1 58.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.647 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.5 t -76.69 -12.86 60.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 110.111 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.603 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.7 m -66.53 150.99 48.16 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.001 -1.062 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.554 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.9 -9.91 75.66 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -67.93 -167.7 4.03 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.563 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.0 Cg_endo -141.48 140.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 116.956 -1.563 . . . . 0.0 112.143 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.427 HD12 HD13 ' A' ' 106' ' ' LEU . 4.1 mp -94.2 94.02 8.11 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 94' ' ' LEU . 6.0 mp -85.65 150.24 24.76 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.411 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -59.51 -162.89 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 16.57 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.645 1.339 . . . . 0.0 110.504 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.1 m -124.78 -51.98 1.69 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.06 40.64 0.02 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.406 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.4 m80 -119.99 129.42 54.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.449 ' HB2' ' CB ' ' A' ' 94' ' ' LEU . . . -70.26 121.16 17.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.563 -0.711 . . . . 0.0 110.001 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 118' ' ' ARG . 5.0 t -110.24 -29.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.803 -0.561 . . . . 0.0 110.112 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -155.12 150.38 21.86 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.985 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 16.7 mt -119.37 120.86 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.341 -1.093 . . . . 0.0 108.073 177.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.9 t80 -50.01 128.94 19.86 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.948 0.88 . . . . 0.0 113.044 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 170' ' ' VAL . 29.9 ttt180 -117.06 -27.88 6.4 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.723 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.404 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -165.39 147.59 7.7 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.08 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.426 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.42 140.43 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.583 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 52.7 t -91.19 92.66 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 86.1 m -94.49 123.32 37.84 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.77 0.795 . . . . 0.0 111.479 -177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 161' ' ' ARG . 75.9 m -85.37 -97.51 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.773 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.451 ' N ' HG22 ' A' ' 160' ' ' THR . 39.7 ttm180 -69.77 -55.5 9.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.782 -1.199 . . . . 0.0 109.119 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.424 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -163.96 28.32 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.424 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.8 m -148.83 146.01 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -81.34 129.25 34.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.568 -0.708 . . . . 0.0 111.168 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.82 15.22 13.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.266 0.555 . . . . 0.0 109.999 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.39 153.02 2.29 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.687 HG21 HG11 ' A' ' 116' ' ' VAL . 11.7 m -130.1 138.22 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.513 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -105.3 147.63 27.91 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 36.6 p90 -153.2 165.61 35.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.169 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 82' ' ' LEU . 59.6 t -86.15 130.07 51.39 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.86 157.52 51.49 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.759 1.4 . . . . 0.0 110.487 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.474 ' HA ' ' CE ' ' A' ' 175' ' ' MET . 7.2 p -76.03 -23.28 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.644 . . . . 0.0 109.653 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 177' ' ' THR . 53.5 tp10 -58.52 -30.83 67.37 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.6 m -73.31 -36.8 66.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.36 0.6 . . . . 0.0 109.631 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.685 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -67.96 -36.6 80.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.522 -0.737 . . . . 0.0 109.019 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.98 -33.1 71.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.885 -0.509 . . . . 0.0 110.33 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 173' ' ' GLU . 30.5 p . . . . . 0 N--CA 1.498 1.946 0 O-C-N 121.173 -0.954 . . . . 0.0 110.453 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.502 2.136 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 45' ' ' ALA . 61.6 t -140.01 140.69 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.945 -1.097 . . . . 0.0 111.268 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 87.9 mt-30 -91.01 121.39 32.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.309 179.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.9 t -80.44 138.89 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.75 169.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.088 0.946 . . . . 0.0 111.544 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -142.76 120.0 11.52 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.787 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.6 p -107.15 -179.07 3.82 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.66 -16.48 16.39 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.659 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.3 p -102.69 -39.68 6.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.268 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -174.64 -168.91 0.39 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.064 -1.023 . . . . 0.0 111.855 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 m -116.57 147.43 41.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.7 p90 -161.76 -142.97 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 85.5 mt -134.33 161.48 34.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.675 -1.265 . . . . 0.0 113.352 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -147.84 123.43 10.45 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.143 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 142' ' ' PRO . 25.1 m -97.9 120.04 37.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.486 -0.759 . . . . 0.0 110.674 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 21.5 m -76.79 125.99 30.21 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.123 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -123.16 124.61 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 52.67 45.3 28.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.307 -0.87 . . . . 0.0 110.625 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.6 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 70.05 22.64 77.28 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.168 -1.015 . . . . 0.0 110.74 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' NE1' ' A' ' 53' ' ' TRP . 61.9 t -130.01 111.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.261 -1.141 . . . . 0.0 109.24 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 15.6 t -74.61 121.85 22.25 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 87.0 m95 -112.84 126.21 55.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.901 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.1 t -131.51 178.96 6.33 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 140' ' ' GLY . 16.6 m -89.57 123.84 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.705 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.02 -39.97 87.66 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.487 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 34.6 p-80 -71.31 74.42 0.72 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.872 0.844 . . . . 0.0 109.069 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.07 -25.51 0.71 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.407 -1.055 . . . . 0.0 110.859 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.596 HD22 ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.514 2.77 0 CA-C-O 120.59 0.234 . . . . 0.0 111.284 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 109.947 179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.476 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.6 mt . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 120.928 0.394 . . . . 0.0 111.455 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 10.1 m 60.52 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.488 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 3.8 pt20 -80.06 159.29 26.21 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.335 -0.853 . . . . 0.0 112.167 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' GLN . 96.6 mmm -108.77 -30.01 8.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.058 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 1.3 t80 -140.37 164.22 30.69 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.525 -0.734 . . . . 0.0 109.248 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.901 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.8 m -154.35 115.33 4.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 0.0 110.304 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.405 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 14.4 t-20 -99.15 74.03 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.431 -0.793 . . . . 0.0 109.168 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 76' ' ' THR . 79.1 t -60.05 -39.97 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.272 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -55.19 -26.08 36.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -111.99 -2.59 15.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.682 -0.636 . . . . 0.0 110.589 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t0 62.56 55.18 2.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 109.249 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 175' ' ' MET . 18.6 tp -147.14 151.75 37.31 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.901 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -147.1 139.34 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.068 -1.02 . . . . 0.0 109.296 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.45 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -124.69 122.14 4.62 Favored Glycine 0 N--CA 1.5 2.933 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.656 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.901 ' CZ3' HG22 ' A' ' 54' ' ' THR . 9.4 m-90 -90.36 -166.72 1.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.076 -0.661 . . . . 0.0 109.387 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 74' ' ' MET . 30.1 tt0 -112.55 96.96 6.28 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.501 2.075 0 O-C-N 121.498 -0.751 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.581 ' C ' HD22 ' A' ' 94' ' ' LEU . 11.1 m . . . . . 0 N--CA 1.495 1.803 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 93' ' ' SER . 4.6 mm? -110.01 160.59 16.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.34 -0.85 . . . . 0.0 111.133 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.417 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.1 p -112.12 157.12 40.71 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.611 -0.68 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo . . . . . 0 C--N 1.315 -1.192 0 O-C-N 123.874 1.46 . . . . 0.0 109.592 179.118 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 t . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 121.363 0.602 . . . . 0.0 110.752 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.8 m -105.09 18.85 21.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.725 -0.609 . . . . 0.0 109.989 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -70.47 76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 118' ' ' ARG . 82.0 mt -94.11 174.32 7.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.283 0.563 . . . . 0.0 109.664 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.6 p90 -152.4 136.1 16.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 142' ' ' PRO . 40.8 tp -103.83 141.25 36.44 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.724 0.774 . . . . 0.0 111.146 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -86.31 119.92 35.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.4 p -80.44 179.98 7.44 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.097 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -43.02 -27.92 0.23 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.756 -0.59 . . . . 0.0 112.24 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -115.27 -50.92 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.865 . . . . 0.0 111.571 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.62 -179.0 7.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.89 -1.131 . . . . 0.0 110.338 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 114' ' ' ILE . 57.7 t0 -60.09 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.163 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.4 t 51.67 25.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.392 -0.817 . . . . 0.0 110.726 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 126' ' ' LEU . 6.5 tp -164.83 100.07 0.83 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.874 . . . . 0.0 111.024 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.82 136.41 2.11 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.571 1.301 . . . . 0.0 109.761 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.802 HG22 HD12 ' A' ' 126' ' ' LEU . 48.9 t -130.4 140.32 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.324 -0.86 . . . . 0.0 111.027 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -93.77 119.47 32.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.9 ttm-85 -60.59 127.38 31.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.802 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -99.77 -0.01 40.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.666 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.75 -177.37 43.86 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 82.8 m-20 -69.23 -20.02 63.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -1.03 . . . . 0.0 110.171 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 p -123.47 15.15 9.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.409 -0.807 . . . . 0.0 111.642 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -143.25 144.59 32.2 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.14 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.14 140.99 10.79 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.71 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.6 t -88.69 111.37 21.87 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.759 -0.848 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 114' ' ' ILE . 23.6 tp -70.31 110.23 5.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.01 -18.88 65.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.852 -0.53 . . . . 0.0 110.655 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' ILE . 47.4 t -129.95 82.25 66.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 110.399 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.8 Cg_endo -61.19 143.84 98.71 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.856 1.45 . . . . 0.0 109.907 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -154.99 168.36 12.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.643 -0.661 . . . . 0.0 109.345 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.86 125.37 18.43 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.842 1.443 . . . . 0.0 110.354 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.05 -27.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 121.516 0.674 . . . . 0.0 110.534 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 39.7 t -61.42 -15.08 33.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.785 -0.572 . . . . 0.0 110.135 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -86.75 -31.79 20.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 136' ' ' LYS . 84.4 mt -76.7 -55.85 5.13 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.79 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 133' ' ' SER . 4.5 pttt 7.12 104.74 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.22 -4.2 55.14 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.3 p -76.07 -14.78 60.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.534 -0.98 . . . . 0.0 109.261 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.559 ' HB2' HG21 ' A' ' 55' ' ' VAL . 4.0 m -61.97 142.23 57.58 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.161 -0.962 . . . . 0.0 110.143 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.06 -10.11 75.13 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -65.05 -162.02 0.68 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.668 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.5 Cg_endo -146.69 138.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 116.605 -1.796 . . . . 0.0 112.469 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 151' ' ' VAL . 3.4 mp -96.0 97.84 9.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.3 mp -87.29 151.68 22.93 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.414 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -64.42 -159.62 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 51.2 Cg_endo -96.8 17.34 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.503 1.265 . . . . 0.0 110.098 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.5 p -130.54 11.06 5.27 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.273 -0.892 . . . . 0.0 112.066 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.52 32.0 10.84 Favored Glycine 0 N--CA 1.502 3.039 0 O-C-N 120.917 -1.114 . . . . 0.0 110.558 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.417 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.7 m80 -113.91 118.45 34.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -1.19 . . . . 0.0 110.536 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.22 123.41 24.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.505 -0.747 . . . . 0.0 110.222 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.2 m -123.35 -5.56 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.551 -0.718 . . . . 0.0 111.572 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -160.04 127.67 1.84 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.791 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 66.4 mt -105.58 120.71 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -1.082 . . . . 0.0 108.555 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 15.8 t80 -50.75 128.61 21.2 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.621 0.724 . . . . 0.0 112.601 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 170' ' ' VAL . 64.6 ttt180 -116.78 -26.45 6.95 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.867 -0.521 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -164.96 149.18 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.957 . . . . 0.0 111.751 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.98 141.59 32.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.718 -0.614 . . . . 0.0 110.889 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.536 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 49.1 t -95.15 93.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -89.43 117.78 28.6 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.13 0.967 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.8 m -83.92 -69.96 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.16 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -117.36 57.57 0.8 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.057 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.42 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 80.04 16.35 76.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.4 m -146.84 139.9 19.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 121.374 -1.074 . . . . 0.0 108.27 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.98 129.92 35.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.732 0.777 . . . . 0.0 111.338 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -123.86 17.28 9.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.272 0.558 . . . . 0.0 110.077 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -174.33 139.93 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.717 HG21 HG11 ' A' ' 116' ' ' VAL . 22.3 m -113.31 138.67 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.148 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -108.5 143.33 37.63 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.2 p90 -150.96 166.02 31.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.12 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 155' ' ' ARG . 52.4 t -87.3 130.53 47.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.996 -0.44 . . . . 0.0 110.326 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.7 135.82 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 O-C-N 123.722 1.38 . . . . 0.0 110.195 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 151' ' ' VAL . 11.6 p -70.21 -29.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.588 -0.695 . . . . 0.0 110.129 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.08 -31.09 69.69 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 177' ' ' THR . 18.8 m -72.6 -35.28 67.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.609 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.599 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.4 mtp -64.68 -47.16 79.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -62.75 -44.46 96.15 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.937 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 174' ' ' SER . 13.8 t . . . . . 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 110.683 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.497 1.898 0 CA-C-O 120.868 0.366 . . . . 0.0 111.536 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 107' ' ' VAL . 62.7 t -110.08 129.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.391 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 19.4 mp0 -95.59 117.65 30.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.523 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -84.81 131.66 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 43' ' ' PHE . 33.9 m -140.43 178.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.493 -0.754 . . . . 0.0 109.268 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 m -140.91 126.94 19.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.718 0.771 . . . . 0.0 109.209 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 40' ' ' THR . 14.7 t -113.0 -168.57 1.34 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.36 5.04 0.82 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 24.1 p -120.89 -39.35 2.73 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.701 -1.25 . . . . 0.0 111.941 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -173.08 -155.38 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.098 -1.001 . . . . 0.0 112.348 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 m -102.71 119.01 38.09 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 36' ' ' VAL 0.27 3.3 m-85 -90.25 -174.67 4.26 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 117.398 2.369 . . . . 0.0 117.398 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' A' ' 138' ' ' SER . 26.5 mt -142.55 136.07 28.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.378 -2.192 . . . . 0.0 106.842 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 54' ' ' THR . . . -145.78 136.66 24.48 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 142' ' ' PRO . 34.6 m -101.69 125.77 48.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.583 -0.698 . . . . 0.0 111.586 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -72.45 119.98 17.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.72 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.83 129.97 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.456 -0.777 . . . . 0.0 109.994 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 50.12 40.14 21.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.472 -0.768 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.96 26.57 74.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.521 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.5 t -138.75 115.97 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.267 -1.137 . . . . 0.0 109.658 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 35.2 t -76.72 118.61 19.52 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.521 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 91.8 m95 -106.27 124.24 49.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.0 111.189 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.892 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -130.65 179.98 5.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 139' ' ' SER . 2.8 m -84.32 123.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 C-N-CA 117.195 -1.802 . . . . 0.0 113.373 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.425 ' CA ' HG22 ' A' ' 83' ' ' VAL . 25.5 t80 -59.98 -40.31 88.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.802 . . . . 0.0 109.9 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.473 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 29.6 p-80 -69.2 101.9 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.701 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.16 -41.72 1.42 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.947 . . . . 0.0 109.997 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.769 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 109.505 179.322 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.408 ' HB ' HD21 ' A' ' 64' ' ' LEU . 4.5 mt . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.086 0.47 . . . . 0.0 111.441 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.6 m 58.7 136.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.955 0.883 . . . . 0.0 112.175 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.517 ' HG2' ' CE2' ' A' ' 85' ' ' TRP . 16.1 mt-30 -80.28 157.19 26.5 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.531 -0.731 . . . . 0.0 112.564 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 88.8 mtp -100.56 -38.23 8.45 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.21 -176.46 4.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.837 HG23 HG13 ' A' ' 83' ' ' VAL . 69.7 m -153.49 127.42 8.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.559 -0.713 . . . . 0.0 109.59 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.16 76.96 2.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.95 -40.06 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.643 -0.66 . . . . 0.0 110.009 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.41 -26.17 40.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.476 -0.765 . . . . 0.0 108.972 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -112.59 0.02 15.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.643 . . . . 0.0 110.735 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.03 59.71 2.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.045 -1.034 . . . . 0.0 109.189 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.534 HD21 ' CG ' ' A' ' 175' ' ' MET . 24.3 tp -145.99 154.01 41.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.171 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.837 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -141.41 135.83 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.76 121.99 4.7 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.949 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.892 ' CZ3' HG22 ' A' ' 54' ' ' THR . 11.1 m-90 -89.92 -173.11 3.77 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -104.05 91.66 4.05 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 52' ' ' CYS . . . . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.805 -0.56 . . . . 0.0 110.28 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.3 t . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 144' ' ' LEU . 88.4 mt -106.61 159.68 16.01 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.086 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.64 166.1 11.42 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.97 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 151' ' ' VAL . 39.4 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 124.054 1.555 . . . . 0.0 110.905 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -103.72 18.33 22.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 111.19 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.51 78.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 143' ' ' LEU . 88.5 mt -89.75 174.19 7.85 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.477 0.656 . . . . 0.0 110.546 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.9 113.49 9.02 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.52 146.64 24.47 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.127 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 33' ' ' VAL . 74.0 t -92.97 119.42 40.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.159 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 44' ' ' LEU . 66.0 p -85.94 175.24 8.73 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.43 ' N ' HD11 ' A' ' 44' ' ' LEU . 32.2 ttp180 -42.86 -28.61 0.26 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.796 -0.565 . . . . 0.0 111.954 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -100.07 -69.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.12 -163.27 1.74 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.438 -0.789 . . . . 0.0 109.506 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' HG22 ' A' ' 107' ' ' VAL . 73.9 m-20 -57.29 -66.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.741 -0.599 . . . . 0.0 110.585 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.7 t 56.58 -85.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.99 -0.444 . . . . 0.0 111.298 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 126' ' ' LEU . 44.0 pt -76.51 145.28 75.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.078 -1.013 . . . . 0.0 112.006 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 53.3 Cg_endo -112.63 153.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 O-C-N 123.756 1.398 . . . . 0.0 108.657 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 167' ' ' VAL . 38.2 t -136.42 139.64 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.074 -1.016 . . . . 0.0 111.66 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.32 118.49 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.8 ttm180 -63.37 122.2 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.0 110.219 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -101.05 7.43 43.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.688 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.32 173.59 42.09 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.446 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 75.5 m-20 -60.3 -25.83 66.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.379 -1.071 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.7 18.58 7.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.548 -0.72 . . . . 0.0 111.85 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.41 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 92.7 mtt180 -138.12 143.41 40.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.833 -1.167 . . . . 0.0 111.012 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -140.11 142.17 12.26 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.421 ' C ' HG13 ' A' ' 116' ' ' VAL . 20.1 t -89.64 110.99 21.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.971 -0.723 . . . . 0.0 109.814 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 129' ' ' PRO . 61.4 tp -69.96 113.74 7.47 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.99 -20.96 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.874 -0.516 . . . . 0.0 110.756 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 m -126.77 80.86 70.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.3 Cg_endo -57.43 139.79 91.21 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 O-C-N 123.754 1.397 . . . . 0.0 110.346 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -146.96 163.15 30.14 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -55.47 124.49 16.42 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.808 1.425 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . 0.653 ' HA ' HD12 ' A' ' 135' ' ' LEU . 14.8 p -51.61 -23.46 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.888 -0.507 . . . . 0.0 111.639 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -57.19 -34.34 68.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.312 -0.868 . . . . 0.0 109.28 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -74.22 -21.87 59.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 132' ' ' VAL . 95.5 mt -85.02 -0.49 54.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.77 109.89 2.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.108 -0.995 . . . . 0.0 108.81 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.94 -6.73 64.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.875 ' HA ' HD12 ' A' ' 44' ' ' LEU . 12.7 t -74.27 -13.32 60.75 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.562 -0.963 . . . . 0.0 108.686 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.3 147.68 39.98 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.372 -0.83 . . . . 0.0 109.384 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.455 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.25 -12.16 68.37 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.3 -157.6 0.22 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 46' ' ' THR . 47.9 Cg_endo -144.12 132.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 116.514 -1.857 . . . . 0.0 113.426 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.3 mp -89.24 85.79 6.7 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 175.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 145' ' ' CYS . 0.7 OUTLIER -92.57 138.32 31.61 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 0.0 112.524 -175.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.854 ' N ' HD12 ' A' ' 144' ' ' LEU . 61.3 m -56.48 -177.17 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -91.18 3.6 4.36 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.553 1.291 . . . . 0.0 110.536 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.4 m -103.63 -15.97 15.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.82 28.64 3.11 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.422 ' N ' ' CD1' ' A' ' 144' ' ' LEU . 74.2 m80 -116.65 109.98 17.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.103 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.74 121.97 22.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 96' ' ' PRO . 26.8 m -122.65 -1.35 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 112.077 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -158.68 138.01 5.5 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.334 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.455 HG23 ' C ' ' A' ' 140' ' ' GLY . 25.7 mt -120.09 118.42 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.7 t80 -49.92 127.31 16.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.873 0.844 . . . . 0.0 112.9 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.697 ' HB2' HG23 ' A' ' 170' ' ' VAL . 61.7 ttt-85 -121.58 -21.53 6.18 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.619 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.477 ' HB3' ' HB2' ' A' ' 168' ' ' ASP . . . -162.82 138.96 7.25 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.917 -1.114 . . . . 0.0 112.148 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.01 138.97 36.35 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.641 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 39.9 t -89.91 94.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -89.99 110.02 21.02 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.104 0.954 . . . . 0.0 112.793 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 163' ' ' VAL . 30.3 m -100.48 125.18 46.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.3 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 56.3 22.81 6.59 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -0.827 . . . . 0.0 111.31 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.23 17.71 36.13 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.019 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 160' ' ' THR . 34.8 m -144.3 139.99 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.117 -1.225 . . . . 0.0 109.0 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -78.12 122.09 25.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.274 -0.891 . . . . 0.0 111.552 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -116.24 15.95 15.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.794 -0.566 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.33 150.89 2.42 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.702 HG21 HG11 ' A' ' 116' ' ' VAL . 17.3 m -128.6 136.77 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.633 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 156' ' ' ALA . 84.7 m-20 -105.43 150.45 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.477 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.7 p90 -154.51 161.09 41.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.914 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 155' ' ' ARG . 60.3 t -80.34 139.93 52.27 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 174' ' ' SER . 47.4 Cg_endo -82.17 148.24 14.91 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.779 1.41 . . . . 0.0 110.525 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.22 -30.06 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.644 -0.66 . . . . 0.0 110.007 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.85 -31.48 69.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 109.014 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 171' ' ' PRO . 35.0 t -73.06 -31.04 64.14 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.438 0.637 . . . . 0.0 109.559 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.534 ' CG ' HD21 ' A' ' 82' ' ' LEU . 2.7 mtp -70.03 -39.39 75.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.658 -0.651 . . . . 0.0 109.461 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -59.99 -41.46 92.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.655 -0.653 . . . . 0.0 109.433 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 32.7 p . . . . . 0 N--CA 1.495 1.783 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.497 178.844 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 . . . . . 0 N--CA 1.502 2.171 0 CA-C-O 121.023 0.44 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.25 124.28 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -94.59 124.2 38.48 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.504 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.2 t -80.29 131.17 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.7 175.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.414 -0.803 . . . . 0.0 110.262 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.5 p -146.32 133.24 20.18 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.837 0.827 . . . . 0.0 109.206 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.3 p -108.25 -179.73 3.97 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.69 -14.92 23.82 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 p -107.92 -32.34 7.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 113.185 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.88 -169.98 0.72 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.705 -1.247 . . . . 0.0 112.769 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 m -121.43 148.79 43.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.7 p90 -164.3 -145.55 0.09 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.525 -0.734 . . . . 0.0 110.299 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 54' ' ' THR . 82.9 mt -134.87 159.99 39.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.644 -1.285 . . . . 0.0 112.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -143.72 128.79 18.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 142' ' ' PRO . 98.1 m -96.8 132.84 42.11 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.0 111.799 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.19 117.31 20.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.44 129.93 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.041 -1.037 . . . . 0.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 54.05 40.05 31.22 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.534 -0.729 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.95 24.95 74.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.58 123.02 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.544 -0.974 . . . . 0.0 109.099 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.0 m -75.3 143.34 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.563 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.504 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 91.2 m95 -136.0 125.51 25.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.732 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -128.79 -174.21 3.19 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 139' ' ' SER . 35.1 m -86.41 131.52 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.312 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.409 ' HB2' ' N ' ' A' ' 82' ' ' LEU . 19.0 t80 -60.43 -40.09 89.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.776 -0.577 . . . . 0.0 109.641 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.481 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 37.8 p-80 -73.41 72.43 1.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.391 1.091 . . . . 0.0 108.745 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.36 -36.07 0.81 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 83' ' ' VAL . . . . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.808 -0.819 . . . . 0.0 111.143 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.788 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.484 ' H ' HD12 ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.608 0 O-C-N 120.766 -1.209 . . . . 0.0 110.202 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.468 HG22 ' CD1' ' A' ' 85' ' ' TRP . 8.3 mt . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 120.912 0.387 . . . . 0.0 111.527 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 50.9 m 60.06 124.64 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.562 0.696 . . . . 0.0 110.913 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.571 HE22 HG11 ' A' ' 83' ' ' VAL . 95.3 mt-30 -59.94 137.71 58.01 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.271 -0.893 . . . . 0.0 112.547 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.4 ttm -97.08 -27.63 14.5 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.448 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.2 OUTLIER -147.04 167.65 23.52 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 1.033 HG23 HG12 ' A' ' 83' ' ' VAL . 19.0 m -154.61 116.7 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 110.398 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 15.7 t-20 -95.02 75.2 3.5 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.01 -40.04 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -55.8 -26.27 45.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -111.02 0.09 16.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.706 -0.621 . . . . 0.0 110.832 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 60.17 57.4 2.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.499 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.798 HD22 HG11 ' A' ' 170' ' ' VAL . 36.9 tp -148.06 151.53 35.84 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.652 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 1.033 HG12 HG23 ' A' ' 76' ' ' THR . 14.6 m -139.74 140.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 85' ' ' TRP . . . -125.47 171.21 17.38 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.151 -1.499 . . . . 0.0 112.102 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.58 ' HH2' HG22 ' A' ' 54' ' ' THR . 0.2 OUTLIER -148.67 -162.08 1.48 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -100.36 111.31 23.57 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.559 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 111.542 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.488 1.455 0 CA-C-O 121.468 0.652 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.956 HD13 HD21 ' A' ' 144' ' ' LEU . 83.1 mt -109.98 149.91 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 7.6 p -105.38 157.56 34.16 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.339 -178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 N--CA 1.493 1.484 0 O-C-N 123.824 1.434 . . . . 0.0 110.604 179.719 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.3 m -98.4 16.38 21.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 111.268 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -67.81 86.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 86.9 mt -99.02 176.64 5.5 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.616 0.722 . . . . 0.0 111.28 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 96.2 m-85 -144.45 111.13 5.68 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.504 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.6 tp -86.36 143.93 27.6 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.465 0.65 . . . . 0.0 110.315 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' OD1' ' A' ' 112' ' ' ASP . 80.5 t -88.97 114.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.4 p -84.21 174.87 9.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -41.55 -29.33 0.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.816 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -100.04 -70.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.541 -0.724 . . . . 0.0 109.654 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.92 -162.92 1.66 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.523 -0.736 . . . . 0.0 109.023 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.645 ' OD1' HG22 ' A' ' 107' ' ' VAL . 87.9 m-20 -57.81 -63.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.632 -0.667 . . . . 0.0 110.08 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.8 t 54.02 -86.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.008 -0.433 . . . . 0.0 111.617 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 126' ' ' LEU . 1.9 pp -76.23 134.63 70.42 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.101 -0.999 . . . . 0.0 111.731 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 105' ' ' TYR . 52.5 Cg_endo -104.67 148.1 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.604 1.318 . . . . 0.0 109.13 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 167' ' ' VAL . 40.5 t -134.06 138.61 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.275 -0.891 . . . . 0.0 110.803 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.83 124.17 39.73 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.456 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.3 ttm180 -62.62 121.56 13.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.409 -0.807 . . . . 0.0 110.356 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.02 7.4 44.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.631 -0.668 . . . . 0.0 109.574 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.97 173.81 43.73 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 16.8 t0 -61.33 -25.28 67.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -125.71 18.59 7.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.551 -0.718 . . . . 0.0 111.757 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.415 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 95.2 mtt-85 -138.26 145.37 41.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.884 -1.135 . . . . 0.0 111.161 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.29 141.2 10.93 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 116' ' ' VAL . 55.3 p -89.21 113.1 24.27 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.951 -0.735 . . . . 0.0 109.858 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 116' ' ' VAL . 41.1 tp -71.06 110.06 5.52 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.95 -18.0 63.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 110.738 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.0 m -119.95 79.96 25.52 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.615 -0.678 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.72 137.75 78.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.807 1.425 . . . . 0.0 109.903 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -154.11 169.8 9.43 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.699 -0.626 . . . . 0.0 109.344 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.56 124.38 15.34 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.963 1.507 . . . . 0.0 110.335 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.36 -23.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.794 -0.566 . . . . 0.0 111.635 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.324 -0.86 . . . . 0.0 109.356 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -70.67 -28.03 64.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 164' ' ' ALA . 96.8 mt -84.25 -0.32 51.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.557 -0.714 . . . . 0.0 111.271 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -70.31 110.84 5.49 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.76 -10.57 57.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 p -74.65 -15.24 60.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 109.159 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -71.29 151.33 44.32 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 179.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.673 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.74 72.86 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.23 -157.92 3.62 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.6 Cg_endo -142.35 137.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 116.982 -1.546 . . . . 0.0 112.212 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.504 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.2 mt -95.06 99.16 11.21 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.956 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -90.86 146.41 23.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -59.86 -164.8 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 49.0 Cg_endo -90.14 17.98 1.43 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.521 1.274 . . . . 0.0 111.022 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.3 m -126.51 -55.42 1.43 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.096 -1.002 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.0 43.32 0.02 OUTLIER Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.6 m80 -125.19 120.99 32.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -1.037 . . . . 0.0 110.797 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.61 124.3 29.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.266 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.21 -1.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.724 . . . . 0.0 111.901 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.467 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.86 125.46 1.65 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.168 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.453 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.0 mt -105.8 117.48 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.297 -1.119 . . . . 0.0 108.156 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.2 t80 -50.14 126.8 15.43 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.601 0.715 . . . . 0.0 112.529 -177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HB2' HG23 ' A' ' 170' ' ' VAL . 51.7 ttp180 -119.85 -22.48 6.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.82 -0.55 . . . . 0.0 112.224 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.96 136.62 6.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.894 -1.129 . . . . 0.0 111.974 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.0 133.25 40.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 122.001 -0.437 . . . . 0.0 111.375 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.608 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 54.1 t -84.66 91.08 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 64.2 m -94.23 119.73 33.45 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.824 0.821 . . . . 0.0 111.352 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -89.95 -79.96 0.33 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.075 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -106.41 64.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.404 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 72.93 18.79 79.23 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 27.6 m -146.67 137.94 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.29 -1.123 . . . . 0.0 109.016 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -83.14 129.98 35.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.549 -0.72 . . . . 0.0 111.072 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -119.94 14.82 12.46 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.215 0.531 . . . . 0.0 110.089 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.06 152.15 2.84 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 116' ' ' VAL . 9.1 m -132.18 137.3 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.461 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -104.71 152.0 23.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.467 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -153.71 166.66 32.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.644 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.798 HG11 HD22 ' A' ' 82' ' ' LEU . 57.8 t -80.7 130.88 62.5 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.04 148.61 45.18 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.744 1.392 . . . . 0.0 109.863 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.33 -25.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.917 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.98 -29.69 68.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.312 -0.867 . . . . 0.0 108.72 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.903 ' O ' HG22 ' A' ' 177' ' ' THR . 30.9 m -71.08 -32.79 69.52 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.409 0.623 . . . . 0.0 109.395 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.696 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -69.37 -38.45 78.07 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.8 0.81 . . . . 0.0 108.937 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.01 -39.24 85.13 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.589 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 174' ' ' SER . 3.9 t . . . . . 0 N--CA 1.496 1.864 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.27 -178.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.558 ' HA ' HD23 ' A' ' 94' ' ' LEU . 97.4 mt-10 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.747 HG22 ' HG3' ' A' ' 142' ' ' PRO . 63.0 t -138.14 129.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -140.08 141.36 36.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.27 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.47 139.02 18.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.54 159.98 42.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.57 0.7 . . . . 0.0 110.215 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.7 m -137.28 121.39 17.88 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.8 0.81 . . . . 0.0 108.897 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.5 p -107.48 -179.87 4.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -14.92 18.45 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.213 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.6 p -99.14 -40.95 7.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 112.191 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -173.55 -168.52 0.45 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.926 -1.109 . . . . 0.0 112.098 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 p -118.4 144.66 45.76 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 8.4 p90 -161.4 -143.35 0.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.738 . . . . 0.0 110.132 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.559 HD11 ' N ' ' A' ' 109' ' ' ARG . 80.9 mt -134.64 162.96 30.83 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.615 -1.303 . . . . 0.0 112.833 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -151.89 129.84 11.76 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.648 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 75.5 m -103.07 127.7 50.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 0.0 111.418 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 86.9 m -74.82 122.56 23.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.746 -0.596 . . . . 0.0 109.568 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.55 129.48 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.4 t30 49.99 39.99 20.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.584 -0.698 . . . . 0.0 111.264 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.42 26.19 73.84 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 62.9 t -137.82 113.02 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -1.038 . . . . 0.0 109.611 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 7.9 t -74.47 121.28 21.23 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.464 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 87.6 m95 -110.01 129.96 55.6 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.493 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.839 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 4.5 t -136.74 179.99 6.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 139' ' ' SER . 30.3 m -90.2 126.37 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.138 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -60.08 -40.89 91.15 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.451 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -74.64 67.06 1.51 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.13 0.967 . . . . 0.0 108.64 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.1 -36.6 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.875 . . . . 0.0 109.366 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.109 . . . . 0.0 109.034 179.324 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.674 HG22 ' HD1' ' A' ' 85' ' ' TRP . 66.7 mt . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.462 0.648 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -95.37 145.25 25.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.791 -0.568 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 11.5 pt20 -75.27 157.41 34.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.669 -0.645 . . . . 0.0 111.101 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.3 mmm -96.88 -39.97 9.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.706 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.33 -178.18 7.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.598 -0.689 . . . . 0.0 109.333 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.852 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.2 m -150.9 125.55 9.63 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.81 76.69 4.24 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.93 -39.23 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 109.466 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -53.84 -26.2 23.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -115.66 0.64 13.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.656 -0.653 . . . . 0.0 110.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t0 60.37 56.82 3.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.893 -1.129 . . . . 0.0 108.591 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.718 HD22 HG11 ' A' ' 170' ' ' VAL . 22.6 tp -142.77 155.47 44.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.869 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.852 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -145.1 137.55 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.435 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.52 125.99 5.19 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.44 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.839 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.5 m-90 -90.04 -170.04 2.64 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -108.44 109.84 21.22 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.965 0 O-C-N 121.508 -0.745 . . . . 0.0 110.556 -179.343 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 121.464 0.65 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 32' ' ' GLU . 4.6 mm? -75.44 153.89 37.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.99 161.49 22.65 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.364 -0.835 . . . . 0.0 110.8 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo . . . . . 0 N--CA 1.492 1.42 0 O-C-N 123.797 1.42 . . . . 0.0 110.083 -179.929 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.3 m . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.2 m -101.66 7.84 41.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.426 -0.796 . . . . 0.0 111.511 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.88 76.1 1.16 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 108.618 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 145' ' ' CYS . 53.9 mt -95.26 172.42 8.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.753 -0.592 . . . . 0.0 109.808 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 53.0 p90 -152.06 142.2 22.29 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 38.9 tp -115.03 155.8 26.31 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.98 0.895 . . . . 0.0 111.908 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 111' ' ' ALA . 92.4 t -109.97 135.7 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 112' ' ' ASP . 45.1 p -83.25 175.79 9.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.559 ' N ' HD11 ' A' ' 44' ' ' LEU . 70.3 ttt-85 -41.95 -31.29 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.296 0.57 . . . . 0.0 111.422 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -99.99 -70.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.77 -82.44 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.566 -0.709 . . . . 0.0 110.328 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.604 ' HB3' HG23 ' A' ' 108' ' ' THR . 23.2 t0 46.86 90.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.389 -0.82 . . . . 0.0 111.4 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.19 49.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.685 . . . . 0.0 110.439 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.639 HD12 ' CD1' ' A' ' 126' ' ' LEU . 13.1 pt -70.06 156.03 92.49 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.668 ' O ' HD22 ' A' ' 127' ' ' LEU . 43.4 Cg_endo -103.31 141.11 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.982 1.517 . . . . 0.0 111.523 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 167' ' ' VAL . 62.8 t -130.02 130.06 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG2' HD21 ' A' ' 127' ' ' LEU . 21.5 mmm180 -90.26 116.59 28.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 7.3 ttp180 -60.39 123.48 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.93 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -100.01 4.51 44.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 109.935 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.76 176.99 41.78 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 92.5 m-20 -65.64 -21.54 66.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -1.059 . . . . 0.0 110.119 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -124.49 17.0 8.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -140.3 139.93 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.975 -1.078 . . . . 0.0 110.774 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -139.19 144.02 14.77 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 t -90.9 111.97 23.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.789 -0.83 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.639 ' CD1' HD12 ' A' ' 114' ' ' ILE . 44.3 tp -73.49 104.64 4.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.668 HD22 ' O ' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -60.02 -27.43 66.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.225 0.536 . . . . 0.0 110.387 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 t -112.39 105.49 56.12 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.713 -0.617 . . . . 0.0 110.76 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.78 141.74 19.6 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.911 1.479 . . . . 0.0 109.442 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.88 165.23 18.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.573 -0.704 . . . . 0.0 109.258 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.12 125.19 16.93 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.895 1.471 . . . . 0.0 109.935 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -49.64 -25.14 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.799 -0.563 . . . . 0.0 111.254 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.402 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 25.3 t -55.5 -38.12 68.76 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.654 0.74 . . . . 0.0 109.434 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 108' ' ' THR . 53.8 t80 -70.02 -29.18 66.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.87 2.0 50.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.583 -0.698 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 51.9 mttm -70.5 113.01 7.21 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.152 -0.967 . . . . 0.0 108.56 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.7 -9.05 56.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.6 t -75.27 -17.13 60.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.0 109.083 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.693 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -65.14 146.21 55.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 179.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.562 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 96.85 -14.98 63.39 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.54 -158.08 0.61 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.747 ' HG3' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -142.74 140.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 116.683 -1.745 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 4.5 mp -97.08 97.33 9.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.3 mp -90.01 138.13 31.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.689 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.03 -154.89 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -104.16 15.04 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.453 1.238 . . . . 0.0 110.365 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 m -117.14 16.9 14.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.44 37.59 46.8 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -125.2 132.08 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.85 119.97 37.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.18 -1.56 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.269 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.89 126.85 2.35 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.506 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.443 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.3 mt -109.94 117.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.105 -1.232 . . . . 0.0 108.283 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.433 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 15.2 t80 -50.92 128.67 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.419 ' HB3' HG23 ' A' ' 170' ' ' VAL . 34.5 ptt180 -119.34 -25.56 6.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.722 -0.612 . . . . 0.0 111.648 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -160.06 141.44 12.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 111.827 -178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.433 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -95.99 140.1 31.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.4 t -89.95 92.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 61.8 m -92.59 118.17 30.73 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.696 0.76 . . . . 0.0 111.028 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.648 HG22 ' HG3' ' A' ' 161' ' ' ARG . 96.7 m -89.94 -78.38 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 160' ' ' THR . 59.6 mtp85 -105.99 54.58 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 81.79 16.57 72.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -146.36 141.31 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.353 -1.086 . . . . 0.0 108.335 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -84.52 128.29 34.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.545 -0.722 . . . . 0.0 111.047 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -120.0 15.83 12.48 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.163 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.31 145.87 2.23 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -121.65 135.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.698 -177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -102.57 147.34 26.9 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 41.5 p90 -152.65 165.16 36.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.089 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.718 HG11 HD22 ' A' ' 82' ' ' LEU . 67.3 t -81.65 131.81 56.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.09 143.1 31.88 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.887 1.467 . . . . 0.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.77 -29.94 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 109.659 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 177' ' ' THR . 86.4 tt0 -58.98 -33.09 70.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 m -75.54 -29.65 59.48 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.855 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.595 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.5 mtp -69.95 -39.88 75.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 109.586 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.04 -39.92 87.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.73 -0.606 . . . . 0.0 110.069 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 173' ' ' GLU . 64.6 p . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.453 -0.78 . . . . 0.0 109.823 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.982 0 CA-C-O 121.157 0.503 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.3 t -111.26 126.32 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.0 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -96.25 139.85 31.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.417 0.627 . . . . 0.0 110.341 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.639 ' HA ' HD23 ' A' ' 44' ' ' LEU . 99.0 t -80.33 140.16 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.92 159.97 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 122.346 1.069 . . . . 0.0 112.0 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 78.2 p -148.5 116.93 6.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 59' ' ' ALA . 30.2 p -108.71 179.98 4.03 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.396 0.617 . . . . 0.0 109.651 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.65 -16.27 15.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -111.29 -27.35 8.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 113.166 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.41 ' NE2' ' HA3' ' A' ' 58' ' ' GLY . 15.8 pt20 -170.93 -170.01 0.83 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.582 -1.324 . . . . 0.0 112.54 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 75.3 m -127.84 140.79 51.82 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.7 p90 -159.69 -141.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 109.996 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 35' ' ' VAL . 84.4 mt -136.82 171.16 14.92 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.594 -1.316 . . . . 0.0 113.39 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -148.11 122.91 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.389 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 142' ' ' PRO . 93.5 m -85.89 120.83 27.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.592 -0.693 . . . . 0.0 110.541 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 85.3 m -74.46 119.7 19.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.362 178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' CG2' HG22 ' A' ' 46' ' ' THR . 41.5 t -140.89 131.88 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.37 -0.831 . . . . 0.0 110.465 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 52.86 40.03 30.05 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.508 -0.745 . . . . 0.0 111.025 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.625 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.59 27.36 73.58 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.487 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 84.0 t -140.0 118.87 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.542 -0.976 . . . . 0.0 109.675 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -74.04 129.01 37.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.516 ' CD2' ' HB2' ' A' ' 175' ' ' MET . 90.2 m95 -117.33 120.06 37.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.813 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.661 ' O ' HD23 ' A' ' 82' ' ' LEU . 6.5 t -129.15 -178.16 4.53 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.565 HG13 ' CA ' ' A' ' 140' ' ' GLY . 24.1 m -88.42 134.54 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 C-N-CA 118.942 -1.103 . . . . 0.0 113.359 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -64.37 -40.0 94.98 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.366 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.478 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 41.8 p-80 -71.65 75.07 0.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.09 0.948 . . . . 0.0 109.326 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.41 ' HA3' ' NE2' ' A' ' 41' ' ' GLN . . . 158.55 -42.61 0.49 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.774 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.671 -0.9 . . . . 0.0 110.915 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.522 3.148 0 CA-C-O 121.181 0.515 . . . . 0.0 112.377 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 121.709 -0.619 . . . . 0.0 109.6 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -88.1 136.49 32.95 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 111.436 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 19.4 pt20 -73.3 146.47 45.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.812 -0.555 . . . . 0.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.11 -37.71 8.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.517 -0.739 . . . . 0.0 109.955 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -171.96 -177.56 1.95 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.503 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.0 t -159.99 143.6 14.16 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.732 0.777 . . . . 0.0 110.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.92 80.67 1.46 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.93 -39.99 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.74 . . . . 0.0 110.056 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -56.58 -26.55 55.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.288 -0.883 . . . . 0.0 108.853 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -110.39 2.44 19.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.717 -0.614 . . . . 0.0 110.706 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 60.56 56.38 3.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 111.336 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 54' ' ' THR . 2.3 mt -144.54 150.56 37.73 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.527 -0.733 . . . . 0.0 110.261 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -136.95 128.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.27 123.56 5.7 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 118.876 -1.63 . . . . 0.0 113.222 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.491 ' CD1' HD23 ' A' ' 64' ' ' LEU . 5.8 m-90 -92.69 -170.78 2.55 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 122.025 -0.691 . . . . 0.0 109.676 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.2 100.99 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 111.091 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.901 HD13 HD21 ' A' ' 144' ' ' LEU . 68.2 mt -91.37 154.38 19.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.834 -0.541 . . . . 0.0 110.088 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.51 164.51 17.03 Favored Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.555 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.67 ' HB3' HG11 ' A' ' 172' ' ' VAL . 51.5 Cg_endo . . . . . 0 N--CA 1.49 1.272 0 O-C-N 123.87 1.458 . . . . 0.0 110.324 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.265 0.555 . . . . 0.0 110.181 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.2 m -95.4 20.43 9.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.629 -0.669 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -69.97 73.7 0.44 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.611 -0.681 . . . . 0.0 109.188 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 118' ' ' ARG . 76.5 mt -90.17 174.48 7.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.2 p90 -153.14 144.53 23.24 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' PRO . 28.1 tp -116.35 142.53 46.73 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.705 0.764 . . . . 0.0 111.297 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -91.66 125.08 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HD12 ' A' ' 114' ' ' ILE . 72.0 p -85.82 170.66 12.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.731 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -28.89 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.892 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 108' ' ' THR . 73.6 m-70 -99.99 -86.32 0.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.132 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.64 22.33 0.12 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.191 -0.943 . . . . 0.0 111.358 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -66.43 129.07 38.61 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.052 -1.03 . . . . 0.0 110.466 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -69.97 -53.38 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.686 -0.634 . . . . 0.0 110.514 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.741 ' CG2' HD11 ' A' ' 126' ' ' LEU . 83.1 mt 46.46 73.69 0.94 Allowed Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.526 -0.734 . . . . 0.0 111.083 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -59.74 130.52 35.47 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.864 1.455 . . . . 0.0 111.187 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HD12 ' A' ' 126' ' ' LEU . 60.9 t -127.95 131.98 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -87.64 124.59 33.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 108.708 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.652 ' HB2' HD12 ' A' ' 104' ' ' LEU . 3.1 ttm180 -63.93 123.01 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.549 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -97.88 1.45 48.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.4 170.23 38.08 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.1 m-20 -58.7 -23.74 60.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.158 -1.201 . . . . 0.0 110.365 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 93.0 p -121.67 17.6 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 112.331 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -144.07 142.39 30.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.03 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.43 142.71 13.4 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 116' ' ' VAL . 25.0 p -88.77 114.84 25.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.839 -0.8 . . . . 0.0 109.477 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 116' ' ' VAL . 20.5 tp -72.26 109.98 6.38 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.92 -20.58 65.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.86 -0.525 . . . . 0.0 110.375 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -117.67 84.23 19.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.744 -0.597 . . . . 0.0 109.962 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -58.34 138.29 85.04 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.761 1.4 . . . . 0.0 110.381 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -152.99 164.69 19.53 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.55 127.43 24.59 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.77 1.405 . . . . 0.0 110.473 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -50.11 -25.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.814 -0.554 . . . . 0.0 110.702 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -59.91 -37.63 79.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.577 -0.702 . . . . 0.0 109.469 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -69.01 -25.86 64.72 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.76 -1.73 44.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.46 -0.775 . . . . 0.0 110.406 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -70.17 122.1 18.82 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.152 -0.968 . . . . 0.0 108.563 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.92 -11.41 64.23 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.1 t -79.03 -16.23 57.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.443 -1.034 . . . . 0.0 109.672 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.552 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.9 m -62.26 147.42 48.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.565 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.09 -9.91 75.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -68.9 -169.56 5.97 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.1 Cg_endo -140.34 142.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 116.974 -1.551 . . . . 0.0 112.396 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.5 mp -96.59 96.35 8.59 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.901 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -87.39 141.55 28.55 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.575 ' HA ' HD23 ' A' ' 104' ' ' LEU . 85.2 m -63.71 -173.0 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.2 Cg_endo -87.79 17.27 1.74 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 117.249 -1.368 . . . . 0.0 111.6 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -122.03 18.11 10.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.07 -1.018 . . . . 0.0 111.764 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.14 35.74 37.42 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -122.87 123.38 40.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.374 -1.074 . . . . 0.0 110.34 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.95 123.33 34.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.621 -0.674 . . . . 0.0 110.179 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.02 -2.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.638 -0.664 . . . . 0.0 111.694 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -145.45 126.66 2.63 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.419 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 170' ' ' VAL . 18.1 mt -110.07 121.76 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.188 -1.184 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.834 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 8.0 t80 -51.76 122.83 8.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.841 0.829 . . . . 0.0 112.442 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.499 ' HB2' HG13 ' A' ' 170' ' ' VAL . 39.6 ttt-85 -115.9 -29.41 6.37 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.424 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -166.07 169.43 14.56 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.926 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.834 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -139.48 155.12 47.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 15.5 m -107.6 105.39 18.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.742 0.782 . . . . 0.0 109.501 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.5 p -95.36 121.84 37.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 110.36 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.548 HG22 ' HG3' ' A' ' 161' ' ' ARG . 91.0 m -89.98 -79.89 0.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.567 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.548 ' HG3' HG22 ' A' ' 160' ' ' THR . 99.6 mtt180 -96.96 52.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.96 15.94 77.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.2 m -144.67 140.01 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.386 -1.067 . . . . 0.0 108.35 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -81.56 116.93 21.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.657 0.741 . . . . 0.0 111.675 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.57 8.12 45.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.722 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -171.53 141.83 1.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.286 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 124' ' ' GLY . 20.1 m -109.62 143.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.713 0.768 . . . . 0.0 112.687 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -111.19 142.07 43.88 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 34.2 p90 -152.83 165.04 36.65 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.276 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 155' ' ' ARG . 26.9 m -90.68 133.03 33.33 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.908 -0.495 . . . . 0.0 110.015 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.63 157.2 56.35 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.719 1.378 . . . . 0.0 109.936 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.711 HG23 ' HE3' ' A' ' 175' ' ' MET . 7.1 p -64.36 -27.23 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.49 -0.756 . . . . 0.0 109.594 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 177' ' ' THR . 86.2 tt0 -58.59 -25.39 62.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 108.547 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.3 m -74.15 -40.1 62.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.596 -0.69 . . . . 0.0 111.934 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.711 ' HE3' HG23 ' A' ' 172' ' ' VAL . 16.7 ptp -69.85 -41.06 75.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.667 -1.271 . . . . 0.0 108.815 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 175' ' ' MET . 98.9 mt-10 -59.98 -39.97 87.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.793 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 173' ' ' GLU . 43.4 p . . . . . 0 N--CA 1.498 1.966 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.179 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.249 0.547 . . . . 0.0 110.333 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.417 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.524 3.232 0 CA-C-O 121.218 0.532 . . . . 0.0 111.968 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . . . . . . 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.581 HG22 ' HD1' ' A' ' 85' ' ' TRP . 94.5 mt . . . . . 0 N--CA 1.495 1.778 0 CA-C-O 121.136 0.493 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.455 ' CD1' ' N ' ' A' ' 76' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo . . . . . 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.093 0.473 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p . . . . . 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.537 ' CG ' HD21 ' A' ' 94' ' ' LEU . 94.9 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.411 0.624 . . . . 0.0 110.157 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.8 t -130.02 133.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -139.96 151.96 45.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 44' ' ' LEU . 63.5 t -82.77 137.82 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 64' ' ' LEU . 9.1 m -143.95 170.16 9.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.6 t -150.63 149.26 29.63 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.928 0.87 . . . . 0.0 109.603 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.7 t -119.69 -180.0 4.06 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.62 -16.25 2.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.612 -0.68 . . . . 0.0 112.274 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 38' ' ' THR . 76.3 p -98.27 -37.21 9.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.902 -1.124 . . . . 0.0 112.887 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -171.48 -174.21 1.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.805 -1.184 . . . . 0.0 112.313 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.3 p -116.76 143.74 45.29 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.663 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.9 p90 -162.52 -139.09 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 35' ' ' VAL . 76.1 mt -134.57 164.61 27.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 113.363 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.45 125.29 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.315 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.776 ' CG2' HD11 ' A' ' 153' ' ' ILE . 5.9 t -83.55 -152.0 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 0.0 110.745 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.521 ' N ' HG23 ' A' ' 46' ' ' THR . 13.6 t -159.35 113.52 2.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.567 HG12 ' ND2' ' A' ' 49' ' ' ASN . 57.1 t -138.71 135.52 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.299 -0.961 . . . . 0.0 111.371 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' ND2' HG12 ' A' ' 48' ' ' VAL . 81.1 m-20 49.99 39.98 20.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.667 -0.645 . . . . 0.0 110.935 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.729 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.28 24.93 74.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.0 t -133.7 113.66 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.831 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 130.08 38.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.515 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.1 m95 -118.46 133.93 55.48 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.453 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.814 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -139.01 -178.47 5.35 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.677 HG13 ' CA ' ' A' ' 140' ' ' GLY . 21.2 m -82.77 134.26 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.671 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 49.7 t80 -64.22 -39.96 95.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.474 ' CE1' ' HB ' ' A' ' 55' ' ' VAL . 11.5 p-80 -63.11 -16.27 59.43 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.531 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 38' ' ' THR . . . -90.7 -82.7 1.4 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' A' ' 38' ' ' THR . . . . . . . . 0 N--CA 1.5 2.052 0 O-C-N 121.397 -1.061 . . . . 0.0 111.19 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.528 HD22 ' CZ2' ' A' ' 85' ' ' TRP . 20.2 tp . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 120.316 0.103 . . . . 0.0 110.898 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.476 ' HB3' HG12 ' A' ' 36' ' ' VAL . . . . . . . . 0 N--CA 1.5 2.057 0 O-C-N 120.876 -1.14 . . . . 0.0 110.565 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.49 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.039 0 CA-C-O 120.869 0.366 . . . . 0.0 110.198 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 70.0 m -139.32 132.86 30.34 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 8.1 pt20 -76.22 153.22 36.25 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.444 -0.785 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.5 ttp -107.88 -30.05 8.71 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TYR . . . . . 0.476 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -148.84 167.71 24.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.891 HG23 ' CG1' ' A' ' 83' ' ' VAL . 29.7 m -154.03 114.15 3.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.636 -0.665 . . . . 0.0 110.428 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 76.98 4.22 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.746 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 98.3 t -59.95 -40.0 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.405 -0.809 . . . . 0.0 109.724 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.55 -25.85 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.68 -1.23 16.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.792 -0.567 . . . . 0.0 110.703 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.92 57.72 3.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.1 -1.0 . . . . 0.0 109.332 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 170' ' ' VAL . 42.9 tp -147.77 153.55 39.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.691 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.891 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -143.09 131.78 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.73 124.79 5.79 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.768 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.3 m-90 -84.69 170.01 13.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 122.049 -0.677 . . . . 0.0 109.771 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.28 89.29 4.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 109.352 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . . . . . . 0 N--CA 1.496 1.851 0 O-C-N 121.552 -0.717 . . . . 0.0 110.532 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.231 0.539 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 ' CG ' ' A' ' 32' ' ' GLU . 97.1 mt -90.14 170.03 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 110.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 92.6 m -111.94 164.18 15.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 52.6 Cg_endo . . . . . 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.639 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.1 t . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.136 0.493 . . . . 0.0 109.812 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -89.95 11.76 19.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.0 111.386 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -70.01 80.08 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 108.694 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 143' ' ' LEU . 96.0 mt -86.62 176.73 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.66 . . . . 0.0 110.95 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -146.24 100.89 3.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HG ' ' A' ' 143' ' ' LEU . 35.0 tp -76.24 139.95 41.39 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.513 0.673 . . . . 0.0 110.013 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 33' ' ' VAL . 78.3 t -85.32 111.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' ALA . 55.5 p -81.38 172.39 13.61 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -42.6 -27.95 0.2 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.712 -0.618 . . . . 0.0 112.149 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -100.01 -68.91 0.79 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.407 -0.808 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 108' ' ' THR . . . -146.53 -161.71 1.38 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 26.8 p-10 -60.0 -44.69 94.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.535 -0.728 . . . . 0.0 110.244 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.7 t 46.28 -89.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.625 HD12 ' CD1' ' A' ' 126' ' ' LEU . 50.1 pt -74.84 142.82 77.2 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 112.712 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 44.1 Cg_endo -105.81 141.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 O-C-N 123.777 1.409 . . . . 0.0 108.718 177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 167' ' ' VAL . 41.8 t -133.93 133.13 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.028 -1.045 . . . . 0.0 111.447 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -92.61 119.25 31.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.4 ttm180 -61.06 126.02 25.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 110.798 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -99.1 1.4 45.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.803 -0.56 . . . . 0.0 109.698 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.13 43.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 86.4 m-20 -67.19 -21.87 65.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.7 p -123.38 16.33 9.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.513 -0.742 . . . . 0.0 111.46 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.39 143.56 35.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.072 -1.018 . . . . 0.0 111.244 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -143.34 139.21 8.71 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.48 ' C ' HG13 ' A' ' 116' ' ' VAL . 17.6 t -88.84 110.51 21.11 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.909 -0.76 . . . . 0.0 110.125 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.625 ' CD1' HD12 ' A' ' 114' ' ' ILE . 59.6 tp -71.03 114.58 9.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.782 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 3.5 mm? -68.87 -25.0 64.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.234 0.54 . . . . 0.0 110.335 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.8 m -120.82 84.54 38.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.763 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.2 Cg_endo -61.69 143.26 96.31 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.919 1.483 . . . . 0.0 110.039 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -152.96 167.78 12.72 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -57.54 125.29 18.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.773 1.407 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.9 -25.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.749 -0.594 . . . . 0.0 110.931 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.411 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 21.1 t -57.93 -34.95 70.42 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 109.496 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.87 1.52 38.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.549 -0.719 . . . . 0.0 110.913 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.0 mtpt -72.33 68.92 0.78 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.129 0.966 . . . . 0.0 109.173 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 157.05 -21.28 0.43 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.536 ' HA ' HD12 ' A' ' 44' ' ' LEU . 16.8 t -75.0 -11.45 60.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.506 -0.997 . . . . 0.0 110.367 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -68.71 150.9 47.37 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.314 -0.866 . . . . 0.0 109.216 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . 0.677 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 87.31 -11.49 65.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -70.54 -167.41 6.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PRO . . . . . 0.517 ' HG3' HG22 ' A' ' 33' ' ' VAL . 49.0 Cg_endo -139.98 140.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 116.866 -1.623 . . . . 0.0 111.622 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.482 ' HB3' HD13 ' A' ' 104' ' ' LEU . 2.5 mt -92.67 99.2 11.94 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.4 mp -86.47 142.39 28.41 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.797 0.808 . . . . 0.0 112.759 -176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.04 -170.15 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.36 12.55 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.62 1.326 . . . . 0.0 111.031 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -119.86 -18.95 8.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 111.36 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 39.12 0.81 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 55.9 m80 -122.96 118.65 28.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -1.043 . . . . 0.0 110.538 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -81.08 120.29 24.64 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 109.354 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.18 -3.89 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 112.068 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.462 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.6 124.41 1.85 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.362 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.776 HD11 ' CG2' ' A' ' 46' ' ' THR . 14.9 mt -106.12 121.75 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.014 -1.286 . . . . 0.0 109.009 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.839 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.5 t80 -51.36 124.53 12.09 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.76 0.791 . . . . 0.0 111.978 -178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.0 ttt180 -114.63 -34.13 5.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.843 -0.535 . . . . 0.0 110.818 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.414 ' O ' ' CE1' ' A' ' 154' ' ' PHE . . . -162.54 164.41 26.89 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.488 -0.757 . . . . 0.0 110.326 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.839 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.78 158.06 37.55 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 2.7 t -99.96 98.79 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.9 p -96.23 118.27 32.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.432 1.11 . . . . 0.0 112.32 -177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 162' ' ' GLY . 90.9 m -93.45 119.52 32.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' THR . 32.0 ttm105 65.51 -64.4 0.19 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.958 -0.464 . . . . 0.0 110.135 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.449 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -165.1 25.54 0.18 Allowed Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.819 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.2 m -148.9 139.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -1.186 . . . . 0.0 109.494 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -82.26 123.01 28.65 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.596 0.712 . . . . 0.0 111.679 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -113.83 17.65 17.89 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.25 0.548 . . . . 0.0 109.851 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -172.43 149.34 2.16 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 116' ' ' VAL . 13.8 m -127.4 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.64 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -107.39 149.5 27.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.3 p90 -152.13 166.36 31.91 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.234 -1.386 . . . . 0.0 112.174 -178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 82' ' ' LEU . 66.8 t -80.98 137.41 49.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -78.35 141.35 18.0 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.839 1.442 . . . . 0.0 110.739 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.02 -29.98 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.72 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.06 -32.84 70.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.393 -0.817 . . . . 0.0 108.981 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.8 t -72.1 -33.63 68.01 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' MET . . . . . 0.595 ' CG ' HD21 ' A' ' 82' ' ' LEU . 10.4 mtp -70.03 -36.26 74.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.781 -0.574 . . . . 0.0 110.036 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 58.5 p . . . . . 0 N--CA 1.498 1.962 0 O-C-N 121.417 -0.802 . . . . 0.0 110.792 -179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.133 0.492 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.9 167.53 43.16 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' HG2' ' HG3' ' A' ' 68' ' ' LYS . 18.9 tpt180 -70.03 -61.28 1.84 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.459 -1.024 . . . . 0.0 109.758 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 25.0 t0 48.43 49.96 17.4 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.717 -0.614 . . . . 0.0 112.612 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.456 ' O ' ' CG ' ' A' ' 67' ' ' PRO . 32.2 mttt -115.31 172.48 7.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 110.706 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 63.77 123.94 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.968 -1.083 . . . . 0.0 109.341 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -58.13 127.37 31.74 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.33 -0.856 . . . . 0.0 110.737 -178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.436 HG21 ' O ' ' A' ' 90' ' ' GLY . 93.8 t -86.43 -53.27 10.64 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 CA-C-O 121.516 0.674 . . . . 0.0 110.053 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 48.21 37.39 8.17 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.695 -0.628 . . . . 0.0 111.209 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -126.02 134.1 8.51 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HG2' HD21 ' A' ' 94' ' ' LEU . 57.8 mp0 -69.92 -40.08 75.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.708 -0.878 . . . . 0.0 110.166 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.693 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -123.52 129.98 74.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -116.63 127.78 54.77 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.688 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.766 HG22 HD21 ' A' ' 44' ' ' LEU . 98.5 t -84.33 136.18 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -142.91 174.72 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 119.682 -0.807 . . . . 0.0 110.534 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.1 t -138.24 136.19 36.3 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.093 0.949 . . . . 0.0 109.129 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.8 HG21 ' HA ' ' A' ' 59' ' ' ALA . 19.4 p -113.64 179.9 3.83 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 115.349 -0.841 . . . . 0.0 108.912 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.88 -15.64 32.92 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.04 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 28.5 p -104.78 -36.73 7.31 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.302 -0.873 . . . . 0.0 112.462 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -173.6 -169.14 0.48 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 120.853 -1.154 . . . . 0.0 111.957 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.1 m -123.71 143.76 50.08 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.862 -0.524 . . . . 0.0 109.601 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.421 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.2 p90 -160.26 -138.12 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.549 -0.719 . . . . 0.0 109.911 -178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.766 HD21 HG22 ' A' ' 35' ' ' VAL . 82.0 mt -135.4 166.64 22.7 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.421 -1.425 . . . . 0.0 113.653 -177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -150.05 122.81 8.66 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.243 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.597 HG21 ' HB3' ' A' ' 142' ' ' PRO . 32.7 m -101.14 127.21 47.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.44 -0.787 . . . . 0.0 111.729 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.618 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 93.3 m -74.11 123.11 23.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.825 -0.547 . . . . 0.0 109.827 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -138.95 130.04 34.55 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.455 -0.778 . . . . 0.0 110.096 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 52.67 40.01 29.45 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.476 -0.765 . . . . 0.0 110.906 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.19 28.04 73.49 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 63.5 t -140.04 117.0 9.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.564 -0.963 . . . . 0.0 109.29 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 8.4 t -76.28 122.99 25.22 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.831 -0.748 . . . . 0.0 109.294 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.49 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 95.5 m95 -113.48 130.02 56.42 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.322 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.607 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 11.8 t -133.08 -179.75 5.68 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 140' ' ' GLY . 7.0 m -90.72 131.0 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 C-N-CA 118.534 -1.266 . . . . 0.0 112.076 -179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -59.92 -40.04 87.52 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.043 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.722 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 49.8 p-80 -74.82 68.74 1.77 Allowed 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.29 1.043 . . . . 0.0 108.829 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 172.0 -38.43 0.16 Allowed Glycine 0 N--CA 1.484 1.89 0 N-CA-C 107.421 -2.272 . . . . 0.0 107.421 -179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.8 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -80.02 -66.79 0.83 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.792 -0.828 . . . . 0.0 109.182 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 74.52 -98.84 1.06 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.8 m -91.28 46.36 1.3 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.657 -0.907 . . . . 0.0 110.629 -179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.599 ' HD2' HG23 ' A' ' 72' ' ' THR . 16.6 pttt 37.54 -130.34 0.16 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 123.037 0.535 . . . . 0.0 111.5 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 63' ' ' THR . 49.8 m 47.34 54.11 9.99 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.243 -0.911 . . . . 0.0 111.919 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.6 OUTLIER -86.95 -132.79 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.441 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -141.25 109.02 5.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.964 -1.085 . . . . 0.0 109.547 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -73.06 -149.51 1.15 Allowed Glycine 0 N--CA 1.479 1.539 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.456 ' CG ' ' O ' ' A' ' 26' ' ' LYS . 42.0 Cg_endo -60.18 -32.15 94.11 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 O-C-N 124.321 1.695 . . . . 0.0 109.259 178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HG3' ' HG2' ' A' ' 24' ' ' ARG . 19.9 ptmt -153.33 -2.67 0.21 Allowed 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -148.91 162.44 28.92 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.648 -178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -63.2 125.8 16.53 Favored 'Trans proline' 0 N--CA 1.491 1.349 0 O-C-N 123.956 1.503 . . . . 0.0 111.014 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.506 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 39.8 mt -104.86 152.61 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-O 121.347 0.594 . . . . 0.0 109.676 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.599 HG23 ' HD2' ' A' ' 62' ' ' LYS . 91.3 m -96.24 144.83 26.09 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.731 -0.606 . . . . 0.0 110.626 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.442 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 14.8 pt20 -75.94 151.4 37.3 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.574 -0.704 . . . . 0.0 110.784 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 6.6 ttt -98.78 -39.84 8.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.547 -0.721 . . . . 0.0 110.398 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.552 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.8 OUTLIER -139.97 166.75 23.82 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.63 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.918 HG23 ' CG1' ' A' ' 83' ' ' VAL . 24.0 m -154.68 111.06 3.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.628 -0.67 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.86 78.61 5.38 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 88.8 t -60.04 -40.0 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.428 -0.795 . . . . 0.0 109.767 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -55.74 -26.22 44.46 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.449 -0.782 . . . . 0.0 109.003 177.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -111.66 -0.71 15.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.736 -0.602 . . . . 0.0 110.762 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.7 t70 59.95 57.75 2.97 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.105 -0.997 . . . . 0.0 109.553 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.713 HD13 HG11 ' A' ' 170' ' ' VAL . 52.8 tp -146.23 152.37 39.08 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.976 -0.69 . . . . 0.0 109.92 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.918 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.4 OUTLIER -143.11 127.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -120.25 123.96 5.76 Favored Glycine 0 N--CA 1.498 2.798 0 C-N-CA 119.262 -1.446 . . . . 0.0 111.753 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.607 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.2 m-90 -84.72 -174.94 5.55 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.144 -0.621 . . . . 0.0 109.47 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -110.07 73.71 0.85 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.362 -0.836 . . . . 0.0 109.631 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.34 130.87 88.87 Favored Pre-proline 0 N--CA 1.503 2.175 0 O-C-N 121.791 -0.568 . . . . 0.0 111.436 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.615 ' HB2' ' HD3' ' A' ' 89' ' ' PRO . 40.6 Cg_endo -134.14 -91.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.557 1.65 0 O-C-N 123.658 1.346 . . . . 0.0 110.422 178.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.615 ' HD3' ' HB2' ' A' ' 88' ' ' PRO . 56.9 Cg_endo -81.93 8.64 4.34 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 114.855 -2.964 . . . . 0.0 111.494 179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 29' ' ' VAL . . . -118.5 43.58 1.57 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.618 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -175.43 134.68 0.31 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.419 -1.048 . . . . 0.0 110.651 179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 24.4 tpt180 -73.48 -28.49 61.96 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.545 0.688 . . . . 0.0 110.554 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.67 115.35 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.39 0.614 . . . . 0.0 111.151 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.986 HD13 HD11 ' A' ' 144' ' ' LEU . 85.1 mt -85.65 167.09 15.64 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.661 -0.649 . . . . 0.0 110.121 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.444 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 3.8 m -89.49 135.23 31.21 Favored Pre-proline 0 N--CA 1.495 1.807 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.506 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -66.1 -85.33 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.054 0 O-C-N 123.894 1.471 . . . . 0.0 110.067 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 59.34 114.97 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.207 0 O-C-N 121.081 -1.012 . . . . 0.0 110.463 178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 99' ' ' CYS . 94.1 m -61.05 -40.05 92.16 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.412 -0.805 . . . . 0.0 111.848 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 98' ' ' THR . 1.6 m 61.79 117.3 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.573 0 O-C-N 121.418 -0.801 . . . . 0.0 111.754 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.98 -38.73 92.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 107.445 -2.262 . . . . 0.0 107.445 177.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 70.7 m -70.48 148.9 47.77 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.952 -0.734 . . . . 0.0 109.208 178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.0 m -117.46 14.62 14.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.391 -0.818 . . . . 0.0 111.375 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -72.18 75.75 0.97 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.235 -0.916 . . . . 0.0 108.786 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.553 HD23 ' HA ' ' A' ' 145' ' ' CYS . 79.8 mt -84.28 176.19 8.9 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.479 0.657 . . . . 0.0 111.125 -178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.426 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.9 m-85 -140.96 131.89 26.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 37.5 tp -112.96 148.13 35.68 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.946 0.879 . . . . 0.0 111.529 -178.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 111' ' ' ALA . 83.9 t -119.97 135.88 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.612 HG23 ' HB3' ' A' ' 112' ' ' ASP . 26.7 p -81.08 179.9 7.65 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.287 -0.883 . . . . 0.0 109.525 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.552 ' O ' HG21 ' A' ' 35' ' ' VAL . 13.0 ptm180 -41.87 -29.9 0.23 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.4 p80 -116.66 -50.01 2.63 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.12 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.442 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -156.86 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.934 -1.104 . . . . 0.0 111.597 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.612 ' HB3' HG23 ' A' ' 108' ' ' THR . 16.9 t70 47.08 73.67 0.18 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.088 -1.008 . . . . 0.0 111.203 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.9 t -82.56 99.99 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.98 -0.688 . . . . 0.0 109.189 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 46.8 mm -120.95 150.01 52.21 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.753 -0.592 . . . . 0.0 109.542 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.426 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 48.3 Cg_endo -90.44 133.03 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 124.015 1.534 . . . . 0.0 110.559 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.552 HG11 HG21 ' A' ' 167' ' ' VAL . 61.7 t -127.57 130.03 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.7 tpt180 -90.34 118.23 29.68 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.496 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.6 ttp180 -62.07 125.8 25.11 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.805 -178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 27.5 mmm180 -98.43 4.36 48.43 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.787 -0.571 . . . . 0.0 109.569 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.99 170.67 32.17 Favored Glycine 0 N--CA 1.482 1.738 0 N-CA-C 107.436 -2.266 . . . . 0.0 107.436 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 78.2 m-20 -60.83 -19.69 60.3 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.462 -1.022 . . . . 0.0 110.122 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 88.5 p -121.56 15.98 11.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.471 -0.768 . . . . 0.0 111.822 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -146.08 143.27 29.27 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.987 -1.07 . . . . 0.0 111.431 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.51 141.85 11.81 Favored Glycine 0 N--CA 1.484 1.894 0 N-CA-C 108.384 -1.886 . . . . 0.0 108.384 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.4 ' C ' HG13 ' A' ' 116' ' ' VAL . 3.4 m -90.3 111.6 22.85 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.951 -0.735 . . . . 0.0 110.326 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.482 HD12 HG22 ' A' ' 116' ' ' VAL . 55.5 tp -73.56 109.93 7.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.347 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.404 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 3.8 mm? -60.03 -30.0 68.89 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 121.355 0.597 . . . . 0.0 110.25 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 68.4 m -114.25 97.75 46.6 Favored Pre-proline 0 N--CA 1.491 1.613 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.516 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -64.91 142.18 74.34 Favored 'Trans proline' 0 N--CA 1.489 1.261 0 O-C-N 123.909 1.478 . . . . 0.0 109.965 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -149.99 161.06 32.3 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.81 122.84 12.42 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.832 1.438 . . . . 0.0 110.92 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 15.0 p -49.98 -28.69 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 CA-C-O 121.299 0.571 . . . . 0.0 110.9 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.5 t -59.01 -34.9 72.4 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.66 0.743 . . . . 0.0 109.207 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.467 ' CE2' HG21 ' A' ' 108' ' ' THR . 72.7 t80 -70.04 -27.32 64.56 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 97.4 mt -85.47 5.6 30.48 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.484 -0.76 . . . . 0.0 110.858 179.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 24.3 mmtm -68.11 110.16 3.85 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.41 -7.04 55.98 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.6 p -74.9 -17.93 60.49 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.433 -1.04 . . . . 0.0 109.056 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.09 149.51 50.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.414 -0.804 . . . . 0.0 108.885 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 55' ' ' VAL . . . 91.16 -9.51 77.45 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.415 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -77.15 -151.52 4.41 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 108.6 -1.8 . . . . 0.0 108.6 179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.693 ' HG3' HG22 ' A' ' 33' ' ' VAL . 51.7 Cg_endo -147.5 148.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.844 0 C-N-CA 116.307 -1.996 . . . . 0.0 112.921 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.4 mp -99.89 98.43 9.21 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.333 -1.728 . . . . 0.0 106.333 176.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.986 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -83.43 135.61 34.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.553 ' HA ' HD23 ' A' ' 104' ' ' LEU . 84.4 m -58.82 175.6 0.32 Allowed Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 176.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 40.5 Cg_endo -72.11 -5.04 16.31 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 117.215 -1.39 . . . . 0.0 110.977 178.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.402 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 9.8 t -106.14 -0.22 24.84 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.905 -1.122 . . . . 0.0 112.27 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.69 33.84 6.55 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.444 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 34.7 m170 -114.04 118.53 34.35 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -77.34 121.86 24.33 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.394 -0.816 . . . . 0.0 110.685 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.03 -4.12 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.799 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.472 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -152.79 131.08 3.22 Favored Glycine 0 N--CA 1.497 2.732 0 C-N-CA 119.457 -1.354 . . . . 0.0 111.279 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.504 HD12 ' CE ' ' A' ' 175' ' ' MET . 74.5 mt -109.91 119.14 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 O-C-N 121.098 -1.236 . . . . 0.0 108.163 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.407 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 16.9 t80 -49.99 129.29 20.34 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.393 -0.817 . . . . 0.0 112.362 -177.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.409 ' HB2' HG23 ' A' ' 170' ' ' VAL . 41.8 ttt180 -117.22 -30.08 5.72 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.938 -0.476 . . . . 0.0 111.569 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.82 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.08 146.56 12.51 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.3 -0.96 . . . . 0.0 111.585 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.97 138.29 37.24 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.22 0.533 . . . . 0.0 111.738 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 166' ' ' ALA . 42.9 t -95.72 90.97 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 29.1 p -94.03 122.24 36.33 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 122.115 0.96 . . . . 0.0 112.111 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.514 HG22 ' N ' ' A' ' 161' ' ' ARG . 80.4 m -87.1 -102.07 0.07 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.116 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.514 ' N ' HG22 ' A' ' 160' ' ' THR . 12.8 tpt180 -59.98 -50.0 75.47 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.601 -1.312 . . . . 0.0 109.464 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.443 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -176.18 30.53 0.08 OUTLIER Glycine 0 N--CA 1.493 2.49 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.762 HG23 ' HD3' ' A' ' 165' ' ' LYS . 33.0 m -149.84 145.89 17.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -75.92 125.34 28.91 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 0.0 111.24 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.762 ' HD3' HG23 ' A' ' 163' ' ' VAL . 4.2 mmmm -103.88 7.14 36.84 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.298 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.516 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.26 137.86 0.4 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.552 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -105.82 134.68 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.616 -0.834 . . . . 0.0 112.428 -178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -100.41 146.59 26.82 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.472 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 40.3 p90 -152.55 162.96 40.5 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.314 -177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 82' ' ' LEU . 61.0 t -79.82 143.76 58.75 Favored Pre-proline 0 N--CA 1.499 1.985 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.499 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -83.75 141.54 9.75 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.747 1.393 . . . . 0.0 111.717 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.499 HG23 ' SD ' ' A' ' 175' ' ' MET . 14.9 p -69.05 -27.67 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -59.08 -28.69 66.72 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 31.3 t -70.65 -26.28 63.38 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.504 ' CE ' HD12 ' A' ' 153' ' ' ILE . 66.3 mtt -69.32 -36.62 77.14 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.04 -35.6 75.47 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.778 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 73.9 p -60.74 -40.06 90.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.011 -1.056 . . . . 0.0 109.525 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.552 HG23 ' CG ' ' A' ' 75' ' ' TYR . 94.4 m -64.46 -39.9 94.69 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.61 -39.89 89.84 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -61.7 -39.73 92.52 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.742 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -163.55 121.01 1.83 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.886 -0.509 . . . . 0.0 110.837 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.428 ' O ' ' N ' ' A' ' 184' ' ' LYS . 12.9 p -72.87 87.87 1.32 Allowed 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.956 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 182' ' ' SER . 57.7 tptt 63.58 -61.78 0.15 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 122.218 -0.301 . . . . 0.0 111.303 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 182' ' ' SER . 84.0 tttt 53.22 58.77 4.93 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.965 -1.084 . . . . 0.0 110.403 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -70.54 -39.93 73.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.506 0.669 . . . . 0.0 110.284 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 57.5 mttp . . . . . 0 C--N 1.294 -1.833 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.278 -179.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.82 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.168 0.509 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.9 143.15 14.37 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -120.03 139.98 51.68 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.635 -0.921 . . . . 0.0 110.391 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -81.26 161.71 23.82 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.251 -0.579 . . . . 0.0 109.798 179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -80.04 70.03 6.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.594 -0.691 . . . . 0.0 111.624 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.446 ' HA ' ' HB2' ' A' ' 67' ' ' PRO . 17.4 t-20 47.26 25.05 0.5 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.49 -0.756 . . . . 0.0 112.309 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -147.44 131.5 17.27 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.249 -0.907 . . . . 0.0 110.393 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG13 ' NE2' ' A' ' 34' ' ' GLN . 42.4 t -85.14 -69.88 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.544 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 44.9 39.95 4.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.61 -0.681 . . . . 0.0 112.476 178.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -146.46 143.47 11.56 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.542 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.76 -40.02 72.91 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.795 -0.826 . . . . 0.0 109.985 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -119.89 123.45 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.444 ' NE2' HG13 ' A' ' 29' ' ' VAL . 96.3 mm-40 -94.68 122.84 37.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.55 -0.719 . . . . 0.0 111.314 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.1 t -82.78 132.83 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -141.79 175.13 5.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.756 0.788 . . . . 0.0 110.427 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 41' ' ' GLN . 58.1 m -140.04 149.82 43.62 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.661 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.4 t -116.8 79.03 1.27 Allowed 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 122.376 1.084 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.45 -52.51 0.22 Allowed 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 115.034 -0.984 . . . . 0.0 113.449 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -120.7 9.28 10.73 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.585 -1.322 . . . . 0.0 113.966 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' SER . 16.6 pt20 -161.73 178.07 9.33 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 120.628 -1.295 . . . . 0.0 112.236 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 70.7 m -129.92 150.2 51.31 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.218 0.532 . . . . 0.0 109.942 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 9.9 p90 -160.32 -148.14 0.16 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.736 -0.602 . . . . 0.0 109.414 -179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 138' ' ' SER . 93.5 mt -136.42 165.34 26.05 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.608 -1.308 . . . . 0.0 113.772 -177.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -152.42 130.71 12.03 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.41 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 142' ' ' PRO . 99.7 m -99.9 120.46 39.82 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.402 -0.811 . . . . 0.0 110.956 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -72.15 124.58 25.31 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 44.6 t -138.14 127.66 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.621 -0.831 . . . . 0.0 110.547 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 38.7 t30 50.1 39.97 20.54 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.552 -0.718 . . . . 0.0 111.432 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.35 73.6 Favored Glycine 0 N--CA 1.494 2.564 0 N-CA-C 110.539 -1.025 . . . . 0.0 110.539 179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.471 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.9 t -137.7 115.04 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.311 -1.111 . . . . 0.0 109.348 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 29.1 t -75.4 119.68 19.83 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.841 -0.744 . . . . 0.0 109.25 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.471 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 84.9 m95 -108.53 127.42 53.92 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 119.838 -0.745 . . . . 0.0 109.869 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 6.9 t -133.99 -178.6 5.1 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.638 HG23 ' HA3' ' A' ' 58' ' ' GLY . 21.2 m -93.24 131.29 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.222 0 C-N-CA 118.212 -1.395 . . . . 0.0 112.238 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -60.0 -41.89 93.07 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.764 ' CG ' HD22 ' A' ' 188' ' ' 2ZF . 45.9 p-80 -70.0 -14.5 62.73 Favored 'General case' 0 N--CA 1.495 1.799 0 C-N-CA 119.004 -1.078 . . . . 0.0 109.699 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.661 ' O ' HG21 ' A' ' 38' ' ' THR . . . -93.1 -47.94 2.98 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 107.273 -2.331 . . . . 0.0 107.273 176.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.44 ' HB2' ' CE2' ' A' ' 43' ' ' PHE . . . -90.02 -79.97 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.8 -0.823 . . . . 0.0 109.066 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 53.05 22.53 13.22 Favored Glycine 0 N--CA 1.498 2.797 0 O-C-N 121.3 -0.875 . . . . 0.0 111.086 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 63' ' ' THR . 69.9 m -136.01 13.31 3.35 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.251 -1.146 . . . . 0.0 111.818 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 61' ' ' SER . 26.9 ttpt 60.05 -71.29 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.607 0 O-C-N 121.74 -0.6 . . . . 0.0 111.715 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 61' ' ' SER . 8.9 m -77.3 145.76 37.23 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.831 0.824 . . . . 0.0 111.494 -179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.427 HD23 ' N ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -147.05 -119.29 0.07 Allowed 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -154.34 95.47 1.82 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.739 -1.225 . . . . 0.0 109.424 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.605 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -99.92 -171.1 30.0 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 119.78 -1.2 . . . . 0.0 110.639 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HB2' ' HA ' ' A' ' 27' ' ' ASN . 44.2 Cg_endo -62.76 -21.97 73.49 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 124.154 1.607 . . . . 0.0 110.679 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.462 ' HG2' HD11 ' A' ' 71' ' ' ILE . 17.1 ptpt -102.54 -4.52 25.17 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.054 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.65 -150.42 18.05 Favored Glycine 0 N--CA 1.485 1.952 0 N-CA-C 108.387 -1.885 . . . . 0.0 108.387 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.428 ' HB2' ' CG2' ' A' ' 63' ' ' THR . 42.3 Cg_endo -64.63 112.47 1.97 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.001 1.527 . . . . 0.0 110.477 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.605 HD12 ' HA3' ' A' ' 66' ' ' GLY . 55.3 mt -101.67 149.92 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-O 121.371 0.605 . . . . 0.0 109.941 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.83 153.1 17.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.681 -0.637 . . . . 0.0 110.381 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.407 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 5.4 pt20 -80.09 159.97 25.93 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.658 -0.652 . . . . 0.0 110.389 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.2 ttp -101.91 -32.19 10.34 Favored 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.632 -0.667 . . . . 0.0 109.592 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.49 ' CE1' ' CG2' ' A' ' 178' ' ' THR . 0.5 OUTLIER -149.99 168.98 22.29 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 91.0 m -153.84 118.55 4.96 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.382 -0.824 . . . . 0.0 110.302 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -101.05 74.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 178.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.606 HG23 HG22 ' A' ' 76' ' ' THR . 87.7 t -59.96 -38.65 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.52 -0.738 . . . . 0.0 109.725 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -54.34 -26.79 31.78 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.512 -0.743 . . . . 0.0 109.03 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -114.61 0.71 14.03 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.733 -0.605 . . . . 0.0 111.05 178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.3 t70 60.07 56.84 3.22 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.0 109.671 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.577 HD21 ' HG3' ' A' ' 175' ' ' MET . 35.5 tp -145.96 146.57 31.08 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.06 136.62 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.937 . . . . 0.0 109.579 -178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -122.05 123.78 5.54 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.965 -1.588 . . . . 0.0 111.531 -179.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.778 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.4 m-90 -88.47 -173.72 4.29 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 177.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -104.16 109.97 21.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 0.0 108.628 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.51 125.31 89.37 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.566 -0.709 . . . . 0.0 110.753 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -80.02 167.97 19.44 Favored 'Trans proline' 0 C--N 1.317 -1.111 0 O-C-N 123.833 1.438 . . . . 0.0 109.531 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -58.24 152.65 51.51 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.689 1.363 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.99 -9.92 74.61 Favored Glycine 0 N--CA 1.496 2.663 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.34 118.14 22.94 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.321 -1.105 . . . . 0.0 109.7 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -85.83 88.1 7.51 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 83.1 p -79.33 160.0 26.94 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.452 0.644 . . . . 0.0 110.535 -178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.985 HD13 HD21 ' A' ' 144' ' ' LEU . 90.9 mt -97.91 161.73 13.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.828 -0.545 . . . . 0.0 110.475 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.435 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 94.4 m -103.7 150.01 37.7 Favored Pre-proline 0 N--CA 1.496 1.832 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.664 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -85.04 145.49 9.89 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.97 1.51 . . . . 0.0 109.957 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -163.19 160.98 24.73 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.453 -0.78 . . . . 0.0 110.037 -179.45 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 93.7 m -119.96 124.96 47.25 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.9 m -121.55 150.91 40.96 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.453 -0.779 . . . . 0.0 111.013 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.04 -25.93 68.56 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 27.0 t -100.04 129.19 46.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.503 -0.998 . . . . 0.0 110.043 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 117' ' ' ARG . 5.9 m -98.55 19.78 13.98 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 0.0 110.636 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -69.95 75.56 0.47 Allowed 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.588 HD12 ' HB2' ' A' ' 118' ' ' ARG . 84.2 mt -89.93 175.34 7.24 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.243 0.544 . . . . 0.0 110.067 -179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.446 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 47.9 p90 -151.76 139.01 19.31 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.455 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 41.6 tp -109.82 162.92 14.01 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.774 0.797 . . . . 0.0 111.633 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 111' ' ' ALA . 75.1 t -110.01 123.99 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.803 -0.561 . . . . 0.0 110.197 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.959 ' CG2' HG22 ' A' ' 113' ' ' VAL . 0.2 OUTLIER -82.9 -179.65 7.5 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 53.0 ttt180 -49.18 -24.21 1.62 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.844 -0.535 . . . . 0.0 110.279 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 81.5 m-70 -94.06 -71.33 0.66 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.611 -0.68 . . . . 0.0 110.383 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.797 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.91 -50.88 0.09 Allowed 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 84.0 m-20 -133.91 151.84 51.65 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.988 -1.07 . . . . 0.0 112.827 -177.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.959 HG22 ' CG2' ' A' ' 108' ' ' THR . 15.9 t -118.91 43.23 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 178.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.674 HG21 ' HB2' ' A' ' 128' ' ' SER . 0.1 OUTLIER 59.97 178.65 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -177.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -91.29 138.99 2.34 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.757 1.399 . . . . 0.0 110.871 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.886 HG22 HD12 ' A' ' 126' ' ' LEU . 49.1 t -124.3 132.94 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.094 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . 8.4 tpp85 -90.28 120.04 31.09 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.588 ' HB2' HD12 ' A' ' 104' ' ' LEU . 6.7 ttp180 -64.15 123.37 18.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.189 -0.944 . . . . 0.0 110.16 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.4 mmt180 -100.05 4.55 44.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.621 -0.674 . . . . 0.0 109.778 178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.98 172.74 38.86 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.805 -2.118 . . . . 0.0 107.805 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.0 m-20 -61.97 -22.5 65.71 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.488 -1.007 . . . . 0.0 110.218 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 64.2 p -123.21 17.2 9.9 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.515 -0.741 . . . . 0.0 112.074 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 50.4 ttp180 -144.13 139.43 28.84 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.887 -1.133 . . . . 0.0 111.053 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -135.16 142.9 14.38 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 107.865 -2.094 . . . . 0.0 107.865 179.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.0 t -92.16 110.01 21.39 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.727 -0.866 . . . . 0.0 110.566 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.886 HD12 HG22 ' A' ' 116' ' ' VAL . 18.1 tp -71.59 105.79 3.78 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.7 mt -60.06 -31.49 70.04 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.365 0.602 . . . . 0.0 110.089 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.674 ' HB2' HG21 ' A' ' 114' ' ' ILE . 73.5 m -115.07 94.59 39.19 Favored Pre-proline 0 N--CA 1.494 1.742 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.637 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.5 Cg_endo -65.61 148.06 86.9 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.885 1.466 . . . . 0.0 109.697 179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -156.01 168.76 11.63 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -59.32 125.75 18.88 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.887 1.467 . . . . 0.0 110.334 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 9.6 p -49.96 -24.63 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.762 -0.587 . . . . 0.0 111.387 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.409 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 17.4 t -52.91 -32.84 47.53 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.405 -0.809 . . . . 0.0 109.677 179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.742 ' CE2' HG21 ' A' ' 108' ' ' THR . 71.1 t80 -71.94 -28.87 63.74 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -86.49 0.09 54.96 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.736 . . . . 0.0 111.587 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.409 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 58.1 mtpt -70.78 108.35 4.41 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.28 -0.888 . . . . 0.0 108.647 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 102.16 -9.42 56.27 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.714 -1.355 . . . . 0.0 109.714 -178.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.588 ' HB2' HG22 ' A' ' 108' ' ' THR . 19.3 t -76.16 -14.99 60.15 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.427 -1.043 . . . . 0.0 109.246 177.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.95 147.34 53.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.839 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 94.06 -10.84 71.53 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 -178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -73.23 -158.28 4.7 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 108.536 -1.825 . . . . 0.0 108.536 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.576 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.1 Cg_endo -144.54 144.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.904 0 C-N-CA 116.818 -1.655 . . . . 0.0 112.467 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.637 ' O ' HG22 ' A' ' 151' ' ' VAL . 2.0 mt -98.32 97.57 8.93 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.985 HD21 HD13 ' A' ' 94' ' ' LEU . 6.0 mp -89.47 144.71 25.83 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -176.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 54.6 m -63.95 -174.03 0.11 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 176.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 41.3 Cg_endo -86.01 9.9 3.88 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.603 1.317 . . . . 0.0 110.573 177.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 48.7 m -107.91 -23.52 12.01 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.998 . . . . 0.0 110.767 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 115.8 36.1 1.19 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.435 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 73.0 m80 -120.09 127.73 52.81 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.397 -1.061 . . . . 0.0 110.82 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -78.24 120.82 23.56 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.506 -0.746 . . . . 0.0 109.434 179.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.637 HG22 ' O ' ' A' ' 143' ' ' LEU . 36.0 m -122.43 -4.54 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.896 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.47 ' HA3' ' CD2' ' A' ' 169' ' ' PHE . . . -160.06 128.58 2.0 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.281 -1.438 . . . . 0.0 111.33 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 32.5 mt -107.82 117.93 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.211 -1.17 . . . . 0.0 108.286 177.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.469 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.4 t80 -51.96 128.72 25.09 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.539 0.685 . . . . 0.0 112.402 -177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 70.9 ttt180 -117.75 -29.22 5.77 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.833 -0.542 . . . . 0.0 111.498 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.665 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -161.27 145.63 13.38 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.207 -0.933 . . . . 0.0 111.412 -178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.469 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -99.59 139.39 35.31 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.248 0.547 . . . . 0.0 111.759 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 54.1 t -88.24 93.22 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 72.2 m -91.55 122.26 33.97 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.273 1.035 . . . . 0.0 112.81 -176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.697 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.6 m -120.06 130.06 54.5 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.771 178.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 56.16 23.46 7.01 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.477 -0.764 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.43 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 90.19 20.02 43.89 Favored Glycine 0 N--CA 1.494 2.549 0 O-C-N 121.38 -0.825 . . . . 0.0 111.787 178.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -145.98 142.85 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.06 -1.259 . . . . 0.0 109.352 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.35 129.06 34.25 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.34 -0.85 . . . . 0.0 111.129 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -119.77 11.3 11.87 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.831 -0.543 . . . . 0.0 110.302 178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.522 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -174.33 141.94 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.701 HG21 HG11 ' A' ' 116' ' ' VAL . 19.0 m -113.65 135.17 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.554 -0.858 . . . . 0.0 112.711 -178.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -101.6 145.14 29.46 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.47 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.3 p90 -154.4 163.81 39.59 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.033 -1.467 . . . . 0.0 112.892 -177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 82' ' ' LEU . 65.3 t -86.48 130.0 51.0 Favored Pre-proline 0 N--CA 1.491 1.618 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -78.99 147.48 21.17 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 O-C-N 123.688 1.362 . . . . 0.0 110.831 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 11.1 p -70.0 -30.14 42.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.733 -0.604 . . . . 0.0 109.528 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.88 -32.91 71.16 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 14.7 m -75.01 -32.67 61.67 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 120.148 -0.621 . . . . 0.0 109.559 178.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.577 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -65.03 -35.61 81.74 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.895 -0.503 . . . . 0.0 109.77 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -59.94 -45.73 91.66 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 43.5 p -73.33 -29.89 62.98 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.742 -0.599 . . . . 0.0 109.389 177.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.49 ' CG2' ' CE1' ' A' ' 75' ' ' TYR . 66.8 m -60.06 -39.76 87.11 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 67.0 mtt -60.63 -44.89 95.82 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 120.092 -0.643 . . . . 0.0 109.954 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.2 mtp180 -70.56 -42.81 70.63 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.533 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 10.86 111.27 0.0 OUTLIER 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 45.4 t -172.18 36.65 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -143.67 139.51 29.6 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.672 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -71.37 -40.0 70.88 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.677 -0.64 . . . . 0.0 110.113 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 81.1 tttt 54.07 86.79 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.52 -0.737 . . . . 0.0 110.614 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 38.3 tttt . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 117.979 -1.01 . . . . 0.0 111.101 179.887 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.764 HD22 ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.8 m . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.076 0.465 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -80.02 162.31 46.37 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HD2' HG13 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -147.51 -139.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.951 -0.735 . . . . 0.0 109.161 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 63.61 130.02 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.996 -1.065 . . . . 0.0 109.842 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.448 ' N ' ' HD3' ' A' ' 67' ' ' PRO . 79.1 mttt -65.08 145.95 55.63 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.908 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 59.11 163.5 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.814 . . . . 0.0 110.002 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' GLU . 89.3 mt-30 -52.7 120.2 5.43 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.389 0.614 . . . . 0.0 110.154 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.476 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 3.1 t 59.35 -73.13 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.546 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 28' ' ' GLN . 2.3 mt-10 -166.29 -86.83 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.129 -0.982 . . . . 0.0 110.398 178.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.62 ' H ' ' HB1' ' A' ' 91' ' ' ALA . . . 131.16 -164.71 23.29 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.31 -54.17 11.73 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.626 -0.926 . . . . 0.0 110.262 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.593 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.9 t -129.95 130.05 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.644 -0.66 . . . . 0.0 109.329 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.3 mm-40 -98.99 122.83 42.76 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.527 -0.733 . . . . 0.0 111.443 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 ' C ' HG13 ' A' ' 36' ' ' VAL . 60.9 t -84.86 128.48 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' CG2' HD12 ' A' ' 64' ' ' LEU . 26.9 m -148.02 176.55 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 O-C-N 121.176 -0.953 . . . . 0.0 110.593 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.1 t -149.24 144.25 26.41 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.788 0.804 . . . . 0.0 108.895 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' HE1' ' A' ' 43' ' ' PHE . 5.7 t -118.83 -178.38 3.54 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.54 -17.52 1.29 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.807 -0.558 . . . . 0.0 112.227 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.563 ' H ' HG23 ' A' ' 38' ' ' THR . 73.8 p -96.57 -40.76 8.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.008 -1.058 . . . . 0.0 112.287 -179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -173.17 -170.56 0.64 Allowed 'General case' 0 N--CA 1.507 2.408 0 O-C-N 120.885 -1.134 . . . . 0.0 112.641 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 67.8 m -109.99 143.26 40.22 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.731 ' HE1' HG22 ' A' ' 38' ' ' THR . 12.9 p90 -161.79 -146.38 0.12 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.152 -0.967 . . . . 0.0 110.749 -177.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.407 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 88.7 mt -134.26 166.59 22.45 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.707 1.241 . . . . 0.0 113.925 -176.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.495 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.94 118.56 5.71 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.712 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.609 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.9 m -91.59 123.11 34.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.37 -0.831 . . . . 0.0 111.219 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 47.3 t -74.87 110.0 8.81 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -123.99 130.04 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.538 -0.726 . . . . 0.0 109.771 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.8 t30 51.29 40.03 25.33 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.561 -0.712 . . . . 0.0 110.864 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.433 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.33 27.39 71.65 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.6 t -139.99 117.64 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.419 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -77.23 116.71 18.09 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 120.218 -0.593 . . . . 0.0 109.54 179.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.54 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 93.4 m95 -107.14 124.39 49.62 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.926 -0.71 . . . . 0.0 110.139 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.615 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 9.8 t -128.61 -175.33 3.49 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.603 HG23 ' HA3' ' A' ' 58' ' ' GLY . 27.7 m -93.15 130.19 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.269 0 C-N-CA 118.504 -1.278 . . . . 0.0 112.703 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 63.1 t80 -59.94 -44.17 94.54 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.782 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 30.0 p-80 -66.81 -18.13 65.22 Favored 'General case' 0 N--CA 1.495 1.797 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.774 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.603 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -93.54 -36.12 5.98 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 177.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.666 ' O ' HG21 ' A' ' 38' ' ' THR . . . -79.87 -70.08 0.54 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.663 -0.904 . . . . 0.0 110.503 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.17 118.72 0.01 OUTLIER Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 50.5 40.02 22.34 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.427 -1.043 . . . . 0.0 111.402 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 pttt 36.28 -129.57 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 122.907 0.483 . . . . 0.0 111.939 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 m 49.79 73.13 0.27 Allowed 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.155 -0.965 . . . . 0.0 112.109 178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.629 HD12 ' CG2' ' A' ' 36' ' ' VAL . 4.5 mm? -84.2 -161.52 0.56 Allowed 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.75 100.61 5.16 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 109.489 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.76 -179.48 52.36 Favored Glycine 0 N--CA 1.478 1.46 0 N-CA-C 108.127 -1.989 . . . . 0.0 108.127 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 26' ' ' LYS . 49.9 Cg_endo -65.63 -11.69 31.73 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.763 1.401 . . . . 0.0 111.027 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.412 ' HB2' ' HG3' ' A' ' 24' ' ' ARG . 89.1 mttt -137.82 -1.04 2.05 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.023 -1.071 . . . . 0.0 112.791 -179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 172.23 177.97 42.1 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.09 -1.528 . . . . 0.0 111.017 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -70.84 131.35 19.53 Favored 'Trans proline' 0 N--CA 1.488 1.169 0 O-C-N 124.14 1.6 . . . . 0.0 110.561 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.455 ' CG2' ' CD1' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -90.05 159.99 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 59.7 m -111.94 139.1 47.72 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 121.466 -0.771 . . . . 0.0 112.391 -177.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.487 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 6.9 pt20 -83.99 165.06 18.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.653 -0.654 . . . . 0.0 111.837 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.8 mtp -100.03 -45.45 5.67 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.564 -0.71 . . . . 0.0 109.969 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.428 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -158.84 -177.96 6.9 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.54 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.1 t -159.98 142.69 13.58 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.719 0.771 . . . . 0.0 110.27 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -104.96 83.09 1.94 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 93.1 t -59.96 -40.05 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.471 -0.768 . . . . 0.0 109.756 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -55.15 -26.16 36.87 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.404 -0.81 . . . . 0.0 108.951 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -111.74 0.35 16.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.82 -0.55 . . . . 0.0 110.836 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.4 t0 60.0 59.55 2.38 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 120.973 -1.08 . . . . 0.0 109.356 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.711 HD21 ' HG3' ' A' ' 175' ' ' MET . 44.5 tp -145.72 152.1 39.05 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.454 -178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.583 HG23 HG23 ' A' ' 54' ' ' THR . 1.5 m -140.0 132.07 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.411 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -121.63 126.9 6.67 Favored Glycine 0 N--CA 1.508 3.459 0 C-N-CA 119.251 -1.452 . . . . 0.0 112.852 -177.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.615 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -90.52 -169.59 2.45 Favored 'General case' 0 N--CA 1.508 2.43 0 O-C-N 122.046 -0.679 . . . . 0.0 111.243 178.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -113.04 95.46 5.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.683 -0.636 . . . . 0.0 110.42 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.23 130.0 89.95 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.419 -0.801 . . . . 0.0 109.878 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.03 157.68 34.26 Favored 'Trans proline' 0 C--N 1.314 -1.25 0 O-C-N 123.799 1.421 . . . . 0.0 110.944 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -69.88 152.51 68.72 Favored 'Trans proline' 0 N--CA 1.492 1.425 0 O-C-N 123.821 1.432 . . . . 0.0 110.537 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 104.39 -8.27 47.99 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 120.44 -0.886 . . . . 0.0 110.946 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.62 ' HB1' ' H ' ' A' ' 31' ' ' GLY . . . -86.85 -144.75 0.12 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.152 -1.204 . . . . 0.0 109.31 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -147.48 100.04 3.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.317 -0.864 . . . . 0.0 109.124 179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 38.9 m -92.8 166.93 12.19 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.591 0.71 . . . . 0.0 111.102 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.945 HD13 HD21 ' A' ' 144' ' ' LEU . 83.2 mt -109.78 148.63 31.11 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.2 p -105.53 -173.91 0.3 Allowed Pre-proline 0 N--CA 1.496 1.847 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.189 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -117.44 154.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 0.992 0 O-C-N 123.847 1.446 . . . . 0.0 110.276 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.5 p -142.25 171.08 14.54 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.284 -0.885 . . . . 0.0 111.29 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 22.3 p -50.73 -25.85 4.84 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.469 -0.769 . . . . 0.0 111.833 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 1.2 m 59.63 51.02 6.67 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.229 -0.92 . . . . 0.0 111.66 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -59.68 -40.04 95.99 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.654 -1.778 . . . . 0.0 108.654 178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.7 m -103.18 140.57 37.19 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.741 -0.858 . . . . 0.0 108.869 178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 m -96.49 17.12 16.86 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.415 -0.803 . . . . 0.0 111.217 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -73.56 69.22 1.23 Allowed 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 145' ' ' CYS . 92.7 mt -75.07 174.6 9.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.755 -0.591 . . . . 0.0 110.903 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 87.1 m-85 -140.52 130.01 24.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.676 -0.64 . . . . 0.0 109.519 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.2 tp -110.56 152.03 26.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.727 0.775 . . . . 0.0 111.286 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.516 HG13 ' HA ' ' A' ' 111' ' ' ALA . 81.1 t -108.97 132.26 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.406 ' CG2' ' HB3' ' A' ' 112' ' ' ASP . 75.8 p -80.83 169.36 17.67 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.528 -0.733 . . . . 0.0 109.676 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -34.39 -32.93 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 108' ' ' THR . 81.7 m-70 -97.73 -85.34 0.36 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.516 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -161.79 16.01 0.1 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.177 -0.952 . . . . 0.0 112.327 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.406 ' HB3' ' CG2' ' A' ' 108' ' ' THR . 47.8 t0 -68.43 130.03 41.66 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.835 -1.166 . . . . 0.0 110.036 -178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.534 ' O ' HG13 ' A' ' 113' ' ' VAL . 10.4 p -97.37 117.43 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-O 121.474 0.654 . . . . 0.0 110.698 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 128' ' ' SER . 3.8 tt -116.29 119.82 35.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.572 -0.705 . . . . 0.0 109.654 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.445 ' HB2' HD12 ' A' ' 127' ' ' LEU . 49.0 Cg_endo -70.2 131.32 20.38 Favored 'Trans proline' 0 N--CA 1.494 1.507 0 O-C-N 123.616 1.324 . . . . 0.0 111.701 -178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.637 HG11 HG21 ' A' ' 167' ' ' VAL . 61.4 t -130.0 132.29 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.771 -0.581 . . . . 0.0 109.456 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 -88.19 112.06 22.33 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.262 -0.899 . . . . 0.0 109.074 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 1.0 OUTLIER -54.44 122.56 10.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.406 -0.809 . . . . 0.0 111.13 -178.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -98.51 0.45 45.1 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.636 -0.665 . . . . 0.0 110.047 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.79 -174.4 46.85 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.222 -1.951 . . . . 0.0 108.222 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 91.0 m-20 -70.07 -22.7 63.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.428 -1.043 . . . . 0.0 110.053 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.3 p -124.9 17.38 8.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.569 -0.707 . . . . 0.0 111.465 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.9 mtt180 -139.99 145.2 37.52 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.177 -1.009 . . . . 0.0 111.281 -178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.29 142.14 11.81 Favored Glycine 0 N--CA 1.483 1.811 0 N-CA-C 108.481 -1.848 . . . . 0.0 108.481 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.0 t -88.82 111.56 22.19 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.873 -0.781 . . . . 0.0 109.785 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.518 HD11 ' CD1' ' A' ' 114' ' ' ILE . 44.6 tp -70.38 112.37 6.63 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.507 -0.877 . . . . 0.0 109.08 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 115' ' ' PRO . 87.3 mt -69.95 -19.98 63.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.825 -0.547 . . . . 0.0 110.587 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.544 ' HB2' HD11 ' A' ' 114' ' ' ILE . 36.7 m -120.0 79.96 25.93 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.672 -0.643 . . . . 0.0 109.945 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.429 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.2 Cg_endo -57.78 142.47 96.12 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 O-C-N 123.849 1.447 . . . . 0.0 110.641 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -155.33 167.15 14.71 Favored Pre-proline 0 N--CA 1.488 1.473 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -58.9 128.02 26.46 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.746 1.393 . . . . 0.0 109.76 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 p -50.25 -25.87 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.683 -0.635 . . . . 0.0 111.085 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.416 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 91.0 p -58.44 -30.37 66.87 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.598 -0.689 . . . . 0.0 109.564 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -70.04 -29.31 66.31 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.42 3.98 25.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.594 -0.691 . . . . 0.0 110.757 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.416 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 4.5 mtpm? -66.89 111.63 3.88 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.61 -7.5 55.84 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.6 t -77.81 -13.64 59.83 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.529 -0.983 . . . . 0.0 109.924 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.531 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -67.59 147.35 52.86 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.078 -1.014 . . . . 0.0 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.553 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.96 -9.99 75.44 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 109.02 -1.632 . . . . 0.0 109.02 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -66.87 -163.64 1.72 Allowed Glycine 0 N--CA 1.485 1.921 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.609 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.0 Cg_endo -143.26 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 117.033 -1.512 . . . . 0.0 111.852 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.6 mp -91.77 96.96 10.71 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.945 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -83.6 143.83 29.86 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.201 1.0 . . . . 0.0 113.132 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.498 ' HA ' HD23 ' A' ' 104' ' ' LEU . 12.8 m -69.4 163.75 55.62 Favored Pre-proline 0 N--CA 1.495 1.794 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -63.39 -11.2 24.54 Favored 'Trans proline' 0 N--CA 1.494 1.546 0 O-C-N 123.577 1.304 . . . . 0.0 111.504 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.7 m -95.71 -0.06 51.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.925 -1.11 . . . . 0.0 111.808 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 94.93 33.5 6.62 Favored Glycine 0 N--CA 1.5 2.912 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -118.73 128.49 54.54 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.249 -1.147 . . . . 0.0 109.968 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -91.71 116.66 29.07 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.2 m -122.78 1.28 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.648 . . . . 0.0 111.904 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.499 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -147.96 128.3 2.84 Favored Glycine 0 N--CA 1.496 2.663 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.856 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.401 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 68.8 mt -109.97 120.83 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.018 -1.284 . . . . 0.0 108.181 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.462 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.7 t80 -50.02 129.36 20.54 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.866 0.841 . . . . 0.0 112.711 -176.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.492 ' HB2' HG23 ' A' ' 170' ' ' VAL . 40.1 ttt180 -117.31 -28.51 6.12 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.926 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.756 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.39 149.2 8.34 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.418 -0.913 . . . . 0.0 111.707 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.462 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -102.69 135.86 43.57 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.838 -0.538 . . . . 0.0 111.209 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.0 t -85.12 86.63 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.433 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 27.5 p -88.09 104.05 16.31 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 122.743 1.258 . . . . 0.0 112.191 -177.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.607 ' O ' HG22 ' A' ' 163' ' ' VAL . 8.2 m -99.72 133.91 43.37 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.162 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 83.0 mtt180 54.8 22.88 4.47 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.353 -0.842 . . . . 0.0 110.775 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.431 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 91.21 17.74 49.23 Favored Glycine 0 N--CA 1.493 2.496 0 O-C-N 121.356 -0.84 . . . . 0.0 111.836 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.607 HG22 ' O ' ' A' ' 160' ' ' THR . 34.2 m -146.02 140.74 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.066 -1.255 . . . . 0.0 109.687 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 118.85 19.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.587 -0.696 . . . . 0.0 111.763 -178.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -111.01 10.55 22.14 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.825 -0.547 . . . . 0.0 110.334 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.504 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.04 140.01 0.51 Allowed 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.637 HG21 HG11 ' A' ' 116' ' ' VAL . 17.8 m -112.82 135.88 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 C-N-CA 119.741 -0.784 . . . . 0.0 112.256 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -103.94 147.36 27.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.465 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.1 p90 -154.32 164.25 38.89 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.283 -1.367 . . . . 0.0 112.263 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD22 ' A' ' 82' ' ' LEU . 61.4 t -82.25 138.46 45.36 Favored Pre-proline 0 N--CA 1.498 1.926 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.221 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -77.65 149.3 26.67 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 O-C-N 123.741 1.39 . . . . 0.0 110.786 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.7 p -72.4 -29.71 32.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.652 -0.655 . . . . 0.0 110.316 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.04 -29.29 68.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.242 -0.911 . . . . 0.0 108.846 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.5 t -70.21 -32.65 70.64 Favored 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 120.275 -0.57 . . . . 0.0 109.653 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.711 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -66.52 -39.92 88.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.596 -0.69 . . . . 0.0 109.643 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -60.18 -43.27 96.0 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.631 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 47.7 p -70.0 -31.22 68.78 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.672 -0.642 . . . . 0.0 110.57 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.3 m -60.01 -40.06 87.94 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.452 -0.78 . . . . 0.0 109.195 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 96.7 mtp -63.08 -36.99 85.41 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.914 -0.491 . . . . 0.0 109.782 179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -60.04 -32.96 71.39 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.505 -0.747 . . . . 0.0 110.59 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.98 -150.02 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.721 -0.612 . . . . 0.0 110.248 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 52.32 42.88 31.17 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.097 -1.002 . . . . 0.0 110.239 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -83.37 144.27 29.76 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.353 0.597 . . . . 0.0 110.487 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -71.14 -39.96 71.67 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.577 -0.702 . . . . 0.0 110.777 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 18.1 tptp -81.64 126.72 32.09 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.454 -0.779 . . . . 0.0 110.317 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.494 1.751 0 CA-C-O 118.084 -0.96 . . . . 0.0 110.107 179.523 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.782 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.071 0.462 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 132.12 154.29 7.64 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.2 ttp180 -108.92 138.38 45.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.569 -0.959 . . . . 0.0 109.985 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -81.58 168.97 17.63 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.223 0.535 . . . . 0.0 110.514 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -60.6 154.07 22.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.687 -0.633 . . . . 0.0 110.321 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HA ' ' HB2' ' A' ' 67' ' ' PRO . 21.5 t-20 -70.05 -39.96 75.4 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.614 -0.679 . . . . 0.0 111.182 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -89.76 122.55 32.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.342 -0.848 . . . . 0.0 110.803 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 80.1 t -83.98 -45.47 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 121.359 0.6 . . . . 0.0 110.101 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 50.11 39.92 20.48 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.557 -0.715 . . . . 0.0 111.796 179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -162.96 161.46 33.89 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.66 ' HG3' HG23 ' A' ' 33' ' ' VAL . 11.1 pt-20 -95.37 -24.0 16.91 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.647 -0.913 . . . . 0.0 111.077 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 107' ' ' VAL . 62.1 t -109.96 119.07 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.547 -0.721 . . . . 0.0 109.343 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 -102.26 125.3 48.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.639 -0.663 . . . . 0.0 110.79 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.414 ' C ' HG13 ' A' ' 36' ' ' VAL . 59.0 t -83.68 128.59 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG13 ' C ' ' A' ' 35' ' ' VAL . 32.5 m -146.73 174.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.631 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 26.3 p -146.92 133.63 19.98 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.703 0.763 . . . . 0.0 109.217 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.605 HG21 ' HA ' ' A' ' 59' ' ' ALA . 41.5 p -107.48 -179.93 4.06 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.28 -18.2 5.89 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 120.192 -0.603 . . . . 0.0 111.591 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 p -99.34 -37.23 9.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.928 . . . . 0.0 112.607 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.4 ' NE2' ' HA3' ' A' ' 58' ' ' GLY . 14.9 pt20 -171.47 -170.0 0.77 Allowed 'General case' 0 N--CA 1.51 2.549 0 O-C-N 120.62 -1.3 . . . . 0.0 113.13 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 28.6 p -116.25 141.14 48.54 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 14.9 p90 -163.67 -146.36 0.1 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.236 -0.915 . . . . 0.0 110.638 -178.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.851 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -131.92 160.43 35.77 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.777 -1.202 . . . . 0.0 113.121 -177.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.451 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.28 128.44 9.74 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 114.889 -1.05 . . . . 0.0 108.817 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.87 ' CG2' HD11 ' A' ' 153' ' ' ILE . 7.6 t -80.01 -151.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.294 -0.879 . . . . 0.0 110.461 -179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.481 ' N ' HG23 ' A' ' 46' ' ' THR . 4.8 t -160.12 106.35 1.57 Allowed 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.99 130.03 65.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.425 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 53.2 40.01 30.58 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.797 -0.564 . . . . 0.0 110.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.79 25.64 75.32 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 45.5 t -133.93 113.06 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.545 -0.973 . . . . 0.0 109.745 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 20.4 t -76.07 121.87 23.43 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.546 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.4 m95 -108.47 127.56 54.02 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.548 -0.861 . . . . 0.0 109.474 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.685 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 5.4 t -135.58 -179.14 5.46 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 -178.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.598 HG13 ' CA ' ' A' ' 140' ' ' GLY . 14.5 m -89.69 126.81 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 C-N-CA 118.18 -1.408 . . . . 0.0 112.213 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 21.3 t80 -59.95 -42.49 94.17 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.61 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.804 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 30.0 p-80 -71.31 73.74 0.7 Allowed 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.589 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.4 ' HA3' ' NE2' ' A' ' 41' ' ' GLN . . . 156.83 -32.72 0.56 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.708 -1.757 . . . . 0.0 108.708 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.605 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -82.24 -69.99 0.58 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.575 -0.956 . . . . 0.0 110.927 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 118.64 0.1 15.61 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.9 m 53.43 66.72 1.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.129 -1.218 . . . . 0.0 111.266 179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.7 ttmm -165.58 -62.86 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.343 -0.943 . . . . 0.0 112.227 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 71' ' ' ILE . 14.0 t -157.21 158.98 37.22 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 121.779 0.8 . . . . 0.0 111.839 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.468 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -149.61 -130.6 0.05 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.719 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -146.28 88.77 1.81 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.874 -1.141 . . . . 0.0 109.013 179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -88.79 -176.28 46.82 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.419 ' HB2' ' HA ' ' A' ' 27' ' ' ASN . 47.6 Cg_endo -58.99 -20.12 51.73 Favored 'Trans proline' 0 N--CA 1.489 1.255 0 O-C-N 124.085 1.571 . . . . 0.0 110.543 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -108.5 0.0 20.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.416 -0.803 . . . . 0.0 111.295 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.99 -157.16 15.4 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -59.96 120.07 7.65 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.84 1.442 . . . . 0.0 111.35 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.718 HG22 ' HD1' ' A' ' 85' ' ' TRP . 34.9 mt -107.16 141.47 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.6 m -91.23 140.97 29.3 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.421 0.629 . . . . 0.0 110.826 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -62.25 147.02 49.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.783 -0.573 . . . . 0.0 110.407 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 63.8 ttp -100.84 -29.87 12.0 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.617 -0.677 . . . . 0.0 109.538 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.529 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.4 OUTLIER -149.96 169.97 19.93 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.522 -0.736 . . . . 0.0 109.522 -179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.905 HG23 ' CG1' ' A' ' 83' ' ' VAL . 27.3 m -154.28 112.41 3.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.559 -0.713 . . . . 0.0 110.69 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 20.4 t-20 -91.12 77.85 5.95 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.9 t -60.02 -40.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.492 -0.755 . . . . 0.0 109.421 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -56.07 -25.6 45.91 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -111.94 -1.41 15.47 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.734 -0.604 . . . . 0.0 110.833 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.414 ' N ' ' O ' ' A' ' 77' ' ' ASN . 3.8 t0 60.78 57.36 2.68 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.965 -1.085 . . . . 0.0 109.152 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.919 HD22 HG11 ' A' ' 170' ' ' VAL . 17.0 tp -145.36 154.52 42.4 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 120.284 -0.566 . . . . 0.0 109.657 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.905 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -145.67 128.22 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.407 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -114.9 119.76 4.76 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.296 -1.431 . . . . 0.0 112.037 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.718 ' HD1' HG22 ' A' ' 71' ' ' ILE . 5.4 m-90 -86.45 174.61 8.86 Favored 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 177.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -95.93 91.75 6.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.304 -0.872 . . . . 0.0 109.009 178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -69.92 153.83 95.15 Favored Pre-proline 0 N--CA 1.497 1.905 0 O-C-N 121.587 -0.696 . . . . 0.0 111.153 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -95.54 173.01 1.16 Allowed 'Trans proline' 0 N--CA 1.487 1.13 0 O-C-N 123.935 1.492 . . . . 0.0 109.485 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -69.71 136.38 32.98 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.89 1.468 . . . . 0.0 110.287 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 126.41 -32.28 3.77 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.475 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . . . -82.38 59.13 4.42 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.719 -0.871 . . . . 0.0 110.371 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.445 ' HB3' ' CA ' ' A' ' 32' ' ' GLU . 28.5 ttm180 24.07 95.25 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.645 0 C-N-CA 124.313 1.045 . . . . 0.0 113.022 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.9 m -85.28 107.34 17.26 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.259 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.665 ' CD1' HD21 ' A' ' 144' ' ' LEU . 73.3 mt -84.25 159.96 20.86 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.6 163.34 18.09 Favored Pre-proline 0 N--CA 1.497 1.887 0 O-C-N 121.379 -0.826 . . . . 0.0 111.024 -179.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.11 160.49 49.43 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 O-C-N 124.071 1.564 . . . . 0.0 109.848 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.445 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 51.2 t -166.21 158.54 14.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.446 -0.784 . . . . 0.0 111.051 -179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.492 HG23 ' O ' ' A' ' 98' ' ' THR . 6.2 t -151.67 66.86 0.87 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.697 -0.627 . . . . 0.0 109.654 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 53.4 m -69.35 -40.05 77.77 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.47 -0.769 . . . . 0.0 110.203 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 109.22 -14.68 33.42 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.9 m -63.23 -38.36 90.87 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.19 -1.182 . . . . 0.0 109.492 179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 61.17 15.48 6.36 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.778 -0.576 . . . . 0.0 111.399 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -84.56 79.6 9.53 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 118' ' ' ARG . 92.2 mt -88.04 174.6 8.18 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.037 0.923 . . . . 0.0 112.368 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 97.4 m-85 -145.32 129.97 18.02 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.505 HD13 ' HG ' ' A' ' 143' ' ' LEU . 25.0 tp -107.7 144.43 34.81 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 119.268 -0.973 . . . . 0.0 111.629 -178.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.939 HG21 HG21 ' A' ' 33' ' ' VAL . 76.0 t -90.57 120.03 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.304 0.573 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 36.7 p -91.54 178.05 6.05 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.798 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -47.13 -25.98 1.0 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.896 -0.502 . . . . 0.0 111.086 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -97.28 -70.13 0.73 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.638 -0.664 . . . . 0.0 109.311 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -154.06 -164.99 1.99 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 121.95 0.881 . . . . 0.0 110.06 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 8.9 t0 -52.92 -93.96 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.598 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 114' ' ' ILE . 32.9 t 57.02 156.89 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 121.139 -0.976 . . . . 0.0 110.977 179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.699 HG21 HD11 ' A' ' 126' ' ' LEU . 34.3 mt 53.7 105.33 0.03 OUTLIER Pre-proline 0 N--CA 1.501 2.088 0 O-C-N 121.274 -0.892 . . . . 0.0 111.849 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.457 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 50.2 Cg_endo -90.42 150.1 4.4 Favored 'Trans proline' 0 N--CA 1.489 1.253 0 O-C-N 123.803 1.422 . . . . 0.0 109.319 178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.703 HG22 HD12 ' A' ' 126' ' ' LEU . 21.9 t -131.26 139.87 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.322 -0.862 . . . . 0.0 110.832 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -98.49 117.06 32.05 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.529 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 22.5 ttp85 -62.82 129.16 39.23 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.328 -0.857 . . . . 0.0 110.996 -178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -102.92 4.81 37.96 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.445 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.33 178.76 40.82 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -64.56 -26.57 68.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.451 -1.029 . . . . 0.0 109.87 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 92.6 p -120.07 16.86 12.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.662 -0.649 . . . . 0.0 111.868 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -140.04 139.05 35.86 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 118.917 -1.113 . . . . 0.0 111.011 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.529 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.59 138.7 9.15 Favored Glycine 0 N--CA 1.482 1.72 0 N-CA-C 108.057 -2.017 . . . . 0.0 108.057 178.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.488 ' C ' HG13 ' A' ' 116' ' ' VAL . 23.2 t -89.28 110.72 21.46 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 121.909 -0.759 . . . . 0.0 110.181 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.703 HD12 HG22 ' A' ' 116' ' ' VAL . 21.0 tp -70.86 110.67 5.75 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.627 -0.829 . . . . 0.0 108.819 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.97 -21.72 63.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.831 -0.543 . . . . 0.0 110.515 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.693 ' HB2' HG23 ' A' ' 114' ' ' ILE . 70.7 m -120.43 82.95 32.87 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.712 -0.617 . . . . 0.0 110.197 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.547 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.1 Cg_endo -59.42 139.81 91.31 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 O-C-N 123.803 1.423 . . . . 0.0 110.152 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.1 mtt180 -152.27 164.26 20.88 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -54.06 125.97 20.51 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 O-C-N 123.786 1.414 . . . . 0.0 110.93 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.7 p -50.08 -25.59 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.86 -0.525 . . . . 0.0 110.91 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 54.0 m -58.81 -35.36 72.73 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.605 -0.684 . . . . 0.0 109.496 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -68.4 -28.13 66.82 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.5 mt -82.2 0.95 38.74 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.588 -0.695 . . . . 0.0 110.351 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 49.4 mmtt -70.63 119.49 14.86 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 121.256 -0.903 . . . . 0.0 108.597 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.53 -10.09 66.83 Favored Glycine 0 C--N 1.286 -2.207 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -177.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.851 ' HA ' HD12 ' A' ' 44' ' ' LEU . 27.4 t -78.65 -13.5 59.79 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.56 -0.965 . . . . 0.0 109.815 178.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.513 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.5 m -61.25 142.51 56.77 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.007 -1.058 . . . . 0.0 110.695 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.598 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.94 -9.71 76.35 Favored Glycine 0 N--CA 1.482 1.745 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -61.66 -179.23 3.25 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.054 -2.018 . . . . 0.0 108.054 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.6 ' CG ' HG22 ' A' ' 33' ' ' VAL . 54.0 Cg_endo -128.04 136.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 117.206 -1.396 . . . . 0.0 111.761 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.505 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.5 mt -94.52 97.19 9.97 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.665 HD21 ' CD1' ' A' ' 94' ' ' LEU . 7.3 mp -89.62 141.31 28.71 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.425 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -59.35 -167.33 0.01 OUTLIER Pre-proline 0 N--CA 1.5 2.036 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -91.97 16.46 1.45 Allowed 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.749 1.394 . . . . 0.0 110.905 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.7 m -122.03 -51.08 2.02 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.18 -0.95 . . . . 0.0 110.916 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.62 42.42 0.02 OUTLIER Glycine 0 N--CA 1.495 2.596 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 79.3 m80 -127.13 126.62 43.24 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.385 -1.068 . . . . 0.0 110.507 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -88.0 103.0 15.29 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.429 ' HA ' ' HB ' ' A' ' 172' ' ' VAL . 35.5 m -109.92 8.18 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 C-N-CA 119.945 -0.702 . . . . 0.0 112.386 -178.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.444 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -159.19 134.08 3.62 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.447 -1.359 . . . . 0.0 110.873 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.87 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.6 mt -118.27 120.81 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.288 -1.124 . . . . 0.0 108.309 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.442 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 19.3 t80 -54.33 128.03 29.74 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.398 0.618 . . . . 0.0 112.5 -177.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.486 ' HB3' HG23 ' A' ' 170' ' ' VAL . 7.2 ptm180 -119.28 -24.17 6.49 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.77 -0.581 . . . . 0.0 111.311 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.712 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.52 148.39 12.67 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.59 -179.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.442 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -104.88 143.81 32.63 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.291 0.567 . . . . 0.0 111.38 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 47.2 t -94.74 88.41 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.0 p -89.88 111.08 22.01 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-O 122.505 1.145 . . . . 0.0 112.454 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 162' ' ' GLY . 93.6 m -92.59 125.95 37.45 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.426 ' HB3' ' O ' ' A' ' 160' ' ' THR . 73.9 ttt180 62.14 -70.6 0.05 OUTLIER 'General case' 0 N--CA 1.505 2.323 0 O-C-N 122.014 -0.429 . . . . 0.0 110.056 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -161.05 24.98 0.25 Allowed Glycine 0 N--CA 1.494 2.565 0 C-N-CA 120.178 -1.011 . . . . 0.0 110.588 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.441 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.65 144.85 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 121.086 -1.244 . . . . 0.0 109.472 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.07 123.55 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.434 0.635 . . . . 0.0 111.123 -179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 69.7 mttt -112.47 11.41 19.84 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.784 -0.573 . . . . 0.0 110.581 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.455 ' HB3' HG21 ' A' ' 158' ' ' VAL . . . -173.77 144.47 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 116' ' ' VAL . 15.9 m -117.87 137.3 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 CA-C-O 121.889 0.852 . . . . 0.0 112.674 -178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -104.02 146.01 29.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 105.79 -1.93 . . . . 0.0 105.79 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.444 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 33.9 p90 -154.61 160.62 41.56 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 118.17 -1.412 . . . . 0.0 112.205 -177.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.919 HG11 HD22 ' A' ' 82' ' ' LEU . 59.9 t -81.2 129.98 64.63 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -73.6 155.87 49.65 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 O-C-N 123.749 1.394 . . . . 0.0 110.784 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 151' ' ' VAL . 7.5 p -71.41 -24.39 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.616 -0.677 . . . . 0.0 109.49 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -58.87 -30.23 67.58 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.1 m -71.9 -39.97 69.19 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.496 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.584 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.9 mpp? -64.72 -39.69 94.07 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -32.21 70.75 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.812 -0.555 . . . . 0.0 110.334 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -59.96 -37.51 79.81 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.442 -0.787 . . . . 0.0 109.94 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.529 HG23 ' CG ' ' A' ' 75' ' ' TYR . 99.0 m -60.31 -45.45 93.34 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.438 -0.789 . . . . 0.0 109.023 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 179' ' ' MET . 86.8 mtp -62.49 -40.11 95.63 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.248 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.447 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 53.4 mtm180 -72.05 -29.36 64.08 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.507 -0.745 . . . . 0.0 110.005 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.447 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 59.94 20.05 9.08 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.701 -0.624 . . . . 0.0 110.96 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 13.4 t 58.14 -79.61 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.939 -0.475 . . . . 0.0 111.47 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 181' ' ' ALA . 98.8 mttt -84.93 137.07 33.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.263 -0.898 . . . . 0.0 110.413 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -86.31 12.28 10.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.735 -0.603 . . . . 0.0 111.414 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.0 -32.57 70.82 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.11 -0.994 . . . . 0.0 110.179 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.0 mttm . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.822 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.804 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.129 0.49 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.7 -174.02 52.86 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -63.22 143.45 57.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.593 -0.946 . . . . 0.0 110.141 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -151.38 112.78 4.37 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.267 0.556 . . . . 0.0 110.007 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -83.32 62.89 6.96 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.874 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -83.24 -152.8 0.12 Allowed 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.603 -0.685 . . . . 0.0 109.358 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -79.99 167.46 20.43 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.594 -0.691 . . . . 0.0 109.512 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 29' ' ' VAL . 32.6 m -86.25 16.5 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 O-C-N 121.504 -0.748 . . . . 0.0 111.24 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 44.3 mm-40 66.21 -61.69 0.28 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.763 -0.585 . . . . 0.0 111.601 178.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.99 -95.63 0.51 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -100.33 -47.07 5.06 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.742 -0.858 . . . . 0.0 110.854 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.569 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.0 t -110.06 120.44 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 38.3 mt-30 -93.02 130.16 38.71 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.532 -0.867 . . . . 0.0 110.752 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.5 ' HA ' HD23 ' A' ' 44' ' ' LEU . 75.5 t -77.77 130.09 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 64' ' ' LEU . 34.7 m -137.77 168.93 19.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 C-N-CA 119.137 -1.025 . . . . 0.0 110.961 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 77.4 p -157.89 143.93 17.38 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.829 HG21 ' O ' ' A' ' 58' ' ' GLY . 4.5 t -109.37 -177.7 3.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.71 -14.44 0.91 Allowed 'General case' 0 C--N 1.29 -1.996 0 O-C-N 121.577 -0.702 . . . . 0.0 112.869 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.764 HG22 HG23 ' A' ' 38' ' ' THR . 9.5 t -112.0 -21.27 11.64 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 114.513 1.301 . . . . 0.0 114.513 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.696 ' HG2' HG23 ' A' ' 40' ' ' THR . 4.8 pt20 -169.65 -171.88 1.31 Allowed 'General case' 0 N--CA 1.511 2.595 0 O-C-N 120.368 -1.457 . . . . 0.0 113.174 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 80.3 p -125.59 146.65 49.6 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.7 p90 -162.79 -142.58 0.07 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.497 -0.752 . . . . 0.0 109.554 -178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.3 mt -135.63 162.03 33.87 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.525 -1.359 . . . . 0.0 113.229 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.46 130.0 12.22 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.286 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.613 HG21 ' HB3' ' A' ' 142' ' ' PRO . 57.2 m -99.92 125.35 45.91 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.577 -0.702 . . . . 0.0 111.218 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.4 t -73.0 119.46 17.28 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.18 135.44 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.469 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 52.69 39.7 28.96 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.69 -0.632 . . . . 0.0 110.907 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 67.67 23.37 73.89 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.604 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.5 t -140.62 120.2 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.367 -1.078 . . . . 0.0 110.335 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 57.9 m -73.99 120.61 19.81 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.604 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.7 m95 -107.17 125.97 51.78 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.732 -0.787 . . . . 0.0 110.236 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.752 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.5 t -132.93 -176.41 4.11 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.729 HG11 ' HB2' ' A' ' 139' ' ' SER . 32.3 m -87.03 127.17 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 C-N-CA 118.346 -1.342 . . . . 0.0 112.83 -178.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -61.61 -40.03 93.38 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.818 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 41.6 p-80 -72.54 68.85 0.83 Allowed 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.342 -0.943 . . . . 0.0 109.286 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.829 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.14 -59.45 0.28 Allowed Glycine 0 N--CA 1.484 1.856 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 43' ' ' PHE . . . -70.5 -40.04 73.79 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.694 -0.886 . . . . 0.0 111.2 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.72 -105.71 3.31 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -175.6 57.03 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.252 -1.146 . . . . 0.0 110.992 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 44.3 tptt -166.69 -102.86 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.8 -1.187 . . . . 0.0 112.119 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.538 HG23 ' CB ' ' A' ' 70' ' ' PRO . 20.5 m -84.48 108.24 17.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.746 -1.221 . . . . 0.0 111.648 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 64' ' ' LEU 0.266 2.0 tm? -94.84 -12.53 26.8 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.326 0.584 . . . . 0.0 110.462 179.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 62.77 105.23 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.344 -0.847 . . . . 0.0 109.987 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -120.51 179.41 16.43 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -61.27 -17.65 54.12 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 O-C-N 123.945 1.497 . . . . 0.0 110.65 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -98.46 1.7 46.98 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.339 -0.851 . . . . 0.0 111.14 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 120.51 -168.13 13.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.099 -1.601 . . . . 0.0 109.099 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' CB ' HG23 ' A' ' 63' ' ' THR . 47.5 Cg_endo -65.53 116.9 4.17 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.937 1.493 . . . . 0.0 110.022 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.776 HG22 ' HD1' ' A' ' 85' ' ' TRP . 63.4 mt -97.44 139.92 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.527 0.679 . . . . 0.0 109.676 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 81.9 m -96.24 140.01 31.56 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.111 0.481 . . . . 0.0 110.3 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -66.01 149.84 49.6 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.568 -0.708 . . . . 0.0 110.627 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 96.3 mmm -103.55 -27.27 12.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.731 -0.606 . . . . 0.0 109.889 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.786 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -154.95 171.15 20.17 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.516 -0.74 . . . . 0.0 109.314 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.847 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.9 m -154.12 115.86 4.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.632 -0.667 . . . . 0.0 110.531 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -94.76 76.36 3.67 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.3 t -59.99 -33.06 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.686 -0.634 . . . . 0.0 109.298 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -52.6 -26.6 13.95 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -127.07 8.36 6.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.13 178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.4 t70 62.42 61.77 1.22 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.222 -0.924 . . . . 0.0 110.765 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.855 HD22 HG11 ' A' ' 170' ' ' VAL . 36.5 tp -144.19 152.56 41.04 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.847 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.32 133.41 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.471 -0.768 . . . . 0.0 109.493 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.65 121.67 5.17 Favored Glycine 0 N--CA 1.5 2.946 0 C-N-CA 119.232 -1.461 . . . . 0.0 111.767 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.776 ' HD1' HG22 ' A' ' 71' ' ' ILE . 6.2 m-90 -89.19 -169.68 2.6 Favored 'General case' 0 N--CA 1.509 2.524 0 O-C-N 121.795 -0.826 . . . . 0.0 109.359 178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -94.05 107.68 19.58 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . . . -69.98 148.96 96.38 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.563 -0.711 . . . . 0.0 112.522 -177.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 54.7 Cg_endo -118.88 175.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.485 1.024 0 O-C-N 123.928 1.488 . . . . 0.0 109.233 177.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -71.49 152.78 60.44 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 O-C-N 123.695 1.366 . . . . 0.0 110.864 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 105.58 -36.37 4.45 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.417 ' HB1' ' NE2' ' A' ' 34' ' ' GLN . . . -82.74 14.91 2.89 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.992 -0.711 . . . . 0.0 112.302 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 36.56 101.77 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 t -80.48 124.47 28.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.483 HD22 ' N ' ' A' ' 94' ' ' LEU . 4.5 mm? -85.26 173.46 10.35 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.844 -0.535 . . . . 0.0 110.349 -179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.804 HG22 ' CD ' ' A' ' 96' ' ' PRO . 0.2 OUTLIER -95.19 -168.4 0.17 Allowed Pre-proline 0 N--CA 1.5 2.063 0 O-C-N 121.596 -0.69 . . . . 0.0 110.915 -178.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.804 ' CD ' HG22 ' A' ' 95' ' ' THR . 49.6 Cg_endo -132.85 125.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.837 0 O-C-N 123.986 1.519 . . . . 0.0 109.318 177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.465 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -159.97 162.46 34.37 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.233 -0.917 . . . . 0.0 110.013 -179.321 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.2 p -115.35 120.01 38.18 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 7.5 m -105.91 129.67 54.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.421 -0.799 . . . . 0.0 111.037 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.74 -39.22 96.4 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.392 -1.083 . . . . 0.0 110.392 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.6 m -60.01 -37.12 78.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.483 -1.01 . . . . 0.0 110.137 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 2.7 m 58.08 21.44 7.9 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.778 -0.576 . . . . 0.0 111.0 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -83.0 71.07 10.12 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 177.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.484 HD23 ' CA ' ' A' ' 145' ' ' CYS . 73.0 mt -79.75 174.38 11.64 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.819 0.819 . . . . 0.0 111.779 -177.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 94.0 m-85 -140.47 126.44 19.51 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.673 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.4 tp -109.3 128.59 55.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.342 -0.849 . . . . 0.0 111.427 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.423 HG13 ' HA ' ' A' ' 111' ' ' ALA . 76.1 t -75.59 134.74 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 112' ' ' ASP . 45.6 p -84.42 175.94 9.0 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.536 -0.728 . . . . 0.0 110.239 -179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -32.92 -33.58 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.511 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.402 ' N ' ' O ' ' A' ' 108' ' ' THR . 4.1 p80 -112.88 -65.24 1.2 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.31 179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.423 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -158.6 -33.99 0.07 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 120.956 -1.09 . . . . 0.0 113.198 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 48.4 m-20 -44.01 116.54 1.01 Allowed 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.331 -0.856 . . . . 0.0 112.038 -177.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 106' ' ' LEU . 34.0 m -84.29 137.09 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 CA-C-O 121.264 0.554 . . . . 0.0 110.665 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.803 HG21 HD11 ' A' ' 126' ' ' LEU . 48.3 mm -113.9 110.85 48.64 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.632 -0.668 . . . . 0.0 109.454 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 46.0 Cg_endo -64.28 120.01 7.22 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 O-C-N 123.875 1.46 . . . . 0.0 110.688 -179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.674 HG22 HD12 ' A' ' 126' ' ' LEU . 48.6 t -127.51 133.93 66.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.641 -0.662 . . . . 0.0 109.219 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.4 mmt85 -87.44 118.84 27.16 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.216 -0.928 . . . . 0.0 108.763 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.1 ttm180 -62.31 122.17 15.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.34 -0.85 . . . . 0.0 110.273 -179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -97.46 0.16 47.17 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.607 -0.683 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.0 176.62 44.36 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 108.093 -2.003 . . . . 0.0 108.093 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.419 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 77.7 m-20 -62.3 -24.06 67.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -1.028 . . . . 0.0 110.422 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 58.8 p -123.65 17.34 9.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.511 -0.743 . . . . 0.0 111.962 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -141.67 141.8 33.36 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.01 -1.056 . . . . 0.0 111.136 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.78 142.66 13.23 Favored Glycine 0 N--CA 1.483 1.828 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.496 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.0 t -88.64 110.69 21.15 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.803 -0.822 . . . . 0.0 109.563 -179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.803 HD11 HG21 ' A' ' 114' ' ' ILE . 23.8 tp -69.46 109.99 4.51 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.569 -0.853 . . . . 0.0 108.804 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.51 -25.88 64.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.854 -0.528 . . . . 0.0 110.282 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 31.1 t -107.04 102.42 42.98 Favored Pre-proline 0 N--CA 1.491 1.588 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.262 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.19 130.69 11.29 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 O-C-N 124.077 1.567 . . . . 0.0 109.573 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 2.2 mtm-85 -152.46 163.13 24.55 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -55.39 128.39 30.26 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.744 1.391 . . . . 0.0 110.508 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.2 p -51.25 -24.91 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.854 -0.529 . . . . 0.0 111.135 -179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.403 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 79.9 p -57.51 -31.33 65.92 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.517 -0.739 . . . . 0.0 109.618 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -70.02 -28.81 65.79 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.3 mt -83.48 2.4 37.05 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.482 -0.761 . . . . 0.0 111.024 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.3 mtpt -66.86 107.81 2.33 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.37 -8.79 58.9 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 -177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.9 t -72.97 -16.61 61.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.383 -1.069 . . . . 0.0 108.427 177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.729 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -70.46 151.29 45.29 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.321 -0.862 . . . . 0.0 110.046 179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.672 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.45 -10.05 74.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 -179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.53 -159.68 4.78 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.613 ' HB3' HG21 ' A' ' 46' ' ' THR . 50.4 Cg_endo -138.73 138.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.323 -0.808 0 O-C-N 123.821 1.432 . . . . 0.0 111.977 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.673 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.0 mt -95.43 95.38 8.4 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.603 ' N ' HD12 ' A' ' 144' ' ' LEU . 6.9 mp -87.21 133.6 33.64 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.629 ' HB3' HG21 ' A' ' 151' ' ' VAL . 32.1 p -82.51 -172.46 0.36 Allowed Pre-proline 0 N--CA 1.489 1.504 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 145' ' ' CYS . 47.9 Cg_endo -84.24 20.53 1.2 Allowed 'Trans proline' 0 N--CA 1.494 1.538 0 O-C-N 123.106 1.056 . . . . 0.0 112.453 -178.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 50.1 m -100.88 -18.03 16.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.015 -1.053 . . . . 0.0 111.102 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 99.98 39.94 3.21 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.785 ' CE1' HG22 ' A' ' 151' ' ' VAL . 0.2 OUTLIER -149.93 165.57 32.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.268 -1.136 . . . . 0.0 110.871 -179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -92.51 120.2 32.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.669 -0.645 . . . . 0.0 109.425 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.785 HG22 ' CE1' ' A' ' 149' ' ' HIS . 2.6 t -99.97 -20.14 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.662 -0.649 . . . . 0.0 110.888 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.54 ' HA3' ' CD1' ' A' ' 169' ' ' PHE . . . -159.4 140.94 7.16 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.287 -1.435 . . . . 0.0 111.741 -178.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.481 HD11 ' HE1' ' A' ' 175' ' ' MET . 49.5 mt -107.17 118.93 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.146 -1.208 . . . . 0.0 107.792 176.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.456 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 20.8 t80 -52.69 127.34 22.78 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.579 0.704 . . . . 0.0 111.957 -178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 13.6 ttp180 -116.02 -28.69 6.55 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.849 -0.532 . . . . 0.0 111.962 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.695 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -160.37 140.9 11.73 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.044 -1.063 . . . . 0.0 112.201 -178.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.456 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.64 134.37 41.66 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.726 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.535 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 38.9 t -89.96 92.44 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.1 p -89.99 109.91 20.92 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 122.52 1.152 . . . . 0.0 112.364 -177.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.516 ' O ' HG22 ' A' ' 163' ' ' VAL . 25.4 m -97.14 121.76 39.4 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.779 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 59.97 19.93 8.99 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.381 -0.824 . . . . 0.0 110.905 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 102.02 13.61 31.06 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.395 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.516 HG22 ' O ' ' A' ' 160' ' ' THR . 33.9 m -144.91 140.03 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 118.684 1.242 . . . . 0.0 109.445 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -76.2 129.94 37.48 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.833 0.825 . . . . 0.0 111.603 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.63 14.43 7.02 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.731 178.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.535 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.21 150.84 2.49 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.666 HG21 HG11 ' A' ' 116' ' ' VAL . 9.6 m -133.64 135.84 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 119.376 -0.929 . . . . 0.0 112.695 -178.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -102.14 149.08 24.64 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.54 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 36.1 p90 -154.74 164.68 38.43 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 118.076 -1.45 . . . . 0.0 112.583 -177.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.855 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -84.61 137.25 38.82 Favored Pre-proline 0 N--CA 1.499 2.003 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.303 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -81.59 145.64 14.74 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 O-C-N 123.582 1.306 . . . . 0.0 111.99 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.58 HG23 ' SD ' ' A' ' 175' ' ' MET . 10.7 p -69.97 -27.61 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.619 -0.676 . . . . 0.0 109.607 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.84 -29.97 65.38 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 29.9 m -73.1 -22.9 60.47 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 120.275 -0.57 . . . . 0.0 110.151 178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.58 ' SD ' HG23 ' A' ' 172' ' ' VAL . 66.3 mtt -68.72 -40.11 80.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.206 -0.934 . . . . 0.0 108.931 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.07 -39.21 85.25 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.89 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 68.2 p -60.06 -28.46 67.81 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.422 -0.799 . . . . 0.0 110.688 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.786 HG23 ' CG ' ' A' ' 75' ' ' TYR . 35.9 m -62.66 -52.88 61.6 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.309 -0.87 . . . . 0.0 108.805 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.8 mtp -69.27 -32.95 72.47 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 120.076 -0.65 . . . . 0.0 109.734 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -80.98 -15.63 55.7 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.449 -0.782 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -167.82 165.55 13.95 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.332 -0.855 . . . . 0.0 110.791 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -168.8 33.44 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.564 -0.71 . . . . 0.0 110.087 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -89.91 6.8 40.41 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.636 -0.665 . . . . 0.0 110.803 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt 52.55 32.62 11.91 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.976 -1.078 . . . . 0.0 110.698 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -80.19 159.76 25.86 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.702 -0.624 . . . . 0.0 110.571 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp . . . . . 0 N--CA 1.499 1.999 0 CA-C-O 118.019 -0.991 . . . . 0.0 111.201 179.634 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.818 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 43.9 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.056 0.455 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 168.54 -82.46 0.1 OUTLIER Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -61.76 139.99 58.27 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.59 -0.947 . . . . 0.0 110.12 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -79.76 159.94 26.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.795 -0.566 . . . . 0.0 109.654 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' O ' ' N ' ' A' ' 28' ' ' GLN . 59.0 mttm -97.16 112.93 24.5 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.779 -0.768 . . . . 0.0 111.365 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 48.33 -83.97 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 26' ' ' LYS . 79.8 mt-30 -106.91 158.0 17.34 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.123 -0.986 . . . . 0.0 111.056 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 62.0 t -81.15 -62.27 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.434 0.635 . . . . 0.0 109.677 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 49.99 39.94 20.02 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.609 -0.682 . . . . 0.0 111.809 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -152.44 145.51 13.2 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.815 -1.183 . . . . 0.0 111.209 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -70.05 -40.0 75.38 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.848 -0.796 . . . . 0.0 110.452 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.564 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.7 t -111.03 119.96 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -95.54 132.67 40.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.71 -0.619 . . . . 0.0 110.444 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -80.8 138.31 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.667 HG23 ' CE2' ' A' ' 43' ' ' PHE . 16.5 m -139.99 171.72 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.621 0.724 . . . . 0.0 110.138 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.9 t -153.29 153.42 32.6 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.448 ' O ' ' HB3' ' A' ' 39' ' ' ALA . 2.9 t -117.82 75.86 1.03 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.546 1.165 . . . . 0.0 109.358 178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.13 -48.69 0.21 Allowed 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.8 t -120.7 11.08 11.14 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.446 -1.408 . . . . 0.0 114.007 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.423 ' HG2' HG23 ' A' ' 38' ' ' THR . 14.7 pt20 -160.01 169.96 22.33 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.593 -1.317 . . . . 0.0 111.746 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 75.5 m -128.8 152.25 48.68 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 121.49 0.662 . . . . 0.0 110.131 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.667 ' CE2' HG23 ' A' ' 36' ' ' VAL . 8.3 p90 -160.5 -145.72 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.435 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 78.2 mt -135.27 165.54 25.21 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.36 -1.462 . . . . 0.0 113.843 -177.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.497 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -151.99 126.84 9.63 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.25 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 53.4 m -104.94 127.46 52.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.352 -0.843 . . . . 0.0 111.44 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 44.7 t -74.55 121.36 21.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.792 -0.567 . . . . 0.0 109.517 178.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.469 HG11 HG23 ' A' ' 172' ' ' VAL . 48.8 t -131.47 130.18 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.912 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.5 t30 53.77 39.98 30.95 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.479 -0.763 . . . . 0.0 110.728 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 25.5 75.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -136.14 122.36 30.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.482 -1.011 . . . . 0.0 109.271 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 6.4 t -74.17 139.22 44.32 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.409 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.465 ' CE3' HD21 ' A' ' 82' ' ' LEU . 78.2 m95 -136.1 130.02 32.73 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.924 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.76 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 8.8 t -139.13 -174.74 3.94 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.635 HG23 ' HA3' ' A' ' 58' ' ' GLY . 13.4 m -87.99 131.83 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 C-N-CA 118.279 -1.368 . . . . 0.0 112.31 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.521 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 33.7 t80 -60.03 -41.97 93.38 Favored 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 109.268 -0.641 . . . . 0.0 109.268 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.78 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 29.4 p-80 -69.96 -13.96 62.48 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 119.223 -0.991 . . . . 0.0 109.735 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.635 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -97.04 -41.32 3.54 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.894 -2.083 . . . . 0.0 107.894 177.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB3' HG21 ' A' ' 83' ' ' VAL . . . -85.05 -72.62 0.47 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.606 -0.938 . . . . 0.0 110.358 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.69 160.66 0.14 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.551 ' O ' HG22 ' A' ' 63' ' ' THR . 4.2 m 58.08 18.69 5.4 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.489 -1.006 . . . . 0.0 111.832 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 61' ' ' SER . 96.4 mttt 62.05 -59.39 0.12 Allowed 'General case' 0 N--CA 1.514 2.747 0 CA-C-O 121.56 0.695 . . . . 0.0 112.567 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 61' ' ' SER . 5.5 t -72.18 159.4 34.18 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-O 121.881 0.848 . . . . 0.0 111.633 -178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.513 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -146.98 -121.75 0.06 Allowed 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.513 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -150.02 86.58 1.44 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.791 -1.193 . . . . 0.0 109.8 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.593 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -93.05 -176.4 40.84 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -56.67 -22.28 43.35 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 O-C-N 123.81 1.426 . . . . 0.0 110.556 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -101.18 0.02 36.86 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.599 -0.688 . . . . 0.0 110.922 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.65 -149.21 17.69 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.447 ' HB2' ' OG1' ' A' ' 63' ' ' THR . 40.5 Cg_endo -63.85 116.95 3.99 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.892 1.469 . . . . 0.0 111.065 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.593 HD12 ' HA3' ' A' ' 66' ' ' GLY . 64.8 mt -112.88 130.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 CA-C-O 122.175 0.988 . . . . 0.0 112.001 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.7 m -130.76 123.59 29.53 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -137.97 -60.69 0.63 Allowed 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 -176.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.433 ' C ' ' CG ' ' A' ' 75' ' ' TYR . 10.8 mmt -92.91 -65.84 0.97 Allowed 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 118.873 -1.131 . . . . 0.0 113.538 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.446 ' CE1' ' CG2' ' A' ' 178' ' ' THR . 0.1 OUTLIER 174.88 -171.82 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 O-C-N 120.941 -1.099 . . . . 0.0 112.012 -176.544 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.895 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.8 m -138.43 117.3 12.38 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -94.37 81.96 4.03 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.535 -0.728 . . . . 0.0 109.768 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 90.2 t -61.06 -40.07 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.579 -0.701 . . . . 0.0 109.425 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -54.02 -26.75 27.99 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.497 -0.752 . . . . 0.0 109.075 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -111.82 -2.2 15.32 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.734 -0.604 . . . . 0.0 110.706 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 41.2 t0 59.94 55.09 3.95 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.097 -1.002 . . . . 0.0 108.436 -178.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD22 HG11 ' A' ' 170' ' ' VAL . 42.5 tp -146.95 156.43 43.05 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 120.212 -0.595 . . . . 0.0 109.903 -178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.895 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.2 OUTLIER -144.33 138.71 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.448 ' C ' ' CE3' ' A' ' 85' ' ' TRP . . . -136.66 162.28 25.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 118.632 -1.746 . . . . 0.0 113.079 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.76 ' CZ3' HG22 ' A' ' 54' ' ' THR . 2.6 m-90 -148.25 170.12 18.59 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 114.297 -0.951 . . . . 0.0 108.927 178.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -85.48 115.38 23.17 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.97 134.49 95.04 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.612 -0.68 . . . . 0.0 110.746 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -74.99 158.61 42.15 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 O-C-N 123.832 1.438 . . . . 0.0 110.228 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -67.78 145.12 67.92 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.895 1.471 . . . . 0.0 109.953 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 121.42 -24.49 7.26 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -88.9 -152.12 0.23 Allowed 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.458 -1.025 . . . . 0.0 109.095 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -152.93 106.88 3.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.638 -0.664 . . . . 0.0 109.976 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.732 ' C ' HD22 ' A' ' 94' ' ' LEU . 40.1 p -84.72 164.61 18.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.476 -0.765 . . . . 0.0 110.385 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.732 HD22 ' C ' ' A' ' 93' ' ' SER . 3.2 mm? -120.86 163.83 17.59 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.57 -0.706 . . . . 0.0 109.673 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 26.3 m -102.01 145.1 29.89 Favored Pre-proline 0 N--CA 1.498 1.94 0 C-N-CA 119.716 -0.793 . . . . 0.0 110.079 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.835 ' HB3' HG21 ' A' ' 172' ' ' VAL . 52.5 Cg_endo -98.45 135.62 0.32 Allowed 'Trans proline' 0 N--CA 1.488 1.178 0 O-C-N 123.751 1.395 . . . . 0.0 110.694 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 11.8 p -151.23 147.34 26.87 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.645 -0.659 . . . . 0.0 110.48 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.7 m -68.06 -39.92 82.87 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.428 -0.795 . . . . 0.0 111.574 -179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 87.1 m 55.84 172.47 0.03 OUTLIER 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.363 -0.836 . . . . 0.0 111.062 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -103.83 3.3 45.28 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 48.3 t -129.66 137.41 50.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.117 -1.225 . . . . 0.0 110.019 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 67.1 m -103.61 19.02 20.61 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.558 -0.713 . . . . 0.0 110.669 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 35.5 p-10 -72.97 67.57 0.86 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.438 -0.788 . . . . 0.0 108.943 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.565 HD23 ' HA ' ' A' ' 145' ' ' CYS . 88.3 mt -81.71 174.73 11.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.873 -0.517 . . . . 0.0 109.914 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 43.5 p90 -154.06 138.84 17.07 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD12 ' O ' ' A' ' 142' ' ' PRO . 34.9 tp -113.29 153.85 27.77 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.98 0.895 . . . . 0.0 111.603 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 111' ' ' ALA . 98.3 t -110.29 136.8 45.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.557 HG23 ' HB3' ' A' ' 112' ' ' ASP . 31.6 p -81.76 -178.94 7.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.188 -0.945 . . . . 0.0 110.059 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -36.33 -32.62 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -119.78 -51.14 2.27 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.339 -0.85 . . . . 0.0 111.291 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.504 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -153.28 -95.4 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.967 -1.083 . . . . 0.0 111.719 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.557 ' HB3' HG23 ' A' ' 108' ' ' THR . 17.2 t0 44.07 70.23 0.34 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.095 -1.003 . . . . 0.0 111.7 -179.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.586 ' O ' HG13 ' A' ' 113' ' ' VAL . 13.7 p -71.78 64.85 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.435 -0.791 . . . . 0.0 109.926 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.749 HD12 ' CD1' ' A' ' 126' ' ' LEU . 12.3 pt -70.04 150.03 96.24 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.522 -0.736 . . . . 0.0 110.073 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -102.05 130.16 0.12 Allowed 'Trans proline' 0 C--N 1.316 -1.136 0 O-C-N 123.715 1.376 . . . . 0.0 110.032 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG11 HG21 ' A' ' 167' ' ' VAL . 49.1 t -127.45 131.94 69.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.51 -0.744 . . . . 0.0 110.187 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -88.11 117.32 26.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.6 ttm180 -61.8 123.87 19.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 110.552 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 22.6 mmm180 -97.29 1.07 49.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.781 -0.574 . . . . 0.0 109.81 178.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.86 179.72 43.01 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.011 -2.035 . . . . 0.0 108.011 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.6 m-20 -64.84 -23.42 67.23 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.326 -1.102 . . . . 0.0 110.362 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.0 p -123.2 16.83 9.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.513 -0.742 . . . . 0.0 111.752 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -140.0 142.8 36.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.061 -1.024 . . . . 0.0 111.095 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.49 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -142.06 140.7 10.25 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.434 ' C ' HG13 ' A' ' 116' ' ' VAL . 5.7 m -89.94 110.02 21.01 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.8 -0.824 . . . . 0.0 110.151 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.749 ' CD1' HD12 ' A' ' 114' ' ' ILE . 31.9 tp -72.98 108.55 5.95 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.18 -28.03 68.45 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.322 0.582 . . . . 0.0 109.801 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.6 m -109.99 103.75 54.15 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.85 -0.531 . . . . 0.0 110.171 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.37 140.54 36.99 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 123.877 1.461 . . . . 0.0 109.955 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 22.8 mtt-85 -147.09 159.26 43.18 Favored Pre-proline 0 C--N 1.305 -1.343 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -61.18 124.41 14.77 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.898 1.473 . . . . 0.0 110.361 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.13 -26.41 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 CA-C-O 121.328 0.585 . . . . 0.0 110.685 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 58.0 m -60.02 -38.3 82.28 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 178.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.414 ' CE2' HG21 ' A' ' 108' ' ' THR . 48.7 t80 -69.32 -27.53 65.45 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.69 2.76 36.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.556 -0.715 . . . . 0.0 110.783 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -68.65 109.6 3.87 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.77 -8.87 58.24 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -177.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 31.8 t -76.1 -15.69 60.05 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.491 -1.005 . . . . 0.0 109.079 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.22 154.64 41.32 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.235 -0.916 . . . . 0.0 109.608 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 44' ' ' LEU . . . 89.99 -8.48 79.74 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -74.92 -159.04 6.89 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.391 -1.883 . . . . 0.0 108.391 179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.637 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.96 148.01 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.853 0 C-N-CA 116.588 -1.808 . . . . 0.0 112.582 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.402 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 1.8 mt -99.49 98.27 9.18 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.727 -1.582 . . . . 0.0 106.727 177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.488 ' HB2' ' CZ ' ' A' ' 105' ' ' TYR . 4.6 mm? -82.14 137.07 35.06 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 122.133 0.968 . . . . 0.0 113.182 -176.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.565 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.5 OUTLIER -66.62 -161.48 0.0 OUTLIER Pre-proline 0 N--CA 1.497 1.883 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.9 Cg_endo -92.16 17.27 1.3 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.714 1.376 . . . . 0.0 110.978 178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.44 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 0.5 OUTLIER -138.74 25.82 2.55 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.122 -0.986 . . . . 0.0 111.962 -179.441 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.11 37.96 59.66 Favored Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 41.6 m170 -118.91 118.91 32.79 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.559 -0.965 . . . . 0.0 110.095 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -80.49 125.12 29.56 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.568 -0.708 . . . . 0.0 109.856 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 34.4 m -127.03 -6.17 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 120.149 -0.62 . . . . 0.0 111.615 -179.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.92 130.31 2.8 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.263 -1.446 . . . . 0.0 111.509 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.574 HD12 ' CE ' ' A' ' 175' ' ' MET . 70.3 mt -109.25 116.06 51.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.436 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 18.7 t80 -51.87 128.66 24.65 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.6 -0.688 . . . . 0.0 112.272 -177.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.424 ' HB3' HG23 ' A' ' 170' ' ' VAL . 35.3 ptt180 -119.44 -24.48 6.32 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.702 -0.624 . . . . 0.0 112.308 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.598 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -159.2 139.12 11.86 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.125 -1.03 . . . . 0.0 112.269 -178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.436 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.36 136.72 39.82 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.769 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.979 HG11 ' HB3' ' A' ' 166' ' ' ALA . 7.3 p -102.99 98.88 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 29.0 p -93.47 123.53 36.84 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-O 122.209 1.004 . . . . 0.0 111.278 -178.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.535 HG22 ' HG3' ' A' ' 161' ' ' ARG . 93.9 m -86.38 -70.02 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.119 -179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.535 ' HG3' HG22 ' A' ' 160' ' ' THR . 89.9 mtt180 -104.19 26.18 9.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.475 -0.765 . . . . 0.0 110.206 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 107.69 10.27 27.15 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.8 m -141.26 138.93 33.3 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.152 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.515 ' O ' HD23 ' A' ' 126' ' ' LEU . . . -80.1 114.11 18.77 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.667 -177.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 14.9 ptmt -96.95 11.54 35.62 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 120.254 -0.578 . . . . 0.0 110.606 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.979 ' HB3' HG11 ' A' ' 158' ' ' VAL . . . -167.77 154.49 8.0 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.612 HG21 HG11 ' A' ' 116' ' ' VAL . 17.4 m -128.58 140.02 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 C-N-CA 119.324 -0.951 . . . . 0.0 112.947 -177.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -107.46 146.45 31.74 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 38.7 p90 -152.98 165.09 36.65 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 118.445 -1.302 . . . . 0.0 111.999 -178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.517 HG11 HD22 ' A' ' 82' ' ' LEU . 58.4 t -83.37 137.64 42.15 Favored Pre-proline 0 N--CA 1.495 1.779 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.831 179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -81.94 146.22 14.47 Favored 'Trans proline' 0 N--CA 1.49 1.286 0 O-C-N 123.78 1.411 . . . . 0.0 110.747 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.835 HG21 ' HB3' ' A' ' 96' ' ' PRO . 14.7 p -70.03 -29.68 41.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.629 -0.67 . . . . 0.0 109.61 179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -58.32 -29.54 65.99 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 5.7 m -73.42 -24.82 60.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.8 -0.562 . . . . 0.0 110.234 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.574 ' CE ' HD12 ' A' ' 153' ' ' ILE . 64.3 mtt -65.67 -46.2 80.01 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.324 -0.86 . . . . 0.0 109.023 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.06 -41.07 91.57 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.301 0.572 . . . . 0.0 109.959 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 30.6 p -70.22 -22.63 62.9 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.624 -0.673 . . . . 0.0 110.965 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.446 ' CG2' ' CE1' ' A' ' 75' ' ' TYR . 93.6 m -61.6 -50.07 74.06 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.296 -0.878 . . . . 0.0 109.71 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 25.5 ptm -68.55 -24.85 64.67 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.696 -0.801 . . . . 0.0 109.644 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -66.54 -16.41 64.13 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.493 -0.754 . . . . 0.0 110.583 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.459 ' O ' ' CB ' ' A' ' 182' ' ' SER . . . -166.72 -148.0 0.09 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.346 -0.846 . . . . 0.0 110.53 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 181' ' ' ALA . 1.5 p 86.1 -31.76 0.05 OUTLIER 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 123.682 0.793 . . . . 0.0 110.967 -179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -149.09 -42.89 0.14 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.267 -0.896 . . . . 0.0 110.231 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 48.6 tptt 56.84 32.48 21.46 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.335 -0.853 . . . . 0.0 110.258 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.1 mtmt -154.71 159.95 41.04 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.532 -0.73 . . . . 0.0 110.814 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.006 179.531 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.78 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 53.1 m . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.049 0.452 . . . . 0.0 110.101 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.93 -10.02 75.29 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.436 -1.066 . . . . 0.0 110.436 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -95.68 140.4 30.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.279 -1.13 . . . . 0.0 109.924 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 12.0 t70 -79.51 166.89 21.48 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.255 0.55 . . . . 0.0 110.096 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -140.28 160.65 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.914 -0.714 . . . . 0.0 111.018 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.5 m120 51.33 53.7 12.41 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.506 -0.746 . . . . 0.0 111.473 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 53.23 -175.89 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.478 -0.764 . . . . 0.0 110.97 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.614 HG13 ' HG2' ' A' ' 34' ' ' GLN . 63.3 t -80.83 -42.91 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 120.042 -0.663 . . . . 0.0 110.181 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 48.74 39.8 14.62 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.673 -0.642 . . . . 0.0 111.616 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.65 176.36 47.94 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' CA ' ' HB3' ' A' ' 92' ' ' ARG . 86.3 tt0 -93.85 -23.49 18.1 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.83 -0.806 . . . . 0.0 111.697 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG22 ' CG ' ' A' ' 142' ' ' PRO . 63.1 t -110.03 120.03 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.229 -0.919 . . . . 0.0 110.373 -178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.614 ' HG2' HG13 ' A' ' 29' ' ' VAL . 29.2 mt-30 -100.01 124.36 45.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.805 -0.559 . . . . 0.0 110.623 179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 58.4 t -82.29 133.84 28.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.6 m -139.42 174.53 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.891 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.3 m -147.99 126.48 12.41 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.741 HG21 ' O ' ' A' ' 59' ' ' ALA . 10.0 t -106.34 -179.14 3.85 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.49 -16.89 4.28 Favored 'General case' 0 C--N 1.29 -1.985 0 O-C-N 121.823 -0.548 . . . . 0.0 112.377 -178.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.616 ' H ' HG23 ' A' ' 38' ' ' THR . 74.4 p -102.49 -34.85 8.98 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.036 -1.04 . . . . 0.0 113.245 -178.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -172.83 -169.17 0.55 Allowed 'General case' 0 N--CA 1.509 2.508 0 O-C-N 120.776 -1.203 . . . . 0.0 112.756 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 87.2 p -116.71 145.3 43.56 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.691 ' HE1' HG22 ' A' ' 38' ' ' THR . 11.1 p90 -162.02 -143.86 0.09 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.21 -0.931 . . . . 0.0 110.802 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.731 HD21 ' HA ' ' A' ' 109' ' ' ARG . 44.1 mt -129.06 161.77 29.23 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 120.618 -1.301 . . . . 0.0 114.0 -177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.472 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -153.3 123.61 7.08 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 114.612 -1.176 . . . . 0.0 108.759 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.905 ' CG2' HD11 ' A' ' 153' ' ' ILE . 9.7 t -80.47 -156.56 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.137 -0.977 . . . . 0.0 110.283 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 23.4 m -153.16 112.42 3.81 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.9 t -140.0 137.03 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 C-N-CA 119.545 -0.862 . . . . 0.0 111.104 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.6 m120 50.58 39.45 21.31 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.577 -0.702 . . . . 0.0 111.163 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.71 26.59 74.41 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.587 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 55.6 t -137.6 118.13 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.485 -1.009 . . . . 0.0 110.218 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.423 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 27.7 t -75.53 120.08 20.46 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.587 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 89.1 m95 -106.74 128.74 54.47 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.03 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.73 ' O ' HD12 ' A' ' 82' ' ' LEU . 15.0 t -134.5 -177.76 4.75 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.658 HG23 ' HA3' ' A' ' 58' ' ' GLY . 6.4 m -89.52 125.47 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.346 0 C-N-CA 118.28 -1.368 . . . . 0.0 111.792 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -60.0 -41.88 93.07 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.584 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.827 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 26.1 p-80 -66.04 -34.42 78.04 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.85 -1.14 . . . . 0.0 108.437 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.658 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -71.23 -34.23 64.4 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.189 -1.965 . . . . 0.0 108.189 177.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.741 ' O ' HG21 ' A' ' 38' ' ' THR . . . -79.97 -70.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.681 -0.894 . . . . 0.0 110.14 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 114.55 -63.02 0.32 Allowed Glycine 0 N--CA 1.493 2.477 0 C-N-CA 119.989 -1.101 . . . . 0.0 110.611 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.3 p -175.77 87.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.175 -1.191 . . . . 0.0 111.349 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 8.4 mtpt 57.18 -163.52 0.18 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.522 1.153 . . . . 0.0 111.404 178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 61.9 m 49.89 70.94 0.44 Allowed 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.028 -0.987 . . . . 0.0 112.393 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.897 HD22 ' CE2' ' A' ' 85' ' ' TRP 0.254 11.8 tp -91.86 -155.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.67 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.42 ' H ' ' HG ' ' A' ' 64' ' ' LEU . . . -143.01 100.01 3.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.077 -1.015 . . . . 0.0 109.607 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.509 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -92.05 -169.52 41.0 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 25' ' ' ASP . 48.4 Cg_endo -71.34 -13.46 30.66 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 O-C-N 124.194 1.628 . . . . 0.0 111.015 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -108.21 -24.89 11.33 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.21 -0.931 . . . . 0.0 111.016 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 155.64 -151.08 22.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.37 121.19 7.27 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.93 1.489 . . . . 0.0 110.845 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.509 ' CD1' ' HA3' ' A' ' 66' ' ' GLY . 72.6 mt -100.15 150.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 53.9 m -93.62 127.8 39.47 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.644 -0.66 . . . . 0.0 110.102 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 4.0 pt20 -64.88 163.9 13.5 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.619 -0.676 . . . . 0.0 110.146 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -93.51 -40.08 10.52 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.0 110.118 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.447 ' CE1' ' CH2' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -155.72 -176.65 6.06 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.569 -0.707 . . . . 0.0 109.447 179.294 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.862 HG23 ' CG1' ' A' ' 83' ' ' VAL . 57.6 m -152.01 123.5 7.82 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.787 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.415 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 27.8 t-20 -93.77 77.84 4.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.0 t -60.0 -40.1 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.681 -0.637 . . . . 0.0 109.686 -178.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -55.25 -25.8 35.79 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.369 -0.832 . . . . 0.0 108.98 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -112.41 -0.61 15.27 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.74 -0.6 . . . . 0.0 110.906 178.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.2 t70 60.04 56.77 3.26 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.046 -1.034 . . . . 0.0 109.321 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.73 HD12 ' O ' ' A' ' 54' ' ' THR . 40.3 tp -144.37 154.53 43.09 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.095 -0.642 . . . . 0.0 109.984 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.862 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -142.05 133.26 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.93 123.21 5.54 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 119.319 -1.419 . . . . 0.0 112.058 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.897 ' CE2' HD22 ' A' ' 64' ' ' LEU . 3.6 m-90 -88.25 -171.7 3.48 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 122.063 -0.669 . . . . 0.0 109.395 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -100.01 111.94 24.24 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.37 130.02 93.55 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.446 -0.784 . . . . 0.0 111.85 -178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 89' ' ' PRO . 48.9 Cg_endo -90.96 175.21 2.52 Favored 'Trans proline' 0 N--CA 1.489 1.249 0 O-C-N 123.795 1.419 . . . . 0.0 109.063 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 88' ' ' PRO . 40.6 Cg_endo -62.47 143.64 93.54 Favored 'Trans proline' 0 N--CA 1.494 1.558 0 O-C-N 123.549 1.289 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.28 -3.55 66.48 Favored Glycine 0 N--CA 1.494 2.561 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.619 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -87.99 22.52 2.35 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.008 -1.29 . . . . 0.0 112.207 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HG2' HD21 ' A' ' 94' ' ' LEU . 40.3 ttt180 31.34 96.01 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.594 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 178.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.695 ' C ' HD22 ' A' ' 94' ' ' LEU . 41.5 t -84.59 130.04 34.77 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.441 -0.787 . . . . 0.0 110.036 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 148' ' ' GLY . 4.4 mm? -115.95 170.93 8.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.766 -0.584 . . . . 0.0 109.585 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.1 p -126.69 164.05 37.12 Favored Pre-proline 0 N--CA 1.495 1.822 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.19 -179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -81.81 159.03 18.72 Favored 'Trans proline' 0 C--N 1.316 -1.176 0 O-C-N 123.923 1.486 . . . . 0.0 109.436 179.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.44 ' HB3' ' CG ' ' A' ' 149' ' ' HIS . 9.0 p -132.56 -40.51 0.98 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.43 -0.794 . . . . 0.0 111.829 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.9 m 48.02 36.93 6.93 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.18 -0.95 . . . . 0.0 110.731 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 27.1 p -65.14 -35.46 81.19 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.677 . . . . 0.0 111.097 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 135.93 -35.27 2.16 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.5 t -68.34 130.04 41.7 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.535 -0.979 . . . . 0.0 109.508 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.3 m -102.67 9.86 38.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.554 -0.716 . . . . 0.0 111.438 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -71.97 75.73 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.132 -0.98 . . . . 0.0 108.584 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.411 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 97.8 mt -78.96 174.67 11.3 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.389 0.614 . . . . 0.0 111.138 -178.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.431 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 77.5 m-85 -144.37 127.3 16.41 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.479 HD13 ' HG ' ' A' ' 143' ' ' LEU . 38.1 tp -115.07 153.56 30.49 Favored 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.923 0.868 . . . . 0.0 111.841 -178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 111' ' ' ALA . 97.7 t -119.17 135.17 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.595 ' C ' HD11 ' A' ' 44' ' ' LEU . 68.8 p -85.22 175.28 9.04 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.132 -0.98 . . . . 0.0 110.35 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.731 ' HA ' HD21 ' A' ' 44' ' ' LEU . 63.8 ttt180 -37.16 -34.61 0.09 Allowed 'General case' 0 N--CA 1.509 2.497 0 CA-C-O 121.172 0.51 . . . . 0.0 112.056 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -100.15 -70.0 0.75 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.479 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.41 -80.09 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.864 179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.568 ' HB3' HG23 ' A' ' 108' ' ' THR . 11.4 t70 46.6 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.593 -0.692 . . . . 0.0 111.595 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 98.1 t -89.69 107.67 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.249 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.563 HD12 HD11 ' A' ' 126' ' ' LEU . 23.6 pt -130.95 159.99 68.86 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.7 -0.625 . . . . 0.0 109.731 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.431 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 49.9 Cg_endo -106.88 134.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.966 1.508 . . . . 0.0 111.224 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.67 HG11 HG21 ' A' ' 167' ' ' VAL . 46.6 t -124.23 130.07 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 20.5 mmm-85 -89.13 115.34 26.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.329 -0.857 . . . . 0.0 108.92 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.494 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 28.4 ttp85 -59.91 126.18 26.57 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.237 -0.915 . . . . 0.0 110.737 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.1 mmt180 -103.3 8.09 38.29 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.185 -0.606 . . . . 0.0 109.676 177.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.41 -179.65 43.84 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.356 -1.897 . . . . 0.0 108.356 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 12.0 p-10 -59.96 -36.39 77.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.387 -1.067 . . . . 0.0 110.365 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -121.09 19.18 11.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.882 -0.511 . . . . 0.0 112.091 -179.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.8 mtm180 -131.24 141.05 49.95 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.974 -1.079 . . . . 0.0 110.558 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.76 143.54 13.54 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.769 -1.732 . . . . 0.0 108.769 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 1.1 m -92.06 110.12 21.48 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 122.097 -0.649 . . . . 0.0 110.02 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.563 HD11 HD12 ' A' ' 114' ' ' ILE . 45.3 tp -72.67 109.89 6.63 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.639 -0.824 . . . . 0.0 108.993 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.4 mt -68.7 -31.03 69.83 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 121.457 0.646 . . . . 0.0 109.596 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 23.2 m -105.88 107.92 60.54 Favored Pre-proline 0 N--CA 1.493 1.725 0 C-N-CA 120.401 -0.519 . . . . 0.0 109.88 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -78.56 143.28 19.0 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 123.84 1.442 . . . . 0.0 110.357 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 mmt-85 -148.36 160.01 37.77 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -60.36 126.24 19.54 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.842 1.443 . . . . 0.0 110.4 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.3 p -53.08 -26.12 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.75 -0.594 . . . . 0.0 110.675 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.409 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.6 m -59.31 -34.66 72.59 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.881 0.848 . . . . 0.0 109.212 178.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -73.82 -26.78 60.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.399 -0.813 . . . . 0.0 109.514 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.27 -4.82 58.01 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 0.0 112.939 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.88 66.59 1.55 Allowed 'General case' 0 N--CA 1.509 2.507 0 CA-C-O 122.647 1.213 . . . . 0.0 109.025 179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 174.51 -26.42 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.683 ' HA ' HD12 ' A' ' 44' ' ' LEU . 3.8 t -72.57 -9.1 58.17 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.395 -1.062 . . . . 0.0 111.841 -178.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.524 ' HB3' HG11 ' A' ' 55' ' ' VAL . 7.1 m -58.6 142.31 49.72 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 120.869 -1.145 . . . . 0.0 109.559 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.59 ' N ' HG13 ' A' ' 55' ' ' VAL . . . 90.47 -9.86 76.26 Favored Glycine 0 N--CA 1.484 1.881 0 N-CA-C 108.546 -1.821 . . . . 0.0 108.546 -177.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.02 157.06 53.56 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.455 ' HB2' HD11 ' A' ' 144' ' ' LEU . 55.4 Cg_endo -103.01 138.24 0.13 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.92 1.484 . . . . 0.0 112.799 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.479 ' HG ' HD13 ' A' ' 106' ' ' LEU . 3.9 mp -100.16 98.81 9.47 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 177.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.626 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.6 mp -87.64 147.81 25.1 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.028 0.918 . . . . 0.0 113.064 -176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.46 -158.86 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.798 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -99.69 16.61 0.42 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 O-C-N 123.69 1.363 . . . . 0.0 110.732 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 23.4 p -127.42 0.14 6.29 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.156 -0.965 . . . . 0.0 112.271 -179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.83 ' O ' HD12 ' A' ' 94' ' ' LEU . . . 99.94 39.97 3.21 Favored Glycine 0 N--CA 1.5 2.92 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.44 ' CG ' ' HB3' ' A' ' 97' ' ' CYS . 79.8 m80 -125.75 121.84 34.53 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.293 -1.122 . . . . 0.0 110.791 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.94 101.51 12.41 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.07 7.13 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.643 -0.661 . . . . 0.0 112.237 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.464 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -156.58 134.74 4.17 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.791 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.905 HD11 ' CG2' ' A' ' 46' ' ' THR . 1.1 mt -118.66 122.63 69.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.385 -1.068 . . . . 0.0 108.398 178.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.506 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.3 t80 -50.86 128.56 21.35 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.894 0.854 . . . . 0.0 112.326 -177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.55 ' HB2' HG23 ' A' ' 170' ' ' VAL . 34.2 ttt180 -116.78 -29.77 5.95 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.872 -0.518 . . . . 0.0 110.751 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.859 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.93 153.21 10.1 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.273 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.506 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -107.15 141.49 38.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.812 -0.555 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.579 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 30.5 t -94.5 93.42 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.6 p -91.8 115.78 28.34 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 122.383 1.087 . . . . 0.0 112.704 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 162' ' ' GLY . 22.1 m -92.02 120.28 32.51 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 160' ' ' THR . 14.8 ttm180 65.3 -67.67 0.12 Allowed 'General case' 0 N--CA 1.506 2.37 0 O-C-N 121.986 -0.446 . . . . 0.0 109.892 -178.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.452 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -161.7 24.49 0.23 Allowed Glycine 0 N--CA 1.495 2.578 0 C-N-CA 120.232 -0.985 . . . . 0.0 110.686 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 34.6 m -150.01 143.18 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.151 -1.205 . . . . 0.0 109.76 179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.0 130.0 35.06 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.663 0.744 . . . . 0.0 111.547 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -125.58 16.42 8.18 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.179 0.514 . . . . 0.0 109.837 178.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.579 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.39 150.02 2.27 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.67 HG21 HG11 ' A' ' 116' ' ' VAL . 13.3 m -130.29 137.67 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.27 -0.972 . . . . 0.0 113.013 -178.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -104.32 145.51 30.14 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 29.5 p90 -152.98 161.9 41.98 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 118.243 -1.383 . . . . 0.0 112.541 -177.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.583 HG11 HD22 ' A' ' 82' ' ' LEU . 75.7 t -79.41 139.87 55.8 Favored Pre-proline 0 N--CA 1.494 1.749 0 CA-C-N 116.099 -0.501 . . . . 0.0 109.979 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -84.37 156.74 12.62 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.683 1.36 . . . . 0.0 110.698 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -70.03 -25.71 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.665 -0.647 . . . . 0.0 109.64 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.589 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.89 -26.74 66.13 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.49 -0.756 . . . . 0.0 108.964 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 51.8 p -75.47 -33.07 60.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.599 -0.688 . . . . 0.0 110.348 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.571 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.1 mpp? -66.92 -48.46 68.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.314 -0.866 . . . . 0.0 109.724 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 177' ' ' THR . 12.5 pt-20 -62.4 -40.4 96.38 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.555 -0.715 . . . . 0.0 110.441 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 173' ' ' GLU . 33.8 p -63.31 -37.8 88.66 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.602 -0.686 . . . . 0.0 109.962 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.2 m -60.56 -40.03 90.15 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -65.27 -39.75 93.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.662 -0.649 . . . . 0.0 109.25 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -63.58 -29.95 71.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.537 -0.727 . . . . 0.0 110.939 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -164.67 159.68 19.14 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.621 -0.674 . . . . 0.0 110.941 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.77 52.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.591 -0.693 . . . . 0.0 109.695 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -144.83 151.13 38.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.717 -0.615 . . . . 0.0 109.605 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 20.9 mtmm -70.07 -39.98 75.31 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.98 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 43.5 tptt 53.94 99.33 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.51 -0.744 . . . . 0.0 110.696 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 42.5 mttp . . . . . 0 N--CA 1.494 1.74 0 CA-C-O 117.941 -1.028 . . . . 0.0 110.183 -179.969 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.859 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.077 0.465 . . . . 0.0 110.244 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -84.32 178.25 51.72 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 13.4 tpt180 -59.98 -49.95 75.65 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.542 -0.975 . . . . 0.0 109.543 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 40.8 t0 50.0 50.36 18.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.794 -0.566 . . . . 0.0 112.163 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -84.68 -152.72 0.14 Allowed 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.417 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.7 t-20 -154.75 92.5 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.167 -0.958 . . . . 0.0 110.718 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -163.93 55.14 0.16 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.65 -0.656 . . . . 0.0 109.971 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.506 HG11 ' CB ' ' A' ' 91' ' ' ALA . 80.1 t -87.98 -50.08 13.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.399 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 49.64 39.96 18.62 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.554 -0.716 . . . . 0.0 111.373 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -160.08 172.02 36.48 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.87 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.3 pt-20 -98.32 -39.15 8.96 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.81 -0.818 . . . . 0.0 111.381 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' A' ' 32' ' ' GLU . 62.5 t -114.56 119.99 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.351 -0.843 . . . . 0.0 109.454 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.444 ' CG ' HG13 ' A' ' 29' ' ' VAL . 6.5 mm100 -102.94 121.98 43.64 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.67 -0.644 . . . . 0.0 111.353 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 44' ' ' LEU . 78.3 t -83.96 130.82 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.31 175.1 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.879 0.847 . . . . 0.0 110.818 -178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.2 p -138.41 129.43 26.95 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.724 0.773 . . . . 0.0 109.309 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.538 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.1 p -110.9 -179.08 3.64 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -57.03 -17.22 9.21 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.61 -179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.5 p -101.33 -41.12 6.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 112.278 -179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -175.61 -162.51 0.1 Allowed 'General case' 0 N--CA 1.509 2.485 0 O-C-N 121.033 -1.042 . . . . 0.0 111.457 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 74.8 m -121.76 146.93 46.56 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.707 -0.621 . . . . 0.0 109.371 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 7.4 p90 -160.71 -141.22 0.07 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.624 -0.673 . . . . 0.0 109.764 -179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.717 HD12 ' HA ' ' A' ' 138' ' ' SER . 61.0 mt -130.79 161.0 32.72 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.489 -1.382 . . . . 0.0 114.271 -177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.446 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.58 120.2 4.28 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.491 -1.231 . . . . 0.0 109.693 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.564 HG22 ' H ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER -85.75 -159.99 0.5 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.146 -0.971 . . . . 0.0 110.162 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.564 ' H ' HG22 ' A' ' 46' ' ' THR . 39.1 t -149.98 113.14 4.89 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.8 t -130.04 129.95 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.058 -177.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.0 t-20 51.78 40.0 26.76 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.653 -0.654 . . . . 0.0 110.715 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.95 26.53 74.23 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.476 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 41.5 t -133.86 111.9 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.369 -1.077 . . . . 0.0 109.616 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.477 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 29.3 t -75.47 129.53 37.42 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.496 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 84.7 m95 -118.58 129.27 55.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.55 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.585 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 12.5 t -135.72 179.7 6.18 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 140' ' ' GLY . 12.3 m -88.66 133.33 31.26 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.696 0 C-N-CA 118.349 -1.34 . . . . 0.0 112.819 -178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 93.8 t80 -59.97 -42.5 94.29 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.728 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 46.9 p-80 -74.0 69.57 1.46 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 178.22 -35.85 0.08 OUTLIER Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.538 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -79.8 -69.39 0.59 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.496 -1.003 . . . . 0.0 108.79 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.94 -92.67 1.36 Allowed Glycine 0 N--CA 1.494 2.544 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.467 178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.3 m -89.06 39.24 0.92 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.536 -0.979 . . . . 0.0 111.816 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.0 mttp 48.21 -173.26 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.101 0.953 . . . . 0.0 112.144 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 60.76 135.49 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.708 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -144.11 -128.96 0.08 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.785 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.434 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -145.2 91.95 2.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.844 -1.16 . . . . 0.0 110.239 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -65.93 -153.42 0.18 Allowed Glycine 0 N--CA 1.484 1.838 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.23 -20.92 24.06 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 124.243 1.654 . . . . 0.0 109.922 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -142.21 0.7 1.36 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.344 -0.943 . . . . 0.0 113.12 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 176.43 173.14 41.79 Favored Glycine 0 N--CA 1.498 2.814 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.74 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -60.83 129.62 29.76 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.91 1.479 . . . . 0.0 111.324 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.685 HG22 ' HD1' ' A' ' 85' ' ' TRP . 40.3 mt -105.48 146.95 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.407 ' O ' ' CD1' ' A' ' 85' ' ' TRP . 6.2 m -94.83 144.79 25.36 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.71 0.766 . . . . 0.0 111.596 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HB3' ' CZ2' ' A' ' 85' ' ' TRP . 14.3 pt20 -78.45 160.34 27.78 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.872 -0.518 . . . . 0.0 111.2 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.9 mmm -93.34 -39.61 10.85 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.662 -0.649 . . . . 0.0 109.609 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 -176.37 5.92 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.533 -0.73 . . . . 0.0 109.516 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.897 HG23 ' CG1' ' A' ' 83' ' ' VAL . 8.4 m -149.94 118.71 6.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.726 -0.609 . . . . 0.0 109.384 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.451 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 32.1 t30 -91.67 77.26 5.64 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.147 -1.056 . . . . 0.0 108.147 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.3 t -60.02 -38.14 75.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.734 -0.604 . . . . 0.0 109.42 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -54.73 -25.98 31.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -115.91 1.28 13.31 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.696 -0.627 . . . . 0.0 111.139 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t70 60.03 59.99 2.25 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.969 -1.082 . . . . 0.0 108.971 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.532 HD21 ' CG ' ' A' ' 175' ' ' MET . 27.4 tp -147.04 152.5 38.66 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.818 -0.753 . . . . 0.0 110.597 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.897 ' CG1' HG23 ' A' ' 76' ' ' THR . 1.0 OUTLIER -140.18 130.76 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.595 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -126.35 127.07 5.94 Favored Glycine 0 N--CA 1.498 2.789 0 C-N-CA 118.913 -1.613 . . . . 0.0 112.12 -178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.685 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.9 m-90 -90.4 178.47 6.12 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.19 84.05 2.96 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.299 -0.875 . . . . 0.0 108.709 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.418 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -69.97 158.49 87.16 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.79 -0.569 . . . . 0.0 111.581 -178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -100.01 -170.0 0.1 OUTLIER 'Trans proline' 0 N--CA 1.486 1.075 0 O-C-N 124.017 1.535 . . . . 0.0 108.618 178.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -87.36 12.06 3.04 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 O-C-N 123.62 1.327 . . . . 0.0 111.552 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.55 -28.77 13.45 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.506 ' CB ' HG11 ' A' ' 29' ' ' VAL . . . -85.21 57.34 4.4 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.803 -0.822 . . . . 0.0 110.554 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 15.8 tpt180 25.6 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.703 0 C-N-CA 124.014 0.926 . . . . 0.0 112.721 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 72.6 m -83.17 108.14 16.22 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.83 -0.748 . . . . 0.0 110.051 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.607 HD13 HD21 ' A' ' 144' ' ' LEU . 91.0 mt -82.74 164.07 20.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.785 -0.572 . . . . 0.0 110.132 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.46 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 95.2 m -115.98 153.73 48.31 Favored Pre-proline 0 N--CA 1.496 1.867 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.474 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -102.6 135.81 0.13 Allowed 'Trans proline' 0 N--CA 1.493 1.481 0 O-C-N 123.404 1.213 . . . . 0.0 111.023 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.415 ' SG ' ' CG ' ' A' ' 149' ' ' HIS . 26.7 p -145.68 151.76 38.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.461 -0.774 . . . . 0.0 110.703 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 45.4 p -86.48 103.79 15.35 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 90.3 m -99.49 137.77 37.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.531 -0.731 . . . . 0.0 110.898 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.09 -35.23 86.9 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.1 m -83.91 127.18 33.67 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.732 -0.864 . . . . 0.0 109.887 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.2 m -97.01 17.04 17.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.602 -0.686 . . . . 0.0 110.605 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -71.49 73.27 0.74 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 98.2 mt -77.72 175.12 10.23 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.33 0.586 . . . . 0.0 110.342 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -141.7 120.61 12.77 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 154' ' ' PHE . 22.0 tp -100.09 140.2 34.66 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.503 0.668 . . . . 0.0 110.233 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.669 HG21 HG21 ' A' ' 33' ' ' VAL . 83.8 t -91.75 120.05 40.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 CA-C-O 121.204 0.526 . . . . 0.0 110.344 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.2 p -84.63 173.31 10.86 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -38.84 -31.73 0.07 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 121.983 -0.448 . . . . 0.0 112.195 -179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -100.26 -69.25 0.78 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.55 -0.719 . . . . 0.0 109.828 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -147.84 -162.35 1.53 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.526 ' OD1' HG22 ' A' ' 107' ' ' VAL . 84.6 m-20 -60.34 -77.56 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.181 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.9 t 50.87 22.98 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 O-C-N 121.526 -0.734 . . . . 0.0 111.312 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.493 HG23 ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -171.27 117.05 0.44 Allowed Pre-proline 0 N--CA 1.501 2.111 0 O-C-N 121.011 -1.056 . . . . 0.0 110.299 -179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -98.91 145.07 0.48 Allowed 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.748 1.393 . . . . 0.0 109.357 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.611 HG22 HD12 ' A' ' 126' ' ' LEU . 47.5 t -133.97 139.55 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 111.073 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -97.06 120.26 37.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 8.4 ttp180 -60.02 125.2 22.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.221 -0.924 . . . . 0.0 111.063 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -101.68 5.37 41.43 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.707 -0.621 . . . . 0.0 109.419 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.56 169.07 34.77 Favored Glycine 0 N--CA 1.484 1.839 0 N-CA-C 107.645 -2.182 . . . . 0.0 107.645 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.428 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 26.9 t0 -58.48 -22.93 56.46 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.473 -1.016 . . . . 0.0 110.634 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -124.61 17.15 8.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.529 -0.732 . . . . 0.0 111.361 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -139.99 144.55 37.05 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.045 -1.034 . . . . 0.0 110.953 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.79 141.07 10.64 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.579 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.0 t -88.67 112.03 22.63 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.926 -0.75 . . . . 0.0 109.954 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.655 HD23 ' HA ' ' A' ' 129' ' ' PRO . 38.5 tp -72.89 107.36 5.24 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.18 -19.92 65.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.809 -0.557 . . . . 0.0 110.535 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 60.0 m -122.45 79.99 46.27 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.672 -0.643 . . . . 0.0 109.898 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.655 ' HA ' HD23 ' A' ' 126' ' ' LEU . 45.0 Cg_endo -58.51 150.4 68.95 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 O-C-N 123.771 1.406 . . . . 0.0 110.374 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 54.6 mtt-85 -151.14 163.07 24.9 Favored Pre-proline 0 N--CA 1.487 1.38 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.55 122.56 11.97 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 O-C-N 123.774 1.407 . . . . 0.0 110.299 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 7.9 p -49.72 -25.51 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.808 -0.558 . . . . 0.0 111.524 -178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 66.3 m -59.58 -39.97 85.86 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.608 0.718 . . . . 0.0 109.242 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -69.94 -27.08 64.45 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 96.2 mt -85.3 1.65 47.45 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.575 -0.703 . . . . 0.0 111.644 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 43.9 mttm -74.23 66.01 1.24 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.989 -1.07 . . . . 0.0 109.029 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 172.1 -24.4 0.08 OUTLIER Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.664 -1.774 . . . . 0.0 108.664 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.717 ' HA ' HD12 ' A' ' 44' ' ' LEU . 83.1 p -70.59 -13.77 62.22 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.53 -0.982 . . . . 0.0 111.65 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.545 ' HB3' HG11 ' A' ' 55' ' ' VAL . 6.9 m -60.97 141.93 56.91 Favored 'General case' 0 N--CA 1.505 2.298 0 O-C-N 120.973 -1.079 . . . . 0.0 109.833 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.622 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.02 -9.98 75.51 Favored Glycine 0 N--CA 1.484 1.897 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.35 -161.44 0.49 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.45 -1.86 . . . . 0.0 108.45 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.509 ' HB2' HD11 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -146.36 137.4 0.0 OUTLIER 'Trans proline' 0 C--N 1.324 -0.753 0 C-N-CA 116.282 -2.012 . . . . 0.0 112.277 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.464 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.4 mt -95.09 96.52 9.29 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.619 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.7 mp -87.68 145.14 26.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 33.0 m -67.92 174.77 2.08 Favored Pre-proline 0 N--CA 1.494 1.752 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -74.69 -2.03 11.91 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 O-C-N 123.655 1.345 . . . . 0.0 111.695 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 38.1 m -103.3 0.07 30.97 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.974 -1.079 . . . . 0.0 112.085 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 96.26 36.24 5.24 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.46 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 77.3 m80 -121.16 124.04 43.75 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.295 -1.121 . . . . 0.0 110.902 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -84.57 115.41 22.6 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.765 -0.584 . . . . 0.0 109.447 179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.6 m -122.8 1.44 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.605 -0.684 . . . . 0.0 111.839 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -155.0 136.65 5.25 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.721 -1.228 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 20.2 mt -119.83 120.05 62.13 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 177.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 106' ' ' LEU . 12.0 t80 -50.14 127.6 17.24 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.903 0.859 . . . . 0.0 113.28 -176.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.496 ' HB2' HG23 ' A' ' 170' ' ' VAL . 38.7 ttt-85 -116.67 -28.64 6.32 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.741 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.715 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -164.89 151.21 10.37 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.112 -0.993 . . . . 0.0 111.689 -179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.519 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.59 146.73 29.27 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 111.65 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.669 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 58.6 t -90.06 94.96 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 83.5 m -91.57 119.2 31.28 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.258 1.028 . . . . 0.0 112.711 -176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.625 ' O ' HG22 ' A' ' 163' ' ' VAL . 94.3 m -120.04 132.59 55.52 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.989 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 56.78 23.79 8.38 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.509 -0.744 . . . . 0.0 110.59 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.448 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.04 19.31 51.35 Favored Glycine 0 N--CA 1.494 2.5 0 C-N-CA 120.561 -0.828 . . . . 0.0 111.818 178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.625 HG22 ' O ' ' A' ' 160' ' ' THR . 34.9 m -147.15 143.85 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.015 -1.285 . . . . 0.0 109.564 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.93 126.03 30.49 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.425 -0.797 . . . . 0.0 111.26 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 50.2 pttt -118.82 15.74 13.48 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.295 0.569 . . . . 0.0 110.051 178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.669 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.19 149.05 1.75 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.607 ' CG2' HG11 ' A' ' 116' ' ' VAL . 15.6 m -124.01 135.42 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 C-N-CA 119.774 -0.77 . . . . 0.0 112.03 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -106.08 149.32 26.84 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.9 p90 -154.53 163.96 39.41 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 118.267 -1.373 . . . . 0.0 112.791 -177.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 155' ' ' ARG . 63.0 t -80.27 141.56 53.71 Favored Pre-proline 0 N--CA 1.498 1.945 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.314 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -82.79 151.21 14.55 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 O-C-N 123.702 1.369 . . . . 0.0 110.754 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 13.4 p -73.16 -30.04 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.654 -0.654 . . . . 0.0 110.136 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -58.93 -32.95 70.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.43 -0.794 . . . . 0.0 109.144 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 53.9 m -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.19 -0.604 . . . . 0.0 109.884 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.532 ' CG ' HD21 ' A' ' 82' ' ' LEU . 4.8 mtp -69.92 -40.01 75.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.692 -0.63 . . . . 0.0 109.911 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -61.41 -40.01 92.84 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.739 -0.601 . . . . 0.0 110.289 179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 57.7 p -66.03 -24.03 66.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.436 -0.79 . . . . 0.0 111.592 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -62.36 -40.49 96.6 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.118 -0.989 . . . . 0.0 109.139 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 82.6 mmm -65.21 -38.54 90.76 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 44.5 ttm180 -60.91 -28.29 68.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.778 -0.576 . . . . 0.0 111.104 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 182' ' ' SER . . . -166.02 -44.4 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.659 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 181' ' ' ALA . 1.4 t 75.49 -55.61 0.62 Allowed 'General case' 0 N--CA 1.513 2.716 0 O-C-N 121.723 -0.611 . . . . 0.0 110.605 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' O ' ' N ' ' A' ' 185' ' ' LYS . 36.1 mttm -142.64 101.66 3.91 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.27 -0.894 . . . . 0.0 110.264 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 59.58 -72.52 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.174 0 O-C-N 122.071 -0.393 . . . . 0.0 110.867 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.468 ' N ' ' O ' ' A' ' 183' ' ' LYS . 44.9 pttt -159.84 32.8 0.18 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.239 -0.913 . . . . 0.0 110.493 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 20.8 ttmt . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.986 179.78 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.728 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.4 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.52 -171.01 39.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.96 170.63 10.88 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.957 -0.731 . . . . 0.0 109.943 179.73 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 24' ' ' ARG . 3.0 t70 85.24 -174.75 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 123.791 0.837 . . . . 0.0 109.495 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.13 139.09 57.25 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.899 -177.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 22' ' ' THR . 10.3 t-20 -159.45 139.58 11.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -63.32 140.07 58.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.793 -0.567 . . . . 0.0 110.475 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 ' O ' ' HB1' ' A' ' 91' ' ' ALA . 34.5 m -80.81 -15.26 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.769 -0.582 . . . . 0.0 110.821 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.97 66.95 0.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.301 -0.874 . . . . 0.0 109.762 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.55 155.49 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -98.36 -40.06 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.952 . . . . 0.0 110.333 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.785 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -77.06 -28.74 54.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.03 -112.16 3.57 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -162.93 40.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.94 . . . . 0.0 110.292 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -169.74 161.12 9.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 111.317 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 70' ' ' PRO . 77.6 m 42.08 -100.09 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER 80.9 -29.32 0.12 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.697 0.799 . . . . 0.0 111.968 -178.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 73.01 99.51 0.07 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.619 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -105.53 -169.59 23.69 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.76 -17.6 60.03 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 124.021 1.537 . . . . 0.0 110.623 179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -104.55 5.16 33.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 111.375 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.7 -155.99 15.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' THR . 46.5 Cg_endo -70.61 111.07 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.782 1.411 . . . . 0.0 110.143 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.619 HD12 ' HA3' ' A' ' 66' ' ' GLY . 94.5 mt -105.73 148.99 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.65 . . . . 0.0 110.108 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.859 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.02 149.91 96.27 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.61 161.3 28.01 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 124.026 1.54 . . . . 0.0 109.816 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.03 19.96 1.2 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.722 1.38 . . . . 0.0 111.119 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.34 -15.08 36.4 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -76.69 -160.25 0.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.329 -1.101 . . . . 0.0 108.962 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -77.86 -40.0 41.58 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.585 0.707 . . . . 0.0 110.752 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m 52.82 101.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.82 171.84 2.59 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.8 t -52.81 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.84 -0.538 . . . . 0.0 111.634 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m 49.97 55.01 10.09 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.981 -1.074 . . . . 0.0 112.089 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.75 173.95 11.91 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.02 -1.05 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.57 19.28 7.56 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m -137.5 152.63 49.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.142 -1.21 . . . . 0.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p -59.92 -32.48 70.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.859 HG23 ' CG ' ' A' ' 75' ' ' TYR . 78.9 m -60.62 -44.99 95.69 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.1 mtp -61.33 -40.24 93.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.44 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.7 mtt85 -70.08 -39.97 75.29 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.896 0.855 . . . . 0.0 109.487 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 60.1 7.13 1.12 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 36.37 31.06 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.422 -0.799 . . . . 0.0 113.086 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -85.28 -47.12 10.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 50.0 41.45 23.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.442 -0.787 . . . . 0.0 111.486 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.63 130.01 34.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.47 -0.769 . . . . 0.0 109.848 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 34.7 mttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.215 -179.793 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.787 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.153 0.502 . . . . 0.0 110.252 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.63 -57.97 3.76 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 24' ' ' ARG . 30.4 ttt85 -107.44 5.0 26.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.532 -0.981 . . . . 0.0 111.282 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.0 t70 60.13 -154.48 0.37 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.821 -1.174 . . . . 0.0 110.327 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 33.9 mttp -110.03 25.76 11.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.439 -0.788 . . . . 0.0 111.928 -178.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 26' ' ' LYS . 17.0 t-20 66.41 -59.97 0.33 Allowed 'General case' 0 N--CA 1.513 2.682 0 O-C-N 121.561 -0.712 . . . . 0.0 111.789 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -100.82 128.34 46.9 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.942 -1.099 . . . . 0.0 110.509 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 91' ' ' ALA . 60.1 t -84.18 -56.87 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-O 121.438 0.637 . . . . 0.0 109.785 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 46.53 34.73 2.52 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.741 -0.599 . . . . 0.0 112.011 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -166.37 150.11 16.88 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG3' HG23 ' A' ' 33' ' ' VAL . 2.4 pt-20 -70.05 -25.78 63.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.73 -0.865 . . . . 0.0 110.655 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.799 HG22 ' HG3' ' A' ' 142' ' ' PRO . 46.8 t -109.89 140.01 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.481 -0.762 . . . . 0.0 109.653 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -138.83 147.76 42.88 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.574 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 78.6 t -86.0 130.52 36.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.337 0.589 . . . . 0.0 109.756 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.68 HG23 ' CE2' ' A' ' 43' ' ' PHE . 35.9 m -132.67 159.99 42.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.7 -0.625 . . . . 0.0 109.603 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.8 m -141.56 149.93 41.43 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.19 -0.671 . . . . 0.0 109.19 -179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 2.4 t -115.42 76.77 1.02 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.498 1.142 . . . . 0.0 109.755 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 38' ' ' THR . . . 63.3 -48.9 0.22 Allowed 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.6 p -120.06 9.72 11.26 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 120.405 -1.434 . . . . 0.0 113.851 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -161.36 170.52 19.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 120.646 -1.284 . . . . 0.0 111.703 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.2 t -127.75 154.36 45.46 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.496 0.665 . . . . 0.0 109.825 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.68 ' CE2' HG23 ' A' ' 36' ' ' VAL . 10.0 p90 -162.95 -145.8 0.1 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 138' ' ' SER . 79.4 mt -135.69 161.71 34.77 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.488 -1.383 . . . . 0.0 112.852 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -149.98 130.4 13.83 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.771 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 21.8 m -112.42 125.29 54.05 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.364 -0.835 . . . . 0.0 111.453 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 27.5 p -74.16 130.14 39.19 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 121.493 0.663 . . . . 0.0 110.784 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.658 HG11 HG23 ' A' ' 172' ' ' VAL . 44.8 t -140.34 137.27 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 C-N-CA 120.201 -0.599 . . . . 0.0 110.25 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 52.09 37.88 22.67 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.387 -0.821 . . . . 0.0 110.785 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.74 28.06 72.52 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG22 ' SD ' ' A' ' 74' ' ' MET . 89.2 t -138.94 120.02 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.487 -1.008 . . . . 0.0 109.812 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 33.9 m -72.43 129.31 38.05 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 73.3 m95 -122.9 133.28 54.41 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.8 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.821 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 3.7 t -140.57 -179.21 5.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.734 HG23 ' HA3' ' A' ' 58' ' ' GLY . 4.8 m -88.81 128.29 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.459 0 C-N-CA 118.146 -1.422 . . . . 0.0 111.895 -179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.705 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 88.3 t80 -59.98 -40.08 87.91 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.831 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 43.1 p-80 -67.8 -20.06 65.15 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.487 -1.285 . . . . 0.0 108.518 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.734 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -85.51 -35.25 12.13 Favored Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.196 -2.362 . . . . 0.0 107.196 176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.464 ' HA ' ' HB ' ' A' ' 38' ' ' THR . . . -90.02 -80.03 0.33 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.742 -0.858 . . . . 0.0 109.08 178.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.99 9.28 75.72 Favored Glycine 0 N--CA 1.496 2.647 0 O-C-N 121.331 -0.856 . . . . 0.0 111.923 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.0 p -140.46 15.61 2.38 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 118.957 1.379 . . . . 0.0 111.864 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.575 ' HG2' HG23 ' A' ' 72' ' ' THR . 40.0 tttt 68.34 -59.11 0.45 Allowed 'General case' 0 N--CA 1.515 2.787 0 O-C-N 121.22 -0.925 . . . . 0.0 110.122 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.849 HG22 ' OG1' ' A' ' 72' ' ' THR . 64.9 p -79.67 169.98 17.2 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -147.8 -128.76 0.06 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.556 -0.715 . . . . 0.0 109.368 179.95 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.468 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -146.15 84.49 1.65 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.026 -1.046 . . . . 0.0 108.285 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.694 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -106.83 -176.04 22.99 Favored Glycine 0 N--CA 1.493 2.455 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.577 -178.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.403 ' HB3' ' O ' ' A' ' 27' ' ' ASN . 47.1 Cg_endo -54.06 -24.04 31.1 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.923 1.486 . . . . 0.0 110.763 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -99.96 6.63 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.723 -0.611 . . . . 0.0 110.627 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.49 -144.27 17.21 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.455 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 42.9 Cg_endo -69.05 109.89 2.28 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 123.916 1.482 . . . . 0.0 109.084 178.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.694 HD12 ' HA3' ' A' ' 66' ' ' GLY . 72.1 mt -101.18 137.81 27.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-O 122.265 1.031 . . . . 0.0 111.821 -178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.849 ' OG1' HG22 ' A' ' 63' ' ' THR . 96.6 m -137.1 126.67 25.22 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HB2' ' HA ' ' A' ' 85' ' ' TRP . 97.7 mm-40 -138.3 -71.67 0.42 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.505 ' SD ' HG22 ' A' ' 51' ' ' VAL . 29.6 mtt -87.67 -64.68 1.11 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 -174.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.541 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 0.0 OUTLIER -171.56 -168.15 0.58 Allowed 'General case' 0 N--CA 1.511 2.577 0 C-N-CA 118.548 -1.261 . . . . 0.0 113.182 -176.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.875 HG23 ' CG1' ' A' ' 83' ' ' VAL . 99.5 m -149.75 115.3 5.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 115.155 -0.929 . . . . 0.0 108.618 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 75' ' ' TYR . 3.0 t-20 -99.04 83.58 2.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 0.0 109.182 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.705 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 61.0 t -63.96 -37.4 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 120.213 -0.595 . . . . 0.0 109.427 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -53.77 -27.13 27.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.593 -0.692 . . . . 0.0 109.254 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -113.18 -1.78 14.27 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 120.062 -0.655 . . . . 0.0 110.675 178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.6 t70 61.23 54.97 3.09 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.098 -1.001 . . . . 0.0 108.672 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD13 HG11 ' A' ' 170' ' ' VAL . 16.6 tp -147.12 148.83 31.98 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.875 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -142.87 139.93 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.318 -0.863 . . . . 0.0 108.87 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 74' ' ' MET . . . -131.29 133.24 7.14 Favored Glycine 0 N--CA 1.485 1.945 0 C-N-CA 118.931 -1.604 . . . . 0.0 110.882 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.821 ' CZ3' HG22 ' A' ' 54' ' ' THR . 21.0 m-90 -106.96 -160.83 0.75 Allowed 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.402 ' HB2' ' HB3' ' A' ' 73' ' ' GLN . 66.7 tt0 -116.18 113.39 23.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.54 143.25 97.93 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.543 -0.723 . . . . 0.0 110.961 -178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -104.19 163.94 0.21 Allowed 'Trans proline' 0 N--CA 1.486 1.037 0 O-C-N 123.845 1.445 . . . . 0.0 110.006 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -64.26 130.21 26.38 Favored 'Trans proline' 0 N--CA 1.492 1.382 0 O-C-N 123.897 1.472 . . . . 0.0 110.376 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 140.82 -30.16 2.3 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.501 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -91.91 -146.78 0.21 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.692 -0.887 . . . . 0.0 109.543 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -154.66 112.38 3.44 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 5.9 m -82.64 139.14 33.91 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.386 0.612 . . . . 0.0 110.784 -178.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.732 HD12 ' HB2' ' A' ' 150' ' ' ALA . 68.2 mt -96.6 165.34 12.2 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.7 168.05 8.46 Favored Pre-proline 0 N--CA 1.5 2.072 0 C-N-CA 119.362 -0.935 . . . . 0.0 111.615 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -68.71 132.79 25.9 Favored 'Trans proline' 0 N--CA 1.486 1.039 0 O-C-N 124.003 1.528 . . . . 0.0 109.869 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.46 ' SG ' ' CB ' ' A' ' 145' ' ' CYS . 2.2 t -70.15 -40.06 74.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.729 -0.607 . . . . 0.0 112.027 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m 50.77 50.01 19.85 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.384 -0.822 . . . . 0.0 112.299 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -151.84 169.93 21.04 Favored 'General case' 0 N--CA 1.509 2.519 0 O-C-N 121.243 -0.911 . . . . 0.0 110.011 177.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.76 16.34 58.45 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 120.558 -0.829 . . . . 0.0 111.424 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.8 m -75.48 120.24 20.64 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.006 -1.291 . . . . 0.0 109.412 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 66.7 m -105.02 -2.52 24.35 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.24 -0.913 . . . . 0.0 111.793 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -70.75 76.21 0.61 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.017 -1.052 . . . . 0.0 109.17 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.1 mt -84.37 174.69 9.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.744 0.783 . . . . 0.0 111.845 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 115' ' ' PRO . 93.7 m-85 -146.39 130.96 17.8 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.417 HD21 ' OG ' ' A' ' 138' ' ' SER . 43.9 tp -112.73 152.69 28.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 122.012 0.91 . . . . 0.0 111.759 -178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.6 t -109.95 131.09 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.448 ' C ' HD11 ' A' ' 44' ' ' LEU . 80.0 p -81.94 169.06 17.23 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.455 -0.778 . . . . 0.0 110.283 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.531 ' HA ' HD21 ' A' ' 44' ' ' LEU . 58.6 ttp180 -34.0 -33.54 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.549 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -98.76 -85.29 0.38 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 178.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.34 5.34 0.07 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.17 -0.956 . . . . 0.0 113.06 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -60.07 137.91 57.99 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.561 -1.337 . . . . 0.0 109.956 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 63.1 t -110.27 120.05 60.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.614 -0.679 . . . . 0.0 110.319 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.599 HD11 ' HB3' ' A' ' 128' ' ' SER . 6.1 tt -120.01 112.43 34.89 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.723 -0.611 . . . . 0.0 109.577 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.438 ' HB3' ' CE1' ' A' ' 105' ' ' TYR . 45.5 Cg_endo -62.55 132.07 36.44 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.596 1.314 . . . . 0.0 111.487 -178.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.692 HG22 HD12 ' A' ' 126' ' ' LEU . 48.7 t -129.93 134.18 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -91.07 119.99 31.68 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.287 -0.883 . . . . 0.0 108.769 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.491 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 9.4 ttm180 -58.71 124.28 19.2 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.922 . . . . 0.0 110.958 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -99.58 3.44 45.37 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.729 -0.607 . . . . 0.0 109.634 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.51 179.31 45.96 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 108.1 -2.0 . . . . 0.0 108.1 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.413 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 84.5 m-20 -63.41 -27.09 69.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.358 -1.084 . . . . 0.0 110.216 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 83.2 p -123.49 18.67 9.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.6 -0.688 . . . . 0.0 111.808 -179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -138.52 145.83 41.22 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.089 -1.007 . . . . 0.0 111.378 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.53 142.17 12.11 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 108.369 -1.893 . . . . 0.0 108.369 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.455 ' C ' HG13 ' A' ' 116' ' ' VAL . 13.7 t -90.4 110.01 21.12 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.872 -0.781 . . . . 0.0 110.227 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.692 HD12 HG22 ' A' ' 116' ' ' VAL . 31.0 tp -70.36 108.42 4.23 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -60.51 -35.41 75.89 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 121.585 0.707 . . . . 0.0 109.732 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.599 ' HB3' HD11 ' A' ' 114' ' ' ILE . 47.3 t -110.87 107.82 57.82 Favored Pre-proline 0 C--N 1.298 -1.673 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.254 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -74.45 148.17 37.59 Favored 'Trans proline' 0 N--CA 1.489 1.225 0 O-C-N 123.873 1.46 . . . . 0.0 109.899 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.1 mtt85 -150.02 160.96 32.54 Favored Pre-proline 0 N--CA 1.488 1.43 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -57.91 124.3 15.67 Favored 'Trans proline' 0 N--CA 1.492 1.417 0 O-C-N 123.858 1.451 . . . . 0.0 110.441 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -50.01 -27.22 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.268 0.556 . . . . 0.0 110.806 -179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.423 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 68.4 m -57.47 -30.88 65.42 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.823 0.82 . . . . 0.0 109.23 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -74.09 -29.05 61.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.383 -0.823 . . . . 0.0 109.125 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.3 mt -90.05 -1.42 57.95 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -74.6 65.85 1.35 Allowed 'General case' 0 N--CA 1.513 2.68 0 O-C-N 120.8 -1.188 . . . . 0.0 109.369 179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 173.6 -25.39 0.08 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.3 -1.92 . . . . 0.0 108.3 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.701 ' HA ' HD12 ' A' ' 44' ' ' LEU . 8.2 t -70.32 -12.58 61.68 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.404 -1.056 . . . . 0.0 111.316 -178.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.442 ' HB3' HG11 ' A' ' 55' ' ' VAL . 11.1 m -59.92 140.4 56.72 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.039 -1.038 . . . . 0.0 110.27 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.621 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 88.93 -7.98 80.83 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -67.06 -158.21 0.74 Allowed Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.492 -1.843 . . . . 0.0 108.492 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.799 ' HG3' HG22 ' A' ' 33' ' ' VAL . 58.6 Cg_endo -143.32 140.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 116.356 -1.963 . . . . 0.0 112.077 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.411 ' O ' HD22 ' A' ' 104' ' ' LEU . 2.5 mt -99.93 96.25 7.43 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.3 mp -86.93 132.58 33.77 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.816 0.817 . . . . 0.0 112.737 -177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.49 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -61.25 -161.44 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 177.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -98.85 15.78 0.53 Allowed 'Trans proline' 0 C--N 1.315 -1.221 0 O-C-N 123.666 1.351 . . . . 0.0 110.15 177.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 2.0 m -120.33 12.4 11.7 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.209 -0.932 . . . . 0.0 112.047 -179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.51 37.38 20.64 Favored Glycine 0 N--CA 1.502 3.035 0 O-C-N 120.94 -1.1 . . . . 0.0 110.488 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -127.15 128.75 46.67 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -1.132 . . . . 0.0 110.639 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.732 ' HB2' HD12 ' A' ' 94' ' ' LEU . . . -92.61 100.13 12.71 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.4 m -109.99 6.79 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 119.93 -0.708 . . . . 0.0 112.177 -178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.466 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -149.95 124.43 1.76 Allowed Glycine 0 N--CA 1.494 2.534 0 C-N-CA 119.278 -1.439 . . . . 0.0 111.462 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.619 HD12 ' CE ' ' A' ' 175' ' ' MET . 22.6 mt -109.98 120.07 60.3 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.092 -1.24 . . . . 0.0 107.984 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.485 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.5 t80 -52.56 128.83 27.29 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.673 0.749 . . . . 0.0 112.495 -177.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.436 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.3 ttp180 -116.27 -28.19 6.61 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.851 -0.53 . . . . 0.0 110.993 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.797 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.3 151.0 9.52 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.2 -0.938 . . . . 0.0 111.836 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.485 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -105.73 145.31 31.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.824 -0.547 . . . . 0.0 111.331 -179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 166' ' ' ALA . 49.0 t -93.43 91.48 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.3 p -94.59 113.84 25.72 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.667 1.222 . . . . 0.0 112.625 -177.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.46 ' O ' ' N ' ' A' ' 162' ' ' GLY . 62.8 m -98.57 133.31 43.1 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 160' ' ' THR . 19.8 ttp180 63.45 -72.43 0.05 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -178.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 160' ' ' THR . . . -164.39 25.83 0.19 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.452 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -149.95 144.02 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.056 -1.261 . . . . 0.0 109.569 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -79.18 127.59 32.23 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.592 0.71 . . . . 0.0 111.038 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 53.6 pttt -118.35 14.89 13.88 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.176 0.512 . . . . 0.0 110.04 178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.6 ' HB3' ' HB ' ' A' ' 158' ' ' VAL . . . -172.72 146.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.686 HG21 HG11 ' A' ' 116' ' ' VAL . 14.7 m -121.12 135.39 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 CA-C-O 121.729 0.776 . . . . 0.0 112.464 -178.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -103.39 147.14 27.48 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 36.2 p90 -156.14 161.26 40.37 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 118.306 -1.358 . . . . 0.0 112.757 -178.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 155' ' ' ARG . 62.9 t -87.55 130.34 47.61 Favored Pre-proline 0 N--CA 1.496 1.845 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.863 178.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -79.23 156.69 26.01 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 O-C-N 123.53 1.279 . . . . 0.0 110.438 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.658 HG23 HG11 ' A' ' 48' ' ' VAL . 14.1 p -70.06 -29.94 41.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.49 -0.756 . . . . 0.0 109.905 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -59.47 -27.63 66.28 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 41.2 p -75.04 -25.99 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.706 -0.621 . . . . 0.0 110.236 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.619 ' CE ' HD12 ' A' ' 153' ' ' ILE . 55.4 mtt -64.65 -50.07 68.52 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.647 -0.821 . . . . 0.0 109.306 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -62.91 -45.11 94.05 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.126 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 75.5 p -69.77 -40.74 75.88 Favored 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.756 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.41 ' CG2' ' OH ' ' A' ' 75' ' ' TYR . 85.9 m -68.96 -40.06 79.12 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 85.0 mmm -66.84 -25.57 66.49 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.009 -0.677 . . . . 0.0 109.66 178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 75.8 ttt-85 -59.15 -22.5 61.02 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.304 -0.872 . . . . 0.0 110.657 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -162.57 154.92 18.99 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.385 -0.822 . . . . 0.0 111.221 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.8 t -173.17 47.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.472 -0.767 . . . . 0.0 109.749 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.1 mttp 49.99 -139.97 0.82 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.501 -0.749 . . . . 0.0 110.43 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 47.5 tptt 56.56 36.95 28.38 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.648 -1.283 . . . . 0.0 109.388 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -70.0 -40.05 75.5 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.804 0.811 . . . . 0.0 109.68 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 42.7 mmtm . . . . . 0 N--CA 1.496 1.85 0 CA-C-O 117.903 -1.046 . . . . 0.0 111.47 179.182 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.831 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.191 0.519 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 93.58 -9.92 73.31 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 110.739 -0.945 . . . . 0.0 110.739 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -103.7 4.6 35.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.041 -1.27 . . . . 0.0 111.231 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 50.2 t0 47.83 76.98 0.1 Allowed 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.336 -0.852 . . . . 0.0 111.643 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -73.85 65.82 1.08 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.917 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -159.6 136.61 9.48 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -65.86 141.99 58.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.644 -0.66 . . . . 0.0 109.289 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.851 HG11 ' HB2' ' A' ' 91' ' ' ALA . 39.1 t -79.99 -70.0 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.393 -179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 43.71 38.94 2.21 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.783 -0.573 . . . . 0.0 112.533 178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -148.88 158.76 27.78 Favored Glycine 0 N--CA 1.494 2.542 0 C-N-CA 119.628 -1.272 . . . . 0.0 111.174 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.845 ' HG2' HD21 ' A' ' 94' ' ' LEU . 24.7 mp0 -70.0 -35.66 74.55 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.99 -0.712 . . . . 0.0 110.318 179.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.3 t -107.58 121.18 60.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.673 -0.642 . . . . 0.0 109.755 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -91.61 127.96 37.26 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.895 -0.722 . . . . 0.0 110.491 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 45.5 t -83.71 127.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 178.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.49 173.99 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.305 0 O-C-N 121.36 -0.838 . . . . 0.0 110.38 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 8.2 t -150.1 141.99 23.81 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.822 0.82 . . . . 0.0 109.081 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.76 HG21 ' O ' ' A' ' 58' ' ' GLY . 6.2 t -117.48 179.34 4.08 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -18.48 1.51 Allowed 'General case' 0 C--N 1.29 -1.991 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.505 ' H ' HG23 ' A' ' 38' ' ' THR . 67.5 p -104.55 -31.09 9.61 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.995 -1.066 . . . . 0.0 113.595 -178.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -171.88 -169.14 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 120.588 -1.32 . . . . 0.0 113.183 -178.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.405 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 53.6 m -118.4 145.71 44.98 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.668 ' HE1' HG22 ' A' ' 38' ' ' THR . 10.2 p90 -161.12 -145.2 0.11 Allowed 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.384 -0.822 . . . . 0.0 110.71 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 88.9 mt -134.08 160.66 37.11 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 120.629 -1.294 . . . . 0.0 113.287 -176.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.484 ' HB1' ' SG ' ' A' ' 52' ' ' CYS . . . -150.18 126.72 10.87 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.068 179.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.581 HG21 ' HB3' ' A' ' 142' ' ' PRO . 59.3 m -96.74 127.28 42.57 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.115 -0.99 . . . . 0.0 111.743 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 22.3 m -76.32 123.82 26.53 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.854 -0.529 . . . . 0.0 110.434 178.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.6 t -138.52 130.01 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.54 -0.725 . . . . 0.0 110.19 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 50.37 39.92 21.55 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.355 -0.84 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 70.34 26.16 74.6 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 53.2 t -136.19 113.86 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.451 -1.029 . . . . 0.0 109.556 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.484 ' SG ' ' HB1' ' A' ' 45' ' ' ALA . 47.5 t -75.65 119.97 20.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.73 -0.606 . . . . 0.0 109.399 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 86.7 m95 -107.68 123.45 48.53 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.494 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.88 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.0 t -127.62 -179.87 5.15 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.619 HG11 ' HB3' ' A' ' 139' ' ' SER . 10.5 m -90.22 124.99 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.275 0 C-N-CA 118.194 -1.403 . . . . 0.0 111.999 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.412 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.819 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 41.4 p-80 -73.02 68.56 0.93 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 122.119 0.962 . . . . 0.0 108.809 178.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.76 ' O ' HG21 ' A' ' 38' ' ' THR . . . 168.57 -49.31 0.22 Allowed Glycine 0 N--CA 1.484 1.887 0 N-CA-C 107.56 -2.216 . . . . 0.0 107.56 -179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -85.39 -78.61 0.25 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.71 -0.876 . . . . 0.0 109.753 178.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 43.56 28.39 1.01 Allowed Glycine 0 N--CA 1.503 3.16 0 O-C-N 121.521 -0.737 . . . . 0.0 111.688 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 63' ' ' THR . 27.3 p -131.89 10.08 4.61 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.264 -1.139 . . . . 0.0 112.31 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 61' ' ' SER . 20.3 ttmt 62.51 -64.63 0.09 Allowed 'General case' 0 N--CA 1.515 2.805 0 CA-C-N 118.581 0.628 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.864 HG23 ' HB2' ' A' ' 70' ' ' PRO . 90.7 m -81.0 138.13 36.05 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.845 0.831 . . . . 0.0 111.683 -178.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.466 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.6 OUTLIER -142.26 -135.04 0.1 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 178.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.466 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -137.85 100.03 4.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.743 -1.223 . . . . 0.0 110.712 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.444 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -96.45 172.92 29.38 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -63.75 -12.98 34.18 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.934 1.492 . . . . 0.0 110.996 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -112.51 -13.72 13.31 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.219 -0.926 . . . . 0.0 111.873 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 148.6 -163.64 29.03 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.864 ' HB2' HG23 ' A' ' 63' ' ' THR . 47.6 Cg_endo -66.59 121.33 8.55 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 O-C-N 123.944 1.497 . . . . 0.0 109.597 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.748 HG22 ' HD1' ' A' ' 85' ' ' TRP . 27.0 mt -94.35 143.79 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 121.666 0.746 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.409 HG23 ' HD3' ' A' ' 62' ' ' LYS . 31.7 m -99.94 140.34 34.29 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.922 -0.486 . . . . 0.0 110.534 -179.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.424 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.3 pt20 -72.19 156.05 39.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.524 -0.735 . . . . 0.0 110.416 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 98.6 mtp -95.35 -35.51 11.74 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.499 0.666 . . . . 0.0 109.27 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.427 ' CD1' ' N ' ' A' ' 75' ' ' TYR . 0.1 OUTLIER -159.26 -177.02 6.15 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.906 HG23 HG13 ' A' ' 83' ' ' VAL . 89.4 m -150.48 122.49 8.22 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.653 -0.654 . . . . 0.0 109.565 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -96.79 76.41 2.78 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 86.6 t -60.04 -39.91 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.651 -0.655 . . . . 0.0 109.71 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -54.95 -26.09 33.96 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -110.48 -2.58 16.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.703 -0.623 . . . . 0.0 110.794 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.9 t0 60.01 54.97 3.95 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.907 -1.121 . . . . 0.0 108.372 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.63 HD21 ' CG ' ' A' ' 175' ' ' MET . 8.1 tp -147.33 153.57 39.86 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.349 -0.54 . . . . 0.0 109.839 -178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.906 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -144.18 141.2 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -124.14 122.01 4.65 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.094 -1.527 . . . . 0.0 111.877 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.88 ' CZ3' HG22 ' A' ' 54' ' ' THR . 6.9 m-90 -90.99 -170.24 2.61 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -101.83 112.72 25.43 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 88' ' ' PRO . . . -64.27 138.39 97.41 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.421 -0.799 . . . . 0.0 110.48 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 87' ' ' ALA . 53.8 Cg_endo -114.36 167.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.923 0 O-C-N 123.751 1.395 . . . . 0.0 110.674 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -61.05 146.16 98.08 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 O-C-N 123.846 1.445 . . . . 0.0 110.631 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.88 -45.44 1.15 Allowed Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.851 ' HB2' HG11 ' A' ' 29' ' ' VAL . . . -88.37 -152.71 0.22 Allowed 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.87 -0.783 . . . . 0.0 109.828 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -154.27 114.47 3.89 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.1 m -84.48 157.48 21.32 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.46 0.648 . . . . 0.0 111.12 -178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 144' ' ' LEU . 73.4 mt -109.37 158.61 17.75 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.919 -0.488 . . . . 0.0 109.927 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.418 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.2 p -101.1 149.98 36.71 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.475 -0.766 . . . . 0.0 110.662 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.27 170.49 11.94 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 O-C-N 123.834 1.439 . . . . 0.0 110.637 -179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 149' ' ' HIS . 20.0 t -167.16 152.82 7.68 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 51.6 m -136.53 111.93 9.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.2 p -150.07 169.95 20.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.441 -0.787 . . . . 0.0 110.862 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -82.55 3.63 81.65 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.268 -1.133 . . . . 0.0 110.268 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.5 m -89.33 109.97 20.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.964 -1.315 . . . . 0.0 109.794 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.0 m -98.42 4.88 48.47 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.586 -0.696 . . . . 0.0 111.439 -179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -70.56 73.8 0.54 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 145' ' ' CYS . 89.8 mt -83.53 175.56 9.69 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.584 0.707 . . . . 0.0 111.085 -178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 115' ' ' PRO . 89.6 m-85 -143.54 123.96 13.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 26.8 tp -100.6 141.07 33.97 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.615 0.721 . . . . 0.0 110.925 -178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.424 ' CB ' HG21 ' A' ' 33' ' ' VAL . 53.5 t -89.89 120.27 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.919 -0.488 . . . . 0.0 109.693 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 54.5 p -85.27 176.74 8.14 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.622 -0.674 . . . . 0.0 109.221 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 47.2 ttp180 -42.73 -29.19 0.29 Allowed 'General case' 0 N--CA 1.506 2.363 0 CA-C-O 121.052 0.453 . . . . 0.0 111.654 -179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -102.52 -67.92 0.85 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.552 -0.717 . . . . 0.0 110.091 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.31 -163.09 1.7 Allowed 'General case' 0 N--CA 1.483 1.21 0 O-C-N 121.474 -0.766 . . . . 0.0 109.546 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -55.55 -71.95 0.08 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.668 -0.645 . . . . 0.0 110.747 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.736 HG11 ' OH ' ' A' ' 134' ' ' TYR . 33.6 t 65.41 -52.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 126' ' ' LEU . 44.7 pt -118.9 149.96 47.66 Favored Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 120.72 -1.237 . . . . 0.0 112.087 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . 53.8 Cg_endo -111.07 156.74 0.05 OUTLIER 'Trans proline' 0 N--CA 1.488 1.198 0 O-C-N 123.721 1.379 . . . . 0.0 109.736 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.656 HG11 ' CG2' ' A' ' 167' ' ' VAL . 39.4 t -139.05 139.97 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.284 -0.885 . . . . 0.0 111.272 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -95.68 116.02 28.27 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.485 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.9 ttm180 -58.06 125.51 23.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.186 -0.946 . . . . 0.0 111.379 -178.076 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 30.6 mmm180 -96.89 -2.67 43.4 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.246 -0.649 . . . . 0.0 109.246 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.42 -176.28 44.71 Favored Glycine 0 N--CA 1.484 1.892 0 N-CA-C 107.826 -2.11 . . . . 0.0 107.826 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 94.1 m-20 -70.01 -18.5 63.32 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.293 -1.122 . . . . 0.0 110.243 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.6 p -120.17 14.23 12.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.493 -0.754 . . . . 0.0 111.916 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -148.98 147.57 28.74 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.798 -1.161 . . . . 0.0 112.059 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -140.37 138.57 9.12 Favored Glycine 0 N--CA 1.481 1.673 0 N-CA-C 107.453 -2.259 . . . . 0.0 107.453 178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.407 ' C ' HG13 ' A' ' 116' ' ' VAL . 22.4 t -88.89 109.98 20.69 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.833 -0.804 . . . . 0.0 110.265 -178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.549 HD11 HD12 ' A' ' 114' ' ' ILE . 51.8 tp -73.67 109.01 6.85 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 85.7 mt -66.64 -19.75 65.84 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.693 -0.63 . . . . 0.0 110.392 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 57.9 m -119.96 79.97 25.61 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.669 -0.644 . . . . 0.0 110.212 179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.418 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.9 Cg_endo -57.68 146.99 82.51 Favored 'Trans proline' 0 N--CA 1.495 1.597 0 O-C-N 123.681 1.359 . . . . 0.0 110.087 179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 39.4 mtt-85 -154.13 168.5 11.69 Favored Pre-proline 0 N--CA 1.488 1.429 0 O-C-N 121.696 -0.627 . . . . 0.0 109.659 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -61.39 124.93 15.68 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.943 1.496 . . . . 0.0 110.077 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 13.9 p -47.75 -24.33 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.813 -0.555 . . . . 0.0 111.923 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.3 p -57.5 -34.25 68.88 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.398 -0.814 . . . . 0.0 109.514 179.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.736 ' OH ' HG11 ' A' ' 113' ' ' VAL . 69.2 t80 -69.92 -29.59 66.79 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.4 mt -83.85 4.14 30.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.59 -0.694 . . . . 0.0 110.857 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -69.41 114.13 7.37 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-O 122.146 0.974 . . . . 0.0 109.039 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 98.66 -7.91 61.51 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 45.6 t -73.81 -17.14 61.12 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.504 -0.998 . . . . 0.0 109.569 178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.619 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.9 m -65.3 148.7 51.24 Favored 'General case' 0 N--CA 1.506 2.359 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.052 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.586 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.0 75.35 Favored Glycine 0 N--CA 1.483 1.812 0 N-CA-C 109.043 -1.623 . . . . 0.0 109.043 -178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -69.36 -167.22 5.31 Favored Glycine 0 N--CA 1.485 1.94 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.581 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.6 Cg_endo -139.58 147.85 0.0 OUTLIER 'Trans proline' 0 N--CA 1.481 0.762 0 C-N-CA 117.087 -1.476 . . . . 0.0 111.734 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.509 ' HB3' HD13 ' A' ' 104' ' ' LEU . 3.1 mt -97.55 102.29 14.02 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 1.025 HD11 HD13 ' A' ' 94' ' ' LEU . 4.5 mm? -81.32 130.04 34.87 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 112.962 0.726 . . . . 0.0 112.962 -176.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.546 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -65.96 -160.18 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -95.21 16.24 0.96 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 O-C-N 123.635 1.334 . . . . 0.0 110.712 178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 8.0 p -130.77 19.93 5.07 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.245 -0.909 . . . . 0.0 111.691 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 72.41 30.47 64.58 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.418 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 50.8 m170 -115.92 118.64 33.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.486 -1.008 . . . . 0.0 109.907 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -75.66 124.69 27.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 0.0 109.906 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.406 ' HA ' ' CG1' ' A' ' 172' ' ' VAL . 33.3 m -125.58 -2.54 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.663 -0.648 . . . . 0.0 111.559 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.474 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.18 128.63 2.42 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.487 -1.34 . . . . 0.0 111.317 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.421 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 23.3 mt -110.07 119.98 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.06 -1.259 . . . . 0.0 107.866 177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 14.0 t80 -52.0 127.31 20.99 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.808 0.813 . . . . 0.0 112.909 -177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.449 ' HB2' HG23 ' A' ' 170' ' ' VAL . 57.3 ttp180 -115.68 -28.13 6.85 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.947 -0.471 . . . . 0.0 110.82 179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.835 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -164.53 148.92 9.5 Favored 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.918 -179.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.91 141.98 33.92 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.416 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 60.4 t -89.65 92.41 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -88.49 117.89 27.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.33 1.062 . . . . 0.0 112.218 -176.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.627 ' O ' HG22 ' A' ' 163' ' ' VAL . 88.6 m -120.04 131.96 55.3 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.262 -0.881 . . . . 0.0 108.725 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.422 ' HG2' HG22 ' A' ' 160' ' ' THR . 57.6 mmt-85 58.3 21.25 8.03 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.401 -0.812 . . . . 0.0 110.224 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.423 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 89.83 18.86 49.9 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.532 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.627 HG22 ' O ' ' A' ' 160' ' ' THR . 34.1 m -145.98 143.91 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 121.235 -1.156 . . . . 0.0 109.4 179.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.56 121.29 23.7 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.476 -0.765 . . . . 0.0 110.854 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -111.11 11.14 21.96 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.714 -0.617 . . . . 0.0 110.51 178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.52 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -175.25 139.46 0.46 Allowed 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.656 ' CG2' HG11 ' A' ' 116' ' ' VAL . 17.1 m -110.09 137.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 C-N-CA 119.745 -0.782 . . . . 0.0 112.155 -178.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -106.55 148.09 28.66 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.826 -1.546 . . . . 0.0 106.826 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.474 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.9 p90 -155.21 164.57 38.63 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.363 -1.335 . . . . 0.0 112.616 -177.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.607 HG11 HD22 ' A' ' 82' ' ' LEU . 50.2 t -84.23 135.68 41.45 Favored Pre-proline 0 N--CA 1.497 1.902 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.068 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.9 148.83 46.36 Favored 'Trans proline' 0 N--CA 1.49 1.312 0 O-C-N 123.843 1.444 . . . . 0.0 110.099 179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.406 ' CG1' ' HA ' ' A' ' 151' ' ' VAL . 7.3 p -71.68 -28.53 31.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 0.0 109.922 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.476 ' O ' HG23 ' A' ' 177' ' ' THR . 98.9 mt-10 -59.95 -30.62 69.21 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.465 -0.772 . . . . 0.0 109.128 178.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 37.4 t -72.12 -33.68 68.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.786 -0.571 . . . . 0.0 110.159 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.63 ' CG ' HD21 ' A' ' 82' ' ' LEU . 3.4 mtp -68.26 -40.08 82.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.681 -0.637 . . . . 0.0 109.685 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -62.5 -40.05 95.47 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.723 -0.611 . . . . 0.0 109.843 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 173' ' ' GLU . 69.8 p -69.86 -31.96 70.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.551 -0.718 . . . . 0.0 111.78 -179.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.4 m -60.02 -50.03 75.34 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.14 -0.975 . . . . 0.0 109.701 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 27.4 ptm -70.04 -26.37 64.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.634 -0.666 . . . . 0.0 109.837 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -70.04 -17.48 63.25 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.464 -0.772 . . . . 0.0 111.211 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -62.66 -54.13 44.05 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.392 -0.818 . . . . 0.0 110.162 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 30.0 p 39.07 60.33 1.48 Allowed 'General case' 0 N--CA 1.508 2.467 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.94 -67.15 0.79 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.425 -0.797 . . . . 0.0 110.662 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.9 mtmt -151.78 22.02 0.69 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.601 -0.687 . . . . 0.0 110.589 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 40.4 tttt -156.02 131.04 9.24 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.294 -0.879 . . . . 0.0 110.648 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 54.1 mttp . . . . . 0 N--CA 1.494 1.76 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.126 179.658 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.835 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 22' ' ' THR . 6.7 t . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.184 0.516 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -116.61 164.73 12.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.4 mmt180 -79.99 -70.0 0.55 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.531 -0.982 . . . . 0.0 111.234 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 41.78 31.9 0.23 Allowed 'General case' 0 N--CA 1.507 2.394 0 CA-C-O 121.291 0.567 . . . . 0.0 111.295 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -134.83 76.97 1.66 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.908 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -161.02 39.57 0.15 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.51 -0.744 . . . . 0.0 110.596 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 54.65 102.54 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.432 -0.793 . . . . 0.0 111.01 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.535 ' CB ' ' HB2' ' A' ' 91' ' ' ALA . 90.5 t -81.28 -59.34 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.037 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 48.42 36.92 7.88 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.585 -0.697 . . . . 0.0 111.447 179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -131.15 149.83 19.28 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -77.41 -47.69 19.13 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.843 -0.798 . . . . 0.0 110.522 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.502 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.6 t -125.55 130.04 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -94.85 120.44 35.07 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.398 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG22 ' CD2' ' A' ' 44' ' ' LEU . 61.6 t -84.01 130.26 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.412 HG13 ' C ' ' A' ' 35' ' ' VAL . 30.4 m -146.32 171.26 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 C-N-CA 119.619 -0.832 . . . . 0.0 110.641 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.0 p -142.21 127.91 19.21 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.699 0.762 . . . . 0.0 109.183 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.54 HG21 ' HA ' ' A' ' 59' ' ' ALA . 69.2 p -107.76 179.94 4.09 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 61' ' ' SER . . . -56.62 -17.11 7.56 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.51 -179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -96.55 -41.41 8.56 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.273 -0.892 . . . . 0.0 112.019 -179.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -173.47 -170.27 0.59 Allowed 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.869 -1.144 . . . . 0.0 112.511 -179.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.408 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 55.4 m -112.58 141.32 46.48 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' HD23 ' A' ' 44' ' ' LEU . 17.0 p90 -163.64 -145.72 0.1 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 0.0 110.628 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 109' ' ' ARG . 92.0 mt -137.75 169.04 18.47 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.714 -1.241 . . . . 0.0 112.54 -177.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.428 ' HB2' ' OG1' ' A' ' 54' ' ' THR . . . -150.25 127.35 11.23 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.66 HG21 ' HB3' ' A' ' 142' ' ' PRO . 62.6 m -99.13 127.81 45.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.248 -0.907 . . . . 0.0 111.526 -178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 93.6 m -74.6 124.29 26.39 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 120.466 -0.494 . . . . 0.0 109.8 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.2 t -137.56 126.79 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.482 -0.761 . . . . 0.0 109.992 179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 51.8 40.05 26.89 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.621 -0.675 . . . . 0.0 111.1 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.756 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 71.71 26.78 72.17 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.433 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 60.8 t -139.81 115.94 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.396 -1.061 . . . . 0.0 109.409 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 8.2 t -76.63 121.83 23.79 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.91 -0.716 . . . . 0.0 109.287 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.522 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 94.2 m95 -109.75 126.87 54.19 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.894 -0.723 . . . . 0.0 109.671 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.775 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 1.4 t -132.21 176.83 8.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG13 ' CA ' ' A' ' 140' ' ' GLY . 15.6 m -87.31 126.01 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 C-N-CA 118.307 -1.357 . . . . 0.0 111.649 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.9 t80 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.619 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.725 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 31.9 p-80 -66.85 -19.99 65.84 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.573 -1.251 . . . . 0.0 109.144 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.556 ' HA3' HG23 ' A' ' 55' ' ' VAL . . . -81.75 -39.27 12.2 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 107.658 -2.177 . . . . 0.0 107.658 177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -79.97 -69.96 0.55 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.681 -0.894 . . . . 0.0 109.166 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.25 -61.07 0.59 Allowed Glycine 0 N--CA 1.494 2.558 0 C-N-CA 120.919 -0.657 . . . . 0.0 111.617 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.639 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . 31.6 m -98.9 14.31 29.45 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.34 -1.094 . . . . 0.0 111.946 -178.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 51.48 -164.72 0.06 Allowed 'General case' 0 N--CA 1.485 1.301 0 O-C-N 121.016 -1.053 . . . . 0.0 110.56 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 63' ' ' THR . 95.6 m 51.25 71.71 0.42 Allowed 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.377 0.608 . . . . 0.0 111.342 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.46 HD21 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -87.52 -137.41 0.09 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.73 109.46 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.901 -1.124 . . . . 0.0 110.518 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.475 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -75.42 -159.3 7.72 Favored Glycine 0 N--CA 1.483 1.803 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.07 -22.35 30.79 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 124.215 1.64 . . . . 0.0 109.877 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -143.23 -1.52 1.05 Allowed 'General case' 0 N--CA 1.501 2.112 0 C-N-CA 119.122 -1.031 . . . . 0.0 113.166 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -171.64 169.97 42.96 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 119.386 -1.388 . . . . 0.0 110.938 -179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.46 121.86 9.8 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 O-C-N 124.09 1.574 . . . . 0.0 110.673 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.632 HG22 ' HD1' ' A' ' 85' ' ' TRP . 42.9 mt -97.16 143.74 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 86.9 m -98.14 145.33 26.69 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.492 0.663 . . . . 0.0 111.553 -178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.445 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 2.4 pp0? -77.27 155.24 32.23 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.774 -0.579 . . . . 0.0 109.933 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 38.2 ttm -102.58 -29.14 11.74 Favored 'General case' 0 N--CA 1.484 1.233 0 O-C-N 121.536 -0.727 . . . . 0.0 110.501 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.702 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -147.72 164.73 32.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.283 -0.886 . . . . 0.0 109.235 -179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.857 HG23 ' CG1' ' A' ' 83' ' ' VAL . 31.3 m -150.86 116.95 5.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.608 -0.683 . . . . 0.0 110.137 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 78.05 4.2 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.97 -33.56 53.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.852 -0.53 . . . . 0.0 109.929 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -53.1 -26.59 16.99 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -123.55 3.97 8.98 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.867 178.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.1 t70 64.22 61.72 0.88 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.94 -1.1 . . . . 0.0 109.883 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.707 HD13 HG11 ' A' ' 170' ' ' VAL . 17.6 tp -142.41 151.74 42.11 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.82 -0.55 . . . . 0.0 109.535 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.857 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -143.86 129.15 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.401 -0.812 . . . . 0.0 109.58 -179.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -117.07 122.49 5.48 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.29 -1.433 . . . . 0.0 111.192 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.775 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.1 m-90 -85.9 -171.74 3.74 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.988 -0.713 . . . . 0.0 110.12 178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -102.57 95.26 6.11 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.756 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -66.13 145.1 98.98 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.44 -0.787 . . . . 0.0 110.853 -178.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -92.61 156.25 2.92 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 124.062 1.559 . . . . 0.0 109.68 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -60.85 119.86 7.26 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 O-C-N 123.751 1.395 . . . . 0.0 110.561 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 128.13 -15.32 6.17 Favored Glycine 0 N--CA 1.493 2.482 0 C-N-CA 120.36 -0.924 . . . . 0.0 110.808 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.535 ' HB2' ' CB ' ' A' ' 29' ' ' VAL . . . -89.45 97.33 11.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -1.135 . . . . 0.0 110.043 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.6 tpm_? 24.22 -76.49 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.861 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' ALA . 0.5 OUTLIER 63.33 75.86 0.38 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.737 0.779 . . . . 0.0 109.88 -178.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.669 HD13 HD21 ' A' ' 144' ' ' LEU . 85.0 mt -71.15 163.96 26.57 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.24 155.48 37.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.836 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.82 172.3 11.95 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.969 1.51 . . . . 0.0 110.242 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 149' ' ' HIS . 24.7 t -160.88 160.02 30.46 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.551 -0.718 . . . . 0.0 110.515 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.5 p -142.53 41.62 1.6 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.752 -0.592 . . . . 0.0 110.693 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 29.5 p -76.28 154.45 35.13 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.283 -0.886 . . . . 0.0 110.351 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -81.95 -8.44 86.64 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 120.435 -0.888 . . . . 0.0 110.914 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 71.5 m -60.0 -40.04 87.85 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.916 -1.344 . . . . 0.0 110.604 -179.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 3.0 m 54.26 20.38 2.61 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.531 -0.731 . . . . 0.0 111.254 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.3 m-20 -86.45 79.59 8.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 143' ' ' LEU . 96.5 mt -89.53 170.61 10.35 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.381 0.61 . . . . 0.0 110.678 -178.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 45.1 p90 -155.86 140.75 17.2 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 39.6 tp -112.13 153.17 27.39 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-O 122.07 0.938 . . . . 0.0 111.748 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 111' ' ' ALA . 86.0 t -109.99 130.01 63.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.536 ' CG2' HD11 ' A' ' 114' ' ' ILE . 60.1 p -81.35 171.6 14.59 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.412 -0.805 . . . . 0.0 110.284 -179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.743 ' HA ' HD21 ' A' ' 44' ' ' LEU . 26.4 ttp180 -32.26 -33.24 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.434 ' N ' ' O ' ' A' ' 108' ' ' THR . 83.3 m-70 -98.87 -87.19 0.35 Allowed 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.916 -0.714 . . . . 0.0 109.108 178.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 107' ' ' VAL . . . -164.2 26.37 0.07 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.124 -0.985 . . . . 0.0 111.226 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -61.2 158.28 14.36 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.066 -1.021 . . . . 0.0 110.694 -178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 62.0 t -107.11 120.03 57.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.587 ' CG2' HD11 ' A' ' 126' ' ' LEU . 85.9 mt -130.01 83.86 62.29 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.633 -0.667 . . . . 0.0 110.259 -178.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -65.68 120.61 7.83 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 O-C-N 123.982 1.517 . . . . 0.0 110.744 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.72 HG11 ' CG2' ' A' ' 167' ' ' VAL . 62.6 t -124.48 132.95 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.606 -0.684 . . . . 0.0 109.422 179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -84.86 120.09 26.07 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.449 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 3.1 ttm180 -60.82 123.51 17.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.135 -0.978 . . . . 0.0 110.569 -178.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 57.4 mmm-85 -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.743 -0.598 . . . . 0.0 109.491 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.72 -179.94 43.89 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 108.116 -1.994 . . . . 0.0 108.116 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.422 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 30.1 p-10 -62.04 -29.32 70.2 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.534 -0.98 . . . . 0.0 110.564 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 29.1 m -121.52 18.55 11.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.831 -0.543 . . . . 0.0 112.056 -178.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -139.31 144.33 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.025 -1.047 . . . . 0.0 111.04 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.477 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.41 140.4 10.24 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.62 ' C ' HG13 ' A' ' 116' ' ' VAL . 18.3 t -87.59 109.97 20.04 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.782 -0.834 . . . . 0.0 109.821 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.669 HD12 HG22 ' A' ' 116' ' ' VAL . 22.8 tp -69.33 105.78 2.68 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 91.2 mt -66.51 -25.34 66.64 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 121.202 0.525 . . . . 0.0 110.055 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.7 p -106.41 100.71 31.37 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.764 -0.585 . . . . 0.0 110.158 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.88 134.25 16.19 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 O-C-N 124.024 1.539 . . . . 0.0 109.55 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.67 167.22 14.38 Favored Pre-proline 0 N--CA 1.49 1.537 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -57.98 128.71 29.93 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 O-C-N 123.824 1.434 . . . . 0.0 110.55 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.2 p -51.69 -26.43 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.628 -0.67 . . . . 0.0 110.616 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.429 ' O ' ' CG ' ' A' ' 136' ' ' LYS . 75.3 m -57.86 -31.36 66.61 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.719 0.771 . . . . 0.0 109.274 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -70.86 -30.89 67.41 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.362 -0.836 . . . . 0.0 109.141 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.482 HD12 ' CB ' ' A' ' 164' ' ' ALA . 98.3 mt -89.98 -0.02 57.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.539 -0.725 . . . . 0.0 112.557 -179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.429 ' CG ' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -75.7 124.81 27.88 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 120.837 -1.164 . . . . 0.0 109.001 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 43' ' ' PHE . . . 99.66 -11.4 61.12 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 108.766 -1.733 . . . . 0.0 108.766 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 52.0 p -78.55 -10.24 59.65 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.34 -1.094 . . . . 0.0 109.669 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.528 ' HB2' HG21 ' A' ' 55' ' ' VAL . 1.5 m -60.45 143.86 52.43 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.15 -0.969 . . . . 0.0 110.247 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.589 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.81 -9.94 75.47 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 -178.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -65.11 -163.53 0.89 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.66 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.8 Cg_endo -139.19 135.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 116.624 -1.784 . . . . 0.0 112.145 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.492 ' O ' HD22 ' A' ' 104' ' ' LEU . 3.9 mp -94.82 97.11 9.8 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.669 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -88.76 141.48 28.47 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 121.953 0.882 . . . . 0.0 113.33 -176.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.413 ' HB3' ' HD2' ' A' ' 146' ' ' PRO . 1.3 m -74.01 -172.82 0.26 Allowed Pre-proline 0 N--CA 1.494 1.77 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 177.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.0 Cg_endo -82.02 5.28 6.43 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 O-C-N 123.739 1.389 . . . . 0.0 111.446 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.439 ' HB3' ' CE1' ' A' ' 149' ' ' HIS . 14.1 m -110.2 17.8 20.59 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.996 -1.065 . . . . 0.0 111.883 -179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 71.72 38.31 61.09 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.455 ' CB ' ' HB2' ' A' ' 97' ' ' CYS . 46.4 m170 -122.97 123.64 41.37 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.465 -1.021 . . . . 0.0 110.883 -179.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.476 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -87.16 102.76 14.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.7 m -110.04 7.4 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 120.033 -0.667 . . . . 0.0 111.912 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.449 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -154.61 133.94 4.06 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.575 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.404 HD12 ' SD ' ' A' ' 175' ' ' MET . 40.1 mt -116.52 120.91 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.276 -1.132 . . . . 0.0 108.072 177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.457 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.0 t80 -49.96 127.71 17.06 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.857 0.837 . . . . 0.0 112.978 -177.093 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.417 ' HB2' HG23 ' A' ' 170' ' ' VAL . 59.5 ttp180 -114.28 -30.33 6.64 Favored 'General case' 0 N--CA 1.484 1.238 0 O-C-N 121.942 -0.474 . . . . 0.0 111.059 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.81 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.16 150.42 9.38 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.684 -179.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.457 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -101.62 140.77 35.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.885 -0.51 . . . . 0.0 111.173 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.694 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 57.3 t -93.12 88.37 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.509 -0.744 . . . . 0.0 109.006 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.2 p -92.84 115.72 28.38 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 122.273 1.035 . . . . 0.0 111.103 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 95.5 m -90.01 -80.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.502 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.3 ttt180 -97.71 61.23 1.58 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.172 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.438 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 70.03 19.13 75.21 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.438 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.3 m -147.74 140.18 18.71 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 O-C-N 121.282 -1.128 . . . . 0.0 108.956 179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -80.24 128.27 33.33 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 121.546 0.688 . . . . 0.0 111.325 -178.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 43.3 pttt -122.22 16.14 10.65 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.18 0.514 . . . . 0.0 109.716 178.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.694 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.55 154.13 3.68 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.72 ' CG2' HG11 ' A' ' 116' ' ' VAL . 11.4 m -135.27 138.88 47.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-O 121.885 0.85 . . . . 0.0 112.237 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -107.23 148.34 29.06 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 177.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 35.7 p90 -153.45 163.95 39.05 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 118.425 -1.31 . . . . 0.0 111.713 -178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.707 HG11 HD13 ' A' ' 82' ' ' LEU . 99.0 t -80.02 141.63 54.83 Favored Pre-proline 0 N--CA 1.499 1.994 0 O-C-N 121.994 -0.442 . . . . 0.0 110.714 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -78.42 150.87 25.54 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 O-C-N 123.819 1.431 . . . . 0.0 110.523 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.6 p -81.69 -28.13 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.689 . . . . 0.0 110.355 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 55.3 tp10 -59.95 -32.49 70.86 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 8.1 t -75.52 -29.71 59.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 120.186 -0.606 . . . . 0.0 109.987 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.594 ' CG ' HD21 ' A' ' 82' ' ' LEU . 7.3 mtp -69.92 -37.93 76.07 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 0.0 109.653 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.96 -36.4 77.03 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 120.532 -0.467 . . . . 0.0 110.265 179.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 34.2 p -60.44 -30.66 69.79 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.399 -0.813 . . . . 0.0 110.624 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.702 HG23 ' CG ' ' A' ' 75' ' ' TYR . 47.3 m -60.08 -46.02 90.97 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.096 -1.003 . . . . 0.0 108.901 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.0 mtp -60.53 -39.33 87.47 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -83.5 -13.7 54.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.547 -0.721 . . . . 0.0 111.192 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 50.71 -165.72 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.175 -0.953 . . . . 0.0 110.941 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -172.23 -47.04 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.448 -0.783 . . . . 0.0 110.563 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -151.39 159.98 43.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.456 -0.777 . . . . 0.0 110.589 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.3 pttt -74.18 -26.3 60.2 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.7 -0.625 . . . . 0.0 110.66 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 63.1 tttm 55.44 85.63 0.06 Allowed 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.44 -0.788 . . . . 0.0 110.422 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 65.2 pttt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 117.986 -1.007 . . . . 0.0 110.435 -179.788 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.81 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.4 m . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 89.97 -9.98 75.48 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.8 tmm_? -80.26 133.88 36.03 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.104 -1.233 . . . . 0.0 110.22 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 20.9 t0 49.36 37.79 12.48 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.822 -0.549 . . . . 0.0 111.332 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -134.94 29.98 3.4 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.368 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 49.5 p-10 -157.99 173.97 15.94 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.584 0.707 . . . . 0.0 109.924 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -71.97 -160.6 0.06 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.955 -0.466 . . . . 0.0 110.516 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 29' ' ' VAL . 33.7 m -87.04 16.39 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.532 -0.73 . . . . 0.0 111.763 -179.07 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 34' ' ' GLN . 57.4 mm-40 63.47 -67.37 0.09 Allowed 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 123.031 0.533 . . . . 0.0 111.771 179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 114.44 -123.66 6.12 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.59 ' HA ' HD21 ' A' ' 94' ' ' LEU . 50.1 mt-10 -66.31 -40.0 89.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.612 -0.934 . . . . 0.0 111.48 -179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.402 HG22 ' HG3' ' A' ' 142' ' ' PRO . 62.1 t -125.08 129.96 73.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.328 -0.858 . . . . 0.0 110.658 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG2' ' HB2' ' A' ' 30' ' ' GLU . 96.7 mt-30 -99.24 123.77 43.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.622 -0.674 . . . . 0.0 110.623 179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 44' ' ' LEU . 62.7 t -81.69 131.22 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.8 m -140.91 174.03 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.094 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 88.0 p -145.49 125.78 13.89 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.718 0.77 . . . . 0.0 108.98 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.536 HG21 ' HA ' ' A' ' 59' ' ' ALA . 47.6 p -103.52 -179.54 3.98 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.34 -15.03 8.83 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.528 -179.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 24.1 p -100.42 -39.21 8.08 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 112.572 -179.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -172.02 -170.0 0.71 Allowed 'General case' 0 N--CA 1.509 2.493 0 O-C-N 120.798 -1.189 . . . . 0.0 112.694 -179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 73.6 m -115.21 141.54 47.88 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 12.6 p90 -162.61 -147.33 0.12 Allowed 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.428 -0.795 . . . . 0.0 110.499 -178.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 138' ' ' SER . 74.0 mt -132.07 166.01 22.72 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.602 -1.311 . . . . 0.0 113.342 -176.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -152.86 131.86 12.58 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.837 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.563 HG21 ' HB3' ' A' ' 142' ' ' PRO . 94.1 m -96.75 123.65 40.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 84.2 m -73.78 127.22 32.22 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.68 -0.637 . . . . 0.0 109.805 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' CD1' ' A' ' 53' ' ' TRP . 38.7 t -140.42 127.24 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.796 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 49.98 40.7 21.76 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.585 -0.697 . . . . 0.0 111.619 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 73.54 26.93 68.59 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.561 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 59.9 t -139.94 117.37 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.433 -1.04 . . . . 0.0 109.572 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 13.6 t -75.68 119.62 19.96 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.561 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 96.2 m95 -106.86 125.74 51.4 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.902 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.67 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.2 t -132.52 -179.26 5.34 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.603 HG11 ' HB3' ' A' ' 139' ' ' SER . 24.0 m -90.22 125.57 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 C-N-CA 118.193 -1.403 . . . . 0.0 112.242 -178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -60.03 -39.99 87.81 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.833 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 30.5 p-80 -73.42 68.64 1.12 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.294 -0.963 . . . . 0.0 109.139 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 164.09 -38.13 0.31 Allowed Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -80.02 -69.99 0.55 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.597 -0.943 . . . . 0.0 110.224 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.95 16.4 33.32 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.04 88.02 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.024 -1.28 . . . . 0.0 109.793 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 57.3 mttm -150.62 -171.26 3.88 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.923 0.868 . . . . 0.0 110.662 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.432 ' HB ' ' CB ' ' A' ' 70' ' ' PRO . 2.6 p -79.74 -6.43 57.24 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.422 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.473 HD13 HG22 ' A' ' 38' ' ' THR . 4.3 mm? 49.48 -159.95 0.06 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.163 -0.961 . . . . 0.0 110.572 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -145.4 91.84 2.17 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.486 ' HA3' HD11 ' A' ' 71' ' ' ILE . . . -85.52 174.82 48.89 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -178.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -62.81 -14.93 43.74 Favored 'Trans proline' 0 C--N 1.316 -1.158 0 O-C-N 124.043 1.549 . . . . 0.0 110.204 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 22.8 pttp -105.97 -15.14 14.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.912 . . . . 0.0 110.891 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 139.59 -156.84 24.91 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' CB ' ' HB ' ' A' ' 63' ' ' THR . 44.4 Cg_endo -63.81 117.04 4.05 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 124.047 1.551 . . . . 0.0 110.834 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.486 HD11 ' HA3' ' A' ' 66' ' ' GLY . 68.0 mt -89.56 145.67 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 24.4 m -93.61 137.61 32.71 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.47 -0.769 . . . . 0.0 111.742 -178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -70.03 141.54 52.86 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.734 -0.604 . . . . 0.0 109.899 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 65.8 ttp -105.33 -34.36 7.89 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 121.427 -0.796 . . . . 0.0 110.693 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.664 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -153.33 170.47 20.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.467 -0.771 . . . . 0.0 109.755 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.883 HG23 ' CG1' ' A' ' 83' ' ' VAL . 71.5 m -153.4 115.94 4.44 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.597 -0.69 . . . . 0.0 110.449 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.93 76.6 3.14 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.473 HG23 HG22 ' A' ' 76' ' ' THR . 93.6 t -60.06 -39.99 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.451 -0.781 . . . . 0.0 109.553 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -55.65 -26.64 45.52 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -110.86 -0.4 16.9 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.751 -0.593 . . . . 0.0 110.751 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 7.2 t70 60.17 56.31 3.35 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.947 -1.096 . . . . 0.0 109.393 -179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.794 HD22 HG11 ' A' ' 170' ' ' VAL . 49.1 tp -145.57 153.19 40.8 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.883 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -146.03 130.68 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.521 -0.737 . . . . 0.0 109.415 -179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.78 121.01 5.11 Favored Glycine 0 N--CA 1.497 2.762 0 C-N-CA 119.352 -1.404 . . . . 0.0 111.625 -178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.67 ' CZ3' HG22 ' A' ' 54' ' ' THR . 5.3 m-90 -87.07 -170.28 2.99 Favored 'General case' 0 N--CA 1.506 2.367 0 O-C-N 121.88 -0.777 . . . . 0.0 109.314 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -100.01 112.22 24.51 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.427 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -63.6 133.83 95.66 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.973 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -96.13 154.82 1.38 Allowed 'Trans proline' 0 N--CA 1.485 1.002 0 O-C-N 123.943 1.496 . . . . 0.0 110.048 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -62.05 144.27 95.94 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 O-C-N 123.753 1.396 . . . . 0.0 110.499 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 127.86 -49.73 0.91 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.44 -137.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 122.045 -0.679 . . . . 0.0 109.954 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -151.84 -29.65 0.17 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.865 -1.147 . . . . 0.0 112.77 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.658 ' C ' HD22 ' A' ' 94' ' ' LEU . 10.7 t 60.64 154.81 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.457 -0.777 . . . . 0.0 110.768 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 93' ' ' SER . 3.7 mm? -114.32 150.62 34.22 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.532 -0.73 . . . . 0.0 109.846 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.406 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 2.9 p -98.46 151.06 37.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.434 -0.791 . . . . 0.0 110.93 -179.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.77 153.81 29.93 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 O-C-N 123.865 1.455 . . . . 0.0 110.037 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.467 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 44.3 t -160.48 159.97 31.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.516 -0.74 . . . . 0.0 110.857 -179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 32.7 m -150.07 67.7 0.98 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.764 -0.585 . . . . 0.0 109.69 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 58.2 m -70.05 -33.79 72.4 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.554 -0.716 . . . . 0.0 109.787 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 120.86 -16.54 9.45 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 62.1 m -88.72 139.29 30.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.154 -1.203 . . . . 0.0 109.793 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 5.7 m -106.65 15.87 25.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.573 -0.704 . . . . 0.0 110.971 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -73.1 78.39 1.23 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 145' ' ' CYS . 68.3 mt -99.12 175.09 6.02 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.395 0.616 . . . . 0.0 110.32 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' PRO . 51.3 p90 -150.27 131.75 14.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.427 HD13 HD12 ' A' ' 143' ' ' LEU . 21.9 tp -92.99 147.25 22.99 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.846 0.831 . . . . 0.0 110.897 -178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.571 HG13 ' O ' ' A' ' 111' ' ' ALA . 80.9 t -90.07 110.0 21.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 65.4 p -81.38 177.58 8.89 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 120.022 -0.671 . . . . 0.0 109.216 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 22.1 ttp180 -43.74 -25.51 0.18 Allowed 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.817 -0.552 . . . . 0.0 111.744 -179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -90.16 -79.18 0.35 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.473 -0.767 . . . . 0.0 109.573 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.571 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -151.38 -44.07 0.11 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.291 -0.881 . . . . 0.0 111.183 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -163.84 -65.33 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.653 -0.654 . . . . 0.0 109.746 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.611 HG11 ' OH ' ' A' ' 134' ' ' TYR . 38.6 t 64.42 -58.88 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.492 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 179.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.022 HD12 HD11 ' A' ' 126' ' ' LEU . 46.6 pt -125.41 150.96 69.26 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 120.951 -1.093 . . . . 0.0 111.737 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 105' ' ' TYR . 54.0 Cg_endo -106.65 163.87 0.13 Allowed 'Trans proline' 0 N--CA 1.487 1.123 0 O-C-N 123.804 1.423 . . . . 0.0 109.788 178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 HD12 ' A' ' 126' ' ' LEU . 48.8 t -136.1 140.08 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.366 -0.834 . . . . 0.0 110.856 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -95.0 115.81 27.9 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.463 ' CZ ' HG12 ' A' ' 151' ' ' VAL . 1.7 ttm180 -59.99 124.8 21.33 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.249 -0.907 . . . . 0.0 110.963 -178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -99.26 -0.05 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.666 -0.646 . . . . 0.0 109.766 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 173.43 179.83 44.35 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.441 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 34.4 m-20 -65.12 -22.89 67.0 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.617 -0.931 . . . . 0.0 110.251 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.2 p -124.96 17.41 8.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.492 -0.755 . . . . 0.0 111.46 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 21.6 ttm180 -140.66 140.83 35.05 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.068 -1.02 . . . . 0.0 111.088 -178.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.48 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -139.73 141.25 11.47 Favored Glycine 0 N--CA 1.484 1.849 0 N-CA-C 108.144 -1.982 . . . . 0.0 108.144 179.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.471 ' C ' HG13 ' A' ' 116' ' ' VAL . 7.3 t -89.9 112.19 23.48 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.834 -0.803 . . . . 0.0 110.161 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.022 HD11 HD12 ' A' ' 114' ' ' ILE . 21.9 tp -71.2 104.47 3.1 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.415 HD12 ' HG2' ' A' ' 115' ' ' PRO . 98.3 mt -60.04 -32.67 71.13 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.465 0.65 . . . . 0.0 110.079 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 28.6 t -112.89 99.92 49.62 Favored Pre-proline 0 C--N 1.299 -1.613 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.698 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.28 145.97 74.0 Favored 'Trans proline' 0 N--CA 1.49 1.278 0 O-C-N 123.908 1.478 . . . . 0.0 109.018 178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.1 mtp85 -154.29 163.17 25.01 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.599 -0.688 . . . . 0.0 109.685 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -60.52 122.8 11.85 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 O-C-N 124.064 1.56 . . . . 0.0 109.88 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.2 p -46.5 -25.14 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.928 -0.482 . . . . 0.0 111.724 -178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 79.4 p -58.23 -34.32 70.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.453 -0.779 . . . . 0.0 108.992 178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.611 ' OH ' HG11 ' A' ' 113' ' ' VAL . 46.6 t80 -69.99 -30.03 67.26 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 95.5 mt -82.25 2.02 33.91 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.553 -0.717 . . . . 0.0 110.763 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -72.21 112.44 8.29 Favored 'General case' 0 N--CA 1.483 1.181 0 O-C-N 121.234 -0.916 . . . . 0.0 108.603 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.98 -10.1 58.43 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.647 ' HA ' HD12 ' A' ' 44' ' ' LEU . 11.5 t -76.69 -12.86 60.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.403 -1.057 . . . . 0.0 110.111 178.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.603 ' HB3' HG11 ' A' ' 55' ' ' VAL . 2.7 m -66.53 150.99 48.16 Favored 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.001 -1.062 . . . . 0.0 109.971 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.554 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.9 -9.91 75.66 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -67.93 -167.7 4.03 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.563 ' HB3' HG21 ' A' ' 46' ' ' THR . 56.0 Cg_endo -141.48 140.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.845 0 C-N-CA 116.956 -1.563 . . . . 0.0 112.143 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.427 HD12 HD13 ' A' ' 106' ' ' LEU . 4.1 mp -94.2 94.02 8.11 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 94' ' ' LEU . 6.0 mp -85.65 150.24 24.76 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -176.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.411 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -59.51 -162.89 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.167 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 178.098 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -91.39 16.57 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 O-C-N 123.645 1.339 . . . . 0.0 110.504 178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 40.1 m -124.78 -51.98 1.69 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.136 -0.977 . . . . 0.0 110.427 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 153.06 40.64 0.02 OUTLIER Glycine 0 N--CA 1.496 2.652 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.467 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 77.4 m80 -119.99 129.42 54.27 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -1.147 . . . . 0.0 110.326 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.449 ' HB2' ' CB ' ' A' ' 94' ' ' LEU . . . -70.26 121.16 17.08 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.563 -0.711 . . . . 0.0 110.001 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.463 HG12 ' CZ ' ' A' ' 118' ' ' ARG . 5.0 t -110.24 -29.41 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.803 -0.561 . . . . 0.0 110.112 -179.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.536 ' HA3' ' CE1' ' A' ' 169' ' ' PHE . . . -155.12 150.38 21.86 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 119.945 -1.121 . . . . 0.0 110.985 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 16.7 mt -119.37 120.86 64.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 O-C-N 121.341 -1.093 . . . . 0.0 108.073 177.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.426 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 12.9 t80 -50.01 128.94 19.86 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-O 121.948 0.88 . . . . 0.0 113.044 -176.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.554 ' HB2' HG23 ' A' ' 170' ' ' VAL . 29.9 ttt180 -117.06 -27.88 6.4 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.723 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.833 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -165.39 147.59 7.7 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.187 -1.005 . . . . 0.0 112.08 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.426 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -98.42 140.43 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.234 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.583 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 52.7 t -91.19 92.66 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 86.1 m -94.49 123.32 37.84 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.77 0.795 . . . . 0.0 111.479 -177.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.451 HG22 ' N ' ' A' ' 161' ' ' ARG . 75.9 m -85.37 -97.51 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.773 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.451 ' N ' HG22 ' A' ' 160' ' ' THR . 39.7 ttm180 -69.77 -55.5 9.7 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.782 -1.199 . . . . 0.0 109.119 179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.424 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -163.96 28.32 0.22 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.424 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.8 m -148.83 146.01 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -81.34 129.25 34.55 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.568 -0.708 . . . . 0.0 111.168 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -118.82 15.22 13.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.266 0.555 . . . . 0.0 109.999 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.583 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -173.39 153.02 2.29 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.687 HG21 HG11 ' A' ' 116' ' ' VAL . 11.7 m -130.1 138.22 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 C-N-CA 119.371 -0.932 . . . . 0.0 112.513 -178.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -105.3 147.63 27.91 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.536 ' CE1' ' HA3' ' A' ' 152' ' ' GLY . 36.6 p90 -153.2 165.61 35.14 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.185 -1.406 . . . . 0.0 112.169 -177.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.794 HG11 HD22 ' A' ' 82' ' ' LEU . 59.6 t -86.15 130.07 51.39 Favored Pre-proline 0 N--CA 1.493 1.705 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -72.86 157.52 51.49 Favored 'Trans proline' 0 N--CA 1.49 1.305 0 O-C-N 123.759 1.4 . . . . 0.0 110.487 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.474 ' HA ' ' CE ' ' A' ' 175' ' ' MET . 7.2 p -76.03 -23.28 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.67 -0.644 . . . . 0.0 109.653 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.484 ' O ' HG23 ' A' ' 177' ' ' THR . 53.5 tp10 -58.52 -30.83 67.37 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 178.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 68.6 m -73.31 -36.8 66.3 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 121.36 0.6 . . . . 0.0 109.631 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.685 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -67.96 -36.6 80.35 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.522 -0.737 . . . . 0.0 109.019 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.402 ' O ' ' HG2' ' A' ' 179' ' ' MET . 98.9 mt-10 -59.98 -33.1 71.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.885 -0.509 . . . . 0.0 110.33 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 173' ' ' GLU . 30.5 p -63.27 -28.88 70.33 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.173 -0.954 . . . . 0.0 110.453 -179.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.664 HG23 ' CG ' ' A' ' 75' ' ' TYR . 53.6 m -65.4 -51.5 59.92 Favored 'General case' 0 N--CA 1.498 1.975 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.202 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 176' ' ' GLU . 25.1 ptm -66.75 -27.88 67.96 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.733 -0.787 . . . . 0.0 109.691 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.401 ' HG3' ' HG3' ' A' ' 179' ' ' MET . 99.1 mtt180 -89.42 -15.7 32.61 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.275 -0.891 . . . . 0.0 110.728 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 177' ' ' THR . . . 56.92 118.5 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.901 0.858 . . . . 0.0 111.125 -179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.8 p -65.2 78.73 0.05 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.462 -0.774 . . . . 0.0 111.073 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.8 mttm -89.04 140.33 29.54 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.477 -0.764 . . . . 0.0 110.019 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -160.03 59.99 0.36 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.504 -0.747 . . . . 0.0 110.255 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 56.6 tttp -77.8 134.49 38.01 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.594 -0.691 . . . . 0.0 109.711 179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 43.0 mttt . . . . . 0 N--CA 1.499 1.995 0 CA-C-O 117.972 -1.013 . . . . 0.0 110.935 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.833 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.8 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.178 0.513 . . . . 0.0 110.173 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.06 -178.03 50.88 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -114.15 129.51 56.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.554 -0.969 . . . . 0.0 110.785 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -77.67 -42.76 33.48 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.647 0.737 . . . . 0.0 110.045 179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.471 ' HE3' HG21 ' A' ' 35' ' ' VAL . 62.0 mttt -149.95 -172.34 4.13 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 116.18 -0.463 . . . . 0.0 109.881 179.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -158.26 51.43 0.42 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.456 -0.778 . . . . 0.0 110.281 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 98.6 mt-30 -117.54 123.52 46.47 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.521 -0.737 . . . . 0.0 110.289 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.449 ' HA ' ' HA ' ' A' ' 91' ' ' ALA . 34.3 m -97.42 18.5 2.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.907 -0.496 . . . . 0.0 111.332 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -74.93 -46.69 34.02 Favored 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 113.738 1.014 . . . . 0.0 113.738 -177.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' N ' ' A' ' 92' ' ' ARG . . . 151.11 -154.57 25.65 Favored Glycine 0 N--CA 1.503 3.126 0 C-N-CA 119.417 -1.373 . . . . 0.0 111.109 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 31' ' ' GLY . 97.8 mt-10 75.23 -106.87 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.136 0 C-N-CA 125.148 1.379 . . . . 0.0 114.558 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.646 HG13 ' O ' ' A' ' 45' ' ' ALA . 61.6 t -140.01 140.69 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.552 0 O-C-N 120.945 -1.097 . . . . 0.0 111.268 -175.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.402 ' HG3' ' HG2' ' A' ' 92' ' ' ARG . 87.9 mt-30 -91.01 121.39 32.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.655 -0.653 . . . . 0.0 110.309 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.471 HG21 ' HE3' ' A' ' 26' ' ' LYS . 77.9 t -80.44 138.89 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 178.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.0 m -140.75 169.97 14.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 CA-C-O 122.088 0.946 . . . . 0.0 111.544 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.9 m -142.76 120.0 11.52 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.787 HG21 ' HA ' ' A' ' 59' ' ' ALA . 62.6 p -107.15 -179.07 3.82 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-O 121.368 0.604 . . . . 0.0 109.466 -178.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.66 -16.48 16.39 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.146 -0.622 . . . . 0.0 111.659 -178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 19.3 p -102.69 -39.68 6.94 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.46 -0.896 . . . . 0.0 112.268 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -174.64 -168.91 0.39 Allowed 'General case' 0 N--CA 1.507 2.395 0 O-C-N 121.064 -1.023 . . . . 0.0 111.855 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 58.2 m -116.57 147.43 41.84 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 11.7 p90 -161.76 -142.97 0.08 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.444 -0.785 . . . . 0.0 110.126 -178.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.423 ' O ' ' HA3' ' A' ' 140' ' ' GLY . 85.5 mt -134.33 161.48 34.86 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.675 -1.265 . . . . 0.0 113.352 -177.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.646 ' O ' HG13 ' A' ' 33' ' ' VAL . . . -147.84 123.43 10.45 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 115.019 -0.992 . . . . 0.0 109.143 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.668 HG21 ' HB3' ' A' ' 142' ' ' PRO . 25.1 m -97.9 120.04 37.59 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.486 -0.759 . . . . 0.0 110.674 -179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 21.5 m -76.79 125.99 30.21 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.693 -0.803 . . . . 0.0 111.123 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 62.5 t -123.16 124.61 70.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 52.67 45.3 28.93 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.307 -0.87 . . . . 0.0 110.625 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.6 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 70.05 22.64 77.28 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.168 -1.015 . . . . 0.0 110.74 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.406 ' CG1' ' NE1' ' A' ' 53' ' ' TRP . 61.9 t -130.01 111.65 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.261 -1.141 . . . . 0.0 109.24 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 15.6 t -74.61 121.85 22.25 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.757 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.45 ' CZ3' ' N ' ' A' ' 84' ' ' GLY . 87.0 m95 -112.84 126.21 55.19 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.901 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 2.1 t -131.51 178.96 6.33 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.569 HG13 ' CA ' ' A' ' 140' ' ' GLY . 16.6 m -89.57 123.84 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 C-N-CA 117.948 -1.501 . . . . 0.0 111.705 -179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -60.02 -39.97 87.66 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.748 ' CG ' HD22 ' A' ' 188' ' ' 2ZF . 34.6 p-80 -71.31 74.42 0.72 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.872 0.844 . . . . 0.0 109.069 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 154.07 -25.51 0.71 Allowed Glycine 0 N--CA 1.485 1.955 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 -179.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.787 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -88.24 -80.01 0.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.407 -1.055 . . . . 0.0 110.859 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 47.77 24.32 2.88 Favored Glycine 0 N--CA 1.503 3.125 0 O-C-N 121.252 -0.905 . . . . 0.0 111.741 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.615 ' OG ' HG22 ' A' ' 38' ' ' THR . 26.4 p -111.63 -19.81 12.36 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.98 -1.306 . . . . 0.0 111.395 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 61' ' ' SER . 83.5 tttt 67.82 -60.54 0.4 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.572 -0.705 . . . . 0.0 111.684 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.639 ' C ' HD23 ' A' ' 64' ' ' LEU . 24.5 p -83.84 -32.1 25.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.439 -0.788 . . . . 0.0 113.053 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.639 HD23 ' C ' ' A' ' 63' ' ' THR . 0.5 OUTLIER 44.14 -142.89 0.17 Allowed 'General case' 0 N--CA 1.514 2.77 0 O-C-N 121.985 -0.447 . . . . 0.0 111.284 -178.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.452 ' N ' ' HG ' ' A' ' 64' ' ' LEU . . . -150.71 102.07 2.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.154 -0.966 . . . . 0.0 109.947 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -90.3 -178.71 44.21 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -63.85 -16.44 54.85 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 O-C-N 124.001 1.527 . . . . 0.0 110.396 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -112.49 2.35 16.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.32 -0.863 . . . . 0.0 111.117 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.6 -160.91 18.09 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 108.402 -1.879 . . . . 0.0 108.402 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -57.97 123.52 13.88 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.638 1.336 . . . . 0.0 110.264 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.476 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.6 mt -87.57 -25.7 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.643 -0.661 . . . . 0.0 111.455 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 71' ' ' ILE . 10.1 m 60.52 128.87 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.305 0 CA-C-O 121.606 0.717 . . . . 0.0 110.488 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 3.8 pt20 -80.06 159.29 26.21 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.335 -0.853 . . . . 0.0 112.167 -178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.405 ' HG3' ' HB2' ' A' ' 86' ' ' GLN . 96.6 mmm -108.77 -30.01 8.38 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.058 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.462 ' CD1' ' C ' ' A' ' 75' ' ' TYR . 1.3 t80 -140.37 164.22 30.69 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 121.525 -0.734 . . . . 0.0 109.248 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.901 HG23 ' CG1' ' A' ' 83' ' ' VAL . 39.8 m -154.35 115.33 4.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.738 . . . . 0.0 110.304 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.405 ' HB2' ' CE1' ' A' ' 75' ' ' TYR . 14.4 t-20 -99.15 74.03 1.94 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.431 -0.793 . . . . 0.0 109.168 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG23 HG22 ' A' ' 76' ' ' THR . 79.1 t -60.05 -39.97 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.292 -0.88 . . . . 0.0 109.272 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -55.19 -26.08 36.81 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.497 -0.752 . . . . 0.0 109.117 177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -111.99 -2.59 15.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.682 -0.636 . . . . 0.0 110.589 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.6 t0 62.56 55.18 2.27 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.11 -0.994 . . . . 0.0 109.249 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.599 HD21 ' HG3' ' A' ' 175' ' ' MET . 18.6 tp -147.14 151.75 37.31 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.901 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -147.1 139.34 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 121.068 -1.02 . . . . 0.0 109.296 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.45 ' N ' ' CZ3' ' A' ' 53' ' ' TRP . . . -124.69 122.14 4.62 Favored Glycine 0 N--CA 1.5 2.933 0 C-N-CA 119.034 -1.555 . . . . 0.0 111.656 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.901 ' CZ3' HG22 ' A' ' 54' ' ' THR . 9.4 m-90 -90.36 -166.72 1.65 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 122.076 -0.661 . . . . 0.0 109.387 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.405 ' HB2' ' HG3' ' A' ' 74' ' ' MET . 30.1 tt0 -112.55 96.96 6.28 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.344 -0.847 . . . . 0.0 109.996 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.6 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.02 160.03 82.01 Favored Pre-proline 0 N--CA 1.501 2.075 0 O-C-N 121.498 -0.751 . . . . 0.0 111.127 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.748 ' HG2' ' HB3' ' A' ' 91' ' ' ALA . 47.0 Cg_endo -101.42 158.35 0.38 Allowed 'Trans proline' 0 N--CA 1.486 1.046 0 O-C-N 123.936 1.493 . . . . 0.0 110.324 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -60.11 109.52 0.63 Allowed 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.785 1.413 . . . . 0.0 112.664 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 114.49 -63.09 0.31 Allowed Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.748 ' HB3' ' HG2' ' A' ' 88' ' ' PRO . . . -61.03 105.11 0.44 Allowed 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 122.214 1.007 . . . . 0.0 109.85 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HB3' ' HB2' ' A' ' 47' ' ' CYS . 8.5 mpt_? 52.7 108.94 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.948 0 CA-C-O 122.105 0.955 . . . . 0.0 112.446 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.581 ' C ' HD22 ' A' ' 94' ' ' LEU . 11.1 m -165.02 107.2 0.82 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 93' ' ' SER . 4.6 mm? -110.01 160.59 16.3 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.34 -0.85 . . . . 0.0 111.133 -178.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.417 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 1.1 p -112.12 157.12 40.71 Favored Pre-proline 0 N--CA 1.494 1.759 0 O-C-N 121.611 -0.68 . . . . 0.0 110.459 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -87.84 151.59 7.27 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.874 1.46 . . . . 0.0 109.592 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.538 ' HB2' ' CG ' ' A' ' 149' ' ' HIS . 49.8 t -155.25 -71.88 0.12 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.521 -0.737 . . . . 0.0 110.767 -178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 5.0 m 51.62 59.09 4.82 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.149 -0.969 . . . . 0.0 111.693 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 28.6 p -140.0 152.15 46.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.193 -0.942 . . . . 0.0 112.04 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.57 -46.77 3.63 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 177.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 t -168.92 169.94 9.37 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.563 -0.963 . . . . 0.0 110.752 -179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.8 m -105.09 18.85 21.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.725 -0.609 . . . . 0.0 109.989 178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -70.47 76.97 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.472 HD12 ' HB2' ' A' ' 118' ' ' ARG . 82.0 mt -94.11 174.32 7.21 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.283 0.563 . . . . 0.0 109.664 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.6 p90 -152.4 136.1 16.18 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 142' ' ' PRO . 40.8 tp -103.83 141.25 36.44 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.724 0.774 . . . . 0.0 111.146 -177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 112' ' ' ASP . 74.0 t -86.31 119.92 35.22 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 33.4 p -80.44 179.98 7.44 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.657 -0.817 . . . . 0.0 109.097 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -43.02 -27.92 0.23 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.756 -0.59 . . . . 0.0 112.24 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -115.27 -50.92 2.72 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.315 -0.865 . . . . 0.0 111.571 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -153.62 -179.0 7.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.89 -1.131 . . . . 0.0 110.338 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 114' ' ' ILE . 57.7 t0 -60.09 -84.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.163 179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 113' ' ' VAL . 48.4 t 51.67 25.17 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.392 -0.817 . . . . 0.0 110.726 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.864 HD11 HD11 ' A' ' 126' ' ' LEU . 6.5 tp -164.83 100.07 0.83 Allowed Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 121.301 -0.874 . . . . 0.0 111.024 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -90.82 136.41 2.11 Favored 'Trans proline' 0 N--CA 1.494 1.518 0 O-C-N 123.571 1.301 . . . . 0.0 109.761 179.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.802 HG22 HD12 ' A' ' 126' ' ' LEU . 48.9 t -130.4 140.32 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 121.324 -0.86 . . . . 0.0 111.027 -179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 12.2 mmm180 -93.77 119.47 32.79 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.472 ' HB2' HD12 ' A' ' 104' ' ' LEU . 10.9 ttm-85 -60.59 127.38 31.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.142 -0.974 . . . . 0.0 110.802 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -99.77 -0.01 40.78 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.604 -0.685 . . . . 0.0 109.666 178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 170.75 -177.37 43.86 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 82.8 m-20 -69.23 -20.02 63.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.449 -1.03 . . . . 0.0 110.171 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 37.5 p -123.47 15.15 9.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.409 -0.807 . . . . 0.0 111.642 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 60.7 mtt180 -143.25 144.59 32.2 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 119.065 -1.054 . . . . 0.0 111.14 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -141.14 140.99 10.79 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 107.889 -2.084 . . . . 0.0 107.889 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.71 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.6 t -88.69 111.37 21.87 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.759 -0.848 . . . . 0.0 109.67 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.864 HD11 HD11 ' A' ' 114' ' ' ILE . 23.6 tp -70.31 110.23 5.15 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.01 -18.88 65.58 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.852 -0.53 . . . . 0.0 110.655 -179.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.496 ' HB3' HD12 ' A' ' 114' ' ' ILE . 47.4 t -129.95 82.25 66.93 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.556 -0.715 . . . . 0.0 110.399 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.704 ' HA ' HD23 ' A' ' 126' ' ' LEU . 46.8 Cg_endo -61.19 143.84 98.71 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 O-C-N 123.856 1.45 . . . . 0.0 109.907 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -154.99 168.36 12.22 Favored Pre-proline 0 C--N 1.304 -1.395 0 O-C-N 121.643 -0.661 . . . . 0.0 109.345 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -57.86 125.37 18.43 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 O-C-N 123.842 1.443 . . . . 0.0 110.354 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.0 p -50.05 -27.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 CA-C-O 121.516 0.674 . . . . 0.0 110.534 -179.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 136' ' ' LYS . 39.7 t -61.42 -15.08 33.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.785 -0.572 . . . . 0.0 110.135 177.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -86.75 -31.79 20.75 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.621 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 136' ' ' LYS . 84.4 mt -76.7 -55.85 5.13 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 120.071 -0.652 . . . . 0.0 109.79 -179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.481 ' HG2' ' O ' ' A' ' 133' ' ' SER . 4.5 pttt 7.12 104.74 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.22 -4.2 55.14 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 94.3 p -76.07 -14.78 60.19 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.534 -0.98 . . . . 0.0 109.261 178.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.559 ' HB2' HG21 ' A' ' 55' ' ' VAL . 4.0 m -61.97 142.23 57.58 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.161 -0.962 . . . . 0.0 110.143 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.569 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.06 -10.11 75.13 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 -178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -65.05 -162.02 0.68 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.725 -1.75 . . . . 0.0 108.725 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.668 ' HB3' HG21 ' A' ' 46' ' ' THR . 55.5 Cg_endo -146.69 138.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.834 0 C-N-CA 116.605 -1.796 . . . . 0.0 112.469 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.684 ' O ' HG22 ' A' ' 151' ' ' VAL . 3.4 mp -96.0 97.84 9.91 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.607 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.3 mp -87.29 151.68 22.93 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.414 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.1 OUTLIER -64.42 -159.62 0.0 OUTLIER Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.215 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 51.2 Cg_endo -96.8 17.34 0.64 Allowed 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.503 1.265 . . . . 0.0 110.098 178.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 7.5 p -130.54 11.06 5.27 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.273 -0.892 . . . . 0.0 112.066 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 89.52 32.0 10.84 Favored Glycine 0 N--CA 1.502 3.039 0 O-C-N 120.917 -1.114 . . . . 0.0 110.558 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.538 ' CG ' ' HB2' ' A' ' 97' ' ' CYS . 77.7 m80 -113.91 118.45 34.22 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -1.19 . . . . 0.0 110.536 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.22 123.41 24.47 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.505 -0.747 . . . . 0.0 110.222 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.684 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.2 m -123.35 -5.56 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.551 -0.718 . . . . 0.0 111.572 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.519 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -160.04 127.67 1.84 Allowed Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.635 -1.269 . . . . 0.0 110.791 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.418 ' HA ' ' O ' ' A' ' 141' ' ' GLY . 66.4 mt -105.58 120.71 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.36 -1.082 . . . . 0.0 108.555 177.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.414 ' CE1' ' O ' ' A' ' 156' ' ' ALA . 15.8 t80 -50.75 128.61 21.2 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.621 0.724 . . . . 0.0 112.601 -177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.56 ' HB2' HG23 ' A' ' 170' ' ' VAL . 64.6 ttt180 -116.78 -26.45 6.95 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.867 -0.521 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.731 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -164.96 149.18 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.17 -0.957 . . . . 0.0 111.751 -179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -99.98 141.59 32.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.718 -0.614 . . . . 0.0 110.889 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.536 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 49.1 t -95.15 93.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -89.43 117.78 28.6 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-O 122.13 0.967 . . . . 0.0 110.898 -178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 97.8 m -83.92 -69.96 0.6 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.16 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.5 ttm180 -117.36 57.57 0.8 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.057 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.42 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 80.04 16.35 76.95 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.4 m -146.84 139.9 19.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 O-C-N 121.374 -1.074 . . . . 0.0 108.27 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.98 129.92 35.89 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.732 0.777 . . . . 0.0 111.338 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -123.86 17.28 9.4 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 121.272 0.558 . . . . 0.0 110.077 178.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.536 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -174.33 139.93 0.63 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.717 HG21 HG11 ' A' ' 116' ' ' VAL . 22.3 m -113.31 138.67 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 C-N-CA 119.595 -0.842 . . . . 0.0 112.148 -178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -108.5 143.33 37.63 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 177.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.48 ' CD2' ' HA3' ' A' ' 152' ' ' GLY . 39.2 p90 -150.96 166.02 31.94 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 118.317 -1.353 . . . . 0.0 112.12 -177.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.56 HG23 ' HB2' ' A' ' 155' ' ' ARG . 52.4 t -87.3 130.53 47.36 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.996 -0.44 . . . . 0.0 110.326 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -66.7 135.82 39.97 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 O-C-N 123.722 1.38 . . . . 0.0 110.195 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.581 HG11 ' HA ' ' A' ' 151' ' ' VAL . 11.6 p -70.21 -29.9 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.588 -0.695 . . . . 0.0 110.129 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.08 -31.09 69.69 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.455 ' HA ' HG22 ' A' ' 177' ' ' THR . 18.8 m -72.6 -35.28 67.84 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 120.22 -0.592 . . . . 0.0 109.609 178.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.599 ' HG3' HD21 ' A' ' 82' ' ' LEU . 1.4 mtp -64.68 -47.16 79.41 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.517 -0.739 . . . . 0.0 109.53 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 179' ' ' MET . 80.6 mm-40 -62.75 -44.46 96.15 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 120.414 -0.515 . . . . 0.0 110.937 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.455 HG22 ' HA ' ' A' ' 174' ' ' SER . 13.8 t -72.92 -40.02 65.82 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.179 -0.95 . . . . 0.0 110.683 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.424 ' N ' HG23 ' A' ' 177' ' ' THR . 83.6 m -64.29 -42.12 96.54 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.057 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 176' ' ' GLU . 24.6 ptm -67.24 -26.67 66.7 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.221 -0.992 . . . . 0.0 109.247 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 50.5 ttt-85 -63.85 -23.63 67.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 0.0 109.987 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -166.76 -79.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.551 -0.718 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.413 ' HB2' ' HA ' ' A' ' 178' ' ' THR . 44.9 t 50.01 69.88 0.56 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.147 -0.971 . . . . 0.0 111.468 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -143.2 140.69 30.85 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.38 -0.825 . . . . 0.0 110.555 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -72.01 -38.84 69.52 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.618 -0.676 . . . . 0.0 109.767 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -78.27 129.97 35.69 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.691 -0.631 . . . . 0.0 110.328 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 51.6 pttt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.972 -1.014 . . . . 0.0 110.473 179.93 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.748 HD22 ' CG ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.8 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.114 0.483 . . . . 0.0 110.172 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 73.68 91.04 0.14 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -69.98 -59.92 2.62 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.583 -0.951 . . . . 0.0 110.332 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 36.21 62.06 0.73 Allowed 'General case' 0 N--CA 1.512 2.643 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -139.99 146.39 39.03 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.989 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 34.4 t30 67.69 139.04 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.437 -0.789 . . . . 0.0 110.68 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.8 tp60 58.85 109.77 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.498 0.666 . . . . 0.0 110.789 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG23 ' H ' ' A' ' 31' ' ' GLY . 33.8 m -86.43 0.84 5.95 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.847 -0.533 . . . . 0.0 111.439 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' HB2' ' HG3' ' A' ' 34' ' ' GLN . 78.6 mm-40 56.67 20.04 4.74 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.118 -0.989 . . . . 0.0 111.612 179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.566 ' H ' HG23 ' A' ' 29' ' ' VAL . . . 58.68 -120.79 23.99 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.411 ' HG2' ' HB3' ' A' ' 92' ' ' ARG . 94.7 mt-10 -98.43 -34.87 10.47 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.728 -0.866 . . . . 0.0 111.536 -178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 107' ' ' VAL . 62.7 t -110.08 129.25 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.433 -0.792 . . . . 0.0 110.391 -178.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.403 ' HG3' ' HB2' ' A' ' 30' ' ' GLU . 19.4 mp0 -95.59 117.65 30.84 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.523 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 80.0 t -84.81 131.66 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 43' ' ' PHE . 33.9 m -140.43 178.45 3.22 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.493 -0.754 . . . . 0.0 109.268 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 m -140.91 126.94 19.43 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.718 0.771 . . . . 0.0 109.209 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.492 HG23 ' H ' ' A' ' 40' ' ' THR . 14.7 t -113.0 -168.57 1.34 Allowed 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.36 5.04 0.82 Allowed 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.492 ' H ' HG23 ' A' ' 38' ' ' THR . 24.1 p -120.89 -39.35 2.73 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.701 -1.25 . . . . 0.0 111.941 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -173.08 -155.38 0.08 Allowed 'General case' 0 N--CA 1.51 2.547 0 O-C-N 121.098 -1.001 . . . . 0.0 112.348 -178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.7 m -102.71 119.01 38.09 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.693 ' HB2' HG23 ' A' ' 36' ' ' VAL 0.27 3.3 m-85 -90.25 -174.67 4.26 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 117.398 2.369 . . . . 0.0 117.398 -175.505 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.875 HD12 ' HA ' ' A' ' 138' ' ' SER . 26.5 mt -142.55 136.07 28.9 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 112.378 -2.192 . . . . 0.0 106.842 174.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.476 ' HB2' ' CB ' ' A' ' 54' ' ' THR . . . -145.78 136.66 24.48 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.531 HG21 ' HB3' ' A' ' 142' ' ' PRO . 34.6 m -101.69 125.77 48.41 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.583 -0.698 . . . . 0.0 111.586 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 42.1 t -72.45 119.98 17.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.72 -0.613 . . . . 0.0 109.945 179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 51.1 t -136.83 129.97 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 O-C-N 121.456 -0.777 . . . . 0.0 109.994 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 50.12 40.14 21.04 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.472 -0.768 . . . . 0.0 111.038 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 69.96 26.57 74.17 Favored Glycine 0 N--CA 1.494 2.553 0 N-CA-C 110.266 -1.134 . . . . 0.0 110.266 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.521 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 58.5 t -138.75 115.97 11.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.267 -1.137 . . . . 0.0 109.658 179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 87' ' ' ALA . 35.2 t -76.72 118.61 19.52 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.521 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 91.8 m95 -106.27 124.24 49.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.0 111.189 -179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.892 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -130.65 179.98 5.63 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 179.095 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG21 ' HB2' ' A' ' 139' ' ' SER . 2.8 m -84.32 123.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.28 0 C-N-CA 117.195 -1.802 . . . . 0.0 113.373 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.425 ' CA ' HG22 ' A' ' 83' ' ' VAL . 25.5 t80 -59.98 -40.31 88.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.418 -0.802 . . . . 0.0 109.9 178.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.716 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 29.6 p-80 -69.2 101.9 1.57 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.094 -1.042 . . . . 0.0 108.701 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 135.16 -41.72 1.42 Allowed Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.799 -1.72 . . . . 0.0 108.799 -178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -76.8 -76.71 0.16 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.59 -0.947 . . . . 0.0 109.997 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 51.52 22.72 8.28 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.6 m -129.02 -2.4 5.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.25 -1.147 . . . . 0.0 111.786 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.7 tttp 66.71 -65.66 0.2 Allowed 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.378 -0.826 . . . . 0.0 110.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.8 p -81.93 159.94 23.49 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.744 0.783 . . . . 0.0 110.888 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD12 ' HB ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -149.46 -126.99 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -147.21 83.75 1.57 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.89 -1.131 . . . . 0.0 109.505 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' CA ' ' CD1' ' A' ' 71' ' ' ILE . . . -63.76 -166.68 0.95 Allowed Glycine 0 N--CA 1.484 1.895 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -59.48 -21.0 59.65 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 O-C-N 124.043 1.549 . . . . 0.0 110.785 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 23.3 mtpp -145.02 4.28 1.09 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 119.155 -1.018 . . . . 0.0 112.991 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 164.98 -176.25 40.77 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.457 -1.354 . . . . 0.0 110.158 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -56.7 130.21 38.75 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 O-C-N 123.799 1.42 . . . . 0.0 111.141 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.409 ' CD1' ' CA ' ' A' ' 66' ' ' GLY . 4.5 mt -89.37 -14.06 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.714 -0.616 . . . . 0.0 111.441 -179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.6 m 58.7 136.48 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 121.955 0.883 . . . . 0.0 112.175 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.517 ' HG2' ' CE2' ' A' ' 85' ' ' TRP . 16.1 mt-30 -80.28 157.19 26.5 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.531 -0.731 . . . . 0.0 112.564 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 88.8 mtp -100.56 -38.23 8.45 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 176.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -164.21 -176.46 4.46 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.837 HG23 HG13 ' A' ' 83' ' ' VAL . 69.7 m -153.49 127.42 8.94 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.559 -0.713 . . . . 0.0 109.59 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.16 76.96 2.67 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 91.6 t -59.95 -40.06 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.643 -0.66 . . . . 0.0 110.009 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -55.41 -26.17 40.08 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.476 -0.765 . . . . 0.0 108.972 178.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -112.59 0.02 15.31 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.671 -0.643 . . . . 0.0 110.735 178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.3 t0 60.03 59.71 2.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.045 -1.034 . . . . 0.0 109.189 -179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.534 HD21 ' CG ' ' A' ' 175' ' ' MET . 24.3 tp -145.99 154.01 41.41 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.171 -178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.837 HG13 HG23 ' A' ' 76' ' ' THR . 0.0 OUTLIER -141.41 135.83 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.713 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -123.76 121.99 4.7 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.949 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.892 ' CZ3' HG22 ' A' ' 54' ' ' THR . 11.1 m-90 -89.92 -173.11 3.77 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -104.05 91.66 4.05 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 52' ' ' CYS . . . -67.96 131.97 92.26 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.805 -0.56 . . . . 0.0 110.28 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -67.71 148.83 78.37 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 O-C-N 123.952 1.501 . . . . 0.0 109.426 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -62.36 114.4 2.34 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.913 1.481 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 148.04 -32.77 1.27 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -72.32 60.42 0.44 Allowed 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.6 -0.941 . . . . 0.0 111.291 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.411 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 2.8 tpt85 29.59 95.86 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 178.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.3 t -83.45 123.79 30.05 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.454 HD13 HD22 ' A' ' 144' ' ' LEU . 88.4 mt -106.61 159.68 16.01 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 120.454 -0.499 . . . . 0.0 110.086 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.64 166.1 11.42 Favored Pre-proline 0 N--CA 1.494 1.762 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.97 -179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.473 ' O ' HG12 ' A' ' 151' ' ' VAL . 39.4 Cg_endo -65.29 -79.36 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.272 0 O-C-N 124.054 1.555 . . . . 0.0 110.905 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.461 ' CB ' ' CD2' ' A' ' 149' ' ' HIS . 0.5 OUTLIER 56.11 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.051 -1.031 . . . . 0.0 110.195 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.8 m -83.51 89.31 7.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.586 -0.696 . . . . 0.0 109.222 179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 51.0 m -71.33 144.47 49.9 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.694 -0.629 . . . . 0.0 110.864 -179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -62.47 -39.93 98.45 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.091 -2.004 . . . . 0.0 108.091 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 t -74.62 130.01 38.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.882 -0.775 . . . . 0.0 109.406 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 75.7 m -103.72 18.33 22.15 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 0.0 111.19 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -72.51 78.4 1.05 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' A' ' 143' ' ' LEU . 88.5 mt -89.75 174.19 7.85 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.477 0.656 . . . . 0.0 110.546 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -138.9 113.49 9.02 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 27.8 tp -89.52 146.64 24.47 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 120.027 -0.669 . . . . 0.0 110.127 -178.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.998 HG21 HG21 ' A' ' 33' ' ' VAL . 74.0 t -92.97 119.42 40.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 121.139 0.495 . . . . 0.0 110.159 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.653 ' C ' HD11 ' A' ' 44' ' ' LEU . 66.0 p -85.94 175.24 8.73 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' N ' HD11 ' A' ' 44' ' ' LEU . 32.2 ttp180 -42.86 -28.61 0.26 Allowed 'General case' 0 N--CA 1.509 2.479 0 O-C-N 121.796 -0.565 . . . . 0.0 111.954 -178.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -100.07 -69.39 0.77 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.537 -0.727 . . . . 0.0 109.698 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -149.12 -163.27 1.74 Allowed 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.438 -0.789 . . . . 0.0 109.506 179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.516 ' OD1' HG22 ' A' ' 107' ' ' VAL . 73.9 m-20 -57.29 -66.7 0.41 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.741 -0.599 . . . . 0.0 110.585 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.7 t 56.58 -85.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.99 -0.444 . . . . 0.0 111.298 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.533 HD12 ' CD1' ' A' ' 126' ' ' LEU . 44.0 pt -76.51 145.28 75.3 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.078 -1.013 . . . . 0.0 112.006 -178.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 53.3 Cg_endo -112.63 153.64 0.04 OUTLIER 'Trans proline' 0 N--CA 1.485 0.981 0 O-C-N 123.756 1.398 . . . . 0.0 108.657 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.702 HG11 HG21 ' A' ' 167' ' ' VAL . 38.2 t -136.42 139.64 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.074 -1.016 . . . . 0.0 111.66 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -94.32 118.49 31.69 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.8 ttm180 -63.37 122.2 15.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.007 -1.058 . . . . 0.0 110.219 -178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -101.05 7.43 43.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.134 -0.627 . . . . 0.0 109.688 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 176.32 173.59 42.09 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.249 -1.94 . . . . 0.0 108.249 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.446 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 75.5 m-20 -60.3 -25.83 66.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.379 -1.071 . . . . 0.0 110.396 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -126.7 18.58 7.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.548 -0.72 . . . . 0.0 111.85 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.41 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 92.7 mtt180 -138.12 143.41 40.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.833 -1.167 . . . . 0.0 111.012 -178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.495 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -140.11 142.17 12.26 Favored Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.521 -1.832 . . . . 0.0 108.521 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.421 ' C ' HG13 ' A' ' 116' ' ' VAL . 20.1 t -89.64 110.99 21.82 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.971 -0.723 . . . . 0.0 109.814 -179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 129' ' ' PRO . 61.4 tp -69.96 113.74 7.47 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.404 -0.918 . . . . 0.0 109.174 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.6 mt -69.99 -20.96 63.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.874 -0.516 . . . . 0.0 110.756 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.3 m -126.77 80.86 70.03 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.691 -0.63 . . . . 0.0 110.441 -179.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.3 Cg_endo -57.43 139.79 91.21 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 O-C-N 123.754 1.397 . . . . 0.0 110.346 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -146.96 163.15 30.14 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -55.47 124.49 16.42 Favored 'Trans proline' 0 N--CA 1.494 1.535 0 O-C-N 123.808 1.425 . . . . 0.0 110.735 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.653 ' HA ' HD12 ' A' ' 135' ' ' LEU . 14.8 p -51.61 -23.46 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.888 -0.507 . . . . 0.0 111.639 -178.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 94.9 p -57.19 -34.34 68.4 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.312 -0.868 . . . . 0.0 109.28 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -74.22 -21.87 59.61 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.653 HD12 ' HA ' ' A' ' 132' ' ' VAL . 95.5 mt -85.02 -0.49 54.6 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 0.0 111.194 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -65.77 109.89 2.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.108 -0.995 . . . . 0.0 108.81 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.94 -6.73 64.44 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -176.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.875 ' HA ' HD12 ' A' ' 44' ' ' LEU . 12.7 t -74.27 -13.32 60.75 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 121.562 -0.963 . . . . 0.0 108.686 177.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.644 ' HB2' HG21 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -75.3 147.68 39.98 Favored 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.372 -0.83 . . . . 0.0 109.384 179.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.455 ' C ' HG23 ' A' ' 153' ' ' ILE . . . 95.25 -12.16 68.37 Favored Glycine 0 N--CA 1.483 1.796 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -64.3 -157.6 0.22 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.531 ' HB3' HG21 ' A' ' 46' ' ' THR . 47.9 Cg_endo -144.12 132.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.858 0 C-N-CA 116.514 -1.857 . . . . 0.0 113.426 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.522 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.3 mp -89.24 85.79 6.7 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 175.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.854 HD12 ' N ' ' A' ' 145' ' ' CYS . 0.7 OUTLIER -92.57 138.32 31.61 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.757 0.789 . . . . 0.0 112.524 -175.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.854 ' N ' HD12 ' A' ' 144' ' ' LEU . 61.3 m -56.48 -177.17 0.05 OUTLIER Pre-proline 0 N--CA 1.503 2.209 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -91.18 3.6 4.36 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.553 1.291 . . . . 0.0 110.536 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 15.4 m -103.63 -15.97 15.64 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.207 -0.933 . . . . 0.0 111.419 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 113.82 28.64 3.11 Favored Glycine 0 N--CA 1.498 2.804 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.461 ' CD2' ' CB ' ' A' ' 97' ' ' CYS . 74.2 m80 -116.65 109.98 17.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.103 . . . . 0.0 110.723 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -74.74 121.97 22.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.545 -0.722 . . . . 0.0 109.302 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 96' ' ' PRO . 26.8 m -122.65 -1.35 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.513 -0.742 . . . . 0.0 112.077 -179.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.477 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -158.68 138.01 5.5 Favored Glycine 0 N--CA 1.493 2.48 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.334 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.455 HG23 ' C ' ' A' ' 140' ' ' GLY . 25.7 mt -120.09 118.42 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 177.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.464 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 13.7 t80 -49.92 127.31 16.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.873 0.844 . . . . 0.0 112.9 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.697 ' HB2' HG23 ' A' ' 170' ' ' VAL . 61.7 ttt-85 -121.58 -21.53 6.18 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.619 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.59 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.82 138.96 7.25 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.917 -1.114 . . . . 0.0 112.148 -178.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.464 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -100.01 138.97 36.35 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.229 0.538 . . . . 0.0 111.936 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.641 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 39.9 t -89.91 94.41 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 77.2 m -89.99 110.02 21.02 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.104 0.954 . . . . 0.0 112.793 -175.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.706 ' O ' HG22 ' A' ' 163' ' ' VAL . 30.3 m -100.48 125.18 46.77 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.3 177.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 56.3 22.81 6.59 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.376 -0.827 . . . . 0.0 111.31 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.23 17.71 36.13 Favored Glycine 0 N--CA 1.497 2.715 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.019 178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.706 HG22 ' O ' ' A' ' 160' ' ' THR . 34.8 m -144.3 139.99 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.117 -1.225 . . . . 0.0 109.0 178.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -78.12 122.09 25.16 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.274 -0.891 . . . . 0.0 111.552 -177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -116.24 15.95 15.88 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.794 -0.566 . . . . 0.0 110.052 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.641 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.33 150.89 2.42 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.702 HG21 HG11 ' A' ' 116' ' ' VAL . 17.3 m -128.6 136.77 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.633 -178.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.477 ' HB2' ' HB3' ' A' ' 156' ' ' ALA . 84.7 m-20 -105.43 150.45 25.27 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 176.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.477 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 42.7 p90 -154.51 161.09 41.83 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.065 -1.454 . . . . 0.0 112.914 -178.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.697 HG23 ' HB2' ' A' ' 155' ' ' ARG . 60.3 t -80.34 139.93 52.27 Favored Pre-proline 0 N--CA 1.494 1.755 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.1 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 174' ' ' SER . 47.4 Cg_endo -82.17 148.24 14.91 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 O-C-N 123.779 1.41 . . . . 0.0 110.525 179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.22 -30.06 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.644 -0.66 . . . . 0.0 110.007 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.85 -31.48 69.79 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.459 -0.776 . . . . 0.0 109.014 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.4 ' HB2' ' HG2' ' A' ' 171' ' ' PRO . 35.0 t -73.06 -31.04 64.14 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.438 0.637 . . . . 0.0 109.559 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.534 ' CG ' HD21 ' A' ' 82' ' ' LEU . 2.7 mtp -70.03 -39.39 75.8 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.658 -0.651 . . . . 0.0 109.461 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -59.99 -41.46 92.08 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.655 -0.653 . . . . 0.0 109.433 179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 32.7 p -69.73 -33.92 73.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.497 178.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 94.7 m -63.16 -40.03 96.38 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 98.2 mtp -63.04 -32.41 73.77 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.844 -0.535 . . . . 0.0 109.687 178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 59.6 ttp180 -59.97 -40.01 87.62 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.407 -0.808 . . . . 0.0 109.595 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -70.89 150.02 46.17 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 8.2 t -170.64 76.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.5 -0.75 . . . . 0.0 110.159 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 56.74 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.823 -0.548 . . . . 0.0 110.809 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -160.22 -49.86 0.05 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.101 -1.0 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 8.1 tttt 50.05 -144.24 0.52 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.353 -0.842 . . . . 0.0 110.451 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 N--CA 1.496 1.855 0 O-C-N 121.052 -1.03 . . . . 0.0 110.024 -179.972 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.716 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.037 0.446 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.26 -57.47 1.2 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 49.2 ttt180 60.08 129.34 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 122.031 0.92 . . . . 0.0 110.895 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -79.97 157.29 26.87 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.871 -0.518 . . . . 0.0 110.036 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -147.62 173.97 12.21 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.677 -179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 53.27 50.06 18.45 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.5 -0.75 . . . . 0.0 111.098 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 56.3 169.25 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.475 -0.766 . . . . 0.0 110.797 179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG13 ' HG2' ' A' ' 34' ' ' GLN . 66.8 t -80.47 -48.97 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 CA-C-O 121.48 0.657 . . . . 0.0 110.591 -179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 90' ' ' GLY . 98.2 mt-10 49.93 40.03 19.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.635 -0.665 . . . . 0.0 111.877 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -164.57 171.81 40.15 Favored Glycine 0 N--CA 1.5 2.954 0 C-N-CA 119.752 -1.213 . . . . 0.0 111.172 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.448 ' HG3' ' CD ' ' A' ' 92' ' ' ARG . 99.5 mt-10 -85.41 -47.05 10.34 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.831 -0.805 . . . . 0.0 111.663 -179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.6 t -108.25 124.28 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.606 -0.684 . . . . 0.0 110.222 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.507 ' HG2' HG13 ' A' ' 29' ' ' VAL . 74.5 mt-30 -94.59 124.2 38.48 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.504 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.2 t -80.29 131.17 34.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.2 m -139.7 175.85 6.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 O-C-N 121.414 -0.803 . . . . 0.0 110.262 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 93.5 p -146.32 133.24 20.18 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.837 0.827 . . . . 0.0 109.206 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.457 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.3 p -108.25 -179.73 3.97 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.69 -14.92 23.82 Favored 'General case' 0 C--N 1.29 -2.002 0 C-N-CA 119.821 -0.752 . . . . 0.0 111.021 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 10.2 p -107.92 -32.34 7.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.15 -0.969 . . . . 0.0 113.185 -178.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -171.88 -169.98 0.72 Allowed 'General case' 0 N--CA 1.509 2.489 0 O-C-N 120.705 -1.247 . . . . 0.0 112.769 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 m -121.43 148.79 43.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.403 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 16.7 p90 -164.3 -145.55 0.09 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.525 -0.734 . . . . 0.0 110.299 -178.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 54' ' ' THR . 82.9 mt -134.87 159.99 39.66 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.644 -1.285 . . . . 0.0 112.513 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -143.72 128.79 18.62 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.652 HG21 ' HB3' ' A' ' 142' ' ' PRO . 98.1 m -96.8 132.84 42.11 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.0 111.799 -178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.19 117.31 20.09 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.4 t -132.44 129.93 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 O-C-N 121.041 -1.037 . . . . 0.0 110.826 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 54.05 40.05 31.22 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 121.534 -0.729 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.559 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.95 24.95 74.44 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.58 123.02 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.544 -0.974 . . . . 0.0 109.099 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 40.0 m -75.3 143.34 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.563 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 91.2 m95 -136.0 125.51 25.15 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.732 179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -128.79 -174.21 3.19 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 121.259 -0.901 . . . . 0.0 109.281 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 139' ' ' SER . 35.1 m -86.41 131.52 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.315 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.312 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.409 ' HB2' ' N ' ' A' ' 82' ' ' LEU . 19.0 t80 -60.43 -40.09 89.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.776 -0.577 . . . . 0.0 109.641 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.849 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 37.8 p-80 -73.41 72.43 1.33 Allowed 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.391 1.091 . . . . 0.0 108.745 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 152.36 -36.07 0.81 Allowed Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.364 -2.294 . . . . 0.0 107.364 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.856 ' CB ' HG21 ' A' ' 83' ' ' VAL . . . -83.18 0.47 45.17 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.808 -0.819 . . . . 0.0 111.143 178.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -49.54 -23.91 5.08 Favored Glycine 0 N--CA 1.502 3.041 0 O-C-N 121.077 -1.014 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 62' ' ' LYS . 63.6 m -66.23 -9.81 35.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.358 -1.083 . . . . 0.0 111.185 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 61' ' ' SER . 40.0 ttpt 64.42 -71.91 0.07 Allowed 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.563 -0.71 . . . . 0.0 110.948 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.532 HG22 ' OG1' ' A' ' 72' ' ' THR . 1.0 OUTLIER -80.06 100.08 8.01 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.473 0.654 . . . . 0.0 110.402 -179.663 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.484 HD12 ' H ' ' A' ' 65' ' ' ALA . 0.5 OUTLIER -92.03 -126.93 0.09 Allowed 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.484 ' H ' HD12 ' A' ' 64' ' ' LEU . . . -146.35 97.39 2.93 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.766 -1.209 . . . . 0.0 110.202 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.46 ' HA3' ' CD1' ' A' ' 71' ' ' ILE . . . -89.09 -179.95 45.49 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.75 -1.74 . . . . 0.0 108.75 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -60.99 -17.84 54.06 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 O-C-N 123.933 1.491 . . . . 0.0 110.46 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 59.0 mttm -109.74 3.91 21.34 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.331 -0.856 . . . . 0.0 111.3 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.82 -159.66 14.34 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.415 -1.874 . . . . 0.0 108.415 -179.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -58.39 123.49 13.73 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 O-C-N 123.648 1.341 . . . . 0.0 110.621 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.468 HG22 ' CD1' ' A' ' 85' ' ' TRP . 8.3 mt -88.05 -22.81 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.736 -0.602 . . . . 0.0 111.527 -178.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.532 ' OG1' HG22 ' A' ' 63' ' ' THR . 50.9 m 60.06 124.64 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.562 0.696 . . . . 0.0 110.913 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.571 HE22 HG11 ' A' ' 83' ' ' VAL . 95.3 mt-30 -59.94 137.71 58.01 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.271 -0.893 . . . . 0.0 112.547 -178.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.4 ttm -97.08 -27.63 14.5 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.739 ' CD2' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -147.04 167.65 23.52 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 1.033 HG23 HG12 ' A' ' 83' ' ' VAL . 19.0 m -154.61 116.7 4.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 110.398 179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 15.7 t-20 -95.02 75.2 3.5 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -60.01 -40.04 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 121.516 -0.74 . . . . 0.0 109.619 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -55.8 -26.27 45.41 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -111.02 0.09 16.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.706 -0.621 . . . . 0.0 110.832 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 11.1 t70 60.17 57.4 2.97 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.084 -1.01 . . . . 0.0 109.499 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.798 HD22 HG11 ' A' ' 170' ' ' VAL . 36.9 tp -148.06 151.53 35.84 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.16 -0.616 . . . . 0.0 109.652 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 1.033 HG12 HG23 ' A' ' 76' ' ' THR . 14.6 m -139.74 140.04 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' HA2' ' CE3' ' A' ' 85' ' ' TRP . . . -125.47 171.21 17.38 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 119.151 -1.499 . . . . 0.0 112.102 -179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.58 ' HH2' HG22 ' A' ' 54' ' ' THR . 0.2 OUTLIER -148.67 -162.08 1.48 Allowed 'General case' 0 N--CA 1.516 2.855 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.258 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -100.36 111.31 23.57 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.559 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -68.19 134.2 91.45 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.646 -0.659 . . . . 0.0 111.542 -178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -86.55 176.3 4.87 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.974 1.512 . . . . 0.0 109.443 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -76.13 149.73 32.57 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 O-C-N 123.847 1.446 . . . . 0.0 110.651 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 30' ' ' GLU . . . 94.67 -9.98 70.9 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.267 179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.28 39.95 0.93 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.853 -1.381 . . . . 0.0 111.546 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.448 ' CD ' ' HG3' ' A' ' 32' ' ' GLU . 49.9 mtt-85 27.96 96.79 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.552 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.9 t -83.49 129.74 34.99 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.411 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.956 HD13 HD21 ' A' ' 144' ' ' LEU . 83.1 mt -109.98 149.91 29.26 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.401 ' OG1' ' CD2' ' A' ' 149' ' ' HIS . 7.6 p -105.38 157.56 34.16 Favored Pre-proline 0 N--CA 1.494 1.755 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.339 -178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -89.62 163.06 5.28 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 O-C-N 123.824 1.434 . . . . 0.0 110.604 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 1.8 p -155.82 169.2 24.93 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.391 -0.818 . . . . 0.0 111.488 -179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.433 ' O ' ' HB2' ' A' ' 99' ' ' CYS . 94.0 m -61.18 -40.1 92.62 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.72 -0.613 . . . . 0.0 110.583 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 98' ' ' THR . 74.2 m 64.59 79.23 0.26 Allowed 'General case' 0 N--CA 1.505 2.281 0 CA-C-O 121.235 0.54 . . . . 0.0 112.353 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -63.41 -33.2 86.62 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 12.8 m -111.85 144.2 41.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.797 -0.825 . . . . 0.0 108.948 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 73.3 m -98.4 16.38 21.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.408 -0.807 . . . . 0.0 111.268 -179.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 48.1 t0 -67.81 86.71 0.23 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 143' ' ' LEU . 86.9 mt -99.02 176.64 5.5 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 121.616 0.722 . . . . 0.0 111.28 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.423 ' CD1' ' HB3' ' A' ' 115' ' ' PRO . 96.2 m-85 -144.45 111.13 5.68 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.504 HD13 ' HG ' ' A' ' 143' ' ' LEU . 26.6 tp -86.36 143.93 27.6 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.465 0.65 . . . . 0.0 110.315 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.645 HG22 ' OD1' ' A' ' 112' ' ' ASP . 80.5 t -88.97 114.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.4 p -84.21 174.87 9.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.989 -0.684 . . . . 0.0 109.45 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 15.2 tpt180 -41.55 -29.33 0.16 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.816 -179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -100.04 -70.04 0.75 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.541 -0.724 . . . . 0.0 109.654 178.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -148.92 -162.92 1.66 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.523 -0.736 . . . . 0.0 109.023 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.645 ' OD1' HG22 ' A' ' 107' ' ' VAL . 87.9 m-20 -57.81 -63.88 1.09 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.632 -0.667 . . . . 0.0 110.08 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.8 t 54.02 -86.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 122.008 -0.433 . . . . 0.0 111.617 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.592 HD13 ' CD1' ' A' ' 126' ' ' LEU . 1.9 pp -76.23 134.63 70.42 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.101 -0.999 . . . . 0.0 111.731 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.423 ' HB3' ' CD1' ' A' ' 105' ' ' TYR . 52.5 Cg_endo -104.67 148.1 0.14 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 O-C-N 123.604 1.318 . . . . 0.0 109.13 178.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.717 HG11 ' CG2' ' A' ' 167' ' ' VAL . 40.5 t -134.06 138.61 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.275 -0.891 . . . . 0.0 110.803 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -95.83 124.17 39.73 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.456 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 2.3 ttm180 -62.62 121.56 13.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.409 -0.807 . . . . 0.0 110.356 -178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 24.5 mmt180 -100.02 7.4 44.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.631 -0.668 . . . . 0.0 109.574 177.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 177.97 173.81 43.73 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 107.741 -2.144 . . . . 0.0 107.741 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 16.8 t0 -61.33 -25.28 67.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -1.024 . . . . 0.0 110.243 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -125.71 18.59 7.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.551 -0.718 . . . . 0.0 111.757 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.415 ' N ' ' CE1' ' A' ' 169' ' ' PHE . 95.2 mtt-85 -138.26 145.37 41.24 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.884 -1.135 . . . . 0.0 111.161 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -141.29 141.2 10.93 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.615 ' C ' HG13 ' A' ' 116' ' ' VAL . 55.3 p -89.21 113.1 24.27 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.951 -0.735 . . . . 0.0 109.858 -179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.609 HD12 HG22 ' A' ' 116' ' ' VAL . 41.1 tp -71.06 110.06 5.52 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.687 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.2 mt -69.95 -18.0 63.34 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.792 -0.568 . . . . 0.0 110.738 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 53.0 m -119.95 79.96 25.52 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.615 -0.678 . . . . 0.0 110.281 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -59.72 137.75 78.91 Favored 'Trans proline' 0 N--CA 1.494 1.502 0 O-C-N 123.807 1.425 . . . . 0.0 109.903 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -154.11 169.8 9.43 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.699 -0.626 . . . . 0.0 109.344 -179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -59.56 124.38 15.34 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.963 1.507 . . . . 0.0 110.335 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 159' ' ' CYS . 15.0 p -49.36 -23.47 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.794 -0.566 . . . . 0.0 111.635 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -54.41 -37.54 65.19 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.324 -0.86 . . . . 0.0 109.356 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -70.67 -28.03 64.48 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.473 ' CD1' ' HB3' ' A' ' 164' ' ' ALA . 96.8 mt -84.25 -0.32 51.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.557 -0.714 . . . . 0.0 111.271 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 27.1 mttt -70.31 110.84 5.49 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.76 -10.57 57.45 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.132 -1.587 . . . . 0.0 109.132 -177.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 60.5 p -74.65 -15.24 60.82 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.373 -1.075 . . . . 0.0 109.159 178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.743 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -71.29 151.33 44.32 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.449 179.233 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.673 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 89.92 -10.74 72.86 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -72.23 -157.92 3.62 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.648 -1.781 . . . . 0.0 108.648 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.652 ' HB3' HG21 ' A' ' 46' ' ' THR . 49.6 Cg_endo -142.35 137.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.482 0.803 0 C-N-CA 116.982 -1.546 . . . . 0.0 112.212 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.504 ' HG ' HD13 ' A' ' 106' ' ' LEU . 2.2 mt -95.06 99.16 11.21 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.956 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -90.86 146.41 23.95 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.4 ' CB ' ' CD ' ' A' ' 146' ' ' PRO . 0.0 OUTLIER -59.86 -164.8 0.0 OUTLIER Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.703 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.4 ' CD ' ' CB ' ' A' ' 145' ' ' CYS . 49.0 Cg_endo -90.14 17.98 1.43 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 O-C-N 123.521 1.274 . . . . 0.0 111.022 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 71.3 m -126.51 -55.42 1.43 Allowed 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.096 -1.002 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 160.0 43.32 0.02 OUTLIER Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.401 ' CD2' ' OG1' ' A' ' 95' ' ' THR . 77.6 m80 -125.19 120.99 32.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.438 -1.037 . . . . 0.0 110.797 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -81.61 124.3 29.41 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.513 -0.742 . . . . 0.0 109.266 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 29.4 m -129.21 -1.99 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.541 -0.724 . . . . 0.0 111.901 -178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.467 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -155.86 125.46 1.65 Allowed Glycine 0 N--CA 1.493 2.488 0 C-N-CA 119.426 -1.368 . . . . 0.0 111.168 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.453 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.0 mt -105.8 117.48 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.297 -1.119 . . . . 0.0 108.156 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.458 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 16.2 t80 -50.14 126.8 15.43 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.601 0.715 . . . . 0.0 112.529 -177.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.51 ' HB2' HG23 ' A' ' 170' ' ' VAL . 51.7 ttp180 -119.85 -22.48 6.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.82 -0.55 . . . . 0.0 112.224 -178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -161.96 136.62 6.99 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.894 -1.129 . . . . 0.0 111.974 -178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.458 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.0 133.25 40.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 122.001 -0.437 . . . . 0.0 111.375 -179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.608 ' CB ' ' HB3' ' A' ' 166' ' ' ALA . 54.1 t -84.66 91.08 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 178.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.454 ' HG ' HG21 ' A' ' 132' ' ' VAL . 64.2 m -94.23 119.73 33.45 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.824 0.821 . . . . 0.0 111.352 -177.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -89.95 -79.96 0.33 Allowed 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.075 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.9 ttt85 -106.41 64.38 0.66 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.402 -0.811 . . . . 0.0 109.404 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 72.93 18.79 79.23 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 110.206 -1.158 . . . . 0.0 110.206 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 27.6 m -146.67 137.94 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.29 -1.123 . . . . 0.0 109.016 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -83.14 129.98 35.07 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.549 -0.72 . . . . 0.0 111.072 -179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -119.94 14.82 12.46 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.215 0.531 . . . . 0.0 110.089 178.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.608 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -172.06 152.15 2.84 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.717 ' CG2' HG11 ' A' ' 116' ' ' VAL . 9.1 m -132.18 137.3 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 C-N-CA 119.247 -0.981 . . . . 0.0 112.461 -178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -104.71 152.0 23.04 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 176.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.467 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.7 p90 -153.71 166.66 32.14 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.087 -1.445 . . . . 0.0 112.644 -178.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.798 HG11 HD22 ' A' ' 82' ' ' LEU . 57.8 t -80.7 130.88 62.5 Favored Pre-proline 0 N--CA 1.495 1.807 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.094 179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.04 148.61 45.18 Favored 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 123.744 1.392 . . . . 0.0 109.863 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.33 -25.31 23.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.557 -0.714 . . . . 0.0 109.917 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -59.98 -29.69 68.61 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.312 -0.867 . . . . 0.0 108.72 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.903 ' O ' HG22 ' A' ' 177' ' ' THR . 30.9 m -71.08 -32.79 69.52 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.409 0.623 . . . . 0.0 109.395 178.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.696 ' HG3' HD21 ' A' ' 82' ' ' LEU . 0.3 OUTLIER -69.37 -38.45 78.07 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.8 0.81 . . . . 0.0 108.937 178.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -60.01 -39.24 85.13 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.589 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.903 HG22 ' O ' ' A' ' 174' ' ' SER . 3.9 t -60.28 -25.78 65.99 Favored 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 119.554 -0.859 . . . . 0.0 111.27 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.739 HG23 ' CD2' ' A' ' 75' ' ' TYR . 95.2 m -63.97 -49.93 70.59 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.156 -0.965 . . . . 0.0 108.765 178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 78.1 mtm -63.36 -40.0 96.06 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -70.07 -31.42 69.0 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.576 -0.703 . . . . 0.0 109.854 179.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . 59.49 152.41 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.492 0.663 . . . . 0.0 110.873 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 33.4 t -172.86 38.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.405 -0.809 . . . . 0.0 109.844 -179.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -76.07 -39.96 54.23 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.748 -0.595 . . . . 0.0 110.497 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 52.5 tttp 57.23 35.34 26.05 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.414 -0.804 . . . . 0.0 109.422 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 52.7 tttm 57.2 162.78 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.613 -0.679 . . . . 0.0 110.417 -179.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 58.1 mttm . . . . . 0 N--CA 1.496 1.87 0 CA-C-O 118.045 -0.978 . . . . 0.0 110.029 -179.654 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.849 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 22' ' ' THR . 7.8 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.077 0.465 . . . . 0.0 110.174 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -173.75 179.95 44.8 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -140.95 165.33 27.83 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.012 -0.699 . . . . 0.0 109.296 179.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 67' ' ' PRO . 84.6 m-20 -74.26 139.25 44.16 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 40.1 mttt -130.1 155.14 46.68 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.847 -0.741 . . . . 0.0 110.953 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 62.3 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.525 -0.734 . . . . 0.0 111.079 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 56.03 111.28 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 CA-C-O 121.696 0.76 . . . . 0.0 111.353 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.628 ' CG1' ' HB2' ' A' ' 91' ' ' ALA . 65.8 t -79.92 -40.07 20.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 120.163 -0.615 . . . . 0.0 110.118 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 45.44 93.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 CA-C-O 121.44 0.638 . . . . 0.0 111.34 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.597 ' CA ' ' HB1' ' A' ' 91' ' ' ALA . . . -91.08 96.26 2.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 -178.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.558 ' HA ' HD23 ' A' ' 94' ' ' LEU . 97.4 mt-10 -151.11 -78.47 0.13 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 178.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.747 HG22 ' HG3' ' A' ' 142' ' ' PRO . 63.0 t -138.14 129.37 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 177.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -140.08 141.36 36.19 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.27 -179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.47 139.02 18.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.54 159.98 42.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.57 0.7 . . . . 0.0 110.215 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 66.7 m -137.28 121.39 17.88 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-O 121.8 0.81 . . . . 0.0 108.897 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.616 HG21 ' HA ' ' A' ' 59' ' ' ALA . 24.5 p -107.48 -179.87 4.04 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.0 -14.92 18.45 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 120.011 -0.676 . . . . 0.0 111.213 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 20.6 p -99.14 -40.95 7.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 112.191 -179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -173.55 -168.52 0.45 Allowed 'General case' 0 N--CA 1.508 2.458 0 O-C-N 120.926 -1.109 . . . . 0.0 112.098 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 71.3 p -118.4 144.66 45.76 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 8.4 p90 -161.4 -143.35 0.09 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.52 -0.738 . . . . 0.0 110.132 -178.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD11 ' N ' ' A' ' 109' ' ' ARG . 80.9 mt -134.64 162.96 30.83 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.615 -1.303 . . . . 0.0 112.833 -177.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 53' ' ' TRP . . . -151.89 129.84 11.76 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.648 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.637 HG21 ' HB3' ' A' ' 142' ' ' PRO . 75.5 m -103.07 127.7 50.23 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.238 -0.914 . . . . 0.0 111.418 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 52' ' ' CYS . 86.9 m -74.82 122.56 23.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.746 -0.596 . . . . 0.0 109.568 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -136.55 129.48 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.348 -0.845 . . . . 0.0 110.461 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 43.4 t30 49.99 39.99 20.15 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.584 -0.698 . . . . 0.0 111.264 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 71.42 26.19 73.84 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.577 HG21 ' SD ' ' A' ' 179' ' ' MET . 62.9 t -137.82 113.02 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.436 -1.038 . . . . 0.0 109.611 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.44 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 7.9 t -74.47 121.28 21.23 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.464 ' CD2' ' HG2' ' A' ' 175' ' ' MET . 87.6 m95 -110.01 129.96 55.6 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.97 -0.692 . . . . 0.0 110.493 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.839 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 4.5 t -136.74 179.99 6.04 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.693 HG11 ' HB2' ' A' ' 139' ' ' SER . 30.3 m -90.2 126.37 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 C-N-CA 118.486 -1.286 . . . . 0.0 112.138 -178.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -60.08 -40.89 91.15 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.701 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 36.8 p-80 -74.64 67.06 1.51 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.13 0.967 . . . . 0.0 108.64 178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 170.1 -36.6 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 107.745 -2.142 . . . . 0.0 107.745 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.616 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -90.03 -79.96 0.33 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.712 -0.875 . . . . 0.0 109.366 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 48.41 25.27 4.28 Favored Glycine 0 N--CA 1.5 2.907 0 O-C-N 121.368 -0.833 . . . . 0.0 111.218 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.5 ' O ' ' N ' ' A' ' 63' ' ' THR . 26.4 p -132.14 1.72 3.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.276 -1.132 . . . . 0.0 112.02 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 61' ' ' SER . 96.3 mttt 61.17 -66.81 0.06 Allowed 'General case' 0 N--CA 1.508 2.452 0 CA-C-O 121.945 0.879 . . . . 0.0 110.733 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 61' ' ' SER . 11.5 m -79.13 139.97 37.91 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 121.663 0.744 . . . . 0.0 110.363 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.432 ' CD2' ' NE1' ' A' ' 85' ' ' TRP . 0.5 OUTLIER -143.74 -130.61 0.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.21 93.33 2.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.925 -1.109 . . . . 0.0 109.034 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.551 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -100.0 -171.74 30.01 Favored Glycine 0 N--CA 1.495 2.581 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.6 -178.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HG3' HG13 ' A' ' 29' ' ' VAL . 44.3 Cg_endo -61.07 -18.8 60.12 Favored 'Trans proline' 0 N--CA 1.492 1.401 0 O-C-N 124.105 1.582 . . . . 0.0 110.649 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 84.3 mttt -108.83 7.43 26.18 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 110.955 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.09 -153.3 16.85 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.463 ' HB2' HG23 ' A' ' 63' ' ' THR . 44.0 Cg_endo -64.88 116.16 3.66 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 124.007 1.53 . . . . 0.0 111.18 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.674 HG22 ' HD1' ' A' ' 85' ' ' TRP . 66.7 mt -104.97 140.0 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 CA-C-O 121.462 0.648 . . . . 0.0 109.751 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.5 m -95.37 145.25 25.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.791 -0.568 . . . . 0.0 110.513 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 85' ' ' TRP . 11.5 pt20 -75.27 157.41 34.47 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.669 -0.645 . . . . 0.0 111.101 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 95.3 mmm -96.88 -39.97 9.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.653 -0.654 . . . . 0.0 109.706 179.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.33 -178.18 7.14 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.598 -0.689 . . . . 0.0 109.333 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.852 HG23 ' CG1' ' A' ' 83' ' ' VAL . 88.2 m -150.9 125.55 9.63 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.623 -0.673 . . . . 0.0 109.428 -179.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -93.81 76.69 4.24 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 98.2 t -59.93 -39.23 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.699 -0.626 . . . . 0.0 109.466 -178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -53.84 -26.2 23.29 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -115.66 0.64 13.31 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.656 -0.653 . . . . 0.0 110.947 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 14.7 t0 60.37 56.82 3.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.893 -1.129 . . . . 0.0 108.591 -179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.718 HD22 HG11 ' A' ' 170' ' ' VAL . 22.6 tp -142.77 155.47 44.84 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 120.39 -0.524 . . . . 0.0 109.869 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.852 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.1 OUTLIER -145.1 137.55 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.41 -0.806 . . . . 0.0 109.435 -179.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -128.52 125.99 5.19 Favored Glycine 0 N--CA 1.498 2.822 0 C-N-CA 119.073 -1.537 . . . . 0.0 111.44 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.839 ' CZ3' HG22 ' A' ' 54' ' ' THR . 4.5 m-90 -90.04 -170.04 2.64 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -108.44 109.84 21.22 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.27 147.91 98.29 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.508 -0.745 . . . . 0.0 110.556 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -104.11 167.29 0.2 Allowed 'Trans proline' 0 N--CA 1.488 1.19 0 O-C-N 123.727 1.383 . . . . 0.0 110.354 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.489 ' O ' HG21 ' A' ' 29' ' ' VAL . 46.9 Cg_endo -63.64 169.6 9.71 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 O-C-N 123.876 1.461 . . . . 0.0 110.406 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 89.97 -9.97 75.5 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.628 ' HB2' ' CG1' ' A' ' 29' ' ' VAL . . . -98.01 -147.96 0.32 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.362 -1.081 . . . . 0.0 108.899 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -153.0 -39.74 0.1 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.279 -0.888 . . . . 0.0 111.108 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 62.5 131.05 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.464 0.65 . . . . 0.0 110.553 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 32' ' ' GLU . 4.6 mm? -75.44 153.89 37.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 0.0 109.566 179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.99 161.49 22.65 Favored Pre-proline 0 N--CA 1.498 1.927 0 O-C-N 121.364 -0.835 . . . . 0.0 110.8 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -61.09 165.32 12.62 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 O-C-N 123.797 1.42 . . . . 0.0 110.083 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.403 ' SG ' ' CB ' ' A' ' 145' ' ' CYS . 4.0 t -108.17 120.26 41.82 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.519 -0.738 . . . . 0.0 111.736 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 94.2 m -70.06 -41.32 74.32 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.916 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 8.3 p -69.36 142.54 53.95 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.316 -0.865 . . . . 0.0 110.304 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.86 14.8 55.69 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -179.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.3 m -59.99 136.98 58.18 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.952 -1.322 . . . . 0.0 109.568 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.2 m -101.66 7.84 41.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.426 -0.796 . . . . 0.0 111.511 -179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -72.88 76.1 1.16 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.196 -0.94 . . . . 0.0 108.618 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.689 HD23 ' HA ' ' A' ' 145' ' ' CYS . 53.9 mt -95.26 172.42 8.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.753 -0.592 . . . . 0.0 109.808 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 53.0 p90 -152.06 142.2 22.29 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 107' ' ' VAL . 38.9 tp -115.03 155.8 26.31 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.98 0.895 . . . . 0.0 111.908 -177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 111' ' ' ALA . 92.4 t -109.97 135.7 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.604 HG23 ' HB3' ' A' ' 112' ' ' ASP . 45.1 p -83.25 175.79 9.65 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.264 -0.898 . . . . 0.0 110.149 -179.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.559 ' N ' HD11 ' A' ' 44' ' ' LEU . 70.3 ttt-85 -41.95 -31.29 0.33 Allowed 'General case' 0 N--CA 1.506 2.344 0 CA-C-O 121.296 0.57 . . . . 0.0 111.422 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -99.99 -70.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.489 ' O ' HG13 ' A' ' 107' ' ' VAL . . . -154.77 -82.44 0.08 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.566 -0.709 . . . . 0.0 110.328 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.604 ' HB3' HG23 ' A' ' 108' ' ' THR . 23.2 t0 46.86 90.82 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.389 -0.82 . . . . 0.0 111.4 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.19 49.47 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.603 -0.685 . . . . 0.0 110.439 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.639 HD12 ' CD1' ' A' ' 126' ' ' LEU . 13.1 pt -70.06 156.03 92.49 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.507 -0.745 . . . . 0.0 109.88 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.668 ' O ' HD22 ' A' ' 127' ' ' LEU . 43.4 Cg_endo -103.31 141.11 0.14 Allowed 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.982 1.517 . . . . 0.0 111.523 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.558 HG11 HG21 ' A' ' 167' ' ' VAL . 62.8 t -130.02 130.06 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.545 ' HG2' HD21 ' A' ' 127' ' ' LEU . 21.5 mmm180 -90.26 116.59 28.35 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.468 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 7.3 ttp180 -60.39 123.48 17.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.412 -0.805 . . . . 0.0 110.93 -178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -100.01 4.51 44.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.578 -0.701 . . . . 0.0 109.935 177.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.76 176.99 41.78 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 107.896 -2.081 . . . . 0.0 107.896 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 92.5 m-20 -65.64 -21.54 66.57 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.401 -1.059 . . . . 0.0 110.119 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.4 m -124.49 17.0 8.92 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.455 -0.778 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 27.2 ttt85 -140.3 139.93 35.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.975 -1.078 . . . . 0.0 110.774 -178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -139.19 144.02 14.77 Favored Glycine 0 N--CA 1.484 1.854 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.8 t -90.9 111.97 23.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.789 -0.83 . . . . 0.0 110.18 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.639 ' CD1' HD12 ' A' ' 114' ' ' ILE . 44.3 tp -73.49 104.64 4.54 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.668 HD22 ' O ' ' A' ' 115' ' ' PRO . 0.0 OUTLIER -60.02 -27.43 66.89 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.225 0.536 . . . . 0.0 110.387 -179.439 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 29.4 t -112.39 105.49 56.12 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.713 -0.617 . . . . 0.0 110.76 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -77.78 141.74 19.6 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 O-C-N 123.911 1.479 . . . . 0.0 109.442 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -154.88 165.23 18.63 Favored Pre-proline 0 N--CA 1.487 1.409 0 O-C-N 121.573 -0.704 . . . . 0.0 109.258 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -60.12 125.19 16.93 Favored 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.895 1.471 . . . . 0.0 109.935 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.9 p -49.64 -25.14 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.799 -0.563 . . . . 0.0 111.254 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.402 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 25.3 t -55.5 -38.12 68.76 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.654 0.74 . . . . 0.0 109.434 179.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.437 ' CE2' HG21 ' A' ' 108' ' ' THR . 53.8 t80 -70.02 -29.18 66.18 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.87 2.0 50.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.583 -0.698 . . . . 0.0 111.507 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 51.9 mttm -70.5 113.01 7.21 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.152 -0.967 . . . . 0.0 108.56 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 101.7 -9.05 56.81 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.557 ' HA ' HD12 ' A' ' 44' ' ' LEU . 30.6 t -75.27 -17.13 60.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.433 -1.039 . . . . 0.0 109.083 177.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.693 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.0 OUTLIER -65.14 146.21 55.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.146 -0.971 . . . . 0.0 110.13 179.367 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.562 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 96.85 -14.98 63.39 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -66.54 -158.08 0.61 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.747 ' HG3' HG22 ' A' ' 33' ' ' VAL . 56.8 Cg_endo -142.74 140.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 116.683 -1.745 . . . . 0.0 112.028 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 104' ' ' LEU . 4.5 mp -97.08 97.33 9.13 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 177.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.614 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.3 mp -90.01 138.13 31.76 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 -176.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.689 ' HA ' HD23 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -64.03 -154.89 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 177.469 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -104.16 15.04 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.26 0 O-C-N 123.453 1.238 . . . . 0.0 110.365 178.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 9.4 m -117.14 16.9 14.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.175 -0.953 . . . . 0.0 111.593 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 74.44 37.59 46.8 Favored Glycine 0 N--CA 1.498 2.795 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -125.2 132.08 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.445 -1.032 . . . . 0.0 110.429 -179.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -97.85 119.97 37.4 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.556 -0.715 . . . . 0.0 109.179 179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.8 m -125.18 -1.56 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.269 -178.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.89 126.85 2.35 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 119.376 -1.393 . . . . 0.0 111.506 -179.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.443 HG23 ' C ' ' A' ' 140' ' ' GLY . 48.3 mt -109.94 117.65 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.105 -1.232 . . . . 0.0 108.283 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.433 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 15.2 t80 -50.92 128.67 21.81 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -177.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.419 ' HB3' HG23 ' A' ' 170' ' ' VAL . 34.5 ptt180 -119.34 -25.56 6.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.722 -0.612 . . . . 0.0 111.648 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.724 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -160.06 141.44 12.54 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 111.827 -178.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.433 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -95.99 140.1 31.22 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.558 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 52.4 t -89.95 92.09 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 61.8 m -92.59 118.17 30.73 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-O 121.696 0.76 . . . . 0.0 111.028 -177.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.648 HG22 ' HG3' ' A' ' 161' ' ' ARG . 96.7 m -89.94 -78.38 0.37 Allowed 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.489 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.648 ' HG3' HG22 ' A' ' 160' ' ' THR . 59.6 mtp85 -105.99 54.58 0.69 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.305 -0.872 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.416 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 81.79 16.57 72.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 162' ' ' GLY . 33.1 m -146.36 141.31 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 O-C-N 121.353 -1.086 . . . . 0.0 108.335 179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -84.52 128.29 34.51 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.545 -0.722 . . . . 0.0 111.047 -178.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -120.0 15.83 12.48 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.163 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.523 ' HB3' ' CB ' ' A' ' 158' ' ' VAL . . . -171.31 145.87 2.23 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 179.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 116' ' ' VAL . 16.0 m -121.65 135.94 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 C-N-CA 119.522 -0.871 . . . . 0.0 112.698 -177.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -102.57 147.34 26.9 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 105.928 -1.878 . . . . 0.0 105.928 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.481 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 41.5 p90 -152.65 165.16 36.11 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.089 -178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.718 HG11 HD22 ' A' ' 82' ' ' LEU . 67.3 t -81.65 131.81 56.76 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.054 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -74.09 143.1 31.88 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 O-C-N 123.887 1.467 . . . . 0.0 110.433 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 8.8 p -70.77 -29.94 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.77 -0.581 . . . . 0.0 109.659 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 177' ' ' THR . 86.4 tt0 -58.98 -33.09 70.28 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.45 -0.781 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 47.4 m -75.54 -29.65 59.48 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 120.205 -0.598 . . . . 0.0 109.855 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.595 ' HG3' HD21 ' A' ' 82' ' ' LEU . 3.5 mtp -69.95 -39.88 75.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.619 -0.675 . . . . 0.0 109.586 179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -60.04 -39.92 87.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.73 -0.606 . . . . 0.0 110.069 179.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.402 HG23 ' O ' ' A' ' 173' ' ' GLU . 64.6 p -64.59 -36.05 82.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.453 -0.78 . . . . 0.0 109.823 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.447 HG21 ' HH2' ' A' ' 53' ' ' TRP . 94.4 m -61.55 -40.06 93.36 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.577 ' SD ' HG21 ' A' ' 51' ' ' VAL . 94.4 mtp -65.34 -35.47 81.07 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 -59.99 -36.01 76.25 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.677 -0.639 . . . . 0.0 110.446 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.6 -40.07 92.27 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.743 -0.598 . . . . 0.0 110.217 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 67.15 -69.0 0.14 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.551 -0.718 . . . . 0.0 110.62 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 185' ' ' LYS . 80.5 tttt -150.79 80.07 1.33 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.374 -0.829 . . . . 0.0 110.307 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 15.9 tptm 60.01 -68.14 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 122.174 -0.329 . . . . 0.0 111.465 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 183' ' ' LYS . 16.5 ptpt -159.49 169.98 22.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 0.0 110.539 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 66.1 mmtt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.19 179.965 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.724 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 121.105 0.478 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -162.35 101.48 0.19 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.433 ' CD ' ' HB2' ' A' ' 25' ' ' ASP . 1.6 tmm_? -138.96 157.5 45.89 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.888 -0.771 . . . . 0.0 110.046 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.433 ' HB2' ' CD ' ' A' ' 24' ' ' ARG . 56.1 t0 54.78 47.15 23.05 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.797 -0.564 . . . . 0.0 110.56 -179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 60.8 pttt -149.84 161.31 42.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.597 -0.841 . . . . 0.0 110.677 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 60.47 119.63 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.518 -0.739 . . . . 0.0 111.07 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -58.35 169.25 0.9 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.359 -0.838 . . . . 0.0 110.185 179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 91' ' ' ALA . 35.4 m -79.98 -6.06 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 O-C-N 121.583 -0.698 . . . . 0.0 111.765 -178.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.06 66.87 0.62 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.005 -1.06 . . . . 0.0 110.0 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -147.8 156.58 27.01 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 120.308 -0.948 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.39 -52.07 6.47 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.731 -0.864 . . . . 0.0 111.078 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.3 t -111.26 126.32 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.604 -0.685 . . . . 0.0 110.0 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -96.25 139.85 31.79 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 121.417 0.627 . . . . 0.0 110.341 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.639 ' HA ' HD23 ' A' ' 44' ' ' LEU . 99.0 t -80.33 140.16 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.3 m -129.92 159.97 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 122.346 1.069 . . . . 0.0 112.0 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 78.2 p -148.5 116.93 6.53 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 178.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.774 HG21 ' HA ' ' A' ' 59' ' ' ALA . 30.2 p -108.71 179.98 4.03 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 121.396 0.617 . . . . 0.0 109.651 -178.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.65 -16.27 15.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 120.204 -0.599 . . . . 0.0 111.848 -178.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 25.1 p -111.29 -27.35 8.71 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.144 -1.022 . . . . 0.0 113.166 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.41 ' NE2' ' HA3' ' A' ' 58' ' ' GLY . 15.8 pt20 -170.93 -170.01 0.83 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.582 -1.324 . . . . 0.0 112.54 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 75.3 m -127.84 140.79 51.82 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 5.7 p90 -159.69 -141.79 0.08 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.55 -0.719 . . . . 0.0 109.996 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.639 HD23 ' HA ' ' A' ' 35' ' ' VAL . 84.4 mt -136.82 171.16 14.92 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.594 -1.316 . . . . 0.0 113.39 -176.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.58 ' HB2' ' HB ' ' A' ' 54' ' ' THR . . . -148.11 122.91 9.94 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.389 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.491 HG21 ' HB3' ' A' ' 142' ' ' PRO . 93.5 m -85.89 120.83 27.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.592 -0.693 . . . . 0.0 110.541 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.761 ' SG ' ' HB1' ' A' ' 91' ' ' ALA . 85.3 m -74.46 119.7 19.02 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.965 -0.694 . . . . 0.0 109.362 178.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' CG2' HG22 ' A' ' 46' ' ' THR . 41.5 t -140.89 131.88 28.26 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 O-C-N 121.37 -0.831 . . . . 0.0 110.465 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 52.86 40.03 30.05 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.508 -0.745 . . . . 0.0 111.025 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.625 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 67.59 27.36 73.58 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.702 HG21 ' HE1' ' A' ' 179' ' ' MET . 84.0 t -140.0 118.87 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.542 -0.976 . . . . 0.0 109.675 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 86.4 m -74.04 129.01 37.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.516 ' CD2' ' HB2' ' A' ' 175' ' ' MET . 90.2 m95 -117.33 120.06 37.03 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.813 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.661 ' O ' HD23 ' A' ' 82' ' ' LEU . 6.5 t -129.15 -178.16 4.53 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 120.141 -0.623 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.565 HG13 ' CA ' ' A' ' 140' ' ' GLY . 24.1 m -88.42 134.54 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 C-N-CA 118.942 -1.103 . . . . 0.0 113.359 -177.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.7 t80 -64.37 -40.0 94.98 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.366 178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.794 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 41.8 p-80 -71.65 75.07 0.82 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 122.09 0.948 . . . . 0.0 109.326 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.41 ' HA3' ' NE2' ' A' ' 41' ' ' GLN . . . 158.55 -42.61 0.49 Allowed Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.329 -1.908 . . . . 0.0 108.329 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.774 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -80.2 -69.97 0.55 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.671 -0.9 . . . . 0.0 110.915 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.42 -89.9 0.81 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.789 -1.725 . . . . 0.0 108.789 -178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 78.9 p -175.18 86.91 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.485 -1.009 . . . . 0.0 109.928 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.83 -159.17 0.7 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.516 -0.74 . . . . 0.0 111.162 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 64' ' ' LEU . 10.6 p -77.56 -32.94 54.13 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.732 -0.605 . . . . 0.0 110.932 -179.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.3 OUTLIER 78.84 -28.13 0.16 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.831 0.852 . . . . 0.0 112.377 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 69.84 92.45 0.08 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.709 -0.619 . . . . 0.0 109.6 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -86.76 -179.65 49.03 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.849 -1.701 . . . . 0.0 108.849 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -62.81 -14.81 42.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.963 1.507 . . . . 0.0 110.778 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 10.7 pttt -104.8 -22.45 13.19 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.228 -0.92 . . . . 0.0 111.199 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 151.79 -164.82 30.46 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -67.05 114.66 3.27 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.873 1.459 . . . . 0.0 110.606 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 63' ' ' THR . 91.4 mt -97.14 141.66 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 25.1 m -88.1 136.49 32.95 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.5 -0.75 . . . . 0.0 111.436 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 19.4 pt20 -73.3 146.47 45.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.812 -0.555 . . . . 0.0 110.182 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 94.6 mtp -100.11 -37.71 8.84 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.517 -0.739 . . . . 0.0 109.955 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.408 ' CG ' HG22 ' A' ' 178' ' ' THR . 0.1 OUTLIER -171.96 -177.56 1.95 Allowed 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.503 ' CB ' HG12 ' A' ' 83' ' ' VAL . 5.0 t -159.99 143.6 14.16 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.732 0.777 . . . . 0.0 110.13 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -106.92 80.67 1.46 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 97.6 t -59.93 -39.99 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.74 . . . . 0.0 110.056 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -56.58 -26.55 55.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.288 -0.883 . . . . 0.0 108.853 177.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -110.39 2.44 19.0 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.717 -0.614 . . . . 0.0 110.706 178.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 15.6 t0 60.56 56.38 3.09 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.095 -1.003 . . . . 0.0 111.336 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.661 HD23 ' O ' ' A' ' 54' ' ' THR . 2.3 mt -144.54 150.56 37.73 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.527 -0.733 . . . . 0.0 110.261 178.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.587 HG23 HG23 ' A' ' 54' ' ' THR . 1.0 OUTLIER -136.95 128.48 42.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 107.57 -1.271 . . . . 0.0 107.57 179.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.27 123.56 5.7 Favored Glycine 0 N--CA 1.503 3.107 0 C-N-CA 118.876 -1.63 . . . . 0.0 113.222 -177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.491 ' CD1' HD23 ' A' ' 64' ' ' LEU . 5.8 m-90 -92.69 -170.78 2.55 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 122.025 -0.691 . . . . 0.0 109.676 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -97.2 100.99 12.46 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.625 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -69.4 130.02 91.19 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.498 -0.751 . . . . 0.0 111.091 -178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -73.3 158.55 48.41 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 O-C-N 123.925 1.487 . . . . 0.0 109.504 179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -67.62 119.17 6.18 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.773 1.407 . . . . 0.0 110.405 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 136.39 -30.18 2.73 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.761 ' HB1' ' SG ' ' A' ' 47' ' ' CYS . . . -72.84 58.58 0.46 Allowed 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.534 -0.98 . . . . 0.0 111.481 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 25.73 96.99 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.599 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 178.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 64.7 m -81.5 107.3 14.15 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.275 -0.97 . . . . 0.0 108.822 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.901 HD13 HD21 ' A' ' 144' ' ' LEU . 68.2 mt -91.37 154.38 19.24 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.834 -0.541 . . . . 0.0 110.088 -178.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.51 164.51 17.03 Favored Pre-proline 0 N--CA 1.494 1.77 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.555 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.67 ' HB3' HG11 ' A' ' 172' ' ' VAL . 51.5 Cg_endo -98.49 153.42 0.75 Allowed 'Trans proline' 0 N--CA 1.49 1.272 0 O-C-N 123.87 1.458 . . . . 0.0 110.324 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 22.5 p -159.96 159.93 32.82 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.496 -0.753 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.6 p -99.97 118.9 37.36 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 75.0 m -119.99 141.39 49.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.561 -0.712 . . . . 0.0 110.888 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -64.05 -26.25 70.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 47.3 t -99.98 127.12 46.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.529 -0.983 . . . . 0.0 110.181 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 52.2 m -95.4 20.43 9.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.629 -0.669 . . . . 0.0 110.503 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -69.97 73.7 0.44 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.611 -0.681 . . . . 0.0 109.188 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.652 HD12 ' HB2' ' A' ' 118' ' ' ARG . 76.5 mt -90.17 174.48 7.59 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 144' ' ' LEU . 51.2 p90 -153.14 144.53 23.24 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.412 ' CD1' ' N ' ' A' ' 142' ' ' PRO . 28.1 tp -116.35 142.53 46.73 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.705 0.764 . . . . 0.0 111.297 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.4 t -91.66 125.08 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.716 ' CG2' HD12 ' A' ' 114' ' ' ILE . 72.0 p -85.82 170.66 12.2 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.56 -0.712 . . . . 0.0 110.731 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 33.1 tpt180 -28.89 -36.42 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.728 0 C-N-CA 123.702 0.801 . . . . 0.0 112.892 -179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.44 ' N ' ' O ' ' A' ' 108' ' ' THR . 73.6 m-70 -99.99 -86.32 0.39 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.947 -0.701 . . . . 0.0 109.132 178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.64 22.33 0.12 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.191 -0.943 . . . . 0.0 111.358 179.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -66.43 129.07 38.61 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.052 -1.03 . . . . 0.0 110.466 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 97.1 t -69.97 -53.38 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 121.686 -0.634 . . . . 0.0 110.514 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.741 ' CG2' HD11 ' A' ' 126' ' ' LEU . 83.1 mt 46.46 73.69 0.94 Allowed Pre-proline 0 N--CA 1.506 2.359 0 O-C-N 121.526 -0.734 . . . . 0.0 111.083 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -59.74 130.52 35.47 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 O-C-N 123.864 1.455 . . . . 0.0 111.187 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.781 HG22 HD12 ' A' ' 126' ' ' LEU . 60.9 t -127.95 131.98 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.688 -0.633 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 11.7 mmm180 -87.64 124.59 33.69 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.295 -0.878 . . . . 0.0 108.708 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.652 ' HB2' HD12 ' A' ' 104' ' ' LEU . 3.1 ttm180 -63.93 123.01 17.87 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.549 -178.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 16.8 mmt85 -97.88 1.45 48.14 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.691 -0.631 . . . . 0.0 109.624 177.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.4 170.23 38.08 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.549 -2.22 . . . . 0.0 107.549 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.402 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 85.1 m-20 -58.7 -23.74 60.09 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.158 -1.201 . . . . 0.0 110.365 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 169' ' ' PHE . 93.0 p -121.67 17.6 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.535 -0.728 . . . . 0.0 112.331 -179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.8 ttt180 -144.07 142.39 30.6 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.074 -1.05 . . . . 0.0 111.03 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.645 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -138.43 142.71 13.4 Favored Glycine 0 N--CA 1.484 1.859 0 N-CA-C 108.005 -2.038 . . . . 0.0 108.005 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.666 ' C ' HG13 ' A' ' 116' ' ' VAL . 25.0 p -88.77 114.84 25.82 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.839 -0.8 . . . . 0.0 109.477 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.781 HD12 HG22 ' A' ' 116' ' ' VAL . 20.5 tp -72.26 109.98 6.38 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.955 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.3 mt -67.92 -20.58 65.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.86 -0.525 . . . . 0.0 110.375 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 70.0 m -117.67 84.23 19.22 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.744 -0.597 . . . . 0.0 109.962 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -58.34 138.29 85.04 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 O-C-N 123.761 1.4 . . . . 0.0 110.381 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -152.99 164.69 19.53 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -58.55 127.43 24.59 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.77 1.405 . . . . 0.0 110.473 -179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.7 p -50.11 -25.29 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.814 -0.554 . . . . 0.0 110.702 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 69.7 m -59.91 -37.63 79.97 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.577 -0.702 . . . . 0.0 109.469 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -69.01 -25.86 64.72 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 84.7 mt -80.76 -1.73 44.04 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.46 -0.775 . . . . 0.0 110.406 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -70.17 122.1 18.82 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 121.152 -0.968 . . . . 0.0 108.563 178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 97.92 -11.41 64.23 Favored Glycine 0 C--N 1.286 -2.223 0 N-CA-C 109.001 -1.639 . . . . 0.0 109.001 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 46.1 t -79.03 -16.23 57.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.443 -1.034 . . . . 0.0 109.672 178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.552 ' HB3' HG11 ' A' ' 55' ' ' VAL . 14.9 m -62.26 147.42 48.09 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.24 -0.912 . . . . 0.0 110.225 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.565 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.09 -9.91 75.82 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.418 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -68.9 -169.56 5.97 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' A' ' 46' ' ' THR . 48.1 Cg_endo -140.34 142.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.321 -0.898 0 C-N-CA 116.974 -1.551 . . . . 0.0 112.396 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.475 ' N ' HD12 ' A' ' 143' ' ' LEU . 5.5 mp -96.59 96.35 8.59 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.901 HD21 HD13 ' A' ' 94' ' ' LEU . 7.2 mp -87.39 141.55 28.55 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -176.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.575 ' HA ' HD23 ' A' ' 104' ' ' LEU . 85.2 m -63.71 -173.0 0.07 OUTLIER Pre-proline 0 N--CA 1.5 2.056 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 176.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 145' ' ' CYS . 42.2 Cg_endo -87.79 17.27 1.74 Allowed 'Trans proline' 0 N--CA 1.498 1.737 0 C-N-CA 117.249 -1.368 . . . . 0.0 111.6 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 13.9 m -122.03 18.11 10.87 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.07 -1.018 . . . . 0.0 111.764 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.14 35.74 37.42 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -122.87 123.38 40.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.374 -1.074 . . . . 0.0 110.34 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -90.95 123.33 34.36 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.621 -0.674 . . . . 0.0 110.179 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.02 -2.45 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.638 -0.664 . . . . 0.0 111.694 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.495 ' HA3' ' CE2' ' A' ' 169' ' ' PHE . . . -145.45 126.66 2.63 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.836 -1.173 . . . . 0.0 110.419 -179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.432 ' HB ' HG23 ' A' ' 170' ' ' VAL . 18.1 mt -110.07 121.76 63.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.188 -1.184 . . . . 0.0 108.407 177.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.834 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 8.0 t80 -51.76 122.83 8.86 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.841 0.829 . . . . 0.0 112.442 -177.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.499 ' HB2' HG13 ' A' ' 170' ' ' VAL . 39.6 ttt-85 -115.9 -29.41 6.37 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.95 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.874 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -166.07 169.43 14.56 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 119.244 -0.982 . . . . 0.0 110.926 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.834 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -139.48 155.12 47.76 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.882 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 15.5 m -107.6 105.39 18.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-O 121.742 0.782 . . . . 0.0 109.501 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.5 p -95.36 121.84 37.45 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.001 0.905 . . . . 0.0 110.36 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.548 HG22 ' HG3' ' A' ' 161' ' ' ARG . 91.0 m -89.98 -79.89 0.33 Allowed 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.567 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.548 ' HG3' HG22 ' A' ' 160' ' ' THR . 99.6 mtt180 -96.96 52.66 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 79.96 15.94 77.99 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 32.2 m -144.67 140.01 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 O-C-N 121.386 -1.067 . . . . 0.0 108.35 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -81.56 116.93 21.56 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.657 0.741 . . . . 0.0 111.675 -178.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -98.57 8.12 45.29 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 120.5 -0.48 . . . . 0.0 110.722 178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.882 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -171.53 141.83 1.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.257 -0.902 . . . . 0.0 109.286 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.645 HG22 ' O ' ' A' ' 124' ' ' GLY . 20.1 m -109.62 143.42 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 121.713 0.768 . . . . 0.0 112.687 -177.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -111.19 142.07 43.88 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.495 ' CE2' ' HA3' ' A' ' 152' ' ' GLY . 34.2 p90 -152.83 165.04 36.65 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 118.383 -1.327 . . . . 0.0 112.276 -177.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG13 ' HB2' ' A' ' 155' ' ' ARG . 26.9 m -90.68 133.03 33.33 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.908 -0.495 . . . . 0.0 110.015 178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.63 157.2 56.35 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.719 1.378 . . . . 0.0 109.936 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.711 HG23 ' HE3' ' A' ' 175' ' ' MET . 7.1 p -64.36 -27.23 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.49 -0.756 . . . . 0.0 109.594 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.782 ' O ' HG23 ' A' ' 177' ' ' THR . 86.2 tt0 -58.59 -25.39 62.55 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.853 -1.154 . . . . 0.0 108.547 177.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 57.3 m -74.15 -40.1 62.83 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.596 -0.69 . . . . 0.0 111.934 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.711 ' HE3' HG23 ' A' ' 172' ' ' VAL . 16.7 ptp -69.85 -41.06 75.4 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.667 -1.271 . . . . 0.0 108.815 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.428 ' N ' ' CG ' ' A' ' 175' ' ' MET . 98.9 mt-10 -59.98 -39.97 87.53 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.793 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.782 HG23 ' O ' ' A' ' 173' ' ' GLU . 43.4 p -61.69 -23.32 66.02 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.179 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.418 ' HA ' ' HB2' ' A' ' 182' ' ' SER . 45.0 m -65.06 -39.92 93.98 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.702 ' HE1' HG21 ' A' ' 51' ' ' VAL . 67.6 mtt -62.44 -34.74 77.37 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 61.9 ttt-85 -60.0 -27.5 66.92 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.748 -0.595 . . . . 0.0 110.527 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -165.0 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.531 -0.731 . . . . 0.0 111.568 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.418 ' HB2' ' HA ' ' A' ' 178' ' ' THR . 31.2 t 41.28 49.99 3.4 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.246 -0.908 . . . . 0.0 112.293 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -86.44 131.62 34.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.414 -0.804 . . . . 0.0 110.222 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 5.8 pttt -77.13 -22.58 52.41 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.431 -0.793 . . . . 0.0 111.145 -179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -157.73 160.04 37.48 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.419 -0.801 . . . . 0.0 110.797 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 117.959 -1.02 . . . . 0.0 111.198 179.835 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.874 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.4 ' N ' ' ND2' ' A' ' 27' ' ' ASN . 2.8 p . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 88.52 -171.01 39.38 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.53 ' HB2' ' HB1' ' A' ' 65' ' ' ALA . 0.0 OUTLIER -69.96 170.63 10.88 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.957 -0.731 . . . . 0.0 109.943 179.73 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 24' ' ' ARG . 3.0 t70 85.24 -174.75 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.674 0 C-N-CA 123.791 0.837 . . . . 0.0 109.495 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.4 ttpt -59.13 139.09 57.25 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.899 -177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.4 ' ND2' ' N ' ' A' ' 22' ' ' THR . 10.3 t-20 -159.45 139.58 11.92 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -63.32 140.07 58.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.793 -0.567 . . . . 0.0 110.475 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.443 ' O ' ' HB1' ' A' ' 91' ' ' ALA . 34.5 m -80.81 -15.26 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.769 -0.582 . . . . 0.0 110.821 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -71.97 66.95 0.6 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.301 -0.874 . . . . 0.0 109.762 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -142.55 155.49 25.77 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 56.3 mp0 -98.36 -40.06 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.581 -0.952 . . . . 0.0 110.333 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 142' ' ' PRO . 61.1 t -124.51 130.0 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.552 -0.717 . . . . 0.0 109.695 -179.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -107.97 139.78 42.08 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.594 -0.691 . . . . 0.0 110.241 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.496 ' HA ' HD23 ' A' ' 44' ' ' LEU . 87.1 t -80.96 139.97 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.459 HG23 ' CD2' ' A' ' 43' ' ' PHE . 35.8 m -142.65 159.21 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 C-N-CA 119.4 -0.92 . . . . 0.0 110.68 -178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 42' ' ' SER . 82.8 p -150.85 142.55 23.69 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-O 121.535 0.683 . . . . 0.0 109.242 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.452 HG21 ' HA ' ' A' ' 59' ' ' ALA . 0.8 OUTLIER -106.04 179.02 4.39 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.64 -18.23 11.42 Favored 'General case' 0 C--N 1.291 -1.939 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.738 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.5 p -117.51 -12.92 10.32 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -163.83 174.54 11.42 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 120.898 1.681 . . . . 0.0 113.665 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 37' ' ' SER . 71.0 m -117.36 144.4 44.96 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.459 ' CD2' HG23 ' A' ' 36' ' ' VAL . 16.0 p90 -162.89 -148.88 0.14 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.274 -0.891 . . . . 0.0 110.224 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.496 HD23 ' HA ' ' A' ' 35' ' ' VAL . 91.2 mt -135.63 170.12 16.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.67 -1.269 . . . . 0.0 113.362 -177.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' CB ' ' HB ' ' A' ' 54' ' ' THR . . . -156.81 124.33 5.38 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.976 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.633 HG22 ' H ' ' A' ' 47' ' ' CYS . 6.0 m -89.37 -175.65 4.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.56 -0.712 . . . . 0.0 109.412 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.633 ' H ' HG22 ' A' ' 46' ' ' THR . 46.2 t -141.82 117.6 10.44 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.53 HG22 ' HB2' ' A' ' 94' ' ' LEU . 67.3 t -137.41 134.51 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.85 -178.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 51' ' ' VAL . 33.6 m120 52.8 40.06 29.92 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.645 -0.659 . . . . 0.0 110.501 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.662 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 66.48 26.88 72.84 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 49' ' ' ASN . 41.9 t -133.63 114.46 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.422 -1.046 . . . . 0.0 109.407 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 19.0 t -75.22 129.97 38.36 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.019 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.512 ' CZ2' HG11 ' A' ' 51' ' ' VAL . 93.1 m95 -117.2 128.92 55.57 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.703 -0.799 . . . . 0.0 110.292 -179.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.561 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 14.9 t -136.47 -177.64 4.81 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.624 HG13 ' CA ' ' A' ' 140' ' ' GLY . 35.0 m -89.64 125.07 42.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 C-N-CA 118.453 -1.299 . . . . 0.0 112.277 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.97 -40.02 87.65 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.785 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 36.8 p-80 -75.07 66.16 1.58 Allowed 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.898 0.856 . . . . 0.0 108.793 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 38' ' ' THR . . . 163.9 -49.77 0.3 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 -179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.452 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -77.06 -28.74 54.82 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.729 -0.865 . . . . 0.0 110.043 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 75.03 -112.16 3.57 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 m -162.93 40.2 0.11 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.602 -0.94 . . . . 0.0 110.292 179.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 tttt -169.74 161.12 9.1 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.233 -0.917 . . . . 0.0 111.317 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.503 HG23 ' HB3' ' A' ' 70' ' ' PRO . 77.6 m 42.08 -100.09 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' ALA . 0.2 OUTLIER 80.9 -29.32 0.12 Allowed 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.697 0.799 . . . . 0.0 111.968 -178.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 64' ' ' LEU . . . 73.01 99.51 0.07 Allowed 'General case' 0 N--CA 1.509 2.498 0 CA-C-O 121.566 0.698 . . . . 0.0 110.301 -179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.619 ' HA3' HD12 ' A' ' 71' ' ' ILE . . . -105.53 -169.59 23.69 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.76 -17.6 60.03 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 O-C-N 124.021 1.537 . . . . 0.0 110.623 179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -104.55 5.16 33.68 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.197 -0.939 . . . . 0.0 111.375 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 111.7 -155.99 15.84 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.228 -1.949 . . . . 0.0 108.228 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' THR . 46.5 Cg_endo -70.61 111.07 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.782 1.411 . . . . 0.0 110.143 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.619 HD12 ' HA3' ' A' ' 66' ' ' GLY . 94.5 mt -105.73 148.99 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.661 -0.65 . . . . 0.0 110.108 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 m -93.84 140.05 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.397 -0.814 . . . . 0.0 110.887 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.439 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 0.0 OUTLIER -65.78 146.45 54.75 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.621 -0.674 . . . . 0.0 110.934 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 59.8 ttp -97.97 -35.15 10.55 Favored 'General case' 0 C--N 1.31 -1.141 0 O-C-N 121.686 -0.634 . . . . 0.0 110.244 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.859 ' CG ' HG23 ' A' ' 178' ' ' THR . 0.2 OUTLIER -150.26 170.36 19.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 110.016 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.823 HG23 ' CG1' ' A' ' 83' ' ' VAL . 26.7 m -153.55 115.07 4.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.728 -0.607 . . . . 0.0 110.506 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 82' ' ' LEU . 0.2 OUTLIER -90.0 80.24 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 62.6 t -60.0 -33.74 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.745 -0.597 . . . . 0.0 109.52 -179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -51.94 -26.1 9.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.737 -0.602 . . . . 0.0 109.411 178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -127.28 3.6 6.35 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.171 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.9 t70 66.23 64.55 0.52 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.982 -1.073 . . . . 0.0 109.784 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.692 HD22 HG11 ' A' ' 170' ' ' VAL . 39.8 tp -144.21 152.99 41.61 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.659 -0.651 . . . . 0.0 109.747 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.823 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -142.9 126.91 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.428 ' HA3' ' CZ3' ' A' ' 53' ' ' TRP . . . -119.41 123.43 5.64 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.326 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.581 ' HD1' HG22 ' A' ' 71' ' ' ILE . 3.7 m-90 -84.83 -174.27 5.18 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -105.77 84.32 2.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.267 -0.896 . . . . 0.0 109.044 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.662 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.02 149.91 96.27 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.829 -0.544 . . . . 0.0 110.932 -179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -78.61 161.3 28.01 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 O-C-N 124.026 1.54 . . . . 0.0 109.816 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -89.03 19.96 1.2 Allowed 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.722 1.38 . . . . 0.0 111.119 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -98.34 -15.08 36.4 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 29' ' ' VAL . . . -76.69 -160.25 0.15 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 121.329 -1.101 . . . . 0.0 108.962 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -77.86 -40.0 41.58 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.585 0.707 . . . . 0.0 110.752 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 10.5 m 52.82 101.67 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.343 0.592 . . . . 0.0 111.137 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 150' ' ' ALA . 65.0 mt -70.04 159.64 33.45 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.55 -0.719 . . . . 0.0 110.244 -179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.22 168.88 8.12 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.469 -0.769 . . . . 0.0 110.992 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -59.82 171.84 2.59 Favored 'Trans proline' 0 N--CA 1.495 1.591 0 O-C-N 123.976 1.514 . . . . 0.0 111.582 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 14.8 t -52.81 -74.62 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.84 -0.538 . . . . 0.0 111.634 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.9 m 49.97 55.01 10.09 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 120.981 -1.074 . . . . 0.0 112.089 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 30.9 p -146.75 173.95 11.91 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.02 -1.05 . . . . 0.0 111.093 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -123.57 19.28 7.56 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 73.5 m -137.5 152.63 49.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.142 -1.21 . . . . 0.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.5 m -108.75 20.0 19.01 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.487 -0.758 . . . . 0.0 111.138 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -79.41 87.45 5.05 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 145' ' ' CYS . 58.8 mt -99.0 177.31 5.28 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.616 0.722 . . . . 0.0 111.34 -178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -145.59 112.61 6.06 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' CD1' ' A' ' 143' ' ' LEU . 29.7 tp -87.13 140.2 29.79 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.608 0.718 . . . . 0.0 110.945 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.74 HG22 ' OD1' ' A' ' 112' ' ' ASP . 75.5 t -90.0 119.29 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 43.9 p -83.28 174.13 11.0 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.849 -0.74 . . . . 0.0 109.154 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -44.18 -27.55 0.41 Allowed 'General case' 0 N--CA 1.507 2.377 0 O-C-N 121.851 -0.531 . . . . 0.0 111.321 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -99.58 -69.77 0.75 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.567 -0.708 . . . . 0.0 109.384 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -150.4 -165.03 2.16 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 121.408 -0.807 . . . . 0.0 109.422 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.816 ' O ' HG22 ' A' ' 114' ' ' ILE . 82.2 m-20 -58.91 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.76 -0.588 . . . . 0.0 110.351 179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.528 HG12 ' O ' ' A' ' 112' ' ' ASP . 7.7 p 39.98 30.15 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.316 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.034 HD11 HD11 ' A' ' 126' ' ' LEU . 1.7 tp -166.89 122.56 0.9 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.409 -0.807 . . . . 0.0 110.829 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.879 ' HG2' HD11 ' A' ' 127' ' ' LEU . 47.6 Cg_endo -109.29 133.75 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.616 1.324 . . . . 0.0 110.133 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 126' ' ' LEU . 39.4 t -131.0 139.39 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.55 -0.719 . . . . 0.0 110.423 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -97.66 120.04 37.32 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.493 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 51.1 ttp180 -61.96 129.84 42.8 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.211 -0.931 . . . . 0.0 110.904 -178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -104.37 4.43 33.46 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.252 -0.579 . . . . 0.0 109.624 176.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 172.8 -178.96 44.58 Favored Glycine 0 N--CA 1.487 2.083 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.427 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 87.5 m-20 -67.89 -23.1 65.08 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.502 -0.999 . . . . 0.0 110.035 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 p -125.39 17.46 8.27 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.505 -0.747 . . . . 0.0 111.498 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 -140.36 139.05 35.29 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.007 -1.058 . . . . 0.0 111.23 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 118' ' ' ARG . . . -136.79 141.78 12.82 Favored Glycine 0 N--CA 1.484 1.899 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.481 ' C ' HG13 ' A' ' 116' ' ' VAL . 30.7 t -90.98 107.5 19.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.78 -0.835 . . . . 0.0 110.54 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.034 HD11 HD11 ' A' ' 114' ' ' ILE . 46.7 tp -76.63 91.17 3.4 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 178.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.879 HD11 ' HG2' ' A' ' 115' ' ' PRO . 0.4 OUTLIER -60.06 -27.35 66.89 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.618 -0.676 . . . . 0.0 110.544 -179.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 41.4 t -100.44 99.14 9.13 Favored Pre-proline 0 C--N 1.297 -1.701 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.27 143.31 35.12 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 O-C-N 123.883 1.465 . . . . 0.0 110.942 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -152.25 159.98 32.03 Favored Pre-proline 0 C--N 1.304 -1.404 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -57.64 126.32 21.49 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 123.752 1.396 . . . . 0.0 110.713 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.6 -25.7 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.708 -0.62 . . . . 0.0 110.537 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.3 m -60.09 -36.1 76.66 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.766 0.793 . . . . 0.0 109.111 178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -70.0 -26.55 64.12 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 92.7 mt -85.91 0.96 51.8 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.434 -0.791 . . . . 0.0 110.946 179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -68.82 111.93 5.2 Favored 'General case' 0 N--CA 1.485 1.275 0 O-C-N 121.19 -0.944 . . . . 0.0 108.923 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.75 -8.93 58.31 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -177.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 30.4 t -73.87 -15.89 61.14 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 121.476 -1.014 . . . . 0.0 109.158 178.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.598 ' HB2' HG11 ' A' ' 55' ' ' VAL . 0.6 OUTLIER -70.39 160.0 33.12 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.146 -0.971 . . . . 0.0 109.817 179.186 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.624 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 90.41 -16.21 58.2 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.032 -1.627 . . . . 0.0 109.032 -178.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -76.69 -157.24 7.66 Favored Glycine 0 N--CA 1.481 1.642 0 N-CA-C 107.507 -2.237 . . . . 0.0 107.507 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.537 ' CG ' HG22 ' A' ' 33' ' ' VAL . 44.0 Cg_endo -148.25 149.63 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.932 0 C-N-CA 116.499 -1.868 . . . . 0.0 112.048 179.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.585 ' O ' HG22 ' A' ' 151' ' ' VAL . 5.0 mp -94.48 99.13 11.36 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.439 ' CD2' ' N ' ' A' ' 144' ' ' LEU . 4.5 mm? -83.43 133.06 34.93 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.831 0.824 . . . . 0.0 112.839 -176.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . 0.581 ' HA ' HD23 ' A' ' 104' ' ' LEU . 1.2 m -67.89 -170.8 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 107.842 -1.169 . . . . 0.0 107.842 177.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -85.6 10.29 3.76 Favored 'Trans proline' 0 N--CA 1.494 1.521 0 O-C-N 123.614 1.323 . . . . 0.0 111.095 178.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 75.2 m -119.26 9.33 11.66 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.122 -0.986 . . . . 0.0 111.597 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 80.11 35.88 26.06 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -115.86 125.6 52.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.54 -0.976 . . . . 0.0 110.357 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.819 ' HB2' HD13 ' A' ' 94' ' ' LEU . . . -78.06 112.33 14.89 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 143' ' ' LEU . 35.6 m -112.91 -10.51 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 C-N-CA 119.965 -0.694 . . . . 0.0 111.896 -178.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.521 ' O ' HD12 ' A' ' 143' ' ' LEU . . . -159.99 129.87 2.29 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 118.946 -1.597 . . . . 0.0 111.781 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.609 HD12 ' CE ' ' A' ' 175' ' ' MET . 23.5 mt -105.48 118.0 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.438 ' HB3' ' HA ' ' A' ' 139' ' ' SER . 19.5 t80 -49.38 128.79 17.75 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.723 0.773 . . . . 0.0 111.953 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.518 ' HB2' HG23 ' A' ' 170' ' ' VAL . 47.3 ttt-85 -115.34 -30.21 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.836 -0.54 . . . . 0.0 111.662 -178.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.787 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -163.22 145.2 9.91 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.321 -0.952 . . . . 0.0 111.364 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.405 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -96.28 141.07 30.06 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.145 0.498 . . . . 0.0 111.361 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.534 ' O ' ' HA ' ' A' ' 164' ' ' ALA . 38.6 t -97.74 92.66 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 163' ' ' VAL . 28.4 p -90.49 117.56 29.28 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.178 0.989 . . . . 0.0 111.106 -178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 41.6 m -85.31 -69.95 0.62 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.903 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -111.63 49.34 0.9 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.378 -0.826 . . . . 0.0 109.451 179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.401 ' C ' HG13 ' A' ' 163' ' ' VAL . . . 85.85 14.4 67.5 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.7 m -145.88 141.25 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 179.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' A' ' 158' ' ' VAL . . . -77.57 128.13 33.63 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.849 0.833 . . . . 0.0 111.527 -178.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -119.17 13.34 12.86 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.247 0.546 . . . . 0.0 109.929 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 158' ' ' VAL . . . -173.24 148.99 1.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.52 HG21 HG11 ' A' ' 116' ' ' VAL . 15.7 m -130.01 139.16 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-O 122.084 0.945 . . . . 0.0 112.595 -178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -104.72 150.72 24.51 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 177.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.5 ' CD1' ' HA3' ' A' ' 152' ' ' GLY . 42.4 p90 -155.84 165.01 37.78 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.201 -1.4 . . . . 0.0 112.716 -178.081 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.692 HG11 HD22 ' A' ' 82' ' ' LEU . 59.5 t -83.62 132.46 49.17 Favored Pre-proline 0 N--CA 1.494 1.753 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.588 179.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -82.96 152.21 14.4 Favored 'Trans proline' 0 N--CA 1.493 1.498 0 O-C-N 123.716 1.377 . . . . 0.0 111.485 -179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . 0.506 HG23 ' SD ' ' A' ' 175' ' ' MET . 12.7 p -70.04 -28.75 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -57.44 -30.52 65.07 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 1.2 m -73.38 -21.41 60.52 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 120.229 -0.588 . . . . 0.0 110.099 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.609 ' CE ' HD12 ' A' ' 153' ' ' ILE . 67.5 mtt -69.89 -37.69 76.09 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 178.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.0 -38.26 82.09 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.742 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 62.9 p -59.92 -32.48 70.81 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.859 HG23 ' CG ' ' A' ' 75' ' ' TYR . 78.9 m -60.62 -44.99 95.69 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 95.1 mtp -61.33 -40.24 93.51 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.948 -0.701 . . . . 0.0 109.44 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 181' ' ' ALA . 84.7 mtt85 -70.08 -39.97 75.29 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.896 0.855 . . . . 0.0 109.487 178.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 180' ' ' ARG . . . 60.1 7.13 1.12 Allowed 'General case' 0 N--CA 1.508 2.459 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 36.37 31.06 0.02 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 O-C-N 121.422 -0.799 . . . . 0.0 113.086 179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -85.28 -47.12 10.36 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.275 -0.89 . . . . 0.0 110.498 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 50.0 41.45 23.2 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.442 -0.787 . . . . 0.0 111.486 179.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 57.6 tptt -79.63 130.01 34.99 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.47 -0.769 . . . . 0.0 109.848 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 34.7 mttm . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.06 -0.972 . . . . 0.0 110.215 -179.793 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.787 HD13 ' HB2' ' A' ' 156' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.427 HG23 ' CB ' ' A' ' 37' ' ' SER . 3.0 p . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.123 0.487 . . . . 0.0 110.245 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -73.67 149.37 41.57 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.412 ' HD3' ' N ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER -129.89 151.04 50.89 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.778 -0.836 . . . . 0.0 109.838 179.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.412 ' N ' ' HD3' ' A' ' 24' ' ' ARG . 51.6 t0 59.2 72.56 0.52 Allowed 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.449 0.643 . . . . 0.0 110.33 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -99.99 17.63 20.5 Favored 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.883 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 68.44 -61.22 0.41 Allowed 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.851 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.5 tp60 -60.76 151.34 29.81 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.339 -0.851 . . . . 0.0 109.949 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 62.7 t -76.18 -40.07 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.623 -0.673 . . . . 0.0 110.124 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 10.9 tp10 -169.07 -33.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.574 -0.704 . . . . 0.0 111.284 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.97 -157.25 51.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.537 ' CG ' HD21 ' A' ' 94' ' ' LEU . 94.9 mt-10 -90.03 -54.63 3.95 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.611 -0.935 . . . . 0.0 110.157 179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.517 HG22 ' HG3' ' A' ' 142' ' ' PRO . 60.8 t -130.02 133.15 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.0 109.442 -179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -139.96 151.96 45.96 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.389 -0.82 . . . . 0.0 110.86 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 44' ' ' LEU . 63.5 t -82.77 137.82 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.476 ' CG2' HD11 ' A' ' 64' ' ' LEU . 9.1 m -143.95 170.16 9.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.427 ' CB ' HG23 ' A' ' 22' ' ' THR . 47.6 t -150.63 149.26 29.63 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-O 121.928 0.87 . . . . 0.0 109.603 -179.011 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.773 HG21 ' O ' ' A' ' 58' ' ' GLY . 3.7 t -119.69 -180.0 4.06 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.62 -16.25 2.32 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.612 -0.68 . . . . 0.0 112.274 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 38' ' ' THR . 76.3 p -98.27 -37.21 9.75 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.902 -1.124 . . . . 0.0 112.887 -178.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.3 pt20 -171.48 -174.21 1.37 Allowed 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.805 -1.184 . . . . 0.0 112.313 -178.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 79.3 p -116.76 143.74 45.29 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.663 ' HE1' HG22 ' A' ' 38' ' ' THR . 6.9 p90 -162.52 -139.09 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.49 -0.756 . . . . 0.0 109.896 -178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 35' ' ' VAL . 76.1 mt -134.57 164.61 27.09 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 120.578 -1.326 . . . . 0.0 113.363 -177.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -153.45 125.29 7.79 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.315 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.776 ' CG2' HD11 ' A' ' 153' ' ' ILE . 5.9 t -83.55 -152.0 0.12 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.527 -0.733 . . . . 0.0 110.745 -179.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.521 ' N ' HG23 ' A' ' 46' ' ' THR . 13.6 t -159.35 113.52 2.35 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.567 HG12 ' ND2' ' A' ' 49' ' ' ASN . 57.1 t -138.71 135.52 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 C-N-CA 119.299 -0.961 . . . . 0.0 111.371 -177.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' ND2' HG12 ' A' ' 48' ' ' VAL . 81.1 m-20 49.99 39.98 20.13 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.667 -0.645 . . . . 0.0 110.935 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.729 ' C ' ' HB3' ' A' ' 87' ' ' ALA . . . 68.28 24.93 74.84 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.459 HG11 ' CZ2' ' A' ' 53' ' ' TRP . 61.0 t -133.7 113.66 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.541 -0.976 . . . . 0.0 109.831 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.8 130.08 38.82 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.529 ' HH2' HG21 ' A' ' 178' ' ' THR . 93.1 m95 -118.46 133.93 55.48 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.453 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.814 HG22 ' CZ3' ' A' ' 85' ' ' TRP . 7.4 t -139.01 -178.47 5.35 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.677 HG13 ' CA ' ' A' ' 140' ' ' GLY . 21.2 m -82.77 134.26 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 C-N-CA 118.332 -1.347 . . . . 0.0 112.671 -178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.746 ' CZ ' HG22 ' A' ' 78' ' ' VAL . 49.7 t80 -64.22 -39.96 95.07 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 177.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.824 ' CB ' HD22 ' A' ' 188' ' ' 2ZF . 11.5 p-80 -63.11 -16.27 59.43 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.041 -1.064 . . . . 0.0 109.531 179.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.773 ' O ' HG21 ' A' ' 38' ' ' THR . . . -90.7 -82.7 1.4 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 177.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.65 ' HA ' HG21 ' A' ' 38' ' ' THR . . . -92.15 40.73 1.05 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.397 -1.061 . . . . 0.0 111.19 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.63 63.21 0.45 Allowed Glycine 0 N--CA 1.499 2.856 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.5 t -173.98 -85.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.297 -1.119 . . . . 0.0 109.84 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -175.19 -174.36 0.74 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.148 -0.97 . . . . 0.0 108.847 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.611 HG23 ' CB ' ' A' ' 70' ' ' PRO . 64.2 m 48.8 75.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 122.0 0.905 . . . . 0.0 111.337 178.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.537 ' N ' ' O ' ' A' ' 70' ' ' PRO . 20.2 tp -89.53 -98.82 0.1 Allowed 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.898 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' PRO . . . -171.17 116.46 0.44 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.876 -1.14 . . . . 0.0 110.565 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.601 ' CA ' HD12 ' A' ' 71' ' ' ILE . . . -137.45 176.35 20.63 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -64.01 -15.79 51.23 Favored 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 124.077 1.567 . . . . 0.0 110.506 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 13.4 pttm -101.07 -20.4 15.37 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.105 -0.997 . . . . 0.0 111.416 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 167.31 -122.2 1.03 Allowed Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.611 ' CB ' HG23 ' A' ' 63' ' ' THR . 50.3 Cg_endo -98.06 9.15 1.08 Allowed 'Trans proline' 0 N--CA 1.495 1.6 0 O-C-N 123.635 1.334 . . . . 0.0 111.584 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.601 HD12 ' CA ' ' A' ' 66' ' ' GLY . 0.2 OUTLIER 52.98 -179.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 120.882 -1.136 . . . . 0.0 110.198 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 71' ' ' ILE . 70.0 m -139.32 132.86 30.34 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.28 -0.888 . . . . 0.0 110.736 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.443 ' HA ' ' CD1' ' A' ' 85' ' ' TRP . 8.1 pt20 -76.22 153.22 36.25 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.444 -0.785 . . . . 0.0 110.909 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.5 ttp -107.88 -30.05 8.71 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 121.713 -0.617 . . . . 0.0 110.611 -179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TYR . . . . . 0.681 ' CD2' HG23 ' A' ' 178' ' ' THR . 0.1 OUTLIER -148.84 167.71 24.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.276 -0.89 . . . . 0.0 109.644 -178.536 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.891 HG23 ' CG1' ' A' ' 83' ' ' VAL . 29.7 m -154.03 114.15 3.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.636 -0.665 . . . . 0.0 110.428 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.83 76.98 4.22 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.746 HG22 ' CZ ' ' A' ' 56' ' ' TYR . 98.3 t -59.95 -40.0 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.405 -0.809 . . . . 0.0 109.724 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -56.55 -25.85 53.28 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.3 mm100 -110.68 -1.23 16.83 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.792 -0.567 . . . . 0.0 110.703 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.92 57.72 3.0 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.1 -1.0 . . . . 0.0 109.332 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 170' ' ' VAL . 42.9 tp -147.77 153.55 39.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.08 -0.648 . . . . 0.0 109.691 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.891 ' CG1' HG23 ' A' ' 76' ' ' THR . 0.5 OUTLIER -143.09 131.78 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -122.73 124.79 5.79 Favored Glycine 0 N--CA 1.498 2.804 0 C-N-CA 119.163 -1.494 . . . . 0.0 111.768 -178.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.814 ' CZ3' HG22 ' A' ' 54' ' ' THR . 3.3 m-90 -84.69 170.01 13.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 122.049 -0.677 . . . . 0.0 109.771 178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -99.28 89.29 4.17 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.553 -0.717 . . . . 0.0 109.352 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.729 ' HB3' ' C ' ' A' ' 50' ' ' GLY . . . -70.08 144.19 92.41 Favored Pre-proline 0 N--CA 1.496 1.851 0 O-C-N 121.552 -0.717 . . . . 0.0 110.532 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -90.42 179.89 1.79 Allowed 'Trans proline' 0 N--CA 1.491 1.35 0 O-C-N 123.809 1.426 . . . . 0.0 109.864 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -87.98 13.39 2.61 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 O-C-N 123.789 1.415 . . . . 0.0 111.539 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -87.95 -25.44 31.91 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.472 ' HB1' ' HB3' ' A' ' 30' ' ' GLU . . . -88.42 -143.12 0.13 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.713 -0.875 . . . . 0.0 109.84 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -154.07 108.63 3.06 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.18 -0.95 . . . . 0.0 109.885 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.2 m -87.71 157.07 19.16 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.7 -0.625 . . . . 0.0 110.582 -179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.537 HD21 ' CG ' ' A' ' 32' ' ' GLU . 97.1 mt -90.14 170.03 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.592 -0.692 . . . . 0.0 110.161 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.445 ' HB ' ' CD2' ' A' ' 149' ' ' HIS . 92.6 m -111.94 164.18 15.8 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.472 -0.768 . . . . 0.0 110.008 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 95' ' ' THR . 52.6 Cg_endo -119.45 142.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.488 1.168 0 O-C-N 123.523 1.275 . . . . 0.0 110.639 179.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.407 ' SG ' ' CG ' ' A' ' 149' ' ' HIS . 18.0 p -160.52 160.0 31.41 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.453 -0.78 . . . . 0.0 110.77 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 99' ' ' CYS . 12.8 t -74.85 -38.65 61.93 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.633 -0.667 . . . . 0.0 111.842 -179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . 0.421 ' N ' HG23 ' A' ' 98' ' ' THR . 92.9 m 59.37 -79.65 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 O-C-N 121.711 -0.618 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 98' ' ' THR . . . 137.72 -28.16 2.77 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 40.1 t -101.75 130.04 48.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.459 -1.024 . . . . 0.0 109.812 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.6 m -89.95 11.76 19.51 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.586 -0.696 . . . . 0.0 111.386 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -70.01 80.08 0.49 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.22 -0.925 . . . . 0.0 108.694 179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 143' ' ' LEU . 96.0 mt -86.62 176.73 7.63 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.485 0.66 . . . . 0.0 110.95 -178.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -146.24 100.89 3.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.448 HD13 ' HG ' ' A' ' 143' ' ' LEU . 35.0 tp -76.24 139.95 41.39 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.513 0.673 . . . . 0.0 110.013 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.452 HG11 HG11 ' A' ' 33' ' ' VAL . 78.3 t -85.32 111.11 20.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 109.616 -0.512 . . . . 0.0 109.616 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.418 ' N ' ' O ' ' A' ' 111' ' ' ALA . 55.5 p -81.38 172.39 13.61 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -42.6 -27.95 0.2 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.712 -0.618 . . . . 0.0 112.149 -178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -100.01 -68.91 0.79 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.407 -0.808 . . . . 0.0 109.839 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.418 ' O ' ' N ' ' A' ' 108' ' ' THR . . . -146.53 -161.71 1.38 Allowed 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 107' ' ' VAL . 26.8 p-10 -60.0 -44.69 94.39 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.535 -0.728 . . . . 0.0 110.244 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 96.7 t 46.28 -89.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 N-CA-C 112.561 0.578 . . . . 0.0 112.561 178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.625 HD12 ' CD1' ' A' ' 126' ' ' LEU . 50.1 pt -74.84 142.82 77.2 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.025 -1.047 . . . . 0.0 112.712 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 114' ' ' ILE . 44.1 Cg_endo -105.81 141.74 0.09 OUTLIER 'Trans proline' 0 N--CA 1.482 0.851 0 O-C-N 123.777 1.409 . . . . 0.0 108.718 177.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 167' ' ' VAL . 41.8 t -133.93 133.13 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.028 -1.045 . . . . 0.0 111.447 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -92.61 119.25 31.86 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 177.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.438 ' HA ' ' HA2' ' A' ' 124' ' ' GLY . 13.4 ttm180 -61.06 126.02 25.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.226 -0.922 . . . . 0.0 110.798 -177.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -99.1 1.4 45.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.803 -0.56 . . . . 0.0 109.698 177.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.29 -179.13 43.28 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 107.878 -2.089 . . . . 0.0 107.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.415 ' O ' ' CZ ' ' A' ' 169' ' ' PHE . 86.4 m-20 -67.19 -21.87 65.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.289 -1.124 . . . . 0.0 110.103 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.7 p -123.38 16.33 9.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.513 -0.742 . . . . 0.0 111.46 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -140.39 143.56 35.74 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.072 -1.018 . . . . 0.0 111.244 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 167' ' ' VAL . . . -143.34 139.21 8.71 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 108.152 -1.979 . . . . 0.0 108.152 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.48 ' C ' HG13 ' A' ' 116' ' ' VAL . 17.6 t -88.84 110.51 21.11 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.909 -0.76 . . . . 0.0 110.125 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.625 ' CD1' HD12 ' A' ' 114' ' ' ILE . 59.6 tp -71.03 114.58 9.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.782 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 127' ' ' LEU . 3.5 mm? -68.87 -25.0 64.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.234 0.54 . . . . 0.0 110.335 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 66.8 m -120.82 84.54 38.19 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.791 -0.568 . . . . 0.0 110.763 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.495 ' HA ' HD23 ' A' ' 126' ' ' LEU . 47.2 Cg_endo -61.69 143.26 96.31 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 O-C-N 123.919 1.483 . . . . 0.0 110.039 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -152.96 167.78 12.72 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -57.54 125.29 18.32 Favored 'Trans proline' 0 N--CA 1.492 1.404 0 O-C-N 123.773 1.407 . . . . 0.0 110.459 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 10.9 p -50.9 -25.67 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.749 -0.594 . . . . 0.0 110.931 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.411 ' HA ' ' CD ' ' A' ' 136' ' ' LYS . 21.1 t -57.93 -34.95 70.42 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.556 -0.715 . . . . 0.0 109.717 179.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -69.98 -29.24 66.29 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.781 -0.574 . . . . 0.0 109.496 179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 78.1 mt -82.87 1.52 38.92 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.549 -0.719 . . . . 0.0 110.913 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.411 ' CD ' ' HA ' ' A' ' 133' ' ' SER . 59.0 mtpt -72.33 68.92 0.78 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 122.129 0.966 . . . . 0.0 109.173 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 157.05 -21.28 0.43 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.389 -1.885 . . . . 0.0 108.389 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.536 ' HA ' HD12 ' A' ' 44' ' ' LEU . 16.8 t -75.0 -11.45 60.11 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.506 -0.997 . . . . 0.0 110.367 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . 0.4 ' CB ' HG11 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -68.71 150.9 47.37 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.314 -0.866 . . . . 0.0 109.216 179.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.677 ' CA ' HG13 ' A' ' 55' ' ' VAL . . . 87.31 -11.49 65.41 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 153' ' ' ILE . . . -70.54 -167.41 6.86 Favored Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.517 ' HG3' HG22 ' A' ' 33' ' ' VAL . 49.0 Cg_endo -139.98 140.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.928 0 C-N-CA 116.866 -1.623 . . . . 0.0 111.622 179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.482 ' HB3' HD13 ' A' ' 104' ' ' LEU . 2.5 mt -92.67 99.2 11.94 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.408 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.615 ' N ' HD12 ' A' ' 144' ' ' LEU . 7.4 mp -86.47 142.39 28.41 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 121.797 0.808 . . . . 0.0 112.759 -176.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.04 -170.15 0.03 OUTLIER Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -88.36 12.55 2.78 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 O-C-N 123.62 1.326 . . . . 0.0 111.031 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 54.5 m -119.86 -18.95 8.11 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.21 -0.931 . . . . 0.0 111.36 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 117.39 39.12 0.81 Allowed Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.241 -1.543 . . . . 0.0 109.241 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CD2' ' HB ' ' A' ' 95' ' ' THR . 55.9 m80 -122.96 118.65 28.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.427 -1.043 . . . . 0.0 110.538 -179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.504 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -81.08 120.29 24.64 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.555 -0.716 . . . . 0.0 109.354 179.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 35.6 m -128.18 -3.89 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.591 -0.693 . . . . 0.0 112.068 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.462 ' CA ' ' CD2' ' A' ' 169' ' ' PHE . . . -148.6 124.41 1.85 Allowed Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.859 -1.162 . . . . 0.0 110.362 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.776 HD11 ' CG2' ' A' ' 46' ' ' THR . 14.9 mt -106.12 121.75 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.099 0 O-C-N 121.014 -1.286 . . . . 0.0 109.009 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.839 ' HZ ' ' HB2' ' A' ' 157' ' ' ALA . 10.5 t80 -51.36 124.53 12.09 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.76 0.791 . . . . 0.0 111.978 -178.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.632 ' HB2' HG23 ' A' ' 170' ' ' VAL . 27.0 ttt180 -114.63 -34.13 5.3 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.843 -0.535 . . . . 0.0 110.818 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.728 ' HB2' HD13 ' A' ' 188' ' ' 2ZF . . . -162.54 164.41 26.89 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.488 -0.757 . . . . 0.0 110.326 -179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.839 ' HB2' ' HZ ' ' A' ' 154' ' ' PHE . . . -126.78 158.06 37.55 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.553 0.692 . . . . 0.0 111.61 -178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 166' ' ' ALA . 2.7 t -99.96 98.79 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 164' ' ' ALA . 28.9 p -96.23 118.27 32.45 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 122.432 1.11 . . . . 0.0 112.32 -177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.409 ' O ' ' N ' ' A' ' 162' ' ' GLY . 90.9 m -93.45 119.52 32.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' THR . 32.0 ttm105 65.51 -64.4 0.19 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.958 -0.464 . . . . 0.0 110.135 -178.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.449 ' C ' HG13 ' A' ' 163' ' ' VAL . . . -165.1 25.54 0.18 Allowed Glycine 0 N--CA 1.496 2.675 0 C-N-CA 120.135 -1.031 . . . . 0.0 110.819 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' A' ' 159' ' ' CYS . 33.2 m -148.9 139.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.184 -1.186 . . . . 0.0 109.494 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 159' ' ' CYS . . . -82.26 123.01 28.65 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.596 0.712 . . . . 0.0 111.679 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -113.83 17.65 17.89 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.25 0.548 . . . . 0.0 109.851 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.591 ' HB3' ' CG2' ' A' ' 158' ' ' VAL . . . -172.43 149.34 2.16 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 116' ' ' VAL . 13.8 m -127.4 139.68 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 C-N-CA 119.523 -0.871 . . . . 0.0 112.64 -178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -107.39 149.5 27.8 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' CD2' ' CA ' ' A' ' 152' ' ' GLY . 42.3 p90 -152.13 166.36 31.91 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.234 -1.386 . . . . 0.0 112.174 -178.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 82' ' ' LEU . 66.8 t -80.98 137.41 49.94 Favored Pre-proline 0 N--CA 1.497 1.889 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.5 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -78.35 141.35 18.0 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 O-C-N 123.839 1.442 . . . . 0.0 110.739 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 9.3 p -70.02 -29.98 42.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.727 -0.608 . . . . 0.0 109.72 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -59.06 -32.84 70.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.393 -0.817 . . . . 0.0 108.981 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 46.8 t -72.1 -33.63 68.01 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' MET . . . . . 0.595 ' CG ' HD21 ' A' ' 82' ' ' LEU . 10.4 mtp -70.03 -36.26 74.93 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 179' ' ' MET . 98.9 mt-10 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.781 -0.574 . . . . 0.0 110.036 179.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 58.5 p -66.98 -19.91 65.8 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.417 -0.802 . . . . 0.0 110.792 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.681 HG23 ' CD2' ' A' ' 75' ' ' TYR . 94.4 m -60.79 -53.66 54.68 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.181 -0.95 . . . . 0.0 109.894 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 176' ' ' GLU . 17.1 ptm -60.66 -33.76 73.29 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -70.28 -25.81 63.51 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.537 0.684 . . . . 0.0 109.311 177.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 183' ' ' LYS . . . 52.92 32.95 13.47 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.564 -0.71 . . . . 0.0 111.014 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 7.1 t 55.91 -81.71 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.041 0 O-C-N 122.202 -0.311 . . . . 0.0 111.236 179.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 181' ' ' ALA . 35.0 ttmt -152.86 29.24 0.52 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.214 -0.929 . . . . 0.0 110.082 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 97.7 mttt 50.55 43.98 27.29 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.267 -0.896 . . . . 0.0 111.282 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -151.95 137.2 17.49 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.608 -0.682 . . . . 0.0 110.18 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.311 -179.806 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' 2ZF . . . . . 0.824 HD22 ' CB ' ' A' ' 57' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_